PATHWAY_ID	PATHWAY_NAME	ENTITYA	TYPEA	IDA	DATABASEA	ENTITYB	TYPEB	IDB	DATABASEB	EFFECT	MECHANISM	RESIDUE	SEQUENCE	TAX_ID	CELL_DATA	TISSUE_DATA	MODULATOR_COMPLEX	TARGET_COMPLEX	MODIFICATIONA	MODASEQ	MODIFICATIONB	MODBSEQ	PMID	DIRECT	NOTES	ANNOTATOR	SENTENCE	SCORE	SIGNOR_ID
SIGNOR-AML	"Acute Myeloid Leukemia"	SOS1	protein	Q07889	UNIPROT	NRAS	protein	P01111	UNIPROT	"up-regulates activity"	"guanine nucleotide exchange factor"			9606	BTO:0000938								11560935	t		lperfetto	"Sos and Ras-GRF are two families of guanine nucleotide exchange factors that activate Ras proteins in cells. Sos proteins are ubiquitously expressed and are activated in response to cell-surface tyrosine kinase stimulation Sos1 and Ras-GRF1 activate the Ras proteins Ha-Ras, N-Ras, and Ki-Ras"	0.781	SIGNOR-110566
SIGNOR-AML	"Acute Myeloid Leukemia"	NRAS	protein	P01111	UNIPROT	BRAF	protein	P15056	UNIPROT	"up-regulates activity"	binding			9606									21779497	t		lperfetto	"The raf family of proteins (raf-1, a-raf, and b-raf) is serine/threonine kinases that bind to the effector region of ras-gtp, thus inducing translocation of the protein to the plasma membrane. Once there, raf proteins are activated and phosphorylated by different protein kinases."	0.855	SIGNOR-175219
SIGNOR-AML	"Acute Myeloid Leukemia"	PTPN11	protein	Q06124	UNIPROT	NRAS	protein	P01111	UNIPROT	"up-regulates activity"	dephosphorylation	Tyr32	QNHFVDEyDPTIEDS	9606	BTO:0000007								26617336	t		miannu	"Here we identify SHP2 as the ubiquitously expressed tyrosine phosphatase that preferentially binds to and dephosphorylates Ras to increase its association with Raf and activate downstream proliferative Ras/ERK/MAPK signalling."	0.679	SIGNOR-255754
SIGNOR-AML	"Acute Myeloid Leukemia"	CBL	protein	P22681	UNIPROT	KIT	protein	P10721	UNIPROT	"down-regulates activity"	ubiquitination			9606									15315962	t		miannu	"KIT binds to and induces the phosphorylation of Cbl proteins, which in turn act as E3 ligases, mediating the ubiquitination and degradation of KIT and themselves. Tyrosine kinase binding and RING finger domains of Cbl are essential for Cbl-mediated ubiquitination and degradation of KIT."	0.62	SIGNOR-260104
SIGNOR-AML	"Acute Myeloid Leukemia"	CBLB	protein	Q13191	UNIPROT	KIT	protein	P10721	UNIPROT	"down-regulates activity"	ubiquitination			9606									15315962	t		miannu	"KIT binds to and induces the phosphorylation of Cbl proteins, which in turn act as E3 ligases, mediating the ubiquitination and degradation of KIT and themselves. Tyrosine kinase binding and RING finger domains of Cbl are essential for Cbl-mediated ubiquitination and degradation of KIT."	0.324	SIGNOR-260105
SIGNOR-AML	"Acute Myeloid Leukemia"	STAT3	protein	P40763	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606	BTO:0002314								18177723	f		miannu	"Altogether, these data demonstrate that IL-6 loss results in deficient STAT3 signaling in activated satellite cells, leading to their reduced proliferation and myogenic progression, and highlight the major role played by the IL-6/STAT3 axis in controlling these processes during compensatory hypertrophy."	0.7	SIGNOR-255632
SIGNOR-AML	"Acute Myeloid Leukemia"	KITLG	protein	P21583	UNIPROT	KIT	protein	P10721	UNIPROT	"up-regulates activity"	binding			9606									17259966	t		miannu	"The most relevant and still unique mast-cell growth factor is SCF, which is the ligand of KIT, a receptor with tyrosine-kinase activity that is expressed on the surface of all human and murine mast cells"	0.935	SIGNOR-254946
SIGNOR-AML	"Acute Myeloid Leukemia"	KIT	protein	P10721	UNIPROT	JAK2	protein	O60674	UNIPROT	"up-regulates activity"	binding			9606									15526160	t		miannu	"C-Kit stimulates rapid and transient tyrosine phosphorylation of JAK2. JAK2 was found to be constitutively associated with c-Kit, with increased association after ligand stimulation of c-Kit"	0.616	SIGNOR-254954
SIGNOR-AML	"Acute Myeloid Leukemia"	CBFbeta-MYH11	"fusion protein"	SIGNOR-FP3	SIGNOR	Differentiation	phenotype	SIGNOR-PH37	SIGNOR	down-regulates				9606									29958106	f		miannu	"In adult hematopoiesis, allelic CBFβ-SMMHC expression alters hematopoietic stem cell (HSC) differentiation, with clonal expansion of the short-term HSCs and pre-leukemic myeloid progenitor cells"	0.7	SIGNOR-255736
SIGNOR-AML	"Acute Myeloid Leukemia"	STAT3	protein	P40763	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606	BTO:0002314								25194572	f		lperfetto	"STAT3 signaling controls satellite cell expansion and skeletal muscle repair"	0.7	SIGNOR-245048
SIGNOR-AML	"Acute Myeloid Leukemia"	KIT	protein	P10721	UNIPROT	GRB2	protein	P62993	UNIPROT	"up-regulates activity"	binding			9606					phosphorylation:Tyr703	DHAEAALyKNLLHSK			10377264	t		gcesareni	"We furthermore demonstrate that the adapter protein Grb2 is a specific binding partner for both phosphorylated Tyr-703 and phosphorylated Tyr-936, whereas the adapter protein Grb7 binds selectively to phosphorylated Tyr-936."	0.652	SIGNOR-248283
SIGNOR-AML	"Acute Myeloid Leukemia"	CDK1	protein	P06493	UNIPROT	CUX1	protein	P39880	UNIPROT	down-regulates	phosphorylation	Ser1237	TEYSQGAsPQPQHQL	9606									11584018	t		lperfetto	"Phosphorylation of serines 1237 and 1270 caused inhibition of dna binding in vitro. In cotransfection studies, cyclin a-cdk1 inhibited cdp/cux stable dna binding and prevented repression of the p21(waf1) reporter."	0.355	SIGNOR-110908
SIGNOR-AML	"Acute Myeloid Leukemia"	CDK1	protein	P06493	UNIPROT	CUX1	protein	P39880	UNIPROT	down-regulates	phosphorylation	Ser1270	YQQKPYPsPKTIEDL	9606									11584018	t		lperfetto	"Phosphorylation of serines 1237 and 1270 caused inhibition of dna binding in vitro. In cotransfection studies, cyclin a-cdk1 inhibited cdp/cux stable dna binding and prevented repression of the p21(waf1) reporter."	0.355	SIGNOR-110912
SIGNOR-AML	"Acute Myeloid Leukemia"	CUX1	protein	P39880	UNIPROT	PIK3IP1	protein	Q96FE7	UNIPROT	"down-regulates quantity by repression"	"transcriptional regulation"			9606									24316979	t		miannu	"We demonstrate that CUX1 deficiency activates phosphoinositide 3-kinase (PI3K) signaling through direct transcriptional downregulation of the PI3K inhibitor PIK3IP1 (phosphoinositide-3-kinase interacting protein 1), leading to increased tumor growth and susceptibility to PI3K-AKT inhibition."	0.37	SIGNOR-260072
SIGNOR-AML	"Acute Myeloid Leukemia"	PIK3IP1	protein	Q96FE7	UNIPROT	PI3K	complex	SIGNOR-C156	SIGNOR	"down-regulates activity"	binding			9606									24316979	t		miannu	"We demonstrate that CUX1 deficiency activates phosphoinositide 3-kinase (PI3K) signaling through direct transcriptional downregulation of the PI3K inhibitor PIK3IP1 (phosphoinositide-3-kinase interacting protein 1), leading to increased tumor growth and susceptibility to PI3K-AKT inhibition."	0.278	SIGNOR-260073
SIGNOR-AML	"Acute Myeloid Leukemia"	KIT	protein	P10721	UNIPROT	PI3K	complex	SIGNOR-C156	SIGNOR	"up-regulates activity"				9534	BTO:0001538								7509796	t			"Tyrosine residue 719 of the c-kit receptor is essential for binding of the P85 subunit of phosphatidylinositol (PI) 3-kinase and for c-kit-associated PI 3-kinase activity in COS-1 cells"	0.724	SIGNOR-255949
SIGNOR-AML	"Acute Myeloid Leukemia"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	MDM2	protein	Q00987	UNIPROT	"up-regulates activity"	phosphorylation	Ser188	RKRHKSDsISLSFDE	9606									15169778	t		lperfetto	"Stabilization of mdm2 via decreased ubiquitination is mediated by protein kinase b/akt-dependent phosphorylationhere we show that pkb inhibits mdm2 self-ubiquitination via phosphorylation of mdm2 on ser(166) and ser(188)"	0.2	SIGNOR-244300
SIGNOR-AML	"Acute Myeloid Leukemia"	NOTCH1	protein	P46531	UNIPROT	HES1	protein	Q14469	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			9606									19165418	f		lperfetto	"Several lines of evidence have suggested that these genes are indeed direct notch target genes: a) the promoters of hes1, hes5 and hes7 as well as hey1, hey2 and heyl subfamily of hes, related with yrpw motif) can be activated by a constitutive active form of notch1."	0.776	SIGNOR-183507
SIGNOR-AML	"Acute Myeloid Leukemia"	ZBTB16	protein	Q05516	UNIPROT	Apoptosis	phenotype	SIGNOR-PH2	SIGNOR	up-regulates				10090	BTO:0002882								9710637	f		fcortellessa	"PLZF overexpression leads to apoptosis."	0.7	SIGNOR-261686
SIGNOR-AML	"Acute Myeloid Leukemia"	NOTCH1	protein	P46531	UNIPROT	Differentiation	phenotype	SIGNOR-PH37	SIGNOR	up-regulates				9606									18342499	f		flangone	"Genetic ablation or activation of the pathway reveals that Notch signalling promotes differentiation of the hair follicle, sebaceous gland and interfollicular epidermal lineages"	0.7	SIGNOR-241998
SIGNOR-AML	"Acute Myeloid Leukemia"	SNW1	protein	Q13573	UNIPROT	NOTCH1	protein	P46531	UNIPROT	up-regulates	binding			9606									11404076	t		gcesareni	"We find that Notch 3 IC, like Notch 1 IC, can bind the SKIP and PCAF proteins"	0.605	SIGNOR-108499
SIGNOR-AML	"Acute Myeloid Leukemia"	PARP1	protein	P09874	UNIPROT	Apoptosis	phenotype	SIGNOR-PH2	SIGNOR	down-regulates				10090									11907276	f		amattioni	"Caspase-3 cleaves parp-1. During cd95-mediated apoptosis proteolytic inactivation of parp-1 by caspases prevents atp depletion and thereby ensures the execution of the apoptotic process"	0.7	SIGNOR-111680
SIGNOR-AML	"Acute Myeloid Leukemia"	NCOR2	protein	Q9Y618	UNIPROT	SNW1	protein	Q13573	UNIPROT	up-regulates	binding			9606	BTO:0000222	BTO:0000887							10713164	t	"Ncor2 is a Skip corepressor"	gcesareni	"Protein-protein interaction assays demonstrated interaction between skip and the corepressor smrt."	0.595	SIGNOR-74227
SIGNOR-AML	"Acute Myeloid Leukemia"	FLT3	protein	P36888	UNIPROT	STAT5A	protein	P42229	UNIPROT	"up-regulates activity"	phosphorylation			10090	BTO:0001516								12796379	t			"FLT3-ITDs induced a strong activation of STAT5. FLT3-ITD mutants induce an autophosphorylation of the receptor, interleukin 3-independent growth in Ba/F3 cells, and a strong STAT5 and mitogen-activated protein kinase (MAPK) activation."	0.611	SIGNOR-261516
SIGNOR-AML	"Acute Myeloid Leukemia"	STAT5A	protein	P42229	UNIPROT	CDKN1A	protein	P38936	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			10090									15003515	f			"Flt3 Mutation Activates p21WAF1/CIP1 Gene Expression Through the Action of STAT5. Co-transfection of p21 promoter-luciferase constructs with Flt3-ITD plasmid into K562 and BaF3 cells results in the induction of p21 promoter activity and a -692/-684 STAT site is important for the induction. STAT5a binds specifically to this element and Flt3-ITD enhances the protein binding to this site."	0.325	SIGNOR-261518
SIGNOR-AML	"Acute Myeloid Leukemia"	FLT3	protein	P36888	UNIPROT	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	"up-regulates activity"				10090									14981546	f			"These data confirm previous findings that FLT3 receptors with ITD mutations efficiently trigger the activation of ERK, STAT5 and Akt in the absence of FL stimulation."	0.292	SIGNOR-261521
SIGNOR-AML	"Acute Myeloid Leukemia"	FLT3	protein	P36888	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation			10090	BTO:0001516								14981546	t			"These data confirm previous findings that FLT3 receptors with ITD mutations efficiently trigger the activation of ERK, STAT5 and Akt in the absence of FL stimulation."	0.432	SIGNOR-261522
SIGNOR-AML	"Acute Myeloid Leukemia"	FLT3	protein	P36888	UNIPROT	CEBPA	protein	P49715	UNIPROT	"down-regulates quantity by repression"	"transcriptional regulation"			10090									14592841	f			"Thus, induction of C/EBPα and PU.1 expression is inhibited in 32D cells due to the expression of FLT3/ITD"	0.639	SIGNOR-261529
SIGNOR-AML	"Acute Myeloid Leukemia"	CEBPA	protein	P49715	UNIPROT	SPI1	protein	P17947	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			10090									14592841	t			"Activation of C/EBPα induces PU.1 expression, cell cycle arrest, and differentiation in 32D cells expressing FLT3/ITD"	0.528	SIGNOR-261531
SIGNOR-AML	"Acute Myeloid Leukemia"	FLT3	protein	P36888	UNIPROT	PTPN6	protein	P29350	UNIPROT	"down-regulates quantity by repression"	"transcriptional regulation"			9606									15574429	f			"Expression of FLT3/ITD induces down-regulation of SHP-1 expression and activity"	0.364	SIGNOR-261532
SIGNOR-AML	"Acute Myeloid Leukemia"	FLT3	protein	P36888	UNIPROT	FZD4	protein	Q9ULV1	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			10090	BTO:0002882								15650056	f			"AML-typical Flt3 mutations induce the expression of Frizzled-4 on the mRNA and protein level, mimicking the effects of IL-3."	0.2	SIGNOR-261533
SIGNOR-AML	"Acute Myeloid Leukemia"	NOTCH	proteinfamily	SIGNOR-PF30	SIGNOR	HES1	protein	Q14469	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			9606									32195003	f			"Notch signaling is initiated by the interaction of Notch ligands and receptors on adjacent cells, which further triggers two proteolytic cleavage events. The first cleavage releases a functional extracellular domain (NECD); the second cleavage, mediated by γ-secretase, releases the intracellular domain (NICD) into the cytoplasm. The NICD then translocates to the nucleus, binds to the transcription factor CBF/Su (H)/LAG-2 (CSL), and recruits Mastermind-like protein 1 and p300/CBP to induce transcription of Notch target genes, including Hes1, p21, Akt, cyclin D1, and mTOR"	0.2	SIGNOR-261534
SIGNOR-AML	"Acute Myeloid Leukemia"	HES1	protein	Q14469	UNIPROT	FLT3	protein	P36888	UNIPROT	"down-regulates quantity by repression"	"transcriptional regulation"			10090									25234168	t			"We then found that Hes1 directly bound to the promoter region of the FMS-like tyrosine kinase 3 (FLT3) gene and downregulated the promoter activity."	0.2	SIGNOR-261563
SIGNOR-AML	"Acute Myeloid Leukemia"	FLT3	protein	P36888	UNIPROT	RAC1	protein	P63000	UNIPROT	"up-regulates activity"				10090									18192505	f			"Inhibition of FLT3/ITD leads to a small decrease in RAC1 activity"	0.2	SIGNOR-261536
SIGNOR-AML	"Acute Myeloid Leukemia"	FLT3	protein	P36888	UNIPROT	ZBTB16	protein	Q05516	UNIPROT	"down-regulates activity"				10090	BTO:0002181								14982881	f			"We report here that the Flt3-ITD interferes with the transcriptional and biologic action of the PLZF transcriptional repressor. In the presence of Flt3-ITD, PLZF-SMRT interaction was reduced, transcriptional repression by PLZF was inhibited, and PLZF-mediated growth suppression of leukemia cells was partially blocked. Furthermore, overexpression of Flt3-ITD led to a partial relocalization of SMRT protein from the nucleus to the cytoplasm."	0.314	SIGNOR-261537
SIGNOR-AML	"Acute Myeloid Leukemia"	FLT3	protein	P36888	UNIPROT	NCOR2	protein	Q9Y618	UNIPROT	"down-regulates activity"	relocalization			10090									14982881	f			"We report here that the Flt3-ITD interferes with the transcriptional and biologic action of the PLZF transcriptional repressor. In the presence of Flt3-ITD, PLZF-SMRT interaction was reduced, transcriptional repression by PLZF was inhibited, and PLZF-mediated growth suppression of leukemia cells was partially blocked. Furthermore, overexpression of Flt3-ITD led to a partial relocalization of SMRT protein from the nucleus to the cytoplasm."	0.258	SIGNOR-261538
SIGNOR-AML	"Acute Myeloid Leukemia"	RELA	protein	Q04206	UNIPROT	NCOR2	protein	Q9Y618	UNIPROT	"down-regulates activity"	relocalization			10090									14982881	t			"Furthermore, overexpression of Flt3-ITD led to a partial relocalization of SMRT protein from the nucleus to the cytoplasm. This indicates that shuttling of p65 was necessary for Flt3-ITD-mediated SMRT nuclear export."	0.402	SIGNOR-261539
SIGNOR-AML	"Acute Myeloid Leukemia"	FLT3	protein	P36888	UNIPROT	SHC1	protein	P29353	UNIPROT	"up-regulates activity"	phosphorylation			10090	BTO:0002882								15769897	t			"we observed constitutive activation of Erk-1 and Erk-2, Akt, and of Shc by both Flt3-ITD and Flt3-D835Y"	0.449	SIGNOR-261540
SIGNOR-AML	"Acute Myeloid Leukemia"	STAT5A	protein	P42229	UNIPROT	BCL2L1	protein	Q07817	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			10090									15626738	t			"FLT3-ITD-TKD dual mutants induce hyperactivation of STAT5 and up-regulation of its downstream targets Bcl-x(L) and RAD51 in Ba/F3 cells"	0.66	SIGNOR-261551
SIGNOR-AML	"Acute Myeloid Leukemia"	STAT5A	protein	P42229	UNIPROT	RAD51	protein	Q06609	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			10090									15626738	t			"FLT3-ITD-TKD dual mutants induce hyperactivation of STAT5 and up-regulation of its downstream targets Bcl-x(L) and RAD51 in Ba/F3 cells"	0.264	SIGNOR-261552
SIGNOR-AML	"Acute Myeloid Leukemia"	FLT3	protein	P36888	UNIPROT	PTPRJ	protein	Q12913	UNIPROT	"down-regulates activity"				10090									22438257	f			"Taken together, the described findings supported the notion that FLT3 ITD causes reduced DEP-1 activity compared with cells expressing WT FLT3 rather than alterations in mRNA or protein levels."	0.488	SIGNOR-261553
SIGNOR-AML	"Acute Myeloid Leukemia"	FLT3	protein	P36888	UNIPROT	PARP1	protein	P09874	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			10090									21228325	f			"Interestingly, quantitative RT-PCR analysis demonstrated a 2-fold increase in PARP-1 expression. Western blotting analysis of protein nuclear extracts from FLT3/ITD B-cells confirmed that PARP1 was up-regulated, compared with wild-type controls "	0.25	SIGNOR-261554
SIGNOR-AML	"Acute Myeloid Leukemia"	PIM1	protein	P11309	UNIPROT	MYC	protein	P01106	UNIPROT	"up-regulates activity"	phosphorylation			9606									25280219	t			"FLT3-ITD kinase may regulate c-MYC through STAT5-induced enhancement of PIM kinases (Choudhary et al., 2009), which can modulate c-MYC stability and activity via phosphorylation (van der Lugt et al., 1995s). This is supported by the observation that FLT3-ITD CD34+ cells showed higher PIM activity compared to cells expressing FLT3-WT, indicated by increased expression of the PIM targets including p-BAD (Ser112), p-4EBP1 (Thr37/46), and p-c-MYC (Ser62) (Figure 6C); and by the observation that siRNA-mediated inhibition of PIM1, but not PIM2, expression resulted in significantly decreased p-c-MYC (Ser62), c-MYC, and SIRT1 expression in MV4-11 cells"	0.701	SIGNOR-261557
SIGNOR-AML	"Acute Myeloid Leukemia"	MYC	protein	P01106	UNIPROT	USP22	protein	Q9UPT9	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			9606									26049753	f			"USP22 expression was regulated by c-MYC and contributed to c-MYC mediated reduction in SIRT1 polyubiquitination and degradation. USP22 directly interacted with and removing polyubiquitin chains from SIRT1 to increase SIRT1 protein stabilization and expression. These results support a role for USP22 in MYC-mediated increase in SIRT1 protein stabilization, and indicate that FLT3-ITD, c-MYC and USP22 form an oncogenic network that enhances SIRT1 expression and activity in leukemic cells."	0.493	SIGNOR-261560
SIGNOR-AML	"Acute Myeloid Leukemia"	USP22	protein	Q9UPT9	UNIPROT	SIRT1	protein	Q96EB6	UNIPROT	"up-regulates quantity by stabilization"	deubiquitination			9606									26049753	t			"USP22 expression was regulated by c-MYC and contributed to c-MYC mediated reduction in SIRT1 polyubiquitination and degradation. USP22 directly interacted with and removing polyubiquitin chains from SIRT1 to increase SIRT1 protein stabilization and expression. These results support a role for USP22 in MYC-mediated increase in SIRT1 protein stabilization, and indicate that FLT3-ITD, c-MYC and USP22 form an oncogenic network that enhances SIRT1 expression and activity in leukemic cells."	0.533	SIGNOR-261561
SIGNOR-AML	"Acute Myeloid Leukemia"	MIR1-1	mirna	URS000075CF56_9606	RNAcentral	PAX7	protein	P23759	UNIPROT	"down-regulates quantity"	"post transcriptional regulation"			9606									24708856	t		irozzo	"In this study, bioinformatic prediction combined with pathway analysis and validation by qRT-PCR revealed that miR-155 expression positively correlates with the expression of the AP-1 genes c-JUN and FOS, which are known to induce myeloid differentiation"	0.4	SIGNOR-256124
SIGNOR-AML	"Acute Myeloid Leukemia"	SIRT1	protein	Q96EB6	UNIPROT	TP53	protein	P04637	UNIPROT	"down-regulates quantity by destabilization"	deacetylation			9606									25280219	t			"SIRT1 overexpression was associated with down-modulation of p53 activity in FLT3-ITD AML CD34+ cells. SIRT1 can negatively regulate p53 by deacetylating several lysine sites"	0.807	SIGNOR-261562
SIGNOR-AML	"Acute Myeloid Leukemia"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	MDM2	protein	Q00987	UNIPROT	"up-regulates activity"	phosphorylation	Ser166	SSRRRAIsETEENSD	9606									15169778	t		lperfetto	"Stabilization of mdm2 via decreased ubiquitination is mediated by protein kinase b/akt-dependent phosphorylation."	0.2	SIGNOR-244296
SIGNOR-AML	"Acute Myeloid Leukemia"	MAPK8	protein	P45983	UNIPROT	SIRT1	protein	Q96EB6	UNIPROT	up-regulates	phosphorylation	Ser27	ADREAASsPAGEPLR	9606									20027304	t	"This phosphorylation increased sirt1 nuclear localization"	gcesareni	"Human sirt1 was phosphorylated by jnk1 on three sites: ser27, ser47, and thr530 and this phosphorylation of sirt1 increased its nuclear localization and enzymatic activity. Surprisingly, jnk1 phosphorylation of sirt1 showed substrate specificity resulting in deacetylation of histone h3, but not p53."	0.6	SIGNOR-162314
SIGNOR-AML	"Acute Myeloid Leukemia"	MAPK8	protein	P45983	UNIPROT	SIRT1	protein	Q96EB6	UNIPROT	up-regulates	phosphorylation	Ser47	DGPGLERsPGEPGGA	9606									20027304	t	"This phosphorylation increased sirt1 nuclear localization"	gcesareni	"Human sirt1 was phosphorylated by jnk1 on three sites: ser27, ser47, and thr530 and this phosphorylation of sirt1 increased its nuclear localization and enzymatic activity. Surprisingly, jnk1 phosphorylation of sirt1 showed substrate specificity resulting in deacetylation of histone h3, but not p53."	0.6	SIGNOR-162318
SIGNOR-AML	"Acute Myeloid Leukemia"	MAPK8	protein	P45983	UNIPROT	SIRT1	protein	Q96EB6	UNIPROT	up-regulates	phosphorylation	Thr530	YLSELPPtPLHVSED	9606									20027304	t	"This phosphorylation increased sirt1 nuclear localization"	gcesareni	"Human sirt1 was phosphorylated by jnk1 on three sites: ser27, ser47, and thr530 and this phosphorylation of sirt1 increased its nuclear localization and enzymatic activity. Surprisingly, jnk1 phosphorylation of sirt1 showed substrate specificity resulting in deacetylation of histone h3, but not p53."	0.6	SIGNOR-162322
SIGNOR-AML	"Acute Myeloid Leukemia"	RAC1	protein	P63000	UNIPROT	MAPK8	protein	P45983	UNIPROT	"up-regulates activity"	binding			9606									22252525	t		gcesareni	"The mechanism by which pak1 induced cancer growth might involve activation of jnk  in the non-canonical wnt pathway, frizzled uses galfaq or galfai and gbetagamma dimers to activate phospholipase c (plc), resulting in protein kinase c (pkc) activation and calcium mobilization that regulates the transcription factor nfat, and frizzled also signals through the small gtpases rho and rac to c-jun n-terminal kinase (jnk), which activates the ap1 transcription factor."	0.662	SIGNOR-195414
SIGNOR-AML	"Acute Myeloid Leukemia"	SHC1	protein	P29353	UNIPROT	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	"up-regulates activity"				10090	BTO:0000944								17673906	f		lperfetto	"We report that upon TGF__ stimulation, the activated TGF__ type I receptor (T_RI) recruits and directly phosphorylates ShcA proteins on tyrosine and serine. This dual phosphorylation results from an intrinsic T_RI tyrosine kinase activity that complements its well_defined serine_threonine kinase function. TGF___induced ShcA phosphorylation induces ShcA association with Grb2 and Sos, thereby initiating the well_characterised pathway linking receptor tyrosine kinases with Erk MAP kinases."	0.723	SIGNOR-242628
SIGNOR-AML	"Acute Myeloid Leukemia"	FZD4	protein	Q9ULV1	UNIPROT	DVL1	protein	O14640	UNIPROT	"up-regulates activity"	binding			9606									27096005	t		areggio	"Through study of FZD4 and its associated ligand Norrin, we report that a minimum of three residues distal to the KTXXXW motif in the C-terminal tail of Frizzled-4 are essential for DVL recruitment and robust Lef/Tcf-dependent transcriptional activation in response to Norrin."	0.601	SIGNOR-258955
SIGNOR-AML	"Acute Myeloid Leukemia"	DVL1	protein	O14640	UNIPROT	CTNNB1	protein	P35222	UNIPROT	"up-regulates activity"	binding			9606									15735151	t		amattioni	"Activated DVL binds and inhibits the phosphorylation of beta-catenin by GSK3B, blocking beta-catenin degradation so that beta catenin accumulates and translocates to the nucleus, where it interacts with the t cell specific factor (tcf)/lymphoid enhancer binding factor 1 (lef-1) transcription factor and induces the transcription of target genes such as c-jun, c-myc, and cyclin d1."	0.809	SIGNOR-134285
SIGNOR-AML	"Acute Myeloid Leukemia"	EGFR	protein	P00533	UNIPROT	PI3K	complex	SIGNOR-C156	SIGNOR	up-regulates	binding			9606	BTO:0000093	BTO:0000150							26918608	t		lperfetto	"P85alpha promotes nucleolin transcription and subsequently enhances EGFR mRNA stability and EGF-induced malignant cellular transformation."	0.784	SIGNOR-252671
SIGNOR-AML	"Acute Myeloid Leukemia"	PTPN6	protein	P29350	UNIPROT	EGFR	protein	P00533	UNIPROT	down-regulates	dephosphorylation	Tyr1197	STAENAEyLRVAPQS	9606									9733788	t		tpavlidou	"The sh2-domain ptpase shp-1 binds to and dephosphorylates autophosphorylated egfr and may participate in modulation of egfr signaling in epithelial cells. Reduced shp-1 binding to the egfr y1173f mutant resulted in a reduced receptor dephosphorylation by coexpressed shp-1 and less interference with egf-dependent mitogen-activated protein kinase stimulation."	0.413	SIGNOR-59965
SIGNOR-AML	"Acute Myeloid Leukemia"	PTPRJ	protein	Q12913	UNIPROT	PI3K	complex	SIGNOR-C156	SIGNOR	down-regulates	dephosphorylation			9606									18348712	t		gcesareni	"As reduction of pi3k activity by cd148 or shp-1 [32] is not large (2540%), it is likely that these ptps may function as modulators of the pi3k pathway rather than suppressors."	0.261	SIGNOR-252727
SIGNOR-AML	"Acute Myeloid Leukemia"	BAD	protein	Q92934	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	down-regulates				9606	"BTO:0002418;BTO:0002552;BTO:0000018; BTO:0002207;BTO:0002203"								23725574	f		irozzo	"Our data suggested that increased expression of BAD enhance apoptosis and has negative influence on cell proliferation and tumor growth in NSCLC. Bad is a new potential target for tumor interventions."	0.7	SIGNOR-256260
SIGNOR-AML	"Acute Myeloid Leukemia"	BCL2L1	protein	Q07817	UNIPROT	Apoptosis	phenotype	SIGNOR-PH2	SIGNOR	down-regulates				10090	BTO:0003328								9393856	f		fcortellessa	"Bcl-xL Expression Prevents Cytochrome c Redistribution and Subsequent Mitochondrial Depolarization during Apoptosis. Bcl-xL expression prevented both cytochrome c redistribution and mitochondrial membrane depolarization. In contrast, zVAD treatment could not prevent either cytochrome c redistribution or mitochondrial membrane depolarization in control transfectants withdrawn from IL-3. Thus, cytochrome c redistribution from mitochondria is an early apoptotic event that precedes mitochondrial membrane depolarization. Bcl-xL expression functions to inhibit both of these events. In at least some forms of cell death, the ability of Bcl-xL to regulate these mitochondrial events cannot be mimicked by caspase inhibition"	0.7	SIGNOR-261683
SIGNOR-AML	"Acute Myeloid Leukemia"	ZBTB16	protein	Q05516	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	down-regulates				10090	BTO:0002882								9710637	f		fcortellessa	"PLZF expression in 32DG/GM cells is associated with growth suppression and G1 arrest."	0.7	SIGNOR-261685
SIGNOR-AML	"Acute Myeloid Leukemia"	PIM	proteinfamily	SIGNOR-PF34	SIGNOR	BAD	protein	Q92934	UNIPROT	down-regulates	phosphorylation	Ser118	GRELRRMsDEFVDSF	9606									10837473	t		gcesareni	"Similar to pim1, pim2 phosphorylates bad, which antagonizes the pro-apoptotic function of bax"	0.2	SIGNOR-259418
SIGNOR-AML	"Acute Myeloid Leukemia"	BAD	protein	Q92934	UNIPROT	Apoptosis	phenotype	SIGNOR-PH2	SIGNOR	up-regulates				9606	"BTO:0002418;BTO:0002552;BTO:0000018; BTO:0002207;BTO:0002203"								23725574	f		irozzo	"Our data suggested that increased expression of BAD enhance apoptosis and has negative influence on cell proliferation and tumor growth in NSCLC. Bad is a new potential target for tumor interventions."	0.7	SIGNOR-256259
SIGNOR-AML	"Acute Myeloid Leukemia"	FOXO	proteinfamily	SIGNOR-PF27	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	down-regulates				9606	BTO:0000007								14976264	f		lperfetto	"Sirt1 increased foxo3's ability to induce cell cycle arrest and resistance to oxidative stress"	0.7	SIGNOR-252938
SIGNOR-AML	"Acute Myeloid Leukemia"	RAD51	protein	Q06609	UNIPROT	DNA_repair	phenotype	SIGNOR-PH57	SIGNOR	up-regulates													27660832	f		lperfetto	"Rad51 is a key component of homologous recombination (HR) to repair DNA double-strand breaks and it forms Rad51 recombinase filaments of broken single-stranded DNA to promote HR. In addition to its role in DNA repair and cell cycle progression, Rad51 contributes to the reprogramming process during the generation of induced pluripotent stem cells"	0.7	SIGNOR-251508
SIGNOR-AML	"Acute Myeloid Leukemia"	CCND1	protein	P24385	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606	BTO:0000575								11731443	f			"Cyclin D1 regulates mitogen-dependent progression through G1 phase in cultured cells, and its overexpression in malignant cells is thought to contribute to autonomous proliferation in vivo."	0.7	SIGNOR-260014
SIGNOR-AML	"Acute Myeloid Leukemia"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	GSK3B	protein	P49841	UNIPROT	"down-regulates activity"	phosphorylation	Ser9	SGRPRTTsFAESCKP	9606									23552696	t		lperfetto	"Active AKT, a common mediator of cell survival signals induced by radiation through multiple intracellular signaling pathways,11, 12 suppresses apoptosis. AKT positively regulates cyclin D1 expression through inactivation of glycogen synthase kinase 3_ (GSK3_). The AKT-mediated phosphorylation of glycogen synthase kinase 3_ on serine9 decreases its kinase activity for Thr286 of cyclin D1, which inhibits the nuclear export and the cytoplasmic proteasomal degradation of cyclin D1"	0.2	SIGNOR-245428
SIGNOR-AML	"Acute Myeloid Leukemia"	SOX4	protein	Q06945	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606	BTO:0001545								24183681	f		miannu	"These data demonstrate an HSC cell intrinsic role for Sox4 on proliferation induced by loss of C/EBPα."	0.7	SIGNOR-260133
SIGNOR-AML	"Acute Myeloid Leukemia"	GSK3B	protein	P49841	UNIPROT	MYC	protein	P01106	UNIPROT	"down-regulates quantity by destabilization"	phosphorylation	Thr58	KKFELLPtPPLSPSR	9606									14563837	t		gcesareni	"Conversely, overexpression of gsk-3 alpha or gsk-3 beta enhances thr-58 phosphorylation and ubiquitination of c-myc"	0.724	SIGNOR-118844
SIGNOR-AML	"Acute Myeloid Leukemia"	GSK3B	protein	P49841	UNIPROT	CCND1	protein	P24385	UNIPROT	down-regulates	phosphorylation	Thr286	EEVDLACtPTDVRDV	9606	BTO:0000150								16504004	t		gcesareni	"Phosphorylation of cyclin d1 on a single threonine residue near the carboxyl terminus (thr-286) positively regulates proteasomal degradation of d1. Now, we demonstrate that glycogen synthase kinase-3beta (gsk-3beta) phosphorylates cyclin d1 specifically on thr-286, thereby triggering rapid cyclin d1 turnover now, we demonstrate that glycogen synthase kinase-3beta (gsk-3beta) phosphorylates cyclin d1 specifically on thr-286, thereby triggering rapid cyclin d1 turnover."	0.787	SIGNOR-144818
SIGNOR-AML	"Acute Myeloid Leukemia"	FLT3	protein	P36888	UNIPROT	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	"up-regulates activity"				9606									30552988	f		miannu	"Oncogenic, constitutively active mutants of FLT3 are known to be expressed in acute myeloid leukemia and to correlate with poor prognosis. Activation of the receptor mediates cell survival, cell proliferation and differentiation of cells. Several of the signal transduction pathways downstream of FLT3 have been shown to include various members of the SRC family of kinases (SFKs). They are involved in regulating the activity of RAS/ERK pathways through the scaffolding protein GAB2 and the adaptor protein SHC."	0.292	SIGNOR-260132
SIGNOR-AML	"Acute Myeloid Leukemia"	MCL1	protein	Q07820	UNIPROT	BAX	protein	Q07812	UNIPROT	down-regulates	binding			9606									17289999	t		gcesareni	"Which of the multiple pro-survival proteins that can bind Bax (fig. S15A) can functionally restrain it? Mcl-1 must, because neutralizing Mcl-1 by enforced Noxa expression rendered MEFs containing only Bax (Bak KO cells) sensitive to the Bad BH3 mimetic ABT-737 (Fig. 4A), which inactivates Bcl-2, Bcl-xL, and Bcl-w"	0.735	SIGNOR-151787
SIGNOR-AML	"Acute Myeloid Leukemia"	SHC1	protein	P29353	UNIPROT	INPP5D	protein	Q92835	UNIPROT	up-regulates	binding			9606	BTO:0000776								10207047	t		gcesareni	"The results indicate that ship, shc, and grb2 form a ternary complex in stimulated b cells, with grb2 stabilizing the interaction between shc and ship. The interactions between shc, grb2, and ship are therefore analogous to the interactions between shc, grb2, and sos. Shc and grb2 may help to localize ship to the cell membrane, regulating ship's inhibitory function following bcr stimulation."	0.698	SIGNOR-66949
SIGNOR-AML	"Acute Myeloid Leukemia"	PHF6	protein	Q8IWS0	UNIPROT	UBTF	protein	P17480	UNIPROT	down-regulates	binding			9606	BTO:0001271								23229552	t		miannu	"We demonstrate that phf6 is a nucleolus, ribosomal rna promoter-associated protein. Phf6 directly interacts with upstream binding factor (ubf) through its phd1 domain and suppresses ribosomal rna (rrna) transcription by affecting the protein level of ubf"	0.28	SIGNOR-200133
SIGNOR-AML	"Acute Myeloid Leukemia"	UBTF	protein	P17480	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				10090	BTO:0002882								15169904	f		miannu	"Pescadillo (PES1) and the upstream binding factor (UBF1) play a role in ribosome biogenesis, which regulates cell size, an important component of cell proliferation. We have investigated the effects of PES1 and UBF1 on the growth and differentiation of cell lines derived from 32D cells, an interleukin-3 (IL-3)-dependent murine myeloid cell line. Parental 32D cells and 32D IGF-IR cells (expressing increased levels of the type 1 insulin-like growth factor I [IGF-I] receptor [IGF-IR]) do not express insulin receptor substrate 1 (IRS-1) or IRS-2. 32D IGF-IR cells differentiate when the cells are shifted from IL-3 to IGF-I. Ectopic expression of IRS-1 inhibits differentiation and transforms 32D IGF-IR cells into a tumor-forming cell line. We found that PES1 and UBF1 increased cell size and/or altered the cell cycle distribution of 32D-derived cells but failed to make them IL-3 independent. PES1 and UBF1 also failed to inhibit the differentiation program initiated by the activation of the IGF-IR, which is blocked by IRS-1. 32D IGF-IR cells expressing PES1 or UBF1 differentiate into granulocytes like their parental cells. In contrast, PES1 and UBF1 can transform mouse embryo fibroblasts that have high levels of endogenous IRS-1 and are not prone to differentiation. Our results provide a model for one of the theories of myeloid leukemia, in which both a stimulus of proliferation and a block of differentiation are required for leukemia development."	0.7	SIGNOR-260077
SIGNOR-AML	"Acute Myeloid Leukemia"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	MDM2	protein	Q00987	UNIPROT	"up-regulates activity"	phosphorylation	Ser186	RQRKRHKsDSISLSF	9606									11504915	t		lperfetto	"Mitogen-induced activation of phosphatidylinositol 3-kinase (pi3-kinase) and its downstream target, the akt/pkb serine-threonine kinase, results in phosphorylation of mdm2 on serine 166 and serine 186. Phosphorylation on these sites is necessary for translocation of mdm2 from the cytoplasm into the nucleus.Both akt expression and serum treatment induced phosphorylation of mdm2 at ser186."	0.2	SIGNOR-244292
SIGNOR-AML	"Acute Myeloid Leukemia"	RUNX1	protein	Q01196	UNIPROT	hsa-mir-223	mirna	URS000037EC34_9606	RNAcentral	"up-regulates quantity by expression"	"transcriptional regulation"			9606									25092144	f		miannu	"We could show that STAT5 is involved in miR-155 induction. STAT5 knockdown in FLT3-ITD model systems reduced miR-155 expression in vitro and in vivo. In silico analyses predicted an STAT binding site in the miR-155 promoter."	0.4	SIGNOR-255817
SIGNOR-AML	"Acute Myeloid Leukemia"	SPI1	protein	P17947	UNIPROT	miR-155	mirna	URS000062749E_9606	RNAcentral	"up-regulates quantity by expression"	"transcriptional regulation"			9606									25092144	f		miannu	"We showed a strong induction of miR-155 promoter activity by p65. We demonstrate that NF-κB (p65) directly binds to the miR-155 promoter in FLT3-ITD-associated MV4;11 cells."	0.4	SIGNOR-255816
SIGNOR-AML	"Acute Myeloid Leukemia"	INPP5D	protein	Q92835	UNIPROT	PIP3	smallmolecule	CHEBI:16618	ChEBI	"down-regulates quantity"	"chemical modification"			9606									12421919	t		gcesareni	"Two inositol phosphatases implicated in the degradation of PI(3, 4, 5)P3, namely the 5_ phosphatase Src homology 2 domain containing inositol polyphosphate phosphatase (SHIP) and the 3_ phosphatase and tensin homolog deleted on chromosome ten"	0.8	SIGNOR-252428
SIGNOR-AML	"Acute Myeloid Leukemia"	NfKb-p65/p50	complex	SIGNOR-C13	SIGNOR	miR-155	mirna	URS000062749E_9606	RNAcentral	"up-regulates quantity"	"transcriptional regulation"			9606									26055960	f		miannu	"Our results suggest that activating mutation of FLT3 in AML can lead, to increased expression of miR-155, which then causes down-regulation of SPI1 and CEBPB and consequently causes block of myeloid differentiation."	0.4	SIGNOR-255802
SIGNOR-AML	"Acute Myeloid Leukemia"	RUNX1	protein	Q01196	UNIPROT	miR-155	mirna	URS000062749E_9606	RNAcentral	"up-regulates quantity by expression"	"transcriptional regulation"			9606									26910834	f		miannu	"RUNX1high was positively associated with miR-155, miR-125a, miR-99b, miR-133a, miR-130a, miR-25 and miR-92a-1. MiR-155 was previously found to function as an oncogene in CN-AML"	0.4	SIGNOR-255800
SIGNOR-AML	"Acute Myeloid Leukemia"	FLT3	protein	P36888	UNIPROT	miR-155	mirna	URS000062749E_9606	RNAcentral	"up-regulates quantity by expression"	"transcriptional regulation"			10090									25477897	t		miannu	"The three miR-29 family members in mouse bone marrow cells reduced the level of TET2 as well as its metabolic by-product, 5hmC"	0.4	SIGNOR-255796
SIGNOR-AML	"Acute Myeloid Leukemia"	miR-155	mirna	URS000062749E_9606	RNAcentral	CEBPB	protein	P17676	UNIPROT	"down-regulates quantity by repression"	"post transcriptional regulation"			9606									25477897	t		miannu	"The down-regulation of miR-29b is thought to promote DNA hypermethylation in AML since miR-29b can directly target DNMT3A, DNMT3B, and Sp1 (a transcriptional regulator of DNMT3"	0.4	SIGNOR-255795
SIGNOR-AML	"Acute Myeloid Leukemia"	MIR1-1	mirna	URS000075CF56_9606	RNAcentral	IGF1	protein	P05019	UNIPROT	"down-regulates quantity"	"post transcriptional regulation"			9606									25477897	t		miannu	"The down-regulation of miR-29b is thought to promote DNA hypermethylation in AML since miR-29b can directly target DNMT3A, DNMT3B, and Sp1 (a transcriptional regulator of DNMT1"	0.4	SIGNOR-255793
SIGNOR-AML	"Acute Myeloid Leukemia"	KLF2	protein	Q9Y5W3	UNIPROT	mir-143	mirna	URS0000008A99_9606	RNAcentral	"up-regulates quantity"	"transcriptional regulation"			9606									25477897	t		miannu	"Overexpression of miR-155 leads to the activation of the PI3K-Akt pathway through negative regulation of Src Homology 2 domain-containing Inositol-5-Phosphatase (SHIP1)."	0.4	SIGNOR-255769
SIGNOR-AML	"Acute Myeloid Leukemia"	miR-155	mirna	URS000062749E_9606	RNAcentral	FOS	protein	P01100	UNIPROT	"up-regulates quantity by expression"	"post transcriptional regulation"			9606									24708856	t		miannu	"We found overexpression of miR-155 led to increase in cJUN, FOS and TRIB2, and decrease in MEIS1, GFI1, cMYC and JARID2."	0.4	SIGNOR-255766
SIGNOR-AML	"Acute Myeloid Leukemia"	miR-199a	mirna	URS0000759977_9606	RNAcentral	MTOR	protein	P42345	UNIPROT	"up-regulates activity"				9606									26055960	t		miannu	"Our results suggest that activating mutation of FLT3 in AML can lead, to increased expression of miR-155, which then causes down-regulation of SPI1 and CEBPB and consequently causes block of myeloid differentiation."	0.4	SIGNOR-255803
SIGNOR-AML	"Acute Myeloid Leukemia"	miR-132	mirna	URS00001F4E81_9606	RNAcentral	MECP2	protein	P51608	UNIPROT	"down-regulates quantity by repression"	"post transcriptional regulation"			10090									23132946	f		irozzo	"In human leukemic cells with MLL rearrangements (e.g., MONOMAC-6 and THP-1 cells), we found that ectopic expression of miR-495 could significantly inhibit cell growth/proliferation and increase apoptosis while decreasing cell viability."	0.4	SIGNOR-255884
SIGNOR-AML	"Acute Myeloid Leukemia"	STAT5A	protein	P42229	UNIPROT	miR-155	mirna	URS000062749E_9606	RNAcentral	"up-regulates quantity by expression"	"transcriptional regulation"			9606									23132946	f		irozzo	"We then showed that ectopic expression of MLL fusion genes in both human and mouse normal hematopoietic stem/progenitor cells could significantly down-regulate endogenous expression of miR-495 and that the depletion of MLL fusions resulted in the up-regulation of miR-495. Thus, our data suggest that there is an MLL-fusion–mediated negative regulation of the production of miR-495 in hematopoietic cells."	0.4	SIGNOR-255885
SIGNOR-AML	"Acute Myeloid Leukemia"	SPI1	protein	P17947	UNIPROT	miR-338	mirna	URS000075E706_9606	RNAcentral	"up-regulates quantity by expression"	"transcriptional regulation"			9606									23132946	f		irozzo	"We then showed that ectopic expression of MLL fusion genes in both human and mouse normal hematopoietic stem/progenitor cells could significantly down-regulate endogenous expression of miR-495 and that the depletion of MLL fusions resulted in the up-regulation of miR-495. Thus, our data suggest that there is an MLL-fusion–mediated negative regulation of the production of miR-495 in hematopoietic cells."	0.4	SIGNOR-255886
SIGNOR-AML	"Acute Myeloid Leukemia"	TWIST1	protein	Q15672	UNIPROT	mir-10b	mirna	URS00004CAC40_9606	RNAcentral	"up-regulates quantity by expression"	"transcriptional regulation"			9606									23132946	f		irozzo	"We then showed that ectopic expression of MLL fusion genes in both human and mouse normal hematopoietic stem/progenitor cells could significantly down-regulate endogenous expression of miR-495 and that the depletion of MLL fusions resulted in the up-regulation of miR-495. Thus, our data suggest that there is an MLL-fusion–mediated negative regulation of the production of miR-495 in hematopoietic cells."	0.4	SIGNOR-255887
SIGNOR-AML	"Acute Myeloid Leukemia"	FLT3	protein	P36888	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"				9606									16266983	f		gcesareni	"We show that the presence of Flt3-ITD constitutively activates Akt (PKB), a key serine-threonine kinase within the phosphatidylinositol 3-kinase pathway."	0.432	SIGNOR-245064
SIGNOR-AML	"Acute Myeloid Leukemia"	PDPK1	protein	O15530	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation	Thr308	KDGATMKtFCGTPEY	9606									15718470	t		gcesareni	"Akt/PKB activation requires the phosphorylation of Thr308 in the activation loop by the phosphoinositide-dependent kinase 1 (PDK1) and Ser473 within the carboxyl-terminal hydrophobic motif by an unknown kinase."	0.746	SIGNOR-243203
SIGNOR-AML	"Acute Myeloid Leukemia"	PDPK1	protein	O15530	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation			9606									15743829	t		lperfetto	"3-phosphoinositide-dependent kinase 1 (PDK1) phosphorylates the activation loop of a number of protein serine/threonine kinases of the AGC kinase superfamily, including protein kinase B (PKB; also called Akt),"	0.746	SIGNOR-244469
SIGNOR-AML	"Acute Myeloid Leukemia"	TET2	protein	Q6N021	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	down-regulates				9606	BTO:0000738								25601757	f		irozzo	"Cell proliferation was stimulated by the knockdown of either TET2 or WT1 gene in KG-1 cells, but not additively by the co-depletion of both genes. Collectively, these results suggest that TET2 and WT1 function in the same pathway to inhibit leukemia cell proliferation and colony formation."	0.7	SIGNOR-255704
SIGNOR-AML	"Acute Myeloid Leukemia"	FLT3	protein	P36888	UNIPROT	SHC1	protein	P29353	UNIPROT	"up-regulates activity"	phosphorylation	Tyr427	ELFDDPSyVNVQNLD	9606									10482988	t		miannu	"Intracellular FLT3 signaling involves tyrosine phosphorylation of several cytoplasmic proteins including SHC. We have found that upon FLT3 activation SHC phosphorylation occurs at tyrosine 239/240 and 313."	0.449	SIGNOR-251148
SIGNOR-AML	"Acute Myeloid Leukemia"	FLT3	protein	P36888	UNIPROT	SHC1	protein	P29353	UNIPROT	"up-regulates activity"	phosphorylation	Tyr350	EPPDHQYyNDFPGKE	9606									10482988	t		miannu	"Intracellular FLT3 signaling involves tyrosine phosphorylation of several cytoplasmic proteins including SHC. We have found that upon FLT3 activation SHC phosphorylation occurs at tyrosine 239/240 and 313."	0.449	SIGNOR-251147
SIGNOR-AML	"Acute Myeloid Leukemia"	FLT3	protein	P36888	UNIPROT	SHC1	protein	P29353	UNIPROT	"up-regulates activity"	phosphorylation	Tyr349	EEPPDHQyYNDFPGK	9606									10482988	t		miannu	"Intracellular FLT3 signaling involves tyrosine phosphorylation of several cytoplasmic proteins including SHC. We have found that upon FLT3 activation SHC phosphorylation occurs at tyrosine 239/240 and 313."	0.449	SIGNOR-251146
SIGNOR-AML	"Acute Myeloid Leukemia"	DOT1L	protein	Q8TEK3	UNIPROT	MEIS1	protein	O00470	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			9606									20854876	f		irozzo	"Inhibition of EAP components pTEFb and Dot1l show that both contribute significantly to activation of Hoxa9 and Meis1 expression. EAP is dynamically associated with the Hoxa9 and Meis1 loci in hematopoietic cells and rapidly dissociates during induction of differentiation. In the presence of MLL fusion proteins, its dissociation is prevented."	0.402	SIGNOR-256143
SIGNOR-AML	"Acute Myeloid Leukemia"	MLL-ENL	"fusion protein"	SIGNOR-FP7	SIGNOR	RUNX1	protein	Q01196	UNIPROT	"down-regulates quantity by repression"	"transcriptional regulation"			9606									24449215	f		miannu	"However, the functional consequence of MLL fusions on RUNX1/CBFβ activity has not been fully understood. In this report, we show that MLL fusion proteins and the N-terminal MLL portion of MLL fusions downregulate RUNX1 and CBFβ protein expression via the MLL CXXC domain and flanking regions."	0.2	SIGNOR-260127
SIGNOR-AML	"Acute Myeloid Leukemia"	MLL-AF4	"fusion protein"	SIGNOR-FP4	SIGNOR	RUNX1	protein	Q01196	UNIPROT	"down-regulates quantity by repression"	"transcriptional regulation"			9606									24449215	f		miannu	"However, the functional consequence of MLL fusions on RUNX1/CBFβ activity has not been fully understood. In this report, we show that MLL fusion proteins and the N-terminal MLL portion of MLL fusions downregulate RUNX1 and CBFβ protein expression via the MLL CXXC domain and flanking regions."	0.2	SIGNOR-260126
SIGNOR-AML	"Acute Myeloid Leukemia"	RUNX1	protein	Q01196	UNIPROT	SPI1	protein	P17947	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			10090									23817177	f		irozzo	"RUNX1 wild-type protein first binds to the PU.1 URE region and recruits the MLL complex to open up part of the compact chromatin structure. The partially relaxed chromatin allows the binding of another RUNX1 at the PU.1 promoter region to further distort compact DNA structure. The relaxed form of chromatin facilitates the accumulation of transcription factors and cofactors to initiate transcriptional activity."	0.692	SIGNOR-255709
SIGNOR-AML	"Acute Myeloid Leukemia"	MCL1	protein	Q07820	UNIPROT	BAK1	protein	Q16611	UNIPROT	down-regulates	binding			9606									17289999	t		gcesareni	"Bax is held in check by mcl1, bcl-2, and either bcl2l1 or bcl2l2, or by all four. They bind a primed conformer of bak or bax"	0.626	SIGNOR-149774
SIGNOR-AML	"Acute Myeloid Leukemia"	BAK1	protein	Q16611	UNIPROT	Apoptosis	phenotype	SIGNOR-PH2	SIGNOR	up-regulates				9606									23567751	f		miannu	"The mitochondrial pathway of apoptosis proceeds when the outer mitochondrial membrane (OMM) is compromised by the pro-apoptotic BCL-2 family members, BAK and BAX. Once activated, BAK and BAX form proteolipid pores in the OMM leading to mitochondrial outer membrane permeabilization (MOMP), and the release of inner membrane space proteins, such as cytochrome c, which promotes caspase activation."	0.7	SIGNOR-261493
SIGNOR-AML	"Acute Myeloid Leukemia"	MLL-AF4	"fusion protein"	SIGNOR-FP4	SIGNOR	"AEP complex"	complex	SIGNOR-C117	SIGNOR	"up-regulates activity"	binding			9606	BTO:0005261								19956800	t		irozzo	"Although the complex was initially termed ENL associated proteins (EAP), we now propose to redefine EAP as ‘‘elongation assisting proteins’’ to better reflect the function of this protein complex. In this report, we present evidence that the most frequently occurring MLL fusion proteins exploit molecular control mechanisms of transcriptional elongation to transform hematopoietic cells. MLL fusions become incorporated into an ‘‘elongation assisting protein’’ complex, recruit it to their respective target genes, and enforce ectopic transcription."	0.2	SIGNOR-255877
SIGNOR-AML	"Acute Myeloid Leukemia"	"AEP complex"	complex	SIGNOR-C117	SIGNOR	HOXA9	protein	P31269	UNIPROT	"up-regulates quantity by expression"				9606									20854876	f		irozzo	"Inhibition of EAP components pTEFb and Dot1l show that both contribute significantly to activation of Hoxa9 and Meis1 expression. EAP is dynamically associated with the Hoxa9 and Meis1 loci in hematopoietic cells and rapidly dissociates during induction of differentiation. In the presence of MLL fusion proteins, its dissociation is prevented."	0.408	SIGNOR-255879
SIGNOR-AML	"Acute Myeloid Leukemia"	MLL-AF9	"fusion protein"	SIGNOR-FP5	SIGNOR	DOT1L	protein	Q8TEK3	UNIPROT	"up-regulates activity"	binding			10090	BTO:0004052								23996074	t		irozzo	"In this work, we have identified and mapped the protein-protein interaction site between DOT1L and MLL fusion proteins, AF9 and ENL.The MLL fusion proteins, AF9 and ENL, activate target genes in part via recruitment of the histone methyltransferase DOT1L (disruptor of telomeric silencing 1-like).  It is known that the recruitment of DOT1L results in hypermethylation of H3K79 on the prominent MLL fusion downstream target loci Hoxa9 and Meis1"	0.2	SIGNOR-255869
SIGNOR-AML	"Acute Myeloid Leukemia"	MLL-AF4	"fusion protein"	SIGNOR-FP4	SIGNOR	DOT1L	protein	Q8TEK3	UNIPROT	"up-regulates activity"	binding			9606	BTO:0005014								27856324	t		irozzo	"Previously, we found that MLL-AF4 binds to the BCL-2 gene and directly activates it through DOT1L recruitment and increased H3K79me2/3 levels. MLL-AF4 directly controls the active transcription of both BCL-2 and MCL-1 […]. Of all the BCL-2 family members, only BCL-2 and MCL-1 are directly activated by MLL-AF4."	0.2	SIGNOR-255882
SIGNOR-AML	"Acute Myeloid Leukemia"	MEN1	protein	O00255	UNIPROT	MLL-ENL	"fusion protein"	SIGNOR-FP7	SIGNOR	"up-regulates activity"	binding			10090	BTO:0004730								16239140	t		irozzo	"We demonstrate here that oncogenic MLL fusion proteins retain an ability to stably associate with menin through a high-affinity, amino-terminal, conserved binding motif and that this interaction is required for the initiation of MLL-mediated leukemogenesis.These results demonstrate that a human oncoprotein is critically dependent on direct physical interaction with a tumor suppressor protein for its oncogenic activity[...]."	0.2	SIGNOR-255866
SIGNOR-AML	"Acute Myeloid Leukemia"	MEN1	protein	O00255	UNIPROT	MLL-AF9	"fusion protein"	SIGNOR-FP5	SIGNOR	"up-regulates activity"	binding			10090	BTO:0004730								16239140	t		irozzo	"We demonstrate here that oncogenic MLL fusion proteins retain an ability to stably associate with menin through a high-affinity, amino-terminal, conserved binding motif and that this interaction is required for the initiation of MLL-mediated leukemogenesis.These results demonstrate that a human oncoprotein is critically dependent on direct physical interaction with a tumor suppressor protein for its oncogenic activity[...]."	0.2	SIGNOR-255867
SIGNOR-AML	"Acute Myeloid Leukemia"	MEN1	protein	O00255	UNIPROT	MLL-AF4	"fusion protein"	SIGNOR-FP4	SIGNOR	"up-regulates activity"	binding			10090	BTO:0004730								16239140	t		irozzo	"We demonstrate here that oncogenic MLL fusion proteins retain an ability to stably associate with menin through a high-affinity, amino-terminal, conserved binding motif and that this interaction is required for the initiation of MLL-mediated leukemogenesis.These results demonstrate that a human oncoprotein is critically dependent on direct physical interaction with a tumor suppressor protein for its oncogenic activity[...]."	0.2	SIGNOR-255868
SIGNOR-AML	"Acute Myeloid Leukemia"	"MLL Fusion"	"fusion protein"	SIGNOR-FP14	SIGNOR	"AEP complex"	complex	SIGNOR-C117	SIGNOR	"up-regulates activity"	binding			9606	BTO:0005261								19956800	t		miannu	"Although the complex was initially termed ENL associated proteins (EAP), we now propose to redefine EAP as ‘‘elongation assisting proteins’’ to better reflect the function of this protein complex. In this report, we present evidence that the most frequently occurring MLL fusion proteins exploit molecular control mechanisms of transcriptional elongation to transform hematopoietic cells. MLL fusions become incorporated into an ‘‘elongation assisting protein’’ complex, recruit it to their respective target genes, and enforce ectopic transcription."	0.2	SIGNOR-260131
SIGNOR-AML	"Acute Myeloid Leukemia"	MLL-ENL	"fusion protein"	SIGNOR-FP7	SIGNOR	DOT1L	protein	Q8TEK3	UNIPROT	"up-regulates activity"	binding			10090	BTO:0004052								23996074	t		irozzo	"In this work, we have identified and mapped the protein-protein interaction site between DOT1L and MLL fusion proteins, AF9 and ENL. The MLL fusion proteins, AF9 and ENL, activate target genes in part via recruitment of the histone methyltransferase DOT1L (disruptor of telomeric silencing 1-like).  It is known that the recruitment of DOT1L results in hypermethylation of H3K79 on the prominent MLL fusion downstream target loci Hoxa9 and Meis1"	0.2	SIGNOR-255870
SIGNOR-AML	"Acute Myeloid Leukemia"	DOT1L	protein	Q8TEK3	UNIPROT	MCL1	protein	Q07820	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			9606									27856324	f		irozzo	"Previously, we found that MLL-AF4 binds to the BCL-2 gene and directly activates it through DOT1L recruitment and increased H3K79me2/3 levels. MLL-AF4 directly controls the active transcription of both BCL-2 and MCL-1 […]. Of all the BCL-2 family members, only BCL-2 and MCL-1 are directly activated by MLL-AF4."	0.2	SIGNOR-255881
SIGNOR-AML	"Acute Myeloid Leukemia"	RUNX1	protein	Q01196	UNIPROT	MYC	protein	P01106	UNIPROT	"down-regulates quantity by repression"	"transcriptional regulation"			9606									29958106	t		miannu	"RUNX1 represses MYC expression through direct binding at three downstream enhancer elements"	0.336	SIGNOR-260093
SIGNOR-AML	"Acute Myeloid Leukemia"	"AEP complex"	complex	SIGNOR-C117	SIGNOR	MEIS1	protein	O00470	UNIPROT	"up-regulates quantity by expression"				9606									20854876	f		irozzo	"Inhibition of EAP components pTEFb and Dot1l show that both contribute significantly to activation of Hoxa9 and Meis1 expression. EAP is dynamically associated with the Hoxa9 and Meis1 loci in hematopoietic cells and rapidly dissociates during induction of differentiation. In the presence of MLL fusion proteins, its dissociation is prevented."	0.384	SIGNOR-256144
SIGNOR-AML	"Acute Myeloid Leukemia"	BAX	protein	Q07812	UNIPROT	Apoptosis	phenotype	SIGNOR-PH2	SIGNOR	up-regulates				9606									23567751	f		miannu	"The mitochondrial pathway of apoptosis proceeds when the outer mitochondrial membrane (OMM) is compromised by the pro-apoptotic BCL-2 family members, BAK and BAX. Once activated, BAK and BAX form proteolipid pores in the OMM leading to mitochondrial outer membrane permeabilization (MOMP), and the release of inner membrane space proteins, such as cytochrome c, which promotes caspase activation."	0.7	SIGNOR-261494
SIGNOR-AML	"Acute Myeloid Leukemia"	MLL-AF9	"fusion protein"	SIGNOR-FP5	SIGNOR	MECOM	protein	Q03112	UNIPROT	"up-regulates quantity by expression"	methylation			10090	BTO:0001271								22553314	t		irozzo	"We hypothesize, based on our ChIP data, that MLL-AF9 up-regulates EVI1 transcription via H3K79 methylation, which is known to be a major gene regulatory mechanism used by some MLL-fusion proteins in leukemia."	0.2	SIGNOR-255858
SIGNOR-AML	"Acute Myeloid Leukemia"	MLL-AF9	"fusion protein"	SIGNOR-FP5	SIGNOR	"AEP complex"	complex	SIGNOR-C117	SIGNOR	"up-regulates activity"	binding			9606	BTO:0005261								19956800	t		irozzo	"Although the complex was initially termed ENL associated proteins (EAP), we now propose to redefine EAP as ‘‘elongation assisting proteins’’ to better reflect the function of this protein complex. In this report, we present evidence that the most frequently occurring MLL fusion proteins exploit molecular control mechanisms of transcriptional elongation to transform hematopoietic cells. MLL fusions become incorporated into an ‘‘elongation assisting protein’’ complex, recruit it to their respective target genes, and enforce ectopic transcription."	0.2	SIGNOR-255876
SIGNOR-AML	"Acute Myeloid Leukemia"	RAD21	protein	O60216	UNIPROT	RUNX1	protein	Q01196	UNIPROT	"down-regulates quantity by repression"	"transcriptional regulation"			9606									24321385	t		miannu	"We observed that depletion of RAD21 (but not CTCF) enhanced RUNX1 transcription in human HL-60 myelocytic leukemia cells"	0.284	SIGNOR-259973
SIGNOR-AML	"Acute Myeloid Leukemia"	BCOR	protein	Q6W2J9	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	down-regulates				10090	BTO:0004850								26847029	f		irozzo	"Our results strongly suggest that BCOR plays an indispensable role in hematopoiesis by inhibiting myeloid cell proliferation and differentiation and offer a mechanistic explanation for how BCOR regulates gene expression such as Hox genes."	0.7	SIGNOR-256011
SIGNOR-AML	"Acute Myeloid Leukemia"	DOT1L	protein	Q8TEK3	UNIPROT	BCL2	protein	P10415	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			9606									27856324	f		irozzo	"Previously, we found that MLL-AF4 binds to the BCL-2 gene and directly activates it through DOT1L recruitment and increased H3K79me2/3 levels. MLL-AF4 directly controls the active transcription of both BCL-2 and MCL-1 […]. Of all the BCL-2 family members, only BCL-2 and MCL-1 are directly activated by MLL-AF4."	0.2	SIGNOR-255880
SIGNOR-AML	"Acute Myeloid Leukemia"	MLL-ENL	"fusion protein"	SIGNOR-FP7	SIGNOR	"AEP complex"	complex	SIGNOR-C117	SIGNOR	"up-regulates activity"	binding			9606	BTO:0005261								19956800	t		irozzo	"Although the complex was initially termed ENL associated proteins (EAP), we now propose to redefine EAP as ‘‘elongation assisting proteins’’ to better reflect the function of this protein complex. In this report, we present evidence that the most frequently occurring MLL fusion proteins exploit molecular control mechanisms of transcriptional elongation to transform hematopoietic cells. MLL fusions become incorporated into an ‘‘elongation assisting protein’’ complex, recruit it to their respective target genes, and enforce ectopic transcription."	0.2	SIGNOR-255878
SIGNOR-AML	"Acute Myeloid Leukemia"	DOT1L	protein	Q8TEK3	UNIPROT	MYC	protein	P01106	UNIPROT	"up-regulates activity"	binding			9606	BTO:0001939								26199140	t	1	miannu	"Our data suggest that the c-Myc-dependent transcriptional switch is modulated by DOT1L, as in the presence of DOT1L c-Myc preferentially forms an active complex with p300 rather than a repressive complex containing HDAC1 and DNMT1"	0.336	SIGNOR-239362
SIGNOR-AML	"Acute Myeloid Leukemia"	BCOR	protein	Q6W2J9	UNIPROT	Differentiation	phenotype	SIGNOR-PH37	SIGNOR	down-regulates				10090	BTO:0004850								26847029	f		irozzo	"Our results strongly suggest that BCOR plays an indispensable role in hematopoiesis by inhibiting myeloid cell proliferation and differentiation and offer a mechanistic explanation for how BCOR regulates gene expression such as Hox genes."	0.7	SIGNOR-256010
SIGNOR-AML	"Acute Myeloid Leukemia"	MLL-AF9	"fusion protein"	SIGNOR-FP5	SIGNOR	BCOR	protein	Q6W2J9	UNIPROT	"up-regulates activity"	binding			10090	BTO:0000944								12776190	t		irozzo	"As BCoR binds the C-terminus of AF9, it seems likely that BCoR will also bind chimeric MLL–AF9 proteins.  As transcriptional repressors, BCoR or Pc3 bound to MLL–AF9 might interfere with the expression of genes required for normal hematopoiesis."	0.2	SIGNOR-256142
SIGNOR-AML	"Acute Myeloid Leukemia"	MLL-AF9	"fusion protein"	SIGNOR-FP5	SIGNOR	RUNX1	protein	Q01196	UNIPROT	"down-regulates quantity by repression"	"transcriptional regulation"			9606									24449215	f		miannu	"However, the functional consequence of MLL fusions on RUNX1/CBFβ activity has not been fully understood. In this report, we show that MLL fusion proteins and the N-terminal MLL portion of MLL fusions downregulate RUNX1 and CBFβ protein expression via the MLL CXXC domain and flanking regions."	0.2	SIGNOR-260128
SIGNOR-AML	"Acute Myeloid Leukemia"	NPM1	protein	P06748	UNIPROT	HOXA9	protein	P31269	UNIPROT	"down-regulates quantity by repression"	"transcriptional regulation"			9606									30205049	t		miannu	"In AML cells, NPM1 mutations result in abnormal cytoplasmic localization of the mutant protein (NPM1c); however, it is unknown whether NPM1c is required to maintain the leukemic state. Here, we show that loss of NPM1c from the cytoplasm, either through nuclear relocalization or targeted degradation, results in immediate downregulation of homeobox (HOX) genes followed by differentiation."	0.352	SIGNOR-260138
SIGNOR-AML	"Acute Myeloid Leukemia"	FBXW7	protein	Q969H0	UNIPROT	MYC	protein	P01106	UNIPROT	"down-regulates quantity by destabilization"	ubiquitination			9606	BTO:0000007						phosphorylation:Ser62	LLPTPPLsPSRRSGL	15103331	t		lperfetto	"We now show that the F-box protein Fbw7 interacts with and thereby destabilizes c-Myc in a manner dependent on phosphorylation of MB1"	0.767	SIGNOR-249638
SIGNOR-AML	"Acute Myeloid Leukemia"	TP53	protein	P04637	UNIPROT	BCL2	protein	P10415	UNIPROT	"down-regulates activity"	binding			9606									19007744	t	"Cytosolic p53"	lperfetto	"Mechanistic insights into the mitochondrial function of wtp53 came when it was realized that mitochondrially translocated p53 interacts directly with members of the Bcl-2 family, which are central in governing the induction of mitochondrial outer membrane permeabilization. In response to stress, wtp53 interacts with and neutralizes the anti-apoptotic members Bcl-xL and Bcl-2. This interaction stimulates MOMP and subsequent apoptosis"	0.752	SIGNOR-99712
SIGNOR-AML	"Acute Myeloid Leukemia"	MEIS1	protein	O00470	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606	BTO:0001271								19109563	f		irozzo	"These results show that MEIS1 expression is important for MLL-rearranged leukemias and suggest that MEIS1 promotes cell-cycle entry.Flow cytometric analysis of PI-stained nuclei showed that Meis1 knockdown led to a cell-cycle arrest in the G0/G1 phase."	0.7	SIGNOR-255859
SIGNOR-AML	"Acute Myeloid Leukemia"	NPM1	protein	P06748	UNIPROT	CDKN2A	protein	Q8N726	UNIPROT	"up-regulates activity"	binding			10090									16199867	t		gcesareni	"The Arf-NPM interaction seems to be critical in regulating the stability of both proteins. Arf, in fact, induces polyubiquitination and degradation of NPM and inhibits its effects on ribogenesis (18). NPM, instead, protects Arf from degradation and, surprisingly, antagonizes its ability to inhibit cell division"	0.552	SIGNOR-245073
SIGNOR-AML	"Acute Myeloid Leukemia"	NPM1	protein	P06748	UNIPROT	FBXW7	protein	Q969H0	UNIPROT	"up-regulates quantity"	binding			10090	BTO:0002572								18625840	t		gcesareni	"We report here that NPM regulates turnover of the c-Myc oncoprotein by acting on the F-box protein Fbw7 , a component of the E3 ligase complex involved in the ubiquitination and proteasome degradation of c-Myc. NPM was required for nucleolar localization and stabili- zation of Fbw7"	0.48	SIGNOR-245084
SIGNOR-AML	"Acute Myeloid Leukemia"	FBXW7	protein	Q969H0	UNIPROT	MYC	protein	P01106	UNIPROT	"down-regulates quantity"	ubiquitination			9606			SIGNOR-C135						20852628	t		gcesareni	"We now show that the F-box protein Fbw7 interacts with and thereby destabilizes c-Myc in a manner dependent on phosphorylation of MB1. Whereas wild-type Fbw7 promoted c-Myc turnover in cells, an Fbw7 mutant lacking the F-box domain delayed it."	0.767	SIGNOR-243545
SIGNOR-AML	"Acute Myeloid Leukemia"	MYC	protein	P01106	UNIPROT	CDKN2A	protein	P42771	UNIPROT	"down-regulates quantity by repression"	"transcriptional regulation"			9606									12835716	t		gcesareni	"C-myc also directly represses transcription of cdk kinase inhibitors including p27kip1, p21cip1, p15ink4b and p16ink4a"	0.771	SIGNOR-102743
SIGNOR-AML	"Acute Myeloid Leukemia"	TP53	protein	P04637	UNIPROT	Apoptosis	phenotype	SIGNOR-PH2	SIGNOR	up-regulates				9606									24212651	f		miannu	"P53 is a nuclear transcription factor with a pro-apoptotic function"	0.7	SIGNOR-255678
SIGNOR-AML	"Acute Myeloid Leukemia"	CCND1	protein	P24385	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									18177723	f		"andrea cerquone perpetuini"	"Cyclin D1 is necessary for proliferation of different cell types, including myogenic cells."	0.7	SIGNOR-255412
SIGNOR-AML	"Acute Myeloid Leukemia"	DNMT3A	protein	Q9Y6K1	UNIPROT	CCND1	protein	P24385	UNIPROT	"down-regulates quantity by repression"	"transcriptional regulation"			9606									19786833	f		irozzo	"Based on one of these publications, we here showed that the interaction of Dnmt3a with c-myc promote the  speciﬁc methylation of CG  dinucleotides localized in  c-myc boxes  of  promoter  regions  of  CDKN2a, CCND1 and TIMP2  genes.  Acellular  experiments corroborated  and  complemented these results by revealing  that  the  speciﬁcity of  consensus  sequence for  DNA  methylation  of  Dnmt3a is  increased  in presence of c-myc."	0.512	SIGNOR-255808
SIGNOR-AML	"Acute Myeloid Leukemia"	IDH1	protein	O75874	UNIPROT	2-oxoglutarate(2-)	smallmolecule	CHEBI:16810	ChEBI	"up-regulates quantity"	"chemical modification"			9606									29090344	t		miannu	"Two of the most commonly mutated genes in AML encode for two isoforms of isocitrate dehydrogenase (IDH), IDH1 and IDH2. IDH1 and IDH2 are two isoforms of isocitrate dehydrogenase that perform crucial roles in cellular metabolism. Somatic mutations in either of these two genes impart a neomorphic enzymatic activity upon the encoded enzymes resulting in the ability to convert √é¬±-ketoglutarate (√é¬±KG) into the oncometabolite R2-hydroxyglutarate (R2-HG), which can competitively inhibit multiple √é¬±KG-dependent dioxygenases."	0.8	SIGNOR-253135
SIGNOR-AML	"Acute Myeloid Leukemia"	IDH2	protein	P48735	UNIPROT	2-oxoglutarate(2-)	smallmolecule	CHEBI:16810	ChEBI	"up-regulates quantity"	"chemical modification"			9606									29090344	t		miannu	"Two of the most commonly mutated genes in AML encode for two isoforms of isocitrate dehydrogenase (IDH), IDH1 and IDH2. IDH1 and IDH2 are two isoforms of isocitrate dehydrogenase that perform crucial roles in cellular metabolism. Somatic mutations in either of these two genes impart a neomorphic enzymatic activity upon the encoded enzymes resulting in the ability to convert √é¬±-ketoglutarate (√é¬±KG) into the oncometabolite R2-hydroxyglutarate (R2-HG), which can competitively inhibit multiple √é¬±KG-dependent dioxygenases."	0.8	SIGNOR-253134
SIGNOR-AML	"Acute Myeloid Leukemia"	TET2	protein	Q6N021	UNIPROT	WT1	protein	P19544	UNIPROT	"up-regulates activity"	binding			9606	BTO:0000670;BTO:0000738								25601757	t		irozzo	" In this study, we demonstrate that WT1 binds directly to TET2 and recruits TET2 to specific genomic sites to regulate the expression of WT1 target genes."	0.45	SIGNOR-255703
SIGNOR-AML	"Acute Myeloid Leukemia"	WT1	protein	P19544	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	down-regulates				9606	BTO:0000738								25601757	f		irozzo	"Cell proliferation was stimulated by the knockdown of either TET2 or WT1 gene in KG-1 cells, but not additively by the co-depletion of both genes. Collectively, these results suggest that TET2 and WT1 function in the same pathway to inhibit leukemia cell proliferation and colony formation."	0.7	SIGNOR-255705
SIGNOR-AML	"Acute Myeloid Leukemia"	MTOR	protein	P42345	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606		BTO:0000007							20508131	f			"The mammalian target of rapamycin complex 1 (mTORC1) integrates mitogen and nutrient signals to control cell proliferation and cell size."	0.7	SIGNOR-255944
SIGNOR-AML	"Acute Myeloid Leukemia"	JAK2	protein	O60674	UNIPROT	STAT5A	protein	P42229	UNIPROT	"up-regulates activity"	phosphorylation			9606	BTO:0000801								9575217	t		lperfetto	"Jak2 kinase induces tyrosine phosphorylation, dimerization, nuclear translocation, and dna binding of a concomitantly expressed stat5 protein"	0.869	SIGNOR-249507
SIGNOR-AML	"Acute Myeloid Leukemia"	PTPN6	protein	P29350	UNIPROT	JAK2	protein	O60674	UNIPROT	"down-regulates activity"	dephosphorylation			9534									8943354	t			"Direct association with and dephosphorylation of Jak2 kinase by the SH2-domain-containing protein tyrosine phosphatase SHP-1"	0.733	SIGNOR-248466
SIGNOR-AML	"Acute Myeloid Leukemia"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	EP300	protein	Q09472	UNIPROT	up-regulates	phosphorylation			9606				SIGNOR-C7					17964260	t		lperfetto	"Akt1 and 2 promote the association of myod with p300 and pcaf acetyltransferases, via direct phosphorylation of p300."	0.2	SIGNOR-244239
SIGNOR-AML	"Acute Myeloid Leukemia"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	EP300	protein	Q09472	UNIPROT	up-regulates	phosphorylation	Ser1834	MLRRRMAsMQRTGVV	9606									16926151	t		lperfetto	"We find that suberoylanilide hydroxamic acid stimulates akt activity, which is required to phosphorylate p300 at ser(1834). Akt-mediated phosphorylation of p300 dramatically increases its acetyltransferase activity"	0.2	SIGNOR-244236
SIGNOR-AML	"Acute Myeloid Leukemia"	EP300	protein	Q09472	UNIPROT	Differentiation	phenotype	SIGNOR-PH37	SIGNOR	up-regulates				9606									20660310	f		amattioni	"Switch to beta-catenin/p300-mediated gene expression is an essential first step in initiating normal cellular differentiation"	0.7	SIGNOR-229780
SIGNOR-AML	"Acute Myeloid Leukemia"	CBL	protein	P22681	UNIPROT	FLT3	protein	P36888	UNIPROT	"down-regulates activity"	binding			10090	BTO:0001516								19276253	t			"Functionally, CBL negatively regulated FMS-like tyrosine kinase 3 (FLT3) activity and interacted with human FLT3 via the autophosphorylation sites Y589 and Y599 and colocalized in vivo."	0.434	SIGNOR-255739
SIGNOR-AML	"Acute Myeloid Leukemia"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	AP1	complex	SIGNOR-C154	SIGNOR	up-regulates	phosphorylation	Thr331	CTPVVTCtPSCTAYT	9606									12972619	t		lperfetto	"In a previous study we have observed that exposure of nih 3t3 cells to pdgf or serum leads to c-fos phosphorylation by erk on specific residues, thr232, thr325, thr331, and ser374, within the cooh-terminal c-fos tad we have recently shown that erk phosphorylates multiple residues within the carboxylterminal transactivation domain (tad) of c-fos, thus resulting in its increased transcriptional activity."	0.795	SIGNOR-252353
SIGNOR-AML	"Acute Myeloid Leukemia"	GRB2	protein	P62993	UNIPROT	CBL	protein	P22681	UNIPROT	up-regulates	relocalization			9606									11823423	t	"GRB2 is an adapter protein that provides a critical link between cell surface growth factor receptors and the Ras signaling pathway."	gcesareni	"The underlying mechanism seems to involve recruitment of a grb2 c-cbl complex to grb2-specific docking sites of egfr, and concurrent acceleration of receptor ubiquitylation and desensitization."	0.904	SIGNOR-114704
SIGNOR-AML	"Acute Myeloid Leukemia"	PTPN11	protein	Q06124	UNIPROT	KRAS	protein	P01116	UNIPROT	"up-regulates activity"	dephosphorylation	Tyr32	QNHFVDEyDPTIEDS	9606	BTO:0000007								26617336	t		irozzo	"Here we identify SHP2 as the ubiquitously expressed tyrosine phosphatase that preferentially binds to and dephosphorylates Ras to increase its association with Raf and activate downstream proliferative Ras/ERK/MAPK signalling."	0.665	SIGNOR-255982
SIGNOR-AML	"Acute Myeloid Leukemia"	FLT3	protein	P36888	UNIPROT	PTPN11	protein	Q06124	UNIPROT	"up-regulates activity"	binding			10090	BTO:0002882				phosphorylation:Tyr599	VDFREYEyDLKWEFP			16684964	t		gcesareni	"Y599 was additionally found to interact with the protein tyrosine phosphatase SHP2 in a phosphorylation-dependent manner. As Y599F-Flt3-32D was unable to associate with and to phosphorylate SHP2 and since silencing of SHP2 in WT-Flt3-expressing cells mimicked the Y599F-Flt3 phenotype, we hypothesize that recruitment of SHP2 to pY599 contributes to FL-mediated Erk activation and proliferation."	0.523	SIGNOR-245057
SIGNOR-AML	"Acute Myeloid Leukemia"	"all-trans-retinoic acid"	smallmolecule	CHEBI:15367	ChEBI	PML-RARalpha	"fusion protein"	SIGNOR-FP2	SIGNOR	"down-regulates quantity by destabilization"	"chemical inhibition"			9606									19029980	t			"Retinoic acid and arsenic synergize to clear LICs through cooperative PML-RARA degradation, this combination does not enhance differentiation."	0.8	SIGNOR-259926
SIGNOR-AML	"Acute Myeloid Leukemia"	PML-RARalpha	"fusion protein"	SIGNOR-FP2	SIGNOR	CCNA1	protein	P78396	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			9606									11090075	f			"Overexpression of cyclin A1 observed in APL cells is caused by the expression of the aberrant fusion proteins, PML-RARα and PLZF-RARα. PML-RARα itself can lead to activation of the cyclin A1 promoter.Since both fusion proteins disrupt the normal RARα function, our results strongly suggested that the RARα pathway negatively regulates the expression of cyclin A1 and that this negative regulation is disrupted by the aberrant fusion proteins."	0.2	SIGNOR-255725
SIGNOR-AML	"Acute Myeloid Leukemia"	FLT3	protein	P36888	UNIPROT	CTNNB1	protein	P35222	UNIPROT	"up-regulates activity"	phosphorylation			9606	BTO:0001545								17851558	t		miannu	"Endogenous beta-catenin co-immunoprecipitated with endogenous activated FLT3, and recombinant activated FLT3 directly phosphorylated recombinant beta-catenin. Finally, FLT3 inhibitor decreased tyrosine phosphorylation of beta-catenin in leukemia cells obtained from FLT3-ITD-positive AML patients. These data demonstrate that FLT3 activation induces beta-catenin tyrosine phosphorylation and nuclear localization, and thus suggest a mechanism for the association of FLT3 activation and beta-catenin oncogeneic signaling in AML."	0.411	SIGNOR-260124
SIGNOR-AML	"Acute Myeloid Leukemia"	"diarsenic trioxide"	chemical	CHEBI:30621	ChEBI	PML-RARalpha	"fusion protein"	SIGNOR-FP2	SIGNOR	"down-regulates quantity by destabilization"	"chemical inhibition"			9606									24344243	t			"ATO was shown to degrade PML-RARa via its PML moiety further reinforcing the idea that APL is addicted to the PML-RARa oncoprotein"	0.8	SIGNOR-259924
SIGNOR-AML	"Acute Myeloid Leukemia"	PIM1	protein	P11309	UNIPROT	FLT3	protein	P36888	UNIPROT	"up-regulates quantity"	phosphorylation	Tyr591	SSDNEYFyVDFREYE	9606	BTO:0005720								24040307	t			"Pim-1 Kinase Phosphorylates and Stabilizes 130 kDa FLT3 and Promotes Aberrant STAT5 Signaling in Acute Myeloid Leukemia with FLT3 Internal Tandem Duplication[...]Pim-1 inhibition also decreased phosphorylation of FLT3 at tyrosine 591 and of STAT5, and expression of Pim-1 itself, consistent with inhibition of the FLT3-ITD-STAT5 signaling pathway."	0.422	SIGNOR-259927
SIGNOR-AML	"Acute Myeloid Leukemia"	midostaurin	chemical	CHEBI:63452	ChEBI	FLT3	protein	P36888	UNIPROT	"down-regulates activity"	"chemical inhibition"			-1									12124173	t			"PKC412 is a potent inhibitor of mutant FLT3 and is a candidate for testing as an antileukemia agent in AML patients with mutant FLT3 receptors."	0.8	SIGNOR-256308
SIGNOR-AML	"Acute Myeloid Leukemia"	FLT3	protein	P36888	UNIPROT	RUNX1	protein	Q01196	UNIPROT	"up-regulates activity"				9606									28213513	f			"Our finding that RUNX1 protein levels are dependent on FLT3-ITD signaling in AML cells and that, together, they synergize to generate AML. […]Our work demonstrated that Tyr phosphorylation within the ID region of RUNX1 is critical for its oncogenic potential,"	0.363	SIGNOR-256307
SIGNOR-AML	"Acute Myeloid Leukemia"	HHEX	protein	Q03014	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	"up-regulates activity"				10090		BTO:0000089							26728554	f			"Hhex is a potential therapeutic target that is specifically required for AML stem cells to repress tumor suppressor pathways and enable continued self-renewal."	0.7	SIGNOR-256306
SIGNOR-AML	"Acute Myeloid Leukemia"	FLT3	protein	P36888	UNIPROT	PTPN6	protein	P29350	UNIPROT	"down-regulates quantity"	"transcriptional regulation"			9606	BTO:0004760								15574429	f			"Furthermore, a small but reproducible growth/survival advantage was observed in both TF-1 and TF-1/ITD cells when SHP-1 expression was knocked down by RNAi. Taken together, these data provide the first evidence that suppression of SHP-1 by FLT3/ITD signaling may be another mechanism contributing to the transformation by FLT3/ITD mutations"	0.364	SIGNOR-259950
SIGNOR-AML	"Acute Myeloid Leukemia"	CDKN2A	protein	P42771	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	down-regulates				9606	BTO:0000176								7972006	f			"Transfection of the p16INK4 cDNA expression vector into carcinoma cells inhibits their colony-forming efficiency and the p16INK4 expressing cells are selected against with continued passage in vitro. These results are consistent with the hypothesis that p16INK4 is a tumor-suppressor protein and that genetic and epigenetic abnormalities in genes controlling the G1 checkpoint can lead to both escape from senescence and cancer formation."	0.7	SIGNOR-259406
SIGNOR-AML	"Acute Myeloid Leukemia"	ASXL1	protein	Q8IXJ9	UNIPROT	CDKN2A	protein	P42771	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			10090									29967380	t		miannu	"Modeling ASXL1 mutation revealed impaired hematopoiesis caused by derepression of p16Ink4a through aberrant PRC1-mediated histone modification. These results indicated that loss of protein interaction between Asxl1 mutant and Bmi1 affected the activity of PRC1, and subsequent derepression of p16Ink4a by aberrant histone ubiquitination could induce cellular senescence, resulting in low-risk MDS-like phenotypes in Asxl1G643fs/+ mice."	0.302	SIGNOR-260119
SIGNOR-AML	"Acute Myeloid Leukemia"	ASXL1	protein	Q8IXJ9	UNIPROT	NCOA1	protein	Q15788	UNIPROT	"up-regulates activity"	binding			9606									16606617	t		irozzo	"We also show that ASXL1 associates specifically with SRC-1 and cooperates synergistically in the transcriptional activation. Further data indicated that the transactivation domain (AD; amino acids 300–655) of ASXL1, newly defined in this study, interacts with the C-terminal AD2 (amino acids 1217–1441) of SRC-1, suggesting that one AD cooperates with the other AD in transcriptional activation by RAR."	0.284	SIGNOR-255931
SIGNOR-AML	"Acute Myeloid Leukemia"	RARA	protein	P10276	UNIPROT	CCNA1	protein	P78396	UNIPROT	"down-regulates quantity by repression"	"transcriptional regulation"			9606	BTO:0002136								11090075	t		miannu	"RARα is involved in the regulation of cyclin A1. Further studies using ligands selective for various retinoic acid receptors suggested that cyclin A1 expression is negatively regulated by activated RARα."	0.244	SIGNOR-249636
SIGNOR-AML	"Acute Myeloid Leukemia"	ASXL1	protein	Q8IXJ9	UNIPROT	HOXA9	protein	P31269	UNIPROT	"down-regulates quantity by repression"	"transcriptional regulation"			9606									22897849	f		miannu	"ASXL1 siRNA in human primary CD34+ cells form cord blood results in upregulation of HOXA5 and HOXA9 with ASXL1 knockdown (KD) as revealed by quantitative real-time PCR"	0.433	SIGNOR-256127
SIGNOR-AML	"Acute Myeloid Leukemia"	RARA	protein	P10276	UNIPROT	RXRA	protein	P19793	UNIPROT	up-regulates	binding			9606									1310351	t		gcesareni	"Here we report that the transcriptional activity of rar and rxr can be reciprocally modulated by direct interactions between the two proteins"	0.723	SIGNOR-16433
SIGNOR-AML	"Acute Myeloid Leukemia"	FLT3	protein	P36888	UNIPROT	PI3K	complex	SIGNOR-C156	SIGNOR	"up-regulates activity"				10090	BTO:0001516								23246379	f		miannu	"Grb10 transduces signal from FLT3 by direct interaction with p85 and Ba/F3-FLT3-ITD cells expressing Grb10 exhibits higher STAT5 activation.  These results suggest that Grb10 binds to both normal and oncogenic FLT3 and induces PI3K-Akt and STAT5 signaling pathways resulting in an enhanced proliferation, survival and colony formation of hematopoietic cells."	0.561	SIGNOR-260083
SIGNOR-AML	"Acute Myeloid Leukemia"	BCORL1	protein	Q5H9F3	UNIPROT	CTBP1	protein	Q13363	UNIPROT	"up-regulates activity"	binding			9606	BTO:0002181								17379597	t		irozzo	"BCoR-L1 also interacts with the CtBP corepressor through a CtBP-interacting motif in its amino terminus. Furthermore, BCoR-L1 is located on the E-cadherin promoter, a known CtBP-regulated promoter, and represses the E-cadherin promoter activity in a reporter assay."	0.436	SIGNOR-259193
SIGNOR-AML	"Acute Myeloid Leukemia"	SOX4	protein	Q06945	UNIPROT	CTNNB1	protein	P35222	UNIPROT	"up-regulates activity"	binding			9606	BTO:0003104								24970928	t		irozzo	"The findings in this study raise the possibility that Sox4 may also antagonize Lef1 (Tcf1 is not expressed in pro-B lymphocytes) function by controlling the stability of β-catenin in pro-B lymphocytes."	0.599	SIGNOR-256139
SIGNOR-AML	"Acute Myeloid Leukemia"	TP53	protein	P04637	UNIPROT	MDM2	protein	Q00987	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			10090									7958853	f		gcesareni	"The p53 tumor suppressor protein trans-activates mdm2 itself, which is therefore considered a component of a p53 negative feedback loop."	0.968	SIGNOR-34962
SIGNOR-AML	"Acute Myeloid Leukemia"	JUN	protein	P05412	UNIPROT	SPI1	protein	P17947	UNIPROT	"up-regulates activity"	binding			9606	BTO:0004136								12393465	t		apalma	"These results indicate that AML1-ETO competes c-Jun away from binding to the β3β4 domain of PU.1. Thus, the c-Jun coactivation function of PU.1 is down-regulated and this in turn down-regulates transcriptional activity of PU.1."	0.554	SIGNOR-255660
SIGNOR-AML	"Acute Myeloid Leukemia"	CEBPA	protein	P49715	UNIPROT	MYC	protein	P01106	UNIPROT	"down-regulates quantity by repression"	"transcriptional regulation"			9606									12032779	f		miannu	"Several different transcription factors have been implicated in the down-regulation of c-myc expression during differentiation, including C/EBPalpha, CTCF, BLIMP-1, and RFX1."	0.488	SIGNOR-253830
SIGNOR-AML	"Acute Myeloid Leukemia"	AP1	complex	SIGNOR-C154	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									9878062	f		lperfetto	"AP‐1 proteins, including c‐Fos and c‐Jun, are prominent nuclear targets of growth factor induced signaling, making AP‐1 a candidate nuclear effector of growth factor induced proliferation."	0.7	SIGNOR-252356
SIGNOR-AML	"Acute Myeloid Leukemia"	MYC	protein	P01106	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									9552384	f		gcesareni	"C-myc has emerged as one of the central regulators of mammalian cell proliferation."	0.7	SIGNOR-56572
SIGNOR-AML	"Acute Myeloid Leukemia"	AML1-ETO	"fusion protein"	SIGNOR-FP1	SIGNOR	PTGS2	protein	P35354	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			10090	BTO:0004850								23645839	f		miannu	"AML1-ETO (AE) is an oncogene that plays an important role in inducing self-renewal of hematopoietic stem/progenitor cells (HSPCs), leading to the development of leukemia stem cells. Here, we show that AE also induces expression of the Cox-2 gene and activates β-catenin in mouse bone marrow cells."	0.2	SIGNOR-255683
SIGNOR-AML	"Acute Myeloid Leukemia"	CEBPA	protein	P49715	UNIPROT	SOX4	protein	Q06945	UNIPROT	down-regulates	"transcriptional regulation"			9606									24183681	t		apalma	"In summary, our data demonstrate that C/EBPα negatively regulates Sox4 transcription via direct DNA-binding."	0.383	SIGNOR-255675
SIGNOR-AML	"Acute Myeloid Leukemia"	CTNNB1	protein	P35222	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									18697834	f		"Simone Vumbaca"	"we showed that β-catenin, a key component of the canonical Wnt-signalling cascade, is present in quiescent satellite cells in the inactive form, but subsequently becomes activated following satellite-cell activation. This observation suggests that the proliferation initiated by the Wnt-signalling cascade does not have to rely on transcription of β-catenin, but rather on activation of this protein, which is already present within the quiescent satellite cells."	0.7	SIGNOR-255654
SIGNOR-AML	"Acute Myeloid Leukemia"	AML1-ETO	"fusion protein"	SIGNOR-FP1	SIGNOR	PTPRC	protein	P08575	UNIPROT	"down-regulates quantity by repression"	"transcriptional regulation"			10090	BTO:0001271								22740448	f		miannu	"Chromosome translocation 8q22;21q22 [t(8;21)] is commonly associated with acute myeloid leukemia (AML), and the resulting AML1-ETO fusion proteins are involved in the pathogenesis of AML. To identify novel molecular and therapeutic targets, we performed combined gene expression microarray and promoter occupancy (ChIP-chip) profiling using Lin(-)/Sca1(-)/cKit(+) cells, the major leukemia cell population, from an AML mouse model induced by AML1-ETO9a (AE9a).CD45, a protein tyrosine phosphatase and a negative regulator of cytokine/growth factor receptor and JAK/STAT signaling, is among those targets. Its expression is substantially down-regulated in leukemia cells. Consequently, JAK/STAT signaling is enhanced."	0.2	SIGNOR-255686
SIGNOR-AML	"Acute Myeloid Leukemia"	SPI1	protein	P17947	UNIPROT	Differentiation	phenotype	SIGNOR-PH37	SIGNOR	up-regulates				10090	BTO:0004730								12130514	f		lperfetto	"The transcription factor PU.1 is required for normal blood cell development. PU.1 regulates the expression of a number of crucial myeloid genes, such as the macrophage colony-stimulating factor (M-CSF) receptor, the granulocyte colony-stimulating factor (G-CSF) receptor, and the granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor. Myeloid cells derived from PU.1(-/-) mice are blocked at the earliest stage of myeloid differentiation, similar to the blast cells that are the hallmark of human acute myeloid leukemia (AML). These facts led us to hypothesize that molecular abnormalities involving the PU.1 gene could contribute to the development of AML."	0.7	SIGNOR-249633
SIGNOR-AML	"Acute Myeloid Leukemia"	PTPRC	protein	P08575	UNIPROT	JAK2	protein	O60674	UNIPROT	"down-regulates activity"	dephosphorylation	Tyr1007	VLPQDKEyYKVKEPG	10090									11201744	t			"CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling|these results show that CD45 dephosphorylates functionally important tyrosine residues. It should be noted that, as with our phosphatase assays in vitro, Tyr 1022 and Tyr 1023 of JAK1, Tyr 1007 and Tyr 1008 of JAK2, and Tyr 1054 and Tyr 1055 of Tyk2 are indeed hyperphosphorylated in cd45-deficient cells"	0.47	SIGNOR-248348
SIGNOR-AML	"Acute Myeloid Leukemia"	PTPRC	protein	P08575	UNIPROT	JAK2	protein	O60674	UNIPROT	"down-regulates activity"	dephosphorylation	Tyr1008	LPQDKEYyKVKEPGE	10090									11201744	t			"CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling|these results show that CD45 dephosphorylates functionally important tyrosine residues. It should be noted that, as with our phosphatase assays in vitro, Tyr 1022 and Tyr 1023 of JAK1, Tyr 1007 and Tyr 1008 of JAK2, and Tyr 1054 and Tyr 1055 of Tyk2 are indeed hyperphosphorylated in cd45-deficient cells"	0.47	SIGNOR-248349
SIGNOR-AML	"Acute Myeloid Leukemia"	"prostaglandin E2(1-)"	smallmolecule	CHEBI:606564	ChEBI	CTNNB1	protein	P35222	UNIPROT	up-regulates				9606	BTO:0000725								23645839	f		apalma	"Prostaglandin E2 (PGE2), 1 of the major metabolites downstream of both COX-1 and COX-2, has been shown to activate β-catenin–dependent signaling in hematopoietic stem cells (HSCs) and promote HSC expansion"	0.8	SIGNOR-255685
SIGNOR-AML	"Acute Myeloid Leukemia"	PTPRC	protein	P08575	UNIPROT	JAK2	protein	O60674	UNIPROT	"down-regulates activity"	dephosphorylation			10090	BTO:0003620								11201744	t			"CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling"	0.47	SIGNOR-248347
SIGNOR-AML	"Acute Myeloid Leukemia"	SRSF2	protein	Q01130	UNIPROT	MDM2	protein	Q00987	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			9606									27524244	t		miannu	"Using MDM2 P1 and P2 promoter-reporter systems, we screened clones regulating MDM2 transcriptions in a p53-independent manner by overexpression. Nine clones from the screening library showed enhanced MDM2 promoter activity and MDM2 expression in p53-deficient HCT116 cells. Among them, six clones, including NTRK2, GNA15, SFRS2, EIF5A, ELAVL1, and YWHAB mediated MAPK signaling for expressing MDM2."	0.279	SIGNOR-260076
SIGNOR-AML	"Acute Myeloid Leukemia"	AML1-ETO	"fusion protein"	SIGNOR-FP1	SIGNOR	CDKN2A	protein	Q8N726	UNIPROT	down-regulates	"transcriptional regulation"			9606									12091906	t		apalma	"We have identified the p14(ARF) tumor suppressor, a mediator of the p53 oncogene checkpoint, as a direct transcriptional target of AML1 ETO."	0.2	SIGNOR-255677
SIGNOR-AML	"Acute Myeloid Leukemia"	TP53	protein	P04637	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	down-regulates				9606	BTO:0000452								7667317	f			"P53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts"	0.7	SIGNOR-255669
SIGNOR-AML	"Acute Myeloid Leukemia"	AML1-ETO	"fusion protein"	SIGNOR-FP1	SIGNOR	SPI1	protein	P17947	UNIPROT	"down-regulates activity"	binding			9606	BTO:0000318								18519037	t			"We found that AML1-ETO is able to inhibit Sp1 transactivity. We also found that this inhibition of Sp1 transactivity by AML1-ETO is achieved by interaction between Sp1 and RUNT domain of AML1"	0.2	SIGNOR-255671
SIGNOR-AML	"Acute Myeloid Leukemia"	AML1-ETO	"fusion protein"	SIGNOR-FP1	SIGNOR	CEBPA	protein	P49715	UNIPROT	"down-regulates activity"	binding			9606	BTO:0001271								11283671	t		apalma	"Here we show that AML1–ETO blocks C/EBPα –dependent activation of its own promoter and thereby inhibits autoregulation."	0.2	SIGNOR-255672
SIGNOR-AML	"Acute Myeloid Leukemia"	FLT3	protein	P36888	UNIPROT	CEBPA	protein	P49715	UNIPROT	"down-regulates quantity by repression"	"transcriptional regulation"			9606									16146838	f		lperfetto	"Oncogenic mutations of Flt3 also result in the activation of aberrant signaling pathways, including strong activation of STAT5, induction of STAT target genes, and repression of myeloid transcription factors c/EBP-3 and Pu.1."	0.639	SIGNOR-249635
SIGNOR-AML	"Acute Myeloid Leukemia"	AML1-ETO	"fusion protein"	SIGNOR-FP1	SIGNOR	JUN	protein	P05412	UNIPROT	"down-regulates activity"	binding			9606	BTO:0004136								12393465	t	"RUNX1-RUNX1T1 fusion protein (AML-ETO)"	apalma	"Here we show that AML1-ETO blocks the transcriptional activity of PU.1 by displacing its coactivator c-Jun."	0.2	SIGNOR-255670
SIGNOR-AML	"Acute Myeloid Leukemia"	MDM2	protein	Q00987	UNIPROT	TP53	protein	P04637	UNIPROT	"down-regulates quantity by destabilization"	ubiquitination			9606									23150757	t		lperfetto	"Dual Roles of MDM2 in the Regulation of p53: Ubiquitination Dependent and Ubiquitination Independent Mechanisms of MDM2 Repression of p53 Activity"	0.968	SIGNOR-199371
SIGNOR-AML	"Acute Myeloid Leukemia"	MDM2	protein	Q00987	UNIPROT	TP53	protein	P04637	UNIPROT	"down-regulates quantity by destabilization"	ubiquitination			9606									10935507	t		lperfetto	"Many posttranslational modifications of p53, such as phosphorylation, dephosphorylation, acetylation and ribosylation, have been shown to occur following cellular stress. Some of these modifications may activate the p53 protein, interfere with MDM2 binding and/or dictate cellular localization of p53."	0.968	SIGNOR-80528
SIGNOR-AML	"Acute Myeloid Leukemia"	MDM2	protein	Q00987	UNIPROT	TP53	protein	P04637	UNIPROT	"down-regulates quantity by destabilization"	ubiquitination			9606									22337874	t		lperfetto	"The E3 ubiquitin ligase, MDM2, uses a dual-site mechanism to ubiquitinate and degrade the tumor suppressor protein p53, involving interactions with the N-terminal hydrophobic pocket and the acidic domain of MDM2."	0.968	SIGNOR-196116
SIGNOR-AML	"Acute Myeloid Leukemia"	STAT5A	protein	P42229	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									10072077	f			"Here, we demonstrate that, while lymphoid development is normal, Stat5a/b mutant peripheral T cells are profoundly deficient in proliferation and fail to undergo cell cycle progression or to express genes controlling cell cycle progression"	0.7	SIGNOR-254302
SIGNOR-AML	"Acute Myeloid Leukemia"	JAK2	protein	O60674	UNIPROT	STAT5A	protein	P42229	UNIPROT	up-regulates	phosphorylation	Tyr694	LAKAVDGyVKPQIKQ	4932									9575217	t		gcesareni	"Our mutational analysis suggests that the Stat5 SH2 domain is essential for the interaction with Jak2 and that the kinase domain of Jak2 is sufficient for Jak2-Stat5 interaction. Therefore, the Jak kinase domain may be all that is needed to cause Stat phosphorylation in situations where receptor docking is dispensable. [...] Most obviously, mutation of Tyr694 (Stat5a) or Tyr699 (Stat5b) to phenylalanine abolishes phosphorylation"	0.869	SIGNOR-56827
SIGNOR-AML	"Acute Myeloid Leukemia"	AML1-ETO	"fusion protein"	SIGNOR-FP1	SIGNOR	CEBPA	protein	P49715	UNIPROT	"down-regulates activity"	binding			9606	BTO:0001412								11283671	t		irozzo	"AML1–ETO inhibits CEBPA autoregulation in myeloid cells.[…]It was also demonstrated that AML1–ETO and C/EBPα physically interact in vivo."	0.2	SIGNOR-255700
SIGNOR-AML	"Acute Myeloid Leukemia"	CTNNB1	protein	P35222	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									23645839	f		apalma	"For example, prostaglandin E2 (PGE2), 1 of the major metabolites downstream of both COX-1 and COX-2, has been shown to activate β-catenin–dependent signaling in hematopoietic stem cells (HSCs) and promote HSC expansion"	0.7	SIGNOR-255695
SIGNOR-AML	"Acute Myeloid Leukemia"	AML1-ETO	"fusion protein"	SIGNOR-FP1	SIGNOR	JAK2	protein	O60674	UNIPROT	"down-regulates quantity by repression"	"transcriptional regulation"			10090	BTO:0001271								22740448	f		miannu	"Chromosome translocation 8q22;21q22 [t(8;21)] is commonly associated with acute myeloid leukemia (AML), and the resulting AML1-ETO fusion proteins are involved in the pathogenesis of AML. To identify novel molecular and therapeutic targets, we performed combined gene expression microarray and promoter occupancy (ChIP-chip) profiling using Lin(-)/Sca1(-)/cKit(+) cells, the major leukemia cell population, from an AML mouse model induced by AML1-ETO9a (AE9a).CD45, a protein tyrosine phosphatase and a negative regulator of cytokine/growth factor receptor and JAK/STAT signaling, is among those targets. Its expression is substantially down-regulated in leukemia cells. Consequently, JAK/STAT signaling is enhanced."	0.2	SIGNOR-260120
SIGNOR-AML	"Acute Myeloid Leukemia"	SOX4	protein	Q06945	UNIPROT	Differentiation	phenotype	SIGNOR-PH37	SIGNOR	down-regulates				9606	BTO:0001271								24183681	f		apalma	"Collectively, our experiments identified the oncogene Sox4 as a factor mediating increased serial-replating ability and blocked differentiation of Cebpa-deficient progenitors."	0.7	SIGNOR-255676
SIGNOR-AML	"Acute Myeloid Leukemia"	PTPRC	protein	P08575	UNIPROT	JAK2	protein	O60674	UNIPROT	"down-regulates activity"	dephosphorylation			9606									24252238	t		miannu	"Src homology-2 (SH2) containing tyrosine phosphatase and CD45 tyrosine phosphatase play a major role in modulating JAK-STAT pathway. SH2 containing tyrosine phosphatases include SHP1 and SHP2 (shatterproof 1 & 2). Their SH2 domains allow attachment to the phospho-tyrosine residues present on activated receptors, JAKs or STAT proteins, leading to dephosphorylation of the substrates."	0.47	SIGNOR-255679
SIGNOR-AML	"Acute Myeloid Leukemia"	CDKN2A	protein	Q8N726	UNIPROT	MDM2	protein	Q00987	UNIPROT	"down-regulates activity"	relocalization			9606									23416275	t		fstefani	"We propose that p14(arf) increases the binding of p53-mdm2 complexes to chromatin, thereby limiting the access of protein deacetylases to p53."	0.769	SIGNOR-192697
SIGNOR-AML	"Acute Myeloid Leukemia"	STAT5A	protein	P42229	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606	BTO:0004408								15353555	f		miannu	"Here we report that a persistent activation of STAT5A in human CD34+ cells results in enhanced self-renewal. STAT5A drives the expression of a number of proto-oncogenes and cytokines in human CD34+ cells, as well as a number of erythroid-specific genes, favoring erythroid over myeloid differentiation and providing a long-term proliferative advantage for erythroid progenitors."	0.7	SIGNOR-255682
SIGNOR-AML	"Acute Myeloid Leukemia"	PTGS2	protein	P35354	UNIPROT	"prostaglandin E2(1-)"	smallmolecule	CHEBI:606564	ChEBI	"up-regulates quantity"	"chemical modification"			9606									16540375	t			"Arachidonic acid is transformed into PGE2 via cyclooxygenase (COX) enzymes and terminal prostaglandin E synthases (PGES)"	0.8	SIGNOR-255684
SIGNOR-AML	"Acute Myeloid Leukemia"	CCNA1	protein	P78396	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606	BTO:0001884								15829981	f		miannu	"SiRNA mediated silencing of cyclin A1 in highly cyclin A1 expressing ML1 leukemic cells significantly slowed S phase entry, decreased proliferation and inhibited colony formation. "	0.7	SIGNOR-255734
SIGNOR-AML	"Acute Myeloid Leukemia"	NCOA1	protein	Q15788	UNIPROT	ASXL1	protein	Q8IXJ9	UNIPROT	"up-regulates activity"	binding			9606	BTO:0000567								16606617	t		irozzo	"We also show that ASXL1 associates specifically with SRC-1 and cooperates synergistically in the transcriptional activation.Therefore, both the ability to bind SRC-1 and the autonomous activation of ASXL1 are required for its coactivator function.  Further data indicated that the transactivation domain (AD; amino acids 300–655) of ASXL1, newly defined in this study, interacts with the C-terminal AD2 (amino acids 1217–1441) of SRC-1, suggesting that one AD cooperates with the other AD in transcriptional activation by RAR."	0.284	SIGNOR-255924
SIGNOR-AML	"Acute Myeloid Leukemia"	RXRA	protein	P19793	UNIPROT	RARA	protein	P10276	UNIPROT	up-regulates	binding			9606									1310351	t		gcesareni	"Here we report that the transcriptional activity of rar and rxr can be reciprocally modulated by direct interactions between the two proteins"	0.723	SIGNOR-16665
SIGNOR-AML	"Acute Myeloid Leukemia"	ASXL1	protein	Q8IXJ9	UNIPROT	RARA	protein	P10276	UNIPROT	"up-regulates activity"	binding			9606	BTO:0000567								16606617	t		irozzo	"Therefore, ASXL1, a vertebrate PcG/TrxG protein, may mediate RA-regulated cell growth by modulating RAR activity.Finally, the ASXL1-induced accumulation of acetylated H3 may enhance the RAR-mediated transcriptional activity. In this study, we demonstrate that mammalian ASXL1 interacts with the AF-2 AD core of RAR (and RXR) through a novel, promiscuous NR box (LVMQLL) and enhances transcriptional activity of the receptors in certain cells."	0.442	SIGNOR-255910
SIGNOR-AML	"Acute Myeloid Leukemia"	CTBP1	protein	Q13363	UNIPROT	CDKN2A	protein	P42771	UNIPROT	"down-regulates quantity by repression"	"transcriptional regulation"			9606									23303449	f		irozzo	"Our findings suggest an important role of CtBP1 in the transcriptional control of p16INK4a and Brca1[.]. Additionally, the inhibitor of cyclin-dependent protein kinases (CDKs), p16INK4a, whose loss has been related to the pathogenesis of melanoma, was repressed by CtBP1 as well."	0.413	SIGNOR-259195
SIGNOR-AML	"Acute Myeloid Leukemia"	EZH2	protein	Q15910	UNIPROT	HOXA9	protein	P31269	UNIPROT	"down-regulates quantity by repression"	"transcriptional regulation"			9606									20565746	t		miannu	"These data support the proposed regulatory impact of particular PRC2-proteins in expression of HOXA9 and HOXA10 in NK/T-cells. In mammalian cells knockdown of PRC2 components EZH2 or PHF1 led to upregulated HOXA gene expression."	0.397	SIGNOR-260068
SIGNOR-AML	"Acute Myeloid Leukemia"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	EZH2	protein	Q15910	UNIPROT	"down-regulates activity"	phosphorylation	Ser21	CWRKRVKsEYMRLRQ	9606									16224021	t		lperfetto	"Enhancer of zeste homolog 2 (ezh2) is a methyltransferase that plays an important role in many biological processes through its ability to trimethylate lysine 27 in histone h3. Here, we show that akt phosphorylates ezh2 at serine 21 and suppresses its methyltransferase activity by impeding ezh2 binding to histone h3"	0.2	SIGNOR-244259
SIGNOR-AML	"Acute Myeloid Leukemia"	NCOA1	protein	Q15788	UNIPROT	RARA	protein	P10276	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			9606									16606617	f		irozzo	"We also show that ASXL1 associates specifically with SRC-1 and cooperates synergistically in the transcriptional activation. Further data indicated that the transactivation domain (AD; amino acids 300–655) of ASXL1, newly defined in this study, interacts with the C-terminal AD2 (amino acids 1217–1441) of SRC-1, suggesting that one AD cooperates with the other AD in transcriptional activation by RAR."	0.709	SIGNOR-255932
SIGNOR-AML	"Acute Myeloid Leukemia"	ASXL1	protein	Q8IXJ9	UNIPROT	RARA	protein	P10276	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			9606									16606617	f		irozzo	"We also show that ASXL1 associates specifically with SRC-1 and cooperates synergistically in the transcriptional activation. Further data indicated that the transactivation domain (AD; amino acids 300–655) of ASXL1, newly defined in this study, interacts with the C-terminal AD2 (amino acids 1217–1441) of SRC-1, suggesting that one AD cooperates with the other AD in transcriptional activation by RAR."	0.442	SIGNOR-255933
SIGNOR-AML	"Acute Myeloid Leukemia"	PI3K	complex	SIGNOR-C156	SIGNOR	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation			9606									15526160	t		miannu	"C-Kit promotes survival via PI3-kinase-dependent activation of Akt and phosphorylation of Bad, a pro-apoptotic molecule, at S136 in vivo."	0.796	SIGNOR-254950
SIGNOR-AML	"Acute Myeloid Leukemia"	ASXL1	protein	Q8IXJ9	UNIPROT	RXRA	protein	P19793	UNIPROT	"up-regulates activity"	binding			9606	BTO:0000567								16606617	t		irozzo	"In this study, we demonstrate that mammalian ASXL1 interacts with the AF-2 AD core of RAR (and RXR) through a novel, promiscuous NR box (LVMQLL) and enhances transcriptional activity of the receptors in certain cells."	0.282	SIGNOR-255911
SIGNOR-AML	"Acute Myeloid Leukemia"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	FOXO	proteinfamily	SIGNOR-PF27	SIGNOR	down-regulates	relocalization			10090	BTO:0002572								18423396	t		lperfetto	"Akt1/PKBalpha was found to be the major regulator of phosphorylation and nuclear export of FoxO1, whose presence in the nucleus strongly attenuates adipocyte differentiation"	0.912	SIGNOR-252837
SIGNOR-AML	"Acute Myeloid Leukemia"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	BRAF	protein	P15056	UNIPROT	down-regulates	phosphorylation	Ser364	FGQRDRSsSAPNVHI	9606									10869359	t		lperfetto	"We show that phosphorylation of b-raf by akt occurs at multiple residues within its amino terminal regulatory domain, at both the conserved and unique phosphorylation sites. Akt phosphorylated b-raf on s364 and s428 to inactivate its kinase activity b-raf contains three akt consensus sites, table i. One site, ser364 is conserved with c-raf;however, two sites, ser428 and thr439, are unique to b-raf"	0.2	SIGNOR-244152
SIGNOR-AML	"Acute Myeloid Leukemia"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	BRAF	protein	P15056	UNIPROT	down-regulates	phosphorylation	Thr440	EDRNRMKtLGRRDSS	9606									10869359	t		lperfetto	"We show that phosphorylation of b-raf by akt occurs at multiple residues within its amino terminal regulatory domain, at both the conserved and unique phosphorylation sites. Akt phosphorylated b-raf on s364 and s428 to inactivate its kinase activity b-raf contains three akt consensus sites, table i. One site, ser364 is conserved with c-raf;however, two sites, ser428 and thr439, are unique to b-raf"	0.2	SIGNOR-244156
SIGNOR-AML	"Acute Myeloid Leukemia"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	MTOR	protein	P42345	UNIPROT	up-regulates				9606		BTO:0000887;BTO:0001103							12782654	f		lperfetto	"It was shown recently that akt activates mtor through direct phosphorylation of tsc2 the serine/threonine kinase akt is an upstream positive regulator of the mammalian target of rapamycin (mtor). However, the mechanism by which akt activates mtor is not fully understood. The known pathway by which akt activates mtor is via direct phosphorylation and tuberous sclerosis complex 2 (tsc2), which is a negative regulator of mtor."	0.2	SIGNOR-244314
SIGNOR-AML	"Acute Myeloid Leukemia"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	MTOR	protein	P42345	UNIPROT	unknown	phosphorylation	Ser2448	RSRTRTDsYSAGQSV	9606									10910062	t		lperfetto	"AKT phosphorylated mTOR at two COOH-terminal sites (Thr2446 and Ser2448) in vitro, Ser2448 was the major phosphorylation site in insulin-stimulated or -activated AKT-expressing human embryonic kidney cells.  These results demonstrate that mTOR is a direct target of the PI3K-AKT signaling pathway in mitogen-stimulated cells, and that the identified AKT phosphorylation sites are nested within a repressor domain that negatively regulates the catalytic activity of mTOR.¬†"	0.2	SIGNOR-244311
SIGNOR-AML	"Acute Myeloid Leukemia"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	BCL2	protein	P10415	UNIPROT	"up-regulates quantity by stabilization"	phosphorylation	Ser70	RDPVARTsPLQTPAA	9534	BTO:0004055								10677502	t		lperfetto	"Erk1 and erk2 directly phosphorylate bcl2 exclusively at ser-70."	0.2	SIGNOR-244501
SIGNOR-AML	"Acute Myeloid Leukemia"	BCR-ABL	"fusion protein"	SIGNOR-FP6	SIGNOR	GRB2	protein	P62993	UNIPROT	"up-regulates activity"	binding			9534	BTO:0000298				phosphorylation:Tyr177				8402896	t		gcesareni	"BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein. Mutation of Y177 to phenylalanine (Y177F) abolishes GRB-2 binding and abrogates BCR-ABL-induced Ras activation"	0.2	SIGNOR-248199
SIGNOR-AML	"Acute Myeloid Leukemia"	PI3K	complex	SIGNOR-C156	SIGNOR	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"				9606		BTO:0000150							19573809	f		lperfetto	"However, here we show through phosphoprotein profiling and functional genomic studies that many PIK3CA mutant cancer cell lines and human breast tumors exhibit only minimal AKT activation and a diminished reliance on AKT for anchorage-independent growth"	0.796	SIGNOR-252703
SIGNOR-AML	"Acute Myeloid Leukemia"	PI3K	complex	SIGNOR-C156	SIGNOR	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"				9606									12167717	f		lperfetto	"PKB induction requires phosphorylation of two critical residues, threonine 308 in the activation loop and serine 473 near the carboxyl terminus. Membrane localization of PKB was found to be a primary determinant of serine 473 phosphorylation. PI3K activity was equally important for promoting phosphorylation of serine 473,"	0.796	SIGNOR-252715
SIGNOR-AML	"Acute Myeloid Leukemia"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	BRAF	protein	P15056	UNIPROT	down-regulates	phosphorylation	Ser428	GPQRERKsSSSSEDR	9606									10869359	t		lperfetto	"We show that phosphorylation of b-raf by akt occurs at multiple residues within its amino terminal regulatory domain, at both the conserved and unique phosphorylation sites. Akt phosphorylated b-raf on s364 and s428 to inactivate its kinase activity b-raf contains three akt consensus sites, table i. One site, ser364 is conserved with c-raf;however, two sites, ser428 and thr439, are unique to b-raf"	0.2	SIGNOR-244160
SIGNOR-AML	"Acute Myeloid Leukemia"	KDM5A	protein	P29375	UNIPROT	PTEN	protein	P60484	UNIPROT	"down-regulates quantity by destabilization"	"transcriptional regulation"			9606									31374292	t		miannu	"The retinoblastoma binding protein 2 (RBP2) belongs to the KDM5 family, and is also known as JARID1A or KDM5A. We found that histone H3 lysine 4 (H3K4) demethylase RBP2 expression is negatively correlated with BCR-ABL expression, which suggests a regulatory link between these two genes. We also discovered that RBP2 mediates the dephosphorylation of BCR-ABL by directly downregulating PTEN expression, depending on histone demethylase activity, while PTEN targets protein phosphatase activity of BCR-ABL, a phosphatase which directly dephosphorylates BCR-ABL."	0.29	SIGNOR-260079
SIGNOR-AML	"Acute Myeloid Leukemia"	PTEN	protein	P60484	UNIPROT	BCR-ABL	"fusion protein"	SIGNOR-FP6	SIGNOR	"down-regulates activity"	dephosphorylation			9606	BTO:0001544								31374292	t		miannu	"PTEN targets the protein phosphatase activity of BCR-ABL.  PTEN has the same function as PTP1B, which can regulate BCR-ABL dephosphorylation [13]. However, whether PTEN can mediate BCR-ABL dephosphorylation remains unknown. We found that under-expression of PTEN significantly upregulated phosphorylation level of BCR-ABL. In order to verify the mechanisms, co-IP assays were applied, demonstrating the ways in which PTEN and BCR-ABL interact with each other."	0.2	SIGNOR-260080
SIGNOR-AML	"Acute Myeloid Leukemia"	BRAF	protein	P15056	UNIPROT	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	"up-regulates activity"				9606									21900390	f		miannu	"RAF, a cytoplasmic serine-threonine protein kinase, is a member of the RAS-RAF-MEK-ERK cell-signaling pathway [also known as the MAP kinase (MAPK) pathway], and it plays an essential role in mediating cellular differentiation, proliferation, senescence, and survival in response to extracellular cues. Raf phosphorylates and activates MAP-ERK kinase (MEK), which phosphorylates and activates extracellular signal-regulated kinase (ERK)."	0.661	SIGNOR-260082
SIGNOR-AML	"Acute Myeloid Leukemia"	GRB2	protein	P62993	UNIPROT	SOS1	protein	Q07889	UNIPROT	"up-regulates activity"	relocalization			10090	BTO:0000669								23452850	t	"GRB2 associated guanine nucleotide exchange factor Sos activates Ras through the exchange of GDP for GTP"	lperfetto	"Interaction domains of sos1/grb2 are finely tuned for cooperative control of embryonic stem cell fate."	0.914	SIGNOR-235773
SIGNOR-AML	"Acute Myeloid Leukemia"	BCR-ABL	"fusion protein"	SIGNOR-FP6	SIGNOR	JAK2	protein	O60674	UNIPROT	"up-regulates activity"	phosphorylation	Tyr1007	VLPQDKEyYKVKEPG	10090									11593427	t		irozzo	"In this report, we show that Bcr–Abl forms a complex with Jak2, and induces tyrosine phosphorylation of Jak2; full phosphorylation requires the SH2 domain of Bcr–Abl. We found that Y1007 of Jak2 was phosphorylated in Bcr–Abl positive cells; phosphorylation of Jak2 Y1007 is known to be required for Jak2 kinase activation."	0.2	SIGNOR-255812
SIGNOR-AML	"Acute Myeloid Leukemia"	BCR-ABL	"fusion protein"	SIGNOR-FP6	SIGNOR	CSF2RA/CSF2RB	complex	SIGNOR-C212	SIGNOR	"up-regulates activity"	phosphorylation			9606	BTO:0005248								8758906	t		irozzo	"We demonstrated that Bcr-Abl co-immunoprecipitates with, and constitutively phosphorylates, the common βc,subunit of the interleukin 3 and granulocyte/macrophage-colony stimulating factor receptors.We demonstrate that Bcr-Abl interacts with the common βc subunit of the IL-3 family of receptors and phosphorylates it on tyrosine."	0.2	SIGNOR-255999
SIGNOR-AML	"Acute Myeloid Leukemia"	SOS1	protein	Q07889	UNIPROT	KRAS	protein	P01116	UNIPROT	up-regulates	"guanine nucleotide exchange factor"			9606									25624485	t	"Ras proteins bind GDP/GTP and possess intrinsic GTPase activity."	gcesareni	"Because the KRAS-GDP to KRAS-GTP transition catalyzed by the GEF, son of sevenless 1 (SOS1), represents the rate-limiting step for nucleotide exchange, disrupting the activating SOS1/KRAS protein interaction has also been the focus of drug development efforts"	0.829	SIGNOR-201703
SIGNOR-AML	"Acute Myeloid Leukemia"	KRAS	protein	P01116	UNIPROT	PI3K	complex	SIGNOR-C156	SIGNOR	up-regulates	binding			9606									21779497	t		gcesareni	"Grb2 binds and activates sos, which then activates ras, and this activates p110 independently of p85./it was also described that ras interacts with pi3k in a direct manner./lysine residue 227 is essential for the interaction of ras with pi3k phosphatidylinositol 3-kinase (pi3k) is one of the main effector pathways of ras, regulating cell growth, cell cycle entry, cell survival, cytoskeleton reorganization, and metabolism."	0.742	SIGNOR-252698
SIGNOR-AML	"Acute Myeloid Leukemia"	BCR-ABL	"fusion protein"	SIGNOR-FP6	SIGNOR	STAT5A	protein	P42229	UNIPROT	"up-regulates activity"	phosphorylation			10090	BTO:0002882								8642285	t		irozzo	"Phosphorylation of STAT1 and STAT5 was directly due to the tyrosine kinase activity of Bcr/Abl since it could be activated or deactivated by temperature shifting of cells expressing the Bcr/Abl ts mutant.These data suggest that STATs can be activated directly by Bcr/Abl, possibly bypassing JAK family kinase activation."	0.2	SIGNOR-255813
SIGNOR-AML	"Acute Myeloid Leukemia"	BCR-ABL	"fusion protein"	SIGNOR-FP6	SIGNOR	GRB2	protein	P62993	UNIPROT	"down-regulates activity"	phosphorylation	Tyr7	yDFKATAD	9606	BTO:0000007								20554525	t		lperfetto	"More recently, however, tyrosine phosphorylation of Grb2 in BCR-ABL-transformed cells on residues Tyr7, Tyr37, Tyr52, and Tyr209 in the SH3 domains has been reported and shown to negatively regulate the Ras/MAPK pathway."	0.2	SIGNOR-246285
SIGNOR-AML	"Acute Myeloid Leukemia"	BCR-ABL	"fusion protein"	SIGNOR-FP6	SIGNOR	GRB2	protein	P62993	UNIPROT	"down-regulates activity"	phosphorylation	Tyr209	TGMFPRNyVTPVNRN	9606	BTO:0000007								20554525	t		lperfetto	"More recently, however, tyrosine phosphorylation of Grb2 in BCR-ABL-transformed cells on residues Tyr7, Tyr37, Tyr52, and Tyr209 in the SH3 domains has been reported and shown to negatively regulate the Ras/MAPK pathway."	0.2	SIGNOR-246281
SIGNOR-AML	"Acute Myeloid Leukemia"	BCR-ABL	"fusion protein"	SIGNOR-FP6	SIGNOR	GRB2	protein	P62993	UNIPROT	"down-regulates activity"	phosphorylation	Tyr37	EECDQNWyKAELNGK	9606									20554525	t		lperfetto	"More recently, however, tyrosine phosphorylation of Grb2 in BCR-ABL-transformed cells on residues Tyr7, Tyr37, Tyr52, and Tyr209 in the SH3 domains has been reported and shown to negatively regulate the Ras/MAPK pathway."	0.2	SIGNOR-246289
SIGNOR-AML	"Acute Myeloid Leukemia"	BCR-ABL	"fusion protein"	SIGNOR-FP6	SIGNOR	GRB2	protein	P62993	UNIPROT	unknown	phosphorylation	Tyr160	QVPQQPTyVQALFDF	9606	BTO:0000007								20554525	t		lperfetto	"Our data show that BCR-ABL also phosphorylates Grb2 in Tyr160Previous reports suggested an inhibitory role of Grb2 Tyr7, Tyr37, Tyr52, and Tyr209 phosphorylation in receptor tyrosine kinase signaling (16) (43). Instead, in our system Grb2 Tyr160 mutation was not show to have a role in ALCL proliferation."	0.2	SIGNOR-247146
SIGNOR-AML	"Acute Myeloid Leukemia"	BCR-ABL	"fusion protein"	SIGNOR-FP6	SIGNOR	GRB2	protein	P62993	UNIPROT	"down-regulates activity"	phosphorylation	Tyr52	DGFIPKNyIEMKPHP	9606	BTO:0000007								20554525	t		lperfetto	"More recently, however, tyrosine phosphorylation of Grb2 in BCR-ABL-transformed cells on residues Tyr7, Tyr37, Tyr52, and Tyr209 in the SH3 domains has been reported and shown to negatively regulate the Ras/MAPK pathway."	0.2	SIGNOR-246293
SIGNOR-AML	"Acute Myeloid Leukemia"	BCR-ABL	"fusion protein"	SIGNOR-FP6	SIGNOR	GRB2	protein	P62993	UNIPROT	"up-regulates activity"	binding			9606	BTO:0002181								11726515	t		irozzo	"However, direct binding of Grb2 to Bcr/Abl also facilitates its tyrosine phosphorylation, which we propose reflects activation of a physiological negative regulatory mechanism by this oncogenic tyrosine kinase.Direct binding of Grb2 to Bcr/Abl facilitates Grb2 phosphorylation."	0.2	SIGNOR-255820
SIGNOR-AML	"Acute Myeloid Leukemia"	BRAF	protein	P15056	UNIPROT	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	"up-regulates activity"	phosphorylation			9606									21900390	t		miannu	"BRAFV600E has been shown to initiate thyroid follicular cell transformation. The BRAFV600E mutation disrupts the hydrophobic interaction, enabling the BRAF kinase to fold into a catalytically active formation, resulting in an almost 500-fold increase in kinase activity. Mutant BRAF can dimerize and activate MEK without Ras activation."	0.787	SIGNOR-251988
SIGNOR-AML	"Acute Myeloid Leukemia"	BRAF	protein	P15056	UNIPROT	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	up-regulates	phosphorylation			9606									8668348	t		lperfetto	"We show that, consequently, b-raf interacts with mek-1 and mek-2 with a better affinity than does c-raf-1, thus strengthening the notion that b-raf is a stronger mek activator than c-raf-l."	0.787	SIGNOR-244843
SIGNOR-AML	"Acute Myeloid Leukemia"	JAK2	protein	O60674	UNIPROT	CSF2RA/CSF2RB	complex	SIGNOR-C212	SIGNOR	"up-regulates activity"	phosphorylation			9606	BTO:0000876	BTO:0001103							19436055	t		apalma	"The GM-CSF receptor does not have intrinsic tyrosine kinase activity, but associates with the tyrosine kinase Jak2 that is required for Œ≤c transphosphorylation and the initiation of signaling and biological activity"	0.59	SIGNOR-255584
SIGNOR-AML	"Acute Myeloid Leukemia"	CSF2RA/CSF2RB	complex	SIGNOR-C212	SIGNOR	PI3K	complex	SIGNOR-C156	SIGNOR	"up-regulates activity"	binding			9606									19436055	t		miannu	"As a consequence of Jak2 activation and tyrosine phosphorylation of the cytoplasmic tail of Œ≤c, Src homology 2 and phosphotyrosine binding domain proteins are recruited to the active receptor and initiate the major tyrosine phosphorylation-dependent signaling pathways, including the Jak/signal transducer and activator of transcription, Ras/mitogen-activated protein kinase, and phosphatidylinositol 3 (PI-3) kinase pathways"	0.473	SIGNOR-255585
SIGNOR-AML	"Acute Myeloid Leukemia"	CSF2RA/CSF2RB	complex	SIGNOR-C212	SIGNOR	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	"up-regulates activity"				9606	BTO:0000876	BTO:0001103							19436055	f		apalma	"As a consequence of Jak2 activation and tyrosine phosphorylation of the cytoplasmic tail of beta-c, Src homology 2 and phosphotyrosine binding domain proteins are recruited to the active receptor and initiate the major tyrosine phosphorylation-dependent signaling pathways, including the Jak/signal transducer and activator of transcription, Ras/mitogen-activated protein kinase, and phosphatidylinositol 3 (PI-3) kinase pathways"	0.2	SIGNOR-255586
SIGNOR-AML	"Acute Myeloid Leukemia"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	MYC	protein	P01106	UNIPROT	"up-regulates quantity by stabilization"	phosphorylation	Ser62	LLPTPPLsPSRRSGL	10116	BTO:0004725								11018017	t			"Phosphorylation of Ser 62 is required for Ras-induced stabilization of Myc, likely mediated through the action of ERK."	0.2	SIGNOR-252079
SIGNOR-AML	"Acute Myeloid Leukemia"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	BCL2	protein	P10415	UNIPROT	"up-regulates quantity by stabilization"	phosphorylation	Ser87	AAAGPALsPVPPVVH	9606	BTO:0000567								10669763	t		lperfetto	"The results of this study reveal the following novel findings: destruction of the three putative MAP kinase sites at positions 56, 74, and 87 results in ubiquitination and subsequent degradation of the protein. Progressive inactivation of these MAP kinase sites revealed that Bcl-2 stability is mainly regulated by phosphorylation at Thr74 and Ser87, with Ser87 phosphorylation playing a predominant role. TNF-α or the MAP kinase-specific inhibitor PD98059 diminishes Ser87 phosphorylation of Bcl-2 in vivo, while activated ERK2 induces phosphorylation of Bcl-2 in vivo and in vitro."	0.2	SIGNOR-244505
SIGNOR-AML	"Acute Myeloid Leukemia"	HOXA9	protein	P31269	UNIPROT	Differentiation	phenotype	SIGNOR-PH37	SIGNOR	down-regulates				9606	BTO:0000725								14701735	f		irozzo	"Here we demonstrate that MLL-ENL immortalizes cells mainly through inducing a reversible block on myeloid differentiation that is dependent on upregulation of Hoxa9 and Meis1 and that enforced expression of these two genes is sufficient to substitute for MLL-ENL function."	0.7	SIGNOR-255864
SIGNOR-AML	"Acute Myeloid Leukemia"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	BCL2	protein	P10415	UNIPROT	"up-regulates quantity by stabilization"	phosphorylation	Thr74	ARTSPLQtPAAPGAA	9606	BTO:0000567								10669763	t		lperfetto	"The results of this study reveal the following novel findings: destruction of the three putative MAP kinase sites at positions 56, 74, and 87 results in ubiquitination and subsequent degradation of the protein. Progressive inactivation of these MAP kinase sites revealed that Bcl-2 stability is mainly regulated by phosphorylation at Thr74 and Ser87, with Ser87 phosphorylation playing a predominant role. TNF-α or the MAP kinase-specific inhibitor PD98059 diminishes Ser87 phosphorylation of Bcl-2 in vivo, while activated ERK2 induces phosphorylation of Bcl-2 in vivo and in vitro."	0.2	SIGNOR-244494
SIGNOR-AML	"Acute Myeloid Leukemia"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	BCL2	protein	P10415	UNIPROT	"up-regulates quantity by stabilization"	phosphorylation	Thr56	FSSQPGHtPHPAASR	9606									10669763	t		lperfetto	"The results of this study reveal the following novel findings: destruction of the three putative MAP kinase sites at positions 56, 74, and 87 results in ubiquitination and subsequent degradation of the protein. Progressive inactivation of these MAP kinase sites revealed that Bcl-2 stability is mainly regulated by phosphorylation at Thr74 and Ser87."	0.2	SIGNOR-244610
SIGNOR-AML	"Acute Myeloid Leukemia"	FOXO	proteinfamily	SIGNOR-PF27	SIGNOR	Apoptosis	phenotype	SIGNOR-PH2	SIGNOR	up-regulates				9606	BTO:0000007								14976264	f		lperfetto	"Sirt1 inhibited foxo3's ability to induce cell death."	0.7	SIGNOR-252939
SIGNOR-AML	"Acute Myeloid Leukemia"	GRB2	protein	P62993	UNIPROT	SOS1	protein	Q07889	UNIPROT	"up-regulates activity"	relocalization			9606	BTO:0001412								10570290	t	"GRB2 associated guanine nucleotide exchange factor Sos activates Ras through the exchange of GDP for GTP"	lperfetto	"Grb2 binds and activates sos, which then activates ras, and this activates p110 independently of p85."	0.914	SIGNOR-236792
SIGNOR-AML	"Acute Myeloid Leukemia"	GRB2	protein	P62993	UNIPROT	SOS1	protein	Q07889	UNIPROT	"up-regulates activity"	relocalization			9606									8479541	t	"GRB2 associated guanine nucleotide exchange factor Sos activates Ras through the exchange of GDP for GTP"	lperfetto	"Furthermore, our results indicate that the interaction domains of sos1 and grb2 have evolved so as to bind ligands not with maximal strength but with specificities and affinities that maintain cooperativity. Grb2 binds and activates sos, which then activates ras, and this activates p110 independently of p85."	0.914	SIGNOR-39163
SIGNOR-AML	"Acute Myeloid Leukemia"	JAK2	protein	O60674	UNIPROT	MYC	protein	P01106	UNIPROT	"up-regulates quantity by stabilization"	binding			10090									12370803	t		irozzo	"In this study, we show that Jak2 is involved in c-Myc induction by inducing c-MYC mRNA and protecting c-Myc protein from 26S proteasome-dependent degradation. These results indicate that c-Myc is a downstream target of activated Jak2 in Bcr-Abl positive cells. "	0.453	SIGNOR-255810
SIGNOR-AML	"Acute Myeloid Leukemia"	JAK2	protein	O60674	UNIPROT	MYC	protein	P01106	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			10090									12370803	f		irozzo	"In this study, we show that Jak2 is involved in c-Myc induction by inducing c-MYC mRNA and protecting c-Myc protein from 26S proteasome-dependent degradation. These results indicate that c-Myc is a downstream target of activated Jak2 in Bcr-Abl positive cells. "	0.453	SIGNOR-255811
SIGNOR-AML	"Acute Myeloid Leukemia"	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	up-regulates	phosphorylation			9606									11971971	t		lperfetto	"Mapk1 is phosphorylated by map2k1/mek1 and map2k2/mek2 on thr-185 and tyr-187 in response to external stimuli like insulin or ngf. Both phosphorylations are required for activity."	0.758	SIGNOR-244776
SIGNOR-AML	"Acute Myeloid Leukemia"	MTOR	protein	P42345	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation	Ser473	RPHFPQFsYSASGTA	9606	BTO:0000182;BTO:0000018		SIGNOR-C2						15718470	t		lperfetto	"The rictor-mtor complex directly phosphorylated akt/pkb on ser473 in vitro and facilitated thr308 phosphorylation by pdk1"	0.93	SIGNOR-134185
SIGNOR-AML	"Acute Myeloid Leukemia"	MTOR	protein	P42345	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation			9606	BTO:0000132		SIGNOR-C2						21592956	t		lperfetto	"Protein kinase B (PKB, Akt) is a Ser/Thr kinase involved in the regulation of cell survival, proliferation, and metabolism and is activated by dual phosphorylation on Thr(308) in the activation loop and Ser(473) in the hydrophobic motif. It plays a contributory role to platelet function, although little is known about its regulation. In this study, we investigated the role of the mammalian target of rapamycin complex (mTORC)-2 in Akt regulation using the recently identified small molecule ATP competitive mTOR inhibitors PP242 and Torin1."	0.93	SIGNOR-244417
SIGNOR-AML	"Acute Myeloid Leukemia"	KRAS	protein	P01116	UNIPROT	BRAF	protein	P15056	UNIPROT	"up-regulates activity"	binding			9606									21779497	t		miannu	"The raf family of proteins (raf-1, a-raf, and b-raf) is serine/threonine kinases that bind to the effector region of ras-gtp, thus inducing translocation of the protein to the plasma membrane. Once there, raf proteins are activated and phosphorylated by different protein kinases."	0.878	SIGNOR-156906
SIGNOR-AML	"Acute Myeloid Leukemia"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	FOXO	proteinfamily	SIGNOR-PF27	SIGNOR	"down-regulates activity"	phosphorylation	Thr32	QSRPRSCtWPLQRPE	9606	BTO:0000150;BTO:0001130;BTO:0001271;BTO:0000527								19188143	t		lperfetto	"Akt-dependent phosphorylation of foxo3a (thr32, ser253, and ser315 for human foxo3) enhances foxo3a/14-3-3 Interaction and promotes foxo3a nuclear export to the cytoplasm, resulting in the repression of foxo3a transcriptional function"	0.912	SIGNOR-252825
SIGNOR-AML	"Acute Myeloid Leukemia"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	FOXO	proteinfamily	SIGNOR-PF27	SIGNOR	"down-regulates activity"	phosphorylation	Ser253	APRRRAVsMDNSNKY	9606	BTO:0000150;BTO:0001130;BTO:0001271;BTO:0000527								19188143	t		lperfetto	"Akt-dependent phosphorylation of foxo3a (thr32, ser253, and ser315 for human foxo3) enhances foxo3a/14?3?3 Interaction and promotes foxo3a nuclear export to the cytoplasm, resulting in the repression of foxo3a transcriptional function"	0.912	SIGNOR-252826
SIGNOR-AML	"Acute Myeloid Leukemia"	BCR-ABL	"fusion protein"	SIGNOR-FP6	SIGNOR	CSF2RA/CSF2RB	complex	SIGNOR-C212	SIGNOR	"up-regulates activity"	phosphorylation			10090	BTO:0004052								14500898	t		irozzo	"This up-regulation required BCR-ABL tyrosine kinase activity and led to IL-3Rbetac/beta chain tyrosine phosphorylation in the absence of detectable IL-3 production. These results suggested that cytokine-independent IL-3 receptor activation could be a dominant signaling component in BCR-ABL-induced leukemogenesis. However, the IL-3Rβc/β chain could act as a cofactor in BCR-ABL-induced leukemogenesis by activation of its many known oncogenic signaling pathways."	0.2	SIGNOR-256123
SIGNOR-AML	"Acute Myeloid Leukemia"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	FOXO	proteinfamily	SIGNOR-PF27	SIGNOR	down-regulates	phosphorylation	Ser319	TFRPRTSsNASTISG	9606									11237865	t		lperfetto	"The transcription factor, forkhead in rhabdomyosarcoma (fkhr), is phosphorylated at three amino acid residues (thr-24, ser-256 and ser-319) by protein kinase b (pkb)alpha.Fkhr (forkhead in rhabdomyosarcoma), afx (all1 fused gene from chromosome x) and fkhrl1 (fkhr-like 1) are phosphorylated directly by pkb in cells, preventing them from stimulating gene transcription and leading to their exit from the nucleus"	0.912	SIGNOR-252835
SIGNOR-AML	"Acute Myeloid Leukemia"	MTOR	protein	P42345	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606		BTO:0001103							15829723	f		apalma	"Phosphorylation of mTOR by Akt leads to mTOR activation (40, 52) and the subsequent activation of p70S6K (47). This latter event has great potential importance for the promotion of muscle growth by the IGF-I/Akt/mTOR pathway, because p70S6k is a potent stimulator of protein synthesis that can be activated by increases in muscle contraction"	0.7	SIGNOR-255108
SIGNOR-AML	"Acute Myeloid Leukemia"	PI3K	complex	SIGNOR-C156	SIGNOR	PIP3	smallmolecule	CHEBI:16618	ChEBI	"up-regulates quantity"	"chemical modification"			9606									12040186	t		lperfetto	"The activated PI3K converts the plasma membrane lipid phosphatidylinositol-4,5-bisphosphate [PI(4,5)P2] to phosphatidylinositol-3,4,5-trisphosphate [PI(3,4,5)P3]."	0.8	SIGNOR-252713
SIGNOR-AML	"Acute Myeloid Leukemia"	PI3K	complex	SIGNOR-C156	SIGNOR	PIP3	smallmolecule	CHEBI:16618	ChEBI	"up-regulates quantity"	"chemical modification"			9606									24647478	t		lperfetto	"Stimulation of tyrosine kinase receptors initiates a signaling cascade that activates pi3k. Activated pi3k uses pip2 to generate pip3, 24647478"	0.8	SIGNOR-252712
SIGNOR-AML	"Acute Myeloid Leukemia"	PIP3	smallmolecule	CHEBI:16618	ChEBI	PDPK1	protein	O15530	UNIPROT	"up-regulates activity"	"chemical activation"			9606									19951971	t		lperfetto	"PIP3 recruits PDK1 and AKT to the plasma membrane, where PDK1 phosphorylates AKT on Thr308 in the activation loop of the kinase domain."	0.8	SIGNOR-249628
SIGNOR-AML	"Acute Myeloid Leukemia"	BCL2	protein	P10415	UNIPROT	Apoptosis	phenotype	SIGNOR-PH2	SIGNOR	down-regulates				9606									1286168	f		lperfetto	"Bcl-2 functions to inhibit apoptosis in a variety of in vitro and in vivo experiments, suggesting interference with a central mechanism of apoptosis"	0.7	SIGNOR-249611
SIGNOR-AML	"Acute Myeloid Leukemia"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	FOXO	proteinfamily	SIGNOR-PF27	SIGNOR	"down-regulates activity"	phosphorylation	Ser315	DFRSRTNsNASTVSG	9606	BTO:0000150;BTO:0001130;BTO:0001271;BTO:0000527								19188143	t		lperfetto	"Akt-dependent phosphorylation of foxo3a (thr32, ser253, and ser315 for human foxo3) enhances foxo3a/14?3?3 Interaction and promotes foxo3a nuclear export to the cytoplasm, resulting in the repression of foxo3a transcriptional function"	0.912	SIGNOR-252827
SIGNOR-AML	"Acute Myeloid Leukemia"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	FOXO	proteinfamily	SIGNOR-PF27	SIGNOR	down-regulates	phosphorylation	Ser197	APRRRAAsMDSSSKL	9606									16272144	t		lperfetto	"Foxo4 transcription factor, also referred to afx, contains three putative phosphorylation motif sites for protein kinase b (pkb), thr32, ser197, and ser262, and it is proposed that phosphorylated foxo4 stays in the cytosol and is imported to the nucleus through dephosphorylation to induce target gene expression"	0.912	SIGNOR-252828
SIGNOR-AML	"Acute Myeloid Leukemia"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	FOXO	proteinfamily	SIGNOR-PF27	SIGNOR	down-regulates	phosphorylation	Ser262	TFRPRSSsNASSVST	9606									16272144	t		lperfetto	"Foxo4 transcription factor, also referred to afx, contains three putative phosphorylation motif sites for protein kinase b (pkb), thr32, ser197, and ser262, and it is proposed that phosphorylated foxo4 stays in the cytosol and is imported to the nucleus through dephosphorylation to induce target gene expression"	0.912	SIGNOR-252829
SIGNOR-AML	"Acute Myeloid Leukemia"	PDPK1	protein	O15530	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation	Thr308	KDGATMKtFCGTPEY	10090									12808134	t		lperfetto	"Akt1 and akt2 are phosphorylated and activated by the protein kinase pdk1 at thr-308 or thr-309, respectively, in the activation t-loop, and further activation occurs through phosphorylation at ser-473 or ser-474, respectively. In this paper, we demonstrate that this is indeed the case, and report the purification and initial characterization of a 3 phosphoinositide-dependent protein kinase, pdk1, which activates pkb by phosphorylating it at thr308. Akt is directly phosphorylated and activated by pdk1. Akt/pkb activation requires the phosphorylation of thr308 in the activation loop by the phosphoinositide-dependent kinase 1 (pdk1)."	0.746	SIGNOR-134477
SIGNOR-AML	"Acute Myeloid Leukemia"	PDPK1	protein	O15530	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation	Thr308	KDGATMKtFCGTPEY	9606		BTO:0000887;BTO:0001103;BTO:0001760							9512493	t		lperfetto	"The activation of PKBbeta and PKBamma by PDK11 was accompanied by the phosphorylation of the residues equivalent to Thr308 in PKBalpha, namely Thr309 (PKBbeta) and Thr305 (PKBgamma)"	0.746	SIGNOR-244480
SIGNOR-AML	"Acute Myeloid Leukemia"	PDPK1	protein	O15530	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation	Thr308	KDGATMKtFCGTPEY	10116		BTO:0000142							10226025	t		lperfetto	"Protein kinase B (PKB) is activated by phosphorylation of Thr308 and of Ser473. Thr308 is phosphorylated by the 3-phosphoinositide-dependent protein kinase-1 (PDK1) but the identity of the kinase that phosphorylates Ser473 (provisionally termed PDK2) is unknown."	0.746	SIGNOR-244421
SIGNOR-AML	"Acute Myeloid Leukemia"	PIP3	smallmolecule	CHEBI:16618	ChEBI	PDPK1	protein	O15530	UNIPROT	"up-regulates activity"	relocalization			9606									21798082	t		lperfetto	"Pip3 acts in turn as a docking site for two kinases, phosphoinositide-dependent kinase 1 (PDK1) and AKT, and the subsequent phosphorylation of AKT at serine 308 by PDK1, leading to AKT activation."	0.8	SIGNOR-175253
SIGNOR-AML	"Acute Myeloid Leukemia"	PIP3	smallmolecule	CHEBI:16618	ChEBI	PDPK1	protein	O15530	UNIPROT	"up-regulates activity"	relocalization			9534									9637919	t		lperfetto	"In response to PDGF, binding of ptdlns (3,4,5)p3 and/or ptdlns(3,4)p2 to the PH domain of PDK-1 causes its translocation to the plasma membrane where it co-localises with PKB, significantly contributing to the scale of PKB activation."	0.8	SIGNOR-58313
SIGNOR-AML	"Acute Myeloid Leukemia"	PIP3	smallmolecule	CHEBI:16618	ChEBI	PDPK1	protein	O15530	UNIPROT	"up-regulates activity"	"chemical activation"			-1									9094314	t		gcesareni	"We tested the kinase in the presence of several inositol phospholipids and found that only low micromolar concentrations of the D enantiomers of either phosphatidylinositol 3,4,5-triphosphate (PtdIns(3,4,5)P3) or PtdIns(3,4)P2 were effective in potently activating the kinase, which has been named PtdIns(3,4,5)P3-dependent protein kinase-1 (PDK1)"	0.8	SIGNOR-243274
SIGNOR-AML	"Acute Myeloid Leukemia"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	FOXO	proteinfamily	SIGNOR-PF27	SIGNOR	down-regulates	phosphorylation	Ser256	SPRRRAAsMDNNSKF	-1	BTO:0000318								10377430	t		lperfetto	"Here we show that the activation of phosphatidylinositol 3 (PI3) kinase by extracellular growth factors induces phosphorylation, nuclear export, and transcriptional inactivation of FKHR1, a member of the FKHR subclass of the forkhead family of transcription factors. Protein kinase B (PKB)/Akt, a key mediator of PI3 kinase signal transduction, phosphorylated recombinant FKHR1 in vitro at threonine-24 and serine-253. Mutants FKHR1(T24A), FKHR1(S253A), and FKHR1(T24A/S253A) were resistant to both PKB/Akt-mediated phosphorylation and PI3 kinase-stimulated nuclear export."	0.912	SIGNOR-252831
SIGNOR-AML	"Acute Myeloid Leukemia"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	FOXO	proteinfamily	SIGNOR-PF27	SIGNOR	down-regulates	phosphorylation	Thr24	LPRPRSCtWPLPRPE	-1	BTO:0000318								10377430	t		lperfetto	"Here we show that the activation of phosphatidylinositol 3 (PI3) kinase by extracellular growth factors induces phosphorylation, nuclear export, and transcriptional inactivation of FKHR1, a member of the FKHR subclass of the forkhead family of transcription factors. Protein kinase B (PKB)/Akt, a key mediator of PI3 kinase signal transduction, phosphorylated recombinant FKHR1 in vitro at threonine-24 and serine-253. Mutants FKHR1(T24A), FKHR1(S253A), and FKHR1(T24A/S253A) were resistant to both PKB/Akt-mediated phosphorylation and PI3 kinase-stimulated nuclear export."	0.912	SIGNOR-252832
SIGNOR-AML	"Acute Myeloid Leukemia"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	FOXO	proteinfamily	SIGNOR-PF27	SIGNOR	"down-regulates quantity by destabilization"	phosphorylation			9606									21440011	t		lperfetto	"Phosphorylation of FoxOs by Akt inhibits transcriptional functions of FoxOs and contributes to cell survival, growth and proliferation.The PI3K/Akt signaling regulates cell proliferation and survival in part by phosphorylating FoxOs to promote their interaction with 14-3-3 protein that results in nuclear exclusion and eventual ubiquitin proteasome pathway (UPP)-dependent degradation of FoxOs"	0.912	SIGNOR-252833
SIGNOR-AML	"Acute Myeloid Leukemia"	DNMT3A	protein	Q9Y6K1	UNIPROT	CDKN2A	protein	P42771	UNIPROT	"down-regulates quantity by repression"	"transcriptional regulation"			9606									26350239	f		miannu	"Quantitative real-time PCR (qPCR) was used to investigate the effect of DNMT3A on p18INK4C expression, along with the other INK4 members, including p15INK4B, p16INK4A and p19INK4D. The results showed that the depletion of DNMT3A increased the transcriptional levels of the four members of the INK4 family"	0.38	SIGNOR-255809
SIGNOR-AML	"Acute Myeloid Leukemia"	HOXA9	protein	P31269	UNIPROT	MEIS1	protein	O00470	UNIPROT	"up-regulates activity"	binding			-1									9343407	t	2	miannu	"We now show that the Hoxa-9 protein physically interacts with Meis1 proteins.  Hox proteins from the other AbdB-like paralogs, Hoxa-10, Hoxa-11, Hoxd-12, and Hoxb-13, also form DNA binding complexes with Meis1b. DNA binding complexes formed by Meis1 with Hox proteins dissociate much more slowly than DNA complexes with Meis1 alone, suggesting that Hox proteins stabilize the interactions of Meis1 proteins with their DNA targets."	0.619	SIGNOR-241162
SIGNOR-AML	"Acute Myeloid Leukemia"	DNMT3A	protein	Q9Y6K1	UNIPROT	HOXA9	protein	P31269	UNIPROT	"down-regulates quantity by repression"	"transcriptional regulation"			9606									24280869	f		miannu	"HOXA9 is significantly upregulated in both categories of DNMT3A modifications and this has been associated with poor prognosis in AML before (Figure 3d). In fact, almost the entire HOXA and HOXB cluster were significantly upregulated in AML samples with either epimutation or mutation in DNMT3A."	0.339	SIGNOR-256128
SIGNOR-AML	"Acute Myeloid Leukemia"	MEIS1	protein	O00470	UNIPROT	Differentiation	phenotype	SIGNOR-PH37	SIGNOR	down-regulates				9606	BTO:0000725								14701735	f		irozzo	"Here we demonstrate that MLL-ENL immortalizes cells mainly through inducing a reversible block on myeloid differentiation that is dependent on upregulation of Hoxa9 and Meis1 and that enforced expression of these two genes is sufficient to substitute for MLL-ENL function."	0.7	SIGNOR-255865
SIGNOR-AML	"Acute Myeloid Leukemia"	MEIS1	protein	O00470	UNIPROT	Apoptosis	phenotype	SIGNOR-PH2	SIGNOR	down-regulates				9606	BTO:0001271								19109563	f		irozzo	"To discern the mechanisms by which Meis1 inhibition leads to reduced cell growth, we performed cell-cycle and apoptosis analyses.Meis1 knockdown also resulted in increased apoptosis, as evidenced by increased uptake of PI and a stain for activated caspases (CaspaTag) by M26-transduced cells compared with control cells. These results indicate that Meis1 is required for proliferation and survival of 4166 leukemia cells."	0.7	SIGNOR-255860
SIGNOR-AML	"Acute Myeloid Leukemia"	DNMT3A	protein	Q9Y6K1	UNIPROT	MEIS1	protein	O00470	UNIPROT	"down-regulates quantity by repression"	"transcriptional regulation"			9606									28288143	f		miannu	"Our results indicate that, in the absence of mixed lineage leukemia fusions, an alternative pathway for engaging an oncogenic MEIS1-dependent transcriptional program can be mediated by DNMT3A mutations.Under these circumstances, those AML patients carrying the alteration in the DNA methyltransferase would undergo a hypomethylation event at the MEIS1 promoter that would lead to the overexpression of this key oncogene in leukemia."	0.329	SIGNOR-256125
SIGNOR-AML	"Acute Myeloid Leukemia"	DNMT3A	protein	Q9Y6K1	UNIPROT	Differentiation	phenotype	SIGNOR-PH37	SIGNOR	up-regulates				9606									27639498	f		irozzo	"The DNA methyltransferase 3 genes (DNMT3A and DNMT3B) encode methyltransferases that catalyze the addition of a methyl group to the cytosine residue of CpG dinucleotide; therefore they play an essential role in DNA methylation and gene silencing regulatory processes. DNMT3A function is involved in hematopoietic stem cells (HSCs) renewal and myeloid differentiation."	0.7	SIGNOR-255714
SIGNOR-AML	"Acute Myeloid Leukemia"	2-oxoglutarate(2-)	smallmolecule	CHEBI:16810	ChEBI	TET2	protein	Q6N021	UNIPROT	"up-regulates activity"	binding			9606									25699704	t		irozzo	"A second group of AML patients (15%–33% of all cases) harbor mutations in either the isocitrate dehydrogenase (IDH) 1 or 2 gene (Shih et al., 2012). These enzymes produce α-ketoglutarate (α-KG), which is required for TET activity."	0.8	SIGNOR-255706
SIGNOR-AML	"Acute Myeloid Leukemia"	RUNX1	protein	Q01196	UNIPROT	HHEX	protein	Q03014	UNIPROT	"up-regulates quantity"	"transcriptional regulation"			9606									28213513	t			"We identified Hhex as a direct target of RUNX1 and FLT3-ITD stimulation and confirmed high HHEX expression in FLT3-ITD AMLs. HHEX could replace RUNX1 in cooperating with FLT3-ITD to induce AML."	0.272	SIGNOR-256305
SIGNOR-AML	"Acute Myeloid Leukemia"	CBLB	protein	Q13191	UNIPROT	FLT3	protein	P36888	UNIPROT	"down-regulates activity"	ubiquitination			10090	BTO:0001516								19276253	t		miannu	"Functionally, CBL negatively regulated FMS-like tyrosine kinase 3 (FLT3) activity and interacted with human FLT3 via the autophosphorylation sites Y589 and Y599 and colocalized in vivo."	0.323	SIGNOR-260106
SIGNOR-AML	"Acute Myeloid Leukemia"	FLT3	protein	P36888	UNIPROT	ID1	protein	P41134	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			10090									18559972	f		apalma	"In this study, we used specific tyrosine kinase inhibitors to identify critical target genes that are regulated by oncogenic tyrosine kinases. Using oligonucleotide microarrays, we identified genes that are either up- or down-regulated by selective small molecule inhibitors that target the ABL, PDGFβR, or FLT3 kinases. Genes induced by these inhibitors are presumably repressed by activated tyrosine kinases.Among these genes, we detected a 5- to 50-fold reduction in Id1 expression when the cancer cells were treated with inhibitors."	0.263	SIGNOR-255698
SIGNOR-AML	"Acute Myeloid Leukemia"	PML-RARalpha	"fusion protein"	SIGNOR-FP2	SIGNOR	CEBPA	protein	P49715	UNIPROT	"down-regulates quantity by repression"	"transcriptional regulation"			9606									19797526	f			"We therefore conclude that PML-RARα–mediated repression of C/EBPα is driven through a DNA methylation pathway. In accordance with this finding, a recent study in human APL samples described increased C/EBPα promoter methylation, consistent with the ability of PML-RARα to recruit corepressor complexes. Moreover, the PML-RARα effect on C/EBPα repression does not seem to be mediated via direct binding."	0.2	SIGNOR-255726
SIGNOR-AML	"Acute Myeloid Leukemia"	PIM	proteinfamily	SIGNOR-PF34	SIGNOR	Apoptosis	phenotype	SIGNOR-PH2	SIGNOR	down-regulates				9606	BTO:0000574								16146838	f		miannu	"The results of 2 microarray experiments demonstrated that the aberrant activation of STAT proteins by Flt3-ITDs resulted in the up-regulation of several STAT5-responsive genes, such as Pim-1, Pim-2, and members of the SOCS (suppressor of cytokine signaling) protein family. These results are particularly interesting because recent data point to an important role of Pim kinases in the antiapoptosis of hematopoietic cells."	0.7	SIGNOR-255732
SIGNOR-AML	"Acute Myeloid Leukemia"	STAT5A	protein	P42229	UNIPROT	PIM	proteinfamily	SIGNOR-PF34	SIGNOR	"up-regulates quantity by expression"	"transcriptional regulation"			9606	BTO:0004479								29507660	f		irozzo	"FLT3-ITD is the most frequent tyrosine kinase mutation in acute myeloid leukemia (AML) associated with poor prognosis. We previously reported that activation of STAT5 confers resistance to PI3K/Akt inhibitors on the FLT3-ITD-positive AML cell line MV4-11 and 32D cells driven by FLT3-ITD (32D/ITD) but not by FLT3 mutated in the tyrosine kinase domain (32D/TKD). Here, we report the involvement of Pim kinases expressed through STAT5 activation in acquisition of this resistance."	0.413	SIGNOR-255733
SIGNOR-AML	"Acute Myeloid Leukemia"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	FOXO	proteinfamily	SIGNOR-PF27	SIGNOR	down-regulates	phosphorylation			9606									21798082	t		lperfetto	"Akt inactivates protein degradation by phosphorylating and thus repressing the transcription factors of the foxo family, and stimulates protein synthesis via the mammalian target of rapamycin (mtor) and glycogen synthase kinase 3b (gsk3b)."	0.912	SIGNOR-252820
SIGNOR-AML	"Acute Myeloid Leukemia"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	FOXO	proteinfamily	SIGNOR-PF27	SIGNOR	down-regulates	phosphorylation			9606									21620960	t		gcesareni	"Akt phosphorylates members of the foxo factors (forkhead family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localisation. In particular, akt phosphorylates foxo1 on thr24, ser256 and ser319. Foxo 3alfa and foxo4 are phosphorylated on equivalent sites. In addition, phosphorylation of afx by protein kinase b inhibits its transcriptional activity."	0.912	SIGNOR-252824
SIGNOR-AML	"Acute Myeloid Leukemia"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	FOXO	proteinfamily	SIGNOR-PF27	SIGNOR	down-regulates	phosphorylation	Thr32	QSRPRSCtWPLPRPE	9606									16272144	t		lperfetto	"Foxo4 transcription factor, also referred to afx, contains three putative phosphorylation motif sites for protein kinase b (pkb), thr32, ser197, and ser262, and it is proposed that phosphorylated foxo4 stays in the cytosol and is imported to the nucleus through dephosphorylation to induce target gene expression"	0.912	SIGNOR-252830
SIGNOR-AML	"Acute Myeloid Leukemia"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	FOXO	proteinfamily	SIGNOR-PF27	SIGNOR	down-regulates	phosphorylation			9606									18394876	t		lperfetto	"The phosphorylation of the two remaining akt-dependent sites inhibits foxo6 transcriptional activity"	0.912	SIGNOR-252834
SIGNOR-AML	"Acute Myeloid Leukemia"	SOX4	protein	Q06945	UNIPROT	CTNNB1	protein	P35222	UNIPROT	"up-regulates activity"	binding			9606	BTO:0000038								17875931	t		irozzo	"We have demonstrated that Sox17 and Sox4 can directly interact with β-catenin and TCF/LEF proteins.Sox4 enhances β-catenin/TCF activity and the proliferation of SW480 cells.In contrast, Sox4 may function to stabilize β-catenin protein."	0.599	SIGNOR-256138
SIGNOR-AML	"Acute Myeloid Leukemia"	FLT3LG	protein	P49771	UNIPROT	FLT3	protein	P36888	UNIPROT	up-regulates	binding			9606	BTO:0001271								12681969	t		gcesareni	"Flt3 is activated by binding of its natural flt3-ligand (flt3-l),"	0.885	SIGNOR-99750
SIGNOR-AML	"Acute Myeloid Leukemia"	BRAF	protein	P15056	UNIPROT	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	"up-regulates activity"	phosphorylation			-1									8413257	t		lperfetto	"Raf-1 phosphorylation of MEK activated it, as judged by its ability to stimulate the phosphorylation of myelin basic protein by glutathione S-transferase-ERK1."	0.787	SIGNOR-244831
SIGNOR-AML	"Acute Myeloid Leukemia"	FLT3LG	protein	P49771	UNIPROT	FLT3	protein	P36888	UNIPROT	up-regulates	binding			9606									10080542	t		gcesareni	"Flt3 ligand (fl) is an early-acting potent co-stimulatory cytokine that regulates proliferation and differentiation of a number of blood cell lineages. Its receptor flt3/flk2 belongs to class iii receptor tyrosine kinases that also include the receptors for colony-stimulating factor 1"	0.885	SIGNOR-65564
SIGNOR-AML	"Acute Myeloid Leukemia"	FLT3	protein	P36888	UNIPROT	GRB2	protein	P62993	UNIPROT	"up-regulates activity"	binding			10090									10080542	t		gcesareni	"FL stimulation induces association of Grb2 with Flt3, SHP-2,and Shc"	0.606	SIGNOR-245060
SIGNOR-AML	"Acute Myeloid Leukemia"	FLT3	protein	P36888	UNIPROT	STAT5A	protein	P42229	UNIPROT	"up-regulates activity"	phosphorylation	Tyr694	LAKAVDGyVKPQIKQ	10090	BTO:0002882								17356133	t		gcesareni	"in vitro kinase assays revealed that STAT5 is a direct target of Flt3"	0.611	SIGNOR-245069
SIGNOR-AML	"Acute Myeloid Leukemia"	ID1	protein	P41134	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	up-regulates	binding			9606	BTO:0004136								26084673	t		apalma	"We have determined that Id1 physically interacts with AKT1, through its C-terminal region, and promotes AKT1 phosphorylation;"	0.335	SIGNOR-255942
SIGNOR-AML	"Acute Myeloid Leukemia"	GRB10	protein	Q13322	UNIPROT	PI3K	complex	SIGNOR-C156	SIGNOR	"up-regulates activity"	binding			10090	BTO:0001516								23246379	t			"Grb10 transduces signal from FLT3 by direct interaction with p85 and Ba/F3-FLT3-ITD cells expressing Grb10 exhibits higher STAT5 activation"	0.332	SIGNOR-255946
SIGNOR-AML	"Acute Myeloid Leukemia"	FLT3	protein	P36888	UNIPROT	GRB10	protein	Q13322	UNIPROT	"up-regulates activity"	binding			10090	BTO:0001516								23246379	t			"These results suggest that Grb10 binds to both normal and oncogenic FLT3 and induces PI3K–Akt and STAT5 signaling pathways resulting in an enhanced proliferation, survival and colony formation of hematopoietic cells."	0.361	SIGNOR-255947
SIGNOR-AML	"Acute Myeloid Leukemia"	PML-RARalpha	"fusion protein"	SIGNOR-FP2	SIGNOR	NFY	complex	SIGNOR-C1	SIGNOR	"up-regulates activity"	binding			9606	BTO:0000972								18025157	t			"We show that the ID1 and ID2 promoters are activated by PML-RARalpha but, unexpectedly, not by wild-type RARalpha/RXR. Our data support a model in which the PML-RARalpha fusion protein regulates a novel class of target genes by interaction with the Sp1 and NF-Y transcription factors, without directly binding to the DNA, defining a gain-of-function for the oncoprotein."	0.2	SIGNOR-255747
SIGNOR-AML	"Acute Myeloid Leukemia"	NFY	complex	SIGNOR-C1	SIGNOR	ID1	protein	P41134	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			9606									18025157	f			"We show that the ID1 and ID2 promoters are activated by PML-RARalpha but, unexpectedly, not by wild-type RARalpha/RXR. Our data support a model in which the PML-RARalpha fusion protein regulates a novel class of target genes by interaction with the Sp1 and NF-Y transcription factors, without directly binding to the DNA, defining a gain-of-function for the oncoprotein."	0.269	SIGNOR-255746
SIGNOR-AML	"Acute Myeloid Leukemia"	SP1	protein	P08047	UNIPROT	ID1	protein	P41134	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			9606									18025157	f			"We show that the ID1 and ID2 promoters are activated by PML-RARalpha but, unexpectedly, not by wild-type RARalpha/RXR. Our data support a model in which the PML-RARalpha fusion protein regulates a novel class of target genes by interaction with the Sp1 and NF-Y transcription factors, without directly binding to the DNA, defining a gain-of-function for the oncoprotein."	0.2	SIGNOR-255748
SIGNOR-AML	"Acute Myeloid Leukemia"	PML-RARalpha	"fusion protein"	SIGNOR-FP2	SIGNOR	SP1	protein	P08047	UNIPROT	"up-regulates activity"	binding			9606	BTO:0001412								18025157	t			"We show that the ID1 and ID2 promoters are activated by PML-RARalpha but, unexpectedly, not by wild-type RARalpha/RXR. Our data support a model in which the PML-RARalpha fusion protein regulates a novel class of target genes by interaction with the Sp1 and NF-Y transcription factors, without directly binding to the DNA, defining a gain-of-function for the oncoprotein."	0.2	SIGNOR-255749
SIGNOR-AML	"Acute Myeloid Leukemia"	PML-RARalpha	"fusion protein"	SIGNOR-FP2	SIGNOR	SP1	protein	P08047	UNIPROT	"up-regulates activity"	binding			-1									18025157	t			"We show that PML-RARα physically interacts with Sp1 in the absence of DNA. In this report, we show that PML-RARα interacts with Sp1 and may interfere with the expression of genes that are not normally regulated by retinoic acid receptors."	0.2	SIGNOR-255729
SIGNOR-AML	"Acute Myeloid Leukemia"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	AP1	complex	SIGNOR-C154	SIGNOR	up-regulates	phosphorylation	Thr232	GGLPEVAtPESEEAF	9606									7816602	t		lperfetto	"Phosphorylation of the c-fos and c-jun hob1 motif stimulates its activation capacity here we show that the hob1-containing activation domain of c-fos is stimulated by ha-ras in vivo and phosphorylated by a map kinase family member in vitro and that mutating t232 to ala abolishes both functions."	0.795	SIGNOR-252359
SIGNOR-AML	"Acute Myeloid Leukemia"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	AP1	complex	SIGNOR-C154	SIGNOR	up-regulates	phosphorylation	Ser374	PSSDSLSsPTLLAL	9606									12972619	t		lperfetto	"In a previous study we have observed that exposure of nih 3t3 cells to pdgf or serum leads to c-fos phosphorylation by erk on specific residues, thr232, thr325, thr331, and ser374, within the cooh-terminal c-fos tad we have recently shown that erk phosphorylates multiple residues within the carboxylterminal transactivation domain (tad) of c-fos, thus resulting in its increased transcriptional activity."	0.795	SIGNOR-252358
SIGNOR-AML	"Acute Myeloid Leukemia"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	AP1	complex	SIGNOR-C154	SIGNOR	up-regulates	phosphorylation	Thr325	TELEPLCtPVVTCTP	9606									12972619	t		lperfetto	"In a previous study we have observed that exposure of nih 3t3 cells to pdgf or serum leads to c-fos phosphorylation by erk on specific residues, thr232, thr325, thr331, and ser374, within the cooh-terminal c-fos tad we have recently shown that erk phosphorylates multiple residues within the carboxylterminal transactivation domain (tad) of c-fos, thus resulting in its increased transcriptional activity."	0.795	SIGNOR-252357
SIGNOR-AML	"Acute Myeloid Leukemia"	JAK2	protein	O60674	UNIPROT	JAK2	protein	O60674	UNIPROT	"up-regulates activity"	phosphorylation	Tyr221	IRAKIQDyHILTRKR	9606	BTO:0000007								15143187	t			"JAK2 is autophosphorylated on tyrosines 221 and 1007. tyrosines 221 and 570 in JAK2 may serve as regulatory sites in JAK2, with phosphorylation of tyrosine 221 increasing kinase activity and phosphorylation of tyrosine 570 decreasing kinase activity"	0.2	SIGNOR-251356
SIGNOR-AML	"Acute Myeloid Leukemia"	PML-RARalpha	"fusion protein"	SIGNOR-FP2	SIGNOR	AP1	complex	SIGNOR-C154	SIGNOR	"up-regulates activity"				9606	BTO:0000093								8415704	f		miannu	"PML-RAR alpha chimera cooperates with c-Jun and, strikingly, with c-Fos to stimulate the transcription of both synthetic and natural reporter genes containing an AP-1 site"	0.2	SIGNOR-261507
SIGNOR-AML	"Acute Myeloid Leukemia"	KIT	protein	P10721	UNIPROT	PI3K	complex	SIGNOR-C156	SIGNOR	"up-regulates activity"	phosphorylation			9606	BTO:0000830								15526160	t		miannu	"Activation of PI3-kinase by c-Kit has been linked to mitogenesis, differentiation, survival, adhesion, secretion and actin cytoskeletal reorganization. In c-Kit, Y721 has been found to directly interact with PI3-kinase"	0.724	SIGNOR-254949
SIGNOR-AML	"Acute Myeloid Leukemia"	AML1-ETO	"fusion protein"	SIGNOR-FP1	SIGNOR	KIT	protein	P10721	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			9606									29236325	f		irozzo	"We report here that AML1/ETO transactivates c-KIT expression through directly binding to and mediating the long-range interaction between the promoter and intronic enhancer regions of c-KIT."	0.2	SIGNOR-255699
SIGNOR-AML	"Acute Myeloid Leukemia"	AML1-ETO	"fusion protein"	SIGNOR-FP1	SIGNOR	AP1	complex	SIGNOR-C154	SIGNOR	"up-regulates activity"	binding			9606	BTO:0004136								10208431	t		miannu	"The AML1/ETO fusion protein is essential to the development of t(8;21) acute myeloid leukemia (AML) and is well recognized for its dominant-negative effect on the coexisting wild-type protein AML1. On physical interaction, AML1/ETO can form a complex with wild-type AML1 on chromatin, and the runt homology domain of both proteins are responsible for their interactions. More importantly, the relative binding signals of AML1 and AML1/ETO on chromatin determine which genes are repressed or activated by AML1/ETO. Further analysis of coregulators indicates that AML1/ETO transactivates gene expression through recruiting AP-1 to the AML1/ETO-AML1 complex. AML1/ETO transactivates gene expression through recruiting AP-1 to the AML1/ETO-AML1 complex"	0.2	SIGNOR-260094
SIGNOR-AML	"Acute Myeloid Leukemia"	BCR-ABL	"fusion protein"	SIGNOR-FP6	SIGNOR	CTNNB1	protein	P35222	UNIPROT	up-regulates	phosphorylation	Tyr654	RNEGVATyAAAVLFR	9606	BTO:0001271								17318191	t		lperfetto	"Bcr-abl stabilizes beta-catenin in chronic myeloid leukemia through its tyrosine phosphorylationthe notion that y86 and y654 are located respectively within the n_ and c_terminal transcriptional domains of __catenin suggests that one or both residues might regulate the transactivating function of __catenin. In this regard, phosphorylation of y654 was reported to strengthen __catenin association with the basal transcription factor tata_binding protein (tbp)"	0.2	SIGNOR-153431
SIGNOR-AML	"Acute Myeloid Leukemia"	BCR-ABL	"fusion protein"	SIGNOR-FP6	SIGNOR	NRAS	protein	P01111	UNIPROT	"up-regulates activity"				9534									8402896	f		miannu	"BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein. Mutation of Y177 to phenylalanine (Y177F) abolishes GRB-2 binding and abrogates BCR-ABL-induced Ras activation."	0.2	SIGNOR-261506
SIGNOR-AML	"Acute Myeloid Leukemia"	CDKN2A	protein	P42771	UNIPROT	CDK6	protein	Q00534	UNIPROT	down-regulates	binding			9606									8891723	t		miannu	"The first group, including p16ink4a, p15ink4b,p18ink4cand p19ink4d, is specific for the g1 cdks,cdk4and cdk6, inhibiting the kinase activity of cyclin d/cdk4-cdk6 complexes on prb."	0.871	SIGNOR-44557
SIGNOR-AML	"Acute Myeloid Leukemia"	CDK6	protein	Q00534	UNIPROT	RUNX1	protein	Q01196	UNIPROT	"up-regulates activity"	phosphorylation	Ser276	VHPATPIsPGRASGM	9606									21059642	t	"The effect has been demonstrated using Q01196-8"	gcesareni	"Phosphorylation of runx1 on ser-303 by cdks leads its ubiquitin-mediated degradation during g2/m (19). We developed additional evidence that cdks phosphorylate ser-303 and found that ser-48 and ser-424 are also substrates of cdk1/cyclin b and cdk6/cyclin d3. Moreover, we demonstrated that phosphorylation of ser-48, ser-303, and ser-424 strengthens the ability of runx1 to activate transcription and to stimulate proliferation of the ba/f3 hematopoietic cell line (20)."	0.616	SIGNOR-169334
SIGNOR-AML	"Acute Myeloid Leukemia"	"NUP98 Fusion"	"fusion protein"	SIGNOR-FP16	SIGNOR	CDK6	protein	Q00534	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			9606									32344427	f		miannu	"NUP98-fusion proteins directly regulate leukemia-associated gene expression programs in AML. CDK6 expression is under direct transcriptional control of NUP98-fusions and NUP98-fusion AML is particularly sensitive to CDK6 inhibition."	0.2	SIGNOR-261505
SIGNOR-AML	"Acute Myeloid Leukemia"	WT1	protein	P19544	UNIPROT	DNMT3A	protein	Q9Y6K1	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			9606									23042785	t		irozzo	"Here, we show that Wilms' tumour 1 (WT1), a developmental master regulator that can also act as a tumour suppressor or oncoprotein, transcriptionally regulates the de novo DNA methyltransferase 3A (DNMT3A) and that cellular WT1 levels can influence DNA methylation of gene promoters genome-wide. we demonstrate that depletion of WT1 by short-interfering RNAs leads to reduced DNMT3A in Wilms' tumour cells and human embryonal kidney-derived cell lines. Chromatin immunoprecipitation assays demonstrate WT1 recruitment to the DNMT3A promoter region and reporter assays confirm that WT1 directly transactivates DNMT3A expression."	0.381	SIGNOR-255904
SIGNOR-AML	"Acute Myeloid Leukemia"	STAT5A	protein	P42229	UNIPROT	DNMT3A	protein	Q9Y6K1	UNIPROT	"up-regulates quantity"	"transcriptional regulation"			9606									26059451	t			"… these data suggest that STAT5A positively regulates levels of DNMT3A, resulting in inactivation of tumor suppressor genes by epigenetic mechanisms in AML cells"	0.326	SIGNOR-255631
SIGNOR-AML	"Acute Myeloid Leukemia"	STAT5A	protein	P42229	UNIPROT	Apoptosis	phenotype	SIGNOR-PH2	SIGNOR	down-regulates				9606	BTO:0001096								14530308	f		apalma	"Specific inhibition of Stat5a/b promotes apoptosis of IL-2-responsive primary and tumor-derived lymphoid cells"	0.7	SIGNOR-256583
SIGNOR-AML	"Acute Myeloid Leukemia"	RUNX1	protein	Q01196	UNIPROT	Differentiation	phenotype	SIGNOR-PH37	SIGNOR	up-regulates				9606									19334039	f		lperfetto	"AML1/RUNX1 mutants play a central role in the pathogenesis of MDS/AML. Both AML1 mutants are initiating factors for MDS-genesis by inhibiting differentiation of hematopoietic stem cells, and Ni-type mutant requires acquisition of proliferation ability."	0.7	SIGNOR-249631
SIGNOR-AML	"Acute Myeloid Leukemia"	PTEN	protein	P60484	UNIPROT	STAT5A	protein	P42229	UNIPROT	down-regulates	dephosphorylation			9606									20596030	t		miannu	"The forced expression of pten in the eol-1r cells dephosphorylated akt, erk and stat5 /eol-1r cells showed epigenetic silencing of the phosphatase and tensin homolog deleted on chromosome ten (pten) gene. Exposure of eol-1r cells to imatinib failed to dephosphorylate akt, erk and stat5, although pdgfr? Was effectively inactivated. The forced expression of pten negatively regulated these signal pathways and sensitized eol-1r cells to imatinib."	0.438	SIGNOR-166481
SIGNOR-AML	"Acute Myeloid Leukemia"	PTEN	protein	P60484	UNIPROT	PTEN	protein	P60484	UNIPROT	"up-regulates activity"	dephosphorylation	Thr383	HYRYSDTtDSDPENE	9606									22413754	t		miannu	"Overall, our results suggest that PTEN autodephosphorylation may be a critical event in this process; thus a major protein substrate for PTEN may be PTEN itself.|Various studies have demonstrated that PTEN is itself a phosphoprotein, and that the major sites of phosphorylation are found in an acidic stretch (DHYRYSDTTDSDPENE) near the C-terminus [1]. This prompted us to consider whether PTEN may autodephosphorylate these sites"	0.2	SIGNOR-248545
SIGNOR-AML	"Acute Myeloid Leukemia"	PTEN	protein	P60484	UNIPROT	PTEN	protein	P60484	UNIPROT	"up-regulates activity"	dephosphorylation	Thr382	DHYRYSDtTDSDPEN	9606									22413754	t		miannu	"Overall, our results suggest that PTEN autodephosphorylation may be a critical event in this process; thus a major protein substrate for PTEN may be PTEN itself.|Various studies have demonstrated that PTEN is itself a phosphoprotein, and that the major sites of phosphorylation are found in an acidic stretch (DHYRYSDTTDSDPENE) near the C-terminus [1]. This prompted us to consider whether PTEN may autodephosphorylate these sites"	0.2	SIGNOR-248546
SIGNOR-AML	"Acute Myeloid Leukemia"	PTEN	protein	P60484	UNIPROT	PTEN	protein	P60484	UNIPROT	"up-regulates activity"	dephosphorylation	Ser380	EPDHYRYsDTTDSDP	9606									22413754	t		miannu	"Overall, our results suggest that PTEN autodephosphorylation may be a critical event in this process; thus a major protein substrate for PTEN may be PTEN itself.|Various studies have demonstrated that PTEN is itself a phosphoprotein, and that the major sites of phosphorylation are found in an acidic stretch (DHYRYSDTTDSDPENE) near the C-terminus [1]. This prompted us to consider whether PTEN may autodephosphorylate these sites"	0.2	SIGNOR-248544
SIGNOR-AML	"Acute Myeloid Leukemia"	PML-RARalpha	"fusion protein"	SIGNOR-FP2	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606	BTO:0001412								8394219	f			"We expressed the PML-RARa protein in U937 myeloid precursor cells and showed that they lost the capacity to differentiate under the action of different stimuli (vitamin Ds and transforming growth factor pl), acquired enhanced sensitivity to retinoic acid, and exhibited a higher growth rate consequent to diminished apoptotic cell death."	0.7	SIGNOR-255722
SIGNOR-AML	"Acute Myeloid Leukemia"	PI3K	complex	SIGNOR-C156	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606	BTO:0000876	BTO:0001103							19436055	f		apalma	"Low pM concentrations of GM-CSF mediate βc Ser585 phosphorylation, leading to 14-3-3 binding, PI-3 kinase activation, and hemopoietic cell survival, whereas at concentrations of 10 pM or more, GM-CSF mediates βc Tyr577 phosphorylation, Shc recruitment, and PI-3 kinase activation, thereby promoting both survival and proliferation."	0.7	SIGNOR-255577
SIGNOR-AML	"Acute Myeloid Leukemia"	NRAS	protein	P01111	UNIPROT	PI3K	complex	SIGNOR-C156	SIGNOR	"up-regulates activity"	binding			9606									21779497	t		lperfetto	"Grb2 binds and activates sos, which then activates ras, and this activates p110 independently of p85./it was also described that ras interacts with pi3k in a direct manner./lysine residue 227 is essential for the interaction of ras with pi3k"	0.681	SIGNOR-252700
SIGNOR-AML	"Acute Myeloid Leukemia"	"MLL Fusion"	"fusion protein"	SIGNOR-FP14	SIGNOR	RUNX1	protein	Q01196	UNIPROT	"down-regulates quantity by repression"	"transcriptional regulation"			9606									24449215	f		miannu	"However, the functional consequence of MLL fusions on RUNX1/CBFβ activity has not been fully understood. In this report, we show that MLL fusion proteins and the N-terminal MLL portion of MLL fusions downregulate RUNX1 and CBFβ protein expression via the MLL CXXC domain and flanking regions."	0.2	SIGNOR-260129
SIGNOR-AML	"Acute Myeloid Leukemia"	MEN1	protein	O00255	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				10090									16415155	f		irozzo	"We also found that menin is important for the proliferation of MLL oncoprotein-transformed myeloid cells, pointing to a paradoxically oncogenic role for the tumor suppressor menin in proliferation of transformed myeloid cells."	0.7	SIGNOR-255895
SIGNOR-AML	"Acute Myeloid Leukemia"	MEN1	protein	O00255	UNIPROT	"MLL Fusion"	"fusion protein"	SIGNOR-FP14	SIGNOR	"up-regulates activity"	binding			10090	BTO:0004730								16239140	t		miannu	"We demonstrate here that oncogenic MLL fusion proteins retain an ability to stably associate with menin through a high-affinity, amino-terminal, conserved binding motif and that this interaction is required for the initiation of MLL-mediated leukemogenesis.These results demonstrate that a human oncoprotein is critically dependent on direct physical interaction with a tumor suppressor protein for its oncogenic activity."	0.2	SIGNOR-260130
SIGNOR-AML	"Acute Myeloid Leukemia"	MECOM	protein	Q03112	UNIPROT	RUNX1	protein	Q01196	UNIPROT	"down-regulates activity"	binding			10090									17575132	t		irozzo	"The results that we present here support this model and show that EVI1 interacts with and inhibits RUNX1. As for GATA1, EVI1 seems to repress RUNX1 function by interacting specifically with its DNA-binding domain Runt, leading to destabilization and dissolution of the DNA-RUNX1 complex."	0.53	SIGNOR-255716
SIGNOR-AML	"Acute Myeloid Leukemia"	JAK2	protein	O60674	UNIPROT	JAK2	protein	O60674	UNIPROT	up-regulates	phosphorylation	Tyr966	QICKGMEyLGTKRYI	9606	BTO:0000007								20304997	t		lperfetto	"Tyrosines 868, 966, and 972 in the kinase domain of jak2 are autophosphorylated and required for maximal jak2 kinase activity"	0.2	SIGNOR-236290
SIGNOR-AML	"Acute Myeloid Leukemia"	JAK2	protein	O60674	UNIPROT	JAK2	protein	O60674	UNIPROT	up-regulates	phosphorylation	Tyr868	GSVEMCRyDPLQDNT	9606	BTO:0000007								20304997	t		lperfetto	"Tyrosines 868, 966, and 972 in the kinase domain of jak2 are autophosphorylated and required for maximal jak2 kinase activity"	0.2	SIGNOR-236298
SIGNOR-AML	"Acute Myeloid Leukemia"	JAK2	protein	O60674	UNIPROT	JAK2	protein	O60674	UNIPROT	up-regulates	phosphorylation	Tyr221	IRAKIQDyHILTRKR	9606	BTO:0000007								15143187	t		lperfetto	"Autophosphorylation of jak2 on tyrosines 221 and 570 regulates its activity with phosphorylation of tyrosine 221 increasing kinase activity"	0.2	SIGNOR-236506
SIGNOR-AML	"Acute Myeloid Leukemia"	JAK2	protein	O60674	UNIPROT	JAK2	protein	O60674	UNIPROT	"up-regulates activity"	phosphorylation	Tyr972	EYLGTKRyIHRDLAT	9606	BTO:0000007								20304997	t		lperfetto	"Tyrosines 868, 966, and 972 in the kinase domain of jak2 are autophosphorylated and required for maximal jak2 kinase activity"	0.2	SIGNOR-236294
SIGNOR-AML	"Acute Myeloid Leukemia"	JAK2	protein	O60674	UNIPROT	JAK2	protein	O60674	UNIPROT	"up-regulates activity"	phosphorylation	Tyr813	NSLFTPDyELLTEND	9606	BTO:0000007								15121872	t	"16705160:The effect of Ser523 on Jak2 function was independent of Tyr570-mediated inhibition."	lperfetto	"Tyrosine 813 is a site of jak2 autophosphorylation critical for activation of jak2 by sh2-b betawe show that phosphorylation of tyrosine 813 is required for the sh2 domain-containing adapter protein sh2-b beta to bind jak2 and to enhance the activity of jak2 and stat5b."	0.2	SIGNOR-235910
SIGNOR-AML	"Acute Myeloid Leukemia"	JAK2	protein	O60674	UNIPROT	JAK2	protein	O60674	UNIPROT	"up-regulates activity"	phosphorylation	Tyr637	KFGSLDTyLKKNKNC	9606	BTO:0000007								19364823	t	"16705160:The effect of Ser523 on Jak2 function was independent of Tyr570-mediated inhibition."	lperfetto	"Analysis of in vitro autophosphorylated jak2while cytokine receptor stimulation mediates the phosphorylation of both tyr317 and tyr637, these residues oppositely regulate jak2-dependent signaling: the mutation of tyr317 enhances jak2 function, suggesting a role for the phosphorylation of tyr317 in the inhibition of jak2. Conversely, mutation of tyr637 reduces jak2 signaling, suggesting a role for the phosphorylation of this residue in the activation of jak2."	0.2	SIGNOR-235885
SIGNOR-AML	"Acute Myeloid Leukemia"	JAK2	protein	O60674	UNIPROT	JAK2	protein	O60674	UNIPROT	"up-regulates activity"	phosphorylation	Tyr201	DQTPLAIyNSISYKT	9534	BTO:0000298								17027227	t			"Site of Jak2 tyrosine autophosphorylation; namely, tyrosine 201. Jak2 tyrosine residue 201 was the principal mediator of SHP-2 binding as conversion of this tyrosine residue to phenylalanine abolished this interaction"	0.2	SIGNOR-251360
SIGNOR-AML	"Acute Myeloid Leukemia"	JAK2	protein	O60674	UNIPROT	JAK2	protein	O60674	UNIPROT	"up-regulates activity"	phosphorylation	Tyr1007	VLPQDKEyYKVKEPG	-1									9111318	t			"Multiple autophosphorylation sites on Jak2, including Y1007 and Y1008. Activation of Jak2 catalytic activity requires phosphorylation of Y1007 in the kinase activation loop."	0.2	SIGNOR-251357
SIGNOR-AML	"Acute Myeloid Leukemia"	JAK2	protein	O60674	UNIPROT	JAK2	protein	O60674	UNIPROT	unknown	phosphorylation	Tyr1007	VLPQDKEyYKVKEPG	-1									9111318	t			"Within the Jak2 kinase domain, there is a region that has considerable sequence homology to the regulatory region of the insulin receptor and contains two tyrosines, Y1007 and Y1008, that are potential regulatory sites.  Y1007 and Y1008 are sites of trans- or autophosphorylation in vivo and in in vitro kinase reactions. Mutation of Y1007, or both Y1007 and Y1008, to phenylalanine essentially eliminated kinase activity, whereas mutation of Y1008 to phenylalanine had no detectable effect on kinase activity"	0.2	SIGNOR-251358
SIGNOR-AML	"Acute Myeloid Leukemia"	JAK2	protein	O60674	UNIPROT	JAK2	protein	O60674	UNIPROT	down-regulates	phosphorylation	Tyr317	TEQDLQLyCDFPNII	9606	BTO:0000007								19364823	t	"16705160:the phosphorylation of Jak2 on Ser523 inhibits Jak2 activity and represents a novel mechanism for the regulation of Jak2-dependent cytokine signaling."	lperfetto	"Analysis of in vitro autophosphorylated jak2while cytokine receptor stimulation mediates the phosphorylation of both tyr317 and tyr637, these residues oppositely regulate jak2-dependent signaling: the mutation of tyr317 enhances jak2 function, suggesting a role for the phosphorylation of tyr317 in the inhibition of jak2. Conversely, mutation of tyr637 reduces jak2 signaling, suggesting a role for the phosphorylation of this residue in the activation of jak2."	0.2	SIGNOR-236502
SIGNOR-AML	"Acute Myeloid Leukemia"	JAK2	protein	O60674	UNIPROT	JAK2	protein	O60674	UNIPROT	"down-regulates activity"	phosphorylation	Tyr570	VRREVGDyGQLHETE	9606	BTO:0000007								15143187	t			"JAK2 is autophosphorylated on tyrosines 221 and 1007. tyrosines 221 and 570 in JAK2 may serve as regulatory sites in JAK2, with phosphorylation of tyrosine 221 increasing kinase activity and phosphorylation of tyrosine 570 decreasing kinase activity"	0.2	SIGNOR-251359
SIGNOR-AML	"Acute Myeloid Leukemia"	JAK2	protein	O60674	UNIPROT	JAK2	protein	O60674	UNIPROT	"down-regulates activity"	phosphorylation	Tyr570	VRREVGDyGQLHETE	9606									21841788	t		lperfetto	"The jak2 jh2 domain functions as a negative regulator and is presumed to be a catalytically inactive pseudokinase, but the mechanism(s) for its inhibition of jak2 remains unknown. Here we show that jh2 is a dual-specificity protein kinase that phosphorylates two negative regulatory sites in jak2: ser523 and tyr570."	0.2	SIGNOR-176058
SIGNOR-AML	"Acute Myeloid Leukemia"	JAK2	protein	O60674	UNIPROT	JAK2	protein	O60674	UNIPROT	"down-regulates activity"	phosphorylation	Ser523	GVSDVPTsPTLQRPT	9606									21841788	t		lperfetto	"The jak2 jh2 domain functions as a negative regulator and is presumed to be a catalytically inactive pseudokinase, but the mechanism(s) for its inhibition of jak2 remains unknown. Here we show that jh2 is a dual-specificity protein kinase that phosphorylates two negative regulatory sites in jak2: ser523 and tyr570."	0.2	SIGNOR-176054
SIGNOR-AML	"Acute Myeloid Leukemia"	DOT1L	protein	Q8TEK3	UNIPROT	HOXA9	protein	P31269	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			9606									20854876	f		irozzo	"Inhibition of EAP components pTEFb and Dot1l show that both contribute significantly to activation of Hoxa9 and Meis1 expression. EAP is dynamically associated with the Hoxa9 and Meis1 loci in hematopoietic cells and rapidly dissociates during induction of differentiation. In the presence of MLL fusion proteins, its dissociation is prevented."	0.449	SIGNOR-256141
SIGNOR-AML	"Acute Myeloid Leukemia"	CEBPA	protein	P49715	UNIPROT	Differentiation	phenotype	SIGNOR-PH37	SIGNOR	up-regulates				9606	BTO:0004730								16319681	f		lperfetto	"The transcription factor C/EBPalpha controls differentiation and proliferation in normal granulopoiesis in a stage-specific manner. Loss of C/EBPalpha function in myeloid cells in vitro and in vivo leads to a block to myeloid differentiation similar to that which is observed in malignant cells from patients with acute myeloid leukemia. The finding of C/EBPalpha alterations in subgroups of acute myeloid leukemia patients suggests a direct link between critically decreased C/EBPalpha function and the development of the disorder."	0.7	SIGNOR-249632
SIGNOR-AML	"Acute Myeloid Leukemia"	CEBPA	protein	P49715	UNIPROT	CEBPA	protein	P49715	UNIPROT	"up-regulates quantity"	"transcriptional regulation"			9606	BTO:0001056								11283671	t		apalma	"Here, we demonstrate that C/EBPα indeed activates its promoter in transient transfection assays in myeloid cells."	0.2	SIGNOR-255673
SIGNOR-AML	"Acute Myeloid Leukemia"	CDKN2A	protein	Q8N726	UNIPROT	TP53	protein	P04637	UNIPROT	"up-regulates quantity by stabilization"				9606									12091906	f		apalma	"P14/p19 ARF functions by antagonizing MDM2 and thereby stabilizing p53 (refs. 17,18). Thus, loss of p14/p19ARF impairs p53-mediated growth arrest and/or apoptosis in response to activated oncogenes"	0.793	SIGNOR-255694
SIGNOR-AML	"Acute Myeloid Leukemia"	CCNA1	protein	P78396	UNIPROT	WT1	protein	P19544	UNIPROT	"down-regulates quantity by repression"	"transcriptional regulation"			9606									19082485	f		irozzo	"This study identified WT1 as a repressed target of cyclin A1 and suggests that the suppression of WT1 in cyclin A1-overexpressing leukemias might play a role in the growth and suppression of apoptosis in these leukemic cells."	0.39	SIGNOR-255905
SIGNOR-AML	"Acute Myeloid Leukemia"	CBFbeta-MYH11	"fusion protein"	SIGNOR-FP3	SIGNOR	TP53	protein	P04637	UNIPROT	"down-regulates quantity by repression"	"transcriptional regulation"			10090									9834241	f		miannu	"CBFbeta-SMMHC, Expressed in M4eo Acute Myeloid Leukemia, Reduces p53 Induction and Slows Apoptosis in Hematopoietic Cells Exposed to DNA-damaging Agents Reduced p53 induction may be caused in part by direct inhibition of p53 gene transcription, because p53 mRNA levels were reduced by CBFβ-SMMHC. Attenuated p53 induction and slowed apoptosis may contribute to leukemogenesis by CBFβ-SMMHC."	0.2	SIGNOR-256132
SIGNOR-AML	"Acute Myeloid Leukemia"	STAT5A	protein	P42229	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606	BTO:0000830								20535135	f		miannu	"Specifically, SCF-induced activation of JAK2 in human mast cells has been shown to activate STAT5 and STAT6. STAT5 contributes to mast cell homeostasis, by mediating proliferation, survival, and mediator release."	0.7	SIGNOR-256233
SIGNOR-AML	"Acute Myeloid Leukemia"	CBFbeta-MYH11	"fusion protein"	SIGNOR-FP3	SIGNOR	TP53	protein	P04637	UNIPROT	"down-regulates activity"	binding			10090	BTO:0002882								26387755	t			"Here, we show that p53 activity is inhibited in inv(16)+ AML LSCs via interactions with the CBFβ-SMMHC (CM) fusion protein and histone deacetylase 8 (HDAC8).Altogether, these results indicate that CM fusion protein binds to p53 and impairs acetylation and activation of p53."	0.2	SIGNOR-255737
SIGNOR-AML	"Acute Myeloid Leukemia"	CBFbeta-MYH11	"fusion protein"	SIGNOR-FP3	SIGNOR	RUNX1	protein	Q01196	UNIPROT	"down-regulates activity"	binding			9606									29958106	t		miannu	"The genes encoding CBFβ and RUNX1 are frequent targets of mutations in hematologic malignancies. The chromosome inversion inv(16)(p13;q22), found in 8% of acute myeloid leukemia (AML) cases, fuses the CBFB and MYH11 genes to produce the leukemic oncoprotein CBFβ-SMMHC. This fusion protein has higher affinity and altered stoichiometry for RUNX1 relative to the native CBFβ (Cao et al., 1997; Lukasik et al., 2002). During development, CBFβ-SMMHC expression blocks definitive hematopoiesis and embryos die at mid-gestation (Castilla et al., 1996), a similar phenotype to that of Runx1- and Cbfb-knock out embryos (Wang et al., 1996a; Wang et al., 1996b), indicating that CBFβ-SMMHC has a dominant negative effect on RUNX function."	0.2	SIGNOR-255743
SIGNOR-AML	"Acute Myeloid Leukemia"	PML-RARalpha	"fusion protein"	SIGNOR-FP2	SIGNOR	CCNA1	protein	P78396	UNIPROT	"up-regulates activity"				9606									11090075	t		apalma	"We show that the ectopic expression of PML-RARα is sufficient to elevate levels of cyclin A1 in U937 myeloid leukemia cells and cyclin A1 is negatively regulated by the RARα pathway."	0.2	SIGNOR-256373
SIGNOR-AML	"Acute Myeloid Leukemia"	"MLL Fusion"	"fusion protein"	SIGNOR-FP14	SIGNOR	MECOM	protein	Q03112	UNIPROT	"up-regulates quantity by expression"	methylation			10090	BTO:0001271								22553314	t		miannu	"We hypothesize, based on our ChIP data, that MLL-AF9 up-regulates EVI1 transcription via H3K79 methylation, which is known to be a major gene regulatory mechanism used by some MLL-fusion proteins in leukemia."	0.2	SIGNOR-260107
SIGNOR-AML	"Acute Myeloid Leukemia"	"MLL Fusion"	"fusion protein"	SIGNOR-FP14	SIGNOR	DOT1L	protein	Q8TEK3	UNIPROT	"up-regulates activity"	binding			9606	BTO:0001133								18977325	t		miannu	"Recent studies have identified association of multiple MLL-fusion partners including AF4, AF9, and AF10 with DOT1L, a histone H3K79 methyltransferase.This leads to a model where MLL-AF4 recruits DOT1L to MLL target genes, and promotes methylation of H3K79 at loci with existing H3K4 methylation (i.e., by wildtype MLL or other H3K4 methyltransferases) thus stimulating transcriptional elongation of genes that are normally primed but not fully transcribed."	0.2	SIGNOR-260095
SIGNOR-AML	"Acute Myeloid Leukemia"	AMPK	complex	SIGNOR-C15	SIGNOR	TET2	protein	Q6N021	UNIPROT	"up-regulates quantity by stabilization"	phosphorylation	Ser99	GGIKRTVsEPSLSGLL	9606	BTO:0001025								30022161	t			"We identify the tumour suppressor TET2 as a substrate of the AMP-activated kinase (AMPK), which phosphorylates TET2 at serine 99, thereby stabilizing the tumour suppressor. Increased glucose levels impede AMPK-mediated phosphorylation at serine 99, which results in the destabilization of TET2 followed by dysregulation of both 5-hydroxymethylcytosine (5hmC) and the tumour suppressive function of TET2 in vitro and in vivo"	0.2	SIGNOR-256135
SIGNOR-AML	"Acute Myeloid Leukemia"	glucose	chemical	CHEBI:17234	ChEBI	AMPK	complex	SIGNOR-C15	SIGNOR	"down-regulates activity"				10090	BTO:0000222								18477450	f			"Glucose restriction (GR) impaired differentiation of skeletal myoblasts and was associated with activation of the AMP-activated protein kinase (AMPK)."	0.8	SIGNOR-256137
SIGNOR-AML	"Acute Myeloid Leukemia"	AMPK	complex	SIGNOR-C15	SIGNOR	FOXO	proteinfamily	SIGNOR-PF27	SIGNOR	"up-regulates activity"	phosphorylation	Ser399	DNITLPPsQPSPTGG	9606	BTO:0000007								17711846	t		gcesareni	"Phosphorylation by AMPK leads to the activtion of FOXO3 transcriptional activity without affecting FOXO3 subcellular localization."	0.415	SIGNOR-252880
SIGNOR-AML	"Acute Myeloid Leukemia"	FOXO	proteinfamily	SIGNOR-PF27	SIGNOR	CDKN1B	protein	P46527	UNIPROT	"up-regulates quantity"	"transcriptional regulation"			10090									10783894	t		gcesareni	"AFX transcriptionally activates p27kip1, resulting in increased protein levels."	0.2	SIGNOR-252928
SIGNOR-AML	"Acute Myeloid Leukemia"	CDKN1B	protein	P46527	UNIPROT	CDK1	protein	P06493	UNIPROT	down-regulates	binding			9606									15340381	t		gcesareni	"P21 and p27 are key inhibitors of both cdk1 and cdk2."	0.65	SIGNOR-128445
SIGNOR-AML	"Acute Myeloid Leukemia"	CDK1	protein	P06493	UNIPROT	KAT5	protein	Q92993	UNIPROT	up-regulates	phosphorylation	Ser86	TKNGLPGsRPGSPER	9606									16103124	t		gcesareni	"Moreover, app stabilized tip60 through cdk-dependent phosphorylation"	0.477	SIGNOR-139649
SIGNOR-AML	"Acute Myeloid Leukemia"	CDK1	protein	P06493	UNIPROT	KAT5	protein	Q92993	UNIPROT	up-regulates	phosphorylation	Ser90	LPGSRPGsPEREVPA	9606									16103124	t		lperfetto	"Moreover, app stabilized tip60 through cdk-dependent phosphorylation"	0.477	SIGNOR-139653
SIGNOR-AML	"Acute Myeloid Leukemia"	KAT5	protein	Q92993	UNIPROT	SRSF2	protein	Q01130	UNIPROT	down-regulates	acetylation	Lys52	IPRDRYTkESRGFAF	9606									21157427	t		miannu	"In this study, we provide the first evidence that the acetyltransferase tip60 acetylates srsf2 on its lysine 52 residue inside the rna recognition motif, and promotes its proteasomal degradation."	0.466	SIGNOR-170594
SIGNOR-AML	"Acute Myeloid Leukemia"	FOXO	proteinfamily	SIGNOR-PF27	SIGNOR	IDH1	protein	O75874	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			9606									25648147	t		miannu	"We identify FOXOs as transcriptional activators of IDH1. FOXOs promote IDH1 expression and thereby maintain the cytosolic levels of α-ketoglutarate and NADPH."	0.2	SIGNOR-260088
SIGNOR-AML	"Acute Myeloid Leukemia"	AMPK	complex	SIGNOR-C15	SIGNOR	MTOR	protein	P42345	UNIPROT	"down-regulates activity"				9606									30274374	f		miannu	"AMPK inhibits the mTOR pathway through phosphorylation and activation of tuberous sclerosis protein 2 (TSC2) and causes direct activation of unc-51-like autophagy activating kinase 1 (ULK1) via phosphorylation of Ser555, thus promoting initiation of autophagy."	0.572	SIGNOR-260096
SIGNOR-AML	"Acute Myeloid Leukemia"	AMPK	complex	SIGNOR-C15	SIGNOR	TET2	protein	Q6N021	UNIPROT	"up-regulates activity"	phosphorylation			9606	BTO:0001412								31900833	t		miannu	"Inactivation of AMPK suppressed the expression of ten-eleven translocation methylcytosine dioxygenase 2 (TET2) in tumor cells.   Compound C-induced AMPK suppression causes downregulation TET2 and FOXP3 expression, leading to death of parental and HQ-selected U937 cells. These results confirm the connection of AMPK with the TET2–FOXP3 axis in modulating the survival of AML cells and suggest that suppression of the AMPK–TET2–FOXP3 axis suppresses the progression of AML and HQ-induced malignant transformation of AML cells."	0.2	SIGNOR-260097
SIGNOR-AML	"Acute Myeloid Leukemia"	ASXL2	protein	Q76L83	UNIPROT	TET2	protein	Q6N021	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			9606									28516957	f		miannu	"Interestingly, this identified a number of genes known to promote leukemogenesis (either alone or in the context of AML1-ETO leukemia) as differentially expressed by ASXL2 loss. These include downregulation of TET2 as well as NOTCH2 with ASXL2 loss in human AML1-ETO-expressing cells, downregulation of which have been previously shown to functionally promote myeloid leukemogenesis when altered in expression"	0.338	SIGNOR-260074
SIGNOR-AML	"Acute Myeloid Leukemia"	ETV6	protein	P41212	UNIPROT	Differentiation	phenotype	SIGNOR-PH37	SIGNOR	up-regulates				9606	BTO:0000960;BTO:0002062								15958056	f		irozzo	"We thus conclude that TEL is also an accelerator for erythroid differentiation upon cytokine stimulation in human hematopoietic cells. We demonstrated in the present study that TEL accelerates erythroid differentiation induced by a physiological cytokine EPO in human leukemia cell line UT-7/GM."	0.7	SIGNOR-256017
SIGNOR-AML	"Acute Myeloid Leukemia"	JAK2	protein	O60674	UNIPROT	STAT3	protein	P40763	UNIPROT	"up-regulates activity"	phosphorylation	Tyr705	DPGSAAPyLKTKFIC	9606	BTO:0000599								9575217	t		lperfetto	"Inactive cytoplasmic STATs are recruited to the activated receptor by docking of the STAT SH2 domain to selected receptor tyrosine phosphopeptides, where they are in turn phosphorylated on a single tyrosine by Jak kinases. Has been identified tyrosine 705 of Stat3 as the likely site of phosphorylation by Jak kinases during signal transduction."	0.822	SIGNOR-238638
SIGNOR-AML	"Acute Myeloid Leukemia"	KITLG	protein	P21583	UNIPROT	KIT	protein	P10721	UNIPROT	up-regulates	binding			9606									1698556	t		gcesareni	"We have also provided biological and physical evidence that scf is a ligand for the c-kit receptor."	0.935	SIGNOR-21193
SIGNOR-AML	"Acute Myeloid Leukemia"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	ETV6	protein	P41212	UNIPROT	down-regulates	phosphorylation	Ser213	DNMIRRLsPAERAQG	10090	BTO:0000944								15060146	t		miannu	"Leukemia-related transcription factor TEL is negatively regulated through extracellular signal-regulated kinase-induced phosphorylation. Overexpressed TEL becomes phosphorylated in vivo by activated ERK. TEL is also directly phosphorylated in vitro by ERK. The inducible phosphorylation sites are Ser(213) and Ser(257)."	0.2	SIGNOR-260084
SIGNOR-AML	"Acute Myeloid Leukemia"	KIT	protein	P10721	UNIPROT	PTPN11	protein	Q06124	UNIPROT	"up-regulates activity"	phosphorylation			10090	BTO:0002882								22806893	t		irozzo	"SHP2 can be phosphorylated at 2 C-terminal tyrosyl residues by receptor tyrosine kinases, including KIT as well as cytosolic tyrosine kinases, including Src and Abl. The level of tyrosyl phosphorylation of SHP2 has been associated with its recruitment to the receptor.Thus, pharmacologic inhibition of SHP2 phosphatase function might permit SHP2 to return to its inactive conformation resulting in reduced tyrosine phosphorylation."	0.688	SIGNOR-256140
SIGNOR-AML	"Acute Myeloid Leukemia"	SH2B3	protein	Q9UQQ2	UNIPROT	JAK2	protein	O60674	UNIPROT	"down-regulates activity"	binding			10090	BTO:0002882								18618018	t		miannu	"we identified Lnk as a physiological negative regulator of JAK2 in stem cells and TPO/Mpl/JAK2/Lnk as a major regulatory pathway in controlling stem cell self-renewal and quiescence. we identify a direct interaction between Lnk and the Mpl/JAK2 complex that regulates various HSC functions."	0.65	SIGNOR-260075
SIGNOR-AML	"Acute Myeloid Leukemia"	KIT	protein	P10721	UNIPROT	PI3K	complex	SIGNOR-C156	SIGNOR	"up-regulates activity"	binding			10090	BTO:0000141								18179858	t		irozzo	"KIT mutations within the carboxy-terminal region of the cytoplasmic tyrosine kinase domain (TK2), such as KITD816V, stabilize the KIT activation loop conformation in its active form.Previous studies have demonstrated hyperactivation of p85α regulatory subunit of class IA phosphatidylinositol-3-kinase (PI3K) in cell lines expressing the activation loop mutant of KIT. Although p85α is hyperphosphorylated and constitutively bound to KITD814V in cell-line models."	0.724	SIGNOR-256121
SIGNOR-AML	"Acute Myeloid Leukemia"	SH2B3	protein	Q9UQQ2	UNIPROT	BCL2L1	protein	Q07817	UNIPROT	"down-regulates quantity by repression"	"transcriptional regulation"			9606									22101255	f		miannu	"Our results indicated that lnk/sh2b3 constrains expression of bcl-xl and participates in the regulation of hsc homeostasis by maintaining proper responses against various proapoptotic stimuli."	0.2	SIGNOR-177485
SIGNOR-CRC	"Colorectal Carcinoma"	LRP5	protein	O75197	UNIPROT	GSK3B/Axin/APC	complex	SIGNOR-C110	SIGNOR	"down-regulates quantity by destabilization"	relocalization			9606									11336703	t		lperfetto	"Lrp-5, a close homolog of lrp-6 (hey et al., 1998), functions as a coreceptor for wnt proteins in mammalian cells and that it can transduce the canonical wnt signals, at least in part by binding and recruiting axin to membranes"	0.69	SIGNOR-227930
SIGNOR-CRC	"Colorectal Carcinoma"	SMAD3	protein	P84022	UNIPROT	BCL2	protein	P10415	UNIPROT	"down-regulates quantity by repression"	"transcriptional regulation"			9606									16766264	f		irozzo	"This protection is conferred by Smad3’s ability to promote apoptosis by repressing Bcl-2 transcription in vivo through a GC-rich element in the Bcl-2 promoter."	0.2	SIGNOR-256294
SIGNOR-CRC	"Colorectal Carcinoma"	PTEN	protein	P60484	UNIPROT	PTEN	protein	P60484	UNIPROT	"up-regulates activity"	dephosphorylation	Thr383	HYRYSDTtDSDPENE	9606									22413754	t		miannu	"Overall, our results suggest that PTEN autodephosphorylation may be a critical event in this process; thus a major protein substrate for PTEN may be PTEN itself.|Various studies have demonstrated that PTEN is itself a phosphoprotein, and that the major sites of phosphorylation are found in an acidic stretch (DHYRYSDTTDSDPENE) near the C-terminus [1]. This prompted us to consider whether PTEN may autodephosphorylate these sites"	0.2	SIGNOR-248545
SIGNOR-CRC	"Colorectal Carcinoma"	PTEN	protein	P60484	UNIPROT	PTEN	protein	P60484	UNIPROT	"up-regulates activity"	dephosphorylation	Thr382	DHYRYSDtTDSDPEN	9606									22413754	t		miannu	"Overall, our results suggest that PTEN autodephosphorylation may be a critical event in this process; thus a major protein substrate for PTEN may be PTEN itself.|Various studies have demonstrated that PTEN is itself a phosphoprotein, and that the major sites of phosphorylation are found in an acidic stretch (DHYRYSDTTDSDPENE) near the C-terminus [1]. This prompted us to consider whether PTEN may autodephosphorylate these sites"	0.2	SIGNOR-248546
SIGNOR-CRC	"Colorectal Carcinoma"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606		BTO:0001103							20219869	f		apalma	"ERK1/2 activation is a component of the pathway through which many mitogenic growth factors can stimulate cell proliferation"	0.7	SIGNOR-256216
SIGNOR-CRC	"Colorectal Carcinoma"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	MYC	protein	P01106	UNIPROT	"up-regulates quantity by stabilization"	phosphorylation	Ser62	LLPTPPLsPSRRSGL	10116	BTO:0004725								11018017	t			"Phosphorylation of Ser 62 is required for Ras-induced stabilization of Myc, likely mediated through the action of ERK."	0.2	SIGNOR-252079
SIGNOR-CRC	"Colorectal Carcinoma"	GSK3B/Axin/APC	complex	SIGNOR-C110	SIGNOR	CTNNB1	protein	P35222	UNIPROT	"down-regulates activity"	phosphorylation	Ser33	QQQSYLDsGIHSGAT	9606		BTO:0000586							16293724	t		lperfetto	"This leads to the inactivation and release of glycogen synthase kinase 3beta from its complex with axin, thereby relieving the inhibitory phosphorylation of beta-catenin and activating its signaling pathway."	0.896	SIGNOR-227885
SIGNOR-CRC	"Colorectal Carcinoma"	GSK3B/Axin/APC	complex	SIGNOR-C110	SIGNOR	CTNNB1	protein	P35222	UNIPROT	"down-regulates activity"	phosphorylation	Ser37	YLDSGIHsGATTTAP	9606									11955436	t		lperfetto	"Wnt regulation of beta-catenin degradation is essential for development and carcinogenesis. beta-catenin degradation is initiated upon amino-terminal serine/threonine phosphorylation, which is believed to be performed by glycogen synthase kinase-3 (GSK-3) in complex with tumor suppressor proteins Axin and adnomatous polyposis coli (APC)."	0.896	SIGNOR-227901
SIGNOR-CRC	"Colorectal Carcinoma"	ATM	protein	Q13315	UNIPROT	ATM	protein	Q13315	UNIPROT	"up-regulates activity"	phosphorylation	Ser2996	QECKRNLsDIDQSFN	9606									21149446	t		gcesareni	"In human cells, the activation process involves autophosphorylation on three sites (ser367, ser1893, and ser1981) and acetylation on lys3016. We now describe the identification of a new atm phosphorylation site, thr(p)1885 and an additional autophosphorylation site, ser(p)2996, that is highly dna damage-inducible."	0.2	SIGNOR-170473
SIGNOR-CRC	"Colorectal Carcinoma"	PTEN	protein	P60484	UNIPROT	PTEN	protein	P60484	UNIPROT	"up-regulates activity"	dephosphorylation	Ser380	EPDHYRYsDTTDSDP	9606									22413754	t		miannu	"Overall, our results suggest that PTEN autodephosphorylation may be a critical event in this process; thus a major protein substrate for PTEN may be PTEN itself.|Various studies have demonstrated that PTEN is itself a phosphoprotein, and that the major sites of phosphorylation are found in an acidic stretch (DHYRYSDTTDSDPENE) near the C-terminus [1]. This prompted us to consider whether PTEN may autodephosphorylate these sites"	0.2	SIGNOR-248544
SIGNOR-CRC	"Colorectal Carcinoma"	GSK3B/Axin/APC	complex	SIGNOR-C110	SIGNOR	CTNNB1	protein	P35222	UNIPROT	"down-regulates activity"	phosphorylation	Thr41	GIHSGATtTAPSLSG	9606	BTO:0000938	BTO:0000142							19303846	t		lperfetto	"GSK3β regulates β-catenin stability by phosphorylating serine and threonine residues (Ser33/37 and Thr41) important for targeting β-catenin for ubiquitin-dependent proteasomal degradation"	0.896	SIGNOR-227878
SIGNOR-CRC	"Colorectal Carcinoma"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	BCL2	protein	P10415	UNIPROT	"up-regulates quantity by stabilization"	phosphorylation	Ser87	AAAGPALsPVPPVVH	9606	BTO:0000567								10669763	t		lperfetto	"The results of this study reveal the following novel findings: destruction of the three putative MAP kinase sites at positions 56, 74, and 87 results in ubiquitination and subsequent degradation of the protein. Progressive inactivation of these MAP kinase sites revealed that Bcl-2 stability is mainly regulated by phosphorylation at Thr74 and Ser87, with Ser87 phosphorylation playing a predominant role. TNF-α or the MAP kinase-specific inhibitor PD98059 diminishes Ser87 phosphorylation of Bcl-2 in vivo, while activated ERK2 induces phosphorylation of Bcl-2 in vivo and in vitro."	0.2	SIGNOR-244505
SIGNOR-CRC	"Colorectal Carcinoma"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	BCL2	protein	P10415	UNIPROT	"up-regulates quantity by stabilization"	phosphorylation	Thr74	ARTSPLQtPAAPGAA	9606	BTO:0000567								10669763	t		lperfetto	"The results of this study reveal the following novel findings: destruction of the three putative MAP kinase sites at positions 56, 74, and 87 results in ubiquitination and subsequent degradation of the protein. Progressive inactivation of these MAP kinase sites revealed that Bcl-2 stability is mainly regulated by phosphorylation at Thr74 and Ser87, with Ser87 phosphorylation playing a predominant role. TNF-α or the MAP kinase-specific inhibitor PD98059 diminishes Ser87 phosphorylation of Bcl-2 in vivo, while activated ERK2 induces phosphorylation of Bcl-2 in vivo and in vitro."	0.2	SIGNOR-244494
SIGNOR-CRC	"Colorectal Carcinoma"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	BCL2	protein	P10415	UNIPROT	"up-regulates quantity by stabilization"	phosphorylation	Thr56	FSSQPGHtPHPAASR	9606									10669763	t		lperfetto	"The results of this study reveal the following novel findings: destruction of the three putative MAP kinase sites at positions 56, 74, and 87 results in ubiquitination and subsequent degradation of the protein. Progressive inactivation of these MAP kinase sites revealed that Bcl-2 stability is mainly regulated by phosphorylation at Thr74 and Ser87."	0.2	SIGNOR-244610
SIGNOR-CRC	"Colorectal Carcinoma"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	SOS1	protein	Q07889	UNIPROT	down-regulates	phosphorylation	Ser1193	QPTSKAYsPRYSISD	9606									20724475	t		lperfetto	"ERK activation was sufficient for the SOS1 phosphorylation and resulting inhibition of EGF-induced Ras activation. This result also showed that SOS1 could be phosphorylated by ERK in the absence of association with EGFR at the plasma membrane, which is a phosphotyrosine-dependent process."	0.2	SIGNOR-244747
SIGNOR-CRC	"Colorectal Carcinoma"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	SOS1	protein	Q07889	UNIPROT	down-regulates	phosphorylation	Ser1178	IMSKHLDsPPAIPPR	9606									20724475	t		lperfetto	"ERK activation was sufficient for the SOS1 phosphorylation and resulting inhibition of EGF-induced Ras activation. This result also showed that SOS1 could be phosphorylated by ERK in the absence of association with EGFR at the plasma membrane, which is a phosphotyrosine-dependent process."	0.2	SIGNOR-244743
SIGNOR-CRC	"Colorectal Carcinoma"	TGFBR1	protein	P36897	UNIPROT	SMAD3	protein	P84022	UNIPROT	"up-regulates activity"	phosphorylation	Ser423	SPSIRCSsVS	10090	BTO:0005493;BTO:0000165								19458083	t		lperfetto	"A major event leading to smad3 activation is the tgf-beta-induced, tbetari-mediated phosphorylation at two c-terminal serine residues, ser-423 and ser-425, which triggers dissociation of smad3 from its receptors to form a complex with smad4 and accumulate in the nucleus"	0.816	SIGNOR-235385
SIGNOR-CRC	"Colorectal Carcinoma"	TGFBR1	protein	P36897	UNIPROT	SMAD3	protein	P84022	UNIPROT	"up-regulates activity"	phosphorylation	Ser425	SIRCSSVs	10090	BTO:0005493;BTO:0000165								19458083	t		lperfetto	"A major event leading to Smad3 activation is the TGF-beta-induced, TbetaRI-mediated phosphorylation at two C-terminal serine residues, Ser-423 and Ser-425, which triggers dissociation of Smad3 from its receptors to form a complex with Smad4 and accumulate in the nucleus"	0.816	SIGNOR-235380
SIGNOR-CRC	"Colorectal Carcinoma"	IGF1R	protein	P08069	UNIPROT	IGF1R	protein	P08069	UNIPROT	up-regulates	phosphorylation	Tyr1165	RDIYETDyYRKGGKG	9606									7493944	t		lperfetto	"Insulin and insulin-like growth factor (IGF-I) receptors are heterotetrameric proteins consisting of two alpha-and two beta-subunits and members of the transmembrane tyrosine kinase receptors. Specific ligand binding to the receptor triggers a cascade of intracellular events, which begins with autophosphorylation of several tyrosine residues of the beta-subunit of the receptor."	0.2	SIGNOR-26586
SIGNOR-CRC	"Colorectal Carcinoma"	IGF1R	protein	P08069	UNIPROT	IGF1R	protein	P08069	UNIPROT	up-regulates	phosphorylation	Tyr973	RLGNGVLyASVNPEY	-1									7493944	t		lperfetto	"The insulin-like growth factor type I (IGF-I) receptor can become tyrosine phosphorylated and enzymatically activated either in response to ligand or because of the activity of the Src tyrosine kinase. We mapped the sites of IGF-I receptor autophosphorylation to peptides representing three different receptor domains: tyrosines 943 and 950 in the juxtamembrane region; tyrosines 1131, 1135, and 1136 within the kinase domain; and tyrosine 1316 in the carboxyl-terminal domain."	0.2	SIGNOR-246252
SIGNOR-CRC	"Colorectal Carcinoma"	IGF1R	protein	P08069	UNIPROT	IGF1R	protein	P08069	UNIPROT	"up-regulates activity"	phosphorylation	Tyr980	YASVNPEyFSAADVY	-1									7493944	t		lperfetto	"The insulin-like growth factor type I (IGF-I) receptor can become tyrosine phosphorylated and enzymatically activated either in response to ligand or because of the activity of the Src tyrosine kinase. We mapped the sites of IGF-I receptor autophosphorylation to peptides representing three different receptor domains: tyrosines 943 and 950 in the juxtamembrane region; tyrosines 1131, 1135, and 1136 within the kinase domain; and tyrosine 1316 in the carboxyl-terminal domain."	0.2	SIGNOR-246256
SIGNOR-CRC	"Colorectal Carcinoma"	ATM	protein	Q13315	UNIPROT	TP53	protein	P04637	UNIPROT	"up-regulates quantity by stabilization"	phosphorylation	Ser20	PLSQETFsDLWKLLP	9606	BTO:0000552								20663147	t		gcesareni	"DeltaNp63alpha depletion by RNAi reduces steady-state ATM mRNA and protein levels, and attenuates p53 Serine-15 phosphorylation. Conversely, ectopic expression of DeltaNp63alpha in p63-null tumour cells stimulates ATM transcription and p53 Serine-15 phosphorylation"	0.847	SIGNOR-167156
SIGNOR-CRC	"Colorectal Carcinoma"	ATM	protein	Q13315	UNIPROT	TP53	protein	P04637	UNIPROT	"up-regulates quantity by stabilization"	phosphorylation	Ser20	PLSQETFsDLWKLLP	9606	BTO:0002552								17967874	t		gcesareni	"The increased interaction between B56gamma and p53 after DNA damage requires ATM-dependent phosphorylation of p53 at Ser15."	0.847	SIGNOR-158636
SIGNOR-CRC	"Colorectal Carcinoma"	TP53	protein	P04637	UNIPROT	Apoptosis	phenotype	SIGNOR-PH2	SIGNOR	up-regulates				9606									24212651	f		miannu	"P53 is a nuclear transcription factor with a pro-apoptotic function"	0.7	SIGNOR-255678
SIGNOR-CRC	"Colorectal Carcinoma"	PTEN	protein	P60484	UNIPROT	PIK3CA	protein	P42336	UNIPROT	"down-regulates activity"				9606									18794881	f		lperfetto	"The pten tumour suppressor is a lipid and protein phosphatase that inhibits phosphoinositide 3-kinase (pi3k)-dependent by dephosphorylating phosphatidylinositol 3,4,5-trisphosphate (ptdinsp(3))."	0.738	SIGNOR-209856
SIGNOR-CRC	"Colorectal Carcinoma"	KRAS	protein	P01116	UNIPROT	BRAF	protein	P15056	UNIPROT	"up-regulates activity"	binding			9606									21779497	t		miannu	"The raf family of proteins (raf-1, a-raf, and b-raf) is serine/threonine kinases that bind to the effector region of ras-gtp, thus inducing translocation of the protein to the plasma membrane. Once there, raf proteins are activated and phosphorylated by different protein kinases."	0.878	SIGNOR-156906
SIGNOR-CRC	"Colorectal Carcinoma"	KRAS	protein	P01116	UNIPROT	PIK3CA	protein	P42336	UNIPROT	up-regulates	binding			9606									21779497	t		gcesareni	"Grb2 binds and activates sos, which then activates ras, and this activates p110 independently of p85./it was also described that ras interacts with pi3k in a direct manner./lysine residue 227 is essential for the interaction of ras with pi3k phosphatidylinositol 3-kinase (pi3k) is one of the main effector pathways of ras, regulating cell growth, cell cycle entry, cell survival, cytoskeleton reorganization, and metabolism."	0.911	SIGNOR-175204
SIGNOR-CRC	"Colorectal Carcinoma"	GRB2	protein	P62993	UNIPROT	SOS1	protein	Q07889	UNIPROT	"up-regulates activity"	relocalization			10090	BTO:0000669								23452850	t	"GRB2 associated guanine nucleotide exchange factor Sos activates Ras through the exchange of GDP for GTP"	lperfetto	"Interaction domains of sos1/grb2 are finely tuned for cooperative control of embryonic stem cell fate."	0.914	SIGNOR-235773
SIGNOR-CRC	"Colorectal Carcinoma"	GRB2	protein	P62993	UNIPROT	SOS1	protein	Q07889	UNIPROT	"up-regulates activity"	relocalization			9606									8479541	t	"GRB2 associated guanine nucleotide exchange factor Sos activates Ras through the exchange of GDP for GTP"	lperfetto	"Furthermore, our results indicate that the interaction domains of sos1 and grb2 have evolved so as to bind ligands not with maximal strength but with specificities and affinities that maintain cooperativity. Grb2 binds and activates sos, which then activates ras, and this activates p110 independently of p85."	0.914	SIGNOR-39163
SIGNOR-CRC	"Colorectal Carcinoma"	CTNNB1	protein	P35222	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									23645839	f		apalma	"For example, prostaglandin E2 (PGE2), 1 of the major metabolites downstream of both COX-1 and COX-2, has been shown to activate β-catenin–dependent signaling in hematopoietic stem cells (HSCs) and promote HSC expansion"	0.7	SIGNOR-255695
SIGNOR-CRC	"Colorectal Carcinoma"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	BRAF	protein	P15056	UNIPROT	down-regulates	phosphorylation	Thr401	STTGLSAtPPASLPG	9606									21135229	t		lperfetto	"We show that b-raf is a calcineurin substrate;among calcineurin target residues on b-raf is t401, a site of negative feedback phosphorylation by erk1/2. Blocking calcineurin activity in _ cells prevents dephosphorylation of b-raf t401 and decreases b-raf and erk1/2 activities."	0.2	SIGNOR-170339
SIGNOR-CRC	"Colorectal Carcinoma"	BRAF	protein	P15056	UNIPROT	TGFB1	protein	P01137	UNIPROT	"up-regulates quantity"	relocalization			9606									19861538	f		miannu	"The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer.  BRAF induces TGFβ secretion leading to NIS repression in a MEK-ERK–independent manner but cooperating with the MEK-ERK pathway to induce strong tumor invasion, two major traits acquired during PTC progression."	0.249	SIGNOR-251987
SIGNOR-CRC	"Colorectal Carcinoma"	BRAF	protein	P15056	UNIPROT	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	"up-regulates activity"	phosphorylation			9606									21900390	t		miannu	"BRAFV600E has been shown to initiate thyroid follicular cell transformation. The BRAFV600E mutation disrupts the hydrophobic interaction, enabling the BRAF kinase to fold into a catalytically active formation, resulting in an almost 500-fold increase in kinase activity. Mutant BRAF can dimerize and activate MEK without Ras activation."	0.787	SIGNOR-251988
SIGNOR-CRC	"Colorectal Carcinoma"	TGFBR1	protein	P36897	UNIPROT	SMAD3	protein	P84022	UNIPROT	"up-regulates activity"	phosphorylation			9606									19701891	t		miannu	"The binding of TGF‐β1 to its receptor complex activates the intracellular kinase domain of TGF‐βRII, which leads to the phosphorylation and activation of Smad2, Smad3 and Smad4 as well as non‐Smad proteins (Smad‐independent pathway)"	0.816	SIGNOR-254361
SIGNOR-CRC	"Colorectal Carcinoma"	DNA_damage	stimulus	SIGNOR-ST1	SIGNOR	ATM	protein	Q13315	UNIPROT	"up-regulates activity"				9606	BTO:0000007								12556884	f		miannu	"Cellular irradiation induces rapid intermolecular autophosphorylation of serine 1981 that causes dimer dissociation and initiates cellular ATM kinase activity. Most ATM molecules in the cell are rapidly phosphorylated on this site after doses of radiation as low as 0.5 Gy, and binding of a phosphospecific antibody is detectable after the introduction of only a few DNA double-strand breaks in the cell. Activation of the ATM kinase seems to be an initiating event in cellular responses to irradiation."	0.7	SIGNOR-253376
SIGNOR-CRC	"Colorectal Carcinoma"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									19819937	f			"In addition to the JAK2–STAT5 pathway, the Ras GTPase–extracellular signal-regulated kinase (Ras–ERK) pathway has also been implicated in signaling of IL-5 and is important for IL-5-dependent cell survival, proliferation and differentiation of eosinophils."	0.7	SIGNOR-254354
SIGNOR-CRC	"Colorectal Carcinoma"	TP53	protein	P04637	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	down-regulates				9606	BTO:0000452								7667317	f			"P53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts"	0.7	SIGNOR-255669
SIGNOR-CRC	"Colorectal Carcinoma"	GSK3B/Axin/APC	complex	SIGNOR-C110	SIGNOR	CTNNB1	protein	P35222	UNIPROT	"down-regulates activity"	phosphorylation			9606		BTO:0000586							16293724	t		lperfetto	"Because phosphorylation of β-catenin by GSK-3β leads to its rapid ubiquitination and subsequent degradation in the proteosome, inactivation of GSK-3β is often a prerequisite for stimulating the accumulation, nuclear translocation, and functional activity of β-catenin"	0.896	SIGNOR-227893
SIGNOR-CRC	"Colorectal Carcinoma"	TGFB1	protein	P01137	UNIPROT	TGFBR1	protein	P36897	UNIPROT	"up-regulates activity"	binding			9606									22326956	t		"giulio giuliani"	"In Tgfbr2fl/fl control MEPM cells, radioactive TGF-β2 ligands (12.5 kDa) bind to TβRI (53 kDa), TβRII (70 kDa), and TβRIII (100–200 kDa, highly glycosylated molecule) and form the ligand-receptor complexes of TβRI::TGF-β2 (65.5 kDa), TβRII::TGF-β2 (82.5 kDa), and TβRIII::TGF-β2 (112.5–212.5 kDa)"	0.846	SIGNOR-255960
SIGNOR-CRC	"Colorectal Carcinoma"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	SOS1	protein	Q07889	UNIPROT	"down-regulates activity"	phosphorylation			9606		BTO:0000763;BTO:0000149							20724475	t		lperfetto	"ERK activation was sufficient for the SOS1 phosphorylation and resulting inhibition of EGF-induced Ras activation. This result also showed that SOS1 could be phosphorylated by ERK in the absence of association with EGFR at the plasma membrane, which is a phosphotyrosine-dependent process."	0.2	SIGNOR-244591
SIGNOR-CRC	"Colorectal Carcinoma"	SOS1	protein	Q07889	UNIPROT	KRAS	protein	P01116	UNIPROT	up-regulates	"guanine nucleotide exchange factor"			9606									25624485	t	"Ras proteins bind GDP/GTP and possess intrinsic GTPase activity."	gcesareni	"Because the KRAS-GDP to KRAS-GTP transition catalyzed by the GEF, son of sevenless 1 (SOS1), represents the rate-limiting step for nucleotide exchange, disrupting the activating SOS1/KRAS protein interaction has also been the focus of drug development efforts"	0.829	SIGNOR-201703
SIGNOR-CRC	"Colorectal Carcinoma"	SOS1	protein	Q07889	UNIPROT	KRAS	protein	P01116	UNIPROT	up-regulates	"guanine nucleotide exchange factor"			9606									25624485	t	"Ras proteins bind GDP/GTP and possess intrinsic GTPase activity."	gcesareni	"Because the KRAS-GDP to KRAS-GTP transition catalyzed by the GEF, son of sevenless 1 (SOS1), represents the rate-limiting step for nucleotide exchange, disrupting the activating SOS1/KRAS protein interaction has also been the focus of drug development efforts"	0.829	SIGNOR-122075
SIGNOR-CRC	"Colorectal Carcinoma"	SOS1	protein	Q07889	UNIPROT	KRAS	protein	P01116	UNIPROT	up-regulates	"guanine nucleotide exchange factor"			9606									25624485	t	"Ras proteins bind GDP/GTP and possess intrinsic GTPase activity."	gcesareni	"Because the KRAS-GDP to KRAS-GTP transition catalyzed by the GEF, son of sevenless 1 (SOS1), represents the rate-limiting step for nucleotide exchange, disrupting the activating SOS1/KRAS protein interaction has also been the focus of drug development efforts"	0.829	SIGNOR-175256
SIGNOR-CRC	"Colorectal Carcinoma"	SOS1	protein	Q07889	UNIPROT	KRAS	protein	P01116	UNIPROT	up-regulates	"guanine nucleotide exchange factor"			9606									25624485	t	"Ras proteins bind GDP/GTP and possess intrinsic GTPase activity."	gcesareni	"Because the KRAS-GDP to KRAS-GTP transition catalyzed by the GEF, son of sevenless 1 (SOS1), represents the rate-limiting step for nucleotide exchange, disrupting the activating SOS1/KRAS protein interaction has also been the focus of drug development efforts"	0.829	SIGNOR-141647
SIGNOR-CRC	"Colorectal Carcinoma"	TGFB1	protein	P01137	UNIPROT	TGFBR1	protein	P36897	UNIPROT	"up-regulates activity"	binding			9606									22326956	t		lperfetto	"TGF-beta signaling mediates a wide range of biological activities in development and disease. TGF-beta ligands signal through heterodimeric type I and type II receptors (TGF-beta receptor type I [TbetaRI, also known as ALK5 and TGFBR1] and TbetaRII) that are members of the serine/threonine kinase family."	0.846	SIGNOR-196022
SIGNOR-CRC	"Colorectal Carcinoma"	TP53	protein	P04637	UNIPROT	BCL2	protein	P10415	UNIPROT	"down-regulates activity"	binding			9606									19007744	t	"Cytosolic p53"	lperfetto	"Mechanistic insights into the mitochondrial function of wtp53 came when it was realized that mitochondrially translocated p53 interacts directly with members of the Bcl-2 family, which are central in governing the induction of mitochondrial outer membrane permeabilization. In response to stress, wtp53 interacts with and neutralizes the anti-apoptotic members Bcl-xL and Bcl-2. This interaction stimulates MOMP and subsequent apoptosis"	0.752	SIGNOR-99712
SIGNOR-CRC	"Colorectal Carcinoma"	GRB2	protein	P62993	UNIPROT	SOS1	protein	Q07889	UNIPROT	"up-regulates activity"	relocalization			9606	BTO:0001412								10570290	t	"GRB2 associated guanine nucleotide exchange factor Sos activates Ras through the exchange of GDP for GTP"	lperfetto	"Grb2 binds and activates sos, which then activates ras, and this activates p110 independently of p85."	0.914	SIGNOR-236792
SIGNOR-CRC	"Colorectal Carcinoma"	GSK3B/Axin/APC	complex	SIGNOR-C110	SIGNOR	CTNNB1	protein	P35222	UNIPROT	down-regulates	binding			9534	BTO:0000298								9482734	t		lperfetto	"Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin"	0.896	SIGNOR-227862
SIGNOR-CRC	"Colorectal Carcinoma"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	BCL2	protein	P10415	UNIPROT	"up-regulates quantity by stabilization"	phosphorylation	Ser70	RDPVARTsPLQTPAA	9534	BTO:0004055								10677502	t		lperfetto	"Erk1 and erk2 directly phosphorylate bcl2 exclusively at ser-70."	0.2	SIGNOR-244501
SIGNOR-CRC	"Colorectal Carcinoma"	BCL2	protein	P10415	UNIPROT	Apoptosis	phenotype	SIGNOR-PH2	SIGNOR	down-regulates				9606									1286168	f		lperfetto	"Bcl-2 functions to inhibit apoptosis in a variety of in vitro and in vivo experiments, suggesting interference with a central mechanism of apoptosis"	0.7	SIGNOR-249611
SIGNOR-CRC	"Colorectal Carcinoma"	CTNNB1	protein	P35222	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									18697834	f		"Simone Vumbaca"	"we showed that β-catenin, a key component of the canonical Wnt-signalling cascade, is present in quiescent satellite cells in the inactive form, but subsequently becomes activated following satellite-cell activation. This observation suggests that the proliferation initiated by the Wnt-signalling cascade does not have to rely on transcription of β-catenin, but rather on activation of this protein, which is already present within the quiescent satellite cells."	0.7	SIGNOR-255654
SIGNOR-CRC	"Colorectal Carcinoma"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									24743741	f			"Activation of PDGFRα stimulates proliferation of PDGFRα(+) cells through PI3K-Akt and MEK2-MAPK signaling pathways, and aberrant accumulation of PDGFRα(+) cells was conspicuous in muscles of patients with both genetic and non-genetic muscle diseases."	0.7	SIGNOR-254374
SIGNOR-CRC	"Colorectal Carcinoma"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	Survival	phenotype	SIGNOR-PH13	SIGNOR	up-regulates				9606	BTO:0000830								15526160	f			"Numerous studies have implicated the critical importance of the Ras/Erk pathway in cell division and survival"	0.7	SIGNOR-254948
SIGNOR-CRC	"Colorectal Carcinoma"	TGFB1	protein	P01137	UNIPROT	TGFBR1	protein	P36897	UNIPROT	up-regulates	binding			9606									26194464	t		"MARCO ROSINA"	"TGF-b ligands bind to TGF-b type II receptor (TbRII), which transphosphorylates and activates TGF-b type I receptor (TbRI)."	0.846	SIGNOR-255031
SIGNOR-CRC	"Colorectal Carcinoma"	TGFBR1	protein	P36897	UNIPROT	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	up-regulates				9606									26194464	f		"MARCO ROSINA"	"TbRI phosphorylates not only the C-termini of R-Smads but also activates various protein kinases including mitogen-activated protein kinases (MAPKs): extracellular signal regulated kinase (ERK), c-Jun N-terminal kinase (JNK) and p38 MAPK (p38), which then phosphorylate the variable linker regions of R-Smad"	0.313	SIGNOR-255033
SIGNOR-CRC	"Colorectal Carcinoma"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				10090									20219869	f		areggio	"Furthermore, stimulation of myoblasts with CCL2, CCL3, or CCL4 was sufficient to induce phosphorylation and activation of ERK1/2. This outcome may be functionally important because ERK1/2 activation is a component of the pathway through which many mitogenic growth factors can stimulate cell proliferation."	0.7	SIGNOR-255120
SIGNOR-CRC	"Colorectal Carcinoma"	MYC	protein	P01106	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									9552384	f		gcesareni	"C-myc has emerged as one of the central regulators of mammalian cell proliferation."	0.7	SIGNOR-56572
SIGNOR-CRC	"Colorectal Carcinoma"	MYC	protein	P01106	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606		BTO:0001103							21408055	f		"andrea cerquone perpetuini"	"We have demonstrated that following muscle damage, phosphorylated STAT3 (p-STAT3) in SCs increases early (within one hour), inducing downstream target genes (i.e. GP130 and SOCS3), which further regulate the increase in STAT3 production and response (as induced via IL-6), leading to increased cMyc expression, which drives cell proliferation"	0.7	SIGNOR-255414
SIGNOR-CRC	"Colorectal Carcinoma"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	Survival	phenotype	SIGNOR-PH13	SIGNOR	up-regulates				9606	BTO:0000876	BTO:0001103							11602185	f		apalma	"The GM-CSF promoted cell survival and proliferation correlated with MEK-1 dependent ERK1/2, Elk-1 and CREB phosphorylation and Egr-1, c-Fos expression as well as with increased STAT-5, AP-1, c-Myb and NF-kappaB DNA-binding."	0.7	SIGNOR-255579
SIGNOR-CRC	"Colorectal Carcinoma"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606	BTO:0000876	BTO:0001103							11602185	f		apalma	"The GM-CSF promoted cell survival and proliferation correlated with MEK-1 dependent ERK1/2, Elk-1 and CREB phosphorylation and Egr-1, c-Fos expression as well as with increased STAT-5, AP-1, c-Myb and NF-kappaB DNA-binding."	0.7	SIGNOR-255580
SIGNOR-CRC	"Colorectal Carcinoma"	SMAD3	protein	P84022	UNIPROT	MYC	protein	P01106	UNIPROT	"down-regulates quantity by repression"	"transcriptional regulation"			9606									14993291	f		gcesareni	"Smad3 is required for both tgf-beta-induced repression of c-myc and subsequent growth arrest in keratinocytes"	0.689	SIGNOR-123087
SIGNOR-CRC	"Colorectal Carcinoma"	CTNNB1	protein	P35222	UNIPROT	LEF1	protein	Q9UJU2	UNIPROT	"up-regulates activity"	binding			9606									21078818	t		gcesareni	"Phosphorylated lrp5/6 leads to inhibition of the so-called beta-catenin destruction complex (which includes axin, gsk3, dvl, ck1, and the tumor suppressor adenomatous polyposis coli), resulting in the stabilization and translocation of beta-catenin in the nucleus, where it activates target genes through binding to tcf/lef transcription factors."	0.917	SIGNOR-169632
SIGNOR-CRC	"Colorectal Carcinoma"	ERBB2	protein	P04626	UNIPROT	ERBB2	protein	P04626	UNIPROT	up-regulates	phosphorylation	Tyr1196	GAVENPEyLTPQGGA	9606	BTO:0000150								15156151	t		gcesareni	"Stimulation of these molecules, however, failed to induce efficient cell migration in the absence of neu/erbb2 phosphorylation at tyr 1201 or tyr 1227"	0.2	SIGNOR-124856
SIGNOR-CRC	"Colorectal Carcinoma"	ERBB2	protein	P04626	UNIPROT	ERBB2	protein	P04626	UNIPROT	up-regulates	phosphorylation	Tyr1222	PAFDNLYyWDQDPPE	9606									15156151	t		gcesareni	"Stimulation of these molecules, however, failed to induce efficient cell migration in the absence of neu/erbb2 phosphorylation at tyr 1201 or tyr 1227"	0.2	SIGNOR-124860
SIGNOR-CRC	"Colorectal Carcinoma"	LEF1	protein	Q9UJU2	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									17081971	f		amattioni	"The interaction of beta-catenin with the N terminus of tcf/lef transiently converts it into an activator, translating the Wnt signal into the transient transcription of Tcf target genes. The Wnt pathway has distinct transcriptional outputs, which are determined by the identity of the responding cell, and range from cell proliferation and survival to the terminal differentiation of postmitotic cells."	0.7	SIGNOR-229764
SIGNOR-CRC	"Colorectal Carcinoma"	LEF1	protein	Q9UJU2	UNIPROT	Survival	phenotype	SIGNOR-PH13	SIGNOR	up-regulates				9606									17081971	f		amattioni	"The interaction of beta-catenin with the N terminus of tcf/lef transiently converts it into an activator, translating the Wnt signal into the transient transcription of Tcf target genes. The Wnt pathway has distinct transcriptional outputs, which are determined by the identity of the responding cell, and range from cell proliferation and survival to the terminal differentiation of postmitotic cells."	0.7	SIGNOR-229767
SIGNOR-CRC	"Colorectal Carcinoma"	LEF1	protein	Q9UJU2	UNIPROT	MYC	protein	P01106	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			9606									19653274	f		gcesareni	"Expression of Lef-1 FL, but not the newly identified Lef-1 Deltaexon VI, induced the expression of the cell cycle regulating proteins c-myc and cyclin D1 in cooperation with beta-catenin and it enhanced cell proliferation"	0.642	SIGNOR-245351
SIGNOR-CRC	"Colorectal Carcinoma"	PIK3CA	protein	P42336	UNIPROT	Survival	phenotype	SIGNOR-PH13	SIGNOR	up-regulates				9534	BTO:0004055								14665640	f		lperfetto	"Signal transduction pathways triggered by Tie2 have been extensively examined. Tyr-1101of Tie2 directly associates in a phosphotyrosine (pTyr)-dependent manner with the p85 regulatory subunit of phosphatidylinositol (PI) 3-kinase, which in turn activate PI 3-kinase, leading to cell motility and survival"	0.7	SIGNOR-242649
SIGNOR-CRC	"Colorectal Carcinoma"	TGFB1	protein	P01137	UNIPROT	TGFB1	protein	P01137	UNIPROT	"up-regulates activity"	binding			9606									16885528	t		lperfetto	"The active form of TGF-beta is a dimer stabilized by hydrophobic interactions and usually further strengthened by an intersubunit disulfide bridge."	0.2	SIGNOR-148605
SIGNOR-CRC	"Colorectal Carcinoma"	IGF1R	protein	P08069	UNIPROT	IRS2	protein	Q9Y4H2	UNIPROT	up-regulates	phosphorylation			9606									10471495	t		flangone	"Our results reveal that igf-1 receptors promote beta-cell development and survival through the irs-2 signalling pathway."	0.805	SIGNOR-70477
SIGNOR-CRC	"Colorectal Carcinoma"	SMAD3	protein	P84022	UNIPROT	SMAD4	protein	Q13485	UNIPROT	"up-regulates activity"	binding			9606									9843571	t		gcesareni	"TGF-² treatment initiates a kinase cascade that results in the phosphorylation of Smad3, followed by its heteromerization with Smad4 and subsequent translocation into the nucleus."	0.71	SIGNOR-235168
SIGNOR-CRC	"Colorectal Carcinoma"	ATM	protein	Q13315	UNIPROT	TP53	protein	P04637	UNIPROT	"up-regulates quantity by stabilization"	phosphorylation	Ser20	PLSQETFsDLWKLLP	9606	BTO:0001938								15254178	t		lperfetto	"Although the stabilization of p53 was apparently concordant with its phosphorylation on N-terminal serine residues in HFFF-2 cells, it did not require the phosphorylation of Ser15 or Ser20 by ATM, a cellular kinase known to phosphorylate and promote the stabilization of p53 in response to DNA damage."	0.847	SIGNOR-126757
SIGNOR-CRC	"Colorectal Carcinoma"	ATM	protein	Q13315	UNIPROT	TP53	protein	P04637	UNIPROT	"up-regulates quantity by stabilization"	phosphorylation	Ser15	PSVEPPLsQETFSDL	9606									17967874	t		lperfetto	"In this study, we show that the increased interaction between B56gamma and p53 after DNA damage requires ATM-dependent phosphorylation of p53 at Ser15."	0.847	SIGNOR-158632
SIGNOR-CRC	"Colorectal Carcinoma"	ATM	protein	Q13315	UNIPROT	TP53	protein	P04637	UNIPROT	"up-regulates quantity by stabilization"	phosphorylation	Ser15	PSVEPPLsQETFSDL	9606									20663147	t		gcesareni	"Deltanp63 transcriptionally regulates atm to control p53 serine-15 phosphorylation."	0.847	SIGNOR-167152
SIGNOR-CRC	"Colorectal Carcinoma"	ATM	protein	Q13315	UNIPROT	TP53	protein	P04637	UNIPROT	"up-regulates quantity by stabilization"	phosphorylation			9606									17157788	t		miannu	"Atm/atr are generally sensors of dna damage, but, together with the checkpoint kinases chk1 and chk2, they also function as response effectors by phosphorylation of key substrates, such as p53, brca1, and nbs1. In particular, p53 phosphorylation leads to protein accumulation and activation, which in turn promotes cell-cycle arrest or apoptosis."	0.847	SIGNOR-151138
SIGNOR-CRC	"Colorectal Carcinoma"	WNT1	protein	P04628	UNIPROT	LRP5	protein	O75197	UNIPROT	"up-regulates activity"	binding			9606	BTO:0000007								21078818	t		gcesareni	"Ligands such as wnt1, wnt3a, and wnt8 couple the seventransmembrane domain receptor frizzled (fzd) and the single-membrane-spanning low-density receptor-related protein 5/6 (lrp5/6) to activate wnt?Beta-catenin signaling."	0.792	SIGNOR-169645
SIGNOR-CRC	"Colorectal Carcinoma"	WNT1	protein	P04628	UNIPROT	LRP5	protein	O75197	UNIPROT	"up-regulates activity"	binding			9606									15578921	t		gcesareni	"Wnt proteins bind to the frizzled receptors and lrp5/6 co-receptors, and through stabilizing the critical mediator betBeta-catenin, initiate a complex signaling cascade that plays an important role in regulating cell proliferation and differentiation."	0.792	SIGNOR-131574
SIGNOR-CRC	"Colorectal Carcinoma"	ATM	protein	Q13315	UNIPROT	TP53	protein	P04637	UNIPROT	"up-regulates quantity by stabilization"	phosphorylation	Ser9	EEPQSDPsVEPPLSQ	9606									11875057	t		gcesareni	"In response to ionizing radiation (ir), atm, the gene product mutated in ataxia telangiectasia, stabilizes and activates p53 through phosphorylation of ser15 and (indirectly) ser20. Here we show that phosphorylation of p53 on ser46, a residue important for p53 apoptotic activity, as well as on ser9, in response to ir also is dependent on the atm protein kinase. one pathway involves the phosphorylation of p53 and its negative regulator mdm2 by ataxia telangiectasia mutated (atm) and chk2 causing p53 activation and stabilization."	0.847	SIGNOR-115348
SIGNOR-CRC	"Colorectal Carcinoma"	TGFB1	protein	P01137	UNIPROT	TGFBR1	protein	P36897	UNIPROT	"up-regulates activity"	binding			9606									22703233	t		lperfetto	"TGFbeta signals are transmitted via a cell surface receptor complex consisting of the TGFbeta type I receptor (TbetaRI) and TGFbeta type II receptor (TbetaRII). To initiate signal transduction, TGFbeta binds to TbetaRII, which in turn recruits TbetaRI, leading to the formation of a tetrameric receptor complex."	0.846	SIGNOR-249548
SIGNOR-CRC	"Colorectal Carcinoma"	SMAD4	protein	Q13485	UNIPROT	LEF1	protein	Q9UJU2	UNIPROT	"up-regulates activity"				9606	BTO:0000599								10890911	f		lperfetto	"Coexpression of smad2 and smad4, smad3 alone, or smad3 and smad4 resulted in strong enhancement of lef1-dependent transcriptional activity"	0.689	SIGNOR-229311
SIGNOR-CRC	"Colorectal Carcinoma"	SMAD3	protein	P84022	UNIPROT	LEF1	protein	Q9UJU2	UNIPROT	"up-regulates activity"				9606	BTO:0000599								10890911	f		lperfetto	"Coexpression of smad2 and smad4, smad3 alone, or smad3 and smad4 resulted in strong enhancement of lef1-dependent transcriptional activity"	0.514	SIGNOR-229308
SIGNOR-CRC	"Colorectal Carcinoma"	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	down-regulates				9606									18481201	f		lperfetto	"Pd98059, a specific inhibitor of mek in addition, immunoblot and immunostaining analysis revealed that phosphorylation of erk was increased by treatment with sb203580;whereas pd98059 increased the phosphorylation of p38, which implies a seesaw-like balance between erk and p38 phosphorylation."	0.634	SIGNOR-244877
SIGNOR-CRC	"Colorectal Carcinoma"	GSK3B/Axin/APC	complex	SIGNOR-C110	SIGNOR	CTNNB1	protein	P35222	UNIPROT	"down-regulates activity"	phosphorylation	Ser33	QQQSYLDsGIHSGAT	9606	BTO:0000938	BTO:0000142							19303846	t		lperfetto	"GSK3β regulates β-catenin stability by phosphorylating serine and threonine residues (Ser33/37 and Thr41) important for targeting β-catenin for ubiquitin-dependent proteasomal degradation"	0.896	SIGNOR-227870
SIGNOR-CRC	"Colorectal Carcinoma"	GSK3B/Axin/APC	complex	SIGNOR-C110	SIGNOR	CTNNB1	protein	P35222	UNIPROT	"down-regulates activity"	phosphorylation	Ser37	YLDSGIHsGATTTAP	9606		BTO:0000586							16293724	t		lperfetto	"This leads to the inactivation and release of glycogen synthase kinase 3beta from its complex with axin, thereby relieving the inhibitory phosphorylation of beta-catenin and activating its signaling pathway."	0.896	SIGNOR-227889
SIGNOR-CRC	"Colorectal Carcinoma"	GSK3B/Axin/APC	complex	SIGNOR-C110	SIGNOR	CTNNB1	protein	P35222	UNIPROT	"down-regulates activity"	phosphorylation	Ser33	QQQSYLDsGIHSGAT	9606									11955436	t		lperfetto	"Wnt regulation of beta-catenin degradation is essential for development and carcinogenesis. beta-catenin degradation is initiated upon amino-terminal serine/threonine phosphorylation, which is believed to be performed by glycogen synthase kinase-3 (GSK-3) in complex with tumor suppressor proteins Axin and adnomatous polyposis coli (APC)."	0.896	SIGNOR-227897
SIGNOR-CRC	"Colorectal Carcinoma"	GSK3B/Axin/APC	complex	SIGNOR-C110	SIGNOR	CTNNB1	protein	P35222	UNIPROT	"down-regulates activity"	phosphorylation	Thr41	GIHSGATtTAPSLSG	9606									11955436	t		lperfetto	"Wnt regulation of beta-catenin degradation is essential for development and carcinogenesis. beta-catenin degradation is initiated upon amino-terminal serine/threonine phosphorylation, which is believed to be performed by glycogen synthase kinase-3 (GSK-3) in complex with tumor suppressor proteins Axin and adnomatous polyposis coli (APC)."	0.896	SIGNOR-227905
SIGNOR-CRC	"Colorectal Carcinoma"	GSK3B/Axin/APC	complex	SIGNOR-C110	SIGNOR	CTNNB1	protein	P35222	UNIPROT	"down-regulates activity"	phosphorylation	Ser37	YLDSGIHsGATTTAP	9606	BTO:0000938	BTO:0000142							19303846	t		lperfetto	"GSK3β regulates β-catenin stability by phosphorylating serine and threonine residues (Ser33/37 and Thr41) important for targeting β-catenin for ubiquitin-dependent proteasomal degradation"	0.896	SIGNOR-227874
SIGNOR-CRC	"Colorectal Carcinoma"	GSK3B/Axin/APC	complex	SIGNOR-C110	SIGNOR	CTNNB1	protein	P35222	UNIPROT	"down-regulates activity"	phosphorylation	Thr41	GIHSGATtTAPSLSG	9606									23151663	t		lperfetto	"Beta-catenin phosphorylation in vivo is sequentially carried out by two distinct kinases, ckialfa and gsk-3. Ckialfa phosphorylation of s45 proceeds and is required for subsequent gsk-3 phosphorylation of t41, s37, and s33 one key substrate of gsk3 is the transcriptional co-activator beta catenin, whichis inactivated by gsk3 mediated phosphorylation and targeted for proteasomal degradation in unstimulated cells."	0.896	SIGNOR-227866
SIGNOR-CRC	"Colorectal Carcinoma"	CTNNB1	protein	P35222	UNIPROT	LEF1	protein	Q9UJU2	UNIPROT	"up-regulates activity"	binding			9606									23151663	t		gcesareni	"Upon wnt activation, cytoplasmic beta-catenin is stabilized and enters the nucleus, where it associates with transcription factors, notably tcf (t cell factor) and lef (lymphoid enhancer-binding factor), to regulate the transcription of target genes. Thus beta-catenin regulates gene expression by direct interaction with transcription factors such as lef-1, providing a molecular mechanism for the transmission of signals, from cell-adhesion components or wnt protein to the nucleus."	0.917	SIGNOR-199378
SIGNOR-CRC	"Colorectal Carcinoma"	GSK3B/Axin/APC	complex	SIGNOR-C110	SIGNOR	CTNNB1	protein	P35222	UNIPROT	down-regulates	binding			9606									22083140	t		lperfetto	"The role of apc is less clear, but it clearly binds to both b-catenin and axin, and could shuttle b-catenin from the plasma membrane and nucleus to the cytoplasmic axin complex."	0.896	SIGNOR-227881
SIGNOR-CRC	"Colorectal Carcinoma"	CTNNB1	protein	P35222	UNIPROT	LEF1	protein	Q9UJU2	UNIPROT	"up-regulates activity"	binding			9606	BTO:0000782								15735151	t		gcesareni	"Activated dvl binds and inhibits the phosphorylation of beta catenin by gsk3beta/alfa, blocking beta catenin degradation), so that beta catenin accumulates and translocates to the nucleus, where it interacts with the t cell specific factor (tcf)/lymphoid enhancer binding factor 1 (lef-1) transcription factor and induces the transcription of target genes such as c-jun, c-myc, and cyclin d1"	0.917	SIGNOR-134219
SIGNOR-CRC	"Colorectal Carcinoma"	ATM	protein	Q13315	UNIPROT	ATM	protein	Q13315	UNIPROT	"up-regulates activity"	phosphorylation	Ser1981	SLAFEEGsQSTTISS	9606									21149446	t		gcesareni	"In human cells, the activation process involves autophosphorylation on three sites (ser367, ser1893, and ser1981) and acetylation on lys3016. We now describe the identification of a new atm phosphorylation site, thr(p)1885 and an additional autophosphorylation site, ser(p)2996, that is highly dna damage-inducible."	0.2	SIGNOR-170469
SIGNOR-CRC	"Colorectal Carcinoma"	BRAF	protein	P15056	UNIPROT	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	"up-regulates activity"	phosphorylation			10090									8131746	t		lperfetto	"Activation of mek family kinases requires phosphorylation of two conserved ser/thr residueserine residues 218 and 222 of human mek1 are the primary sites for phosphorylation by c-raf."	0.787	SIGNOR-244827
SIGNOR-CRC	"Colorectal Carcinoma"	BRAF	protein	P15056	UNIPROT	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	up-regulates	phosphorylation			9606									8668348	t		lperfetto	"We show that, consequently, b-raf interacts with mek-1 and mek-2 with a better affinity than does c-raf-1, thus strengthening the notion that b-raf is a stronger mek activator than c-raf-l."	0.787	SIGNOR-244843
SIGNOR-CRC	"Colorectal Carcinoma"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	"down-regulates activity"	phosphorylation			9606	BTO:0000007								10567369	t		lperfetto	"An ERK2-binding site at the N terminus of MEK1 was reported to mediate their stable association. We examined the importance of this binding site in the feedback phosphorylation of mek1 on thr(292) and thr(386) by erk2"	0.758	SIGNOR-244858
SIGNOR-CRC	"Colorectal Carcinoma"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	"down-regulates activity"	phosphorylation			9534	BTO:0004055								14993270	t		lperfetto	"We propose that activation of erk during adhesion creates a feedback system in which erk phosphorylates mek1 on t292, and this in turn blocks additional s298 phosphorylation in response to integrin signaling."	0.758	SIGNOR-244862
SIGNOR-CRC	"Colorectal Carcinoma"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	SOS1	protein	Q07889	UNIPROT	"down-regulates activity"	phosphorylation	Ser1132	TLPHGPRsASVSSIS	9534	BTO:0004055								8816480	t		lperfetto	"In this report, we describe the identification of five map kinase sites (s-1137, s-1167, s-1178, s-1193, and s-1197) on hsos1Replacing the MAP kinase phosphorylation sites with alanine residues results in an increase in the binding affinity of Grb2 to hSos1"	0.2	SIGNOR-244580
SIGNOR-CRC	"Colorectal Carcinoma"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	SOS1	protein	Q07889	UNIPROT	"down-regulates activity"	phosphorylation	Ser1167	ESAPAESsPSKIMSK	9534	BTO:0004055								8816480	t		lperfetto	"In this report, we describe the identification of five map kinase sites (s-1137, s-1167, s-1178, s-1193, and s-1197) on hsos1Replacing the MAP kinase phosphorylation sites with alanine residues results in an increase in the binding affinity of Grb2 to hSos1"	0.2	SIGNOR-244584
SIGNOR-CRC	"Colorectal Carcinoma"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	SOS1	protein	Q07889	UNIPROT	"down-regulates activity"	phosphorylation	Ser1197	KAYSPRYsISDRTSI	9534	BTO:0004055								8816480	t		lperfetto	"In this report, we describe the identification of five map kinase sites (s-1137, s-1167, s-1178, s-1193, and s-1197) on hsos1Replacing the MAP kinase phosphorylation sites with alanine residues results in an increase in the binding affinity of Grb2 to hSos1"	0.2	SIGNOR-244588
SIGNOR-CRC	"Colorectal Carcinoma"	ERBB2	protein	P04626	UNIPROT	ERBB2	protein	P04626	UNIPROT	down-regulates	phosphorylation	Tyr1112	DPSPLQRySEDPTVP	9606		BTO:0000149							1706616	t		gcesareni	"However, each of these peptides contains tyrosines that correspond to major autophosphorylation sites of the epidermal growth factor receptor, suggesting that, in addition to y1023 and y1248, y1139 and y1222 also serve as autophosphorylation sites of her2."	0.2	SIGNOR-21211
SIGNOR-CRC	"Colorectal Carcinoma"	ERBB2	protein	P04626	UNIPROT	ERBB2	protein	P04626	UNIPROT	up-regulates	phosphorylation	Tyr1221	SPAFDNLyYWDQDPP	9606		BTO:0000149							1706616	t		gcesareni	"However, each of these peptides contains tyrosines that correspond to major autophosphorylation sites of the epidermal growth factor receptor, suggesting that, in addition to y1023 and y1248, y1139 and y1222 also serve as autophosphorylation sites of her2."	0.2	SIGNOR-21199
SIGNOR-CRC	"Colorectal Carcinoma"	ERBB2	protein	P04626	UNIPROT	ERBB2	protein	P04626	UNIPROT	up-regulates	phosphorylation	Tyr1248	PTAENPEyLGLDVPV	9606		BTO:0000149							1706616	t		gcesareni	"However, each of these peptides contains tyrosines that correspond to major autophosphorylation sites of the epidermal growth factor receptor, suggesting that, in addition to y1023 and y1248, y1139 and y1222 also serve as autophosphorylation sites of her2."	0.2	SIGNOR-21203
SIGNOR-CRC	"Colorectal Carcinoma"	ERBB2	protein	P04626	UNIPROT	GRB2	protein	P62993	UNIPROT	up-regulates	relocalization			9606									14967450	t		gcesareni	"All erbb ligands and receptors couple to activation of the ras-mapk pathway, either directly through sh2 domain-mediated recruitment of grb-2 or indirectly through ptb domain-mediated binding of the shc adaptor"	0.851	SIGNOR-121968
SIGNOR-CRC	"Colorectal Carcinoma"	BRAF	protein	P15056	UNIPROT	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	"up-regulates activity"	phosphorylation			-1									8413257	t		lperfetto	"Raf-1 phosphorylation of MEK activated it, as judged by its ability to stimulate the phosphorylation of myelin basic protein by glutathione S-transferase-ERK1."	0.787	SIGNOR-244831
SIGNOR-CRC	"Colorectal Carcinoma"	ATM	protein	Q13315	UNIPROT	TP53	protein	P04637	UNIPROT	"up-regulates quantity by stabilization"	phosphorylation	Ser15	PSVEPPLsQETFSDL	9606									11875057	t		gcesareni	"In response to ionizing radiation (ir), atm, the gene product mutated in ataxia telangiectasia, stabilizes and activates p53 through phosphorylation of ser15 and (indirectly) ser20. Here we show that phosphorylation of p53 on ser46, a residue important for p53 apoptotic activity, as well as on ser9, in response to ir also is dependent on the atm protein kinase. one pathway involves the phosphorylation of p53 and its negative regulator mdm2 by ataxia telangiectasia mutated (atm) and chk2 causing p53 activation and stabilization."	0.847	SIGNOR-115340
SIGNOR-CRC	"Colorectal Carcinoma"	ATM	protein	Q13315	UNIPROT	TP53	protein	P04637	UNIPROT	"up-regulates quantity by stabilization"	phosphorylation	Ser46	AMDDLMLsPDDIEQW	9606									11875057	t		gcesareni	"In response to ionizing radiation (ir), atm, the gene product mutated in ataxia telangiectasia, stabilizes and activates p53 through phosphorylation of ser15 and (indirectly) ser20. Here we show that phosphorylation of p53 on ser46, a residue important for p53 apoptotic activity, as well as on ser9, in response to ir also is dependent on the atm protein kinase. one pathway involves the phosphorylation of p53 and its negative regulator mdm2 by ataxia telangiectasia mutated (atm) and chk2 causing p53 activation and stabilization."	0.847	SIGNOR-115344
SIGNOR-CRC	"Colorectal Carcinoma"	ATM	protein	Q13315	UNIPROT	TP53	protein	P04637	UNIPROT	"up-regulates quantity by stabilization"	phosphorylation	Ser15	PSVEPPLsQETFSDL	9606	BTO:0000552								15254178	t		lperfetto	"Deltanp63 transcriptionally regulates atm to control p53 serine-15 phosphorylation. We next aimed to identify novel factors that control damage-induced p53 phosphorylation in a keratinocyte model system, and discovered that the epithelial stem cell marker _Np63_ is a novel ATM regulator that controls p53 Serine-15 phosphorylation through transcription of the ATM kinase."	0.847	SIGNOR-126753
SIGNOR-CRC	"Colorectal Carcinoma"	IGF1R	protein	P08069	UNIPROT	IGF1R	protein	P08069	UNIPROT	"up-regulates activity"	phosphorylation	Tyr1161	FGMTRDIyETDYYRK	-1									8940173	t		miannu	"The insulin-like growth factor type I (IGF-I) receptor can become tyrosine phosphorylated and enzymatically activated either in response to ligand or because of the activity of the Src tyrosine kinaseWe mapped the sites of IGF-I receptor autophosphorylation to peptides representing three different receptor domains: tyrosines 943 and 950 in the juxtamembrane region; tyrosines 1131, 1135, and 1136 within the kinase domain; and tyrosine 1316 in the carboxyl-terminal domain."	0.2	SIGNOR-246248
SIGNOR-CRC	"Colorectal Carcinoma"	IGF1R	protein	P08069	UNIPROT	IGF1R	protein	P08069	UNIPROT	"up-regulates activity"	phosphorylation	Tyr1161	FGMTRDIyETDYYRK	9606									7493944	t		lperfetto	"Insulin and insulin-like growth factor (igf-i) receptors are heterotetrameric proteins consisting of two alpha-and two beta-subunits and members of the transmembrane tyrosine kinase receptors. Specific ligand binding to the receptor triggers a cascade of intracellular events, which begins with autophosphorylation of several tyrosine residues of the beta-subunit of the receptor."	0.2	SIGNOR-26582
SIGNOR-CRC	"Colorectal Carcinoma"	IGF1R	protein	P08069	UNIPROT	IGF1R	protein	P08069	UNIPROT	"up-regulates activity"	phosphorylation	Tyr1166	DIYETDYyRKGGKGL	9606									7493944	t		lperfetto	"Insulin and insulin-like growth factor (igf-i) receptors are heterotetrameric proteins consisting of two alpha-and two beta-subunits and members of the transmembrane tyrosine kinase receptors. Specific ligand binding to the receptor triggers a cascade of intracellular events, which begins with autophosphorylation of several tyrosine residues of the beta-subunit of the receptor."	0.2	SIGNOR-26590
SIGNOR-CRC	"Colorectal Carcinoma"	IGF1R	protein	P08069	UNIPROT	IGF1R	protein	P08069	UNIPROT	"up-regulates activity"	phosphorylation	Tyr1166	DIYETDYyRKGGKGL	-1									8940173	t		miannu	"The insulin-like growth factor type I (IGF-I) receptor can become tyrosine phosphorylated and enzymatically activated either in response to ligand or because of the activity of the Src tyrosine kinaseWe mapped the sites of IGF-I receptor autophosphorylation to peptides representing three different receptor domains: tyrosines 943 and 950 in the juxtamembrane region; tyrosines 1131, 1135, and 1136 within the kinase domain; and tyrosine 1316 in the carboxyl-terminal domain."	0.2	SIGNOR-246244
SIGNOR-CRC	"Colorectal Carcinoma"	ATM	protein	Q13315	UNIPROT	ATM	protein	Q13315	UNIPROT	"up-regulates activity"	phosphorylation	Ser367	DTRSLEIsQSYTTTQ	9606									21149446	t		gcesareni	"In human cells, the activation process involves autophosphorylation on three sites (ser367, ser1893, and ser1981) and acetylation on lys3016. We now describe the identification of a new atm phosphorylation site, thr(p)1885 and an additional autophosphorylation site, ser(p)2996, that is highly dna damage-inducible."	0.2	SIGNOR-170477
SIGNOR-CRC	"Colorectal Carcinoma"	ATM	protein	Q13315	UNIPROT	ATM	protein	Q13315	UNIPROT	"up-regulates activity"	phosphorylation	Ser1893	PANLDSEsEHFFRCC	9606									21149446	t		gcesareni	"In human cells, the activation process involves autophosphorylation on three sites (ser367, ser1893, and ser1981) and acetylation on lys3016. We now describe the identification of a new atm phosphorylation site, thr(p)1885 and an additional autophosphorylation site, ser(p)2996, that is highly dna damage-inducible."	0.2	SIGNOR-170465
SIGNOR-CRC	"Colorectal Carcinoma"	CTNNB1	protein	P35222	UNIPROT	MYC	protein	P01106	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			9606									16510874	f		gcesareni	"Beta-cat promotes h3k4 trimethylation at the c-myc gene in vivo. H3k4 trimethylation in vivo requires prior ubiquitination of h2b, and we find that ubiquitin is necessary for transcription initiation on chromatin but not nonchromatin templates in vitro.Chromatin Immunoprecipitation experiments reveal that beta-cat recruits pygopus, bcl-9/legless, and mll/set1-type complexes to the c-myc enhancertogether with the negative wnt regulators, apc, and betatrcp."	0.75	SIGNOR-19153
SIGNOR-CRC	"Colorectal Carcinoma"	ERBB2	protein	P04626	UNIPROT	ERBB2	protein	P04626	UNIPROT	"up-regulates activity"	phosphorylation	Tyr1248	PTAENPEyLGLDVPV	-1									1706616	t			" Y1023 and Y1248, Y1139 and Y1222 also serve as autophosphorylation sites of HER2."	0.2	SIGNOR-251128
SIGNOR-CRC	"Colorectal Carcinoma"	ERBB2	protein	P04626	UNIPROT	ERBB2	protein	P04626	UNIPROT	"up-regulates activity"	phosphorylation	Tyr1023	DLVDAEEyLVPQQGF	9606									1706616	t			"Y1023 and Y1248, Y1139 and Y1222 also serve as autophosphorylation sites of HER2."	0.2	SIGNOR-251129
SIGNOR-CRC	"Colorectal Carcinoma"	ERBB2	protein	P04626	UNIPROT	ERBB2	protein	P04626	UNIPROT	"up-regulates activity"	phosphorylation	Tyr1222	PAFDNLYyWDQDPPE	-1									1706616	t			" Y1023 and Y1248, Y1139 and Y1222 also serve as autophosphorylation sites of HER2."	0.2	SIGNOR-251130
SIGNOR-CRC	"Colorectal Carcinoma"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	SMAD4	protein	Q13485	UNIPROT	up-regulates	phosphorylation	Thr277	GSRTAPYtPNLPHHQ	9606									12801888	t		lperfetto	"Our results suggest that map kinase can phosphorylate thr276 of smad4 and that phosphorylation can lead to enhanced tgf-beta-induced nuclear accumulation and, as a consequence, enhanced transcriptional activity of smad4."	0.2	SIGNOR-244739
SIGNOR-CRC	"Colorectal Carcinoma"	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	up-regulates	phosphorylation			9606									11971971	t		lperfetto	"Mapk1 is phosphorylated by map2k1/mek1 and map2k2/mek2 on thr-185 and tyr-187 in response to external stimuli like insulin or ngf. Both phosphorylations are required for activity."	0.758	SIGNOR-244776
SIGNOR-CRC	"Colorectal Carcinoma"	IGF1R	protein	P08069	UNIPROT	IGF1R	protein	P08069	UNIPROT	"up-regulates activity"	phosphorylation	Tyr1346	SFDERQPyAHMNGGR	-1									8940173	t		miannu	"The insulin-like growth factor type I (IGF-I) receptor can become tyrosine phosphorylated and enzymatically activated either in response to ligand or because of the activity of the Src tyrosine kinaseWe mapped the sites of IGF-I receptor autophosphorylation to peptides representing three different receptor domains: tyrosines 943 and 950 in the juxtamembrane region; tyrosines 1131, 1135, and 1136 within the kinase domain; and tyrosine 1316 in the carboxyl-terminal domain."	0.2	SIGNOR-246260
SIGNOR-CRC	"Colorectal Carcinoma"	IRS2	protein	Q9Y4H2	UNIPROT	PIK3CA	protein	P42336	UNIPROT	"up-regulates activity"	binding			9606									22810696	t		lperfetto	"These results strongly suggest that the IGF2–IGF1R–IRS2 axis signals to PI3K in CRC and imply that therapeutic targeting of the pathway could act to block PI3K activity in this subset of patients."	0.688	SIGNOR-251492
SIGNOR-CRC	"Colorectal Carcinoma"	SMAD4	protein	Q13485	UNIPROT	MYC	protein	P01106	UNIPROT	"down-regulates quantity by repression"	"transcriptional regulation"			9606									11689553	t		lperfetto	"Down-regulation of c-Myc is a critical event for growth inhibition induced by transforming growth factor-β (TGF-β) and is frequently impaired in cancer cells. We determined a Smad-responsive element in the c-mycpromoter."	0.647	SIGNOR-251493
SIGNOR-CRC	"Colorectal Carcinoma"	SMAD3	protein	P84022	UNIPROT	MYC	protein	P01106	UNIPROT	"down-regulates quantity by repression"	"transcriptional regulation"			9606									11689553	t		lperfetto	"Down-regulation of c-Myc is a critical event for growth inhibition induced by transforming growth factor-β (TGF-β) and is frequently impaired in cancer cells. We determined a Smad-responsive element in the c-mycpromoter."	0.689	SIGNOR-251494
SIGNOR-CRC	"Colorectal Carcinoma"	IGF2	protein	P01344	UNIPROT	IGF1R	protein	P08069	UNIPROT	"up-regulates activity"	binding			9606									22810696	t		lperfetto	"These results strongly suggest that the IGF2–IGF1R–IRS2 axis signals to PI3K in CRC and imply that therapeutic targeting of the pathway could act to block PI3K activity in this subset of patients."	0.825	SIGNOR-251495
SIGNOR-CRC	"Colorectal Carcinoma"	DNA_damage	stimulus	SIGNOR-ST1	SIGNOR	ATM	protein	Q13315	UNIPROT	up-regulates				9606									21034966	f		lperfetto	"the ATM-Chk2 and ATR-Chk1 pathways, which are activated by DNA double-strand breaks (DSBs) and single-stranded DNA respectively."	0.7	SIGNOR-242612
SIGNOR-CRC	"Colorectal Carcinoma"	ATM	protein	Q13315	UNIPROT	ATM	protein	Q13315	UNIPROT	unknown	phosphorylation	Ser440	SPLLMILsQLLPQQR	-1									10608806	t		llicata	"Putative ATM in vitro targets include p95/nibrin, Mre11, Brca1, Rad17, PTS, WRN, and ATM (S440) itself."	0.2	SIGNOR-250576
SIGNOR-CRC	"Colorectal Carcinoma"	ERBB2	protein	P04626	UNIPROT	ERBB2	protein	P04626	UNIPROT	"up-regulates activity"	phosphorylation	Tyr1139	TCSPQPEyVNQPDVR	-1									1706616	t			" Y1023 and Y1248, Y1139 and Y1222 also serve as autophosphorylation sites of HER2."	0.2	SIGNOR-251127
SIGNOR-GBM	"Glioblastoma Multiforme"	RASA1	protein	P20936	UNIPROT	HRAS	protein	P01112	UNIPROT	down-regulates	binding			9606									9219684	t		gcesareni	"The three-dimensional structure of the complex between human h-ras bound to guanosine diphosphate and the guanosine triphosphatase (gtpase)-activating domain of the human gtpase-activating protein p120gap (gap-334) in the presence of aluminum fluoride was solved at a resolution of 2.5 angstroms."	0.848	SIGNOR-49477
SIGNOR-GBM	"Glioblastoma Multiforme"	RASA1	protein	P20936	UNIPROT	HRAS	protein	P01112	UNIPROT	down-regulates	binding			9606									10394594	t		lperfetto	"The Ras protein sits at the center of a many-tiered cascade of molecular interactions. Most of the proteins along this cascade are activated by phosphorylation, but Ras uses a bound guanine nucleotide to toggle between its on and off states. Ras hydrolyzes GTP to GDP fairly quickly, turning itself off, and a collection of GTPase-activating proteins (GAPs) speed up the processthe complex between human h-ras bound to guanosine diphosphate and the guanosine triphosphatase (gtpase)-activating domain of the human gtpase-activating protein p120gap (gap-334) in the presence of aluminum fluoride was solved."	0.848	SIGNOR-68990
SIGNOR-GBM	"Glioblastoma Multiforme"	SOS1	protein	Q07889	UNIPROT	HRAS	protein	P01112	UNIPROT	"up-regulates activity"	"guanine nucleotide exchange factor"			9606									23132018	t		lperfetto	"The enhancement of H-Ras GTP levels induced by oncogenic K-Ras was abrogated when the expression of endogenous Sos was suppressed, implicating Sos as an essential intermediate in the cross talk between oncogenic K-Ras and WT H-Ras."	0.892	SIGNOR-39237
SIGNOR-GBM	"Glioblastoma Multiforme"	SOS1	protein	Q07889	UNIPROT	HRAS	protein	P01112	UNIPROT	"up-regulates activity"	"guanine nucleotide exchange factor"			9606									23132018	t		lperfetto	"The enhancement of H-Ras GTP levels induced by oncogenic K-Ras was abrogated when the expression of endogenous Sos was suppressed, implicating Sos as an essential intermediate in the cross talk between oncogenic K-Ras and WT H-Ras."	0.892	SIGNOR-59472
SIGNOR-GBM	"Glioblastoma Multiforme"	HRAS	protein	P01112	UNIPROT	BRAF	protein	P15056	UNIPROT	up-regulates	binding			9606									18098337	t		lperfetto	"BRAF kinase is a downstream target of KRAS and activates the MAPK pathway."	0.879	SIGNOR-160043
SIGNOR-GBM	"Glioblastoma Multiforme"	HRAS	protein	P01112	UNIPROT	BRAF	protein	P15056	UNIPROT	up-regulates	binding			10090	BTO:0000944								7706312	t		lperfetto	"Association of B-Raf with immobilized Ras occurred independently of prior stimulation of cells with serum, suggesting that primarily the production of GTP-Ras by mitogen stimulation is critical for the formation of B-Raf_GTP-Ras complexes."	0.879	SIGNOR-235478
SIGNOR-GBM	"Glioblastoma Multiforme"	NF1	protein	P21359	UNIPROT	HRAS	protein	P01112	UNIPROT	"down-regulates activity"	"gtpase-activating protein"			9606	BTO:0000938								24431436	t		miannu	"Nf1encodes neurofibromin, a protein with multiple functions including ras inactivation (ras gtpase-activating protein or rasgap) and adenylyl cyclase (ac) activation"	0.817	SIGNOR-204357
SIGNOR-GBM	"Glioblastoma Multiforme"	PDPK1	protein	O15530	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation	Thr308	KDGATMKtFCGTPEY	9606									15718470	t		gcesareni	"Akt/PKB activation requires the phosphorylation of Thr308 in the activation loop by the phosphoinositide-dependent kinase 1 (PDK1) and Ser473 within the carboxyl-terminal hydrophobic motif by an unknown kinase."	0.746	SIGNOR-243203
SIGNOR-GBM	"Glioblastoma Multiforme"	PDPK1	protein	O15530	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation			9606									15743829	t		lperfetto	"3-phosphoinositide-dependent kinase 1 (PDK1) phosphorylates the activation loop of a number of protein serine/threonine kinases of the AGC kinase superfamily, including protein kinase B (PKB; also called Akt),"	0.746	SIGNOR-244469
SIGNOR-GBM	"Glioblastoma Multiforme"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	CREB1	protein	P16220	UNIPROT	"up-regulates activity"	phosphorylation	Ser119	EILSRRPsYRKILND	9606									9829964	t			"The nuclear factor CREB stimulates the expression of cellular genes following its protein kinase A-mediated phosphorylation at Ser-133. Ser-133 phosphorylation, in turn, activates target gene expression by promoting recruitment of the co-activator CBP. |When overexpressed in serum-stimulated cells, Akt/PKB potently induced Ser-133 phosphorylation of CREB and promoted recruitment of CBP."	0.2	SIGNOR-251474
SIGNOR-GBM	"Glioblastoma Multiforme"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	BRAF	protein	P15056	UNIPROT	down-regulates	phosphorylation	Ser364	FGQRDRSsSAPNVHI	9606									10869359	t		lperfetto	"We show that phosphorylation of b-raf by akt occurs at multiple residues within its amino terminal regulatory domain, at both the conserved and unique phosphorylation sites. Akt phosphorylated b-raf on s364 and s428 to inactivate its kinase activity b-raf contains three akt consensus sites, table i. One site, ser364 is conserved with c-raf;however, two sites, ser428 and thr439, are unique to b-raf"	0.2	SIGNOR-244152
SIGNOR-GBM	"Glioblastoma Multiforme"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	BRAF	protein	P15056	UNIPROT	down-regulates	phosphorylation	Ser428	GPQRERKsSSSSEDR	9606									10869359	t		lperfetto	"We show that phosphorylation of b-raf by akt occurs at multiple residues within its amino terminal regulatory domain, at both the conserved and unique phosphorylation sites. Akt phosphorylated b-raf on s364 and s428 to inactivate its kinase activity b-raf contains three akt consensus sites, table i. One site, ser364 is conserved with c-raf;however, two sites, ser428 and thr439, are unique to b-raf"	0.2	SIGNOR-244160
SIGNOR-GBM	"Glioblastoma Multiforme"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	BRAF	protein	P15056	UNIPROT	down-regulates	phosphorylation	Thr440	EDRNRMKtLGRRDSS	9606									10869359	t		lperfetto	"We show that phosphorylation of b-raf by akt occurs at multiple residues within its amino terminal regulatory domain, at both the conserved and unique phosphorylation sites. Akt phosphorylated b-raf on s364 and s428 to inactivate its kinase activity b-raf contains three akt consensus sites, table i. One site, ser364 is conserved with c-raf;however, two sites, ser428 and thr439, are unique to b-raf"	0.2	SIGNOR-244156
SIGNOR-GBM	"Glioblastoma Multiforme"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	JUN	protein	P05412	UNIPROT	"up-regulates activity"	phosphorylation			9606	BTO:0000675								23616010			lperfetto	"The results revealed that PAR2-AP and FVIIa could upregulate c-Jun expression and c-Jun phosphorylation in SW620 cells in a time-dependent manner. The effect of FVIIa was significantly blocked by anti-TF and anti-PAR2 antibodies. Protein kinase C_ (PKC_) inhibitor safingol and extracellular signal-regulated kinase 1 and 2 (ERK1/2) inhibitor U0126 abrogated the activation of c-Jun"	0.2	SIGNOR-236767
SIGNOR-GBM	"Glioblastoma Multiforme"	PDPK1	protein	O15530	UNIPROT	PDPK1	protein	O15530	UNIPROT	unknown	phosphorylation	Ser393	MQVSSSSsSHSLSAS	9606									10455013	t		lperfetto	"3-phosphoinositide-dependent protein kinase-1 (pdk1) expressed in unstimulated 293 cells was phosphorylated at ser-25, ser-241, ser-393, ser-396 and ser-410 and the level of phosphorylation of each site was unaffected by stimulation with insulin-like growth factor-1. Mutation of ser-241 to ala abolished pdk1 activity, whereas mutation of the other phosphorylation sites individually to ala did not affect pdk1 activity"	0.2	SIGNOR-235782
SIGNOR-GBM	"Glioblastoma Multiforme"	EGFR	protein	P00533	UNIPROT	EGFR	protein	P00533	UNIPROT	"up-regulates activity"	phosphorylation	Tyr1110	GSVQNPVyHNQPLNP	9606									10653583	t	"Dimerization mediated by a beta hairpin, which protudes from the S1 domains of each ligand bound monomer"	lperfetto	"After binding of epidermal growth factor (EGF), the EGF receptor (EGFR) becomes autophosphorylated via tyrosine."	0.2	SIGNOR-236483
SIGNOR-GBM	"Glioblastoma Multiforme"	EGFR	protein	P00533	UNIPROT	EGFR	protein	P00533	UNIPROT	"up-regulates activity"	phosphorylation	Tyr1172	ISLDNPDyQQDFFPK	10090	BTO:0002882								16122376	t	"Dimerization mediated by a beta hairpin, which protudes from the S1 domains of each ligand bound monomer"	lperfetto	"EGFR possesses three major and two minor tyrosine autophosphorylation sites located at Y1068, Y1148, Y1173, and at Y992 and Y1086 respectively. In addition, EGFR Y1114 is preceded by glutamic acid (Figure 1), which should be preferred by the EGFR kinase as indicated in previous work"	0.2	SIGNOR-236531
SIGNOR-GBM	"Glioblastoma Multiforme"	PDPK1	protein	O15530	UNIPROT	PDPK1	protein	O15530	UNIPROT	unknown	phosphorylation	Ser410	GLPQRSGsNIEQYIH	9606									10455013	t		lperfetto	"3-phosphoinositide-dependent protein kinase-1 (pdk1) expressed in unstimulated 293 cells was phosphorylated at ser-25, ser-241, ser-393, ser-396 and ser-410 and the level of phosphorylation of each site was unaffected by stimulation with insulin-like growth factor-1. Mutation of ser-241 to ala abolished pdk1 activity, whereas mutation of the other phosphorylation sites individually to ala did not affect pdk1 activity"	0.2	SIGNOR-236772
SIGNOR-GBM	"Glioblastoma Multiforme"	PDPK1	protein	O15530	UNIPROT	PDPK1	protein	O15530	UNIPROT	"down-regulates quantity by destabilization"	phosphorylation	Ser241	SKQARANsFVGTAQY	-1									12177059	t		miannu	"PDK1 kinase activity is negatively regulated by binding to 14-3-3 through the PDK1 autophosphorylation site Ser-241. PDK1 binds to 14-3-3 in vivo and in vitro through the residues surrounding the autophosphorylation site Ser-241 and that the association is achieved only when Ser-241 has been phosphorylated"	0.2	SIGNOR-250077
SIGNOR-GBM	"Glioblastoma Multiforme"	PTEN	protein	P60484	UNIPROT	PTEN	protein	P60484	UNIPROT	"up-regulates activity"	dephosphorylation	Ser380	EPDHYRYsDTTDSDP	9606									22413754	t		miannu	"Overall, our results suggest that PTEN autodephosphorylation may be a critical event in this process; thus a major protein substrate for PTEN may be PTEN itself.|Various studies have demonstrated that PTEN is itself a phosphoprotein, and that the major sites of phosphorylation are found in an acidic stretch (DHYRYSDTTDSDPENE) near the C-terminus [1]. This prompted us to consider whether PTEN may autodephosphorylate these sites"	0.2	SIGNOR-248544
SIGNOR-GBM	"Glioblastoma Multiforme"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	JUN	protein	P05412	UNIPROT	"up-regulates activity"	phosphorylation			9606	BTO:0000762								12509763	t		lperfetto	"Substrates for ERK1/2 include nuclear proteins such as C-JUN, this leads to activation of the AP-1 transcription factor, which is made up of FOS-JUN heterodimers."	0.2	SIGNOR-253214
SIGNOR-GBM	"Glioblastoma Multiforme"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	SOS1	protein	Q07889	UNIPROT	"down-regulates activity"	phosphorylation			9606		BTO:0000763;BTO:0000149							20724475	t		lperfetto	"ERK activation was sufficient for the SOS1 phosphorylation and resulting inhibition of EGF-induced Ras activation. This result also showed that SOS1 could be phosphorylated by ERK in the absence of association with EGFR at the plasma membrane, which is a phosphotyrosine-dependent process."	0.2	SIGNOR-244591
SIGNOR-GBM	"Glioblastoma Multiforme"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	SOS1	protein	Q07889	UNIPROT	down-regulates	phosphorylation	Ser1193	QPTSKAYsPRYSISD	9606									20724475	t		lperfetto	"ERK activation was sufficient for the SOS1 phosphorylation and resulting inhibition of EGF-induced Ras activation. This result also showed that SOS1 could be phosphorylated by ERK in the absence of association with EGFR at the plasma membrane, which is a phosphotyrosine-dependent process."	0.2	SIGNOR-244747
SIGNOR-GBM	"Glioblastoma Multiforme"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	SOS1	protein	Q07889	UNIPROT	down-regulates	phosphorylation	Ser1178	IMSKHLDsPPAIPPR	9606									20724475	t		lperfetto	"ERK activation was sufficient for the SOS1 phosphorylation and resulting inhibition of EGF-induced Ras activation. This result also showed that SOS1 could be phosphorylated by ERK in the absence of association with EGFR at the plasma membrane, which is a phosphotyrosine-dependent process."	0.2	SIGNOR-244743
SIGNOR-GBM	"Glioblastoma Multiforme"	SOS1	protein	Q07889	UNIPROT	KRAS	protein	P01116	UNIPROT	up-regulates	"guanine nucleotide exchange factor"			9606									25624485	t	"Ras proteins bind GDP/GTP and possess intrinsic GTPase activity."	gcesareni	"Because the KRAS-GDP to KRAS-GTP transition catalyzed by the GEF, son of sevenless 1 (SOS1), represents the rate-limiting step for nucleotide exchange, disrupting the activating SOS1/KRAS protein interaction has also been the focus of drug development efforts"	0.829	SIGNOR-201703
SIGNOR-GBM	"Glioblastoma Multiforme"	SOS1	protein	Q07889	UNIPROT	KRAS	protein	P01116	UNIPROT	up-regulates	"guanine nucleotide exchange factor"			9606									25624485	t	"Ras proteins bind GDP/GTP and possess intrinsic GTPase activity."	gcesareni	"Because the KRAS-GDP to KRAS-GTP transition catalyzed by the GEF, son of sevenless 1 (SOS1), represents the rate-limiting step for nucleotide exchange, disrupting the activating SOS1/KRAS protein interaction has also been the focus of drug development efforts"	0.829	SIGNOR-122075
SIGNOR-GBM	"Glioblastoma Multiforme"	SOS1	protein	Q07889	UNIPROT	KRAS	protein	P01116	UNIPROT	up-regulates	"guanine nucleotide exchange factor"			9606									25624485	t	"Ras proteins bind GDP/GTP and possess intrinsic GTPase activity."	gcesareni	"Because the KRAS-GDP to KRAS-GTP transition catalyzed by the GEF, son of sevenless 1 (SOS1), represents the rate-limiting step for nucleotide exchange, disrupting the activating SOS1/KRAS protein interaction has also been the focus of drug development efforts"	0.829	SIGNOR-175256
SIGNOR-GBM	"Glioblastoma Multiforme"	SOS1	protein	Q07889	UNIPROT	KRAS	protein	P01116	UNIPROT	up-regulates	"guanine nucleotide exchange factor"			9606									25624485	t	"Ras proteins bind GDP/GTP and possess intrinsic GTPase activity."	gcesareni	"Because the KRAS-GDP to KRAS-GTP transition catalyzed by the GEF, son of sevenless 1 (SOS1), represents the rate-limiting step for nucleotide exchange, disrupting the activating SOS1/KRAS protein interaction has also been the focus of drug development efforts"	0.829	SIGNOR-141647
SIGNOR-GBM	"Glioblastoma Multiforme"	GRB2	protein	P62993	UNIPROT	SOS1	protein	Q07889	UNIPROT	"up-regulates activity"	relocalization			9606	BTO:0001412								10570290	t	"GRB2 associated guanine nucleotide exchange factor Sos activates Ras through the exchange of GDP for GTP"	lperfetto	"Grb2 binds and activates sos, which then activates ras, and this activates p110 independently of p85."	0.914	SIGNOR-236792
SIGNOR-GBM	"Glioblastoma Multiforme"	EGFR	protein	P00533	UNIPROT	CBL	protein	P22681	UNIPROT	up-regulates	relocalization			9606									16829981	t	"Cbl binds directly to Tyr1045 receptors"	gcesareni	"Likewise, cbl is recruited to erbb1 either directly (tyr1045), or indirectly, trough grb2"	0.886	SIGNOR-147826
SIGNOR-GBM	"Glioblastoma Multiforme"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									19819937	f			"In addition to the JAK2–STAT5 pathway, the Ras GTPase–extracellular signal-regulated kinase (Ras–ERK) pathway has also been implicated in signaling of IL-5 and is important for IL-5-dependent cell survival, proliferation and differentiation of eosinophils."	0.7	SIGNOR-254354
SIGNOR-GBM	"Glioblastoma Multiforme"	GRB2	protein	P62993	UNIPROT	CBL	protein	P22681	UNIPROT	up-regulates	relocalization			9606									11823423	t	"GRB2 is an adapter protein that provides a critical link between cell surface growth factor receptors and the Ras signaling pathway."	gcesareni	"The underlying mechanism seems to involve recruitment of a grb2 c-cbl complex to grb2-specific docking sites of egfr, and concurrent acceleration of receptor ubiquitylation and desensitization."	0.904	SIGNOR-114704
SIGNOR-GBM	"Glioblastoma Multiforme"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									24743741	f			"Activation of PDGFRα stimulates proliferation of PDGFRα(+) cells through PI3K-Akt and MEK2-MAPK signaling pathways, and aberrant accumulation of PDGFRα(+) cells was conspicuous in muscles of patients with both genetic and non-genetic muscle diseases."	0.7	SIGNOR-254374
SIGNOR-GBM	"Glioblastoma Multiforme"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				10090									20219869	f		areggio	"Furthermore, stimulation of myoblasts with CCL2, CCL3, or CCL4 was sufficient to induce phosphorylation and activation of ERK1/2. This outcome may be functionally important because ERK1/2 activation is a component of the pathway through which many mitogenic growth factors can stimulate cell proliferation."	0.7	SIGNOR-255120
SIGNOR-GBM	"Glioblastoma Multiforme"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	BRAF	protein	P15056	UNIPROT	down-regulates	phosphorylation	Thr401	STTGLSAtPPASLPG	9606									21135229	t		lperfetto	"We show that b-raf is a calcineurin substrate;among calcineurin target residues on b-raf is t401, a site of negative feedback phosphorylation by erk1/2. Blocking calcineurin activity in _ cells prevents dephosphorylation of b-raf t401 and decreases b-raf and erk1/2 activities."	0.2	SIGNOR-170339
SIGNOR-GBM	"Glioblastoma Multiforme"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606	BTO:0000876	BTO:0001103							11602185	f		apalma	"The GM-CSF promoted cell survival and proliferation correlated with MEK-1 dependent ERK1/2, Elk-1 and CREB phosphorylation and Egr-1, c-Fos expression as well as with increased STAT-5, AP-1, c-Myb and NF-kappaB DNA-binding."	0.7	SIGNOR-255580
SIGNOR-GBM	"Glioblastoma Multiforme"	EGFR	protein	P00533	UNIPROT	GRB2	protein	P62993	UNIPROT	"up-regulates activity"	binding			10090	BTO:0000944								7518560	t		lperfetto	"Erbb1 recruites grb2 through sh2 domain;from these studies, we concluded that grb2 binds directly to the egfr at y-1068, to a lesser extent at y-1086, and indirectly at y-1173. Egfr has six binding sites for the adapter protein grb2, and erbb4 has five, each with different binding strength several tyrosine-based motifs recruit a number of signal transducers to the phosphorylated form of erbb1 such as the adaptor proteins growth-factor-receptor bound-2 (grb2) and src-homology-2-containing (shc)."	0.924	SIGNOR-235721
SIGNOR-GBM	"Glioblastoma Multiforme"	EGFR	protein	P00533	UNIPROT	GRB2	protein	P62993	UNIPROT	unknown	phosphorylation	Tyr209	TGMFPRNyVTPVNRN	9606	BTO:0000017								11726515	t		lperfetto	"Phosphorylation of grb2 by bcr/abl or egf receptor reduced its sh3-dependent binding to sos in vivo, but not its sh2-dependent binding to bcr/abl. Tyr209 within the c-terminal sh3 domain of grb2 was identified as one of the tyrosine phosphorylation sites"	0.924	SIGNOR-235738
SIGNOR-GBM	"Glioblastoma Multiforme"	EGFR	protein	P00533	UNIPROT	GRB2	protein	P62993	UNIPROT	"up-regulates activity"	binding			-1	BTO:0000567								16729043	t		lperfetto	"We determined interaction partners to all cytosolic tyrosine residues of the four members of the ErbB-receptor family in an unbiased fashion by quantitative proteomics using pull-down experiments with pairs of phosphorylated and nonphosphorylated synthetic peptides. Each receptor had characteristic preferences for interacting proteins and most interaction partners had multiple binding sites on each receptor. EGFR and ErbB4 had several docking sites for Grb2, while ErbB3 was characterized by six binding sites for PI3K."	0.924	SIGNOR-236327
SIGNOR-GBM	"Glioblastoma Multiforme"	EGF	protein	P01133	UNIPROT	EGFR	protein	P00533	UNIPROT	up-regulates	binding			9606									12648462	t		lperfetto	"The mammalian ligands that bind the egf receptor (egfr [her1, erb-b1]) include egf, transforming growth factor- (tgf), heparin-binding egf-like growth factor (hb-egf), amphiregulin (ar), betacellulin (btc), epiregulin (epr), and epigen"	0.95	SIGNOR-22716
SIGNOR-GBM	"Glioblastoma Multiforme"	EGFR	protein	P00533	UNIPROT	EGFR	protein	P00533	UNIPROT	"up-regulates activity"	phosphorylation	Tyr1172	ISLDNPDyQQDFFPK	9606	BTO:0000567								10653583	t	"Dimerization mediated by a beta hairpin, which protudes from the S1 domains of each ligand bound monomer"	lperfetto	"After binding of epidermal growth factor (EGF), the EGF receptor (EGFR) becomes autophosphorylated via tyrosine."	0.2	SIGNOR-236467
SIGNOR-GBM	"Glioblastoma Multiforme"	EGFR	protein	P00533	UNIPROT	EGFR	protein	P00533	UNIPROT	"up-regulates activity"	phosphorylation	Tyr1197	STAENAEyLRVAPQS	9606	BTO:0000567								10653583	t	"Dimerization mediated by a beta hairpin, which protudes from the S1 domains of each ligand bound monomer"	lperfetto	"After binding of epidermal growth factor (EGF), the EGF receptor (EGFR) becomes autophosphorylated via tyrosine."	0.2	SIGNOR-236471
SIGNOR-GBM	"Glioblastoma Multiforme"	EGFR	protein	P00533	UNIPROT	EGFR	protein	P00533	UNIPROT	"up-regulates activity"	phosphorylation	Tyr1016	DVVDADEyLIPQQGF	9606	BTO:0000567								10653583	t	"Dimerization mediated by a beta hairpin, which protudes from the S1 domains of each ligand bound monomer"	lperfetto	"After binding of epidermal growth factor (EGF), the EGF receptor (EGFR) becomes autophosphorylated via tyrosine."	0.2	SIGNOR-236475
SIGNOR-GBM	"Glioblastoma Multiforme"	EGFR	protein	P00533	UNIPROT	EGFR	protein	P00533	UNIPROT	"up-regulates activity"	phosphorylation	Tyr1092	TFLPVPEyINQSVPK	9606	BTO:0000567								10653583	t	"Dimerization mediated by a beta hairpin, which protudes from the S1 domains of each ligand bound monomer"	lperfetto	"After binding of epidermal growth factor (EGF), the EGF receptor (EGFR) becomes autophosphorylated via tyrosine."	0.2	SIGNOR-236479
SIGNOR-GBM	"Glioblastoma Multiforme"	EGFR	protein	P00533	UNIPROT	EGFR	protein	P00533	UNIPROT	"up-regulates activity"	phosphorylation	Tyr869	LGAEEKEyHAEGGKV	9606	BTO:0000567								10653583	t	"Dimerization mediated by a beta hairpin, which protudes from the S1 domains of each ligand bound monomer"	lperfetto	"After binding of epidermal growth factor (EGF), the EGF receptor (EGFR) becomes autophosphorylated via tyrosine."	0.2	SIGNOR-236487
SIGNOR-GBM	"Glioblastoma Multiforme"	EGF	protein	P01133	UNIPROT	EGFR	protein	P00533	UNIPROT	"up-regulates activity"	binding			9606									12297050	t		lperfetto	"Epidermal growth factor (egf) regulates cell proliferation and differentiation by binding to the egf receptor (egfr) extracellular region, comprising domains i-iv, with the resultant dimerization of the receptor tyrosine kinase."	0.95	SIGNOR-186159
SIGNOR-GBM	"Glioblastoma Multiforme"	EGFR	protein	P00533	UNIPROT	EGFR	protein	P00533	UNIPROT	"up-regulates activity"	phosphorylation	Tyr1092	TFLPVPEyINQSVPK	10090	BTO:0002882								16122376	t	"Dimerization mediated by a beta hairpin, which protudes from the S1 domains of each ligand bound monomer"	lperfetto	"EGFR possesses three major and two minor tyrosine autophosphorylation sites located at Y1068, Y1148, Y1173, and at Y992 and Y1086 respectively. In addition, EGFR Y1114 is preceded by glutamic acid (Figure 1), which should be preferred by the EGFR kinase as indicated in previous work"	0.2	SIGNOR-236523
SIGNOR-GBM	"Glioblastoma Multiforme"	EGFR	protein	P00533	UNIPROT	EGFR	protein	P00533	UNIPROT	"up-regulates activity"	phosphorylation	Tyr1016	DVVDADEyLIPQQGF	10090	BTO:0002882								16122376	t	"Dimerization mediated by a beta hairpin, which protudes from the S1 domains of each ligand bound monomer"	lperfetto	"EGFR possesses three major and two minor tyrosine autophosphorylation sites located at Y1068, Y1148, Y1173, and at Y992 and Y1086 respectively. In addition, EGFR Y1114 is preceded by glutamic acid (Figure 1), which should be preferred by the EGFR kinase as indicated in previous work"	0.2	SIGNOR-236527
SIGNOR-GBM	"Glioblastoma Multiforme"	PIP3	smallmolecule	CHEBI:16618	ChEBI	PDPK1	protein	O15530	UNIPROT	"up-regulates activity"	relocalization			9606									21798082	t		lperfetto	"Pip3 acts in turn as a docking site for two kinases, phosphoinositide-dependent kinase 1 (PDK1) and AKT, and the subsequent phosphorylation of AKT at serine 308 by PDK1, leading to AKT activation."	0.8	SIGNOR-175253
SIGNOR-GBM	"Glioblastoma Multiforme"	PIP3	smallmolecule	CHEBI:16618	ChEBI	PDPK1	protein	O15530	UNIPROT	"up-regulates activity"	relocalization			9534									9637919	t		lperfetto	"In response to PDGF, binding of ptdlns (3,4,5)p3 and/or ptdlns(3,4)p2 to the PH domain of PDK-1 causes its translocation to the plasma membrane where it co-localises with PKB, significantly contributing to the scale of PKB activation."	0.8	SIGNOR-58313
SIGNOR-GBM	"Glioblastoma Multiforme"	PDPK1	protein	O15530	UNIPROT	PDPK1	protein	O15530	UNIPROT	"up-regulates activity"	phosphorylation	Ser241	SKQARANsFVGTAQY	9606									10455013	t		lperfetto	"Pdk1 is itself phosphorylated in vivo and whether phosphorylation plays a role in regulating its activity/ phosphorylation of ser-241 is essential for the activity of 3-phosphoinositide-dependent protein kinase-1"	0.2	SIGNOR-236789
SIGNOR-GBM	"Glioblastoma Multiforme"	CREB1	protein	P16220	UNIPROT	Survival	phenotype	SIGNOR-PH13	SIGNOR	up-regulates				9606									20660310	f		amattioni	"beta-catenin/CBP-driven transcription is critical for maintenance of an undifferentiated/proliferative state"	0.7	SIGNOR-229777
SIGNOR-GBM	"Glioblastoma Multiforme"	PIK3R1	protein	P27986	UNIPROT	PIK3CA	protein	P42336	UNIPROT	"up-regulates activity"	binding			9534	BTO:0004055								14665640	t		lperfetto	"Signal transduction pathways triggered by Tie2 have been extensively examined. Tyr-1101of Tie2 directly associates in a phosphotyrosine (pTyr)-dependent manner with the p85 regulatory subunit of phosphatidylinositol (PI) 3-kinase, which in turn activate PI 3-kinase, leading to cell motility and survival"	0.936	SIGNOR-242637
SIGNOR-GBM	"Glioblastoma Multiforme"	EGFR	protein	P00533	UNIPROT	EGFR	protein	P00533	UNIPROT	"up-regulates activity"	phosphorylation	Tyr1110	GSVQNPVyHNQPLNP	10090	BTO:0002882								16122376	t	"Dimerization mediated by a beta hairpin, which protudes from the S1 domains of each ligand bound monomer"	lperfetto	"EGFR possesses three major and two minor tyrosine autophosphorylation sites located at Y1068, Y1148, Y1173, and at Y992 and Y1086 respectively. In addition, EGFR Y1114 is preceded by glutamic acid (Figure 1), which should be preferred by the EGFR kinase as indicated in previous work"	0.2	SIGNOR-236516
SIGNOR-GBM	"Glioblastoma Multiforme"	CBL	protein	P22681	UNIPROT	EGFR	protein	P00533	UNIPROT	"down-regulates quantity by destabilization"	ubiquitination			9606									20332299	t		lperfetto	"Ligand binding to EGFR also leads to rapid internalization and proteosomal/lysosomal degradation of the receptors. This process results in a dramatic downregulation of both total and cell surface receptors. EGF-induced degradation of EGFR is thought to be initiated by phosphorylation of tyrosine 1045 of the receptor followed by binding of Cbl adaptor proteins and ubiquitination of the receptor. Internalized EGFR is transported to early endosomes where receptor-ligand complexes are sorted for either degradation or recycling to the cell surface."	0.886	SIGNOR-65642
SIGNOR-GBM	"Glioblastoma Multiforme"	PIP3	smallmolecule	CHEBI:16618	ChEBI	PDPK1	protein	O15530	UNIPROT	"up-regulates activity"	"chemical activation"			-1									9094314	t		gcesareni	"We tested the kinase in the presence of several inositol phospholipids and found that only low micromolar concentrations of the D enantiomers of either phosphatidylinositol 3,4,5-triphosphate (PtdIns(3,4,5)P3) or PtdIns(3,4)P2 were effective in potently activating the kinase, which has been named PtdIns(3,4,5)P3-dependent protein kinase-1 (PDK1)"	0.8	SIGNOR-243274
SIGNOR-GBM	"Glioblastoma Multiforme"	BRAF	protein	P15056	UNIPROT	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	"up-regulates activity"	phosphorylation			10090									8131746	t		lperfetto	"Activation of mek family kinases requires phosphorylation of two conserved ser/thr residueserine residues 218 and 222 of human mek1 are the primary sites for phosphorylation by c-raf."	0.787	SIGNOR-244827
SIGNOR-GBM	"Glioblastoma Multiforme"	BRAF	protein	P15056	UNIPROT	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	up-regulates	phosphorylation			9606									8668348	t		lperfetto	"We show that, consequently, b-raf interacts with mek-1 and mek-2 with a better affinity than does c-raf-1, thus strengthening the notion that b-raf is a stronger mek activator than c-raf-l."	0.787	SIGNOR-244843
SIGNOR-GBM	"Glioblastoma Multiforme"	PDPK1	protein	O15530	UNIPROT	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	"up-regulates activity"	phosphorylation			9606	BTO:0000007								15175348	t		lperfetto	"In vitro kinase assay revealed that the direct targets of pdk1 in the mapk pathway were the upstream mapk kinases mek1 and mek2. The identified pdk1 phosphorylation sites in mek1 and mek2 are ser222 and ser226, respectively, and are known to be essential for full activation"	0.272	SIGNOR-244934
SIGNOR-GBM	"Glioblastoma Multiforme"	PDPK1	protein	O15530	UNIPROT	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	up-regulates	phosphorylation			9606									15175348	t		lperfetto	"The identified pdk1 phosphorylation sites in mek1 and mek2 are ser222 and ser226, respectively, and are known to be essential for full activation."	0.272	SIGNOR-244938
SIGNOR-GBM	"Glioblastoma Multiforme"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	SOS1	protein	Q07889	UNIPROT	"down-regulates activity"	phosphorylation	Ser1132	TLPHGPRsASVSSIS	9534	BTO:0004055								8816480	t		lperfetto	"In this report, we describe the identification of five map kinase sites (s-1137, s-1167, s-1178, s-1193, and s-1197) on hsos1Replacing the MAP kinase phosphorylation sites with alanine residues results in an increase in the binding affinity of Grb2 to hSos1"	0.2	SIGNOR-244580
SIGNOR-GBM	"Glioblastoma Multiforme"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	SOS1	protein	Q07889	UNIPROT	"down-regulates activity"	phosphorylation	Ser1167	ESAPAESsPSKIMSK	9534	BTO:0004055								8816480	t		lperfetto	"In this report, we describe the identification of five map kinase sites (s-1137, s-1167, s-1178, s-1193, and s-1197) on hsos1Replacing the MAP kinase phosphorylation sites with alanine residues results in an increase in the binding affinity of Grb2 to hSos1"	0.2	SIGNOR-244584
SIGNOR-GBM	"Glioblastoma Multiforme"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	SOS1	protein	Q07889	UNIPROT	"down-regulates activity"	phosphorylation	Ser1197	KAYSPRYsISDRTSI	9534	BTO:0004055								8816480	t		lperfetto	"In this report, we describe the identification of five map kinase sites (s-1137, s-1167, s-1178, s-1193, and s-1197) on hsos1Replacing the MAP kinase phosphorylation sites with alanine residues results in an increase in the binding affinity of Grb2 to hSos1"	0.2	SIGNOR-244588
SIGNOR-GBM	"Glioblastoma Multiforme"	PDPK1	protein	O15530	UNIPROT	PDPK1	protein	O15530	UNIPROT	"up-regulates activity"	phosphorylation	Ser241	SKQARANsFVGTAQY	9606									11481331	t		miannu	"In terms of the modulation of PDK1 activity by reversible phosphorylation, five pS sites have been identified on PDK1 in vivo, but only one of these sites, Ser-241 in the activation loop of PDK1, is essential for activity. It seems likely that PDK1 autophosphorylates itself on this residue."	0.2	SIGNOR-250268
SIGNOR-GBM	"Glioblastoma Multiforme"	PTEN	protein	P60484	UNIPROT	CREB1	protein	P16220	UNIPROT	"down-regulates activity"	dephosphorylation	Ser119	EILSRRPsYRKILND	10090	BTO:0002572								21385900	t			"Our study demonstrates that PTEN can dephosphorylate CREB at Ser133 and that PTEN protein phosphatase activity is required for CREB dephosphoryation.|Moreover, we use both in vitro and in vivo experiments to show PTEN can dephosphorylate CREB in a phosphatase-dependent manner, suggesting that CREB is a substrate of PTEN nuclear phosphatase. Loss of Pten results in an elevated RNA level of multiple CREB transcriptional targets and increased cell proliferation, which can be reversed by a nonphosphorylatable CREB mutant or knockdown of CREB. These data reveal a mechanism for PTEN modulation of CREB-mediated gene transcription and cell growth."	0.438	SIGNOR-248543
SIGNOR-GBM	"Glioblastoma Multiforme"	CBL	protein	P22681	UNIPROT	PIK3R1	protein	P27986	UNIPROT	down-regulates	ubiquitination			9606	BTO:0000782								11526404	t		lperfetto	"Cbl-b, a ring-type e3 ubiquitin protein ligase, is implicated in setting the threshold of t lymphocyte activation. The p85 regulatory subunit of phosphatidylinositol 3 kinase (pi3k) was identified as a substrate for cbl-b. We have shown that cbl-b negatively regulated p85 in a proteolysis-independent manner."	0.693	SIGNOR-110060
SIGNOR-GBM	"Glioblastoma Multiforme"	JUN	protein	P05412	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									9878062	f		lperfetto	"Functional data suggest that c-Jun is not merely a target for activation by many of the extracellular stimuli, but that it plays a role in mediating the cellular response. In the case of growth control, three lines of evidence suggest that the transcription factor AP-1, which is composed of FosJun and JunJun dimers, mediates cell proliferation in response to external growth signals in the form of peptide growth factors."	0.7	SIGNOR-233467
SIGNOR-GBM	"Glioblastoma Multiforme"	BRAF	protein	P15056	UNIPROT	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	"up-regulates activity"	phosphorylation			-1									8413257	t		lperfetto	"Raf-1 phosphorylation of MEK activated it, as judged by its ability to stimulate the phosphorylation of myelin basic protein by glutathione S-transferase-ERK1."	0.787	SIGNOR-244831
SIGNOR-GBM	"Glioblastoma Multiforme"	EGFR	protein	P00533	UNIPROT	EGFR	protein	P00533	UNIPROT	"up-regulates activity"	phosphorylation	Tyr1069	EDSFLQRySSDPTGA	9606									10635327	t		llicata	"Initially, an autophosphorylation reaction creates docking sites for several signaling proteins, including a Cbl binding site at tyrosine 1045 of EGFR."	0.2	SIGNOR-251093
SIGNOR-GBM	"Glioblastoma Multiforme"	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	up-regulates	phosphorylation			9606									11971971	t		lperfetto	"Mapk1 is phosphorylated by map2k1/mek1 and map2k2/mek2 on thr-185 and tyr-187 in response to external stimuli like insulin or ngf. Both phosphorylations are required for activity."	0.758	SIGNOR-244776
SIGNOR-GBM	"Glioblastoma Multiforme"	PTEN	protein	P60484	UNIPROT	PIP3	smallmolecule	CHEBI:16618	ChEBI	"down-regulates quantity"	"chemical modification"			9606									11875759	t		lperfetto	"PTEN dephosphorylates PI3P, lowering its cellular levels and resulting in the down-regulation of AKT."	0.8	SIGNOR-228145
SIGNOR-GBM	"Glioblastoma Multiforme"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	ELK1	protein	P19419	UNIPROT	"up-regulates activity"	phosphorylation			9606									23616010	t		lperfetto	"Erk also undergoes rapid translocation into the nucleus, where it phosphorylates and activates a variety of transcription factor targets, including sp1, e2f, elk-1, and ap1."	0.2	SIGNOR-233520
SIGNOR-GBM	"Glioblastoma Multiforme"	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	down-regulates				9606									18481201	f		lperfetto	"Pd98059, a specific inhibitor of mek in addition, immunoblot and immunostaining analysis revealed that phosphorylation of erk was increased by treatment with sb203580;whereas pd98059 increased the phosphorylation of p38, which implies a seesaw-like balance between erk and p38 phosphorylation."	0.634	SIGNOR-244877
SIGNOR-GBM	"Glioblastoma Multiforme"	EGFR	protein	P00533	UNIPROT	PIK3R1	protein	P27986	UNIPROT	up-regulates	binding			9606	BTO:0000093	BTO:0000150							26918608	t		lperfetto	"p85alpha promotes nucleolin transcription and subsequently enhances EGFR mRNA stability and EGF-induced malignant cellular transformation."	0.81	SIGNOR-33633
SIGNOR-GBM	"Glioblastoma Multiforme"	EGFR	protein	P00533	UNIPROT	PIK3R1	protein	P27986	UNIPROT	up-regulates	binding			9606									14967450	t		lperfetto	"The egf-r coimmunoprecipitated with p85 alpha"	0.81	SIGNOR-121959
SIGNOR-GBM	"Glioblastoma Multiforme"	EGFR	protein	P00533	UNIPROT	EGFR	protein	P00533	UNIPROT	"up-regulates activity"	phosphorylation	Tyr1197	STAENAEyLRVAPQS	10090	BTO:0002882								16122376	t	"Dimerization mediated by a beta hairpin, which protudes from the S1 domains of each ligand bound monomer"	lperfetto	"EGFR possesses three major and two minor tyrosine autophosphorylation sites located at Y1068, Y1148, Y1173, and at Y992 and Y1086 respectively. In addition, EGFR Y1114 is preceded by glutamic acid (Figure 1), which should be preferred by the EGFR kinase as indicated in previous work"	0.2	SIGNOR-235951
SIGNOR-GBM	"Glioblastoma Multiforme"	EGFR	protein	P00533	UNIPROT	EGFR	protein	P00533	UNIPROT	"up-regulates activity"	phosphorylation	Tyr869	LGAEEKEyHAEGGKV	10090	BTO:0002882								16122376	t	"Dimerization mediated by a beta hairpin, which protudes from the S1 domains of each ligand bound monomer"	lperfetto	"EGFR possesses three major and two minor tyrosine autophosphorylation sites located at Y1068, Y1148, Y1173, and at Y992 and Y1086 respectively. In addition, EGFR Y1114 is preceded by glutamic acid (Figure 1), which should be preferred by the EGFR kinase as indicated in previous work"	0.2	SIGNOR-235956
SIGNOR-GBM	"Glioblastoma Multiforme"	KRAS	protein	P01116	UNIPROT	BRAF	protein	P15056	UNIPROT	"up-regulates activity"	binding			9606									21779497	t		miannu	"The raf family of proteins (raf-1, a-raf, and b-raf) is serine/threonine kinases that bind to the effector region of ras-gtp, thus inducing translocation of the protein to the plasma membrane. Once there, raf proteins are activated and phosphorylated by different protein kinases."	0.878	SIGNOR-156906
SIGNOR-GBM	"Glioblastoma Multiforme"	KRAS	protein	P01116	UNIPROT	PIK3CA	protein	P42336	UNIPROT	up-regulates	binding			9606									21779497	t		gcesareni	"Grb2 binds and activates sos, which then activates ras, and this activates p110 independently of p85./it was also described that ras interacts with pi3k in a direct manner./lysine residue 227 is essential for the interaction of ras with pi3k phosphatidylinositol 3-kinase (pi3k) is one of the main effector pathways of ras, regulating cell growth, cell cycle entry, cell survival, cytoskeleton reorganization, and metabolism."	0.911	SIGNOR-175204
SIGNOR-GBM	"Glioblastoma Multiforme"	PIK3CA	protein	P42336	UNIPROT	PIP3	smallmolecule	CHEBI:16618	ChEBI	"up-regulates quantity"	"chemical modification"			9606									24647478	t	"AKT is a serine-threonine protein kinase that plays important roles in cell growth, proliferation and apoptosis. It is activated after binding to phosphatidylinositol phosphates (PIPs) with phosphate s at positions 3, 4 and 3,4,5 on the inositol ring"	miannu	"Stimulation of tyrosine kinase receptors initiates a signaling cascade that activates pi3k. Activated pi3k uses pip2 to generate pip3, which recruit akt to the plasma membrane through its pleckstrin homology (ph) domain, permitting its activation by pdks."	0.8	SIGNOR-65409
SIGNOR-GBM	"Glioblastoma Multiforme"	ELK1	protein	P19419	UNIPROT	Cell_growth	phenotype	SIGNOR-PH33	SIGNOR	up-regulates				9606									23426362	f		lperfetto	"AR required ELK1 to up-regulate a major subset of its target genes that was strongly and primarily enriched for cell growth functions"	0.7	SIGNOR-233471
SIGNOR-GBM	"Glioblastoma Multiforme"	PDPK1	protein	O15530	UNIPROT	PDPK1	protein	O15530	UNIPROT	unknown	phosphorylation	Ser396	SSSSSSHsLSASDTG	9606									10455013	t		lperfetto	"3-phosphoinositide-dependent protein kinase-1 (pdk1) expressed in unstimulated 293 cells was phosphorylated at ser-25, ser-241, ser-393, ser-396 and ser-410 and the level of phosphorylation of each site was unaffected by stimulation with insulin-like growth factor-1. Mutation of ser-241 to ala abolished pdk1 activity, whereas mutation of the other phosphorylation sites individually to ala did not affect pdk1 activity"	0.2	SIGNOR-236764
SIGNOR-GBM	"Glioblastoma Multiforme"	PDPK1	protein	O15530	UNIPROT	PDPK1	protein	O15530	UNIPROT	unknown	phosphorylation	Ser25	VVLCSCPsPSMVRTQ	9606									10455013	t		lperfetto	"3-phosphoinositide-dependent protein kinase-1 (pdk1) expressed in unstimulated 293 cells was phosphorylated at ser-25, ser-241, ser-393, ser-396 and ser-410 and the level of phosphorylation of each site was unaffected by stimulation with insulin-like growth factor-1. Mutation of ser-241 to ala abolished pdk1 activity, whereas mutation of the other phosphorylation sites individually to ala did not affect pdk1 activity"	0.2	SIGNOR-236777
SIGNOR-GBM	"Glioblastoma Multiforme"	PTEN	protein	P60484	UNIPROT	PTEN	protein	P60484	UNIPROT	"up-regulates activity"	dephosphorylation	Thr383	HYRYSDTtDSDPENE	9606									22413754	t		miannu	"Overall, our results suggest that PTEN autodephosphorylation may be a critical event in this process; thus a major protein substrate for PTEN may be PTEN itself.|Various studies have demonstrated that PTEN is itself a phosphoprotein, and that the major sites of phosphorylation are found in an acidic stretch (DHYRYSDTTDSDPENE) near the C-terminus [1]. This prompted us to consider whether PTEN may autodephosphorylate these sites"	0.2	SIGNOR-248545
SIGNOR-GBM	"Glioblastoma Multiforme"	PTEN	protein	P60484	UNIPROT	PTEN	protein	P60484	UNIPROT	"up-regulates activity"	dephosphorylation	Thr382	DHYRYSDtTDSDPEN	9606									22413754	t		miannu	"Overall, our results suggest that PTEN autodephosphorylation may be a critical event in this process; thus a major protein substrate for PTEN may be PTEN itself.|Various studies have demonstrated that PTEN is itself a phosphoprotein, and that the major sites of phosphorylation are found in an acidic stretch (DHYRYSDTTDSDPENE) near the C-terminus [1]. This prompted us to consider whether PTEN may autodephosphorylate these sites"	0.2	SIGNOR-248546
SIGNOR-GBM	"Glioblastoma Multiforme"	PIK3R1	protein	P27986	UNIPROT	PIP3	smallmolecule	CHEBI:16618	ChEBI	"up-regulates quantity"				10116									21798082	f		lperfetto	"Phosphorylated irs then acts as docking site to recruit and activate phosphatidylinositol-3-kinase (pi3k) which phosphorylates membrane phospholipids, generating phosphoinositide-3,4,5-triphosphate (pip3) from phosphoinositide-4,5-biphosphate. (pip2)."	0.8	SIGNOR-175678
SIGNOR-GBM	"Glioblastoma Multiforme"	BRAF	protein	P15056	UNIPROT	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	"up-regulates activity"	phosphorylation			9606									21900390	t		miannu	"BRAFV600E has been shown to initiate thyroid follicular cell transformation. The BRAFV600E mutation disrupts the hydrophobic interaction, enabling the BRAF kinase to fold into a catalytically active formation, resulting in an almost 500-fold increase in kinase activity. Mutant BRAF can dimerize and activate MEK without Ras activation."	0.787	SIGNOR-251988
SIGNOR-GBM	"Glioblastoma Multiforme"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	ELK1	protein	P19419	UNIPROT	up-regulates	phosphorylation			9606									7618106	t		lperfetto	"The tcf protein elk-1 is phosphorylated by the jnk and erk groups of mitogen-activated protein (map) kinases causing increased dna binding, ternary complex formation, and transcriptional activation"	0.2	SIGNOR-252081
SIGNOR-GBM	"Glioblastoma Multiforme"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	ELK1	protein	P19419	UNIPROT	up-regulates	phosphorylation	Thr336	GGPGPERtPGSGSGS	9606									7889942	t		gcesareni	"Erki phosphorylates five c-terminal sites in elk-i (s324, t336, s383, s389 and s422) with varying degrees of efficiency."	0.2	SIGNOR-252082
SIGNOR-GBM	"Glioblastoma Multiforme"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	ELK1	protein	P19419	UNIPROT	up-regulates	phosphorylation	Ser383	IHFWSTLsPIAPRSP	9606									7889942	t		gcesareni	"Erki phosphorylates five c-terminal sites in elk-i (s324, t336, s383, s389 and s422) with varying degrees of efficiency."	0.2	SIGNOR-252083
SIGNOR-GBM	"Glioblastoma Multiforme"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	ELK1	protein	P19419	UNIPROT	up-regulates	phosphorylation	Ser422	LSTPVVLsPGPQKP	9606									7889942	t		gcesareni	"Erki phosphorylates five c-terminal sites in elk-i (s324, t336, s383, s389 and s422) with varying degrees of efficiency."	0.2	SIGNOR-252084
SIGNOR-GBM	"Glioblastoma Multiforme"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	ELK1	protein	P19419	UNIPROT	up-regulates	phosphorylation	Ser324	RDLELPLsPSLLGGP	9606									7889942	t		gcesareni	"Erki phosphorylates five c-terminal sites in elk-i (s324, t336, s383, s389 and s422) with varying degrees of efficiency."	0.2	SIGNOR-252085
SIGNOR-GBM	"Glioblastoma Multiforme"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	ELK1	protein	P19419	UNIPROT	up-regulates	phosphorylation	Ser389	LSPIAPRsPAKLSFQ	9606									7889942	t		gcesareni	"Erki phosphorylates five c-terminal sites in elk-i (s324, t336, s383, s389 and s422) with varying degrees of efficiency."	0.2	SIGNOR-252086
SIGNOR-GBM	"Glioblastoma Multiforme"	PIK3CA	protein	P42336	UNIPROT	PIP3	smallmolecule	CHEBI:16618	ChEBI	"up-regulates quantity"	"chemical modification"			9606									24367090	t	"AKT is a serine-threonine protein kinase that plays important roles in cell growth, proliferation and apoptosis. It is activated after binding to phosphatidylinositol phosphates (PIPs) with phosphate s at positions 3, 4 and 3,4,5 on the inositol ring"	miannu	"Insulin activation of phosphoinositide 3-kinase (pi3k) signaling regulates glucose homeostasis through the production of phosphatidylinositol 3,4,5-trisphosphate (pip3). The dual-specificity phosphatase and tensin homolog deleted on chromosome 10 (pten) blocks pi3k signaling by dephosphorylating pip3, and is inhibited through its interaction with phosphatidylinositol 3,4,5-trisphosphate-dependent rac exchanger 2"	0.8	SIGNOR-147948
SIGNOR-GBM	"Glioblastoma Multiforme"	GRB2	protein	P62993	UNIPROT	SOS1	protein	Q07889	UNIPROT	"up-regulates activity"	relocalization			10090	BTO:0000669								23452850	t	"GRB2 associated guanine nucleotide exchange factor Sos activates Ras through the exchange of GDP for GTP"	lperfetto	"Interaction domains of sos1/grb2 are finely tuned for cooperative control of embryonic stem cell fate."	0.914	SIGNOR-235773
SIGNOR-GBM	"Glioblastoma Multiforme"	GRB2	protein	P62993	UNIPROT	SOS1	protein	Q07889	UNIPROT	"up-regulates activity"	relocalization			9606									8479541	t	"GRB2 associated guanine nucleotide exchange factor Sos activates Ras through the exchange of GDP for GTP"	lperfetto	"Furthermore, our results indicate that the interaction domains of sos1 and grb2 have evolved so as to bind ligands not with maximal strength but with specificities and affinities that maintain cooperativity. Grb2 binds and activates sos, which then activates ras, and this activates p110 independently of p85."	0.914	SIGNOR-39163
SIGNOR-GBM	"Glioblastoma Multiforme"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	mTORC1	complex	SIGNOR-C3	SIGNOR	"up-regulates activity"	phosphorylation			10090	BTO:0000011								19593385	t		lperfetto	"In examining the requirements for different Akt-mediated phosphorylation sites on TSC2, we find that only TSC2 mutants lacking all five previously identified Akt sites fully block insulin-stimulated mTORC1 signaling in reconstituted Tsc2 null cells, and this mutant also inhibits adipogenesis"	0.735	SIGNOR-252817
SIGNOR-GBM	"Glioblastoma Multiforme"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	mTORC1	complex	SIGNOR-C3	SIGNOR	"up-regulates activity"	phosphorylation			9606		BTO:0000887;BTO:0001103;BTO:0001760							20138985	t		lperfetto	"Pras40 is an insulin-regulated inhibitor of the mtorc1 protein kinase. Insulin stimulates akt/pkb-mediated phosphorylation of pras40, which prevents its inhibition of mtorc1 in cells and in vitro. Phosphorylation of pras40 on thr246 by pkb/akt facilitates efficient phosphorylation of ser183 by mtorc1."	0.735	SIGNOR-217586
SIGNOR-GBM	"Glioblastoma Multiforme"	mTORC1	complex	SIGNOR-C3	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606		BTO:0000007							20508131	f			"The mammalian target of rapamycin complex 1 (mTORC1) integrates mitogen and nutrient signals to control cell proliferation and cell size."	0.7	SIGNOR-256063
SIGNOR-GBM	"Glioblastoma Multiforme"	mTORC1	complex	SIGNOR-C3	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606		BTO:0001103							15829723	f		apalma	"Phosphorylation of mTOR by Akt leads to mTOR activation (40, 52) and the subsequent activation of p70S6K (47). This latter event has great potential importance for the promotion of muscle growth by the IGF-I/Akt/mTOR pathway, because p70S6k is a potent stimulator of protein synthesis that can be activated by increases in muscle contraction"	0.7	SIGNOR-256064
SIGNOR-GBM	"Glioblastoma Multiforme"	PIP3	smallmolecule	CHEBI:16618	ChEBI	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	relocalization			9606		BTO:0001130							23633519	t		lperfetto	"Akt is a serine-threonine protein kinase that plays important roles in cell growth, proliferation and apoptosis. It is activated after binding to phosphatidylinositol phosphates pips) with phosphate groups at positions 3,4 and 3,4,5 on the inositol ring."	0.8	SIGNOR-236490
SIGNOR-GBM	"Glioblastoma Multiforme"	mTORC1	complex	SIGNOR-C3	SIGNOR	mTORC1	complex	SIGNOR-C3	SIGNOR	"up-regulates activity"	phosphorylation			10090	BTO:0000944								18372248	t		lperfetto	"We propose that after mtorc1 kinase activation by upstream regulators, pras40 is phosphorylated directly by mtor, thus contributing to the relief of pras40-mediated substrate competition. We also find that mutation of ser-221 to ala increases the inhibitory activity of pras40 toward mtorc1."	0.838	SIGNOR-235518
SIGNOR-GPCR_HCC	GPCR_HCC	LPR5/6	complex	SIGNOR-C219	SIGNOR	GSK3B/Axin/APC	complex	SIGNOR-C110	SIGNOR	"down-regulates activity"	binding			9606									19107203	t	"PPPSPxS motif in LRP6/5 must be phosphorylated."	miannu	"These observations demonstrate that phosphorylated lrp6/5 both recruits and directly inhibits gsk3beta using two distinct portions of its cytoplasmic sequence. binding of wnts to the coreceptors frizzled and lrp6/5 leads to phosphorylation of pppspxs motifs in the lrp6/5 intracellular region and the inhibition of gsk3beta bound to the scaffold protein axin."	0.714	SIGNOR-256177
SIGNOR-GPCR_HCC	GPCR_HCC	adrenaline	smallmolecule	CHEBI:33568	ChEBI	ADRB2	protein	P07550	UNIPROT	"up-regulates activity"	"chemical activation"			10030	BTO:0000457								20590599	t		Luana	"Of the agonists studied here, there was a general trend that those with highest intrinsic efficacy were so across all three receptor subtypes (i.e. at the top of Tables 3–5, e.g. fenoterol, terbutaline, metaproterenol and adrenaline)"	0.8	SIGNOR-257878
SIGNOR-GPCR_HCC	GPCR_HCC	GCG	protein	P01275	UNIPROT	GCGR	protein	P47871	UNIPROT	up-regulates	binding			9606	BTO:0000007								22863277	t		milica	"In contrast, stimulation of gs-coupled receptors by glucagon or epinephrine activates lats1/2 kinase activity, thereby inhibiting yap function."	0.781	SIGNOR-198504
SIGNOR-GPCR_HCC	GPCR_HCC	somatostatin	smallmolecule	CHEBI:64628	ChEBI	SSTR2	protein	P30874	UNIPROT	"up-regulates activity"	"chemical activation"			9606	BTO:0002524								31160049	t	"Ligand-GPCR dataset"	Luana	"Here we systematically quantified ligand-induced interactions between 148 GPCRs and all 11 unique G alpha subunit C-termini. For each receptor, we probed chimeric G alpha subunit activation via a transforming growth factor-alpha (TGF alpha) shedding response in HEK293 cells lacking endogenous Gq/11- and G12/13- signaling. | We defined positive coupling if any member of the subfamily scored LogRAi ≥ -1 and negative coupling if all of the members scored LogRAi < -1 (Figure 3A-B). ROC analysis gives AUC = 0.78 (Figure S4A) when considering high-confidence known coupling data and suggested a threshold of LogRAi ≥ -1.0 for defining true couplings. | The score associated to this interaction has a LogRAi ≥ -1.0."	0.8	SIGNOR-257582
SIGNOR-GPCR_HCC	GPCR_HCC	somatostatin	smallmolecule	CHEBI:64628	ChEBI	SSTR5	protein	P35346	UNIPROT	"up-regulates activity"	"chemical activation"			9606	BTO:0002524								31160049	t	"Ligand-GPCR dataset"	Luana	"Here we systematically quantified ligand-induced interactions between 148 GPCRs and all 11 unique G alpha subunit C-termini. For each receptor, we probed chimeric G alpha subunit activation via a transforming growth factor-alpha (TGF alpha) shedding response in HEK293 cells lacking endogenous Gq/11- and G12/13- signaling. | We defined positive coupling if any member of the subfamily scored LogRAi ≥ -1 and negative coupling if all of the members scored LogRAi < -1 (Figure 3A-B). ROC analysis gives AUC = 0.78 (Figure S4A) when considering high-confidence known coupling data and suggested a threshold of LogRAi ≥ -1.0 for defining true couplings. | The score associated to this interaction has a LogRAi ≥ -1.0."	0.8	SIGNOR-257585
SIGNOR-GPCR_HCC	GPCR_HCC	lanreotide	chemical	CHEBI:135901	ChEBI	SSTR2	protein	P30874	UNIPROT	"up-regulates activity"	"chemical activation"			9606									25060168	t		miannu	"Octreotide long-acting release (LAR) and lanreotide Autogel (ATG) are the two somatostatin analogs currently approved for treatment of acromegaly and neuroendocrine tumors (NETs). The strength of these drugs has been their specificity for somatostatin receptor subtype 2."	0.8	SIGNOR-259242
SIGNOR-GPCR_HCC	GPCR_HCC	lanreotide	chemical	CHEBI:135901	ChEBI	SSTR5	protein	P35346	UNIPROT	"up-regulates activity"	"chemical activation"			9606									26416534	t		miannu	"Lanreotide Autogel (known as lanreotide Depot in the USA) is a synthetic octapeptide analog of somatostatin with a longer half-life than the native molecule and with selectivity for somatostatin receptor (SSTR) 2 and, to a lesser extent, SSTR 5"	0.8	SIGNOR-259243
SIGNOR-GPCR_HCC	GPCR_HCC	ADRB2	protein	P07550	UNIPROT	GNAS	protein	P63092	UNIPROT	"up-regulates activity"	binding			9606									31160049	t	"GPCR-Ga dataset"	Luana	"Here we systematically quantified ligand-induced interactions between 148 GPCRs and all 11 unique G alpha subunit C-termini. For each receptor, we probed chimeric G alpha subunit activation via a transforming growth factor-alpha (TGF alpha) shedding response in HEK293 cells lacking endogenous Gq/11- and G12/13- signaling. | We defined positive coupling if any member of the subfamily scored LogRAi ‚â• -1 and negative coupling if all of the members scored LogRAi < -1 (Figure 3A-B). ROC analysis gives AUC = 0.78 (Figure S4A) when considering high-confidence known coupling data and suggested a threshold of LogRAi ‚â• -1.0 for defining true couplings. | The score associated to this interaction has a LogRAi ‚â• -1.0."	0.662	SIGNOR-256809
SIGNOR-GPCR_HCC	GPCR_HCC	GCGR	protein	P47871	UNIPROT	GNAS	protein	P63092	UNIPROT	"up-regulates activity"	binding			9606									12626323	t			"Glucagon signals through its receptor on the cell surface (Fig.1). The binding of glucagon to the extracellular loops of the glucagon receptor results in conformational changes of the latter, leading to subsequent activation of the coupled G proteins. At least two classes of G proteins are known to be associated with and involved in the signal transduction of the glucagon receptor, namely Gsα and Gq. The activation of Gsα leads to activation of adenylate cyclase, increase in intracellular cAMP levels, and subsequent activation of protein kinase A (PKA)."	0.514	SIGNOR-267715
SIGNOR-GPCR_HCC	GPCR_HCC	GNAS	protein	P63092	UNIPROT	Adenylate_cyclase	proteinfamily	SIGNOR-PF92	SIGNOR	"up-regulates activity"	binding			9606									17652154	t		gcesareni	"Because adenylyl cyclases are directly activated by G(s)alpha and the carboxyl termini of the various Galpha proteins determine their receptor coupling specificity, we proposed a set of chimeric G(s)alpha where the COOH-terminal five amino acids are replaced by those of other Galpha proteins and used these to dissect the potential Galpha linked to a given GPCR"	0.744	SIGNOR-267848
SIGNOR-GPCR_HCC	GPCR_HCC	Adenylate_cyclase	proteinfamily	SIGNOR-PF92	SIGNOR	"3',5'-cyclic AMP"	smallmolecule	CHEBI:17489	ChEBI	"up-regulates quantity"	"chemical modification"			9606									11376933	t		miannu	"To date, ten different mammalian isoforms of adenylyl cyclase (AC) have been cloned and characterized. Each isoform has its own distinct tissue distribution and regulatory properties, providing possibilities for different cells to respond diversely to similar stimuli. The product of the enzymatic reaction catalyzed by ACs, cyclic AMP (cAMP) has been shown to play a crucial role for a variety of fundamental physiological cell functions ranging from cell growth and differentiation, to transcriptional regulation and apoptosis."	0.8	SIGNOR-267844
SIGNOR-GPCR_HCC	GPCR_HCC	CREB1	protein	P16220	UNIPROT	Survival	phenotype	SIGNOR-PH13	SIGNOR	up-regulates				9606									20660310	f		amattioni	"beta-catenin/CBP-driven transcription is critical for maintenance of an undifferentiated/proliferative state"	0.7	SIGNOR-229777
SIGNOR-GPCR_HCC	GPCR_HCC	CREB1	protein	P16220	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				10090		BTO:0000763							20660310	f		Luana	"Beta-catenin/CBP-driven transcription is critical for maintenance of an undifferentiated/proliferative state"	0.7	SIGNOR-261288
SIGNOR-GPCR_HCC	GPCR_HCC	SSTR5	protein	P35346	UNIPROT	GNAI1	protein	P63096	UNIPROT	"up-regulates activity"	binding			9606	BTO:0002524								31160049	t	"GPCR-Ga dataset"	Luana	"Here we systematically quantified ligand-induced interactions between 148 GPCRs and all 11 unique G alpha subunit C-termini. For each receptor, we probed chimeric G alpha subunit activation via a transforming growth factor-alpha (TGF alpha) shedding response in HEK293 cells lacking endogenous Gq/11- and G12/13- signaling. | We defined positive coupling if any member of the subfamily scored LogRAi ≥ -1 and negative coupling if all of the members scored LogRAi < -1 (Figure 3A-B). ROC analysis gives AUC = 0.78 (Figure S4A) when considering high-confidence known coupling data and suggested a threshold of LogRAi ≥ -1.0 for defining true couplings. | The score associated to this interaction has a LogRAi ≥ -1.0."	0.5	SIGNOR-256690
SIGNOR-GPCR_HCC	GPCR_HCC	SSTR5	protein	P35346	UNIPROT	GNAI3	protein	P08754	UNIPROT	"up-regulates activity"	binding			9606	BTO:0002524								31160049	t	"GPCR-Ga dataset"	Luana	"Here we systematically quantified ligand-induced interactions between 148 GPCRs and all 11 unique G alpha subunit C-termini. For each receptor, we probed chimeric G alpha subunit activation via a transforming growth factor-alpha (TGF alpha) shedding response in HEK293 cells lacking endogenous Gq/11- and G12/13- signaling. | We defined positive coupling if any member of the subfamily scored LogRAi ≥ -1 and negative coupling if all of the members scored LogRAi < -1 (Figure 3A-B). ROC analysis gives AUC = 0.78 (Figure S4A) when considering high-confidence known coupling data and suggested a threshold of LogRAi ≥ -1.0 for defining true couplings. | The score associated to this interaction has a LogRAi ≥ -1.0."	0.454	SIGNOR-256833
SIGNOR-GPCR_HCC	GPCR_HCC	SSTR2	protein	P30874	UNIPROT	GNAI1	protein	P63096	UNIPROT	"up-regulates activity"	binding			9606	BTO:0002524								31160049	t	"GPCR-Ga dataset"	Luana	"Here we systematically quantified ligand-induced interactions between 148 GPCRs and all 11 unique G alpha subunit C-termini. For each receptor, we probed chimeric G alpha subunit activation via a transforming growth factor-alpha (TGF alpha) shedding response in HEK293 cells lacking endogenous Gq/11- and G12/13- signaling. | We defined positive coupling if any member of the subfamily scored LogRAi ≥ -1 and negative coupling if all of the members scored LogRAi < -1 (Figure 3A-B). ROC analysis gives AUC = 0.78 (Figure S4A) when considering high-confidence known coupling data and suggested a threshold of LogRAi ≥ -1.0 for defining true couplings. | The score associated to this interaction has a LogRAi ≥ -1.0."	0.584	SIGNOR-256684
SIGNOR-GPCR_HCC	GPCR_HCC	SSTR2	protein	P30874	UNIPROT	GNAI3	protein	P08754	UNIPROT	"up-regulates activity"	binding			9606	BTO:0002524								31160049	t	"GPCR-Ga dataset"	Luana	"Here we systematically quantified ligand-induced interactions between 148 GPCRs and all 11 unique G alpha subunit C-termini. For each receptor, we probed chimeric G alpha subunit activation via a transforming growth factor-alpha (TGF alpha) shedding response in HEK293 cells lacking endogenous Gq/11- and G12/13- signaling. | We defined positive coupling if any member of the subfamily scored LogRAi ≥ -1 and negative coupling if all of the members scored LogRAi < -1 (Figure 3A-B). ROC analysis gives AUC = 0.78 (Figure S4A) when considering high-confidence known coupling data and suggested a threshold of LogRAi ≥ -1.0 for defining true couplings. | The score associated to this interaction has a LogRAi ≥ -1.0."	0.454	SIGNOR-256827
SIGNOR-GPCR_HCC	GPCR_HCC	GNAI1	protein	P63096	UNIPROT	Adenylate_cyclase	proteinfamily	SIGNOR-PF92	SIGNOR	"down-regulates activity"	binding			9606									15922020	t		miannu	"Activation of receptors coupled to inhibitory G proteins (Galpha i/o) has opposing consequences for cyclic AMP accumulation and the activity of cyclic AMP-dependent protein kinase, depending on the duration of stimulation. Acute activation inhibits the activity of adenylate cyclase, thereby attenuating cyclic AMP accumulation; in contrast, persistent activation of Galpha i/o-coupled receptors produces a paradoxical enhancement of adenylate cyclase activity, thus increasing cyclic AMP accumulation when the action of the inhibitory receptor is terminated."	0.636	SIGNOR-267853
SIGNOR-GPCR_HCC	GPCR_HCC	GNAI3	protein	P08754	UNIPROT	Adenylate_cyclase	proteinfamily	SIGNOR-PF92	SIGNOR	"down-regulates activity"	binding			9606									19703466	t		miannu	"Adenylate cyclase is regulated by stimulatory hormones through Gs(alpha s beta gamma) and inhibitory hormones through Gi(alpha i beta gamma)"	0.6	SIGNOR-267851
SIGNOR-GPCR_HCC	GPCR_HCC	acetylcholine	smallmolecule	CHEBI:15355	ChEBI	CHRM3	protein	P20309	UNIPROT	"up-regulates activity"	"chemical activation"			9606	BTO:0002524								31160049	t	"Ligand-GPCR dataset"	Luana	"Here we systematically quantified ligand-induced interactions between 148 GPCRs and all 11 unique G alpha subunit C-termini. For each receptor, we probed chimeric G alpha subunit activation via a transforming growth factor-alpha (TGF alpha) shedding response in HEK293 cells lacking endogenous Gq/11- and G12/13- signaling. | We defined positive coupling if any member of the subfamily scored LogRAi ≥ -1 and negative coupling if all of the members scored LogRAi < -1 (Figure 3A-B). ROC analysis gives AUC = 0.78 (Figure S4A) when considering high-confidence known coupling data and suggested a threshold of LogRAi ≥ -1.0 for defining true couplings. | The score associated to this interaction has a LogRAi ≥ -1.0."	0.8	SIGNOR-257470
SIGNOR-GPCR_HCC	GPCR_HCC	vasopressin	smallmolecule	CHEBI:9937	ChEBI	AVPR1A	protein	P37288	UNIPROT	"up-regulates activity"	"chemical activation"			9606	BTO:0002524								31160049	t	"Ligand-GPCR dataset"	Luana	"Here we systematically quantified ligand-induced interactions between 148 GPCRs and all 11 unique G alpha subunit C-termini. For each receptor, we probed chimeric G alpha subunit activation via a transforming growth factor-alpha (TGF alpha) shedding response in HEK293 cells lacking endogenous Gq/11- and G12/13- signaling. | We defined positive coupling if any member of the subfamily scored LogRAi ≥ -1 and negative coupling if all of the members scored LogRAi < -1 (Figure 3A-B). ROC analysis gives AUC = 0.78 (Figure S4A) when considering high-confidence known coupling data and suggested a threshold of LogRAi ≥ -1.0 for defining true couplings. | The score associated to this interaction has a LogRAi ≥ -1.0."	0.8	SIGNOR-257461
SIGNOR-GPCR_HCC	GPCR_HCC	AVPR1A	protein	P37288	UNIPROT	GNAQ	protein	P50148	UNIPROT	"up-regulates activity"	binding			9606	BTO:0002524								31160049	t	"GPCR-Ga dataset"	Luana	"Here we systematically quantified ligand-induced interactions between 148 GPCRs and all 11 unique G alpha subunit C-termini. For each receptor, we probed chimeric G alpha subunit activation via a transforming growth factor-alpha (TGF alpha) shedding response in HEK293 cells lacking endogenous Gq/11- and G12/13- signaling. | We defined positive coupling if any member of the subfamily scored LogRAi ≥ -1 and negative coupling if all of the members scored LogRAi < -1 (Figure 3A-B). ROC analysis gives AUC = 0.78 (Figure S4A) when considering high-confidence known coupling data and suggested a threshold of LogRAi ≥ -1.0 for defining true couplings. | The score associated to this interaction has a LogRAi ≥ -1.0."	0.467	SIGNOR-257077
SIGNOR-GPCR_HCC	GPCR_HCC	ADRA1A	protein	P35348	UNIPROT	GNAQ	protein	P50148	UNIPROT	"up-regulates activity"	binding			9606	BTO:0002524								31160049	t	"GPCR-Ga dataset"	Luana	"Here we systematically quantified ligand-induced interactions between 148 GPCRs and all 11 unique G alpha subunit C-termini. For each receptor, we probed chimeric G alpha subunit activation via a transforming growth factor-alpha (TGF alpha) shedding response in HEK293 cells lacking endogenous Gq/11- and G12/13- signaling. | We defined positive coupling if any member of the subfamily scored LogRAi ≥ -1 and negative coupling if all of the members scored LogRAi < -1 (Figure 3A-B). ROC analysis gives AUC = 0.78 (Figure S4A) when considering high-confidence known coupling data and suggested a threshold of LogRAi ≥ -1.0 for defining true couplings. | The score associated to this interaction has a LogRAi ≥ -1.0."	0.59	SIGNOR-257084
SIGNOR-GPCR_HCC	GPCR_HCC	CHRM3	protein	P20309	UNIPROT	GNAQ	protein	P50148	UNIPROT	"up-regulates activity"	binding			9606	BTO:0002524								31160049	t	"GPCR-Ga dataset"	Luana	"Here we systematically quantified ligand-induced interactions between 148 GPCRs and all 11 unique G alpha subunit C-termini. For each receptor, we probed chimeric G alpha subunit activation via a transforming growth factor-alpha (TGF alpha) shedding response in HEK293 cells lacking endogenous Gq/11- and G12/13- signaling. | We defined positive coupling if any member of the subfamily scored LogRAi ≥ -1 and negative coupling if all of the members scored LogRAi < -1 (Figure 3A-B). ROC analysis gives AUC = 0.78 (Figure S4A) when considering high-confidence known coupling data and suggested a threshold of LogRAi ≥ -1.0 for defining true couplings. | The score associated to this interaction has a LogRAi ≥ -1.0."	0.581	SIGNOR-257018
SIGNOR-GPCR_HCC	GPCR_HCC	CHRM3	protein	P20309	UNIPROT	GNA14	protein	O95837	UNIPROT	"up-regulates activity"	binding			9606	BTO:0002524								31160049	t	"GPCR-Ga dataset"	Luana	"Here we systematically quantified ligand-induced interactions between 148 GPCRs and all 11 unique G alpha subunit C-termini. For each receptor, we probed chimeric G alpha subunit activation via a transforming growth factor-alpha (TGF alpha) shedding response in HEK293 cells lacking endogenous Gq/11- and G12/13- signaling. | We defined positive coupling if any member of the subfamily scored LogRAi ≥ -1 and negative coupling if all of the members scored LogRAi < -1 (Figure 3A-B). ROC analysis gives AUC = 0.78 (Figure S4A) when considering high-confidence known coupling data and suggested a threshold of LogRAi ≥ -1.0 for defining true couplings. | The score associated to this interaction has a LogRAi ≥ -1.0."	0.416	SIGNOR-257134
SIGNOR-GPCR_HCC	GPCR_HCC	CHRM3	protein	P20309	UNIPROT	GNA15	protein	P30679	UNIPROT	"up-regulates activity"	binding			9606	BTO:0002524								31160049	t	"GPCR-Ga dataset"	Luana	"Here we systematically quantified ligand-induced interactions between 148 GPCRs and all 11 unique G alpha subunit C-termini. For each receptor, we probed chimeric G alpha subunit activation via a transforming growth factor-alpha (TGF alpha) shedding response in HEK293 cells lacking endogenous Gq/11- and G12/13- signaling. | We defined positive coupling if any member of the subfamily scored LogRAi ≥ -1 and negative coupling if all of the members scored LogRAi < -1 (Figure 3A-B). ROC analysis gives AUC = 0.78 (Figure S4A) when considering high-confidence known coupling data and suggested a threshold of LogRAi ≥ -1.0 for defining true couplings. | The score associated to this interaction has a LogRAi ≥ -1.0."	0.402	SIGNOR-257224
SIGNOR-GPCR_HCC	GPCR_HCC	ADRA1A	protein	P35348	UNIPROT	GNA11	protein	P29992	UNIPROT	"up-regulates activity"	binding			9534	BTO:0000298								1334487	t			"In this report, we demonstrate that in transfected cos-7 cells Gal4 and Ga16, like Gaq and Ga11, can activate PIPLC j3l and that all three al-ARs, alA, alB and alC, can activate endogenous PI-PLC by coupling to Gaq or Ga11."	0.578	SIGNOR-278121
SIGNOR-GPCR_HCC	GPCR_HCC	GNAQ	protein	P50148	UNIPROT	PLCB1	protein	Q9NQ66	UNIPROT	up-regulates	binding			9606									8245028	t		gcesareni	"The beta- but not the gamma- and delta-type isozymes of inositol phospholipid-specific phospholipase c (plc) are activated by g protein alpha q and beta gamma subunits."	0.772	SIGNOR-37149
SIGNOR-GPCR_HCC	GPCR_HCC	GNA11	protein	P29992	UNIPROT	PLCB1	protein	Q9NQ66	UNIPROT	"up-regulates activity"	binding			9606									27515033	t		scontino	"TRH-R1 receptor, which is coupled to Gq/11 protein, activates phospholipase C, mobilizes calcium and activates protein kinase C."	0.626	SIGNOR-267203
SIGNOR-GPCR_HCC	GPCR_HCC	GNA14	protein	O95837	UNIPROT	PLCB1	protein	Q9NQ66	UNIPROT	"up-regulates activity"	binding			9534	BTO:0000298								1334487	t			"This suggests that both Gal4 and Gal6 can activate PLC b1."	0.472	SIGNOR-278119
SIGNOR-GPCR_HCC	GPCR_HCC	GNA15	protein	P30679	UNIPROT	PLCB1	protein	Q9NQ66	UNIPROT	"up-regulates activity"	binding			9534	BTO:0000298								1334487	t			"This suggests that both Gal4 and Gal6 can activate PLC b1."	0.488	SIGNOR-278120
SIGNOR-GPCR_HCC	GPCR_HCC	PLCB1	protein	Q9NQ66	UNIPROT	1,2-diacyl-sn-glycerol	smallmolecule	CHEBI:17815	ChEBI	"up-regulates quantity"	"chemical modification"			-1									23880553	t		miannu	"Phospholipase C (PLC) enzymes convert phosphatidylinositol-4,5-bisphosphate into the second messengers diacylglycerol and inositol-1,4,5-triphosphate."	0.8	SIGNOR-256496
SIGNOR-GPCR_HCC	GPCR_HCC	1,2-diacyl-sn-glycerol	smallmolecule	CHEBI:17815	ChEBI	PRKCA	protein	P17252	UNIPROT	up-regulates	"chemical activation"			9606									18593525	t		gcesareni	"The increases in the membrane levels of nacholeate itself and of dag induce a translocation and overexpression of protein kinase c (pkc) and subsequent reductions of cyclin d, cyclin-dependent kinases 4 and 6 (cdks 4 and 6), hypophosphorylation of the retinoblastoma protein, inhibition of e2f1 and knockdown of dihydrofolate reductase (dhfr) impairing dna synthesis."	0.8	SIGNOR-179279
SIGNOR-GPCR_HCC	GPCR_HCC	CTNNB1	protein	P35222	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									23645839	f		apalma	"For example, prostaglandin E2 (PGE2), 1 of the major metabolites downstream of both COX-1 and COX-2, has been shown to activate β-catenin–dependent signaling in hematopoietic stem cells (HSCs) and promote HSC expansion"	0.7	SIGNOR-255695
SIGNOR-GPCR_HCC	GPCR_HCC	CTNNB1	protein	P35222	UNIPROT	Metastasis	phenotype	SIGNOR-PH107	SIGNOR	"up-regulates activity"				10090	BTO:0004086								17420453	f			"Overexpression of ERp5 promotes both in vitro migration and invasion and in vivo metastasis of breast cancer cells."	0.7	SIGNOR-256534
SIGNOR-GPCR_HCC	GPCR_HCC	TGFBR2	protein	P37173	UNIPROT	TGFBR1	protein	P36897	UNIPROT	"up-regulates activity"	phosphorylation	Thr200	LPLLVQRtIARTIVL	-1									8576253	t		"giulio giuliani"	"From our present data, it is not easy to deduce the mechanistic significance of serine 172 and threonine 176 of TŒ≤R-I in TGF-Œ≤ signaling. Although it was reported that TGF-Œ≤-induced phosphorylation of these residues was not detected in vivo(22), it is still possible that TŒ≤R-II may phosphorylate these residues as minor phosphorylation site(s)."	0.72	SIGNOR-255962
SIGNOR-GPCR_HCC	GPCR_HCC	CTNNB1	protein	P35222	UNIPROT	LEF1	protein	Q9UJU2	UNIPROT	"up-regulates activity"	binding			9606									21078818	t		gcesareni	"Phosphorylated lrp5/6 leads to inhibition of the so-called beta-catenin destruction complex (which includes axin, gsk3, dvl, ck1, and the tumor suppressor adenomatous polyposis coli), resulting in the stabilization and translocation of beta-catenin in the nucleus, where it activates target genes through binding to tcf/lef transcription factors."	0.917	SIGNOR-169632
SIGNOR-GPCR_HCC	GPCR_HCC	SMAD4	protein	Q13485	UNIPROT	SMAD2/SMAD4	complex	SIGNOR-C8	SIGNOR	"form complex"	binding			9606									11274206	t		gcesareni	"the receptor-regulated Smad, such as Smad2, forms a heterocomplex with the co-mediator Smad, Smad4"	0.719	SIGNOR-235178
SIGNOR-GPCR_HCC	GPCR_HCC	Wnt	proteinfamily	SIGNOR-PF40	SIGNOR	Frizzled	proteinfamily	SIGNOR-PF11	SIGNOR	"up-regulates activity"	binding			9606									23290138	t		miannu	"Wnt proteins bind to the frizzled receptors and lrp5/6 co-receptors, and through stabilizing the critical mediator betBeta-catenin, initiate a complex signaling cascade that plays an important role in regulating cell proliferation and differentiation."	0.842	SIGNOR-256173
SIGNOR-GPCR_HCC	GPCR_HCC	BRAF	protein	P15056	UNIPROT	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	"up-regulates activity"	phosphorylation			10090									8131746	t		lperfetto	"Activation of mek family kinases requires phosphorylation of two conserved ser/thr residueserine residues 218 and 222 of human mek1 are the primary sites for phosphorylation by c-raf."	0.787	SIGNOR-244827
SIGNOR-GPCR_HCC	GPCR_HCC	MET	protein	P08581	UNIPROT	GAB1	protein	Q13480	UNIPROT	"up-regulates activity"	phosphorylation	Tyr627	KGDKQVEyLDLDLDS	9606	BTO:0000018								10734310	t		miannu	"Gab-1 is phosphorylated on the same residues by HGF and EGF receptors. Among 16 peptides only nine were phosphorylated by the EGF and HGF receptors, namely peptides containing the tyrosine residues 285, 307, 373, 407, 448, 473, 590, 628 and 660. we show that in the response to HGF or EGF, Gab1 is phosphorylated in vivo on the same residues. However, a sustained activation of signaling pathways downstream to Gab1 (as a result of its sustained phosphorylation) is achieved only in response to HGF."	0.677	SIGNOR-250289
SIGNOR-GPCR_HCC	GPCR_HCC	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	up-regulates	phosphorylation			9606									11971971	t		lperfetto	"Mapk1 is phosphorylated by map2k1/mek1 and map2k2/mek2 on thr-185 and tyr-187 in response to external stimuli like insulin or ngf. Both phosphorylations are required for activity."	0.758	SIGNOR-244776
SIGNOR-GPCR_HCC	GPCR_HCC	PIP3	smallmolecule	CHEBI:16618	ChEBI	PDPK1	protein	O15530	UNIPROT	"up-regulates activity"	relocalization			9534									9637919	t		lperfetto	"In response to PDGF, binding of ptdlns (3,4,5)p3 and/or ptdlns(3,4)p2 to the PH domain of PDK-1 causes its translocation to the plasma membrane where it co-localises with PKB, significantly contributing to the scale of PKB activation."	0.8	SIGNOR-58313
SIGNOR-GPCR_HCC	GPCR_HCC	SMAD2/SMAD4	complex	SIGNOR-C8	SIGNOR	AP1	complex	SIGNOR-C154	SIGNOR	"up-regulates activity"	binding			9606									22926518	t		miannu	"The activated TGFβ type I receptor kinase propagates the signal within the cell through phosphorylation of the receptor-regulated (R-)Smad proteins Smad2 and Smad3 at their extreme carboxyl-terminal serine residues.1, 2 The activated R-Smads then form heteromeric complexes with the common-partner (Co-)Smad, Smad4, and accumulate in the nucleus, where they can bind DNA and regulate gene expression. The Smads control gene expression in a cell type-specific manner by interacting with other proteins, such as AP-1, AP-2 and Ets transcription factors and specific co-activators and co-repressors."	0.531	SIGNOR-256180
SIGNOR-GPCR_HCC	GPCR_HCC	GAB1	protein	Q13480	UNIPROT	PI3K	complex	SIGNOR-C156	SIGNOR	up-regulates	binding			9606									11043767	t		lperfetto	"We have shown that gab1 colocalizes pi3k with sh2 domain-containing inositol phosphatase (ship) and shp2, two enzymes that regulate pi3k-dependent signaling. The src homology 2 (sh2) domain of the phosphatidylinositol 3-kinase (pi3k) regulatory subunit binds gab1 in a phosphorylation-independent manner. Moreover, the regulatory subunit of pi3k can mediate the association of gab1 and receptor protein-tyrosine kinases including the insulin, egf, and ngf receptors, all of which phosphorylate gab1."	0.515	SIGNOR-252676
SIGNOR-GPCR_HCC	GPCR_HCC	LEF1	protein	Q9UJU2	UNIPROT	Survival	phenotype	SIGNOR-PH13	SIGNOR	up-regulates				9606									17081971	f		amattioni	"The interaction of beta-catenin with the N terminus of tcf/lef transiently converts it into an activator, translating the Wnt signal into the transient transcription of Tcf target genes. The Wnt pathway has distinct transcriptional outputs, which are determined by the identity of the responding cell, and range from cell proliferation and survival to the terminal differentiation of postmitotic cells."	0.7	SIGNOR-229767
SIGNOR-GPCR_HCC	GPCR_HCC	NFE2L2	protein	Q16236	UNIPROT	HMOX1	protein	P09601	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			9606									24024136	t		irozzo	"In both models, the inducer-modified and Nrf2-bound Keap1 is inactivated and, consequently, newly synthesized Nrf2 proteins bypass Keap1 and translocate into the nucleus, bind to the ARE and drive the expression of Nrf2 target genes such as NAD(P)H quinone oxidoreductase 1 (NQO1), heme oxygenase 1 (HMOX1), glutamate-cysteine ligase (GCL) and glutathione S transferases (GSTs)."	0.687	SIGNOR-256276
SIGNOR-GPCR_HCC	GPCR_HCC	PDPK1	protein	O15530	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation	Thr308	KDGATMKtFCGTPEY	10090									12808134	t		lperfetto	"Akt1 and akt2 are phosphorylated and activated by the protein kinase pdk1 at thr-308 or thr-309, respectively, in the activation t-loop, and further activation occurs through phosphorylation at ser-473 or ser-474, respectively. In this paper, we demonstrate that this is indeed the case, and report the purification and initial characterization of a 3 phosphoinositide-dependent protein kinase, pdk1, which activates pkb by phosphorylating it at thr308. Akt is directly phosphorylated and activated by pdk1. Akt/pkb activation requires the phosphorylation of thr308 in the activation loop by the phosphoinositide-dependent kinase 1 (pdk1)."	0.746	SIGNOR-134477
SIGNOR-GPCR_HCC	GPCR_HCC	CTNNB1	protein	P35222	UNIPROT	LEF1	protein	Q9UJU2	UNIPROT	"up-regulates activity"	binding			9606									23151663	t		gcesareni	"Upon wnt activation, cytoplasmic beta-catenin is stabilized and enters the nucleus, where it associates with transcription factors, notably tcf (t cell factor) and lef (lymphoid enhancer-binding factor), to regulate the transcription of target genes. Thus beta-catenin regulates gene expression by direct interaction with transcription factors such as lef-1, providing a molecular mechanism for the transmission of signals, from cell-adhesion components or wnt protein to the nucleus."	0.917	SIGNOR-199378
SIGNOR-GPCR_HCC	GPCR_HCC	NQO1	protein	P15559	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606	BTO:0003934								28599455	f		irozzo	"The results demonstrated that NQO1 siRNA-mediated knockdown effectively impaired colony formation capacity, induced cell cycle arrest at the G1 phase and suppressed migration of KKU-100 cells."	0.7	SIGNOR-256265
SIGNOR-GPCR_HCC	GPCR_HCC	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				10090									20219869	f		areggio	"Furthermore, stimulation of myoblasts with CCL2, CCL3, or CCL4 was sufficient to induce phosphorylation and activation of ERK1/2. This outcome may be functionally important because ERK1/2 activation is a component of the pathway through which many mitogenic growth factors can stimulate cell proliferation."	0.7	SIGNOR-255120
SIGNOR-GPCR_HCC	GPCR_HCC	SMAD3/SMAD4	complex	SIGNOR-C9	SIGNOR	AP1	complex	SIGNOR-C154	SIGNOR	"up-regulates activity"	binding			9606									9732876	t		lperfetto	"Smad3 and smad4 also act together with c-jun and c-fos to activate transcription in response to tgf-beta, through a tgf-beta-inducible association of c-jun with smad3 and an interaction of smad3 and c-fos"	0.649	SIGNOR-253332
SIGNOR-GPCR_HCC	GPCR_HCC	SMAD3	protein	P84022	UNIPROT	SMAD4	protein	Q13485	UNIPROT	"up-regulates activity"	binding			9606									9843571	t		gcesareni	"TGF-² treatment initiates a kinase cascade that results in the phosphorylation of Smad3, followed by its heteromerization with Smad4 and subsequent translocation into the nucleus."	0.71	SIGNOR-235168
SIGNOR-GPCR_HCC	GPCR_HCC	HMOX1	protein	P09601	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606	BTO:0000848								17148680	f		irozzo	"Here we investigated the effects of HO-1 overexpression in murine and human melanoma cells. The most important findings of our study are that 1) overexpression of HO-1 augments the proliferation [.]"	0.7	SIGNOR-256295
SIGNOR-GPCR_HCC	GPCR_HCC	NFE2L2	protein	Q16236	UNIPROT	GSTA1	protein	P08263	UNIPROT	"down-regulates quantity by repression"	"transcriptional regulation"			9606									22459801	f		miannu	"Different expression pattern of Nrf2 regulated genes in end-stage liver disease samples were observed: glutamate-cysteine ligase (GCLC) and glutathione-S-transferase A1 (GSTA1) were significantly down-regulated in most liver disease groups, whereas heme oxidase 1 (HMOX1) and NAD(P)H dehydrogenase [quinone] 1 (NQO1) were not significantly suppressed."	0.344	SIGNOR-254644
SIGNOR-GPCR_HCC	GPCR_HCC	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									24743741	f			"Activation of PDGFRα stimulates proliferation of PDGFRα(+) cells through PI3K-Akt and MEK2-MAPK signaling pathways, and aberrant accumulation of PDGFRα(+) cells was conspicuous in muscles of patients with both genetic and non-genetic muscle diseases."	0.7	SIGNOR-254374
SIGNOR-GPCR_HCC	GPCR_HCC	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	Survival	phenotype	SIGNOR-PH13	SIGNOR	up-regulates				9606									16288293	f		miannu	"Akt promotes both cell growth and cell survival by inactivating its downstream substrates including GSK3, BAD, FOXO and TSC2."	0.7	SIGNOR-251550
SIGNOR-GPCR_HCC	GPCR_HCC	NFE2L2	protein	Q16236	UNIPROT	NQO1	protein	P15559	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			9606									8962164	f		irozzo	"These results indicated that hARE-mediated expression of the NQO1 gene and its induction by xenobiotics and antioxidants are mediated by Nrf1 and Nrf2."	0.49	SIGNOR-256279
SIGNOR-GPCR_HCC	GPCR_HCC	HRAS	protein	P01112	UNIPROT	BRAF	protein	P15056	UNIPROT	up-regulates	binding			9606									18098337	t		lperfetto	"BRAF kinase is a downstream target of KRAS and activates the MAPK pathway."	0.879	SIGNOR-160043
SIGNOR-GPCR_HCC	GPCR_HCC	PIP3	smallmolecule	CHEBI:16618	ChEBI	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	relocalization			9606		BTO:0001130							23633519	t		lperfetto	"Akt is a serine-threonine protein kinase that plays important roles in cell growth, proliferation and apoptosis. It is activated after binding to phosphatidylinositol phosphates pips) with phosphate groups at positions 3,4 and 3,4,5 on the inositol ring."	0.8	SIGNOR-236490
SIGNOR-GPCR_HCC	GPCR_HCC	GSK3B/Axin/APC	complex	SIGNOR-C110	SIGNOR	CTNNB1	protein	P35222	UNIPROT	"down-regulates activity"	phosphorylation	Ser37	YLDSGIHsGATTTAP	9606									11955436	t		lperfetto	"Wnt regulation of beta-catenin degradation is essential for development and carcinogenesis. beta-catenin degradation is initiated upon amino-terminal serine/threonine phosphorylation, which is believed to be performed by glycogen synthase kinase-3 (GSK-3) in complex with tumor suppressor proteins Axin and adnomatous polyposis coli (APC)."	0.896	SIGNOR-227901
SIGNOR-GPCR_HCC	GPCR_HCC	TGFBR1	protein	P36897	UNIPROT	SMAD3	protein	P84022	UNIPROT	"up-regulates activity"	phosphorylation	Ser425	SIRCSSVs	10090	BTO:0005493;BTO:0000165								19458083	t		lperfetto	"A major event leading to Smad3 activation is the TGF-beta-induced, TbetaRI-mediated phosphorylation at two C-terminal serine residues, Ser-423 and Ser-425, which triggers dissociation of Smad3 from its receptors to form a complex with Smad4 and accumulate in the nucleus"	0.816	SIGNOR-235380
SIGNOR-GPCR_HCC	GPCR_HCC	HGF	protein	P14210	UNIPROT	MET	protein	P08581	UNIPROT	up-regulates	binding			9606									8380735	t		gcesareni	"Hgf is the ligand for p190met, the receptor tyrosine kinase encoded by the met proto-oncogene."	0.929	SIGNOR-38429
SIGNOR-GPCR_HCC	GPCR_HCC	MET	protein	P08581	UNIPROT	GRB2	protein	P62993	UNIPROT	"up-regulates activity"	binding			9606									22128289	t		irozzo	"For activation of the mitogen-activated protein kinase (MAPK) cascades, c-MET activation stimulates the activity of the rat sarcoma viral oncogene homolog (RAS) guanine nucleotide exchanger son of sevenless (SOS) via binding with SHC and GRB2 leading to the activation of RAS."	0.698	SIGNOR-256261
SIGNOR-GPCR_HCC	GPCR_HCC	TGFBR2	protein	P37173	UNIPROT	TGFBR1	protein	P36897	UNIPROT	"up-regulates activity"	phosphorylation	Thr200	LPLLVQRtIARTIVL	452646									7774578	t		lperfetto	"The tgf-beta type ii receptor (t beta r-ii) is a transmembrane serine/threonine kinase that, upon ligand binding, recruits and phosphorylates a second transmembrane kinase, t beta r-i, as a requirement for signal transduction.  In contrast to the relatively innocuous nature of single site mutations in the ttsgsgsg sequence, mutation of thr200 or 204 to valine causes marked losses in ligand-induced phosphorylation and signaling."	0.72	SIGNOR-32744
SIGNOR-GPCR_HCC	GPCR_HCC	GRB2	protein	P62993	UNIPROT	SOS1	protein	Q07889	UNIPROT	"up-regulates activity"	relocalization			9606	BTO:0001412								10570290	t	"GRB2 associated guanine nucleotide exchange factor Sos activates Ras through the exchange of GDP for GTP"	lperfetto	"Grb2 binds and activates sos, which then activates ras, and this activates p110 independently of p85."	0.914	SIGNOR-236792
SIGNOR-GPCR_HCC	GPCR_HCC	TGFBR2	protein	P37173	UNIPROT	TGFBR1	protein	P36897	UNIPROT	"up-regulates activity"	phosphorylation	Thr204	VQRTIARtIVLQESI	452646									7774578	t		lperfetto	"The TGF-beta type II receptor (T beta R-II) is a transmembrane serine/threonine kinase that, upon ligand binding, recruits and phosphorylates a second transmembrane kinase, T beta R-I, as a requirement for signal transduction. In contrast to the relatively innocuous nature of single site mutations in the ttsgsgsg sequence, mutation of thr200 or 204 to valine causes marked losses in ligand-induced phosphorylation and signaling."	0.72	SIGNOR-32748
SIGNOR-GPCR_HCC	GPCR_HCC	TGFBR1	protein	P36897	UNIPROT	SMAD3	protein	P84022	UNIPROT	"up-regulates activity"	phosphorylation	Ser423	SPSIRCSsVS	10090	BTO:0005493;BTO:0000165								19458083	t		lperfetto	"A major event leading to smad3 activation is the tgf-beta-induced, tbetari-mediated phosphorylation at two c-terminal serine residues, ser-423 and ser-425, which triggers dissociation of smad3 from its receptors to form a complex with smad4 and accumulate in the nucleus"	0.816	SIGNOR-235385
SIGNOR-GPCR_HCC	GPCR_HCC	KEAP1	protein	Q14145	UNIPROT	NFE2L2	protein	Q16236	UNIPROT	down-regulates	binding			9606									24997453	t		miannu	"Keap1 is an oxidative stress-sensing protein and is a negative regulator of nuclear factor-erythroid-2-related factor 2 (nrf2)."	0.818	SIGNOR-205229
SIGNOR-GPCR_HCC	GPCR_HCC	MET	protein	P08581	UNIPROT	GAB1	protein	Q13480	UNIPROT	"up-regulates activity"	phosphorylation	Tyr285	TEADGELyVFNTPSG	9606	BTO:0000018								10734310	t		miannu	"Gab-1 is phosphorylated on the same residues by HGF and EGF receptors. Among 16 peptides only nine were phosphorylated by the EGF and HGF receptors, namely peptides containing the tyrosine residues 285, 307, 373, 407, 448, 473, 590, 628 and 660. we show that in the response to HGF or EGF, Gab1 is phosphorylated in vivo on the same residues. However, a sustained activation of signaling pathways downstream to Gab1 (as a result of its sustained phosphorylation) is achieved only in response to HGF."	0.677	SIGNOR-250552
SIGNOR-GPCR_HCC	GPCR_HCC	TCF4	protein	P15884	UNIPROT	MYC	protein	P01106	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			9606									18852287	t			"Association of c-Jun, β-catenin, and TCF4 specifically with the downstream enhancer underlies mitogen stimulation of c-Myc transcription."	0.373	SIGNOR-253324
SIGNOR-GPCR_HCC	GPCR_HCC	TGFBR2	protein	P37173	UNIPROT	TGFBR1	protein	P36897	UNIPROT	"up-regulates activity"	phosphorylation	Thr176	PFISEGTtLKDLIYD	9606									8576253	t		lperfetto	"Recent studies have revealed that upon TGF-beta binding several serine and threonine residues in the GS domain of TGF-beta type I receptor (T beta R-I) are phosphorylated by TGF-beta type II receptor (T beta R-II) and that the phosphorylation of GS domain is essential for TGF-beta signalingThese observations indicate that serine 172 and threonine 176 of T beta R-I are dispensable for extracellular matrix protein production but essential to the growth inhibition by TGF-beta"	0.72	SIGNOR-246732
SIGNOR-GPCR_HCC	GPCR_HCC	CTNNB1	protein	P35222	UNIPROT	TCF4	protein	P15884	UNIPROT	"up-regulates activity"	binding			9606	BTO:0000007								11713476	t		amattioni	"beta-catenin interacts with the TCF/Lef family transcription factors."	0.692	SIGNOR-178042
SIGNOR-GPCR_HCC	GPCR_HCC	MYC	protein	P01106	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				10090		BTO:0000724							7882978	f		irozzo	"These observations indicate that continued late-stage expression of L-myc affected differentiation processes directly, rather than indirectly through deregulated growth control, whereas constitutive c-myc expression inhibited proliferative arrest, but did not appear to disturb differentiation."	0.7	SIGNOR-259110
SIGNOR-GPCR_HCC	GPCR_HCC	PI3K	complex	SIGNOR-C156	SIGNOR	PIP3	smallmolecule	CHEBI:16618	ChEBI	"up-regulates quantity"	"chemical modification"			9606									12040186	t		lperfetto	"The activated PI3K converts the plasma membrane lipid phosphatidylinositol-4,5-bisphosphate [PI(4,5)P2] to phosphatidylinositol-3,4,5-trisphosphate [PI(3,4,5)P3]."	0.8	SIGNOR-252713
SIGNOR-GPCR_HCC	GPCR_HCC	TGFBR1	protein	P36897	UNIPROT	SMAD2	protein	Q15796	UNIPROT	"up-regulates activity"	phosphorylation	Ser465	SPSVRCSsMS	9534	BTO:0001538								9346908	t		lperfetto	"Recently, it was demonstrated that Smad2 interacts transiently with and is a direct substrate of the transforming growth factor-_ (TGF-_) type I receptor, T_RI. Phosphorylation sites on smad2 were localized to a carboxyl-terminal fragment containing three serine residues at positions 464, 465, and 467. In this report, we show that T_RI specifically phosphorylates Smad2 on serines 465 and 467.These results indicate that receptor-dependent phosphorylation of Smad2 on serines 465 and 467 is required in mammalian cells to permit association with Smad4 and to propagate TGF-_ signals."	0.828	SIGNOR-236107
SIGNOR-GPCR_HCC	GPCR_HCC	SMAD3/SMAD4	complex	SIGNOR-C9	SIGNOR	AP1	complex	SIGNOR-C154	SIGNOR	"up-regulates activity"	binding			9606									22926518	t		miannu	"The activated TGFβ type I receptor kinase propagates the signal within the cell through phosphorylation of the receptor-regulated (R-)Smad proteins Smad2 and Smad3 at their extreme carboxyl-terminal serine residues.1, 2 The activated R-Smads then form heteromeric complexes with the common-partner (Co-)Smad, Smad4, and accumulate in the nucleus, where they can bind DNA and regulate gene expression. The Smads control gene expression in a cell type-specific manner by interacting with other proteins, such as AP-1, AP-2 and Ets transcription factors and specific co-activators and co-repressors."	0.649	SIGNOR-256181
SIGNOR-GPCR_HCC	GPCR_HCC	SMAD2	protein	Q15796	UNIPROT	SMAD4	protein	Q13485	UNIPROT	"up-regulates activity"	binding			9606					phosphorylation:Ser465;Ser467	SPSVRCSsMS;SVRCSSMs			11274206	t		gcesareni	"the receptor-regulated Smad, such as Smad2, forms a heterocomplex with the co-mediator Smad, Smad4"	0.719	SIGNOR-235183
SIGNOR-GPCR_HCC	GPCR_HCC	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	TERT	protein	O14746	UNIPROT	up-regulates	phosphorylation	Ser824	AVRIRGKsYVQCQGI	9606									10224060	t		lperfetto	"Akt kinase enhances human telomerase activity through phosphorylation of htert subunit as one of its substrate proteins."	0.2	SIGNOR-244357
SIGNOR-GPCR_HCC	GPCR_HCC	AP1	complex	SIGNOR-C154	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									9878062	f		lperfetto	"AP‐1 proteins, including c‐Fos and c‐Jun, are prominent nuclear targets of growth factor induced signaling, making AP‐1 a candidate nuclear effector of growth factor induced proliferation."	0.7	SIGNOR-252356
SIGNOR-GPCR_HCC	GPCR_HCC	IGF1R	protein	P08069	UNIPROT	PI3K	complex	SIGNOR-C156	SIGNOR	up-regulates	binding			9606									18595745	t		gcesareni	"Igf-1 activated both the pi3k and the extracellular signal-regulated kinase [?] (erk [?]) Pathways as evidenced by phosphorylation of either akt or erk1 [?]/2 (respectively)"	0.702	SIGNOR-252690
SIGNOR-GPCR_HCC	GPCR_HCC	GSK3B/Axin/APC	complex	SIGNOR-C110	SIGNOR	CTNNB1	protein	P35222	UNIPROT	"down-regulates activity"	phosphorylation	Ser33	QQQSYLDsGIHSGAT	9606									11955436	t		lperfetto	"Wnt regulation of beta-catenin degradation is essential for development and carcinogenesis. beta-catenin degradation is initiated upon amino-terminal serine/threonine phosphorylation, which is believed to be performed by glycogen synthase kinase-3 (GSK-3) in complex with tumor suppressor proteins Axin and adnomatous polyposis coli (APC)."	0.896	SIGNOR-227897
SIGNOR-GPCR_HCC	GPCR_HCC	GSK3B/Axin/APC	complex	SIGNOR-C110	SIGNOR	CTNNB1	protein	P35222	UNIPROT	"down-regulates activity"	phosphorylation	Thr41	GIHSGATtTAPSLSG	9606									11955436	t		lperfetto	"Wnt regulation of beta-catenin degradation is essential for development and carcinogenesis. beta-catenin degradation is initiated upon amino-terminal serine/threonine phosphorylation, which is believed to be performed by glycogen synthase kinase-3 (GSK-3) in complex with tumor suppressor proteins Axin and adnomatous polyposis coli (APC)."	0.896	SIGNOR-227905
SIGNOR-GPCR_HCC	GPCR_HCC	Wnt	proteinfamily	SIGNOR-PF40	SIGNOR	LPR5/6	complex	SIGNOR-C219	SIGNOR	"up-regulates activity"	binding			9606									23209147	t		miannu	"FZD and LRP5/6 transduce Wnt signal via engaging downstream cytoplasmic components, among which two scaffolding proteins, Dishevelled and Axin, have prominent roles."	0.812	SIGNOR-256174
SIGNOR-GPCR_HCC	GPCR_HCC	EGFR	protein	P00533	UNIPROT	GRB2	protein	P62993	UNIPROT	"up-regulates activity"	binding			-1	BTO:0000567								16729043	t		lperfetto	"We determined interaction partners to all cytosolic tyrosine residues of the four members of the ErbB-receptor family in an unbiased fashion by quantitative proteomics using pull-down experiments with pairs of phosphorylated and nonphosphorylated synthetic peptides. Each receptor had characteristic preferences for interacting proteins and most interaction partners had multiple binding sites on each receptor. EGFR and ErbB4 had several docking sites for Grb2, while ErbB3 was characterized by six binding sites for PI3K."	0.924	SIGNOR-236327
SIGNOR-GPCR_HCC	GPCR_HCC	TGFBR1	protein	P36897	UNIPROT	SMAD2	protein	Q15796	UNIPROT	"up-regulates activity"	phosphorylation	Ser467	SVRCSSMs	9534									9346908	t		lperfetto	"Recently, it was demonstrated that Smad2 interacts transiently with and is a direct substrate of the transforming growth factor-beta (TGF-beta) type I receptor, TbetaRI. Phosphorylation sites on Smad2 were localized to a carboxyl-terminal fragment containing three serine residues at positions 464, 465, and 467.   These results indicate that receptor-dependent phosphorylation of Smad2 on serines 465 and 467 is required in mammalian cells to permit association with Smad4 and to propagate TGF-_ signals."	0.828	SIGNOR-235995
SIGNOR-GPCR_HCC	GPCR_HCC	LEF1	protein	Q9UJU2	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									17081971	f		amattioni	"The interaction of beta-catenin with the N terminus of tcf/lef transiently converts it into an activator, translating the Wnt signal into the transient transcription of Tcf target genes. The Wnt pathway has distinct transcriptional outputs, which are determined by the identity of the responding cell, and range from cell proliferation and survival to the terminal differentiation of postmitotic cells."	0.7	SIGNOR-229764
SIGNOR-GPCR_HCC	GPCR_HCC	TGFA	protein	P01135	UNIPROT	EGFR	protein	P00533	UNIPROT	"up-regulates activity"	binding			9606	BTO:0000584								16585207	t	"Transforming growth factor alpha expression drives constitutive epidermal growth factor receptor pathway activation and sensitivity to gefitinib (Iressa) in human pancreatic cancer cell lines"	gcesareni	"Our data indicate that a subset of cell lines is dependent on TGF-_-mediated activation of the EGFR for cell proliferation and strongly suggest that pancreatic tumors expressing high levels of TGF-_ and phosphorylated (activated) EGFR are EGFR-dependent in vitro and in vivo."	0.9	SIGNOR-93199
SIGNOR-GPCR_HCC	GPCR_HCC	SMAD4	protein	Q13485	UNIPROT	SMAD3/SMAD4	complex	SIGNOR-C9	SIGNOR	"form complex"	binding			9606									9843571	t		lperfetto	"TGF-beta treatment initiates a kinase cascade that results in the phosphorylation of Smad3, followed by its heteromerization with Smad4 and subsequent translocation into the nucleus."	0.71	SIGNOR-229560
SIGNOR-GPCR_HCC	GPCR_HCC	TERT	protein	O14746	UNIPROT	Immortality	phenotype	SIGNOR-PH47	SIGNOR	up-regulates													11327115	f		lperfetto	"Telomerase is tightly repressed in the vast majority of normal human somatic cells but becomes activated during cellular immortalization and in cancers"	0.7	SIGNOR-252292
SIGNOR-GPCR_HCC	GPCR_HCC	MET	protein	P08581	UNIPROT	GAB1	protein	Q13480	UNIPROT	"up-regulates activity"	phosphorylation	Tyr659	VADERVDyVVVDQQK	9606	BTO:0000018								10734310	t		miannu	"Gab-1 is phosphorylated on the same residues by HGF and EGF receptors. Among 16 peptides only nine were phosphorylated by the EGF and HGF receptors, namely peptides containing the tyrosine residues 285, 307, 373, 407, 448, 473, 590, 628 and 660. we show that in the response to HGF or EGF, Gab1 is phosphorylated in vivo on the same residues. However, a sustained activation of signaling pathways downstream to Gab1 (as a result of its sustained phosphorylation) is achieved only in response to HGF."	0.677	SIGNOR-250290
SIGNOR-GPCR_HCC	GPCR_HCC	PI3K	complex	SIGNOR-C156	SIGNOR	PIP3	smallmolecule	CHEBI:16618	ChEBI	"up-regulates quantity"	"chemical modification"			9606									24647478	t		lperfetto	"Stimulation of tyrosine kinase receptors initiates a signaling cascade that activates pi3k. Activated pi3k uses pip2 to generate pip3, 24647478"	0.8	SIGNOR-252712
SIGNOR-GPCR_HCC	GPCR_HCC	GSTA1	protein	P08263	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606	BTO:0000018								29928434	f		irozzo	"Accordingly, downregulation of GSTA1 suppressed tumor growth. In conclusion, GSTA1 plays an important role in regulation of cell proliferation and cell apoptosis in A549 cell line."	0.7	SIGNOR-256296
SIGNOR-GPCR_HCC	GPCR_HCC	PDPK1	protein	O15530	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation			9606									15743829	t		lperfetto	"3-phosphoinositide-dependent kinase 1 (PDK1) phosphorylates the activation loop of a number of protein serine/threonine kinases of the AGC kinase superfamily, including protein kinase B (PKB; also called Akt),"	0.746	SIGNOR-244469
SIGNOR-GPCR_HCC	GPCR_HCC	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	TERT	protein	O14746	UNIPROT	up-regulates	phosphorylation	Ser227	GARRRGGsASRSLPL	9606									10224060	t		lperfetto	"Akt kinase enhances human telomerase activity through phosphorylation of htert subunit as one of its substrate proteins."	0.2	SIGNOR-244361
SIGNOR-GPCR_HCC	GPCR_HCC	BRAF	protein	P15056	UNIPROT	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	"up-regulates activity"	phosphorylation			9606									21900390	t		miannu	"BRAFV600E has been shown to initiate thyroid follicular cell transformation. The BRAFV600E mutation disrupts the hydrophobic interaction, enabling the BRAF kinase to fold into a catalytically active formation, resulting in an almost 500-fold increase in kinase activity. Mutant BRAF can dimerize and activate MEK without Ras activation."	0.787	SIGNOR-251988
SIGNOR-GPCR_HCC	GPCR_HCC	PIP3	smallmolecule	CHEBI:16618	ChEBI	PDPK1	protein	O15530	UNIPROT	"up-regulates activity"	"chemical activation"			9606									19951971	t		lperfetto	"PIP3 recruits PDK1 and AKT to the plasma membrane, where PDK1 phosphorylates AKT on Thr308 in the activation loop of the kinase domain."	0.8	SIGNOR-249628
SIGNOR-GPCR_HCC	GPCR_HCC	NQO1	protein	P15559	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606	BTO:0000849								20226854	f		irozzo	"More importantly, our results also indicate that NF-kappaB p50 correlates with the expression of NQO1 and mediates its role in the proliferation of melanoma cells."	0.7	SIGNOR-256264
SIGNOR-GPCR_HCC	GPCR_HCC	TGFb	proteinfamily	SIGNOR-PF5	SIGNOR	TGFBR2	protein	P37173	UNIPROT	"up-regulates activity"	binding			9606									22326956	t		miannu	"TGF-beta signaling mediates a wide range of biological activities in development and disease. TGF-beta ligands signal through heterodimeric type I and type II receptors (TGF-beta receptor type I [TbetaRI, also known as ALK5 and TGFBR1] and TbetaRII) that are members of the serine/threonine kinase family."	0.2	SIGNOR-256178
SIGNOR-GPCR_HCC	GPCR_HCC	CTNNB1	protein	P35222	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									18697834	f		"Simone Vumbaca"	"we showed that β-catenin, a key component of the canonical Wnt-signalling cascade, is present in quiescent satellite cells in the inactive form, but subsequently becomes activated following satellite-cell activation. This observation suggests that the proliferation initiated by the Wnt-signalling cascade does not have to rely on transcription of β-catenin, but rather on activation of this protein, which is already present within the quiescent satellite cells."	0.7	SIGNOR-255654
SIGNOR-GPCR_HCC	GPCR_HCC	TGFBR2	protein	P37173	UNIPROT	TGFBR1	protein	P36897	UNIPROT	"up-regulates activity"	phosphorylation	Ser172	SLDRPFIsEGTTLKD	9606									8576253	t		lperfetto	"Recent studies have revealed that upon TGF-beta binding several serine and threonine residues in the GS domain of TGF-beta type I receptor (T beta R-I) are phosphorylated by TGF-beta type II receptor (T beta R-II) and that the phosphorylation of GS domain is essential for TGF-beta signalingThese observations indicate that serine 172 and threonine 176 of T beta R-I are dispensable for extracellular matrix protein production but essential to the growth inhibition by TGF-beta"	0.72	SIGNOR-246728
SIGNOR-GPCR_HCC	GPCR_HCC	MET	protein	P08581	UNIPROT	GAB1	protein	Q13480	UNIPROT	"up-regulates activity"	phosphorylation	Tyr589	SHDSEENyVPMNPNL	9606	BTO:0000018								10734310	t		miannu	"Gab-1 is phosphorylated on the same residues by HGF and EGF receptors. Among 16 peptides only nine were phosphorylated by the EGF and HGF receptors, namely peptides containing the tyrosine residues 285, 307, 373, 407, 448, 473, 590, 628 and 660. we show that in the response to HGF or EGF, Gab1 is phosphorylated in vivo on the same residues. However, a sustained activation of signaling pathways downstream to Gab1 (as a result of its sustained phosphorylation) is achieved only in response to HGF."	0.677	SIGNOR-250288
SIGNOR-GPCR_HCC	GPCR_HCC	SMAD2	protein	Q15796	UNIPROT	SMAD2/SMAD4	complex	SIGNOR-C8	SIGNOR	"form complex"	binding			9606					phosphorylation:Ser465;Ser467	SPSVRCSsMS;SVRCSSMs			11274206	t		gcesareni	"the receptor-regulated Smad, such as Smad2, forms a heterocomplex with the co-mediator Smad, Smad4"	0.719	SIGNOR-235188
SIGNOR-GPCR_HCC	GPCR_HCC	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									19819937	f			"In addition to the JAK2–STAT5 pathway, the Ras GTPase–extracellular signal-regulated kinase (Ras–ERK) pathway has also been implicated in signaling of IL-5 and is important for IL-5-dependent cell survival, proliferation and differentiation of eosinophils."	0.7	SIGNOR-254354
SIGNOR-GPCR_HCC	GPCR_HCC	HRAS	protein	P01112	UNIPROT	BRAF	protein	P15056	UNIPROT	up-regulates	binding			10090	BTO:0000944								7706312	t		lperfetto	"Association of B-Raf with immobilized Ras occurred independently of prior stimulation of cells with serum, suggesting that primarily the production of GTP-Ras by mitogen stimulation is critical for the formation of B-Raf_GTP-Ras complexes."	0.879	SIGNOR-235478
SIGNOR-GPCR_HCC	GPCR_HCC	PIP3	smallmolecule	CHEBI:16618	ChEBI	PDPK1	protein	O15530	UNIPROT	"up-regulates activity"	relocalization			9606									21798082	t		lperfetto	"Pip3 acts in turn as a docking site for two kinases, phosphoinositide-dependent kinase 1 (PDK1) and AKT, and the subsequent phosphorylation of AKT at serine 308 by PDK1, leading to AKT activation."	0.8	SIGNOR-175253
SIGNOR-GPCR_HCC	GPCR_HCC	SOS1	protein	Q07889	UNIPROT	HRAS	protein	P01112	UNIPROT	"up-regulates activity"	"guanine nucleotide exchange factor"			9606									23132018	t		lperfetto	"The enhancement of H-Ras GTP levels induced by oncogenic K-Ras was abrogated when the expression of endogenous Sos was suppressed, implicating Sos as an essential intermediate in the cross talk between oncogenic K-Ras and WT H-Ras."	0.892	SIGNOR-39237
SIGNOR-GPCR_HCC	GPCR_HCC	PTEN	protein	P60484	UNIPROT	PIP3	smallmolecule	CHEBI:16618	ChEBI	"down-regulates quantity"	"chemical modification"			9606									11875759	t		lperfetto	"PTEN dephosphorylates PI3P, lowering its cellular levels and resulting in the down-regulation of AKT."	0.8	SIGNOR-228145
SIGNOR-GPCR_HCC	GPCR_HCC	EGFR	protein	P00533	UNIPROT	PI3K	complex	SIGNOR-C156	SIGNOR	up-regulates	binding			9606									14967450	t		lperfetto	"The egf-r coimmunoprecipitated with p85 alpha"	0.784	SIGNOR-252672
SIGNOR-GPCR_HCC	GPCR_HCC	IGF2	protein	P01344	UNIPROT	IGF1R	protein	P08069	UNIPROT	"up-regulates activity"	binding			9606									22810696	t		lperfetto	"These results strongly suggest that the IGF2–IGF1R–IRS2 axis signals to PI3K in CRC and imply that therapeutic targeting of the pathway could act to block PI3K activity in this subset of patients."	0.825	SIGNOR-251495
SIGNOR-GPCR_HCC	GPCR_HCC	EGFR	protein	P00533	UNIPROT	GRB2	protein	P62993	UNIPROT	"up-regulates activity"	binding			10090	BTO:0000944								7518560	t		lperfetto	"Erbb1 recruites grb2 through sh2 domain;from these studies, we concluded that grb2 binds directly to the egfr at y-1068, to a lesser extent at y-1086, and indirectly at y-1173. Egfr has six binding sites for the adapter protein grb2, and erbb4 has five, each with different binding strength several tyrosine-based motifs recruit a number of signal transducers to the phosphorylated form of erbb1 such as the adaptor proteins growth-factor-receptor bound-2 (grb2) and src-homology-2-containing (shc)."	0.924	SIGNOR-235721
SIGNOR-GPCR_HCC	GPCR_HCC	DVL1	protein	O14640	UNIPROT	GSK3B/Axin/APC	complex	SIGNOR-C110	SIGNOR	"down-regulates activity"	binding			9606									20837657	t		lperfetto	"In canonical wnt signaling, dsh phosphorylation inhibits the apcaxingsk3 complex, leading to beta-catenin stabilization."	0.716	SIGNOR-227911
SIGNOR-GPCR_HCC	GPCR_HCC	MYC	protein	P01106	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									9552384	f		gcesareni	"C-myc has emerged as one of the central regulators of mammalian cell proliferation."	0.7	SIGNOR-56572
SIGNOR-GPCR_HCC	GPCR_HCC	TGFb	proteinfamily	SIGNOR-PF5	SIGNOR	TGFBR2	protein	P37173	UNIPROT	"up-regulates activity"	binding			9606	BTO:0000801								22703233	t		miannu	"TGFbeta signals are transmitted via a cell surface receptor complex consisting of the TGFbeta type I receptor (TbetaRI) and TGFbeta type II receptor (TbetaRII). To initiate signal transduction, TGFbeta binds to TbetaRII, which in turn recruits TbetaRI, leading to the formation of a tetrameric receptor complex."	0.2	SIGNOR-256179
SIGNOR-GPCR_HCC	GPCR_HCC	PDPK1	protein	O15530	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation	Thr308	KDGATMKtFCGTPEY	9606									15718470	t		gcesareni	"Akt/PKB activation requires the phosphorylation of Thr308 in the activation loop by the phosphoinositide-dependent kinase 1 (PDK1) and Ser473 within the carboxyl-terminal hydrophobic motif by an unknown kinase."	0.746	SIGNOR-243203
SIGNOR-GPCR_HCC	GPCR_HCC	LEF1	protein	Q9UJU2	UNIPROT	MYC	protein	P01106	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			9606									19653274	f		gcesareni	"Expression of Lef-1 FL, but not the newly identified Lef-1 Deltaexon VI, induced the expression of the cell cycle regulating proteins c-myc and cyclin D1 in cooperation with beta-catenin and it enhanced cell proliferation"	0.642	SIGNOR-245351
SIGNOR-GPCR_HCC	GPCR_HCC	SMAD3	protein	P84022	UNIPROT	SMAD3/SMAD4	complex	SIGNOR-C9	SIGNOR	"form complex"	binding			9606									9843571	t		lperfetto	"TGF-beta treatment initiates a kinase cascade that results in the phosphorylation of Smad3, followed by its heteromerization with Smad4 and subsequent translocation into the nucleus."	0.71	SIGNOR-229557
SIGNOR-GPCR_HCC	GPCR_HCC	Frizzled	proteinfamily	SIGNOR-PF11	SIGNOR	DVL1	protein	O14640	UNIPROT	up-regulates	binding												19279717	t		apalma	"Wnt signaling is transduced through Fz independent of LRP5/6 leading to the activation of Dsh."	0.2	SIGNOR-255891
SIGNOR-GPCR_HCC	GPCR_HCC	PRKACA	protein	P17612	UNIPROT	CTNNB1	protein	P35222	UNIPROT	"up-regulates activity"	phosphorylation	Ser552	QDTQRRTsMGGTQQQ	9606									16476742	t		lperfetto	"In the present study, we have shown that (i) beta-catenin can be phosphorylated by protein kinase a (pka) in vitro and in intact cells at two novel sites, ser-552 and ser-675;(ii) phosphorylation by pka promotes the transcriptional activity (tcf/lef transactivation) of beta-catenin"	0.48	SIGNOR-144478
SIGNOR-GPCR_HCC	GPCR_HCC	LPAR6	protein	P43657	UNIPROT	GNA13	protein	Q14344	UNIPROT	"up-regulates activity"	binding			9606	BTO:0002524								31160049	t	"GPCR-Ga dataset"	Luana	"Here we systematically quantified ligand-induced interactions between 148 GPCRs and all 11 unique G alpha subunit C-termini. For each receptor, we probed chimeric G alpha subunit activation via a transforming growth factor-alpha (TGF alpha) shedding response in HEK293 cells lacking endogenous Gq/11- and G12/13- signaling. | We defined positive coupling if any member of the subfamily scored LogRAi ≥ -1 and negative coupling if all of the members scored LogRAi < -1 (Figure 3A-B). ROC analysis gives AUC = 0.78 (Figure S4A) when considering high-confidence known coupling data and suggested a threshold of LogRAi ≥ -1.0 for defining true couplings. | The score associated to this interaction has a LogRAi ≥ -1.0."	0.357	SIGNOR-257347
SIGNOR-GPCR_HCC	GPCR_HCC	GNA13	protein	Q14344	UNIPROT	RHOA	protein	P61586	UNIPROT	up-regulates	binding			9606									23450633	t		gcesareni	"Ga12/13 recruitment of rho-gefs causes rhoa activation and f-actin assembly, which promotes lats1/lat2 inactivation by an unknown, but myosin-independent mechanism."	0.578	SIGNOR-192111
SIGNOR-GPCR_HCC	GPCR_HCC	RHOA	protein	P61586	UNIPROT	ROCK1	protein	Q13464	UNIPROT	"up-regulates activity"	binding			9606									25010901	t		gcesareni	"Rho-associated coiled-coil containing kinases (ROCK) were originally identified as effectors of the RhoA small GTPase"	0.813	SIGNOR-196740
SIGNOR-GPCR_HCC	GPCR_HCC	ROCK1	protein	Q13464	UNIPROT	MAPK8	protein	P45983	UNIPROT	"up-regulates activity"	phosphorylation			9606									15068801	t		gcesareni	"Instead, we found that rock activates jnk, which then phosphorylates c-jun and atf2 when bound to the c-jun promoter."	0.296	SIGNOR-123717
SIGNOR-GPCR_HCC	GPCR_HCC	MAPK8	protein	P45983	UNIPROT	MYC	protein	P01106	UNIPROT	"up-regulates activity"	phosphorylation	Ser62	LLPTPPLsPSRRSGL	9606	BTO:0000007;BTO:0000567								10551811	t		lperfetto	"The jnk pathway is selectively involved in the c-myc-mediated apoptosis and that the apoptotic function of c-myc is directly regulated by jnk pathway through phosphorylation at ser-62 and ser-71."	0.556	SIGNOR-236018
SIGNOR-GPCR_HCC	GPCR_HCC	MAPK8	protein	P45983	UNIPROT	JUN	protein	P05412	UNIPROT	"up-regulates activity"	phosphorylation	Ser73	VGLLKLAsPELERLI	9534	BTO:0000298								8137421	t		miannu	"JNK1 binds to the c-Jun transactivation domain and phosphorylates it on Ser-63 and Ser-73. The effect on AP-1 transcriptional activity results, in part, from enhanced phosphorylation of the c-Jun NH2-terminal activation domain."	0.909	SIGNOR-250122
SIGNOR-GPCR_HCC	GPCR_HCC	JUN	protein	P05412	UNIPROT	Apoptosis	phenotype	SIGNOR-PH2	SIGNOR	down-regulates				10090									12553907	f			"In contrast, c-Jun is required for the survival of liver tumor cells. Reduced tumor formation strictly correlated with high apoptotic indices in c-Jun-deficient tumors, suggesting that increased apoptosis in c-Jun-deficient liver tumors is the primary cause for impaired tumorigenesis."	0.7	SIGNOR-256560
SIGNOR-GPCR_HCC	GPCR_HCC	JUN	protein	P05412	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									9878062	f		lperfetto	"Functional data suggest that c-Jun is not merely a target for activation by many of the extracellular stimuli, but that it plays a role in mediating the cellular response. In the case of growth control, three lines of evidence suggest that the transcription factor AP-1, which is composed of FosJun and JunJun dimers, mediates cell proliferation in response to external growth signals in the form of peptide growth factors."	0.7	SIGNOR-233467
SIGNOR-GPCR_HCC	GPCR_HCC	JUN	protein	P05412	UNIPROT	Cell_migration	phenotype	SIGNOR-PH38	SIGNOR	up-regulates				9606									23151663	f		amattioni	"Planar cell polarity (PCP) signalling is prominently involved in the regulation of cell polarity, cell motility and morphogenetic movements, throught the activation of JUN transcription factor."	0.7	SIGNOR-229760
SIGNOR-GPCR_HCC	GPCR_HCC	CXCL12	protein	P48061	UNIPROT	CXCR4	protein	P61073	UNIPROT	up-regulates	binding			9606									11859124	t		gcesareni	"To study the role of the sdf-1/cxcr4-chemokine/receptor system as a regulator of vertebrate development, we isolated and characterized a cdna encoding sdf-1 of the lower vertebrate xenopus laevis (xsdf-1). Recombinant xsdf-1 was produced in insect cells, purified, and functionally characterized. Although xsdf-1 is only 64-66% identical with its mammalian counterparts, it is indistinguishable from human (h)sdf-1alpha in terms of activating both x. laevis cxcr4 and hcxcr4. Thus, both xsdf-1 and hsdf-1alpha promoted cxcr4-mediated activation of heterotrimeric g(i2) in a cell-free system and induced release of intracellular calcium ions in and chemotaxis of intact lymphoblastic cells."	0.814	SIGNOR-115029
SIGNOR-GPCR_HCC	GPCR_HCC	CXCR4	protein	P61073	UNIPROT	GNAI1	protein	P63096	UNIPROT	"up-regulates activity"	binding			9606	BTO:0000007								33073183	t		"Marta Tosoni"	"Using this model, we have reported that CXCL12 activates Gi1, Gi2, or Gi3 heterotrimeric G proteins in a concentration-dependent manner"	0.564	SIGNOR-278102
SIGNOR-GPCR_HCC	GPCR_HCC	CXCR4	protein	P61073	UNIPROT	GNAI3	protein	P08754	UNIPROT	"up-regulates activity"	binding			9606	BTO:0000007								33073183	t		"Marta Tosoni"	"Using this model, we have reported that CXCL12 activates Gi1, Gi2, or Gi3 heterotrimeric G proteins in a concentration-dependent manner"	0.482	SIGNOR-278104
SIGNOR-GPCR_HCC	GPCR_HCC	"3',5'-cyclic AMP"	smallmolecule	CHEBI:17489	ChEBI	PRKACA	protein	P17612	UNIPROT	up-regulates	"chemical activation"			9606									16293724	t		gcesareni	"Pge2 receptors are coupled to the G protein Gs, which causes accumulation of cyclic adenosine monophosphate (cAMP) and activates protein kinase a (PKA), we confirmed that PGE2 treatment or transfection of cells with the active catalytic subunit of PKA also stimulated the activity of a cAMP-responsive-element driven reporter gene (CRE-luc)."	0.8	SIGNOR-141786
SIGNOR-GPCR_HCC	GPCR_HCC	PRKACA	protein	P17612	UNIPROT	CREB1	protein	P16220	UNIPROT	"up-regulates activity"	phosphorylation			9606		BTO:0001103							21902831	t		gcesareni	"Phosphorylation of CREB by PKA allows it to initiate the transcription of genes that contain a CRE element, two of which are PAX3 and MYF5."	0.584	SIGNOR-176560
SIGNOR-GPCR_HCC	GPCR_HCC	PRKCA	protein	P17252	UNIPROT	CTNNB1	protein	P35222	UNIPROT	down-regulates	phosphorylation	Ser33	QQQSYLDsGIHSGAT	9606									25058461	t		miannu	"As shown in Fig. 1 B, PKCalpha readily phosphorylated Ser33 and Ser37 / Thr41 on full-length beta-catenin (beta-catenin 1 - 781) and CTD deletion mutant (beta-catenin 1-682).|To examine the effect of the armadillo repeats 1-5 on PKCalpha mediated beta-catenin degradation, DNA constructs expressing beta-catenin 1 - 781 and beta-catenin deletion mutants (beta-catenin 1-422 and beta-catenin 1-138) were transfected into HEK293 cells, followed by treatment with increasing concentrations of A23187 and CGK062, which are known activators of PKCalpha."	0.411	SIGNOR-278492
SIGNOR-GPCR_HCC	GPCR_HCC	"lysophosphatidic acid"	smallmolecule	CHEBI:132742	ChEBI	LPAR6	protein	P43657	UNIPROT	"up-regulates activity"	"chemical activation"			9606	BTO:0002524								31160049	t	"Ligand-GPCR dataset"	Luana	"Here we systematically quantified ligand-induced interactions between 148 GPCRs and all 11 unique G alpha subunit C-termini. For each receptor, we probed chimeric G alpha subunit activation via a transforming growth factor-alpha (TGF alpha) shedding response in HEK293 cells lacking endogenous Gq/11- and G12/13- signaling. | We defined positive coupling if any member of the subfamily scored LogRAi ≥ -1 and negative coupling if all of the members scored LogRAi < -1 (Figure 3A-B). ROC analysis gives AUC = 0.78 (Figure S4A) when considering high-confidence known coupling data and suggested a threshold of LogRAi ≥ -1.0 for defining true couplings. | The score associated to this interaction has a LogRAi ≥ -1.0."	0.8	SIGNOR-257533
SIGNOR-GPCR_HCC	GPCR_HCC	hsa-miR-222-5p	mirna	URS0000153377_9606	RNAcentral	GNAI3	protein	P08754	UNIPROT	"down-regulates quantity by repression"	"post transcriptional regulation"			9606	BTO:0003227								25444921	t		Parnian	"MiR-222 directly binds to the 3′UTR of GNAI3 and post-transcriptionally regulates GNAI3 expression."	0.4	SIGNOR-278031
SIGNOR-GPCR_HCC	GPCR_HCC	hsa-miR-320d	mirna	URS0000010C72_9606	RNAcentral	GNAI1	protein	P63096	UNIPROT	"down-regulates quantity by repression"	"post transcriptional regulation"			9606	BTO:0003227								23691483	t		Parnian	"GNAI1 was a target of miR-320a/c/d in HCC cells.| Western blot assays revealed that miR-320a/c/d dramatically down-regulated the endogenous GNAI1 protein level, which indicates that these miRNAs may directly target GNAI1 in HCC cells.| Taken together, these observations indicate that miR-320a/c/d facilitate the migration and invasion of HCC cells."	0.4	SIGNOR-278028
SIGNOR-GPCR_HCC	GPCR_HCC	hsa-miR-320a-5p	mirna	URS000042A57E_9606	RNAcentral	GNAI1	protein	P63096	UNIPROT	"down-regulates quantity by repression"	"post transcriptional regulation"			9606	BTO:0003227								23691483	t		Parnian	"GNAI1 was a target of miR-320a/c/d in HCC cells.| Western blot assays revealed that miR-320a/c/d dramatically down-regulated the endogenous GNAI1 protein level, which indicates that these miRNAs may directly target GNAI1 in HCC cells."	0.4	SIGNOR-278026
SIGNOR-GPCR_HCC	GPCR_HCC	hsa-miR-320c	mirna	URS0000010D30_9606	RNAcentral	GNAI1	protein	P63096	UNIPROT	"down-regulates quantity by repression"	"post transcriptional regulation"			9606	BTO:0003227								23691483	t		Parnian	"GNAI1 was a target of miR-320a/c/d in HCC cells.| Western blot assays revealed that miR-320a/c/d dramatically down-regulated the endogenous GNAI1 protein level, which indicates that these miRNAs may directly target GNAI1 in HCC cells.| Taken together, these observations indicate that miR-320a/c/d facilitate the migration and invasion of HCC cells."	0.4	SIGNOR-278027
SIGNOR-GPCR_HCC	GPCR_HCC	hsa-miR-30d-5p	mirna	URS000005CF5F_9606	RNAcentral	GNAI2	protein	P04899	UNIPROT	"down-regulates quantity by repression"	"post transcriptional regulation"			9606	BTO:0003227								20054866	t		Parnian	"MiR-30d Post-transcriptionally Down-regulates GNAI2 Expression by Directly Targeting Its 3' -UTR.| Taken together, these observations suggest that miR-30d is a positive metastatic regulator for HCC."	0.4	SIGNOR-278030
SIGNOR-GPCR_HCC	GPCR_HCC	SMO	protein	Q99835	UNIPROT	GNAI2	protein	P04899	UNIPROT	"up-regulates activity"	binding			10090	BTO:0002572								16885213	t		lperfetto	"Using this assay we determined that mouse Smo couples to all members of the Gi family but does not couple to those of other G protein families."	0.433	SIGNOR-148490
SIGNOR-GPCR_HCC	GPCR_HCC	CXCR4	protein	P61073	UNIPROT	GNAI2	protein	P04899	UNIPROT	"up-regulates activity"	binding			9606	BTO:0000007								33073183	t		"Marta Tosoni"	"Using this model, we have reported that CXCL12 activates Gi1, Gi2, or Gi3 heterotrimeric G proteins in a concentration-dependent manner"	0.488	SIGNOR-278103
SIGNOR-GPCR_HCC	GPCR_HCC	GNAI2	protein	P04899	UNIPROT	Cell_migration	phenotype	SIGNOR-PH38	SIGNOR	down-regulates				9606	BTO:0001950								20054866	t		"Marta Tosoni"	"GNAI2 can significantly inhibit HCC cell migration and invasion"	0.7	SIGNOR-278881
SIGNOR-GPCR_HCC	GPCR_HCC	hsa-miR-338-3p	mirna	URS00000254A6_9606	RNAcentral	SMO	protein	Q99835	UNIPROT	"down-regulates quantity by repression"	"post transcriptional regulation"			9606	BTO:0004169								29069716	t		Parnian	"MiR-338-3p suppresses the invasiveness and metastasis of HCC cells by directly targeting the Smoothened (SMO) protein"	0.4	SIGNOR-277973
SIGNOR-GPCR_HCC	GPCR_HCC	SMO	protein	Q99835	UNIPROT	GNAI2	protein	P04899	UNIPROT	"up-regulates activity"	binding			9606									23074268	t		lperfetto	"it was proposed that Smo might signal through activation of Gi proteins to reduce PKA activity."	0.433	SIGNOR-199162
SIGNOR-GPCR_HCC	GPCR_HCC	SMO	protein	Q99835	UNIPROT	GNAI1	protein	P63096	UNIPROT	up-regulates	binding			10090	BTO:0002572								16885213	t		gcesareni	"We found that Smo, by virtue of what appears to be constitutive activity, activates all members of the G(i) family but does not activate members of the G(s), G(q), and G(12) families. The activation is suppressed by cyclopamine and other inhibitors of Hedgehog signaling and is enhanced by the Smo agonist purmorphamine."	0.521	SIGNOR-148487
SIGNOR-GPCR_HCC	GPCR_HCC	"lysophosphatidic acid"	smallmolecule	CHEBI:132742	ChEBI	hsa-miR-122-5p	mirna	URS00003380CC_9606	RNAcentral	"down-regulates activity"	"chemical activation"			9606	BTO:0000599								25965999	f		Parnian	"We found that treatment of HepG2 cells with LPA (12 h) moderately reduced miR-122 levels"	0.4	SIGNOR-280507
SIGNOR-GPCR_HCC	GPCR_HCC	hsa-miR-199a-5p	mirna	URS0000554A4F_9606	RNAcentral	FZD7	protein	O75084	UNIPROT	"down-regulates quantity by repression"	"post transcriptional regulation"			9606	BTO:0003227								25313882	t		Parnian	"These results suggested that miR-199a could significantly suppress the expression of FZD7 through targeting the 3'UTR of its mRNA."	0.4	SIGNOR-277958
SIGNOR-GPCR_HCC	GPCR_HCC	Frizzled	proteinfamily	SIGNOR-PF11	SIGNOR	CTNNB1	protein	P35222	UNIPROT	"up-regulates activity"													18697834	f		"Simone Vumbaca"	"[…] we suggest that Wnt1, Wnt3a and Wnt5a result in the accumulation of Act-β-Cat"	0.2	SIGNOR-255652
SIGNOR-GPCR_HCC	GPCR_HCC	CTNNB1	protein	P35222	UNIPROT	Cell_migration	phenotype	SIGNOR-PH38	SIGNOR	up-regulates				9606	BTO:0001950								15480989	f		parnian	"These observations suggest that the Wnt/β-catenin signal transduction pathway is involved much more commonly in the molecular pathogenesis of HCC than previously recognized because FZD7 overexpression occurred early in the disease process, stabilized wild-type β-catenin levels, and contributed to enhanced tumor cell migration."	0.7	SIGNOR-280436
SIGNOR-GPCR_HCC	GPCR_HCC	WNT3	protein	P56703	UNIPROT	FZD7	protein	O75084	UNIPROT	"up-regulates activity"	binding			9606	BTO:0001950								18313787	t		parnian	"These experiments suggest that activation of the Wnt/β-catenin pathway by Wnt3 is mediated in part through FZD7 in HCC cells."	0.746	SIGNOR-280437
SIGNOR-GPCR_HCC	GPCR_HCC	hsa-miR-27a-5p	mirna	URS00001B341F_9606	RNAcentral	FZD7	protein	O75084	UNIPROT	"down-regulates quantity by repression"	"post transcriptional regulation"			9606	BTO:0004050								24018051	t		Parnian	"Our observations indicate that FZD7 is a target of miR-27a and miR-27a mediates FZD7 expression via posttranslational suppression."	0.4	SIGNOR-277966
SIGNOR-GPCR_HCC	GPCR_HCC	FZD7	protein	O75084	UNIPROT	ABCB1	protein	P08183	UNIPROT	"up-regulates quantity by expression"	"post transcriptional regulation"			9606	BTO:0004050								24018051	f		Parnian	"Knockdown of FZD7 led to decrease the expressions of the MDR1 mRNA and P-gp protein, indicating that FZD7 is involved in the regulation of multidrug resistance in HCC."	0.272	SIGNOR-277983
SIGNOR-GPCR_HCC	GPCR_HCC	FZD7	protein	O75084	UNIPROT	DVL1	protein	O14640	UNIPROT	up-regulates	binding												22179044	t		apalma	"In non-canonical Wnt signalling, Wnt proteins bind Fzd and glypican-4, to activate Dsh at the cell membrane, leading to activation of Rho and JNK"	0.665	SIGNOR-255893
SIGNOR-GPCR_HCC	GPCR_HCC	hsa-miR-122-5p	mirna	URS00003380CC_9606	RNAcentral	MET	protein	P08581	UNIPROT	"down-regulates quantity by repression"	"post transcriptional regulation"			9606	BTO:0000599								25965999	t		Parnian	"These results show that miR-122 directly inhibits c-Met translation by targeting the 3’UTR region."	0.4	SIGNOR-279816
SIGNOR-GPCR_HCC	GPCR_HCC	GNA12	protein	Q03113	UNIPROT	hsa-miR-122-5p	mirna	URS00003380CC_9606	RNAcentral	"down-regulates quantity by repression"	"post transcriptional regulation"			9606	BTO:0000599								25965999	f		parnian	"Our data indicates that Gα12 overexpressed in liver cancer mostly greatly dysregulates the expression of miR-122."	0.4	SIGNOR-280438
SIGNOR-GPCR_HCC	GPCR_HCC	LPAR6	protein	P43657	UNIPROT	GNA12	protein	Q03113	UNIPROT	"up-regulates activity"	binding			9606	BTO:0002524								31160049	t	"GPCR-Ga dataset"	Luana	"Here we systematically quantified ligand-induced interactions between 148 GPCRs and all 11 unique G alpha subunit C-termini. For each receptor, we probed chimeric G alpha subunit activation via a transforming growth factor-alpha (TGF alpha) shedding response in HEK293 cells lacking endogenous Gq/11- and G12/13- signaling. | We defined positive coupling if any member of the subfamily scored LogRAi ≥ -1 and negative coupling if all of the members scored LogRAi < -1 (Figure 3A-B). ROC analysis gives AUC = 0.78 (Figure S4A) when considering high-confidence known coupling data and suggested a threshold of LogRAi ≥ -1.0 for defining true couplings. | The score associated to this interaction has a LogRAi ≥ -1.0."	0.363	SIGNOR-257286
SIGNOR-GPCR_HCC	GPCR_HCC	GNA12	protein	Q03113	UNIPROT	MET	protein	P08581	UNIPROT	"up-regulates activity"				9606	BTO:0000599								25965999	f		parnian	"All of these results indicate that increased levels of Gα12 causes the induction of c-Met by deregulating miR-122."	0.2	SIGNOR-280439
SIGNOR-GPCR_HCC	GPCR_HCC	MET	protein	P08581	UNIPROT	Metastasis	phenotype	SIGNOR-PH107	SIGNOR	up-regulates				9606	BTO:0001033								22035268	f		miannu	"C-Met expression and activation appears to be one of the common mechanisms of resistance to other targeted therapies. Given these multiple roles of c-Met in prostate cancer, several c-Met inhibitors have been developed. Evidence to date suggests that aberrant activation of the HGF/c-Met axis in prostate cancer epithelial cells appears to be a relatively late event in tumor progression. C-Met expression increases in advanced stages of the disease, with the highest expression observed in bone metastases."	0.7	SIGNOR-263658
SIGNOR-GPCR_HCC	GPCR_HCC	"sphingosine 1-phosphate"	smallmolecule	CHEBI:37550	ChEBI	hsa-miR-122-5p	mirna	URS00003380CC_9606	RNAcentral	"down-regulates activity"				9606	BTO:0000599								25965999	f		parnian	"S1P treatment also significantly decreased miR-122 level"	0.4	SIGNOR-280441
SIGNOR-GPCR_HCC	GPCR_HCC	has-mir-126-3p	mirna	URS00001F1DA8_9606	RNAcentral	LRP6	protein	O75581	UNIPROT	"down-regulates quantity by repression"	"post transcriptional regulation"			9606	BTO:0000599								25240815	t		Parnian	"These results provided strong evidence that LRP6 is a target of miR-126-3p in HCC and mediates the metastasis function of miR-126-3p in HCC. | MiR-126-3p inhibits HCC metastasis by directly targeting LRP6."	0.4	SIGNOR-278836
SIGNOR-GPCR_HCC	GPCR_HCC	has-mir-126-3p	mirna	URS00001F1DA8_9606	RNAcentral	Metastasis	phenotype	SIGNOR-PH107	SIGNOR	down-regulates				9606	BTO:0000599								25240815	f		parnian	"Both gain- of function and loss- of function assays indicate that miR-126-3p suppresses metastasis and angiogenesis in HCC cells."	0.4	SIGNOR-280442
SIGNOR-GPCR_HCC	GPCR_HCC	has-mir-126-3p	mirna	URS00001F1DA8_9606	RNAcentral	Angiogenesis	phenotype	SIGNOR-PH46	SIGNOR	down-regulates				9606	BTO:0000599								25240815	f		parnian	"Both gain- of function and loss- of function assays indicate that miR-126-3p suppresses metastasis and angiogenesis in HCC cells."	0.4	SIGNOR-280443
SIGNOR-GPCR_HCC	GPCR_HCC	LRP6	protein	O75581	UNIPROT	Cell_migration	phenotype	SIGNOR-PH38	SIGNOR	up-regulates				9606	BTO:0004050								22570728	t		parnian	"LRP6 enhanced both cell migration and invasion in vitro"	0.7	SIGNOR-280444
SIGNOR-GPCR_HCC	GPCR_HCC	hsa-miR-202-5p	mirna	URS00003D8730_9606	RNAcentral	LRP6	protein	O75581	UNIPROT	"down-regulates quantity by repression"	"post transcriptional regulation"			9606	BTO:0000599								24704686	t		Parnian	"Taken together, our results suggested that LRP6 mRNA is a direct target of miR-202 in HCC cells."	0.4	SIGNOR-278841
SIGNOR-GPCR_HCC	GPCR_HCC	hsa-miR-610	mirna	URS00004DC583_9606	RNAcentral	LRP6	protein	O75581	UNIPROT	"down-regulates quantity by repression"	"post transcriptional regulation"			9606	BTO:0005814								25491321	t		Parnian	"Results indicate that miR-610 negatively regulated these proteins via directly binding to their 3’UTRs. These data further confirm that miR-610 suppresses HCC cell tumorigenicity by inhibiting the activity of β-catenin via targeting LRP6 and TBL1X."	0.4	SIGNOR-278839
SIGNOR-GPCR_HCC	GPCR_HCC	GPER1	protein	Q99527	UNIPROT	hsa-miR-21-5p	mirna	URS000039ED8D_9606	RNAcentral	"up-regulates activity"	"post transcriptional regulation"			9606	BTO:0000599								25969534	f		Parnian	"MiR-21 transcription is regulated by DHEA through GPER."	0.4	SIGNOR-279814
SIGNOR-GPCR_HCC	GPCR_HCC	GPER1	protein	Q99527	UNIPROT	GNAS	protein	P63092	UNIPROT	"up-regulates activity"	binding												10696571	t			"GPCRs transduce their signal via G-protein heterotrimers (αβγ) that dissociate in free Gα-subunit protein and Gβγ-subunit protein complexes following ligand stimulation; the activated receptor induces a conformational change in the associated G protein α-subunit leading to release of GDP followed by binding of GTP and α-subunit dissociation from the receptor."	0.381	SIGNOR-251102
SIGNOR-GPCR_HCC	GPCR_HCC	dehydroepiandrosterone	chemical	CHEBI:28689	ChEBI	hsa-miR-21-5p	mirna	URS000039ED8D_9606	RNAcentral	"up-regulates quantity by expression"	"post transcriptional regulation"			9606	BTO:0000599								25969534	f		Parnian	"Together, these data suggest that the rapid DHEA-induced increase in pri-miR-21 and miR-21 is a transcriptional response that requires GPCR signaling, EGFR activation, Src kinase activity, intact PM structure, and MAPK and PI3K activity."	0.4	SIGNOR-279813
SIGNOR-GPCR_HCC	GPCR_HCC	PTCH1	protein	Q13635	UNIPROT	SMO	protein	Q99835	UNIPROT	"down-regulates activity"	binding			9606									14556242	t		lperfetto	"In the responding cell, active Hedgehog binds to its receptor Patched, a 12-pass transmembrane protein, which frees Smoothened, an adjacent 7-pass transmembrane protein, for downstream signaling.Thus, a balance is created by the antagonism of Hedgehog and Patched, whose relative concentrations alternate with respect to each other."	0.79	SIGNOR-118609
SIGNOR-GPCR_HCC	GPCR_HCC	SHH	protein	Q15465	UNIPROT	PTCH1	protein	Q13635	UNIPROT	"down-regulates activity"	binding			9606									14556242	t		lperfetto	"In the responding cell, active Hedgehog binds to its receptor Patched, a 12-pass transmembrane protein, which frees Smoothened, an adjacent 7-pass transmembrane protein, for downstream signaling.Thus, a balance is created by the antagonism of Hedgehog and Patched, whose relative concentrations alternate with respect to each other."	0.943	SIGNOR-118615
SIGNOR-HT	"Hepatocellular Tumor"	TGFb	proteinfamily	SIGNOR-PF5	SIGNOR	TGFBR2	protein	P37173	UNIPROT	"up-regulates activity"	binding			9606									22326956	t		miannu	"TGF-beta signaling mediates a wide range of biological activities in development and disease. TGF-beta ligands signal through heterodimeric type I and type II receptors (TGF-beta receptor type I [TbetaRI, also known as ALK5 and TGFBR1] and TbetaRII) that are members of the serine/threonine kinase family."	0.2	SIGNOR-256178
SIGNOR-HT	"Hepatocellular Tumor"	SMAD2/SMAD4	complex	SIGNOR-C8	SIGNOR	AP1	complex	SIGNOR-C154	SIGNOR	"up-regulates activity"	binding			9606									22926518	t		miannu	"The activated TGFβ type I receptor kinase propagates the signal within the cell through phosphorylation of the receptor-regulated (R-)Smad proteins Smad2 and Smad3 at their extreme carboxyl-terminal serine residues.1, 2 The activated R-Smads then form heteromeric complexes with the common-partner (Co-)Smad, Smad4, and accumulate in the nucleus, where they can bind DNA and regulate gene expression. The Smads control gene expression in a cell type-specific manner by interacting with other proteins, such as AP-1, AP-2 and Ets transcription factors and specific co-activators and co-repressors."	0.531	SIGNOR-256180
SIGNOR-HT	"Hepatocellular Tumor"	SMAD3/SMAD4	complex	SIGNOR-C9	SIGNOR	AP1	complex	SIGNOR-C154	SIGNOR	"up-regulates activity"	binding			9606									22926518	t		miannu	"The activated TGFβ type I receptor kinase propagates the signal within the cell through phosphorylation of the receptor-regulated (R-)Smad proteins Smad2 and Smad3 at their extreme carboxyl-terminal serine residues.1, 2 The activated R-Smads then form heteromeric complexes with the common-partner (Co-)Smad, Smad4, and accumulate in the nucleus, where they can bind DNA and regulate gene expression. The Smads control gene expression in a cell type-specific manner by interacting with other proteins, such as AP-1, AP-2 and Ets transcription factors and specific co-activators and co-repressors."	0.649	SIGNOR-256181
SIGNOR-HT	"Hepatocellular Tumor"	MET	protein	P08581	UNIPROT	GAB1	protein	Q13480	UNIPROT	"up-regulates activity"	phosphorylation	Tyr589	SHDSEENyVPMNPNL	9606	BTO:0000018								10734310	t		miannu	"Gab-1 is phosphorylated on the same residues by HGF and EGF receptors. Among 16 peptides only nine were phosphorylated by the EGF and HGF receptors, namely peptides containing the tyrosine residues 285, 307, 373, 407, 448, 473, 590, 628 and 660. we show that in the response to HGF or EGF, Gab1 is phosphorylated in vivo on the same residues. However, a sustained activation of signaling pathways downstream to Gab1 (as a result of its sustained phosphorylation) is achieved only in response to HGF."	0.677	SIGNOR-250288
SIGNOR-HT	"Hepatocellular Tumor"	SMAD2	protein	Q15796	UNIPROT	SMAD2/SMAD4	complex	SIGNOR-C8	SIGNOR	"form complex"	binding			9606					phosphorylation:Ser465;Ser467	SPSVRCSsMS;SVRCSSMs			11274206	t		gcesareni	"the receptor-regulated Smad, such as Smad2, forms a heterocomplex with the co-mediator Smad, Smad4"	0.719	SIGNOR-235188
SIGNOR-HT	"Hepatocellular Tumor"	EGFR	protein	P00533	UNIPROT	PI3K	complex	SIGNOR-C156	SIGNOR	up-regulates	binding			9606									14967450	t		lperfetto	"The egf-r coimmunoprecipitated with p85 alpha"	0.784	SIGNOR-252672
SIGNOR-HT	"Hepatocellular Tumor"	SMAD3	protein	P84022	UNIPROT	SMAD4	protein	Q13485	UNIPROT	"up-regulates activity"	binding			9606									9843571	t		gcesareni	"TGF-² treatment initiates a kinase cascade that results in the phosphorylation of Smad3, followed by its heteromerization with Smad4 and subsequent translocation into the nucleus."	0.71	SIGNOR-235168
SIGNOR-HT	"Hepatocellular Tumor"	EGFR	protein	P00533	UNIPROT	GRB2	protein	P62993	UNIPROT	"up-regulates activity"	binding			10090	BTO:0000944								7518560	t		lperfetto	"Erbb1 recruites grb2 through sh2 domain;from these studies, we concluded that grb2 binds directly to the egfr at y-1068, to a lesser extent at y-1086, and indirectly at y-1173. Egfr has six binding sites for the adapter protein grb2, and erbb4 has five, each with different binding strength several tyrosine-based motifs recruit a number of signal transducers to the phosphorylated form of erbb1 such as the adaptor proteins growth-factor-receptor bound-2 (grb2) and src-homology-2-containing (shc)."	0.924	SIGNOR-235721
SIGNOR-HT	"Hepatocellular Tumor"	SMAD4	protein	Q13485	UNIPROT	SMAD3/SMAD4	complex	SIGNOR-C9	SIGNOR	"form complex"	binding			9606									9843571	t		lperfetto	"TGF-beta treatment initiates a kinase cascade that results in the phosphorylation of Smad3, followed by its heteromerization with Smad4 and subsequent translocation into the nucleus."	0.71	SIGNOR-229560
SIGNOR-HT	"Hepatocellular Tumor"	SMAD3/SMAD4	complex	SIGNOR-C9	SIGNOR	AP1	complex	SIGNOR-C154	SIGNOR	"up-regulates activity"	binding			9606									9732876	t		lperfetto	"Smad3 and smad4 also act together with c-jun and c-fos to activate transcription in response to tgf-beta, through a tgf-beta-inducible association of c-jun with smad3 and an interaction of smad3 and c-fos"	0.649	SIGNOR-253332
SIGNOR-HT	"Hepatocellular Tumor"	TGFBR2	protein	P37173	UNIPROT	TGFBR1	protein	P36897	UNIPROT	"up-regulates activity"	phosphorylation	Thr204	VQRTIARtIVLQESI	452646									7774578	t		lperfetto	"The TGF-beta type II receptor (T beta R-II) is a transmembrane serine/threonine kinase that, upon ligand binding, recruits and phosphorylates a second transmembrane kinase, T beta R-I, as a requirement for signal transduction. In contrast to the relatively innocuous nature of single site mutations in the ttsgsgsg sequence, mutation of thr200 or 204 to valine causes marked losses in ligand-induced phosphorylation and signaling."	0.72	SIGNOR-32748
SIGNOR-HT	"Hepatocellular Tumor"	TGFb	proteinfamily	SIGNOR-PF5	SIGNOR	TGFBR2	protein	P37173	UNIPROT	"up-regulates activity"	binding			9606	BTO:0000801								22703233	t		miannu	"TGFbeta signals are transmitted via a cell surface receptor complex consisting of the TGFbeta type I receptor (TbetaRI) and TGFbeta type II receptor (TbetaRII). To initiate signal transduction, TGFbeta binds to TbetaRII, which in turn recruits TbetaRI, leading to the formation of a tetrameric receptor complex."	0.2	SIGNOR-256179
SIGNOR-HT	"Hepatocellular Tumor"	SMAD4	protein	Q13485	UNIPROT	SMAD2/SMAD4	complex	SIGNOR-C8	SIGNOR	"form complex"	binding			9606									11274206	t		gcesareni	"the receptor-regulated Smad, such as Smad2, forms a heterocomplex with the co-mediator Smad, Smad4"	0.719	SIGNOR-235178
SIGNOR-HT	"Hepatocellular Tumor"	TGFBR1	protein	P36897	UNIPROT	SMAD2	protein	Q15796	UNIPROT	"up-regulates activity"	phosphorylation	Ser465	SPSVRCSsMS	9534	BTO:0001538								9346908	t		lperfetto	"Recently, it was demonstrated that Smad2 interacts transiently with and is a direct substrate of the transforming growth factor-_ (TGF-_) type I receptor, T_RI. Phosphorylation sites on smad2 were localized to a carboxyl-terminal fragment containing three serine residues at positions 464, 465, and 467. In this report, we show that T_RI specifically phosphorylates Smad2 on serines 465 and 467.These results indicate that receptor-dependent phosphorylation of Smad2 on serines 465 and 467 is required in mammalian cells to permit association with Smad4 and to propagate TGF-_ signals."	0.828	SIGNOR-236107
SIGNOR-HT	"Hepatocellular Tumor"	SMAD2	protein	Q15796	UNIPROT	SMAD4	protein	Q13485	UNIPROT	"up-regulates activity"	binding			9606					phosphorylation:Ser465;Ser467	SPSVRCSsMS;SVRCSSMs			11274206	t		gcesareni	"the receptor-regulated Smad, such as Smad2, forms a heterocomplex with the co-mediator Smad, Smad4"	0.719	SIGNOR-235183
SIGNOR-HT	"Hepatocellular Tumor"	CTNNB1	protein	P35222	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									23645839	f		apalma	"For example, prostaglandin E2 (PGE2), 1 of the major metabolites downstream of both COX-1 and COX-2, has been shown to activate β-catenin–dependent signaling in hematopoietic stem cells (HSCs) and promote HSC expansion"	0.7	SIGNOR-255695
SIGNOR-HT	"Hepatocellular Tumor"	Wnt	proteinfamily	SIGNOR-PF40	SIGNOR	Frizzled	proteinfamily	SIGNOR-PF11	SIGNOR	"up-regulates activity"	binding			9606									23290138	t		miannu	"Wnt proteins bind to the frizzled receptors and lrp5/6 co-receptors, and through stabilizing the critical mediator betBeta-catenin, initiate a complex signaling cascade that plays an important role in regulating cell proliferation and differentiation."	0.842	SIGNOR-256173
SIGNOR-HT	"Hepatocellular Tumor"	LPR5/6	complex	SIGNOR-C219	SIGNOR	GSK3B/Axin/APC	complex	SIGNOR-C110	SIGNOR	"down-regulates activity"	binding			9606									19107203	t	"PPPSPxS motif in LRP6/5 must be phosphorylated."	miannu	"These observations demonstrate that phosphorylated lrp6/5 both recruits and directly inhibits gsk3beta using two distinct portions of its cytoplasmic sequence. binding of wnts to the coreceptors frizzled and lrp6/5 leads to phosphorylation of pppspxs motifs in the lrp6/5 intracellular region and the inhibition of gsk3beta bound to the scaffold protein axin."	0.714	SIGNOR-256177
SIGNOR-HT	"Hepatocellular Tumor"	Frizzled	proteinfamily	SIGNOR-PF11	SIGNOR	DVL1	protein	O14640	UNIPROT	up-regulates	binding												19279717	t		apalma	"Wnt signaling is transduced through Fz independent of LRP5/6 leading to the activation of Dsh."	0.2	SIGNOR-255891
SIGNOR-HT	"Hepatocellular Tumor"	GSK3B/Axin/APC	complex	SIGNOR-C110	SIGNOR	CTNNB1	protein	P35222	UNIPROT	"down-regulates activity"	phosphorylation	Ser33	QQQSYLDsGIHSGAT	9606									11955436	t		lperfetto	"Wnt regulation of beta-catenin degradation is essential for development and carcinogenesis. beta-catenin degradation is initiated upon amino-terminal serine/threonine phosphorylation, which is believed to be performed by glycogen synthase kinase-3 (GSK-3) in complex with tumor suppressor proteins Axin and adnomatous polyposis coli (APC)."	0.896	SIGNOR-227897
SIGNOR-HT	"Hepatocellular Tumor"	GSK3B/Axin/APC	complex	SIGNOR-C110	SIGNOR	CTNNB1	protein	P35222	UNIPROT	"down-regulates activity"	phosphorylation	Ser37	YLDSGIHsGATTTAP	9606									11955436	t		lperfetto	"Wnt regulation of beta-catenin degradation is essential for development and carcinogenesis. beta-catenin degradation is initiated upon amino-terminal serine/threonine phosphorylation, which is believed to be performed by glycogen synthase kinase-3 (GSK-3) in complex with tumor suppressor proteins Axin and adnomatous polyposis coli (APC)."	0.896	SIGNOR-227901
SIGNOR-HT	"Hepatocellular Tumor"	GSK3B/Axin/APC	complex	SIGNOR-C110	SIGNOR	CTNNB1	protein	P35222	UNIPROT	"down-regulates activity"	phosphorylation	Thr41	GIHSGATtTAPSLSG	9606									11955436	t		lperfetto	"Wnt regulation of beta-catenin degradation is essential for development and carcinogenesis. beta-catenin degradation is initiated upon amino-terminal serine/threonine phosphorylation, which is believed to be performed by glycogen synthase kinase-3 (GSK-3) in complex with tumor suppressor proteins Axin and adnomatous polyposis coli (APC)."	0.896	SIGNOR-227905
SIGNOR-HT	"Hepatocellular Tumor"	DVL1	protein	O14640	UNIPROT	GSK3B/Axin/APC	complex	SIGNOR-C110	SIGNOR	"down-regulates activity"	binding			9606									20837657	t		lperfetto	"In canonical wnt signaling, dsh phosphorylation inhibits the apcaxingsk3 complex, leading to beta-catenin stabilization."	0.716	SIGNOR-227911
SIGNOR-HT	"Hepatocellular Tumor"	CTNNB1	protein	P35222	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									18697834	f		"Simone Vumbaca"	"we showed that β-catenin, a key component of the canonical Wnt-signalling cascade, is present in quiescent satellite cells in the inactive form, but subsequently becomes activated following satellite-cell activation. This observation suggests that the proliferation initiated by the Wnt-signalling cascade does not have to rely on transcription of β-catenin, but rather on activation of this protein, which is already present within the quiescent satellite cells."	0.7	SIGNOR-255654
SIGNOR-HT	"Hepatocellular Tumor"	Wnt	proteinfamily	SIGNOR-PF40	SIGNOR	LPR5/6	complex	SIGNOR-C219	SIGNOR	"up-regulates activity"	binding			9606									23209147	t		miannu	"FZD and LRP5/6 transduce Wnt signal via engaging downstream cytoplasmic components, among which two scaffolding proteins, Dishevelled and Axin, have prominent roles."	0.812	SIGNOR-256174
SIGNOR-HT	"Hepatocellular Tumor"	TGFA	protein	P01135	UNIPROT	EGFR	protein	P00533	UNIPROT	"up-regulates activity"	binding			9606	BTO:0000584								16585207	t	"Transforming growth factor alpha expression drives constitutive epidermal growth factor receptor pathway activation and sensitivity to gefitinib (Iressa) in human pancreatic cancer cell lines"	gcesareni	"Our data indicate that a subset of cell lines is dependent on TGF-_-mediated activation of the EGFR for cell proliferation and strongly suggest that pancreatic tumors expressing high levels of TGF-_ and phosphorylated (activated) EGFR are EGFR-dependent in vitro and in vivo."	0.9	SIGNOR-93199
SIGNOR-HT	"Hepatocellular Tumor"	TCF4	protein	P15884	UNIPROT	MYC	protein	P01106	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			9606									18852287	t			"Association of c-Jun, β-catenin, and TCF4 specifically with the downstream enhancer underlies mitogen stimulation of c-Myc transcription."	0.373	SIGNOR-253324
SIGNOR-HT	"Hepatocellular Tumor"	EGFR	protein	P00533	UNIPROT	GRB2	protein	P62993	UNIPROT	"up-regulates activity"	binding			-1	BTO:0000567								16729043	t		lperfetto	"We determined interaction partners to all cytosolic tyrosine residues of the four members of the ErbB-receptor family in an unbiased fashion by quantitative proteomics using pull-down experiments with pairs of phosphorylated and nonphosphorylated synthetic peptides. Each receptor had characteristic preferences for interacting proteins and most interaction partners had multiple binding sites on each receptor. EGFR and ErbB4 had several docking sites for Grb2, while ErbB3 was characterized by six binding sites for PI3K."	0.924	SIGNOR-236327
SIGNOR-HT	"Hepatocellular Tumor"	CTNNB1	protein	P35222	UNIPROT	TCF4	protein	P15884	UNIPROT	"up-regulates activity"	binding			9606	BTO:0000007								11713476	t		amattioni	"beta-catenin interacts with the TCF/Lef family transcription factors."	0.692	SIGNOR-178042
SIGNOR-HT	"Hepatocellular Tumor"	SMAD3	protein	P84022	UNIPROT	SMAD3/SMAD4	complex	SIGNOR-C9	SIGNOR	"form complex"	binding			9606									9843571	t		lperfetto	"TGF-beta treatment initiates a kinase cascade that results in the phosphorylation of Smad3, followed by its heteromerization with Smad4 and subsequent translocation into the nucleus."	0.71	SIGNOR-229557
SIGNOR-HT	"Hepatocellular Tumor"	CTNNB1	protein	P35222	UNIPROT	LEF1	protein	Q9UJU2	UNIPROT	"up-regulates activity"	binding			9606									23151663	t		gcesareni	"Upon wnt activation, cytoplasmic beta-catenin is stabilized and enters the nucleus, where it associates with transcription factors, notably tcf (t cell factor) and lef (lymphoid enhancer-binding factor), to regulate the transcription of target genes. Thus beta-catenin regulates gene expression by direct interaction with transcription factors such as lef-1, providing a molecular mechanism for the transmission of signals, from cell-adhesion components or wnt protein to the nucleus."	0.917	SIGNOR-199378
SIGNOR-HT	"Hepatocellular Tumor"	CTNNB1	protein	P35222	UNIPROT	LEF1	protein	Q9UJU2	UNIPROT	"up-regulates activity"	binding			9606									21078818	t		gcesareni	"Phosphorylated lrp5/6 leads to inhibition of the so-called beta-catenin destruction complex (which includes axin, gsk3, dvl, ck1, and the tumor suppressor adenomatous polyposis coli), resulting in the stabilization and translocation of beta-catenin in the nucleus, where it activates target genes through binding to tcf/lef transcription factors."	0.917	SIGNOR-169632
SIGNOR-HT	"Hepatocellular Tumor"	LEF1	protein	Q9UJU2	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									17081971	f		amattioni	"The interaction of beta-catenin with the N terminus of tcf/lef transiently converts it into an activator, translating the Wnt signal into the transient transcription of Tcf target genes. The Wnt pathway has distinct transcriptional outputs, which are determined by the identity of the responding cell, and range from cell proliferation and survival to the terminal differentiation of postmitotic cells."	0.7	SIGNOR-229764
SIGNOR-HT	"Hepatocellular Tumor"	LEF1	protein	Q9UJU2	UNIPROT	MYC	protein	P01106	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			9606									19653274	f		gcesareni	"Expression of Lef-1 FL, but not the newly identified Lef-1 Deltaexon VI, induced the expression of the cell cycle regulating proteins c-myc and cyclin D1 in cooperation with beta-catenin and it enhanced cell proliferation"	0.642	SIGNOR-245351
SIGNOR-HT	"Hepatocellular Tumor"	LEF1	protein	Q9UJU2	UNIPROT	Survival	phenotype	SIGNOR-PH13	SIGNOR	up-regulates				9606									17081971	f		amattioni	"The interaction of beta-catenin with the N terminus of tcf/lef transiently converts it into an activator, translating the Wnt signal into the transient transcription of Tcf target genes. The Wnt pathway has distinct transcriptional outputs, which are determined by the identity of the responding cell, and range from cell proliferation and survival to the terminal differentiation of postmitotic cells."	0.7	SIGNOR-229767
SIGNOR-HT	"Hepatocellular Tumor"	MYC	protein	P01106	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									9552384	f		gcesareni	"C-myc has emerged as one of the central regulators of mammalian cell proliferation."	0.7	SIGNOR-56572
SIGNOR-HT	"Hepatocellular Tumor"	MYC	protein	P01106	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				10090		BTO:0000724							7882978	f		irozzo	"These observations indicate that continued late-stage expression of L-myc affected differentiation processes directly, rather than indirectly through deregulated growth control, whereas constitutive c-myc expression inhibited proliferative arrest, but did not appear to disturb differentiation."	0.7	SIGNOR-259110
SIGNOR-HT	"Hepatocellular Tumor"	PTEN	protein	P60484	UNIPROT	PIP3	smallmolecule	CHEBI:16618	ChEBI	"down-regulates quantity"	"chemical modification"			9606									11875759	t		lperfetto	"PTEN dephosphorylates PI3P, lowering its cellular levels and resulting in the down-regulation of AKT."	0.8	SIGNOR-228145
SIGNOR-HT	"Hepatocellular Tumor"	TERT	protein	O14746	UNIPROT	Immortality	phenotype	SIGNOR-PH47	SIGNOR	up-regulates													11327115	f		lperfetto	"Telomerase is tightly repressed in the vast majority of normal human somatic cells but becomes activated during cellular immortalization and in cancers"	0.7	SIGNOR-252292
SIGNOR-HT	"Hepatocellular Tumor"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	TERT	protein	O14746	UNIPROT	up-regulates	phosphorylation	Ser227	GARRRGGsASRSLPL	9606									10224060	t		lperfetto	"Akt kinase enhances human telomerase activity through phosphorylation of htert subunit as one of its substrate proteins."	0.2	SIGNOR-244361
SIGNOR-HT	"Hepatocellular Tumor"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	TERT	protein	O14746	UNIPROT	up-regulates	phosphorylation	Ser824	AVRIRGKsYVQCQGI	9606									10224060	t		lperfetto	"Akt kinase enhances human telomerase activity through phosphorylation of htert subunit as one of its substrate proteins."	0.2	SIGNOR-244357
SIGNOR-HT	"Hepatocellular Tumor"	KEAP1	protein	Q14145	UNIPROT	NFE2L2	protein	Q16236	UNIPROT	down-regulates	binding			9606									24997453	t		miannu	"Keap1 is an oxidative stress-sensing protein and is a negative regulator of nuclear factor-erythroid-2-related factor 2 (nrf2)."	0.818	SIGNOR-205229
SIGNOR-HT	"Hepatocellular Tumor"	PI3K	complex	SIGNOR-C156	SIGNOR	PIP3	smallmolecule	CHEBI:16618	ChEBI	"up-regulates quantity"	"chemical modification"			9606									12040186	t		lperfetto	"The activated PI3K converts the plasma membrane lipid phosphatidylinositol-4,5-bisphosphate [PI(4,5)P2] to phosphatidylinositol-3,4,5-trisphosphate [PI(3,4,5)P3]."	0.8	SIGNOR-252713
SIGNOR-HT	"Hepatocellular Tumor"	NQO1	protein	P15559	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606	BTO:0003934								28599455	f		irozzo	"The results demonstrated that NQO1 siRNA-mediated knockdown effectively impaired colony formation capacity, induced cell cycle arrest at the G1 phase and suppressed migration of KKU-100 cells."	0.7	SIGNOR-256265
SIGNOR-HT	"Hepatocellular Tumor"	NQO1	protein	P15559	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606	BTO:0000849								20226854	f		irozzo	"More importantly, our results also indicate that NF-kappaB p50 correlates with the expression of NQO1 and mediates its role in the proliferation of melanoma cells."	0.7	SIGNOR-256264
SIGNOR-HT	"Hepatocellular Tumor"	NFE2L2	protein	Q16236	UNIPROT	NQO1	protein	P15559	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			9606									8962164	f		irozzo	"These results indicated that hARE-mediated expression of the NQO1 gene and its induction by xenobiotics and antioxidants are mediated by Nrf1 and Nrf2."	0.49	SIGNOR-256279
SIGNOR-HT	"Hepatocellular Tumor"	NFE2L2	protein	Q16236	UNIPROT	HMOX1	protein	P09601	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			9606									24024136	t		irozzo	"In both models, the inducer-modified and Nrf2-bound Keap1 is inactivated and, consequently, newly synthesized Nrf2 proteins bypass Keap1 and translocate into the nucleus, bind to the ARE and drive the expression of Nrf2 target genes such as NAD(P)H quinone oxidoreductase 1 (NQO1), heme oxygenase 1 (HMOX1), glutamate-cysteine ligase (GCL) and glutathione S transferases (GSTs)."	0.687	SIGNOR-256276
SIGNOR-HT	"Hepatocellular Tumor"	NFE2L2	protein	Q16236	UNIPROT	GSTA1	protein	P08263	UNIPROT	"down-regulates quantity by repression"	"transcriptional regulation"			9606									22459801	f		miannu	"Different expression pattern of Nrf2 regulated genes in end-stage liver disease samples were observed: glutamate-cysteine ligase (GCLC) and glutathione-S-transferase A1 (GSTA1) were significantly down-regulated in most liver disease groups, whereas heme oxidase 1 (HMOX1) and NAD(P)H dehydrogenase [quinone] 1 (NQO1) were not significantly suppressed."	0.344	SIGNOR-254644
SIGNOR-HT	"Hepatocellular Tumor"	IGF2	protein	P01344	UNIPROT	IGF1R	protein	P08069	UNIPROT	"up-regulates activity"	binding			9606									22810696	t		lperfetto	"These results strongly suggest that the IGF2–IGF1R–IRS2 axis signals to PI3K in CRC and imply that therapeutic targeting of the pathway could act to block PI3K activity in this subset of patients."	0.825	SIGNOR-251495
SIGNOR-HT	"Hepatocellular Tumor"	IGF1R	protein	P08069	UNIPROT	PI3K	complex	SIGNOR-C156	SIGNOR	up-regulates	binding			9606									18595745	t		gcesareni	"Igf-1 activated both the pi3k and the extracellular signal-regulated kinase [?] (erk [?]) Pathways as evidenced by phosphorylation of either akt or erk1 [?]/2 (respectively)"	0.702	SIGNOR-252690
SIGNOR-HT	"Hepatocellular Tumor"	GAB1	protein	Q13480	UNIPROT	PI3K	complex	SIGNOR-C156	SIGNOR	up-regulates	binding			9606									11043767	t		lperfetto	"We have shown that gab1 colocalizes pi3k with sh2 domain-containing inositol phosphatase (ship) and shp2, two enzymes that regulate pi3k-dependent signaling. The src homology 2 (sh2) domain of the phosphatidylinositol 3-kinase (pi3k) regulatory subunit binds gab1 in a phosphorylation-independent manner. Moreover, the regulatory subunit of pi3k can mediate the association of gab1 and receptor protein-tyrosine kinases including the insulin, egf, and ngf receptors, all of which phosphorylate gab1."	0.515	SIGNOR-252676
SIGNOR-HT	"Hepatocellular Tumor"	MET	protein	P08581	UNIPROT	GAB1	protein	Q13480	UNIPROT	"up-regulates activity"	phosphorylation	Tyr627	KGDKQVEyLDLDLDS	9606	BTO:0000018								10734310	t		miannu	"Gab-1 is phosphorylated on the same residues by HGF and EGF receptors. Among 16 peptides only nine were phosphorylated by the EGF and HGF receptors, namely peptides containing the tyrosine residues 285, 307, 373, 407, 448, 473, 590, 628 and 660. we show that in the response to HGF or EGF, Gab1 is phosphorylated in vivo on the same residues. However, a sustained activation of signaling pathways downstream to Gab1 (as a result of its sustained phosphorylation) is achieved only in response to HGF."	0.677	SIGNOR-250289
SIGNOR-HT	"Hepatocellular Tumor"	MET	protein	P08581	UNIPROT	GRB2	protein	P62993	UNIPROT	"up-regulates activity"	binding			9606									22128289	t		irozzo	"For activation of the mitogen-activated protein kinase (MAPK) cascades, c-MET activation stimulates the activity of the rat sarcoma viral oncogene homolog (RAS) guanine nucleotide exchanger son of sevenless (SOS) via binding with SHC and GRB2 leading to the activation of RAS."	0.698	SIGNOR-256261
SIGNOR-HT	"Hepatocellular Tumor"	MET	protein	P08581	UNIPROT	GAB1	protein	Q13480	UNIPROT	"up-regulates activity"	phosphorylation	Tyr659	VADERVDyVVVDQQK	9606	BTO:0000018								10734310	t		miannu	"Gab-1 is phosphorylated on the same residues by HGF and EGF receptors. Among 16 peptides only nine were phosphorylated by the EGF and HGF receptors, namely peptides containing the tyrosine residues 285, 307, 373, 407, 448, 473, 590, 628 and 660. we show that in the response to HGF or EGF, Gab1 is phosphorylated in vivo on the same residues. However, a sustained activation of signaling pathways downstream to Gab1 (as a result of its sustained phosphorylation) is achieved only in response to HGF."	0.677	SIGNOR-250290
SIGNOR-HT	"Hepatocellular Tumor"	MET	protein	P08581	UNIPROT	GAB1	protein	Q13480	UNIPROT	"up-regulates activity"	phosphorylation	Tyr285	TEADGELyVFNTPSG	9606	BTO:0000018								10734310	t		miannu	"Gab-1 is phosphorylated on the same residues by HGF and EGF receptors. Among 16 peptides only nine were phosphorylated by the EGF and HGF receptors, namely peptides containing the tyrosine residues 285, 307, 373, 407, 448, 473, 590, 628 and 660. we show that in the response to HGF or EGF, Gab1 is phosphorylated in vivo on the same residues. However, a sustained activation of signaling pathways downstream to Gab1 (as a result of its sustained phosphorylation) is achieved only in response to HGF."	0.677	SIGNOR-250552
SIGNOR-HT	"Hepatocellular Tumor"	HMOX1	protein	P09601	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606	BTO:0000848								17148680	f		irozzo	"Here we investigated the effects of HO-1 overexpression in murine and human melanoma cells. The most important findings of our study are that 1) overexpression of HO-1 augments the proliferation [.]"	0.7	SIGNOR-256295
SIGNOR-HT	"Hepatocellular Tumor"	GSTA1	protein	P08263	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606	BTO:0000018								29928434	f		irozzo	"Accordingly, downregulation of GSTA1 suppressed tumor growth. In conclusion, GSTA1 plays an important role in regulation of cell proliferation and cell apoptosis in A549 cell line."	0.7	SIGNOR-256296
SIGNOR-HT	"Hepatocellular Tumor"	PDPK1	protein	O15530	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation	Thr308	KDGATMKtFCGTPEY	10090									12808134	t		lperfetto	"Akt1 and akt2 are phosphorylated and activated by the protein kinase pdk1 at thr-308 or thr-309, respectively, in the activation t-loop, and further activation occurs through phosphorylation at ser-473 or ser-474, respectively. In this paper, we demonstrate that this is indeed the case, and report the purification and initial characterization of a 3 phosphoinositide-dependent protein kinase, pdk1, which activates pkb by phosphorylating it at thr308. Akt is directly phosphorylated and activated by pdk1. Akt/pkb activation requires the phosphorylation of thr308 in the activation loop by the phosphoinositide-dependent kinase 1 (pdk1)."	0.746	SIGNOR-134477
SIGNOR-HT	"Hepatocellular Tumor"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									24743741	f			"Activation of PDGFRα stimulates proliferation of PDGFRα(+) cells through PI3K-Akt and MEK2-MAPK signaling pathways, and aberrant accumulation of PDGFRα(+) cells was conspicuous in muscles of patients with both genetic and non-genetic muscle diseases."	0.7	SIGNOR-254374
SIGNOR-HT	"Hepatocellular Tumor"	GRB2	protein	P62993	UNIPROT	SOS1	protein	Q07889	UNIPROT	"up-regulates activity"	relocalization			9606	BTO:0001412								10570290	t	"GRB2 associated guanine nucleotide exchange factor Sos activates Ras through the exchange of GDP for GTP"	lperfetto	"Grb2 binds and activates sos, which then activates ras, and this activates p110 independently of p85."	0.914	SIGNOR-236792
SIGNOR-HT	"Hepatocellular Tumor"	HGF	protein	P14210	UNIPROT	MET	protein	P08581	UNIPROT	up-regulates	binding			9606									8380735	t		gcesareni	"Hgf is the ligand for p190met, the receptor tyrosine kinase encoded by the met proto-oncogene."	0.929	SIGNOR-38429
SIGNOR-HT	"Hepatocellular Tumor"	PIP3	smallmolecule	CHEBI:16618	ChEBI	PDPK1	protein	O15530	UNIPROT	"up-regulates activity"	relocalization			9534									9637919	t		lperfetto	"In response to PDGF, binding of ptdlns (3,4,5)p3 and/or ptdlns(3,4)p2 to the PH domain of PDK-1 causes its translocation to the plasma membrane where it co-localises with PKB, significantly contributing to the scale of PKB activation."	0.8	SIGNOR-58313
SIGNOR-HT	"Hepatocellular Tumor"	PI3K	complex	SIGNOR-C156	SIGNOR	PIP3	smallmolecule	CHEBI:16618	ChEBI	"up-regulates quantity"	"chemical modification"			9606									24647478	t		lperfetto	"Stimulation of tyrosine kinase receptors initiates a signaling cascade that activates pi3k. Activated pi3k uses pip2 to generate pip3, 24647478"	0.8	SIGNOR-252712
SIGNOR-HT	"Hepatocellular Tumor"	PIP3	smallmolecule	CHEBI:16618	ChEBI	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	relocalization			9606		BTO:0001130							23633519	t		lperfetto	"Akt is a serine-threonine protein kinase that plays important roles in cell growth, proliferation and apoptosis. It is activated after binding to phosphatidylinositol phosphates pips) with phosphate groups at positions 3,4 and 3,4,5 on the inositol ring."	0.8	SIGNOR-236490
SIGNOR-HT	"Hepatocellular Tumor"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	Survival	phenotype	SIGNOR-PH13	SIGNOR	up-regulates				9606									16288293	f		miannu	"Akt promotes both cell growth and cell survival by inactivating its downstream substrates including GSK3, BAD, FOXO and TSC2."	0.7	SIGNOR-251550
SIGNOR-HT	"Hepatocellular Tumor"	BRAF	protein	P15056	UNIPROT	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	"up-regulates activity"	phosphorylation			9606									21900390	t		miannu	"BRAFV600E has been shown to initiate thyroid follicular cell transformation. The BRAFV600E mutation disrupts the hydrophobic interaction, enabling the BRAF kinase to fold into a catalytically active formation, resulting in an almost 500-fold increase in kinase activity. Mutant BRAF can dimerize and activate MEK without Ras activation."	0.787	SIGNOR-251988
SIGNOR-HT	"Hepatocellular Tumor"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									19819937	f			"In addition to the JAK2–STAT5 pathway, the Ras GTPase–extracellular signal-regulated kinase (Ras–ERK) pathway has also been implicated in signaling of IL-5 and is important for IL-5-dependent cell survival, proliferation and differentiation of eosinophils."	0.7	SIGNOR-254354
SIGNOR-HT	"Hepatocellular Tumor"	BRAF	protein	P15056	UNIPROT	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	"up-regulates activity"	phosphorylation			10090									8131746	t		lperfetto	"Activation of mek family kinases requires phosphorylation of two conserved ser/thr residueserine residues 218 and 222 of human mek1 are the primary sites for phosphorylation by c-raf."	0.787	SIGNOR-244827
SIGNOR-HT	"Hepatocellular Tumor"	SOS1	protein	Q07889	UNIPROT	HRAS	protein	P01112	UNIPROT	"up-regulates activity"	"guanine nucleotide exchange factor"			9606									23132018	t		lperfetto	"The enhancement of H-Ras GTP levels induced by oncogenic K-Ras was abrogated when the expression of endogenous Sos was suppressed, implicating Sos as an essential intermediate in the cross talk between oncogenic K-Ras and WT H-Ras."	0.892	SIGNOR-39237
SIGNOR-HT	"Hepatocellular Tumor"	PDPK1	protein	O15530	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation	Thr308	KDGATMKtFCGTPEY	9606									15718470	t		gcesareni	"Akt/PKB activation requires the phosphorylation of Thr308 in the activation loop by the phosphoinositide-dependent kinase 1 (PDK1) and Ser473 within the carboxyl-terminal hydrophobic motif by an unknown kinase."	0.746	SIGNOR-243203
SIGNOR-HT	"Hepatocellular Tumor"	HRAS	protein	P01112	UNIPROT	BRAF	protein	P15056	UNIPROT	up-regulates	binding			10090	BTO:0000944								7706312	t		lperfetto	"Association of B-Raf with immobilized Ras occurred independently of prior stimulation of cells with serum, suggesting that primarily the production of GTP-Ras by mitogen stimulation is critical for the formation of B-Raf_GTP-Ras complexes."	0.879	SIGNOR-235478
SIGNOR-HT	"Hepatocellular Tumor"	PDPK1	protein	O15530	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation			9606									15743829	t		lperfetto	"3-phosphoinositide-dependent kinase 1 (PDK1) phosphorylates the activation loop of a number of protein serine/threonine kinases of the AGC kinase superfamily, including protein kinase B (PKB; also called Akt),"	0.746	SIGNOR-244469
SIGNOR-HT	"Hepatocellular Tumor"	PIP3	smallmolecule	CHEBI:16618	ChEBI	PDPK1	protein	O15530	UNIPROT	"up-regulates activity"	"chemical activation"			9606									19951971	t		lperfetto	"PIP3 recruits PDK1 and AKT to the plasma membrane, where PDK1 phosphorylates AKT on Thr308 in the activation loop of the kinase domain."	0.8	SIGNOR-249628
SIGNOR-HT	"Hepatocellular Tumor"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				10090									20219869	f		areggio	"Furthermore, stimulation of myoblasts with CCL2, CCL3, or CCL4 was sufficient to induce phosphorylation and activation of ERK1/2. This outcome may be functionally important because ERK1/2 activation is a component of the pathway through which many mitogenic growth factors can stimulate cell proliferation."	0.7	SIGNOR-255120
SIGNOR-HT	"Hepatocellular Tumor"	PIP3	smallmolecule	CHEBI:16618	ChEBI	PDPK1	protein	O15530	UNIPROT	"up-regulates activity"	relocalization			9606									21798082	t		lperfetto	"Pip3 acts in turn as a docking site for two kinases, phosphoinositide-dependent kinase 1 (PDK1) and AKT, and the subsequent phosphorylation of AKT at serine 308 by PDK1, leading to AKT activation."	0.8	SIGNOR-175253
SIGNOR-HT	"Hepatocellular Tumor"	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	up-regulates	phosphorylation			9606									11971971	t		lperfetto	"Mapk1 is phosphorylated by map2k1/mek1 and map2k2/mek2 on thr-185 and tyr-187 in response to external stimuli like insulin or ngf. Both phosphorylations are required for activity."	0.758	SIGNOR-244776
SIGNOR-HT	"Hepatocellular Tumor"	HRAS	protein	P01112	UNIPROT	BRAF	protein	P15056	UNIPROT	up-regulates	binding			9606									18098337	t		lperfetto	"BRAF kinase is a downstream target of KRAS and activates the MAPK pathway."	0.879	SIGNOR-160043
SIGNOR-HT	"Hepatocellular Tumor"	TGFBR2	protein	P37173	UNIPROT	TGFBR1	protein	P36897	UNIPROT	"up-regulates activity"	phosphorylation	Thr200	LPLLVQRtIARTIVL	452646									7774578	t		lperfetto	"The tgf-beta type ii receptor (t beta r-ii) is a transmembrane serine/threonine kinase that, upon ligand binding, recruits and phosphorylates a second transmembrane kinase, t beta r-i, as a requirement for signal transduction.  In contrast to the relatively innocuous nature of single site mutations in the ttsgsgsg sequence, mutation of thr200 or 204 to valine causes marked losses in ligand-induced phosphorylation and signaling."	0.72	SIGNOR-32744
SIGNOR-HT	"Hepatocellular Tumor"	TGFBR2	protein	P37173	UNIPROT	TGFBR1	protein	P36897	UNIPROT	"up-regulates activity"	phosphorylation	Thr200	LPLLVQRtIARTIVL	-1									8576253	t		"giulio giuliani"	"From our present data, it is not easy to deduce the mechanistic significance of serine 172 and threonine 176 of TŒ≤R-I in TGF-Œ≤ signaling. Although it was reported that TGF-Œ≤-induced phosphorylation of these residues was not detected in vivo(22), it is still possible that TŒ≤R-II may phosphorylate these residues as minor phosphorylation site(s)."	0.72	SIGNOR-255962
SIGNOR-HT	"Hepatocellular Tumor"	TGFBR2	protein	P37173	UNIPROT	TGFBR1	protein	P36897	UNIPROT	"up-regulates activity"	phosphorylation	Ser172	SLDRPFIsEGTTLKD	9606									8576253	t		lperfetto	"Recent studies have revealed that upon TGF-beta binding several serine and threonine residues in the GS domain of TGF-beta type I receptor (T beta R-I) are phosphorylated by TGF-beta type II receptor (T beta R-II) and that the phosphorylation of GS domain is essential for TGF-beta signalingThese observations indicate that serine 172 and threonine 176 of T beta R-I are dispensable for extracellular matrix protein production but essential to the growth inhibition by TGF-beta"	0.72	SIGNOR-246728
SIGNOR-HT	"Hepatocellular Tumor"	TGFBR1	protein	P36897	UNIPROT	SMAD3	protein	P84022	UNIPROT	"up-regulates activity"	phosphorylation	Ser423	SPSIRCSsVS	10090	BTO:0005493;BTO:0000165								19458083	t		lperfetto	"A major event leading to smad3 activation is the tgf-beta-induced, tbetari-mediated phosphorylation at two c-terminal serine residues, ser-423 and ser-425, which triggers dissociation of smad3 from its receptors to form a complex with smad4 and accumulate in the nucleus"	0.816	SIGNOR-235385
SIGNOR-HT	"Hepatocellular Tumor"	TGFBR1	protein	P36897	UNIPROT	SMAD3	protein	P84022	UNIPROT	"up-regulates activity"	phosphorylation	Ser425	SIRCSSVs	10090	BTO:0005493;BTO:0000165								19458083	t		lperfetto	"A major event leading to Smad3 activation is the TGF-beta-induced, TbetaRI-mediated phosphorylation at two C-terminal serine residues, Ser-423 and Ser-425, which triggers dissociation of Smad3 from its receptors to form a complex with Smad4 and accumulate in the nucleus"	0.816	SIGNOR-235380
SIGNOR-HT	"Hepatocellular Tumor"	TGFBR1	protein	P36897	UNIPROT	SMAD2	protein	Q15796	UNIPROT	"up-regulates activity"	phosphorylation	Ser467	SVRCSSMs	9534									9346908	t		lperfetto	"Recently, it was demonstrated that Smad2 interacts transiently with and is a direct substrate of the transforming growth factor-beta (TGF-beta) type I receptor, TbetaRI. Phosphorylation sites on Smad2 were localized to a carboxyl-terminal fragment containing three serine residues at positions 464, 465, and 467.   These results indicate that receptor-dependent phosphorylation of Smad2 on serines 465 and 467 is required in mammalian cells to permit association with Smad4 and to propagate TGF-_ signals."	0.828	SIGNOR-235995
SIGNOR-HT	"Hepatocellular Tumor"	TGFBR2	protein	P37173	UNIPROT	TGFBR1	protein	P36897	UNIPROT	"up-regulates activity"	phosphorylation	Thr176	PFISEGTtLKDLIYD	9606									8576253	t		lperfetto	"Recent studies have revealed that upon TGF-beta binding several serine and threonine residues in the GS domain of TGF-beta type I receptor (T beta R-I) are phosphorylated by TGF-beta type II receptor (T beta R-II) and that the phosphorylation of GS domain is essential for TGF-beta signalingThese observations indicate that serine 172 and threonine 176 of T beta R-I are dispensable for extracellular matrix protein production but essential to the growth inhibition by TGF-beta"	0.72	SIGNOR-246732
SIGNOR-HT	"Hepatocellular Tumor"	AP1	complex	SIGNOR-C154	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									9878062	f		lperfetto	"AP‐1 proteins, including c‐Fos and c‐Jun, are prominent nuclear targets of growth factor induced signaling, making AP‐1 a candidate nuclear effector of growth factor induced proliferation."	0.7	SIGNOR-252356
SIGNOR-LBC	"Luminal Breast Cancer"	FGFR1	protein	P11362	UNIPROT	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	up-regulates				9606									12270934	f		lperfetto	"Fibroblast growth factor-2 (FGF-2), in the presence of dexamethasone, isobutylmethylxanthine, and insulin, induces a prolonged activation of the MEK/ERK signaling pathway, which lasts for at least 12 h post-induction, and this activity is less sensitive to the MEK inhibitors"	0.31	SIGNOR-244865
SIGNOR-LBC	"Luminal Breast Cancer"	FGFR1	protein	P11362	UNIPROT	FRS2	protein	Q8WU20	UNIPROT	"up-regulates activity"	phosphorylation			10116	BTO:0002809								9182757	t		fspada	"In this report, we demonstrate that FGF stimulation induces tyrosine phosphorylation of a novel lipid anchored docking protein, termed FRS2, that forms a complex with Grb2/Sos, thus linking FGF-receptor activation to the Ras/MAPK signaling pathway."	0.868	SIGNOR-236944
SIGNOR-LBC	"Luminal Breast Cancer"	FRS2	protein	Q8WU20	UNIPROT	GRB2	protein	P62993	UNIPROT	"up-regulates activity"	binding			10116	BTO:0002809								9182757	t		fspada	"In this report, we demonstrate that FGF stimulation induces tyrosine phosphorylation of a novel lipid anchored docking protein, termed FRS2, that forms a complex with Grb2/Sos, thus linking FGF-receptor activation to the Ras/MAPK signaling pathway."	0.805	SIGNOR-236953
SIGNOR-LBC	"Luminal Breast Cancer"	GRB2	protein	P62993	UNIPROT	SOS1	protein	Q07889	UNIPROT	"up-regulates activity"	relocalization			10090	BTO:0000669								23452850	t	"GRB2 associated guanine nucleotide exchange factor Sos activates Ras through the exchange of GDP for GTP"	lperfetto	"Interaction domains of sos1/grb2 are finely tuned for cooperative control of embryonic stem cell fate."	0.914	SIGNOR-235773
SIGNOR-LBC	"Luminal Breast Cancer"	GRB2	protein	P62993	UNIPROT	SOS1	protein	Q07889	UNIPROT	"up-regulates activity"	relocalization			9606									8479541	t	"GRB2 associated guanine nucleotide exchange factor Sos activates Ras through the exchange of GDP for GTP"	lperfetto	"Furthermore, our results indicate that the interaction domains of sos1 and grb2 have evolved so as to bind ligands not with maximal strength but with specificities and affinities that maintain cooperativity. Grb2 binds and activates sos, which then activates ras, and this activates p110 independently of p85."	0.914	SIGNOR-39163
SIGNOR-LBC	"Luminal Breast Cancer"	GRB2	protein	P62993	UNIPROT	SOS1	protein	Q07889	UNIPROT	"up-regulates activity"	relocalization			9606	BTO:0001412								10570290	t	"GRB2 associated guanine nucleotide exchange factor Sos activates Ras through the exchange of GDP for GTP"	lperfetto	"Grb2 binds and activates sos, which then activates ras, and this activates p110 independently of p85."	0.914	SIGNOR-236792
SIGNOR-LBC	"Luminal Breast Cancer"	INSR	protein	P06213	UNIPROT	IRS1	protein	P35568	UNIPROT	"up-regulates activity"	phosphorylation	Tyr1229	SSEDLSAyASISFQK	10029	BTO:0000246								7651388	t		lperfetto	"Therefore, during insulin stimulation irs-1 undergoes tyrosine phosphorylation, and a portion of tyrosine phosphorylated irs-1 associated with the insulin receptor. The insulin receptor substrate-1 (irs-1) is rapidly phosphorylated on several tyrosine residues by the activated insulin receptor. Insulin signals are mediated through tyrosine phosphorylation of specific proteins such as insulin receptor substrate 1 (irs-1) and shc by the activated insulin receptor (ir)."	0.914	SIGNOR-236752
SIGNOR-LBC	"Luminal Breast Cancer"	INSR	protein	P06213	UNIPROT	IRS1	protein	P35568	UNIPROT	"up-regulates activity"	phosphorylation	Tyr1229	SSEDLSAyASISFQK	9606	BTO:0000443								12220227	t		lperfetto	"Here we show that stimulation by insulin of freshly isolated primary adipocytes resulted in the expected rapid tyrosine phosphorylation of the insulin receptor, IRS-1 and IRS-3. Inhibition of PI 3-kinase enhanced the insulin-stimulated phosphorylation of IRS-1 on (i) Tyr(612) and Tyr(941) (p85 binding sites), concomitant with an increased association of the p85 subunit of PI 3-kinase; (ii) Tyr(896) (a Grb2 binding site); and (iii) Tyr(1229) (an SHP-2 binding site), although little or no binding of SHP-2 to IRS-1 was detectable under any conditions."	0.914	SIGNOR-235983
SIGNOR-LBC	"Luminal Breast Cancer"	INSR	protein	P06213	UNIPROT	IRS1	protein	P35568	UNIPROT	"up-regulates activity"	phosphorylation	Tyr612	TLHTDDGyMPMSPGV	10029	BTO:0000246								7651388	t		lperfetto	"Therefore, during insulin stimulation irs-1 undergoes tyrosine phosphorylation, and a portion of tyrosine phosphorylated irs-1 associated with the insulin receptor. The insulin receptor substrate-1 (irs-1) is rapidly phosphorylated on several tyrosine residues by the activated insulin receptor. Insulin signals are mediated through tyrosine phosphorylation of specific proteins such as insulin receptor substrate 1 (irs-1) and shc by the activated insulin receptor (ir)."	0.914	SIGNOR-236756
SIGNOR-LBC	"Luminal Breast Cancer"	INSR	protein	P06213	UNIPROT	IRS1	protein	P35568	UNIPROT	"up-regulates activity"	phosphorylation	Tyr612	TLHTDDGyMPMSPGV	10116									11416002	t		lperfetto	"All known IRS proteins contain multiple YXXM motifs that upon phosphorylation by activated insulin re- ceptors Tyr(612) and Tyr(632) in human insulin receptor substrate-1 are important for full activation of insulin-stimulated phosphatidylinositol 3-kinase activity and translocation of GLUT4 in adipose cells"	0.914	SIGNOR-235971
SIGNOR-LBC	"Luminal Breast Cancer"	INSR	protein	P06213	UNIPROT	IRS1	protein	P35568	UNIPROT	"up-regulates activity"	phosphorylation	Tyr632	GRKGSGDyMPMSPKS	10029	BTO:0000246								7651388	t		lperfetto	"Therefore, during insulin stimulation irs-1 undergoes tyrosine phosphorylation, and a portion of tyrosine phosphorylated irs-1 associated with the insulin receptor. The insulin receptor substrate-1 (irs-1) is rapidly phosphorylated on several tyrosine residues by the activated insulin receptor. Insulin signals are mediated through tyrosine phosphorylation of specific proteins such as insulin receptor substrate 1 (irs-1) and shc by the activated insulin receptor (ir)."	0.914	SIGNOR-236741
SIGNOR-LBC	"Luminal Breast Cancer"	INSR	protein	P06213	UNIPROT	IRS1	protein	P35568	UNIPROT	"up-regulates activity"	phosphorylation	Tyr632	GRKGSGDyMPMSPKS	10116									11416002	t		lperfetto	"All known IRS proteins contain multiple YXXM motifs that upon phosphorylation by activated insulin re- ceptors Tyr(612) and Tyr(632) in human insulin receptor substrate-1 are important for full activation of insulin-stimulated phosphatidylinositol 3-kinase activity and translocation of GLUT4 in adipose cells"	0.914	SIGNOR-236709
SIGNOR-LBC	"Luminal Breast Cancer"	INSR	protein	P06213	UNIPROT	IRS1	protein	P35568	UNIPROT	"up-regulates activity"	phosphorylation	Tyr896	EPKSPGEyVNIEFGS	10029	BTO:0000246								7651388	t		lperfetto	"Therefore, during insulin stimulation irs-1 undergoes tyrosine phosphorylation, and a portion of tyrosine phosphorylated irs-1 associated with the insulin receptor. The insulin receptor substrate-1 (irs-1) is rapidly phosphorylated on several tyrosine residues by the activated insulin receptor. Insulin signals are mediated through tyrosine phosphorylation of specific proteins such as insulin receptor substrate 1 (irs-1) and shc by the activated insulin receptor (ir)."	0.914	SIGNOR-236745
SIGNOR-LBC	"Luminal Breast Cancer"	INSR	protein	P06213	UNIPROT	IRS1	protein	P35568	UNIPROT	"up-regulates activity"	phosphorylation	Tyr941	EETGTEEyMKMDLGP	10116	BTO:0000443								7651388	t		lperfetto	"All known IRS proteins contain multiple YXXM motifs that upon phosphorylation by activated insulin receptors A previous study using phosphopeptides suggested that tyrosine-phosphorylated YXXM motifs at positions 608 and 939 in rat IRS-1 bind with high affinity to SH2 domains of p85, and motifs at positions 460 and 987 bind with lower affinity (10)."	0.914	SIGNOR-235975
SIGNOR-LBC	"Luminal Breast Cancer"	INSR	protein	P06213	UNIPROT	IRS1	protein	P35568	UNIPROT	"up-regulates activity"	phosphorylation	Tyr989	VPSSRGDyMTMQMSC	10116	BTO:0000443								7651388	t		lperfetto	"All known IRS proteins contain multiple YXXM motifs that upon phosphorylation by activated insulin receptors A previous study using phosphopeptides suggested that tyrosine-phosphorylated YXXM motifs at positions 608 and 939 in rat IRS-1 bind with high affinity to SH2 domains of p85, and motifs at positions 460 and 987 bind with lower affinity (10)."	0.914	SIGNOR-235979
SIGNOR-LBC	"Luminal Breast Cancer"	INSR	protein	P06213	UNIPROT	IRS1	protein	P35568	UNIPROT	"up-regulates activity"	phosphorylation	Tyr465	GEEELSNyICMGGKG	10116									7651388	t		lperfetto	"All known IRS proteins contain multiple YXXM motifs that upon phosphorylation by activated insulin receptors A previous study using phosphopeptides suggested that tyrosine-phosphorylated YXXM motifs at positions 608 and 939 in rat IRS-1 bind with high affinity to SH2 domains of p85, and motifs at positions 460 and 987 bind with lower affinity (10)."	0.914	SIGNOR-236713
SIGNOR-LBC	"Luminal Breast Cancer"	INSR	protein	P06213	UNIPROT	IRS1	protein	P35568	UNIPROT	"up-regulates activity"	phosphorylation	Tyr896	EPKSPGEyVNIEFGS	9606									12220227	t		lperfetto	"Here we show that stimulation by insulin of freshly isolated primary adipocytes resulted in the expected rapid tyrosine phosphorylation of the insulin receptor, IRS-1 and IRS-3. Inhibition of PI 3-kinase enhanced the insulin-stimulated phosphorylation of IRS-1 on (i) Tyr(612) and Tyr(941) (p85 binding sites), concomitant with an increased association of the p85 subunit of PI 3-kinase; (ii) Tyr(896) (a Grb2 binding site); and (iii) Tyr(1229) (an SHP-2 binding site), although little or no binding of SHP-2 to IRS-1 was detectable under any conditions."	0.914	SIGNOR-236725
SIGNOR-LBC	"Luminal Breast Cancer"	IRS1	protein	P35568	UNIPROT	PIK3CA	protein	P42336	UNIPROT	"up-regulates activity"	binding			9606									20966354	t		lperfetto	"Irs proteins are capable of both regulating and activating pi3k, depending on the cell of origin."	0.724	SIGNOR-168985
SIGNOR-LBC	"Luminal Breast Cancer"	IRS1	protein	P35568	UNIPROT	GRB2	protein	P62993	UNIPROT	"up-regulates activity"	binding			9606	BTO:0000156								11259577	t		lperfetto	"Association ofinsulinreceptor substrate 1 (irs-1) y895 with grb-2 mediates theinsulinsignaling involved in irs-1-deficient brown adipocyte mitogenesis."	0.806	SIGNOR-236614
SIGNOR-LBC	"Luminal Breast Cancer"	JUN	protein	P05412	UNIPROT	CYP19A1	protein	P11511	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			9606	BTO:0001555								19022561	f		miannu	"We found that both SF1 and LRH1 can transcriptionally cooperate with the AP-1 family members c-JUN and c-FOS, known to be associated with enhanced proliferation of endometrial carcinoma cells, to further enhance activation of the STAR, HSD3B2, and CYP19A1 PII promoters."	0.343	SIGNOR-254876
SIGNOR-LBC	"Luminal Breast Cancer"	JUN	protein	P05412	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									9878062	f		lperfetto	"Functional data suggest that c-Jun is not merely a target for activation by many of the extracellular stimuli, but that it plays a role in mediating the cellular response. In the case of growth control, three lines of evidence suggest that the transcription factor AP-1, which is composed of FosJun and JunJun dimers, mediates cell proliferation in response to external growth signals in the form of peptide growth factors."	0.7	SIGNOR-233467
SIGNOR-LBC	"Luminal Breast Cancer"	KRAS	protein	P01116	UNIPROT	BRAF	protein	P15056	UNIPROT	"up-regulates activity"	binding			9606									21779497	t		miannu	"The raf family of proteins (raf-1, a-raf, and b-raf) is serine/threonine kinases that bind to the effector region of ras-gtp, thus inducing translocation of the protein to the plasma membrane. Once there, raf proteins are activated and phosphorylated by different protein kinases."	0.878	SIGNOR-156906
SIGNOR-LBC	"Luminal Breast Cancer"	KRAS	protein	P01116	UNIPROT	PIK3CA	protein	P42336	UNIPROT	up-regulates	binding			9606									21779497	t		gcesareni	"Grb2 binds and activates sos, which then activates ras, and this activates p110 independently of p85./it was also described that ras interacts with pi3k in a direct manner./lysine residue 227 is essential for the interaction of ras with pi3k phosphatidylinositol 3-kinase (pi3k) is one of the main effector pathways of ras, regulating cell growth, cell cycle entry, cell survival, cytoskeleton reorganization, and metabolism."	0.911	SIGNOR-175204
SIGNOR-LBC	"Luminal Breast Cancer"	MDM2	protein	Q00987	UNIPROT	TP53	protein	P04637	UNIPROT	"down-regulates quantity by destabilization"	ubiquitination			9606									23150757	t		lperfetto	"Dual Roles of MDM2 in the Regulation of p53: Ubiquitination Dependent and Ubiquitination Independent Mechanisms of MDM2 Repression of p53 Activity"	0.968	SIGNOR-199371
SIGNOR-LBC	"Luminal Breast Cancer"	MDM2	protein	Q00987	UNIPROT	TP53	protein	P04637	UNIPROT	"down-regulates quantity by destabilization"	ubiquitination			9606									10935507	t		lperfetto	"Many posttranslational modifications of p53, such as phosphorylation, dephosphorylation, acetylation and ribosylation, have been shown to occur following cellular stress. Some of these modifications may activate the p53 protein, interfere with MDM2 binding and/or dictate cellular localization of p53."	0.968	SIGNOR-80528
SIGNOR-LBC	"Luminal Breast Cancer"	MDM2	protein	Q00987	UNIPROT	TP53	protein	P04637	UNIPROT	"down-regulates quantity by destabilization"	ubiquitination			9606									22337874	t		lperfetto	"The E3 ubiquitin ligase, MDM2, uses a dual-site mechanism to ubiquitinate and degrade the tumor suppressor protein p53, involving interactions with the N-terminal hydrophobic pocket and the acidic domain of MDM2."	0.968	SIGNOR-196116
SIGNOR-LBC	"Luminal Breast Cancer"	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	"up-regulates activity"	phosphorylation			10090									11730323	t			"Raf proteins have been shown to phosphorylate and activate MAPKKs (MAP kinase kinases) called MEKs (MAPK or ERK kinases) which in turn phosphorylate and activate MAPKs (MAP kinases) called ERKs"	0.758	SIGNOR-258989
SIGNOR-LBC	"Luminal Breast Cancer"	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	up-regulates	phosphorylation			9606									11971971	t		lperfetto	"Mapk1 is phosphorylated by map2k1/mek1 and map2k2/mek2 on thr-185 and tyr-187 in response to external stimuli like insulin or ngf. Both phosphorylations are required for activity."	0.758	SIGNOR-244776
SIGNOR-LBC	"Luminal Breast Cancer"	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	IRS1	protein	P35568	UNIPROT	down-regulates	phosphorylation	Ser307	TRRSRTEsITATSPA	9606		BTO:0000887							11160134	t		lperfetto	"Thus, at least three kinases mediate phosphorylation of ser307, including jnk, serine kinases in the pi 3-kinase cascade that are activated byinsulinor igf-1, and mek1-sensitive kinase cascades during tnf-alfa stimulation."	0.2	SIGNOR-244784
SIGNOR-LBC	"Luminal Breast Cancer"	mTORC1	complex	SIGNOR-C3	SIGNOR	Cell_growth	phenotype	SIGNOR-PH33	SIGNOR	up-regulates				9606									23863160	f		lperfetto	"Cellular energy and nutrient status will dictate whether mTORC1 takes over and drives cell growth or conversely whether AMPK becomes active once again to drive consecutive waves of autophagy thorough ULK1."	0.7	SIGNOR-209919
SIGNOR-LBC	"Luminal Breast Cancer"	mTORC1	complex	SIGNOR-C3	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606		BTO:0000007							20508131	f			"The mammalian target of rapamycin complex 1 (mTORC1) integrates mitogen and nutrient signals to control cell proliferation and cell size."	0.7	SIGNOR-256063
SIGNOR-LBC	"Luminal Breast Cancer"	mTORC1	complex	SIGNOR-C3	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606		BTO:0001103							15829723	f		apalma	"Phosphorylation of mTOR by Akt leads to mTOR activation (40, 52) and the subsequent activation of p70S6K (47). This latter event has great potential importance for the promotion of muscle growth by the IGF-I/Akt/mTOR pathway, because p70S6k is a potent stimulator of protein synthesis that can be activated by increases in muscle contraction"	0.7	SIGNOR-256064
SIGNOR-LBC	"Luminal Breast Cancer"	PDPK1	protein	O15530	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation			9606									15743829	t		lperfetto	"3-phosphoinositide-dependent kinase 1 (PDK1) phosphorylates the activation loop of a number of protein serine/threonine kinases of the AGC kinase superfamily, including protein kinase B (PKB; also called Akt),"	0.746	SIGNOR-244469
SIGNOR-LBC	"Luminal Breast Cancer"	PDPK1	protein	O15530	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation	Thr308	KDGATMKtFCGTPEY	10090									12808134	t		lperfetto	"Akt1 and akt2 are phosphorylated and activated by the protein kinase pdk1 at thr-308 or thr-309, respectively, in the activation t-loop, and further activation occurs through phosphorylation at ser-473 or ser-474, respectively. In this paper, we demonstrate that this is indeed the case, and report the purification and initial characterization of a 3 phosphoinositide-dependent protein kinase, pdk1, which activates pkb by phosphorylating it at thr308. Akt is directly phosphorylated and activated by pdk1. Akt/pkb activation requires the phosphorylation of thr308 in the activation loop by the phosphoinositide-dependent kinase 1 (pdk1)."	0.746	SIGNOR-134477
SIGNOR-LBC	"Luminal Breast Cancer"	PDPK1	protein	O15530	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation	Thr308	KDGATMKtFCGTPEY	10116		BTO:0000142							10226025	t		lperfetto	"Protein kinase B (PKB) is activated by phosphorylation of Thr308 and of Ser473. Thr308 is phosphorylated by the 3-phosphoinositide-dependent protein kinase-1 (PDK1) but the identity of the kinase that phosphorylates Ser473 (provisionally termed PDK2) is unknown."	0.746	SIGNOR-244421
SIGNOR-LBC	"Luminal Breast Cancer"	PDPK1	protein	O15530	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation	Thr308	KDGATMKtFCGTPEY	9606									15718470	t		gcesareni	"Akt/PKB activation requires the phosphorylation of Thr308 in the activation loop by the phosphoinositide-dependent kinase 1 (PDK1) and Ser473 within the carboxyl-terminal hydrophobic motif by an unknown kinase."	0.746	SIGNOR-243203
SIGNOR-LBC	"Luminal Breast Cancer"	PDPK1	protein	O15530	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation	Thr308	KDGATMKtFCGTPEY	9606		BTO:0000887;BTO:0001103;BTO:0001760							9512493	t		lperfetto	"The activation of PKBbeta and PKBamma by PDK11 was accompanied by the phosphorylation of the residues equivalent to Thr308 in PKBalpha, namely Thr309 (PKBbeta) and Thr305 (PKBgamma)"	0.746	SIGNOR-244480
SIGNOR-LBC	"Luminal Breast Cancer"	PDPK1	protein	O15530	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	up-regulates	phosphorylation			9606									21798082	t		lperfetto	"Positive feedback involves mtorc2, which phosphorylates akt at serine 473, a phosphorylation required for maximum activation of akt in addition to phosphorylation at threonine 308 by pdk1."	0.746	SIGNOR-244396
SIGNOR-LBC	"Luminal Breast Cancer"	PDPK1	protein	O15530	UNIPROT	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	"up-regulates activity"	phosphorylation			9606	BTO:0000007								15175348	t		lperfetto	"In vitro kinase assay revealed that the direct targets of pdk1 in the mapk pathway were the upstream mapk kinases mek1 and mek2. The identified pdk1 phosphorylation sites in mek1 and mek2 are ser222 and ser226, respectively, and are known to be essential for full activation"	0.272	SIGNOR-244934
SIGNOR-LBC	"Luminal Breast Cancer"	PDPK1	protein	O15530	UNIPROT	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	up-regulates	phosphorylation			9606									15175348	t		lperfetto	"The identified pdk1 phosphorylation sites in mek1 and mek2 are ser222 and ser226, respectively, and are known to be essential for full activation."	0.272	SIGNOR-244938
SIGNOR-LBC	"Luminal Breast Cancer"	PIK3CA	protein	P42336	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"				9606		BTO:0000150							19573809	f		lperfetto	"However, here we show through phosphoprotein profiling and functional genomic studies that many PIK3CA mutant cancer cell lines and human breast tumors exhibit only minimal AKT activation and a diminished reliance on AKT for anchorage-independent growth"	0.821	SIGNOR-236436
SIGNOR-LBC	"Luminal Breast Cancer"	PIK3CA	protein	P42336	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation			9606									12167717	t		lperfetto	"PKB induction requires phosphorylation of two critical residues, threonine 308 in the activation loop and serine 473 near the carboxyl terminus. Membrane localization of PKB was found to be a primary determinant of serine 473 phosphorylation. PI3K activity was equally important for promoting phosphorylation of serine 473,"	0.821	SIGNOR-244429
SIGNOR-LBC	"Luminal Breast Cancer"	PIK3CA	protein	P42336	UNIPROT	IRS1	protein	P35568	UNIPROT	"down-regulates activity"				9606									11160134	f		lperfetto	"Ly294002 or wortmannin were used to determine whether pi 3-kinasedependent pathways mediate ser307 phosphorylation during insulin/igf-1 or TNF-alpha Stimulation. As expected, the pi-3 kinase inhibitors ly294002 or wortmannin inhibited activation of pkb/akt in insulin or igf-1 stimulated 3t3-l1 preadipocytes, but were without effect on erk1/2.  these results suggest that elements of the pi 3-kinase cascade mediate insulin/igf-1stimulated phosphorylation of ser307"	0.724	SIGNOR-104911
SIGNOR-LBC	"Luminal Breast Cancer"	PIK3CA	protein	P42336	UNIPROT	Survival	phenotype	SIGNOR-PH13	SIGNOR	up-regulates				9534	BTO:0004055								14665640	f		lperfetto	"Signal transduction pathways triggered by Tie2 have been extensively examined. Tyr-1101of Tie2 directly associates in a phosphotyrosine (pTyr)-dependent manner with the p85 regulatory subunit of phosphatidylinositol (PI) 3-kinase, which in turn activate PI 3-kinase, leading to cell motility and survival"	0.7	SIGNOR-242649
SIGNOR-LBC	"Luminal Breast Cancer"	PTEN	protein	P60484	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"down-regulates activity"				9606	BTO:0001271								20596030	f		lperfetto	"Exposure of eol-1r cells to imatinib failed to dephosphorylate akt, erk and stat5, although pdgfralpha was effectively inactivated. The forced expression of pten negatively regulated these signal pathways and sensitized eol-1r cells to imatinib."	0.633	SIGNOR-166478
SIGNOR-LBC	"Luminal Breast Cancer"	PTEN	protein	P60484	UNIPROT	PIK3CA	protein	P42336	UNIPROT	"down-regulates activity"				9606									18794881	f		lperfetto	"The pten tumour suppressor is a lipid and protein phosphatase that inhibits phosphoinositide 3-kinase (pi3k)-dependent by dephosphorylating phosphatidylinositol 3,4,5-trisphosphate (ptdinsp(3))."	0.738	SIGNOR-209856
SIGNOR-LBC	"Luminal Breast Cancer"	PTEN	protein	P60484	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"down-regulates activity"				9606	BTO:0001332								19903340	f		lperfetto	"PTEN-mediated suppression of the PI3K/AKT pathway is well established, accumulating evidence suggests that nuclear PTEN also plays a critical role in tumor suppression"	0.633	SIGNOR-244439
SIGNOR-LBC	"Luminal Breast Cancer"	RB1	protein	P06400	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	down-regulates				9606									21524151	f		miannu	"Consistent with this, the magnitude of the response (i.e. the fraction of cells undergoing arrest) appears to diminish the closer the cells are to the time of S-phase entry. The existence of a time gap between full pRb phosphorylation and S-phase entry is also consistent with the notion that E2F, once released from pRb, transcriptionally activates factors needed for S-phase entry, a process which likely requires a significant amount of time."	0.7	SIGNOR-262533
SIGNOR-LBC	"Luminal Breast Cancer"	RB1	protein	P06400	UNIPROT	E2F1	protein	Q01094	UNIPROT	"down-regulates activity"	binding			9606									8255752	t		amattioni	"E2f binds rb. E2f activation domain is the target for rb-induced repression. Rb can silence the 57 residue e2f activation domain. Rb can mask e2f residues involved in the activation process, possibly by mimicking a component of the transcriptional machinery"	0.92	SIGNOR-37305
SIGNOR-LBC	"Luminal Breast Cancer"	RB1	protein	P06400	UNIPROT	G1/S_transition	phenotype	SIGNOR-PH50	SIGNOR	down-regulates				9606									21524151	f		lperfetto	"In its hypophosphorylated state, pRb binds transcription factors of the E2F family which are required for cell cycle progression. As the level of CyclinD/Cdk4/6 complexes increases, pRb becomes phosphorylated and progression through G1 occurs. At a critical level of phosphorylation, E2F is released from pRb. This activates the transcription of CyclinE which complexes with Cdk2 to fully release pRb repression by further phosphorylation, establishing a positive feedback loop. E2F further promotes the transcription of S-phase genes. Thus, CyclinD/Cdk4/6 and CyclinE/Cdk2 together regulate S-phase entry via phosphorylating pRb, which controls pRb binding to E2F"	0.7	SIGNOR-245483
SIGNOR-LBC	"Luminal Breast Cancer"	RHEB	protein	Q15382	UNIPROT	mTORC1	complex	SIGNOR-C3	SIGNOR	"up-regulates activity"				10090	BTO:0000011								19299511	t		lperfetto	"These results suggest that Rheb induces alteration in the binding of 4E-BP1 with mTORC1 to regulate mTORC1 activation."	0.802	SIGNOR-235355
SIGNOR-LBC	"Luminal Breast Cancer"	RHEB	protein	Q15382	UNIPROT	mTORC1	complex	SIGNOR-C3	SIGNOR	"up-regulates activity"				9606									19222999	t		lperfetto	"Recent studies document that Rheb activates mTORC1 via direct, GTP-dependent interaction with the peptidyl-prolyl-cis/trans-isomerase FKBP38, which is proposed to act as an inhibitor of mTORC1."	0.802	SIGNOR-232208
SIGNOR-LBC	"Luminal Breast Cancer"	SOS1	protein	Q07889	UNIPROT	KRAS	protein	P01116	UNIPROT	up-regulates	"guanine nucleotide exchange factor"			9606									25624485	t	"Ras proteins bind GDP/GTP and possess intrinsic GTPase activity."	gcesareni	"Because the KRAS-GDP to KRAS-GTP transition catalyzed by the GEF, son of sevenless 1 (SOS1), represents the rate-limiting step for nucleotide exchange, disrupting the activating SOS1/KRAS protein interaction has also been the focus of drug development efforts"	0.829	SIGNOR-122075
SIGNOR-LBC	"Luminal Breast Cancer"	SOS1	protein	Q07889	UNIPROT	KRAS	protein	P01116	UNIPROT	up-regulates	"guanine nucleotide exchange factor"			9606									25624485	t	"Ras proteins bind GDP/GTP and possess intrinsic GTPase activity."	gcesareni	"Because the KRAS-GDP to KRAS-GTP transition catalyzed by the GEF, son of sevenless 1 (SOS1), represents the rate-limiting step for nucleotide exchange, disrupting the activating SOS1/KRAS protein interaction has also been the focus of drug development efforts"	0.829	SIGNOR-141647
SIGNOR-LBC	"Luminal Breast Cancer"	SOS1	protein	Q07889	UNIPROT	KRAS	protein	P01116	UNIPROT	up-regulates	"guanine nucleotide exchange factor"			9606									25624485	t	"Ras proteins bind GDP/GTP and possess intrinsic GTPase activity."	gcesareni	"Because the KRAS-GDP to KRAS-GTP transition catalyzed by the GEF, son of sevenless 1 (SOS1), represents the rate-limiting step for nucleotide exchange, disrupting the activating SOS1/KRAS protein interaction has also been the focus of drug development efforts"	0.829	SIGNOR-175256
SIGNOR-LBC	"Luminal Breast Cancer"	SOS1	protein	Q07889	UNIPROT	KRAS	protein	P01116	UNIPROT	up-regulates	"guanine nucleotide exchange factor"			9606									25624485	t	"Ras proteins bind GDP/GTP and possess intrinsic GTPase activity."	gcesareni	"Because the KRAS-GDP to KRAS-GTP transition catalyzed by the GEF, son of sevenless 1 (SOS1), represents the rate-limiting step for nucleotide exchange, disrupting the activating SOS1/KRAS protein interaction has also been the focus of drug development efforts"	0.829	SIGNOR-201703
SIGNOR-LBC	"Luminal Breast Cancer"	TP53	protein	P04637	UNIPROT	MDM2	protein	Q00987	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			10090									7958853	f		gcesareni	"The p53 tumor suppressor protein trans-activates mdm2 itself, which is therefore considered a component of a p53 negative feedback loop."	0.968	SIGNOR-34962
SIGNOR-LBC	"Luminal Breast Cancer"	TP53	protein	P04637	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	down-regulates				9606	BTO:0000452								7667317	f			"P53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts"	0.7	SIGNOR-255669
SIGNOR-LBC	"Luminal Breast Cancer"	TSC	complex	SIGNOR-C101	SIGNOR	RHEB	protein	Q15382	UNIPROT	"down-regulates activity"	"gtpase-activating protein"			9606									15340059	t		lperfetto	"Tsc2 functions as a gap to inhibit rheb activity. Tsc2 displays gap (gtpase-activating protein) activity specifically towards the small g protein rheb and inhibits its ability to stimulate the mtor signaling pathway. It has recently been shown that tsc2 has gtpase-activating protein (gap) activity towards the ras family small gtpase rheb (ras homolog enriched in brain), and tsc1/2 antagonizes the mtor signaling pathway via stimulation of gtp hydrolysis of rheb."	0.918	SIGNOR-235895
SIGNOR-LBC	"Luminal Breast Cancer"	TSC	complex	SIGNOR-C101	SIGNOR	mTORC1	complex	SIGNOR-C3	SIGNOR	"down-regulates activity"				9606	BTO:0000007;BTO:0001938								12271141	f		lperfetto	"These findings strongly implicate the tuberin-hamartin tumor suppressor complex as an inhibitor of mtor"	0.627	SIGNOR-251527
SIGNOR-LBC	"Luminal Breast Cancer"	FGF1	protein	P05230	UNIPROT	FGFR1	protein	P11362	UNIPROT	up-regulates	binding			9606									11030354	t		lperfetto	"Crystal structure of a ternary fgf-fgfr-heparin complex reveals a dual role for heparin in fgfr binding and dimerization."	0.915	SIGNOR-83143
SIGNOR-LBC	"Luminal Breast Cancer"	INS	protein	P01308	UNIPROT	INSR	protein	P06213	UNIPROT	"up-regulates activity"	binding			9606									2550426	t		lperfetto	"Our previous studies indicated that amino acid residues 240-250 in the cysteine-rich region of the human insulin receptor alpha-subunit constitute a site in which insulin binds."	0.934	SIGNOR-23001
SIGNOR-LBC	"Luminal Breast Cancer"	CYP19A1	protein	P11511	UNIPROT	17beta-estradiol	smallmolecule	CHEBI:16469	ChEBI	"up-regulates quantity"	"chemical modification"			9606									395188	t		lperfetto	"Studies show that aromatization (a reaction sequence unique in steroid biosynthesis) of androgens to estrogens is not limited to the female reproductive organs but also occurs in extragonadal tissue. Aromatization involves the loss of the angular C-19 methyl group and cis elimination of the 1beta and 2beta hydrogens from the androgen precursors, androstenedione and testosterone, to yield estrone and estradiol, respectively. In men, the production of estrone is 18 ug/day and is mainly extraglandular. Aromatase activity has also been shown in a variety of tissues in mammalian and other species."	0.8	SIGNOR-251528
SIGNOR-LBC	"Luminal Breast Cancer"	17beta-estradiol	smallmolecule	CHEBI:16469	ChEBI	ESR1	protein	P03372	UNIPROT	up-regulates	"chemical activation"			9606	BTO:0000150								17478088	t		gcesareni	"Oestrogen receptors (er)alpha and beta modify the expression of genes involved in cell growth, proliferation and differentiation through binding to oestrogen response elements (eres) located in a number of gene promoters."	0.8	SIGNOR-154660
SIGNOR-LBC	"Luminal Breast Cancer"	ESR1	protein	P03372	UNIPROT	AP1	complex	SIGNOR-C154	SIGNOR	"up-regulates activity"	binding			9606									18247370	t		miannu	"The primary conclusion of the results reported here is that ERα and c‐jun, c‐fos and ATF‐2, but not Fra‐2 AP‐1 factors interact “in vivo” with specific estrogen‐responsive regulatory sequences and AP‐1 cis‐elements within the F promoter of the human ERα gene in osteoblast‐like SaOS‐2 cells."	0.725	SIGNOR-263656
SIGNOR-LBC	"Luminal Breast Cancer"	AP1	complex	SIGNOR-C154	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									9878062	f		lperfetto	"AP‐1 proteins, including c‐Fos and c‐Jun, are prominent nuclear targets of growth factor induced signaling, making AP‐1 a candidate nuclear effector of growth factor induced proliferation."	0.7	SIGNOR-252356
SIGNOR-LBC	"Luminal Breast Cancer"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	BRAF	protein	P15056	UNIPROT	down-regulates	phosphorylation	Thr440	EDRNRMKtLGRRDSS	9606									10869359	t		lperfetto	"We show that phosphorylation of b-raf by akt occurs at multiple residues within its amino terminal regulatory domain, at both the conserved and unique phosphorylation sites. Akt phosphorylated b-raf on s364 and s428 to inactivate its kinase activity b-raf contains three akt consensus sites, table i. One site, ser364 is conserved with c-raf;however, two sites, ser428 and thr439, are unique to b-raf"	0.2	SIGNOR-244156
SIGNOR-LBC	"Luminal Breast Cancer"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	BRAF	protein	P15056	UNIPROT	down-regulates	phosphorylation	Ser428	GPQRERKsSSSSEDR	9606									10869359	t		lperfetto	"We show that phosphorylation of b-raf by akt occurs at multiple residues within its amino terminal regulatory domain, at both the conserved and unique phosphorylation sites. Akt phosphorylated b-raf on s364 and s428 to inactivate its kinase activity b-raf contains three akt consensus sites, table i. One site, ser364 is conserved with c-raf;however, two sites, ser428 and thr439, are unique to b-raf"	0.2	SIGNOR-244160
SIGNOR-LBC	"Luminal Breast Cancer"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	BRAF	protein	P15056	UNIPROT	down-regulates	phosphorylation	Ser364	FGQRDRSsSAPNVHI	9606									10869359	t		lperfetto	"We show that phosphorylation of b-raf by akt occurs at multiple residues within its amino terminal regulatory domain, at both the conserved and unique phosphorylation sites. Akt phosphorylated b-raf on s364 and s428 to inactivate its kinase activity b-raf contains three akt consensus sites, table i. One site, ser364 is conserved with c-raf;however, two sites, ser428 and thr439, are unique to b-raf"	0.2	SIGNOR-244152
SIGNOR-LBC	"Luminal Breast Cancer"	BRAF	protein	P15056	UNIPROT	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	"up-regulates activity"	phosphorylation			-1									8413257	t		lperfetto	"Raf-1 phosphorylation of MEK activated it, as judged by its ability to stimulate the phosphorylation of myelin basic protein by glutathione S-transferase-ERK1."	0.787	SIGNOR-244831
SIGNOR-LBC	"Luminal Breast Cancer"	BRAF	protein	P15056	UNIPROT	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	"up-regulates activity"	phosphorylation			10090									8131746	t		lperfetto	"Activation of mek family kinases requires phosphorylation of two conserved ser/thr residueserine residues 218 and 222 of human mek1 are the primary sites for phosphorylation by c-raf."	0.787	SIGNOR-244827
SIGNOR-LBC	"Luminal Breast Cancer"	BRAF	protein	P15056	UNIPROT	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	"up-regulates activity"				9606									21900390	f		miannu	"RAF, a cytoplasmic serine-threonine protein kinase, is a member of the RAS-RAF-MEK-ERK cell-signaling pathway [also known as the MAP kinase (MAPK) pathway], and it plays an essential role in mediating cellular differentiation, proliferation, senescence, and survival in response to extracellular cues. Raf phosphorylates and activates MAP-ERK kinase (MEK), which phosphorylates and activates extracellular signal-regulated kinase (ERK)."	0.661	SIGNOR-260082
SIGNOR-LBC	"Luminal Breast Cancer"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	ESR1	protein	P03372	UNIPROT	up-regulates	phosphorylation	Ser167	GGRERLAsTNDKGSM	9606									11108261	t		lperfetto	"Studies using mutants of er-alpha demonstrated that akt increased estrogen receptor activity through the amino-terminal activation function-1 (af-1). Serines s104 s106, s118, and s167 appear to play a role in the activation of er-alpha by akt."	0.2	SIGNOR-244251
SIGNOR-LBC	"Luminal Breast Cancer"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	Survival	phenotype	SIGNOR-PH13	SIGNOR	up-regulates				9606									16288293	f		miannu	"Akt promotes both cell growth and cell survival by inactivating its downstream substrates including GSK3, BAD, FOXO and TSC2."	0.7	SIGNOR-251550
SIGNOR-LBC	"Luminal Breast Cancer"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	TSC	complex	SIGNOR-C101	SIGNOR	"down-regulates activity"	phosphorylation			10090	BTO:0000011								19593385	t		lperfetto	"In examining the requirements for different Akt-mediated phosphorylation sites on TSC2, we find that only TSC2 mutants lacking all five previously identified Akt sites fully block insulin-stimulated mTORC1 signaling in reconstituted Tsc2 null cells, and this mutant also inhibits adipogenesis"	0.789	SIGNOR-251526
SIGNOR-LBC	"Luminal Breast Cancer"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	Survival	phenotype	SIGNOR-PH13	SIGNOR	up-regulates				9606	BTO:0000830								15526160	f		miannu	"c-Kit promotes survival via PI3-kinase-dependent activation of Akt and phosphorylation of Bad, a pro-apoptotic molecule, at S136 in vivo."	0.7	SIGNOR-254952
SIGNOR-LBC	"Luminal Breast Cancer"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									24743741	f			"Activation of PDGFRα stimulates proliferation of PDGFRα(+) cells through PI3K-Akt and MEK2-MAPK signaling pathways, and aberrant accumulation of PDGFRα(+) cells was conspicuous in muscles of patients with both genetic and non-genetic muscle diseases."	0.7	SIGNOR-257606
SIGNOR-LBC	"Luminal Breast Cancer"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				10090									16982699	f			"Protein kinase B (PKB/Akt) is an important modulator of insulin signaling, cell proliferation, and survival. Using small interfering RNA duplexes in nontransformed mammalian cells, we show that only Akt1 is essential for cell proliferation"	0.7	SIGNOR-254353
SIGNOR-LBC	"Luminal Breast Cancer"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	mTORC1	complex	SIGNOR-C3	SIGNOR	"up-regulates activity"	phosphorylation			9606		BTO:0000887;BTO:0001103;BTO:0001760							20138985	t		lperfetto	"Pras40 is an insulin-regulated inhibitor of the mtorc1 protein kinase. Insulin stimulates akt/pkb-mediated phosphorylation of pras40, which prevents its inhibition of mtorc1 in cells and in vitro. Phosphorylation of pras40 on thr246 by pkb/akt facilitates efficient phosphorylation of ser183 by mtorc1."	0.735	SIGNOR-217586
SIGNOR-LBC	"Luminal Breast Cancer"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	mTORC1	complex	SIGNOR-C3	SIGNOR	"up-regulates activity"	phosphorylation			10090	BTO:0000011								19593385	t		lperfetto	"In examining the requirements for different Akt-mediated phosphorylation sites on TSC2, we find that only TSC2 mutants lacking all five previously identified Akt sites fully block insulin-stimulated mTORC1 signaling in reconstituted Tsc2 null cells, and this mutant also inhibits adipogenesis"	0.735	SIGNOR-252817
SIGNOR-LBC	"Luminal Breast Cancer"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	MDM2	protein	Q00987	UNIPROT	"up-regulates activity"	phosphorylation	Ser188	RKRHKSDsISLSFDE	9606									15169778	t		lperfetto	"Stabilization of mdm2 via decreased ubiquitination is mediated by protein kinase b/akt-dependent phosphorylationhere we show that pkb inhibits mdm2 self-ubiquitination via phosphorylation of mdm2 on ser(166) and ser(188)"	0.2	SIGNOR-244300
SIGNOR-LBC	"Luminal Breast Cancer"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	MDM2	protein	Q00987	UNIPROT	"up-regulates activity"	phosphorylation	Ser186	RQRKRHKsDSISLSF	9606									11504915	t		lperfetto	"Mitogen-induced activation of phosphatidylinositol 3-kinase (pi3-kinase) and its downstream target, the akt/pkb serine-threonine kinase, results in phosphorylation of mdm2 on serine 166 and serine 186. Phosphorylation on these sites is necessary for translocation of mdm2 from the cytoplasm into the nucleus.Both akt expression and serum treatment induced phosphorylation of mdm2 at ser186."	0.2	SIGNOR-244292
SIGNOR-LBC	"Luminal Breast Cancer"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	MDM2	protein	Q00987	UNIPROT	"up-regulates activity"	phosphorylation	Ser166	SSRRRAIsETEENSD	9606									15169778	t		lperfetto	"Stabilization of mdm2 via decreased ubiquitination is mediated by protein kinase b/akt-dependent phosphorylation."	0.2	SIGNOR-244296
SIGNOR-LBC	"Luminal Breast Cancer"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	ESR1	protein	P03372	UNIPROT	up-regulates	phosphorylation	Ser118	LHPPPQLsPFLQPHG	9606									11108261	t		lperfetto	"Studies using mutants of er-alpha demonstrated that akt increased estrogen receptor activity through the amino-terminal activation function-1 (af-1). Serines s104 s106, s118, and s167 appear to play a role in the activation of er-alpha by akt."	0.2	SIGNOR-244255
SIGNOR-LBC	"Luminal Breast Cancer"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	ESR1	protein	P03372	UNIPROT	up-regulates	phosphorylation	Ser106	PLNSVSPsPLMLLHP	9606									11108261	t		lperfetto	"Studies using mutants of er-alpha demonstrated that akt increased estrogen receptor activity through the amino-terminal activation function-1 (af-1). Serines s104 s106, s118, and s167 appear to play a role in the activation of er-alpha by akt."	0.2	SIGNOR-244247
SIGNOR-LBC	"Luminal Breast Cancer"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	ESR1	protein	P03372	UNIPROT	up-regulates	phosphorylation	Ser104	FPPLNSVsPSPLMLL	9606									11108261	t		lperfetto	"Studies using mutants of er-alpha demonstrated that akt increased estrogen receptor activity through the amino-terminal activation function-1 (af-1). Serines s104 s106, s118, and s167 appear to play a role in the activation of er-alpha by akt."	0.2	SIGNOR-244243
SIGNOR-LBC	"Luminal Breast Cancer"	BRAF	protein	P15056	UNIPROT	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	"up-regulates activity"	phosphorylation			9606									21900390	t		miannu	"BRAFV600E has been shown to initiate thyroid follicular cell transformation. The BRAFV600E mutation disrupts the hydrophobic interaction, enabling the BRAF kinase to fold into a catalytically active formation, resulting in an almost 500-fold increase in kinase activity. Mutant BRAF can dimerize and activate MEK without Ras activation."	0.787	SIGNOR-251988
SIGNOR-LBC	"Luminal Breast Cancer"	BRAF	protein	P15056	UNIPROT	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	up-regulates	phosphorylation			9606									8668348	t		lperfetto	"We show that, consequently, b-raf interacts with mek-1 and mek-2 with a better affinity than does c-raf-1, thus strengthening the notion that b-raf is a stronger mek activator than c-raf-l."	0.787	SIGNOR-244843
SIGNOR-LBC	"Luminal Breast Cancer"	CDKN2A	protein	P42771	UNIPROT	CyclinD/CDK4	complex	SIGNOR-C18	SIGNOR	"down-regulates activity"	binding			9606									11154267	t		lperfetto	"Overexpression of p16INK4a in cells with functional pRb results in inhibition of both Cdk4- and Cdk6-associated kinase activity and pRb phosphorylation, with subsequent cell cycle arrest (46, 50). In addition, inhibition of D cyclin-Cdk4 complex formation by p16INK4a prevents sequestration of p21Cip1 and p27Kip1 by these complexes in early G1, leading to suppression of cyclin E-Cdk2 activity"	0.83	SIGNOR-245459
SIGNOR-LBC	"Luminal Breast Cancer"	CDKN2A	protein	P42771	UNIPROT	CyclinD/CDK4	complex	SIGNOR-C18	SIGNOR	"down-regulates activity"	binding			9606									8891723	t		lperfetto	"The first group, including p16ink4a, p15ink4b,p18ink4cand p19ink4d, is specific for the g1 cdks,cdk4and cdk6, inhibiting the kinase activity of cyclin d/cdk4-cdk6 complexes on prb."	0.83	SIGNOR-217514
SIGNOR-LBC	"Luminal Breast Cancer"	CDKN2A	protein	P42771	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	down-regulates				9606	BTO:0000176								7972006	f			"Transfection of the p16INK4 cDNA expression vector into carcinoma cells inhibits their colony-forming efficiency and the p16INK4 expressing cells are selected against with continued passage in vitro. These results are consistent with the hypothesis that p16INK4 is a tumor-suppressor protein and that genetic and epigenetic abnormalities in genes controlling the G1 checkpoint can lead to both escape from senescence and cancer formation."	0.7	SIGNOR-259406
SIGNOR-LBC	"Luminal Breast Cancer"	CyclinD/CDK4	complex	SIGNOR-C18	SIGNOR	RB1	protein	P06400	UNIPROT	"down-regulates activity"	phosphorylation	Ser780	STRPPTLsPIPHIPR	9606	BTO:0000150								23336272	t		lperfetto	"Cyclin d1 is known to activate cdk4, which then phosphorylates the rb protein, leading to cell cycle progression."	0.864	SIGNOR-216988
SIGNOR-LBC	"Luminal Breast Cancer"	CyclinD/CDK4	complex	SIGNOR-C18	SIGNOR	RB1	protein	P06400	UNIPROT	"down-regulates activity"	phosphorylation	Ser788	PIPHIPRsPYKFPSS	-1									9139732	t		llicata	"In summary, we have shown evidence that CDK4-cyclin D1 phosphorylates Thr5, Ser249, Thr252, Thr356, Thr373, Ser788, Ser795, Ser807, Ser811, and Thr826 of pRB."	0.864	SIGNOR-250759
SIGNOR-LBC	"Luminal Breast Cancer"	CyclinD/CDK4	complex	SIGNOR-C18	SIGNOR	RB1	protein	P06400	UNIPROT	"down-regulates activity"	phosphorylation	Ser795	SPYKFPSsPLRIPGG	9606	BTO:0000150								23336272	t		lperfetto	"Cyclin d1 is known to activate cdk4, which then phosphorylates the rb protein, leading to cell cycle progression."	0.864	SIGNOR-216992
SIGNOR-LBC	"Luminal Breast Cancer"	CyclinD/CDK4	complex	SIGNOR-C18	SIGNOR	RB1	protein	P06400	UNIPROT	"down-regulates activity"	phosphorylation	Thr356	DSFETQRtPRKSNLD	-1									9139732	t		llicata	"In summary, we have shown evidence that CDK4-cyclin D1 phosphorylates Thr5, Ser249, Thr252, Thr356, Thr373, Ser788, Ser795, Ser807, Ser811, and Thr826 of pRB."	0.864	SIGNOR-250760
SIGNOR-LBC	"Luminal Breast Cancer"	CyclinD/CDK4	complex	SIGNOR-C18	SIGNOR	RB1	protein	P06400	UNIPROT	"down-regulates activity"	phosphorylation	Thr5	tPRKTAAT	-1									9139732	t		llicata	"In summary, we have shown evidence that CDK4-cyclin D1 phosphorylates Thr5, Ser249, Thr252, Thr356, Thr373, Ser788, Ser795, Ser807, Ser811, and Thr826 of pRB."	0.864	SIGNOR-250762
SIGNOR-LBC	"Luminal Breast Cancer"	CyclinD/CDK4	complex	SIGNOR-C18	SIGNOR	RB1	protein	P06400	UNIPROT	"down-regulates activity"	phosphorylation	Thr826	LPTPTKMtPRSRILV	9606									9139732	t		lperfetto	"We demonstrate that phosphorylation by either cdk2-cyclin a, which phosphorylates t821, or cdk4-cyclin d1, which phosphorylates threonine 826, can disable prb for subsequent binding of an lxcxe protein."	0.864	SIGNOR-216957
SIGNOR-LBC	"Luminal Breast Cancer"	E2F1	protein	Q01094	UNIPROT	G1/S_transition	phenotype	SIGNOR-PH50	SIGNOR	up-regulates				9606									21524151	f		lperfetto	"In its hypophosphorylated state, pRb binds transcription factors of the E2F family which are required for cell cycle progression. As the level of CyclinD/Cdk4/6 complexes increases, pRb becomes phosphorylated and progression through G1 occurs. At a critical level of phosphorylation, E2F is released from pRb. This activates the transcription of CyclinE which complexes with Cdk2 to fully release pRb repression by further phosphorylation, establishing a positive feedback loop. E2F further promotes the transcription of S-phase genes. Thus, CyclinD/Cdk4/6 and CyclinE/Cdk2 together regulate S-phase entry via phosphorylating pRb, which controls pRb binding to E2F"	0.7	SIGNOR-245477
SIGNOR-LBC	"Luminal Breast Cancer"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	BRAF	protein	P15056	UNIPROT	"down-regulates activity"	phosphorylation	Ser151	VARSNPKsPQKPIVR	9606	BTO:0000848								21478863	t			"We show that overactivation of the MAPK pathway, induced by the oncogenic Ras in melanoma, induces constitutive phosphorylation of BRAF on Ser151 by ERK, which inhibits NRAS-BRAF interaction"	0.2	SIGNOR-259919
SIGNOR-LBC	"Luminal Breast Cancer"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	BRAF	protein	P15056	UNIPROT	down-regulates	phosphorylation	Thr401	STTGLSAtPPASLPG	9606									21135229	t		lperfetto	"We show that b-raf is a calcineurin substrate;among calcineurin target residues on b-raf is t401, a site of negative feedback phosphorylation by erk1/2. Blocking calcineurin activity in _ cells prevents dephosphorylation of b-raf t401 and decreases b-raf and erk1/2 activities."	0.2	SIGNOR-170339
SIGNOR-LBC	"Luminal Breast Cancer"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	E2F1	protein	Q01094	UNIPROT	"up-regulates activity"	phosphorylation			9606									23616010	t		lperfetto	"Erk also undergoes rapid translocation into the nucleus, where it phosphorylates and activates a variety of transcription factor targets, including sp1, e2f, elk-1, and ap1."	0.2	SIGNOR-233526
SIGNOR-LBC	"Luminal Breast Cancer"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	ESR1	protein	P03372	UNIPROT	up-regulates	phosphorylation	Ser104	FPPLNSVsPSPLMLL	9606	BTO:0000567								17615152	t		lperfetto	"In several estrogen response element-containing genes, the s118a mutation strongly reduced induction by e(2), and u0126 did not further reduce expression. Here, we show that serines 104 (s104) and 106 (s106) are also phosphorylated by mapk in vitro and upon stimulation of mapk activity in vivo.Phosphorylation at serines 104 and 106 by erk1/2 mapk is important for estrogen receptor-alpha activity"	0.2	SIGNOR-244647
SIGNOR-LBC	"Luminal Breast Cancer"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	ESR1	protein	P03372	UNIPROT	up-regulates	phosphorylation	Ser106	PLNSVSPsPLMLLHP	9606	BTO:0000567								17615152	t		lperfetto	"In several estrogen response element-containing genes, the s118a mutation strongly reduced induction by e(2), and u0126 did not further reduce expression. Here, we show that serines 104 (s104) and 106 (s106) are also phosphorylated by mapk in vitro and upon stimulation of mapk activity in vivo.Phosphorylation at serines 104 and 106 by erk1/2 mapk is important for estrogen receptor-alpha activity"	0.2	SIGNOR-244651
SIGNOR-LBC	"Luminal Breast Cancer"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	ESR1	protein	P03372	UNIPROT	up-regulates	phosphorylation	Ser118	LHPPPQLsPFLQPHG	9606	BTO:0000567								17615152	t		lperfetto	"In several estrogen response element-containing genes, the s118a mutation strongly reduced induction by e(2), and u0126 did not further reduce expression. Here, we show that serines 104 (s104) and 106 (s106) are also phosphorylated by mapk in vitro and upon stimulation of mapk activity in vivo."	0.2	SIGNOR-244655
SIGNOR-LBC	"Luminal Breast Cancer"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	FGFR1	protein	P11362	UNIPROT	down-regulates	phosphorylation	Ser777	SMPLDQYsPSFPDTR	9606									23405013	t		lperfetto	"Erk-mediated phosphorylation of fibroblast growth factor receptor 1 on ser777 inhibits signaling"	0.2	SIGNOR-244541
SIGNOR-LBC	"Luminal Breast Cancer"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	JUN	protein	P05412	UNIPROT	"up-regulates activity"	phosphorylation			9606	BTO:0000675								23616010			lperfetto	"The results revealed that PAR2-AP and FVIIa could upregulate c-Jun expression and c-Jun phosphorylation in SW620 cells in a time-dependent manner. The effect of FVIIa was significantly blocked by anti-TF and anti-PAR2 antibodies. Protein kinase C_ (PKC_) inhibitor safingol and extracellular signal-regulated kinase 1 and 2 (ERK1/2) inhibitor U0126 abrogated the activation of c-Jun"	0.2	SIGNOR-236767
SIGNOR-LBC	"Luminal Breast Cancer"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	JUN	protein	P05412	UNIPROT	"up-regulates activity"	phosphorylation			9606	BTO:0000762								12509763	t		lperfetto	"Substrates for ERK1/2 include nuclear proteins such as C-JUN, this leads to activation of the AP-1 transcription factor, which is made up of FOS-JUN heterodimers."	0.2	SIGNOR-253214
SIGNOR-LBC	"Luminal Breast Cancer"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	"down-regulates activity"	phosphorylation			9534	BTO:0004055								14993270	t		lperfetto	"We propose that activation of erk during adhesion creates a feedback system in which erk phosphorylates mek1 on t292, and this in turn blocks additional s298 phosphorylation in response to integrin signaling."	0.758	SIGNOR-244862
SIGNOR-LBC	"Luminal Breast Cancer"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	"down-regulates activity"	phosphorylation			9606	BTO:0000007								10567369	t		lperfetto	"An ERK2-binding site at the N terminus of MEK1 was reported to mediate their stable association. We examined the importance of this binding site in the feedback phosphorylation of mek1 on thr(292) and thr(386) by erk2"	0.758	SIGNOR-244858
SIGNOR-LBC	"Luminal Breast Cancer"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				10090									20219869	f		areggio	"Furthermore, stimulation of myoblasts with CCL2, CCL3, or CCL4 was sufficient to induce phosphorylation and activation of ERK1/2. This outcome may be functionally important because ERK1/2 activation is a component of the pathway through which many mitogenic growth factors can stimulate cell proliferation."	0.7	SIGNOR-255120
SIGNOR-LBC	"Luminal Breast Cancer"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									19819937	f			"In addition to the JAK2–STAT5 pathway, the Ras GTPase–extracellular signal-regulated kinase (Ras–ERK) pathway has also been implicated in signaling of IL-5 and is important for IL-5-dependent cell survival, proliferation and differentiation of eosinophils."	0.7	SIGNOR-254354
SIGNOR-LBC	"Luminal Breast Cancer"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									24743741	f			"Activation of PDGFRα stimulates proliferation of PDGFRα(+) cells through PI3K-Akt and MEK2-MAPK signaling pathways, and aberrant accumulation of PDGFRα(+) cells was conspicuous in muscles of patients with both genetic and non-genetic muscle diseases."	0.7	SIGNOR-254374
SIGNOR-LBC	"Luminal Breast Cancer"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606	BTO:0000876	BTO:0001103							11602185	f		apalma	"The GM-CSF promoted cell survival and proliferation correlated with MEK-1 dependent ERK1/2, Elk-1 and CREB phosphorylation and Egr-1, c-Fos expression as well as with increased STAT-5, AP-1, c-Myb and NF-kappaB DNA-binding."	0.7	SIGNOR-255580
SIGNOR-LBC	"Luminal Breast Cancer"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	SOS1	protein	Q07889	UNIPROT	"down-regulates activity"	phosphorylation			9606		BTO:0000763;BTO:0000149							20724475	t		lperfetto	"ERK activation was sufficient for the SOS1 phosphorylation and resulting inhibition of EGF-induced Ras activation. This result also showed that SOS1 could be phosphorylated by ERK in the absence of association with EGFR at the plasma membrane, which is a phosphotyrosine-dependent process."	0.2	SIGNOR-244591
SIGNOR-LBC	"Luminal Breast Cancer"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	SOS1	protein	Q07889	UNIPROT	"down-regulates activity"	phosphorylation	Ser1132	TLPHGPRsASVSSIS	9534	BTO:0004055								8816480	t		lperfetto	"In this report, we describe the identification of five map kinase sites (s-1137, s-1167, s-1178, s-1193, and s-1197) on hsos1Replacing the MAP kinase phosphorylation sites with alanine residues results in an increase in the binding affinity of Grb2 to hSos1"	0.2	SIGNOR-244580
SIGNOR-LBC	"Luminal Breast Cancer"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	SOS1	protein	Q07889	UNIPROT	"down-regulates activity"	phosphorylation	Ser1167	ESAPAESsPSKIMSK	9534	BTO:0004055								8816480	t		lperfetto	"In this report, we describe the identification of five map kinase sites (s-1137, s-1167, s-1178, s-1193, and s-1197) on hsos1Replacing the MAP kinase phosphorylation sites with alanine residues results in an increase in the binding affinity of Grb2 to hSos1"	0.2	SIGNOR-244584
SIGNOR-LBC	"Luminal Breast Cancer"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	SOS1	protein	Q07889	UNIPROT	"down-regulates activity"	phosphorylation	Ser1197	KAYSPRYsISDRTSI	9534	BTO:0004055								8816480	t		lperfetto	"In this report, we describe the identification of five map kinase sites (s-1137, s-1167, s-1178, s-1193, and s-1197) on hsos1Replacing the MAP kinase phosphorylation sites with alanine residues results in an increase in the binding affinity of Grb2 to hSos1"	0.2	SIGNOR-244588
SIGNOR-LBC	"Luminal Breast Cancer"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	SOS1	protein	Q07889	UNIPROT	down-regulates	phosphorylation	Ser1178	IMSKHLDsPPAIPPR	9606									20724475	t		lperfetto	"ERK activation was sufficient for the SOS1 phosphorylation and resulting inhibition of EGF-induced Ras activation. This result also showed that SOS1 could be phosphorylated by ERK in the absence of association with EGFR at the plasma membrane, which is a phosphotyrosine-dependent process."	0.2	SIGNOR-244743
SIGNOR-LBC	"Luminal Breast Cancer"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	SOS1	protein	Q07889	UNIPROT	down-regulates	phosphorylation	Ser1193	QPTSKAYsPRYSISD	9606									20724475	t		lperfetto	"ERK activation was sufficient for the SOS1 phosphorylation and resulting inhibition of EGF-induced Ras activation. This result also showed that SOS1 could be phosphorylated by ERK in the absence of association with EGFR at the plasma membrane, which is a phosphotyrosine-dependent process."	0.2	SIGNOR-244747
SIGNOR-LBC	"Luminal Breast Cancer"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	Survival	phenotype	SIGNOR-PH13	SIGNOR	up-regulates				9606	BTO:0000876	BTO:0001103							11602185	f		apalma	"The GM-CSF promoted cell survival and proliferation correlated with MEK-1 dependent ERK1/2, Elk-1 and CREB phosphorylation and Egr-1, c-Fos expression as well as with increased STAT-5, AP-1, c-Myb and NF-kappaB DNA-binding."	0.7	SIGNOR-255579
SIGNOR-LBC	"Luminal Breast Cancer"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606		BTO:0001103							20219869	f		apalma	"ERK1/2 activation is a component of the pathway through which many mitogenic growth factors can stimulate cell proliferation"	0.7	SIGNOR-256216
SIGNOR-LBC	"Luminal Breast Cancer"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	Survival	phenotype	SIGNOR-PH13	SIGNOR	up-regulates				9606	BTO:0000830								15526160	f			"Numerous studies have implicated the critical importance of the Ras/Erk pathway in cell division and survival"	0.7	SIGNOR-254948
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	CDK1	protein	P06493	UNIPROT	DNM1L	protein	O00429	UNIPROT	"up-regulates activity"	phosphorylation	Ser616	PIPIMPAsPQKGHAV	9606									26352374	t		miannu	"Drp1 is phosphorylated at the Ser616 position and activated predominantly by CDK1."	0.468	SIGNOR-279394
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	"Class II MHC:Antigen"	complex	SIGNOR-C429	SIGNOR	TCR	complex	SIGNOR-C153	SIGNOR	"up-regulates activity"	binding			9606									31001252	t		scontino	"The interaction of T-cell receptors (TCRs) with self- and non-self-peptides in the major histocompatibility complex (MHC) stimulates crucial signaling events, which in turn can activate T lymphocytes."	0.2	SIGNOR-267992
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	"Class I MHC:Antigen"	complex	SIGNOR-C426	SIGNOR	CD8A	protein	P01732	UNIPROT	"up-regulates activity"	binding			9606									21954283	t		scontino	"Molecular recognition of pMHCI complexes is mediated primarily by clonally distributed TCRs expressed on the surface of CTLs. The coreceptor CD8 contributes to this antigen-recognition process by binding to a largely invariant region of the MHCI molecule and by promoting intracellular signaling, the effects of which serve to enhance TCR stimuli triggered by cognate ligands."	0.2	SIGNOR-267991
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	"Class I MHC:Antigen"	complex	SIGNOR-C426	SIGNOR	TCR	complex	SIGNOR-C153	SIGNOR	"up-regulates activity"	binding			9606									31001252	t		scontino	"The interaction of T-cell receptors (TCRs) with self- and non-self-peptides in the major histocompatibility complex (MHC) stimulates crucial signaling events, which in turn can activate T lymphocytes."	0.2	SIGNOR-267993
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	"Class II MHC:Antigen"	complex	SIGNOR-C429	SIGNOR	CD4	protein	P01730	UNIPROT	"up-regulates activity"	binding			9606									31001252	t		scontino	"Extracellular domain of¬†CD4, which is responsible for the recognition of its ligands, is composed of four globular Ig-like domains (D1-D4). The N-terminal D1 domain binds to a segment of the non-polymorphic Œ≤2 domain of MHC class II. CD4 is required for the recognition of most antigens in vivo. The presence of the CD4 coreceptor enhances T cell sensitivity to antigens"	0.2	SIGNOR-267990
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	LCK	protein	P06239	UNIPROT	TCR	complex	SIGNOR-C153	SIGNOR	"up-regulates activity"	phosphorylation			10090									2470098	t			"Last, we demonstrate directly that members of the CD3 complex, including the gamma, delta, and epsilon chains, as well as a putative zeta subunit, can be phosphorylated at tyrosine residues by the CD4/CD8.p56lck complex."	0.2	SIGNOR-259932
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	LCK	protein	P06239	UNIPROT	CD28	protein	P10747	UNIPROT	up-regulates	phosphorylation	Tyr191	SRLLHSDyMNMTPRR	9606									22936936	t		lperfetto	"We demonstrate that emt can phosphorylate all four tyrosines of the cd28 tail, in contrast to lck, which phosphorylates only tyrosine 173. Together with evidence that in vivo, tyrosines other than tyrosine 173 become phosphorylated following cd28 stimulation, this finding suggests that, like lck, one function of emt during cd28 signaling is phosphorylation of the receptor"	0.759	SIGNOR-198755
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	LAT	protein	O43561	UNIPROT	GRB2	protein	P62993	UNIPROT	up-regulates	binding			9606									23150273	t			"Phosphorylated tyrosines 171, 191, and 226 [in LAT] bind to the SH2 domains of the Grb2 family of adaptor proteins and must be present for optimal signalling"	0.807	SIGNOR-251520
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	CD28	protein	P10747	UNIPROT	GRB2	protein	P62993	UNIPROT	up-regulates	binding			9606									24098653	t		fspada	"Binding of the py site in cd28 (py-m-n-m) by pi3k and grb2 through their sh2 domains is a key step that triggers the cd28 signal transduction for t cell activation and differentiation"	0.706	SIGNOR-202706
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	PTPRC	protein	P08575	UNIPROT	LCK	protein	P06239	UNIPROT	"up-regulates activity"	dephosphorylation	Tyr505	FTATEGQyQPQP	9606									11259588	t			"Importantly, and in disagreement with the model that CD45 only activates Lck in vivo, the kinase activity of Lck from cells lacking CD45 was substantially increased. These results support a model in which CD45 dephosphorylates both Tyr505 and Tyr394, the net effect in normal thymocytes being a decrease in enzymatic activity"	0.801	SIGNOR-248350
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	PTPRC	protein	P08575	UNIPROT	FYN	protein	P06241	UNIPROT	"up-regulates activity"	dephosphorylation	Tyr531	FTATEPQyQPGENL	9606	BTO:0000782								11909961	t			"On the membrane SKAP55, via its phosphorylated Tyr-271, further binds the SH2 domain of Fyn to replace the low-affinity bound inhibitory site of the kinase. Consequently, CD45 may have transiently disassociated with the Tyr-232 residue of SKAP55 through dephosphorylation and simultaneously interacted with the released the phosphorylated inhibitory tyrosine residue of Fyn for dephosphorylation, resulting in activation of the Src family kinase Fyn and initiation of TCR-engaged signal transduction."	0.734	SIGNOR-248352
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	FYN	protein	P06241	UNIPROT	LAT	protein	O43561	UNIPROT	up-regulates	phosphorylation	Tyr220	SLDGSREyVNVSQEL	9606									16938345	t		gcesareni	"Both lck and syk, phosphorylate the itam-like motifs on lat at y171y191, which is essential for induction of the interaction of lat with downstream signaling molecules such as grb2, plc-gamma1 and c-cbl, and for activation of mapk-erk."	0.751	SIGNOR-148931
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	FYN	protein	P06241	UNIPROT	LCP2	protein	Q13094	UNIPROT	down-regulates	phosphorylation			9606									9047237	t		lperfetto	"P59fyn_phosphorylated slp-76 at intermediate levels but, significantly, this phosphorylation failed to induce vav?SLP-76 complex formation"	0.758	SIGNOR-46851
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	LCK	protein	P06239	UNIPROT	LCP2	protein	Q13094	UNIPROT	unknown	phosphorylation	Tyr423	NSLNEEWyVSYITRP	-1									8702662	t			"Ability of p56lck to phosphorylate Tyr-423/426 within SLP-76 in vitro"	0.758	SIGNOR-251381
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	ZAP70	protein	P43403	UNIPROT	LCP2	protein	Q13094	UNIPROT	"up-regulates activity"	phosphorylation	Tyr113	SSFEEDDyESPNDDQ	9606	BTO:0000782								12817019	t		lperfetto	"Phosphorylation of slp-76 is required for prolonged erk activation in response to sdf-1_  cr signal transduction results in slp-76 tyrosine phosphorylation at the amino-terminal tyrosines 113, 128, and 145 via a mechanism requiring the zap-70 tyrosine kinase."	0.809	SIGNOR-102507
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	LCK	protein	P06239	UNIPROT	ZAP70	protein	P43403	UNIPROT	"up-regulates activity"	phosphorylation	Tyr493	LGADDSYyTARSAGK	-1									8756661	t		lperfetto	"these data suggest that phosphorylation of ZAP-70 is initiated by a heterologous trans-phosphorylation of ZAP-70 by Lck on Tyr- 493."	0.621	SIGNOR-226628
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	ZAP70	protein	P43403	UNIPROT	LAT	protein	O43561	UNIPROT	"up-regulates activity"	phosphorylation	Tyr156	ADEDEDDyHNPGYLV	9606	BTO:0000782								11368773	t		lperfetto	"In the present study we reconstituted the LAT signalling pathway by demonstrating that a direct tyrosine phosphorylation of LAT with activated protein-tyrosine kinase Zap70 is necessary and sufficient for the association and activation of signalling proteins. Zap-70 efficiently phosphorylates LAT on tyrosine residues at positions 226, 191, 171, 132 and 127."	0.775	SIGNOR-247018
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	LCK	protein	P06239	UNIPROT	LAT	protein	O43561	UNIPROT	up-regulates	phosphorylation	Tyr200	SMESIDDyVNVPESG	9606	BTO:0000782								16938345	t		gcesareni	"Evidence of lat as a dual substrate for lck and syk in t lymphocytes.Lat is a linker protein essential for activation of t lymphocytes. Its rapid tyrosine-phosphorylation upon t cell receptor (tcr) stimulation recruits downstream signaling molecules for membrane targeting and activation."	0.762	SIGNOR-149182
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	LAT	protein	O43561	UNIPROT	PLCG1	protein	P19174	UNIPROT	"up-regulates activity"	binding			9606					phosphorylation:Tyr161;Tyr200	DDYHNPGyLVVLPDS;SMESIDDyVNVPESG			11368773	t		lperfetto	"By substituting these tyrosine residues in LAT with phenylalanine and by utilizing phosphorylated peptides derived from these sites, we mapped the tyrosine residues in LAT required for the direct interaction and activation of Vav, p85/p110alpha and phospholipase Cgamma1 (PLCgamma1). Our results indicate that Tyr(226) and Tyr(191) are required for Vav binding, whereas Tyr(171) and Tyr(132) are necessary for association and activation of phosphoinositide 3-kinase activity and PLCgamma1 respectively."	0.811	SIGNOR-246060
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	LAT	protein	O43561	UNIPROT	PI3K	complex	SIGNOR-C156	SIGNOR	"up-regulates activity"	binding			9606									11368773	t		lperfetto	"By substituting these tyrosine residues in LAT with phenylalanine and by utilizing phosphorylated peptides derived from these sites, we mapped the tyrosine residues in LAT required for the direct interaction and activation of Vav, p85/p110alpha and phospholipase Cgamma1 (PLCgamma1). Our results indicate that Tyr(226) and Tyr(191) are required for Vav binding, whereas Tyr(171) and Tyr(132) are necessary for association and activation of phosphoinositide 3-kinase activity and PLCgamma1 respectively."	0.412	SIGNOR-252734
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	PI3K	complex	SIGNOR-C156	SIGNOR	PIP3	smallmolecule	CHEBI:16618	ChEBI	"up-regulates quantity"	"chemical modification"			9606									24647478	t		lperfetto	"Stimulation of tyrosine kinase receptors initiates a signaling cascade that activates pi3k. Activated pi3k uses pip2 to generate pip3, 24647478"	0.8	SIGNOR-252712
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	PIP3	smallmolecule	CHEBI:16618	ChEBI	PDPK1	protein	O15530	UNIPROT	"up-regulates activity"	relocalization			9606									21798082	t		lperfetto	"Pip3 acts in turn as a docking site for two kinases, phosphoinositide-dependent kinase 1 (PDK1) and AKT, and the subsequent phosphorylation of AKT at serine 308 by PDK1, leading to AKT activation."	0.8	SIGNOR-175253
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	PDPK1	protein	O15530	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation	Thr308	KDGATMKtFCGTPEY	9606									15718470	t		gcesareni	"Akt/PKB activation requires the phosphorylation of Thr308 in the activation loop by the phosphoinositide-dependent kinase 1 (PDK1) and Ser473 within the carboxyl-terminal hydrophobic motif by an unknown kinase."	0.746	SIGNOR-243203
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	IKK-complex	complex	SIGNOR-C14	SIGNOR	up-regulates	phosphorylation			9606	BTO:0001454								19609947	t		lperfetto	"Although there are likely to be multiple levels of crosstalk between the pi3k-akt and nf-kb pathways, one mechanism has been attributed to direct phosphorylation of the amino acid residue t23 on ikb kinase alfa (ikkalfa) by akt, thereby leading to activation of this kinase upstream of nf-kb akt mediates ikkalpha phosphorylation at threonine 23 akt transiently associates in vivo with ikk and induces ikk activation. Akt mediates ikkalfa phosphorylation at threonine 23.Akt phosphorylates ikkalpha on t23, and this phosphorylation event is a prerequisite for the phosphorylation of p65 at s534 by ikkalpha and beta"	0.66	SIGNOR-244281
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	IKK-complex	complex	SIGNOR-C14	SIGNOR	NFKBIA	protein	P25963	UNIPROT	"down-regulates quantity by destabilization"	phosphorylation	Ser36	RHDSGLDsMKDEEYE	9606	BTO:0000567								9346241	t		lperfetto	"We described the purification of a 900 kda protein kinase complex, the ikb kinase (ikk), that phosphorylates ikbalfa and ikbbeta at the sites that mediate their ubiquitination and degradation"	0.889	SIGNOR-209773
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	LCK	protein	P06239	UNIPROT	NFKBIA	protein	P25963	UNIPROT	"down-regulates quantity by destabilization"	phosphorylation	Tyr42	DSMKDEEyEQMVKEL										14534291	t		lperfetto	"Loss of tyrosine kinase p56lck in Jurkat cells abolished NFkappaB activation and partially suppressed and delayed phosphorylation of Tyr-42 of IkappaB upon pervanadate treatment. |Transfection of these cells with wild type Lck but not with mutant Lck F394 followed by H/R induces the tyrosine phosphorylation of inhibitor of nuclear factor kappaB (IkappaBalpha) and transcriptional activation of NFkappaB, and these are inhibited by Lck inhibitors"	0.588	SIGNOR-249374
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	CD3	complex	SIGNOR-C432	SIGNOR	ZAP70	protein	P43403	UNIPROT	"up-regulates activity"	binding			9534									1423621	t			"We have recently identified a 70 kd tyrosine phosphoprotein (ZAP-70) that associates with zeta and undergoes tyrosine phosphorylation following TCR stimulation|Moreover, tyrosine phosphorylation and association of ZAP-70 with zeta require the presence of src family PTKs and provide a potential mechanism by which the src family PTKs and ZAP-70 may interact to mediate TCR signal transduction."	0.699	SIGNOR-252304
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	PLCG1	protein	P19174	UNIPROT	1,2-diacyl-sn-glycerol	smallmolecule	CHEBI:17815	ChEBI	up-regulates	"chemical modification"			9606									21918248	t		gcesareni	"Phospholypase c is an enzyme which catalyzes the hydrolysis of phosphatidylinositol-4,5-biphosphate (p(4,5)p(2)) into second messangers inositol-1,4,5-triphosphate (ins(1,4,5)p3) and dag."	0.8	SIGNOR-176606
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	PLCG1	protein	P19174	UNIPROT	PRKCA	protein	P17252	UNIPROT	up-regulates	phosphorylation			9606									12645577	t		gcesareni	"Tnf-alfa binds to tnfr1 and activates pc-plc to induce pkcalfa and c-src activation, leading to tyrosine phosphorylation of ikkbeta at tyr188 and tyr199."	0.562	SIGNOR-99310
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	PDPK1	protein	O15530	UNIPROT	PRKCA	protein	P17252	UNIPROT	up-regulates	phosphorylation			9606									15209375	t		gcesareni	"One of the most studied events controlled by ptdins(3,4,5)p3, comprises the activation of a of agc family protein kinases, including isoforms of protein kinase b (pkb)/akt, p70 ribosomal s6 kinase (s6k), serum and glucocorticoid-induced protein kinase (sgk) and protein kinase c (pkc), which play crucial roles in regulating physiological processes relevant to metabolism, growth, proliferation and survival. Here, we review recent biochemical, genetic and structural studies on the 3-phosphoinositide-dependent protein kinase-1 (pdk1), which phosphorylates and activates the agc kinase members regulated by pi 3-kinase. We also discuss whether inhibitors of pdk1 might have chemotherapeutic potential in the treatment of cancers in which the pdk1-regulated agc kinases are constitutively activated."	0.422	SIGNOR-126066
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	1,2-diacyl-sn-glycerol	smallmolecule	CHEBI:17815	ChEBI	PRKCA	protein	P17252	UNIPROT	up-regulates	binding			9606									12954613	t	"PKCs (PRKCA, PRKCB and PRKCG) are activated by calcium and diacylglycerol (DAG) in the presence of phosphatidylserine."	gcesareni	"C1a domain is critical for the dag-induced activation of pkcalfa.Furthermore, calcium and diacylglycerol activate protein kinase c, resulting in the phosphorylation of a large variety of substrates."	0.8	SIGNOR-100254
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	PRKCA	protein	P17252	UNIPROT	LCK	protein	P06239	UNIPROT	unknown	phosphorylation	Ser42	TLLIRNGsEVRDPLV	-1									8506364	t		lperfetto	"In vitro kinase assays show that Ser-59 can be uniquely phosphorylated by mitogen-activated protein kinase and that Ser-42 can be phosphorylated by either protein kinase A or protein kinase C."	0.32	SIGNOR-248936
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	PLCG1	protein	P19174	UNIPROT	"1D-myo-inositol 1,4,5-trisphosphate"	smallmolecule	CHEBI:16595	ChEBI	up-regulates	"chemical modification"			9606									21918248	t		gcesareni	"Phospholypase c is an enzyme which catalyzes the hydrolysis of phosphatidylinositol-4,5-biphosphate (p(4,5)p(2)) into second messangers inositol-1,4,5-triphosphate (ins(1,4,5)p3) and dag."	0.8	SIGNOR-176609
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	"1D-myo-inositol 1,4,5-trisphosphate"	smallmolecule	CHEBI:16595	ChEBI	ITPR1	protein	Q14643	UNIPROT	"up-regulates activity"	"chemical activation"			9606									24646566	t		miannu	"The key event in activation of fluid secretion is an increase in intracellular [ca2+] ([ca2+]i) triggered by ip3-induced release of ca2+ from er via the ip3r.  ip3rs determine the site of initiation and the pattern of [ca2+]i signal in the cell."	0.8	SIGNOR-256239
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	ITPR1	protein	Q14643	UNIPROT	calcium(2+)	smallmolecule	CHEBI:29108	ChEBI	"up-regulates quantity"	"chemical modification"			9606									24646566	t		miannu	"The key event in activation of fluid secretion is an increase in intracellular [ca2+] ([ca2+]i) triggered by ip3-induced release of ca2+ from er via the ip3r.  ip3rs determine the site of initiation and the pattern of [ca2+]i signal in the cell."	0.8	SIGNOR-256238
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	calcium(2+)	smallmolecule	CHEBI:29108	ChEBI	CALM1	protein	P0DP23	UNIPROT	up-regulates	"chemical activation"			10090									10448861	t		lperfetto	"Treatment with igf-1 or insulin and dexamethasone mobilizes intracellular calcium, activates the ca2+/calmodulin-dependent phosphatase calcineurin, and induces the nuclear translocation of the transcription factor nf-atc1."	0.8	SIGNOR-235590
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	CALM1	protein	P0DP23	UNIPROT	Calcineurin	complex	SIGNOR-C155	SIGNOR	up-regulates	binding			9606									11796223	t		gcesareni	"Calcium-bound calmodulin associates with calcineurin (cn), releasing the phosphatase from the repressive effects on an autoinhibitory domain."	0.578	SIGNOR-252337
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	1,2-diacyl-sn-glycerol	smallmolecule	CHEBI:17815	ChEBI	calcium(2+)	smallmolecule	CHEBI:29108	ChEBI	up-regulates				9606									18593525	f		gcesareni	"Dag and ip3 initiate further signal transduction pathways through activation of protein kinase c (pkc) and intracellular calcium release."	0.8	SIGNOR-179288
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	calcium(2+)	smallmolecule	CHEBI:29108	ChEBI	PRKCA	protein	P17252	UNIPROT	up-regulates	"chemical activation"			9606		BTO:0000887;BTO:0001103							22944199	t		gcesareni	"The wnt/ca2+ signaling pathway is defined by the activation of plc (phospholipase c) through wnt/fzd resulting in an increase in intracellular ca2+ levels, which activate pkcs (protein kinase c) and camkii (calcium-calmodulin-dependent kinase ii) or cn (calcineurin), a phosphatase that activates the transcription factor nfat (nuclear factor of activated t cell)."	0.8	SIGNOR-198822
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	Calcineurin	complex	SIGNOR-C155	SIGNOR	NFATC1	protein	O95644	UNIPROT	up-regulates	dephosphorylation			9606	BTO:0000782								14722106	t		gcesareni	"Once activated, calcineurin directly dephosphorylates NFAT proteins that are present in a hyperphosphorylated latent form in the cytoplasm and induces their rapid translocation into the nucleus, where in concert with nuclear partner proteins such as the AP-1 transcription factor complex, they are able to bind cooperatively to their target promoter elements and activate the transcription of specific NFAT target genes"	0.827	SIGNOR-252313
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	NFATC1	protein	O95644	UNIPROT	T_cell_activation	phenotype	SIGNOR-PH73	SIGNOR	"up-regulates activity"													10358178	f			"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms."	0.7	SIGNOR-252344
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	PRKCA	protein	P17252	UNIPROT	NFATC1	protein	O95644	UNIPROT	"down-regulates activity"	phosphorylation	Ser294	PHGSPRVsVTDDSWL	9606									12351631	t		lperfetto	"Protein kinase A negatively modulates the nuclear accumulation of NF-ATc1. | Here we show that overexpression of PKA causes phosphorylation and cytoplasmic accumulation of NF-ATc1 in direct opposition to calcineurin by phosphorylating Ser-245, Ser-269, and Ser-294 in the conserved serine-proline repeat domain, and that mutation of these serines blocks the effect of PKA. Activation of endogenous PKA is similarly able to promote phosphorylation of these sites on NF-ATc1 in two lymphoid cell lines."	0.382	SIGNOR-249175
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	PDPK1	protein	O15530	UNIPROT	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	"up-regulates activity"	phosphorylation			9606	BTO:0000007								15175348	t		lperfetto	"In vitro kinase assay revealed that the direct targets of pdk1 in the mapk pathway were the upstream mapk kinases mek1 and mek2. The identified pdk1 phosphorylation sites in mek1 and mek2 are ser222 and ser226, respectively, and are known to be essential for full activation"	0.272	SIGNOR-244934
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	up-regulates	phosphorylation			9606									11971971	t		lperfetto	"Mapk1 is phosphorylated by map2k1/mek1 and map2k2/mek2 on thr-185 and tyr-187 in response to external stimuli like insulin or ngf. Both phosphorylations are required for activity."	0.758	SIGNOR-244776
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	LCK	protein	P06239	UNIPROT	CD3	complex	SIGNOR-C432	SIGNOR	"up-regulates activity"	phosphorylation			9606									8626561	t			"The binding of Lck to the tyrosine-phosphorylated zeta chain of the TcR would serve to strengthen the interaction of the associated CD4 and the TcR complex, leading to increased avidity for the antigen-major histocompatibility protein complex"	0.651	SIGNOR-252305
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	AP1	complex	SIGNOR-C154	SIGNOR	CD3	complex	SIGNOR-C432	SIGNOR	"up-regulates activity"	binding			9606									16473826	t		scontino	"When T cells encounter antigens via the T cell antigen receptor (TCR), information about the quantity and quality of antigen engagement is relayed to the intracellular signal transduction machinery. The TCR itself lacks a significant intracellular domain. Instead, it is associated with CD3 molecules that contain intracellular signaling domains that couple the TCR/CD3 complex to the downstream signaling machinery."	0.341	SIGNOR-267994
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	CD3	complex	SIGNOR-C432	SIGNOR	NCK1	protein	P16333	UNIPROT	"up-regulates activity"	relocalization			9606									12110186	t			"We present strong evidence that ligand engagement of TCR-CD3 induces a conformational change that exposes a proline-rich sequence in CD3ϵ and results in recruitment of the adaptor protein Nck."	0.336	SIGNOR-259935
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	NCK1	protein	P16333	UNIPROT	SOS1	protein	Q07889	UNIPROT	up-regulates	binding			10029	BTO:0000246								7862111	t		lperfetto	"We also found that nck binds directly to the guanine nucleotide exchange factor sos. / by binding to sos, nckmay bring sos to cell membrane where the ras protein is located."	0.618	SIGNOR-236321
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	GRB2	protein	P62993	UNIPROT	SOS1	protein	Q07889	UNIPROT	"up-regulates activity"	relocalization			9606	BTO:0001412								10570290	t	"GRB2 associated guanine nucleotide exchange factor Sos activates Ras through the exchange of GDP for GTP"	lperfetto	"Grb2 binds and activates sos, which then activates ras, and this activates p110 independently of p85."	0.914	SIGNOR-236792
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	SOS1	protein	Q07889	UNIPROT	HRAS	protein	P01112	UNIPROT	"up-regulates activity"	"guanine nucleotide exchange factor"			9606									23132018	t		lperfetto	"The enhancement of H-Ras GTP levels induced by oncogenic K-Ras was abrogated when the expression of endogenous Sos was suppressed, implicating Sos as an essential intermediate in the cross talk between oncogenic K-Ras and WT H-Ras."	0.892	SIGNOR-39237
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	SOS1	protein	Q07889	UNIPROT	"down-regulates activity"	phosphorylation			9606		BTO:0000763;BTO:0000149							20724475	t		lperfetto	"ERK activation was sufficient for the SOS1 phosphorylation and resulting inhibition of EGF-induced Ras activation. This result also showed that SOS1 could be phosphorylated by ERK in the absence of association with EGFR at the plasma membrane, which is a phosphotyrosine-dependent process."	0.2	SIGNOR-244591
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	HRAS	protein	P01112	UNIPROT	BRAF	protein	P15056	UNIPROT	"up-regulates activity"	binding			9606									21779497	t		lperfetto	"The raf family of proteins (raf-1, a-raf, and b-raf) is serine/threonine kinases that bind to the effector region of ras-gtp, thus inducing translocation of the protein to the plasma membrane. Once there, raf proteins are activated and phosphorylated by different protein kinases."	0.879	SIGNOR-147327
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	BRAF	protein	P15056	UNIPROT	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	up-regulates	phosphorylation			9606									8668348	t		lperfetto	"We show that, consequently, b-raf interacts with mek-1 and mek-2 with a better affinity than does c-raf-1, thus strengthening the notion that b-raf is a stronger mek activator than c-raf-l."	0.787	SIGNOR-244843
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	AP1	complex	SIGNOR-C154	SIGNOR	up-regulates	phosphorylation	Thr331	CTPVVTCtPSCTAYT	9606									12972619	t		lperfetto	"In a previous study we have observed that exposure of nih 3t3 cells to pdgf or serum leads to c-fos phosphorylation by erk on specific residues, thr232, thr325, thr331, and ser374, within the cooh-terminal c-fos tad we have recently shown that erk phosphorylates multiple residues within the carboxylterminal transactivation domain (tad) of c-fos, thus resulting in its increased transcriptional activity."	0.795	SIGNOR-252353
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	AP1	complex	SIGNOR-C154	SIGNOR	Immune_response	phenotype	SIGNOR-PH17	SIGNOR	"up-regulates activity"				9606									31340499	f		Luana	"AP-1 Transcription Factors as Regulators of Immune Responses in Cancer"	0.7	SIGNOR-260766
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	CSK	protein	P41240	UNIPROT	LCK	protein	P06239	UNIPROT	down-regulates	phosphorylation	Tyr505	FTATEGQyQPQP	9606	BTO:0000782								1639064	t		gcesareni	"P50csk tyrosine kinase phosphorylates p56lck at tyr-505 and down regulates its catalytic activity."	0.541	SIGNOR-20371
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	PIP3	smallmolecule	CHEBI:16618	ChEBI	mTORC2	complex	SIGNOR-C2	SIGNOR	"up-regulates activity"	"chemical activation"			9606									26293922	t		gcesareni	"PtdIns(3,4,5)P3, but not other PtdInsPn species, interacts with SIN1-PH to release its inhibition on the mTOR kinase domain, thereby triggering mTORC2 activation"	0.8	SIGNOR-252430
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	mTORC2	complex	SIGNOR-C2	SIGNOR	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation	Ser473	RPHFPQFsYSASGTA	9606	BTO:0000182;BTO:0000018								15718470	t		lperfetto	"The rictor-mtor complex directly phosphorylated akt/pkb on ser473 in vitro and facilitated thr308 phosphorylation by pdk1"	0.647	SIGNOR-217008
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	TSC	complex	SIGNOR-C101	SIGNOR	"down-regulates activity"	phosphorylation			10090	BTO:0000011								19593385	t		lperfetto	"In examining the requirements for different Akt-mediated phosphorylation sites on TSC2, we find that only TSC2 mutants lacking all five previously identified Akt sites fully block insulin-stimulated mTORC1 signaling in reconstituted Tsc2 null cells, and this mutant also inhibits adipogenesis"	0.789	SIGNOR-251526
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	TSC	complex	SIGNOR-C101	SIGNOR	RHEB	protein	Q15382	UNIPROT	"down-regulates activity"	"gtpase-activating protein"			9606									15340059	t		lperfetto	"Tsc2 functions as a gap to inhibit rheb activity. Tsc2 displays gap (gtpase-activating protein) activity specifically towards the small g protein rheb and inhibits its ability to stimulate the mtor signaling pathway. It has recently been shown that tsc2 has gtpase-activating protein (gap) activity towards the ras family small gtpase rheb (ras homolog enriched in brain), and tsc1/2 antagonizes the mtor signaling pathway via stimulation of gtp hydrolysis of rheb."	0.918	SIGNOR-235895
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	RHEB	protein	Q15382	UNIPROT	MTOR	protein	P42345	UNIPROT	"up-regulates activity"	binding			9606	BTO:0000007								15854902	t		lperfetto	"Rheb binds and regulates the mTOR kinase."	0.95	SIGNOR-135770
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	MTOR	protein	P42345	UNIPROT	EIF4EBP1	protein	Q13541	UNIPROT	"down-regulates activity"	phosphorylation	Ser65	FLMECRNsPVTKTPP	9606	BTO:0000007		SIGNOR-C3						12747827	t		lperfetto	"Here, we show that a functional TOS motif is required for 4E-BP1 to bind to raptor (a recently identified mTOR-interacting protein), for 4E-BP1 to be efficiently phosphorylated in vitro by themTOR/raptor complex, and for 4E-BP1 to be phosphorylated in vivo at all identified mTOR-regulated sites. mTOR/raptor regulated phosphorylation is necessary for 4E-BPs efficient release from the translational initiation factor eIF4E. We find that the TOS motif is absolutely required for efficient phosphorylation of 4E-BP1 at all the identified mTOR-regulated sites, namely, Thr37/46, Ser65, and Thr70 in vivo."	0.927	SIGNOR-101115
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	EIF4EBP1	protein	Q13541	UNIPROT	EIF4E	protein	P06730	UNIPROT	"down-regulates activity"	binding			9606									23584478	t		lperfetto	"The rate-limiting factor for translation is eukaryotic translation initiation factor 4E (eIF4E), which is negatively regulated by eIF4E-binding protein 1 (4E-BP1)."	0.94	SIGNOR-167176
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	MTOR	protein	P42345	UNIPROT	RPTOR	protein	Q8N122	UNIPROT	"up-regulates activity"	phosphorylation	Ser855	QRVLDTSsLTQSAPA	9606	BTO:0000007								19864431	t		lperfetto	"Strikingly, raptor Ser(863) phosphorylation is absolutely required for raptor Ser(859) and Ser(855) phosphorylation. These data suggest that mTORC1 activation leads to raptor multisite phosphorylation and that raptor Ser(863) phosphorylation functions as a master biochemical switch that modulates hierarchical raptor phosphorylation (e.g. on Ser(859) and Ser(855))"	0.989	SIGNOR-174882
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	PKA	proteinfamily	SIGNOR-PF17	SIGNOR	DNM1L	protein	O00429	UNIPROT	"down-regulates activity"	phosphorylation	Ser637	VPVARKLsAREQRDC	-1									31063459	t		lperfetto	"For example, protein kinase A (PKA) phosphorylation of Drp1S600 has been reported to decrease Drp1 GTPase activity in vitro (23, 24), whereas phosphorylation of the same conserved serine residue by Ca2+-calmodulin–dependent protein kinase Iα (CaMKIα) in Drp1 isoform 3 has been reported to cause a significant increase in mitochondrial fission"	0.2	SIGNOR-262551
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	Calcineurin	complex	SIGNOR-C155	SIGNOR	DNM1L	protein	O00429	UNIPROT	"up-regulates activity"	dephosphorylation	Ser637	VPVARKLsAREQRDC	9606									18838687	t			"When mitochondrial depolarization is associated with sustained cytosolic Ca(2+) rise, it activates the cytosolic phosphatase calcineurin that normally interacts with Drp1. Calcineurin-dependent dephosphorylation of Drp1, and in particular of its conserved serine 637, regulates its translocation to mitochondria as substantiated by site directed mutagenesis."	0.271	SIGNOR-252315
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	MFF	protein	Q9GZY8	UNIPROT	DNM1L	protein	O00429	UNIPROT	"up-regulates activity"	relocalization			9606									21149567	t		gcesareni	"Mff functions as an essential factor in mitochondrial recruitment of Drp1."	0.601	SIGNOR-245957
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	MFN1	protein	Q8IWA4	UNIPROT	"up-regulates activity"	phosphorylation	Thr562	LPRSLASTPTAPTTP	10090	BTO:0002572								25801171	t		Barakat	"Finally, in Mfn1 -/- cells re-expressing the MFN1 T562A mutant, phosphorylation was undetectable even in the presence of EGF. Taken together, these data indicate that ERK phosphorylates MFN1 at T562."	0.2	SIGNOR-274134
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	FIS1	protein	Q9Y3D6	UNIPROT	Mitochondrial_fission	phenotype	SIGNOR-PH143	SIGNOR	up-regulates				9606									25486875	f		lperfetto	"During fission, DRP1 is recruited from the cytosol to the outer mitochondrial membrane, where it assembles with FIS1 to constrict the mitochondrial tubule (2)"	0.7	SIGNOR-272976
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	MFN1	protein	Q8IWA4	UNIPROT	Mitochondrial_fusion	phenotype	SIGNOR-PH218	SIGNOR	up-regulates				9606									25486875	f		lperfetto	"OPA1, MFN1 and MFN2 are essential mediators of the sequential fusion of the outer and inner membranes of adjacent mitochondria"	0.7	SIGNOR-272984
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	MFN2	protein	O95140	UNIPROT	Mitochondrial_fusion	phenotype	SIGNOR-PH218	SIGNOR	up-regulates				9606									25486875	f		lperfetto	"OPA1, MFN1 and MFN2 are essential mediators of the sequential fusion of the outer and inner membranes of adjacent mitochondria"	0.7	SIGNOR-272985
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	OPA1	protein	O60313	UNIPROT	Mitochondrial_fusion	phenotype	SIGNOR-PH218	SIGNOR	up-regulates				9606									25486875	f		lperfetto	"OPA1, MFN1 and MFN2 are essential mediators of the sequential fusion of the outer and inner membranes of adjacent mitochondria"	0.7	SIGNOR-272987
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	CD274	protein	Q9NZQ7	UNIPROT	PDCD1	protein	Q15116	UNIPROT	up-regulates	binding			9606	BTO:0000782								11015443	t		miannu	"Pd-l1, was found to bind pd-1 specifically. The functional significance of this interaction has been demonstrated in t cell assays, in which engagement of pd-1 by pd-l1 leads to the inhibition of tcr-mediated lymphocyte proliferation and cytokine secretion."	0.937	SIGNOR-82604
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	MFF	protein	Q9GZY8	UNIPROT	Mitochondrial_fission	phenotype	SIGNOR-PH143	SIGNOR	up-regulates				9606									33610749	f		lperfetto	"These proteins include the classical mitochondrial fusion (MFN1, MFN2, and OPA1) and fission proteins (DRP1, MFF, FIS1, etc.) as well as several other proteins that are directly or indirectly involved in these processes (e.g. YME1L, OMA1, INF2, GDAP1, MIC13, etc."	0.7	SIGNOR-272983
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	IKK-complex	complex	SIGNOR-C14	SIGNOR	NfKb-p65/p50	complex	SIGNOR-C13	SIGNOR	up-regulates	phosphorylation			9606									15489227	t		lperfetto	"Chromatographic fractionation of cell extracts allowed the identification of two distinct enzymatic activities phosphorylating ser-536. Peak 1 represents an unknown kinase, whereas peak 2 contained ikkalpha, ikkbeta, ikkepsilon, and tbk1. collectively, our results provide evidence for at least five kinases that converge on ser-536 of p65 and a novel function for this phosphorylation site in the recruitment of components of the basal transcriptional machinery to the interleukin-8 promoter."	0.821	SIGNOR-216341
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	NfKb-p65/p50	complex	SIGNOR-C13	SIGNOR	Immune_response	phenotype	SIGNOR-PH17	SIGNOR	up-regulates				9606									12692549	f		lperfetto	"The transcription factors interferon regulatory factor 3 (IRF3) and NF-B are required for the expression of many genes involved in the innate immune response."	0.7	SIGNOR-216319
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	NFATC1	protein	O95644	UNIPROT	IL2	protein	P60568	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			9606									10022916	t		Barakat	"Together, our results demonstrate that dnNFAT inhibits the production of IL-2. Thus, the NFAT transcription factor contributes to the regulation of IL-2 gene expression and therefore plays a critical role in the initiation of immune responses."	0.565	SIGNOR-275405
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	PDCD1	protein	Q15116	UNIPROT	DNM1L	protein	O00429	UNIPROT	"down-regulates activity"				9606	BTO:0000782								34535949	f		Barakat	"Mechanistically, we provided evidence that PD1 signaling downregulates Drp1 activating phosphorylation on Ser616 (and consequently mitochondrial fragmentation) via the inhibition of ERK1/2 and mTOR kinases."	0.2	SIGNOR-275406
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	DNM1L	protein	O00429	UNIPROT	"up-regulates activity"	phosphorylation	Ser616	PIPIMPAsPQKGHAV	9606	BTO:0000007								25658205	t		Barakat	"Here, we show that expression of oncogenic Ras or direct activation of the MAPK pathway leads to increased mitochondrial fragmentation and that blocking this phenotype, through knockdown of the mitochondrial fission-mediating GTPase Drp1, inhibits tumor growth. This fission is driven by Erk2-mediated phosphorylation of Drp1 on Serine 616, and both this phosphorylation and mitochondrial fragmentation are increased in human pancreatic cancer."	0.2	SIGNOR-275407
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	PDCD1	protein	Q15116	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"down-regulates activity"				9606	BTO:0000782								16227604	f		Barakat	"Akt phosphorylation in cells stimulated by CD3/CD28/CTLA-4 or CD3/CD28/PD-1 aAPCs did not have detectable phosphorylated Akt at any time point, indicating that CTLA-4 and PD-1 signaling blocked rather than delayed Akt activation."	0.346	SIGNOR-275408
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	CTLA4	protein	P16410	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"down-regulates activity"				9606	BTO:0000782								16227604	f		Barakat	"Akt phosphorylation in cells stimulated by CD3/CD28/CTLA-4 or CD3/CD28/PD-1 aAPCs did not have detectable phosphorylated Akt at any time point, indicating that CTLA-4 and PD-1 signaling blocked rather than delayed Akt activation."	0.611	SIGNOR-275409
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	PDCD1	protein	Q15116	UNIPROT	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	"down-regulates activity"				9606	BTO:0000782								22740686	f		Barakat	"MEK1/2 was phosphorylated and activated upon activation of T cells through TCR-CD3 and CD28, which resulted in phosphorylation of its downstream target ERK1/2, as determined by Western blotting analysis with an antibody specific for ERK1/2 phosphorylated at Thr202 and Tyr204, markers of activation. PD-1 substantially inhibited the activation of MEK1/2 and ERK1/2"	0.265	SIGNOR-275410
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	PDCD1	protein	Q15116	UNIPROT	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	"down-regulates activity"				9606	BTO:0000782								22740686	f		Barakat	"MEK1/2 was phosphorylated and activated upon activation of T cells through TCR-CD3 and CD28, which resulted in phosphorylation of its downstream target ERK1/2, as determined by Western blotting analysis with an antibody specific for ERK1/2 phosphorylated at Thr202 and Tyr204, markers of activation. PD-1 substantially inhibited the activation of MEK1/2 and ERK1/2"	0.263	SIGNOR-275411
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	LAG3	protein	P18627	UNIPROT	"Class II MHC:Antigen"	complex	SIGNOR-C429	SIGNOR	"down-regulates activity"	binding			9606	BTO:0000782								35413245	t		Barakat	"Binding of LAG-3 to stable peptide-MHC class II limits T cell function and suppresses autoimmunity and anti-cancer immunity"	0.2	SIGNOR-275412
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	PDCD1	protein	Q15116	UNIPROT	"T cell exhaustion"	phenotype	SIGNOR-PH221	SIGNOR	up-regulates				9606	BTO:0000782								28286692	f		Barakat	"Programmed cell death-1 (PD-1) is a major regulator of T-cell exhaustion, and blocking the PD-1 pathway restores T-cell function and improves pathogen control and tumor eradication. Immunotherapy targeting the PD-1 inhibitory receptor pathway has demonstrated significant antitumor activity."	0.7	SIGNOR-275413
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	LAG3	protein	P18627	UNIPROT	"T cell exhaustion"	phenotype	SIGNOR-PH221	SIGNOR	up-regulates				9606	BTO:0000782								27192565	f		Barakat	"Lag-3, Tim-3, and TIGIT are highly expressed on dysfunctional or exhausted T cells in chronic diseases such as chronic viral infection and cancer."	0.7	SIGNOR-275414
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	CTLA4	protein	P16410	UNIPROT	"T cell exhaustion"	phenotype	SIGNOR-PH221	SIGNOR	up-regulates				9606	BTO:0000782								26086965	f		Barakat	"Both PD-1 and CTLA-4 inhibited the activity of Akt, a crucial molecular in regulating glucose metabolism of T cells by elevating glucose transporter 1 expression and glycolysis, suggesting that glucose metabolism may contribute to T-cell exhaustion"	0.7	SIGNOR-275415
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	EIF4E	protein	P06730	UNIPROT	MTFP1	protein	Q9UDX5	UNIPROT	"up-regulates activity"	"translation regulation"			10090	BTO:0002572								28918902	t		Barakat	"In this study, we demonstrate that mTORC1 stimulates mitochondrial fission via 4E-BP-mediated translational regulation of the mitochondrial fission factor MTFP1. Suppression of mTORC1 activity by pharmacological or genetic means causes mitochondrial hyperfusion, branching, and circularization. This is a consequence of downregulation of MTFP1 levels via the mTORC1/4E-BP pathway, thereby eliciting changes in phosphorylation and localization of the mitochondrial fission factor DRP1"	0.2	SIGNOR-275429
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	MTOR	protein	P42345	UNIPROT	DNM1L	protein	O00429	UNIPROT	"up-regulates activity"	phosphorylation	Ser616	PIPIMPAsPQKGHAV	9606	BTO:0000661								34535949	t		Barakat	"Furthermore, we confirmed also in Jurkat cells that the specific silencing of both ERK1/2 and mTOR by siRNA downregulates Drp1 phosphorylation on Ser616"	0.345	SIGNOR-275430
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	MTOR	protein	P42345	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606		BTO:0001103							15829723	f		apalma	"Phosphorylation of mTOR by Akt leads to mTOR activation (40, 52) and the subsequent activation of p70S6K (47). This latter event has great potential importance for the promotion of muscle growth by the IGF-I/Akt/mTOR pathway, because p70S6k is a potent stimulator of protein synthesis that can be activated by increases in muscle contraction"	0.7	SIGNOR-255108
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	DNM1L	protein	O00429	UNIPROT	Mitochondrial_fission	phenotype	SIGNOR-PH143	SIGNOR	up-regulates				9606									25486875	f		lperfetto	"During fission, DRP1 is recruited from the cytosol to the outer mitochondrial membrane, where it assembles with FIS1 to constrict the mitochondrial tubule (2)"	0.7	SIGNOR-272975
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	MTFP1	protein	Q9UDX5	UNIPROT	DNM1L	protein	O00429	UNIPROT	"up-regulates activity"	relocalization			10090	BTO:0002572								28918902	f		Barakat	"Regardless of the precise mechanism, our data establish MTFP1 as an essential regulator of mitochondrial fission through the modulation of DRP1 phosphorylation and recruitment to the mitochondrion."	0.398	SIGNOR-275449
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	E2F1	protein	Q01094	UNIPROT	"up-regulates activity"	phosphorylation			9606									23616010	t		lperfetto	"Erk also undergoes rapid translocation into the nucleus, where it phosphorylates and activates a variety of transcription factor targets, including sp1, e2f, elk-1, and ap1."	0.2	SIGNOR-233526
SIGNOR-MD	"Mitochondrial dynamics in T cell exhaustion"	E2F1	protein	Q01094	UNIPROT	CDK1	protein	P06493	UNIPROT	"up-regulates activity"	"transcriptional regulation"			9606	BTO:0000972								14618416	f		miannu	"To assess transactivating activity of E2F1/DP-1, we also analyzed expression of ten putative transcriptional targets of this complex in HCCs.  Expression levels of TFDP1 and E2F1 correlated with those of seven transcriptional targets ( TYMS, DHFR, PCNA, RRM1, CCNE1, CDC2, and MYBL2) that play important roles in the G1/S transition, and down-regulation of TFDP1 inhibited growth of Hep3B cells."	0.703	SIGNOR-253864
SIGNOR-MM	"Malignant Melanoma"	BAX	protein	Q07812	UNIPROT	Apoptosis	phenotype	SIGNOR-PH2	SIGNOR	up-regulates				9606									23567751	f		miannu	"The mitochondrial pathway of apoptosis proceeds when the outer mitochondrial membrane (OMM) is compromised by the pro-apoptotic BCL-2 family members, BAK and BAX. Once activated, BAK and BAX form proteolipid pores in the OMM leading to mitochondrial outer membrane permeabilization (MOMP), and the release of inner membrane space proteins, such as cytochrome c, which promotes caspase activation."	0.7	SIGNOR-261494
SIGNOR-MM	"Malignant Melanoma"	BAK1	protein	Q16611	UNIPROT	Apoptosis	phenotype	SIGNOR-PH2	SIGNOR	up-regulates				9606									23567751	f		miannu	"The mitochondrial pathway of apoptosis proceeds when the outer mitochondrial membrane (OMM) is compromised by the pro-apoptotic BCL-2 family members, BAK and BAX. Once activated, BAK and BAX form proteolipid pores in the OMM leading to mitochondrial outer membrane permeabilization (MOMP), and the release of inner membrane space proteins, such as cytochrome c, which promotes caspase activation."	0.7	SIGNOR-261493
SIGNOR-MM	"Malignant Melanoma"	"UV stress"	stimulus	SIGNOR-ST7	SIGNOR	CDKN2A	protein	P42771	UNIPROT	up-regulates				9606									11830546	f		miannu	"The expression of the melanoma susceptibility gene product p16 is increased after UVR both in epidermally derived cell lines and in human skin. The increased expression of p16 after exposure to suberythemal doses of UVR is potentiated by α-MSH, a ligand for MC1R, and this effect is mimicked by cAMP, the intracellular mediator of α-MSH signaling via the MC1 receptor."	0.7	SIGNOR-252376
SIGNOR-MM	"Malignant Melanoma"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	BAD	protein	Q92934	UNIPROT	"down-regulates activity"	phosphorylation	Ser99	PFRGRSRsAPPNLWA	9606	BTO:0000938								9346240	t		lperfetto	"Experiments in this study reveal that akt phosphorylates bad both in vitro and in vivo and that akt-mediated phosphorylation of bad effectively blocks bad induced cell death.[...] In addition, these findings implicate a particular phosphorylation site on bad, serine 136, in the suppression of bad-mediated death by akt.[...]The Phosphorylation of bad may lead to the prevention of cell death via a mechanism that involves the selective association of the phosphorylated forms of bad with 14-3-3 protein isoforms. Akt phosphorylates bad in vitro and in vivo we show that growth factor activation of the pi3'k/akt signaling pathway culminates in the phosphorylation of the bcl-2 family member bad, thereby suppressing apoptosis and promoting cell survival. Akt phosphorylates bad in vitro and in vivo erbb-mediated phosphorylation of bad by akt promotes survival by blocking the interaction of this pro-apoptotic molecule with bcl-2 and bcl-x proteins"	0.2	SIGNOR-244144
SIGNOR-MM	"Malignant Melanoma"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	BAD	protein	Q92934	UNIPROT	"down-regulates activity"	phosphorylation	Ser118	GRELRRMsDEFVDSF	9606	BTO:0000938								9346240	t		lperfetto	"Experiments in this study reveal that akt phosphorylates bad both in vitro and in vivo and that akt-mediated phosphorylation of bad effectively blocks bad induced cell death.[...] In addition, these findings implicate a particular phosphorylation site on bad, serine 136, in the suppression of bad-mediated death by akt.[...]The Phosphorylation of bad may lead to the prevention of cell death via a mechanism that involves the selective association of the phosphorylated forms of bad with 14-3-3 protein isoforms. Akt phosphorylates bad in vitro and in vivo we show that growth factor activation of the pi3'k/akt signaling pathway culminates in the phosphorylation of the bcl-2 family member bad, thereby suppressing apoptosis and promoting cell survival. Akt phosphorylates bad in vitro and in vivo erbb-mediated phosphorylation of bad by akt promotes survival by blocking the interaction of this pro-apoptotic molecule with bcl-2 and bcl-x proteins"	0.2	SIGNOR-244148
SIGNOR-MM	"Malignant Melanoma"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	BAD	protein	Q92934	UNIPROT	"down-regulates activity"	phosphorylation	Ser75	EIRSRHSsYPAGTED	9606	BTO:0000007								9381178	t			"Active Akt induced a significant increase in BAD phosphorylation.  mutant BAD with alanine substitutions at Ser112 and Ser136 was not phosphorylated by active Akt .  phosphorylation of BAD by Akt will preclude its binding to membrane-anchored Bcl-xL, leading to increased cell survival."	0.2	SIGNOR-251469
SIGNOR-MM	"Malignant Melanoma"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	BAD	protein	Q92934	UNIPROT	"down-regulates activity"	phosphorylation	Ser99	PFRGRSRsAPPNLWA	9606	BTO:0000007								9381178	t			"Active Akt induced a significant increase in BAD phosphorylation.  mutant BAD with alanine substitutions at Ser112 and Ser136 was not phosphorylated by active Akt .  phosphorylation of BAD by Akt will preclude its binding to membrane-anchored Bcl-xL, leading to increased cell survival."	0.2	SIGNOR-251470
SIGNOR-MM	"Malignant Melanoma"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	BRAF	protein	P15056	UNIPROT	down-regulates	phosphorylation	Thr440	EDRNRMKtLGRRDSS	9606									10869359	t		lperfetto	"We show that phosphorylation of b-raf by akt occurs at multiple residues within its amino terminal regulatory domain, at both the conserved and unique phosphorylation sites. Akt phosphorylated b-raf on s364 and s428 to inactivate its kinase activity b-raf contains three akt consensus sites, table i. One site, ser364 is conserved with c-raf;however, two sites, ser428 and thr439, are unique to b-raf"	0.2	SIGNOR-244156
SIGNOR-MM	"Malignant Melanoma"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	BRAF	protein	P15056	UNIPROT	down-regulates	phosphorylation	Ser428	GPQRERKsSSSSEDR	9606									10869359	t		lperfetto	"We show that phosphorylation of b-raf by akt occurs at multiple residues within its amino terminal regulatory domain, at both the conserved and unique phosphorylation sites. Akt phosphorylated b-raf on s364 and s428 to inactivate its kinase activity b-raf contains three akt consensus sites, table i. One site, ser364 is conserved with c-raf;however, two sites, ser428 and thr439, are unique to b-raf"	0.2	SIGNOR-244160
SIGNOR-MM	"Malignant Melanoma"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	CREB1	protein	P16220	UNIPROT	"up-regulates activity"	phosphorylation	Ser119	EILSRRPsYRKILND	9606	BTO:0000007								9829964	t		gcesareni	"When overexpressed in serum-stimulated cells, Akt/PKB potently induced Ser-133 phosphorylation of CREB and promoted recruitment of CBP. Correspondingly, Akt/PKB stimulated target gene expression via CREB in a phospho(Ser-133)-dependent manner."	0.2	SIGNOR-247992
SIGNOR-MM	"Malignant Melanoma"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	CREB1	protein	P16220	UNIPROT	"up-regulates activity"	phosphorylation	Ser119	EILSRRPsYRKILND	9606									9829964	t			"The nuclear factor CREB stimulates the expression of cellular genes following its protein kinase A-mediated phosphorylation at Ser-133. Ser-133 phosphorylation, in turn, activates target gene expression by promoting recruitment of the co-activator CBP. |When overexpressed in serum-stimulated cells, Akt/PKB potently induced Ser-133 phosphorylation of CREB and promoted recruitment of CBP."	0.2	SIGNOR-251474
SIGNOR-MM	"Malignant Melanoma"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	MDM2	protein	Q00987	UNIPROT	"up-regulates activity"	phosphorylation	Ser188	RKRHKSDsISLSFDE	9606									15169778	t		lperfetto	"Stabilization of mdm2 via decreased ubiquitination is mediated by protein kinase b/akt-dependent phosphorylationhere we show that pkb inhibits mdm2 self-ubiquitination via phosphorylation of mdm2 on ser(166) and ser(188)"	0.2	SIGNOR-244300
SIGNOR-MM	"Malignant Melanoma"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	MDM2	protein	Q00987	UNIPROT	"up-regulates activity"	phosphorylation	Ser186	RQRKRHKsDSISLSF	9606									11504915	t		lperfetto	"Mitogen-induced activation of phosphatidylinositol 3-kinase (pi3-kinase) and its downstream target, the akt/pkb serine-threonine kinase, results in phosphorylation of mdm2 on serine 166 and serine 186. Phosphorylation on these sites is necessary for translocation of mdm2 from the cytoplasm into the nucleus.Both akt expression and serum treatment induced phosphorylation of mdm2 at ser186."	0.2	SIGNOR-244292
SIGNOR-MM	"Malignant Melanoma"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	MDM2	protein	Q00987	UNIPROT	"up-regulates activity"	phosphorylation	Ser166	SSRRRAIsETEENSD	9606									15169778	t		lperfetto	"Stabilization of mdm2 via decreased ubiquitination is mediated by protein kinase b/akt-dependent phosphorylation."	0.2	SIGNOR-244296
SIGNOR-MM	"Malignant Melanoma"	BAD	protein	Q92934	UNIPROT	BCL2	protein	P10415	UNIPROT	"down-regulates activity"	relocalization			9606	BTO:0000007								15694340	t		lperfetto	"Apoptosis is initiated when Bcl-2 and its prosurvival relatives are engaged by proapoptotic BH3-only proteins via interaction of its BH3 domain with a groove on the Bcl-2-like proteins. These interactions have been considered promiscuous, but our analysis of the affinity of eight BH3 peptides for five Bcl-2-like proteins has revealed that the interactions vary over 10,000-fold in affinity, and accordingly, only certain protein pairs associate inside cells. Bim and Puma potently engaged all the prosurvival proteins comparably. Bad, however, bound tightly to Bcl-2, Bcl-xL, and Bcl-w but only weakly to A1 and not to Mcl-1."	0.801	SIGNOR-133756
SIGNOR-MM	"Malignant Melanoma"	BAD	protein	Q92934	UNIPROT	BCL2L1	protein	Q07817	UNIPROT	"down-regulates activity"	binding												7834748	t		lperfetto	"Bad binds more strongly to Bcl-x, than Bcl-2 in mammalian cells, and it reversed the death repressor activity of Bcl-x,, but not that of Bcl-2. When Bad dimerized with Bcl-x,, Bax was displaced and apoptosis was restored."	0.847	SIGNOR-249617
SIGNOR-MM	"Malignant Melanoma"	BAD	protein	Q92934	UNIPROT	BCL2L1	protein	Q07817	UNIPROT	"down-regulates activity"	binding			9606	BTO:0000007								15694340	t		lperfetto	"Bad, however, bound tightly to bcl-2, bcl2l1, and bcl2l2"	0.847	SIGNOR-133759
SIGNOR-MM	"Malignant Melanoma"	BAD	protein	Q92934	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	down-regulates				9606	"BTO:0002418;BTO:0002552;BTO:0000018; BTO:0002207;BTO:0002203"								23725574	f		irozzo	"Our data suggested that increased expression of BAD enhance apoptosis and has negative influence on cell proliferation and tumor growth in NSCLC. Bad is a new potential target for tumor interventions."	0.7	SIGNOR-256260
SIGNOR-MM	"Malignant Melanoma"	BAD	protein	Q92934	UNIPROT	Survival	phenotype	SIGNOR-PH13	SIGNOR	down-regulates				9606	BTO:0000830								15526160	f		miannu	"C-Kit promotes survival via PI3-kinase-dependent activation of Akt and phosphorylation of Bad, a pro-apoptotic molecule, at S136 in vivo."	0.7	SIGNOR-254953
SIGNOR-MM	"Malignant Melanoma"	BAD	protein	Q92934	UNIPROT	TP53	protein	P04637	UNIPROT	"up-regulates activity"	binding			9606	BTO:0002552								17000778	t		lperfetto	"We also demonstrate that bad physically interacts with cytoplasmic p53.  bad is able to direct p53 to the mitochondria and forms a p53/bad complex at the mitochondria.  the mitochondrial p53/bad complex promotes apoptosis"	0.329	SIGNOR-149815
SIGNOR-MM	"Malignant Melanoma"	BCL2	protein	P10415	UNIPROT	Apoptosis	phenotype	SIGNOR-PH2	SIGNOR	down-regulates				9606									1286168	f		lperfetto	"Bcl-2 functions to inhibit apoptosis in a variety of in vitro and in vivo experiments, suggesting interference with a central mechanism of apoptosis"	0.7	SIGNOR-249611
SIGNOR-MM	"Malignant Melanoma"	BCL2L1	protein	Q07817	UNIPROT	BAD	protein	Q92934	UNIPROT	"up-regulates activity"	binding			-1									10949026	t		lperfetto	"Bad dimerizes with bcl-xl at the mitochondrial membrane where it exert its killing effects. Phosphorylation of bad promotes its binding to 14-3-3 protein, which may sequester bad from bcl-xl, thus promoting cell cells survival."	0.847	SIGNOR-81125
SIGNOR-MM	"Malignant Melanoma"	BRAF	protein	P15056	UNIPROT	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	"up-regulates activity"	phosphorylation			9606									21900390	t		miannu	"BRAFV600E has been shown to initiate thyroid follicular cell transformation. The BRAFV600E mutation disrupts the hydrophobic interaction, enabling the BRAF kinase to fold into a catalytically active formation, resulting in an almost 500-fold increase in kinase activity. Mutant BRAF can dimerize and activate MEK without Ras activation."	0.787	SIGNOR-251988
SIGNOR-MM	"Malignant Melanoma"	BRAF	protein	P15056	UNIPROT	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	"up-regulates activity"	phosphorylation			10090									8131746	t		lperfetto	"Activation of mek family kinases requires phosphorylation of two conserved ser/thr residueserine residues 218 and 222 of human mek1 are the primary sites for phosphorylation by c-raf."	0.787	SIGNOR-244827
SIGNOR-MM	"Malignant Melanoma"	BRAF	protein	P15056	UNIPROT	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	up-regulates	phosphorylation			9606									8668348	t		lperfetto	"We show that, consequently, b-raf interacts with mek-1 and mek-2 with a better affinity than does c-raf-1, thus strengthening the notion that b-raf is a stronger mek activator than c-raf-l."	0.787	SIGNOR-244843
SIGNOR-MM	"Malignant Melanoma"	BRAF	protein	P15056	UNIPROT	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	"up-regulates activity"	phosphorylation			-1									8413257	t		lperfetto	"Raf-1 phosphorylation of MEK activated it, as judged by its ability to stimulate the phosphorylation of myelin basic protein by glutathione S-transferase-ERK1."	0.787	SIGNOR-244831
SIGNOR-MM	"Malignant Melanoma"	CDKN2A	protein	P42771	UNIPROT	CyclinD/CDK4	complex	SIGNOR-C18	SIGNOR	"down-regulates activity"	binding			9606									11154267	t		lperfetto	"Overexpression of p16INK4a in cells with functional pRb results in inhibition of both Cdk4- and Cdk6-associated kinase activity and pRb phosphorylation, with subsequent cell cycle arrest (46, 50). In addition, inhibition of D cyclin-Cdk4 complex formation by p16INK4a prevents sequestration of p21Cip1 and p27Kip1 by these complexes in early G1, leading to suppression of cyclin E-Cdk2 activity"	0.83	SIGNOR-245459
SIGNOR-MM	"Malignant Melanoma"	CDKN2A	protein	P42771	UNIPROT	CyclinD/CDK4	complex	SIGNOR-C18	SIGNOR	"down-regulates activity"	binding			9606									8891723	t		lperfetto	"The first group, including p16ink4a, p15ink4b,p18ink4cand p19ink4d, is specific for the g1 cdks,cdk4and cdk6, inhibiting the kinase activity of cyclin d/cdk4-cdk6 complexes on prb."	0.83	SIGNOR-217514
SIGNOR-MM	"Malignant Melanoma"	CREB1	protein	P16220	UNIPROT	BCL2	protein	P10415	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			10116	BTO:0001009								10753867	f		lperfetto	"Creb activity by akt signaling leads to increased bcl-2 promoter activity and cell survival."	0.466	SIGNOR-76558
SIGNOR-MM	"Malignant Melanoma"	CREB1	protein	P16220	UNIPROT	BCL2	protein	P10415	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			9606	BTO:0000776;BTO:0003076								8816467	f		lperfetto	"Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis"	0.466	SIGNOR-43927
SIGNOR-MM	"Malignant Melanoma"	CREB1	protein	P16220	UNIPROT	BCL2L1	protein	Q07817	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			9606									16205321	f		gcesareni	"The results showed that the nuclear pkcalpha was significantly decreased in the liver during sepsis, which was accompanied by decreases in phospho-creb content, dna-binding activity of creb, and bcl-xl expression."	0.362	SIGNOR-140911
SIGNOR-MM	"Malignant Melanoma"	CREB1	protein	P16220	UNIPROT	MITF	protein	O75030	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"												10841026	t		lperfetto	"Therefore, the molecular steps linking cAMPto melanogenesis up-regulation appear currently better elucidated. cAMP activates PKA, and PKA phosphorylates and activates CREB which, when activated, binds to the CRE domain present in the microphthalmia promoter,thereby up-regulating its transcription."	0.641	SIGNOR-249619
SIGNOR-MM	"Malignant Melanoma"	CREB1	protein	P16220	UNIPROT	Survival	phenotype	SIGNOR-PH13	SIGNOR	up-regulates				9606									20660310	f		amattioni	"beta-catenin/CBP-driven transcription is critical for maintenance of an undifferentiated/proliferative state"	0.7	SIGNOR-229777
SIGNOR-MM	"Malignant Melanoma"	CyclinD/CDK4	complex	SIGNOR-C18	SIGNOR	RB1	protein	P06400	UNIPROT	"down-regulates activity"	phosphorylation	Thr826	LPTPTKMtPRSRILV	9606									9139732	t		lperfetto	"We demonstrate that phosphorylation by either cdk2-cyclin a, which phosphorylates t821, or cdk4-cyclin d1, which phosphorylates threonine 826, can disable prb for subsequent binding of an lxcxe protein."	0.864	SIGNOR-216957
SIGNOR-MM	"Malignant Melanoma"	CyclinD/CDK4	complex	SIGNOR-C18	SIGNOR	RB1	protein	P06400	UNIPROT	"down-regulates activity"	phosphorylation	Ser795	SPYKFPSsPLRIPGG	9606	BTO:0000150								23336272	t		lperfetto	"Cyclin d1 is known to activate cdk4, which then phosphorylates the rb protein, leading to cell cycle progression."	0.864	SIGNOR-216992
SIGNOR-MM	"Malignant Melanoma"	CyclinD/CDK4	complex	SIGNOR-C18	SIGNOR	RB1	protein	P06400	UNIPROT	"down-regulates activity"	phosphorylation	Ser780	STRPPTLsPIPHIPR	9606	BTO:0000150								23336272	t		lperfetto	"Cyclin d1 is known to activate cdk4, which then phosphorylates the rb protein, leading to cell cycle progression."	0.864	SIGNOR-216988
SIGNOR-MM	"Malignant Melanoma"	CyclinD/CDK4	complex	SIGNOR-C18	SIGNOR	RB1	protein	P06400	UNIPROT	"down-regulates activity"	phosphorylation	Thr5	tPRKTAAT	-1									9139732	t		llicata	"In summary, we have shown evidence that CDK4-cyclin D1 phosphorylates Thr5, Ser249, Thr252, Thr356, Thr373, Ser788, Ser795, Ser807, Ser811, and Thr826 of pRB."	0.864	SIGNOR-250762
SIGNOR-MM	"Malignant Melanoma"	CyclinD/CDK4	complex	SIGNOR-C18	SIGNOR	RB1	protein	P06400	UNIPROT	"down-regulates activity"	phosphorylation	Ser788	PIPHIPRsPYKFPSS	-1									9139732	t		llicata	"In summary, we have shown evidence that CDK4-cyclin D1 phosphorylates Thr5, Ser249, Thr252, Thr356, Thr373, Ser788, Ser795, Ser807, Ser811, and Thr826 of pRB."	0.864	SIGNOR-250759
SIGNOR-MM	"Malignant Melanoma"	CyclinD/CDK4	complex	SIGNOR-C18	SIGNOR	RB1	protein	P06400	UNIPROT	"down-regulates activity"	phosphorylation	Thr356	DSFETQRtPRKSNLD	-1									9139732	t		llicata	"In summary, we have shown evidence that CDK4-cyclin D1 phosphorylates Thr5, Ser249, Thr252, Thr356, Thr373, Ser788, Ser795, Ser807, Ser811, and Thr826 of pRB."	0.864	SIGNOR-250760
SIGNOR-MM	"Malignant Melanoma"	E2F1	protein	Q01094	UNIPROT	G1/S_transition	phenotype	SIGNOR-PH50	SIGNOR	up-regulates				9606									21524151	f		lperfetto	"In its hypophosphorylated state, pRb binds transcription factors of the E2F family which are required for cell cycle progression. As the level of CyclinD/Cdk4/6 complexes increases, pRb becomes phosphorylated and progression through G1 occurs. At a critical level of phosphorylation, E2F is released from pRb. This activates the transcription of CyclinE which complexes with Cdk2 to fully release pRb repression by further phosphorylation, establishing a positive feedback loop. E2F further promotes the transcription of S-phase genes. Thus, CyclinD/Cdk4/6 and CyclinE/Cdk2 together regulate S-phase entry via phosphorylating pRb, which controls pRb binding to E2F"	0.7	SIGNOR-245477
SIGNOR-MM	"Malignant Melanoma"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	BAD	protein	Q92934	UNIPROT	"down-regulates activity"	phosphorylation			-1									8929531	t		lperfetto	"The rapid phosphorylation of bad following il-3 connects a proximal survival signal with the bcl-2 family, modulating this checkpoint for apoptosis.phosphorylatedBAD is bound to 14-3-3 within the cytosol, while only nonphosphorylated BAD is heterodimerized with membrane-bound BCL-XL."	0.2	SIGNOR-244497
SIGNOR-MM	"Malignant Melanoma"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	BCL2	protein	P10415	UNIPROT	"up-regulates quantity by stabilization"	phosphorylation	Ser87	AAAGPALsPVPPVVH	9606	BTO:0000567								10669763	t		lperfetto	"The results of this study reveal the following novel findings: destruction of the three putative MAP kinase sites at positions 56, 74, and 87 results in ubiquitination and subsequent degradation of the protein. Progressive inactivation of these MAP kinase sites revealed that Bcl-2 stability is mainly regulated by phosphorylation at Thr74 and Ser87, with Ser87 phosphorylation playing a predominant role. TNF-α or the MAP kinase-specific inhibitor PD98059 diminishes Ser87 phosphorylation of Bcl-2 in vivo, while activated ERK2 induces phosphorylation of Bcl-2 in vivo and in vitro."	0.2	SIGNOR-244505
SIGNOR-MM	"Malignant Melanoma"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	BCL2	protein	P10415	UNIPROT	"up-regulates quantity by stabilization"	phosphorylation	Thr74	ARTSPLQtPAAPGAA	9606	BTO:0000567								10669763	t		lperfetto	"The results of this study reveal the following novel findings: destruction of the three putative MAP kinase sites at positions 56, 74, and 87 results in ubiquitination and subsequent degradation of the protein. Progressive inactivation of these MAP kinase sites revealed that Bcl-2 stability is mainly regulated by phosphorylation at Thr74 and Ser87, with Ser87 phosphorylation playing a predominant role. TNF-α or the MAP kinase-specific inhibitor PD98059 diminishes Ser87 phosphorylation of Bcl-2 in vivo, while activated ERK2 induces phosphorylation of Bcl-2 in vivo and in vitro."	0.2	SIGNOR-244494
SIGNOR-MM	"Malignant Melanoma"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	BCL2	protein	P10415	UNIPROT	"up-regulates quantity by stabilization"	phosphorylation	Thr56	FSSQPGHtPHPAASR	9606									10669763	t		lperfetto	"The results of this study reveal the following novel findings: destruction of the three putative MAP kinase sites at positions 56, 74, and 87 results in ubiquitination and subsequent degradation of the protein. Progressive inactivation of these MAP kinase sites revealed that Bcl-2 stability is mainly regulated by phosphorylation at Thr74 and Ser87."	0.2	SIGNOR-244610
SIGNOR-MM	"Malignant Melanoma"	GRB2	protein	P62993	UNIPROT	SOS1	protein	Q07889	UNIPROT	"up-regulates activity"	relocalization			10090	BTO:0000669								23452850	t	"GRB2 associated guanine nucleotide exchange factor Sos activates Ras through the exchange of GDP for GTP"	lperfetto	"Interaction domains of sos1/grb2 are finely tuned for cooperative control of embryonic stem cell fate."	0.914	SIGNOR-235773
SIGNOR-MM	"Malignant Melanoma"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	Survival	phenotype	SIGNOR-PH13	SIGNOR	up-regulates				9606	BTO:0000876	BTO:0001103							11602185	f		apalma	"The GM-CSF promoted cell survival and proliferation correlated with MEK-1 dependent ERK1/2, Elk-1 and CREB phosphorylation and Egr-1, c-Fos expression as well as with increased STAT-5, AP-1, c-Myb and NF-kappaB DNA-binding."	0.7	SIGNOR-255579
SIGNOR-MM	"Malignant Melanoma"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	Survival	phenotype	SIGNOR-PH13	SIGNOR	up-regulates				9606	BTO:0000830								15526160	f			"Numerous studies have implicated the critical importance of the Ras/Erk pathway in cell division and survival"	0.7	SIGNOR-254948
SIGNOR-MM	"Malignant Melanoma"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	SOS1	protein	Q07889	UNIPROT	"down-regulates activity"	phosphorylation	Ser1197	KAYSPRYsISDRTSI	9534	BTO:0004055								8816480	t		lperfetto	"In this report, we describe the identification of five map kinase sites (s-1137, s-1167, s-1178, s-1193, and s-1197) on hsos1Replacing the MAP kinase phosphorylation sites with alanine residues results in an increase in the binding affinity of Grb2 to hSos1"	0.2	SIGNOR-244588
SIGNOR-MM	"Malignant Melanoma"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	SOS1	protein	Q07889	UNIPROT	"down-regulates activity"	phosphorylation	Ser1167	ESAPAESsPSKIMSK	9534	BTO:0004055								8816480	t		lperfetto	"In this report, we describe the identification of five map kinase sites (s-1137, s-1167, s-1178, s-1193, and s-1197) on hsos1Replacing the MAP kinase phosphorylation sites with alanine residues results in an increase in the binding affinity of Grb2 to hSos1"	0.2	SIGNOR-244584
SIGNOR-MM	"Malignant Melanoma"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	SOS1	protein	Q07889	UNIPROT	"down-regulates activity"	phosphorylation	Ser1132	TLPHGPRsASVSSIS	9534	BTO:0004055								8816480	t		lperfetto	"In this report, we describe the identification of five map kinase sites (s-1137, s-1167, s-1178, s-1193, and s-1197) on hsos1Replacing the MAP kinase phosphorylation sites with alanine residues results in an increase in the binding affinity of Grb2 to hSos1"	0.2	SIGNOR-244580
SIGNOR-MM	"Malignant Melanoma"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	SOS1	protein	Q07889	UNIPROT	"down-regulates activity"	phosphorylation			9606		BTO:0000763;BTO:0000149							20724475	t		lperfetto	"ERK activation was sufficient for the SOS1 phosphorylation and resulting inhibition of EGF-induced Ras activation. This result also showed that SOS1 could be phosphorylated by ERK in the absence of association with EGFR at the plasma membrane, which is a phosphotyrosine-dependent process."	0.2	SIGNOR-244591
SIGNOR-MM	"Malignant Melanoma"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	SOS1	protein	Q07889	UNIPROT	down-regulates	phosphorylation	Ser1178	IMSKHLDsPPAIPPR	9606									20724475	t		lperfetto	"ERK activation was sufficient for the SOS1 phosphorylation and resulting inhibition of EGF-induced Ras activation. This result also showed that SOS1 could be phosphorylated by ERK in the absence of association with EGFR at the plasma membrane, which is a phosphotyrosine-dependent process."	0.2	SIGNOR-244743
SIGNOR-MM	"Malignant Melanoma"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	SOS1	protein	Q07889	UNIPROT	down-regulates	phosphorylation	Ser1193	QPTSKAYsPRYSISD	9606									20724475	t		lperfetto	"ERK activation was sufficient for the SOS1 phosphorylation and resulting inhibition of EGF-induced Ras activation. This result also showed that SOS1 could be phosphorylated by ERK in the absence of association with EGFR at the plasma membrane, which is a phosphotyrosine-dependent process."	0.2	SIGNOR-244747
SIGNOR-MM	"Malignant Melanoma"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	RPS6KA5	protein	O75582	UNIPROT	"up-regulates activity"	phosphorylation	Ser376	EKLFQGYsFVAPSIL	9606									15568999	t		lperfetto	"In the present study, we show that, in addition to being phosphorylated on Thr-581 and Ser-360 by ERK1/2 or p38, MSK1 can autophosphorylate on at least six sites: Ser-212, Ser-376, Ser-381, Ser-750, Ser-752 and Ser-758. Of these sites, the N-terminal T-loop residue Ser-212 and the 'hydrophobic motif' Ser-376 are phosphorylated by the C-terminal kinase domain of MSK1, and their phosphorylation is essential for the catalytic activity of the N-terminal kinase domain of MSK1"	0.2	SIGNOR-249574
SIGNOR-MM	"Malignant Melanoma"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	RPS6KA5	protein	O75582	UNIPROT	up-regulates	phosphorylation	Thr581	PDNQPLKtPCFTLHY	9606									18267068	t		lperfetto	"Together, our in vivo and in vitro studies indicate that the pkc/c-raf/mek/erk pathway plays a major role in the s6k1 activation in hypertrophic cardiac growth."	0.2	SIGNOR-249573
SIGNOR-MM	"Malignant Melanoma"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	RPS6KA5	protein	O75582	UNIPROT	up-regulates	phosphorylation	Ser360	TEMDPTYsPAALPQS	9606									18267068	t		lperfetto	"Together, our in vivo and in vitro studies indicate that the pkc/c-raf/mek/erk pathway plays a major role in the s6k1 activation in hypertrophic cardiac growth."	0.2	SIGNOR-249572
SIGNOR-MM	"Malignant Melanoma"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606	BTO:0000876	BTO:0001103							11602185	f		apalma	"The GM-CSF promoted cell survival and proliferation correlated with MEK-1 dependent ERK1/2, Elk-1 and CREB phosphorylation and Egr-1, c-Fos expression as well as with increased STAT-5, AP-1, c-Myb and NF-kappaB DNA-binding."	0.7	SIGNOR-255580
SIGNOR-MM	"Malignant Melanoma"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				10090									20219869	f		areggio	"Furthermore, stimulation of myoblasts with CCL2, CCL3, or CCL4 was sufficient to induce phosphorylation and activation of ERK1/2. This outcome may be functionally important because ERK1/2 activation is a component of the pathway through which many mitogenic growth factors can stimulate cell proliferation."	0.7	SIGNOR-255120
SIGNOR-MM	"Malignant Melanoma"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									24743741	f			"Activation of PDGFRα stimulates proliferation of PDGFRα(+) cells through PI3K-Akt and MEK2-MAPK signaling pathways, and aberrant accumulation of PDGFRα(+) cells was conspicuous in muscles of patients with both genetic and non-genetic muscle diseases."	0.7	SIGNOR-254374
SIGNOR-MM	"Malignant Melanoma"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									19819937	f			"In addition to the JAK2–STAT5 pathway, the Ras GTPase–extracellular signal-regulated kinase (Ras–ERK) pathway has also been implicated in signaling of IL-5 and is important for IL-5-dependent cell survival, proliferation and differentiation of eosinophils."	0.7	SIGNOR-254354
SIGNOR-MM	"Malignant Melanoma"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606		BTO:0001103							20219869	f		apalma	"ERK1/2 activation is a component of the pathway through which many mitogenic growth factors can stimulate cell proliferation"	0.7	SIGNOR-256216
SIGNOR-MM	"Malignant Melanoma"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	MITF	protein	O75030	UNIPROT	down-regulates	phosphorylation	Ser180	PGSSAPNsPMAMLTL	9606									10673502	t	"The effect has been demonstrated using O75030-9"	gcesareni	"The current study reveals that c-kit signaling triggers two phosphorylation events on mi, which up-regulate transactivation potential yet simultaneously target mi for ubiquitin-dependent proteolysis. The specific activation/degradation signals derive from mapk/erk targeting of serine 73the results suggested that s1p reduced melanin synthesis via s1p(3) receptor-mediated erk and rsk-1 activation, and subsequent mitf dual phosphorylation and degradation."	0.2	SIGNOR-249575
SIGNOR-MM	"Malignant Melanoma"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	"down-regulates activity"	phosphorylation			9534	BTO:0004055								14993270	t		lperfetto	"We propose that activation of erk during adhesion creates a feedback system in which erk phosphorylates mek1 on t292, and this in turn blocks additional s298 phosphorylation in response to integrin signaling."	0.758	SIGNOR-244862
SIGNOR-MM	"Malignant Melanoma"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	"down-regulates activity"	phosphorylation			9606	BTO:0000007								10567369	t		lperfetto	"An ERK2-binding site at the N terminus of MEK1 was reported to mediate their stable association. We examined the importance of this binding site in the feedback phosphorylation of mek1 on thr(292) and thr(386) by erk2"	0.758	SIGNOR-244858
SIGNOR-MM	"Malignant Melanoma"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	E2F1	protein	Q01094	UNIPROT	"up-regulates activity"	phosphorylation			9606									23616010	t		lperfetto	"Erk also undergoes rapid translocation into the nucleus, where it phosphorylates and activates a variety of transcription factor targets, including sp1, e2f, elk-1, and ap1."	0.2	SIGNOR-233526
SIGNOR-MM	"Malignant Melanoma"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	BRAF	protein	P15056	UNIPROT	down-regulates	phosphorylation	Thr401	STTGLSAtPPASLPG	9606									21135229	t		lperfetto	"We show that b-raf is a calcineurin substrate;among calcineurin target residues on b-raf is t401, a site of negative feedback phosphorylation by erk1/2. Blocking calcineurin activity in _ cells prevents dephosphorylation of b-raf t401 and decreases b-raf and erk1/2 activities."	0.2	SIGNOR-170339
SIGNOR-MM	"Malignant Melanoma"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	BCL2	protein	P10415	UNIPROT	"up-regulates quantity by stabilization"	phosphorylation	Ser70	RDPVARTsPLQTPAA	9534	BTO:0004055								10677502	t		lperfetto	"Erk1 and erk2 directly phosphorylate bcl2 exclusively at ser-70."	0.2	SIGNOR-244501
SIGNOR-MM	"Malignant Melanoma"	GRB2	protein	P62993	UNIPROT	SOS1	protein	Q07889	UNIPROT	"up-regulates activity"	relocalization			9606									8479541	t	"GRB2 associated guanine nucleotide exchange factor Sos activates Ras through the exchange of GDP for GTP"	lperfetto	"Furthermore, our results indicate that the interaction domains of sos1 and grb2 have evolved so as to bind ligands not with maximal strength but with specificities and affinities that maintain cooperativity. Grb2 binds and activates sos, which then activates ras, and this activates p110 independently of p85."	0.914	SIGNOR-39163
SIGNOR-MM	"Malignant Melanoma"	GRB2	protein	P62993	UNIPROT	SOS1	protein	Q07889	UNIPROT	"up-regulates activity"	relocalization			9606	BTO:0001412								10570290	t	"GRB2 associated guanine nucleotide exchange factor Sos activates Ras through the exchange of GDP for GTP"	lperfetto	"Grb2 binds and activates sos, which then activates ras, and this activates p110 independently of p85."	0.914	SIGNOR-236792
SIGNOR-MM	"Malignant Melanoma"	KIT	protein	P10721	UNIPROT	GRB2	protein	P62993	UNIPROT	"up-regulates activity"	binding			9606					phosphorylation:Tyr703	DHAEAALyKNLLHSK			10377264	t		gcesareni	"We furthermore demonstrate that the adapter protein Grb2 is a specific binding partner for both phosphorylated Tyr-703 and phosphorylated Tyr-936, whereas the adapter protein Grb7 binds selectively to phosphorylated Tyr-936."	0.652	SIGNOR-248283
SIGNOR-MM	"Malignant Melanoma"	KIT	protein	P10721	UNIPROT	KIT	protein	P10721	UNIPROT	"up-regulates activity"	phosphorylation	Tyr568	EEINGNNyVYIDPTQ	9606	BTO:0001271								12824176	t		lperfetto	"Upon binding its ligand, stem cell factor (scf), c-kit forms an active dimer that autophosphorylates itself and activates a signaling cascade that induces cell growth./ Tyr-568 and tyr-570 are significantly phosphorylated"	0.2	SIGNOR-102633
SIGNOR-MM	"Malignant Melanoma"	KIT	protein	P10721	UNIPROT	KIT	protein	P10721	UNIPROT	"up-regulates activity"	phosphorylation	Tyr570	INGNNYVyIDPTQLP	9606									12824176	t		lperfetto	"Upon binding its ligand, stem cell factor (scf), c-kit forms an active dimer that autophosphorylates itself and activates a signaling cascade that induces cell growth./ Tyr-568 and tyr-570 are significantly phosphorylated"	0.2	SIGNOR-102637
SIGNOR-MM	"Malignant Melanoma"	KIT	protein	P10721	UNIPROT	KIT	protein	P10721	UNIPROT	"up-regulates activity"	phosphorylation	Tyr823	DIKNDSNyVVKGNAR	9606									12824176	t		lperfetto	"Upon binding its ligand, stem cell factor (scf), c-kit forms an active dimer that autophosphorylates itself and activates a signaling cascade that induces cell growth. / tyr-823 is the last tyrosine residue to be autophosphorylated"	0.2	SIGNOR-102641
SIGNOR-MM	"Malignant Melanoma"	KIT	protein	P10721	UNIPROT	KIT	protein	P10721	UNIPROT	up-regulates	phosphorylation	Tyr703	DHAEAALyKNLLHSK	9606									10377264	t		miannu	"Identification of tyr-703 and tyr-936 as autophosphorylation sites in c-kit/scfr"	0.2	SIGNOR-68643
SIGNOR-MM	"Malignant Melanoma"	KIT	protein	P10721	UNIPROT	KIT	protein	P10721	UNIPROT	up-regulates	phosphorylation	Tyr936	SESTNHIySNLANCS	9606									10377264	t		miannu	"Identification of tyr-703 and tyr-936 as autophosphorylation sites in c-kit/scfr"	0.2	SIGNOR-68647
SIGNOR-MM	"Malignant Melanoma"	KITLG	protein	P21583	UNIPROT	KIT	protein	P10721	UNIPROT	"up-regulates activity"	binding			9606									17259966	t		miannu	"The most relevant and still unique mast-cell growth factor is SCF, which is the ligand of KIT, a receptor with tyrosine-kinase activity that is expressed on the surface of all human and murine mast cells"	0.935	SIGNOR-254946
SIGNOR-MM	"Malignant Melanoma"	KITLG	protein	P21583	UNIPROT	KIT	protein	P10721	UNIPROT	up-regulates	binding			9606									1698556	t		gcesareni	"We have also provided biological and physical evidence that scf is a ligand for the c-kit receptor."	0.935	SIGNOR-21193
SIGNOR-MM	"Malignant Melanoma"	MDM2	protein	Q00987	UNIPROT	TP53	protein	P04637	UNIPROT	"down-regulates quantity by destabilization"	ubiquitination			9606									23150757	t		lperfetto	"Dual Roles of MDM2 in the Regulation of p53: Ubiquitination Dependent and Ubiquitination Independent Mechanisms of MDM2 Repression of p53 Activity"	0.968	SIGNOR-199371
SIGNOR-MM	"Malignant Melanoma"	MDM2	protein	Q00987	UNIPROT	TP53	protein	P04637	UNIPROT	"down-regulates quantity by destabilization"	ubiquitination			9606									10935507	t		lperfetto	"Many posttranslational modifications of p53, such as phosphorylation, dephosphorylation, acetylation and ribosylation, have been shown to occur following cellular stress. Some of these modifications may activate the p53 protein, interfere with MDM2 binding and/or dictate cellular localization of p53."	0.968	SIGNOR-80528
SIGNOR-MM	"Malignant Melanoma"	MDM2	protein	Q00987	UNIPROT	TP53	protein	P04637	UNIPROT	"down-regulates quantity by destabilization"	ubiquitination			9606									22337874	t		lperfetto	"The E3 ubiquitin ligase, MDM2, uses a dual-site mechanism to ubiquitinate and degrade the tumor suppressor protein p53, involving interactions with the N-terminal hydrophobic pocket and the acidic domain of MDM2."	0.968	SIGNOR-196116
SIGNOR-MM	"Malignant Melanoma"	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	up-regulates	phosphorylation			9606									11971971	t		lperfetto	"Mapk1 is phosphorylated by map2k1/mek1 and map2k2/mek2 on thr-185 and tyr-187 in response to external stimuli like insulin or ngf. Both phosphorylations are required for activity."	0.758	SIGNOR-244776
SIGNOR-MM	"Malignant Melanoma"	MITF	protein	O75030	UNIPROT	BCL2	protein	P10415	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"												12086670	t		lperfetto	"MITF directly occupies the BCL2 promoter in vivo and this suggest that BCL2 may be a direct transcriptional target of MITF"	0.481	SIGNOR-249618
SIGNOR-MM	"Malignant Melanoma"	NRAS	protein	P01111	UNIPROT	BRAF	protein	P15056	UNIPROT	"up-regulates activity"	binding			9606									21779497	t		lperfetto	"The raf family of proteins (raf-1, a-raf, and b-raf) is serine/threonine kinases that bind to the effector region of ras-gtp, thus inducing translocation of the protein to the plasma membrane. Once there, raf proteins are activated and phosphorylated by different protein kinases."	0.855	SIGNOR-175219
SIGNOR-MM	"Malignant Melanoma"	NRAS	protein	P01111	UNIPROT	PIK3CA	protein	P42336	UNIPROT	"up-regulates activity"	binding			9606									21779497	t		lperfetto	"Grb2 binds and activates sos, which then activates ras, and this activates p110 independently of p85./it was also described that ras interacts with pi3k in a direct manner./lysine residue 227 is essential for the interaction of ras with pi3k"	0.844	SIGNOR-175222
SIGNOR-MM	"Malignant Melanoma"	PDPK1	protein	O15530	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation			9606									15743829	t		lperfetto	"3-phosphoinositide-dependent kinase 1 (PDK1) phosphorylates the activation loop of a number of protein serine/threonine kinases of the AGC kinase superfamily, including protein kinase B (PKB; also called Akt),"	0.746	SIGNOR-244469
SIGNOR-MM	"Malignant Melanoma"	PDPK1	protein	O15530	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation	Thr308	KDGATMKtFCGTPEY	9606									15718470	t		gcesareni	"Akt/PKB activation requires the phosphorylation of Thr308 in the activation loop by the phosphoinositide-dependent kinase 1 (PDK1) and Ser473 within the carboxyl-terminal hydrophobic motif by an unknown kinase."	0.746	SIGNOR-243203
SIGNOR-MM	"Malignant Melanoma"	PDPK1	protein	O15530	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation	Thr308	KDGATMKtFCGTPEY	10090									12808134	t		lperfetto	"Akt1 and akt2 are phosphorylated and activated by the protein kinase pdk1 at thr-308 or thr-309, respectively, in the activation t-loop, and further activation occurs through phosphorylation at ser-473 or ser-474, respectively. In this paper, we demonstrate that this is indeed the case, and report the purification and initial characterization of a 3 phosphoinositide-dependent protein kinase, pdk1, which activates pkb by phosphorylating it at thr308. Akt is directly phosphorylated and activated by pdk1. Akt/pkb activation requires the phosphorylation of thr308 in the activation loop by the phosphoinositide-dependent kinase 1 (pdk1)."	0.746	SIGNOR-134477
SIGNOR-MM	"Malignant Melanoma"	PDPK1	protein	O15530	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation	Thr308	KDGATMKtFCGTPEY	9606		BTO:0000887;BTO:0001103;BTO:0001760							9512493	t		lperfetto	"The activation of PKBbeta and PKBamma by PDK11 was accompanied by the phosphorylation of the residues equivalent to Thr308 in PKBalpha, namely Thr309 (PKBbeta) and Thr305 (PKBgamma)"	0.746	SIGNOR-244480
SIGNOR-MM	"Malignant Melanoma"	PDPK1	protein	O15530	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation	Thr308	KDGATMKtFCGTPEY	10116		BTO:0000142							10226025	t		lperfetto	"Protein kinase B (PKB) is activated by phosphorylation of Thr308 and of Ser473. Thr308 is phosphorylated by the 3-phosphoinositide-dependent protein kinase-1 (PDK1) but the identity of the kinase that phosphorylates Ser473 (provisionally termed PDK2) is unknown."	0.746	SIGNOR-244421
SIGNOR-MM	"Malignant Melanoma"	PDPK1	protein	O15530	UNIPROT	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	"up-regulates activity"	phosphorylation			9606	BTO:0000007								15175348	t		lperfetto	"In vitro kinase assay revealed that the direct targets of pdk1 in the mapk pathway were the upstream mapk kinases mek1 and mek2. The identified pdk1 phosphorylation sites in mek1 and mek2 are ser222 and ser226, respectively, and are known to be essential for full activation"	0.272	SIGNOR-244934
SIGNOR-MM	"Malignant Melanoma"	PDPK1	protein	O15530	UNIPROT	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	up-regulates	phosphorylation			9606									15175348	t		lperfetto	"The identified pdk1 phosphorylation sites in mek1 and mek2 are ser222 and ser226, respectively, and are known to be essential for full activation."	0.272	SIGNOR-244938
SIGNOR-MM	"Malignant Melanoma"	PIK3CA	protein	P42336	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation			9606									12167717	t		lperfetto	"PKB induction requires phosphorylation of two critical residues, threonine 308 in the activation loop and serine 473 near the carboxyl terminus. Membrane localization of PKB was found to be a primary determinant of serine 473 phosphorylation. PI3K activity was equally important for promoting phosphorylation of serine 473,"	0.821	SIGNOR-244429
SIGNOR-MM	"Malignant Melanoma"	PIK3CA	protein	P42336	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"				9606		BTO:0000150							19573809	f		lperfetto	"However, here we show through phosphoprotein profiling and functional genomic studies that many PIK3CA mutant cancer cell lines and human breast tumors exhibit only minimal AKT activation and a diminished reliance on AKT for anchorage-independent growth"	0.821	SIGNOR-236436
SIGNOR-MM	"Malignant Melanoma"	PIK3CA	protein	P42336	UNIPROT	PIP3	smallmolecule	CHEBI:16618	ChEBI	"up-regulates quantity"	"chemical modification"			9606									24367090	t	"AKT is a serine-threonine protein kinase that plays important roles in cell growth, proliferation and apoptosis. It is activated after binding to phosphatidylinositol phosphates (PIPs) with phosphate s at positions 3, 4 and 3,4,5 on the inositol ring"	miannu	"Insulin activation of phosphoinositide 3-kinase (pi3k) signaling regulates glucose homeostasis through the production of phosphatidylinositol 3,4,5-trisphosphate (pip3). The dual-specificity phosphatase and tensin homolog deleted on chromosome 10 (pten) blocks pi3k signaling by dephosphorylating pip3, and is inhibited through its interaction with phosphatidylinositol 3,4,5-trisphosphate-dependent rac exchanger 2"	0.8	SIGNOR-147948
SIGNOR-MM	"Malignant Melanoma"	PIK3CA	protein	P42336	UNIPROT	PIP3	smallmolecule	CHEBI:16618	ChEBI	"up-regulates quantity"	"chemical modification"			9606									24647478	t	"AKT is a serine-threonine protein kinase that plays important roles in cell growth, proliferation and apoptosis. It is activated after binding to phosphatidylinositol phosphates (PIPs) with phosphate s at positions 3, 4 and 3,4,5 on the inositol ring"	miannu	"Stimulation of tyrosine kinase receptors initiates a signaling cascade that activates pi3k. Activated pi3k uses pip2 to generate pip3, which recruit akt to the plasma membrane through its pleckstrin homology (ph) domain, permitting its activation by pdks."	0.8	SIGNOR-65409
SIGNOR-MM	"Malignant Melanoma"	PTEN	protein	P60484	UNIPROT	CREB1	protein	P16220	UNIPROT	"down-regulates activity"	dephosphorylation	Ser119	EILSRRPsYRKILND	10090	BTO:0002572								21385900	t			"Our study demonstrates that PTEN can dephosphorylate CREB at Ser133 and that PTEN protein phosphatase activity is required for CREB dephosphoryation.|Moreover, we use both in vitro and in vivo experiments to show PTEN can dephosphorylate CREB in a phosphatase-dependent manner, suggesting that CREB is a substrate of PTEN nuclear phosphatase. Loss of Pten results in an elevated RNA level of multiple CREB transcriptional targets and increased cell proliferation, which can be reversed by a nonphosphorylatable CREB mutant or knockdown of CREB. These data reveal a mechanism for PTEN modulation of CREB-mediated gene transcription and cell growth."	0.438	SIGNOR-248543
SIGNOR-MM	"Malignant Melanoma"	PTEN	protein	P60484	UNIPROT	PTEN	protein	P60484	UNIPROT	"up-regulates activity"	dephosphorylation	Thr383	HYRYSDTtDSDPENE	9606									22413754	t		miannu	"Overall, our results suggest that PTEN autodephosphorylation may be a critical event in this process; thus a major protein substrate for PTEN may be PTEN itself.|Various studies have demonstrated that PTEN is itself a phosphoprotein, and that the major sites of phosphorylation are found in an acidic stretch (DHYRYSDTTDSDPENE) near the C-terminus [1]. This prompted us to consider whether PTEN may autodephosphorylate these sites"	0.2	SIGNOR-248545
SIGNOR-MM	"Malignant Melanoma"	PTEN	protein	P60484	UNIPROT	PTEN	protein	P60484	UNIPROT	"up-regulates activity"	dephosphorylation	Thr382	DHYRYSDtTDSDPEN	9606									22413754	t		miannu	"Overall, our results suggest that PTEN autodephosphorylation may be a critical event in this process; thus a major protein substrate for PTEN may be PTEN itself.|Various studies have demonstrated that PTEN is itself a phosphoprotein, and that the major sites of phosphorylation are found in an acidic stretch (DHYRYSDTTDSDPENE) near the C-terminus [1]. This prompted us to consider whether PTEN may autodephosphorylate these sites"	0.2	SIGNOR-248546
SIGNOR-MM	"Malignant Melanoma"	PTEN	protein	P60484	UNIPROT	PTEN	protein	P60484	UNIPROT	"up-regulates activity"	dephosphorylation	Ser380	EPDHYRYsDTTDSDP	9606									22413754	t		miannu	"Overall, our results suggest that PTEN autodephosphorylation may be a critical event in this process; thus a major protein substrate for PTEN may be PTEN itself.|Various studies have demonstrated that PTEN is itself a phosphoprotein, and that the major sites of phosphorylation are found in an acidic stretch (DHYRYSDTTDSDPENE) near the C-terminus [1]. This prompted us to consider whether PTEN may autodephosphorylate these sites"	0.2	SIGNOR-248544
SIGNOR-MM	"Malignant Melanoma"	PTEN	protein	P60484	UNIPROT	PIP3	smallmolecule	CHEBI:16618	ChEBI	"down-regulates quantity"	"chemical modification"			9606									11875759	t		lperfetto	"PTEN dephosphorylates PI3P, lowering its cellular levels and resulting in the down-regulation of AKT."	0.8	SIGNOR-228145
SIGNOR-MM	"Malignant Melanoma"	PIP3	smallmolecule	CHEBI:16618	ChEBI	PDPK1	protein	O15530	UNIPROT	"up-regulates activity"	"chemical activation"			9606									19951971	t		lperfetto	"PIP3 recruits PDK1 and AKT to the plasma membrane, where PDK1 phosphorylates AKT on Thr308 in the activation loop of the kinase domain."	0.8	SIGNOR-249628
SIGNOR-MM	"Malignant Melanoma"	PIP3	smallmolecule	CHEBI:16618	ChEBI	PDPK1	protein	O15530	UNIPROT	"up-regulates activity"	relocalization			9606									21798082	t		lperfetto	"Pip3 acts in turn as a docking site for two kinases, phosphoinositide-dependent kinase 1 (PDK1) and AKT, and the subsequent phosphorylation of AKT at serine 308 by PDK1, leading to AKT activation."	0.8	SIGNOR-175253
SIGNOR-MM	"Malignant Melanoma"	PIP3	smallmolecule	CHEBI:16618	ChEBI	PDPK1	protein	O15530	UNIPROT	"up-regulates activity"	relocalization			9534									9637919	t		lperfetto	"In response to PDGF, binding of ptdlns (3,4,5)p3 and/or ptdlns(3,4)p2 to the PH domain of PDK-1 causes its translocation to the plasma membrane where it co-localises with PKB, significantly contributing to the scale of PKB activation."	0.8	SIGNOR-58313
SIGNOR-MM	"Malignant Melanoma"	PIP3	smallmolecule	CHEBI:16618	ChEBI	PDPK1	protein	O15530	UNIPROT	"up-regulates activity"	"chemical activation"			-1									9094314	t		gcesareni	"We tested the kinase in the presence of several inositol phospholipids and found that only low micromolar concentrations of the D enantiomers of either phosphatidylinositol 3,4,5-triphosphate (PtdIns(3,4,5)P3) or PtdIns(3,4)P2 were effective in potently activating the kinase, which has been named PtdIns(3,4,5)P3-dependent protein kinase-1 (PDK1)"	0.8	SIGNOR-243274
SIGNOR-MM	"Malignant Melanoma"	RB1	protein	P06400	UNIPROT	E2F1	protein	Q01094	UNIPROT	"down-regulates activity"	binding			9606									8255752	t		amattioni	"E2f binds rb. E2f activation domain is the target for rb-induced repression. Rb can silence the 57 residue e2f activation domain. Rb can mask e2f residues involved in the activation process, possibly by mimicking a component of the transcriptional machinery"	0.92	SIGNOR-37305
SIGNOR-MM	"Malignant Melanoma"	RB1	protein	P06400	UNIPROT	G1/S_transition	phenotype	SIGNOR-PH50	SIGNOR	down-regulates				9606									21524151	f		lperfetto	"In its hypophosphorylated state, pRb binds transcription factors of the E2F family which are required for cell cycle progression. As the level of CyclinD/Cdk4/6 complexes increases, pRb becomes phosphorylated and progression through G1 occurs. At a critical level of phosphorylation, E2F is released from pRb. This activates the transcription of CyclinE which complexes with Cdk2 to fully release pRb repression by further phosphorylation, establishing a positive feedback loop. E2F further promotes the transcription of S-phase genes. Thus, CyclinD/Cdk4/6 and CyclinE/Cdk2 together regulate S-phase entry via phosphorylating pRb, which controls pRb binding to E2F"	0.7	SIGNOR-245483
SIGNOR-MM	"Malignant Melanoma"	RPS6KA5	protein	O75582	UNIPROT	CREB1	protein	P16220	UNIPROT	up-regulates	phosphorylation	Ser119	EILSRRPsYRKILND	9606	BTO:0000567								9687510	t		lperfetto	"Msk1 is localized in the nucleus of unstimulated or stimulated cells, and phosphorylates creb at ser133_ .MSK1 Is activated in vitro by mapk2/erk2 or sapk2/p38. Endogenous msk1 is activated in 293 cells by either growth factor/phorbol ester stimulation, or by exposure to uv radiation, and oxidative and chemical stres msk was the kinase responsible for phosphorylation of the transcription factor creb in response to tcr stimulation. Pka, ca2+-calmodulin-dependent kinase iv (camkiv), msk, p70s6k and rsk phosphorylate creb."	0.735	SIGNOR-59458
SIGNOR-MM	"Malignant Melanoma"	RPS6KA5	protein	O75582	UNIPROT	RPS6KA5	protein	O75582	UNIPROT	unknown	phosphorylation	Ser750	RRKMKKTsTSTETRS	9606									15568999	t		lperfetto	"Msk1 can autophosphorylate on at least six sites: ser-212, ser-376, ser-381, ser-750, ser-752 and ser-758.  ser-750, ser-752 and ser-758 are phosphorylated by the n-terminal kinase domain;however, their function is not known."	0.2	SIGNOR-131399
SIGNOR-MM	"Malignant Melanoma"	RPS6KA5	protein	O75582	UNIPROT	RPS6KA5	protein	O75582	UNIPROT	unknown	phosphorylation	Ser752	KMKKTSTsTETRSSS	9606									15568999	t		lperfetto	"Msk1 can autophosphorylate on at least six sites: ser-212, ser-376, ser-381, ser-750, ser-752 and ser-758.  ser-750, ser-752 and ser-758 are phosphorylated by the n-terminal kinase domain;however, their function is not known."	0.2	SIGNOR-131403
SIGNOR-MM	"Malignant Melanoma"	RPS6KA5	protein	O75582	UNIPROT	RPS6KA5	protein	O75582	UNIPROT	unknown	phosphorylation	Ser758	TSTETRSsSSESSHS	9606									15568999	t		lperfetto	"Msk1 can autophosphorylate on at least six sites: ser-212, ser-376, ser-381, ser-750, ser-752 and ser-758.  ser-750, ser-752 and ser-758 are phosphorylated by the n-terminal kinase domain;however, their function is not known."	0.2	SIGNOR-131407
SIGNOR-MM	"Malignant Melanoma"	RPS6KA5	protein	O75582	UNIPROT	RPS6KA5	protein	O75582	UNIPROT	"up-regulates activity"	phosphorylation	Ser212	DETERAYsFCGTIEY	9606									15568999	t		lperfetto	"Msk1 can autophosphorylate on at least six sites: ser-212, ser-376, ser-381, ser-750, ser-752 and ser-758. Of these sites, the n-terminal t-loop residue ser-212 and the 'hydrophobic motif' ser-376 are phosphorylated by the c-terminal kinase domain of msk1, and their phosphorylation is essential for the catalytic activity of the n-terminal kinase domain of msk1 and therefore for the phosphorylation of msk1 substrates in vitro."	0.2	SIGNOR-131387
SIGNOR-MM	"Malignant Melanoma"	RPS6KA5	protein	O75582	UNIPROT	RPS6KA5	protein	O75582	UNIPROT	"up-regulates activity"	phosphorylation	Ser376	EKLFQGYsFVAPSIL	9606									15568999	t		lperfetto	"Msk1 can autophosphorylate on at least six sites: ser-212, ser-376, ser-381, ser-750, ser-752 and ser-758. Of these sites, the n-terminal t-loop residue ser-212 and the 'hydrophobic motif' ser-376 are phosphorylated by the c-terminal kinase domain of msk1, and their phosphorylation is essential for the catalytic activity of the n-terminal kinase domain of msk1 and therefore for the phosphorylation of msk1 substrates in vitro."	0.2	SIGNOR-131391
SIGNOR-MM	"Malignant Melanoma"	RPS6KA5	protein	O75582	UNIPROT	RPS6KA5	protein	O75582	UNIPROT	"up-regulates activity"	phosphorylation	Ser381	GYSFVAPsILFKRNA	9606									15568999	t		lperfetto	"Msk1 can autophosphorylate on at least six sites: ser-212, ser-376, ser-381, ser-750, ser-752 and ser-758. Of these sites, the n-terminal t-loop residue ser-212 and the 'hydrophobic motif' ser-376 are phosphorylated by the c-terminal kinase domain of msk1, and their phosphorylation is essential for the catalytic activity of the n-terminal kinase domain of msk1 and therefore for the phosphorylation of msk1 substrates in vitro."	0.2	SIGNOR-131395
SIGNOR-MM	"Malignant Melanoma"	SOS1	protein	Q07889	UNIPROT	NRAS	protein	P01111	UNIPROT	"up-regulates activity"	"guanine nucleotide exchange factor"			9606									21779497	t		lperfetto	"Grb2 binds and activates sos, which then activates ras, and this activates p110 independently of p85."	0.781	SIGNOR-175259
SIGNOR-MM	"Malignant Melanoma"	SOS1	protein	Q07889	UNIPROT	NRAS	protein	P01111	UNIPROT	"up-regulates activity"	"guanine nucleotide exchange factor"			9606	BTO:0000938								11560935	t		lperfetto	"Sos and Ras-GRF are two families of guanine nucleotide exchange factors that activate Ras proteins in cells. Sos proteins are ubiquitously expressed and are activated in response to cell-surface tyrosine kinase stimulation Sos1 and Ras-GRF1 activate the Ras proteins Ha-Ras, N-Ras, and Ki-Ras"	0.781	SIGNOR-110566
SIGNOR-MM	"Malignant Melanoma"	TP53	protein	P04637	UNIPROT	Apoptosis	phenotype	SIGNOR-PH2	SIGNOR	up-regulates				9606									24212651	f		miannu	"P53 is a nuclear transcription factor with a pro-apoptotic function"	0.7	SIGNOR-255678
SIGNOR-MM	"Malignant Melanoma"	TP53	protein	P04637	UNIPROT	BCL2	protein	P10415	UNIPROT	"down-regulates activity"	binding			9606									19007744	t	"Cytosolic p53"	lperfetto	"Mechanistic insights into the mitochondrial function of wtp53 came when it was realized that mitochondrially translocated p53 interacts directly with members of the Bcl-2 family, which are central in governing the induction of mitochondrial outer membrane permeabilization. In response to stress, wtp53 interacts with and neutralizes the anti-apoptotic members Bcl-xL and Bcl-2. This interaction stimulates MOMP and subsequent apoptosis"	0.752	SIGNOR-99712
SIGNOR-MM	"Malignant Melanoma"	TP53	protein	P04637	UNIPROT	MDM2	protein	Q00987	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			10090									7958853	f		gcesareni	"The p53 tumor suppressor protein trans-activates mdm2 itself, which is therefore considered a component of a p53 negative feedback loop."	0.968	SIGNOR-34962
SIGNOR-MM	"Malignant Melanoma"	TP53	protein	P04637	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	down-regulates				9606	BTO:0000452								7667317	f			"P53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts"	0.7	SIGNOR-255669
SIGNOR-MM	"Malignant Melanoma"	BCL2	protein	P10415	UNIPROT	BAK1	protein	Q16611	UNIPROT	down-regulates	binding			9606									17289999	t		gcesareni	"Bax is held in check by mcl1, bcl-2, and either bcl2l1 or bcl2l2, or by all four. They bind a primed conformer of bak or bax bax/bak are kept in check by the pro-survival bcl-2 family members and also proposes that for apoptotic death to occur, all pro-survival bcl-2-like proteins present within a given cell need to be neutralised by bh3-only proteins, thereby derepressing bax/bak"	0.676	SIGNOR-152980
SIGNOR-MM	"Malignant Melanoma"	BCL2	protein	P10415	UNIPROT	BAX	protein	Q07812	UNIPROT	"down-regulates activity"	binding			9606	BTO:0000776;BTO:0000785								8183370	t		lperfetto	"Bcl-2 has the unique oncogenic role of extending cell survival by inhibiting a variety of apoptotic deaths. Bcl-2 exerts its action through heterodimerization with bax."	0.637	SIGNOR-36898
SIGNOR-NSCLCN	"Non-small-cell lung cancer (NSCLC)"	KRAS	protein	P01116	UNIPROT	PI3K	complex	SIGNOR-C156	SIGNOR	up-regulates	binding			9606									21779497	t		gcesareni	"Grb2 binds and activates sos, which then activates ras, and this activates p110 independently of p85./it was also described that ras interacts with pi3k in a direct manner./lysine residue 227 is essential for the interaction of ras with pi3k phosphatidylinositol 3-kinase (pi3k) is one of the main effector pathways of ras, regulating cell growth, cell cycle entry, cell survival, cytoskeleton reorganization, and metabolism."	0.742	SIGNOR-252698
SIGNOR-NSCLCN	"Non-small-cell lung cancer (NSCLC)"	KRAS	protein	P01116	UNIPROT	RASSF1	protein	Q9NS23	UNIPROT	"up-regulates activity"	binding			9606									22195963	t		lperfetto	"Mutant K-Ras promotes MST2 activation in two ways (i.e., by direct disruption of the inhibitory Raf-1-MST2 complex (Matallanas et al., 2008) and by forming an activating (i.e., by direct disruption of the inhibitory Raf-1-MST2 complex K-Ras-RASSF1AMST2 complex, as reported here"	0.652	SIGNOR-249585
SIGNOR-NSCLCN	"Non-small-cell lung cancer (NSCLC)"	TP53	protein	P04637	UNIPROT	BCL2	protein	P10415	UNIPROT	"down-regulates activity"	binding			9606									19007744	t	"Cytosolic p53"	lperfetto	"Mechanistic insights into the mitochondrial function of wtp53 came when it was realized that mitochondrially translocated p53 interacts directly with members of the Bcl-2 family, which are central in governing the induction of mitochondrial outer membrane permeabilization. In response to stress, wtp53 interacts with and neutralizes the anti-apoptotic members Bcl-xL and Bcl-2. This interaction stimulates MOMP and subsequent apoptosis"	0.752	SIGNOR-99712
SIGNOR-NSCLCN	"Non-small-cell lung cancer (NSCLC)"	DNA_damage	stimulus	SIGNOR-ST1	SIGNOR	TP53	protein	P04637	UNIPROT	"up-regulates quantity"				9606									19879762	f		lperfetto	"In the case of DNA-damage, phosphorylation of both p53 and Mdm2 by the checkpoint kinases ATM, ATR, Chk1 and Chk2 contributes to the dissociation of the Mdm2-p53 complex, leading to enhanced cellular p53 levels that primarily accumulate in the nucleus."	0.7	SIGNOR-209690
SIGNOR-NSCLCN	"Non-small-cell lung cancer (NSCLC)"	TP53	protein	P04637	UNIPROT	BAK1	protein	Q16611	UNIPROT	up-regulates	binding			9606									15077116	t		gcesareni	"P53 interacts with the pro-apoptotic mitochondrial membrane protein bak"	0.694	SIGNOR-124122
SIGNOR-NSCLCN	"Non-small-cell lung cancer (NSCLC)"	BCL2	protein	P10415	UNIPROT	BAK1	protein	Q16611	UNIPROT	down-regulates	binding			9606									9463381	t		amattioni	"Bcl-2 bind to bax or five other pro-apoptotic relatives (bak, bad, bik, bid or bim)"	0.676	SIGNOR-55546
SIGNOR-NSCLCN	"Non-small-cell lung cancer (NSCLC)"	HRAS	protein	P01112	UNIPROT	BRAF	protein	P15056	UNIPROT	up-regulates	binding			10090	BTO:0000944								7706312	t		lperfetto	"Association of B-Raf with immobilized Ras occurred independently of prior stimulation of cells with serum, suggesting that primarily the production of GTP-Ras by mitogen stimulation is critical for the formation of B-Raf_GTP-Ras complexes."	0.879	SIGNOR-235478
SIGNOR-NSCLCN	"Non-small-cell lung cancer (NSCLC)"	"ErbB receptor family"	proteinfamily	SIGNOR-PF36	SIGNOR	GRB2	protein	P62993	UNIPROT	"up-regulates activity"	binding			9606									14967450	t		miannu	"All erbb ligands and receptors couple to activation of the ras-mapk pathway, either directly through sh2 domain-mediated recruitment of grb-2 or indirectly through ptb domain-mediated binding of the shc adaptor"	0.2	SIGNOR-256162
SIGNOR-NSCLCN	"Non-small-cell lung cancer (NSCLC)"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				10090									20219869	f		areggio	"Furthermore, stimulation of myoblasts with CCL2, CCL3, or CCL4 was sufficient to induce phosphorylation and activation of ERK1/2. This outcome may be functionally important because ERK1/2 activation is a component of the pathway through which many mitogenic growth factors can stimulate cell proliferation."	0.7	SIGNOR-255120
SIGNOR-NSCLCN	"Non-small-cell lung cancer (NSCLC)"	SOS1	protein	Q07889	UNIPROT	HRAS	protein	P01112	UNIPROT	"up-regulates activity"	"guanine nucleotide exchange factor"			9606									23132018	t		lperfetto	"The enhancement of H-Ras GTP levels induced by oncogenic K-Ras was abrogated when the expression of endogenous Sos was suppressed, implicating Sos as an essential intermediate in the cross talk between oncogenic K-Ras and WT H-Ras."	0.892	SIGNOR-39237
SIGNOR-NSCLCN	"Non-small-cell lung cancer (NSCLC)"	BRAF	protein	P15056	UNIPROT	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	"up-regulates activity"	phosphorylation			10090									8131746	t		lperfetto	"Activation of mek family kinases requires phosphorylation of two conserved ser/thr residueserine residues 218 and 222 of human mek1 are the primary sites for phosphorylation by c-raf."	0.787	SIGNOR-244827
SIGNOR-NSCLCN	"Non-small-cell lung cancer (NSCLC)"	"ErbB receptor family"	proteinfamily	SIGNOR-PF36	SIGNOR	PI3K	complex	SIGNOR-C156	SIGNOR	"up-regulates activity"	binding			9606									17306385	t		miannu	"Another phospholipid modifying signaling pathway activated by RTKs is the PI3K pathway. This heterodimeric enzyme comprises two subunits, the p85 regulatory subunit harboring two SH2 domains, and the p110 catalytic subunit. PI3K activation may be achieved by binding of its p85 regulatory subunit to an activated receptor. Alternatively, RTK signaling may activate the small G protein Ras, which in turn recruits PI3K to the plasma membrane and induces a stimulatory conformational change in the lipid kinase"	0.784	SIGNOR-256168
SIGNOR-NSCLCN	"Non-small-cell lung cancer (NSCLC)"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									19819937	f			"In addition to the JAK2–STAT5 pathway, the Ras GTPase–extracellular signal-regulated kinase (Ras–ERK) pathway has also been implicated in signaling of IL-5 and is important for IL-5-dependent cell survival, proliferation and differentiation of eosinophils."	0.7	SIGNOR-254354
SIGNOR-NSCLCN	"Non-small-cell lung cancer (NSCLC)"	BRAF	protein	P15056	UNIPROT	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	"up-regulates activity"	phosphorylation			9606									21900390	t		miannu	"BRAFV600E has been shown to initiate thyroid follicular cell transformation. The BRAFV600E mutation disrupts the hydrophobic interaction, enabling the BRAF kinase to fold into a catalytically active formation, resulting in an almost 500-fold increase in kinase activity. Mutant BRAF can dimerize and activate MEK without Ras activation."	0.787	SIGNOR-251988
SIGNOR-NSCLCN	"Non-small-cell lung cancer (NSCLC)"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	Survival	phenotype	SIGNOR-PH13	SIGNOR	up-regulates				9606									16288293	f		miannu	"Akt promotes both cell growth and cell survival by inactivating its downstream substrates including GSK3, BAD, FOXO and TSC2."	0.7	SIGNOR-251550
SIGNOR-NSCLCN	"Non-small-cell lung cancer (NSCLC)"	PIP3	smallmolecule	CHEBI:16618	ChEBI	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	relocalization			9606		BTO:0001130							23633519	t		lperfetto	"Akt is a serine-threonine protein kinase that plays important roles in cell growth, proliferation and apoptosis. It is activated after binding to phosphatidylinositol phosphates pips) with phosphate groups at positions 3,4 and 3,4,5 on the inositol ring."	0.8	SIGNOR-236490
SIGNOR-NSCLCN	"Non-small-cell lung cancer (NSCLC)"	PI3K	complex	SIGNOR-C156	SIGNOR	PIP3	smallmolecule	CHEBI:16618	ChEBI	"up-regulates quantity"	"chemical modification"			9606									24647478	t		lperfetto	"Stimulation of tyrosine kinase receptors initiates a signaling cascade that activates pi3k. Activated pi3k uses pip2 to generate pip3, 24647478"	0.8	SIGNOR-252712
SIGNOR-NSCLCN	"Non-small-cell lung cancer (NSCLC)"	PIP3	smallmolecule	CHEBI:16618	ChEBI	PDPK1	protein	O15530	UNIPROT	"up-regulates activity"	relocalization			9534									9637919	t		lperfetto	"In response to PDGF, binding of ptdlns (3,4,5)p3 and/or ptdlns(3,4)p2 to the PH domain of PDK-1 causes its translocation to the plasma membrane where it co-localises with PKB, significantly contributing to the scale of PKB activation."	0.8	SIGNOR-58313
SIGNOR-NSCLCN	"Non-small-cell lung cancer (NSCLC)"	GRB2	protein	P62993	UNIPROT	SOS1	protein	Q07889	UNIPROT	"up-regulates activity"	relocalization			9606	BTO:0001412								10570290	t	"GRB2 associated guanine nucleotide exchange factor Sos activates Ras through the exchange of GDP for GTP"	lperfetto	"Grb2 binds and activates sos, which then activates ras, and this activates p110 independently of p85."	0.914	SIGNOR-236792
SIGNOR-NSCLCN	"Non-small-cell lung cancer (NSCLC)"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									24743741	f			"Activation of PDGFRα stimulates proliferation of PDGFRα(+) cells through PI3K-Akt and MEK2-MAPK signaling pathways, and aberrant accumulation of PDGFRα(+) cells was conspicuous in muscles of patients with both genetic and non-genetic muscle diseases."	0.7	SIGNOR-254374
SIGNOR-NSCLCN	"Non-small-cell lung cancer (NSCLC)"	PDPK1	protein	O15530	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation	Thr308	KDGATMKtFCGTPEY	10090									12808134	t		lperfetto	"Akt1 and akt2 are phosphorylated and activated by the protein kinase pdk1 at thr-308 or thr-309, respectively, in the activation t-loop, and further activation occurs through phosphorylation at ser-473 or ser-474, respectively. In this paper, we demonstrate that this is indeed the case, and report the purification and initial characterization of a 3 phosphoinositide-dependent protein kinase, pdk1, which activates pkb by phosphorylating it at thr308. Akt is directly phosphorylated and activated by pdk1. Akt/pkb activation requires the phosphorylation of thr308 in the activation loop by the phosphoinositide-dependent kinase 1 (pdk1)."	0.746	SIGNOR-134477
SIGNOR-NSCLCN	"Non-small-cell lung cancer (NSCLC)"	PDPK1	protein	O15530	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation	Thr308	KDGATMKtFCGTPEY	9606									15718470	t		gcesareni	"Akt/PKB activation requires the phosphorylation of Thr308 in the activation loop by the phosphoinositide-dependent kinase 1 (PDK1) and Ser473 within the carboxyl-terminal hydrophobic motif by an unknown kinase."	0.746	SIGNOR-243203
SIGNOR-NSCLCN	"Non-small-cell lung cancer (NSCLC)"	PDPK1	protein	O15530	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation			9606									15743829	t		lperfetto	"3-phosphoinositide-dependent kinase 1 (PDK1) phosphorylates the activation loop of a number of protein serine/threonine kinases of the AGC kinase superfamily, including protein kinase B (PKB; also called Akt),"	0.746	SIGNOR-244469
SIGNOR-NSCLCN	"Non-small-cell lung cancer (NSCLC)"	PIP3	smallmolecule	CHEBI:16618	ChEBI	PDPK1	protein	O15530	UNIPROT	"up-regulates activity"	"chemical activation"			9606									19951971	t		lperfetto	"PIP3 recruits PDK1 and AKT to the plasma membrane, where PDK1 phosphorylates AKT on Thr308 in the activation loop of the kinase domain."	0.8	SIGNOR-249628
SIGNOR-NSCLCN	"Non-small-cell lung cancer (NSCLC)"	PIP3	smallmolecule	CHEBI:16618	ChEBI	PDPK1	protein	O15530	UNIPROT	"up-regulates activity"	relocalization			9606									21798082	t		lperfetto	"Pip3 acts in turn as a docking site for two kinases, phosphoinositide-dependent kinase 1 (PDK1) and AKT, and the subsequent phosphorylation of AKT at serine 308 by PDK1, leading to AKT activation."	0.8	SIGNOR-175253
SIGNOR-NSCLCN	"Non-small-cell lung cancer (NSCLC)"	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	up-regulates	phosphorylation			9606									11971971	t		lperfetto	"Mapk1 is phosphorylated by map2k1/mek1 and map2k2/mek2 on thr-185 and tyr-187 in response to external stimuli like insulin or ngf. Both phosphorylations are required for activity."	0.758	SIGNOR-244776
SIGNOR-NSCLCN	"Non-small-cell lung cancer (NSCLC)"	HRAS	protein	P01112	UNIPROT	BRAF	protein	P15056	UNIPROT	up-regulates	binding			9606									18098337	t		lperfetto	"BRAF kinase is a downstream target of KRAS and activates the MAPK pathway."	0.879	SIGNOR-160043
SIGNOR-NSCLCN	"Non-small-cell lung cancer (NSCLC)"	TGFA	protein	P01135	UNIPROT	EGFR	protein	P00533	UNIPROT	"up-regulates activity"	binding			9606	BTO:0000584								16585207	t	"Transforming growth factor alpha expression drives constitutive epidermal growth factor receptor pathway activation and sensitivity to gefitinib (Iressa) in human pancreatic cancer cell lines"	gcesareni	"Our data indicate that a subset of cell lines is dependent on TGF-_-mediated activation of the EGFR for cell proliferation and strongly suggest that pancreatic tumors expressing high levels of TGF-_ and phosphorylated (activated) EGFR are EGFR-dependent in vitro and in vivo."	0.9	SIGNOR-93199
SIGNOR-NSCLCN	"Non-small-cell lung cancer (NSCLC)"	EGFR	protein	P00533	UNIPROT	PI3K	complex	SIGNOR-C156	SIGNOR	up-regulates	binding			9606	BTO:0000093	BTO:0000150							26918608	t		lperfetto	"P85alpha promotes nucleolin transcription and subsequently enhances EGFR mRNA stability and EGF-induced malignant cellular transformation."	0.784	SIGNOR-252671
SIGNOR-NSCLCN	"Non-small-cell lung cancer (NSCLC)"	EGFR	protein	P00533	UNIPROT	PI3K	complex	SIGNOR-C156	SIGNOR	up-regulates	binding			9606									14967450	t		lperfetto	"The egf-r coimmunoprecipitated with p85 alpha"	0.784	SIGNOR-252672
SIGNOR-NSCLCN	"Non-small-cell lung cancer (NSCLC)"	EGF	protein	P01133	UNIPROT	EGFR	protein	P00533	UNIPROT	"up-regulates activity"	binding			9606									12297050	t		lperfetto	"Epidermal growth factor (egf) regulates cell proliferation and differentiation by binding to the egf receptor (egfr) extracellular region, comprising domains i-iv, with the resultant dimerization of the receptor tyrosine kinase."	0.95	SIGNOR-186159
SIGNOR-NSCLCN	"Non-small-cell lung cancer (NSCLC)"	EGFR	protein	P00533	UNIPROT	GRB2	protein	P62993	UNIPROT	"up-regulates activity"	binding			10090	BTO:0000944								7518560	t		lperfetto	"Erbb1 recruites grb2 through sh2 domain;from these studies, we concluded that grb2 binds directly to the egfr at y-1068, to a lesser extent at y-1086, and indirectly at y-1173. Egfr has six binding sites for the adapter protein grb2, and erbb4 has five, each with different binding strength several tyrosine-based motifs recruit a number of signal transducers to the phosphorylated form of erbb1 such as the adaptor proteins growth-factor-receptor bound-2 (grb2) and src-homology-2-containing (shc)."	0.924	SIGNOR-235721
SIGNOR-NSCLCN	"Non-small-cell lung cancer (NSCLC)"	EGFR	protein	P00533	UNIPROT	GRB2	protein	P62993	UNIPROT	"up-regulates activity"	binding			-1	BTO:0000567								16729043	t		lperfetto	"We determined interaction partners to all cytosolic tyrosine residues of the four members of the ErbB-receptor family in an unbiased fashion by quantitative proteomics using pull-down experiments with pairs of phosphorylated and nonphosphorylated synthetic peptides. Each receptor had characteristic preferences for interacting proteins and most interaction partners had multiple binding sites on each receptor. EGFR and ErbB4 had several docking sites for Grb2, while ErbB3 was characterized by six binding sites for PI3K."	0.924	SIGNOR-236327
SIGNOR-NSCLCN	"Non-small-cell lung cancer (NSCLC)"	IGF1R	protein	P08069	UNIPROT	PI3K	complex	SIGNOR-C156	SIGNOR	up-regulates	binding			9606									18595745	t		gcesareni	"Igf-1 activated both the pi3k and the extracellular signal-regulated kinase [?] (erk [?]) Pathways as evidenced by phosphorylation of either akt or erk1 [?]/2 (respectively)"	0.702	SIGNOR-252690
SIGNOR-NSCLCN	"Non-small-cell lung cancer (NSCLC)"	KRAS	protein	P01116	UNIPROT	BRAF	protein	P15056	UNIPROT	"up-regulates activity"	binding			9606									21779497	t		miannu	"The raf family of proteins (raf-1, a-raf, and b-raf) is serine/threonine kinases that bind to the effector region of ras-gtp, thus inducing translocation of the protein to the plasma membrane. Once there, raf proteins are activated and phosphorylated by different protein kinases."	0.878	SIGNOR-156906
SIGNOR-PC	"Prostate Cancer"	PTEN	protein	P60484	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"down-regulates activity"				9606	BTO:0001332								19903340	f		lperfetto	"PTEN-mediated suppression of the PI3K/AKT pathway is well established, accumulating evidence suggests that nuclear PTEN also plays a critical role in tumor suppression"	0.633	SIGNOR-244439
SIGNOR-PC	"Prostate Cancer"	ERG	protein	P11308	UNIPROT	MYC	protein	P01106	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			9606									25277175	f		miannu	"Increased expression of ERG or other ETS factors under control of androgen responsive promoter (TMPRSS2) is an inevitable consequence of the fusion events, and it activates transcriptional program that contributes to oncogenesis by upregulating expression of, among others, MYC, EZH2 and SOX9 and repressing NKX3."	0.283	SIGNOR-251554
SIGNOR-PC	"Prostate Cancer"	ERG	protein	P11308	UNIPROT	EZH2	protein	Q15910	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			9606									25277175	f		miannu	"Increased expression of ERG or other ETS factors under control of androgen responsive promoter (TMPRSS2) is an inevitable consequence of the fusion events, and it activates transcriptional program that contributes to oncogenesis by upregulating expression of, among others, MYC, EZH2 and SOX9 and repressing NKX3."	0.342	SIGNOR-251555
SIGNOR-PC	"Prostate Cancer"	AR	protein	P10275	UNIPROT	TMPRSS2	protein	O15393	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			9606									24505269	t		miannu	"Recurrent gene fusion between the androgen-regulated gene TMPRSS2 and members of the ETS transcription factor family, most commonly ERG, are present in about 50% of prostate cancer cases. Presence of this fusion gene is a critical event in the development of prostate cancer. the more aggressive phenotype that arises with the presence of TMPRSS2-ERG at least in part is caused by changes in the tumor stroma."	0.576	SIGNOR-251545
SIGNOR-PC	"Prostate Cancer"	HGF	protein	P14210	UNIPROT	MET	protein	P08581	UNIPROT	up-regulates	binding			9606									8380735	t		gcesareni	"Hgf is the ligand for p190met, the receptor tyrosine kinase encoded by the met proto-oncogene."	0.929	SIGNOR-38429
SIGNOR-PC	"Prostate Cancer"	TMPRSS2	protein	O15393	UNIPROT	HGF	protein	P14210	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			9606									25122198	t		miannu	"we identified pro-hepatocyte growth factor (HGF) as a TMPRSS2 substrate and confirmed that HGF and it’s cognate receptor c-Met are activated in prostate cancers expressing TMPRSS2, a finding that also associated with the acquisition of a pro-invasive mesenchymal gene expression program."	0.2	SIGNOR-263657
SIGNOR-PC	"Prostate Cancer"	MET	protein	P08581	UNIPROT	Metastasis	phenotype	SIGNOR-PH107	SIGNOR	up-regulates				9606	BTO:0001033								22035268	f		miannu	"C-Met expression and activation appears to be one of the common mechanisms of resistance to other targeted therapies. Given these multiple roles of c-Met in prostate cancer, several c-Met inhibitors have been developed. Evidence to date suggests that aberrant activation of the HGF/c-Met axis in prostate cancer epithelial cells appears to be a relatively late event in tumor progression. C-Met expression increases in advanced stages of the disease, with the highest expression observed in bone metastases."	0.7	SIGNOR-263658
SIGNOR-PC	"Prostate Cancer"	PTEN	protein	P60484	UNIPROT	PIP3	smallmolecule	CHEBI:16618	ChEBI	"down-regulates quantity"	"chemical modification"			9606									11875759	t		lperfetto	"PTEN dephosphorylates PI3P, lowering its cellular levels and resulting in the down-regulation of AKT."	0.8	SIGNOR-228145
SIGNOR-PC	"Prostate Cancer"	PIP3	smallmolecule	CHEBI:16618	ChEBI	PDPK1	protein	O15530	UNIPROT	"up-regulates activity"	relocalization			9534									9637919	t		lperfetto	"In response to PDGF, binding of ptdlns (3,4,5)p3 and/or ptdlns(3,4)p2 to the PH domain of PDK-1 causes its translocation to the plasma membrane where it co-localises with PKB, significantly contributing to the scale of PKB activation."	0.8	SIGNOR-58313
SIGNOR-PC	"Prostate Cancer"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	Survival	phenotype	SIGNOR-PH13	SIGNOR	up-regulates				9606	BTO:0000830								15526160	f		miannu	"c-Kit promotes survival via PI3-kinase-dependent activation of Akt and phosphorylation of Bad, a pro-apoptotic molecule, at S136 in vivo."	0.7	SIGNOR-254952
SIGNOR-PC	"Prostate Cancer"	AR	protein	P10275	UNIPROT	Differentiation	phenotype	SIGNOR-PH37	SIGNOR	up-regulates				9606									15861399	f		miannu	"AR homodimers recruit a panoply of factors including coactivators and mediator proteins whose enzymatic activities promote chromatin remodeling and transcriptional regulation of target genes leading to cell differentiation, survival, and proliferation"	0.7	SIGNOR-251538
SIGNOR-PC	"Prostate Cancer"	AR	protein	P10275	UNIPROT	NKX3-1	protein	Q99801	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			9606									16697957	t		miannu	"Whereas androgen receptor (AR) positively regulates NKX3.1 expression, NKX3.1 negatively modulates AR transcription and consequently the AR-associated signaling events."	0.504	SIGNOR-251546
SIGNOR-PC	"Prostate Cancer"	AR	protein	P10275	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									15861399	f		miannu	"AR homodimers recruit a panoply of factors including coactivators and mediator proteins whose enzymatic activities promote chromatin remodeling and transcriptional regulation of target genes leading to cell differentiation, survival, and proliferation"	0.7	SIGNOR-251540
SIGNOR-PC	"Prostate Cancer"	AR	protein	P10275	UNIPROT	UBE2C	protein	O00762	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			9606									19632176	t		miannu	"The evolution of prostate cancer from an androgen-dependent state (ADPCa) to one that is androgen-independent (AIPCa) marks its lethal progression. The androgen receptor (AR) is essential in both, though its function in AIPCa is poorly understood. We have defined the direct AR-dependent target genes in both AIPCa and ADPCa by generating AR-dependent gene expression profiles and AR cistromes. In contrast to ADPCa, AR selectively up-regulates M-phase cell cycle genes in AIPCa including UBE2C, a gene that inactivates the M-phase checkpoint."	0.398	SIGNOR-251543
SIGNOR-PC	"Prostate Cancer"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	Survival	phenotype	SIGNOR-PH13	SIGNOR	up-regulates				9606									16288293	f		miannu	"Akt promotes both cell growth and cell survival by inactivating its downstream substrates including GSK3, BAD, FOXO and TSC2."	0.7	SIGNOR-251550
SIGNOR-PC	"Prostate Cancer"	NKX3-1	protein	Q99801	UNIPROT	AR	protein	P10275	UNIPROT	"down-regulates quantity by repression"	"transcriptional regulation"			9606									16697957	t		miannu	"Whereas androgen receptor (AR) positively regulates NKX3.1 expression, NKX3.1 negatively modulates AR transcription and consequently the AR-associated signaling events."	0.504	SIGNOR-251547
SIGNOR-PC	"Prostate Cancer"	TP53	protein	P04637	UNIPROT	MDM2	protein	Q00987	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			10090									7958853	f		gcesareni	"The p53 tumor suppressor protein trans-activates mdm2 itself, which is therefore considered a component of a p53 negative feedback loop."	0.968	SIGNOR-34962
SIGNOR-PC	"Prostate Cancer"	TP53	protein	P04637	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	down-regulates				9606	BTO:0000452								7667317	f			"P53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts"	0.7	SIGNOR-255669
SIGNOR-PC	"Prostate Cancer"	FOXA1	protein	P55317	UNIPROT	AR	protein	P10275	UNIPROT	"down-regulates quantity by repression"	"transcriptional regulation"			9606									24875621	t		miannu	"FOXA1 directly inhibits AR expression and thus the transcription of its target genes.  FOXA1 inhibits AR gene expression in prostate cancer. oss of FOXA1 may lead to androgen-independent AR signaling and thus castration-resistant prostate cancer progression. Indeed, we have recently reported that FOXA1 is downregulated in CRPC"	0.77	SIGNOR-251541
SIGNOR-PC	"Prostate Cancer"	MDM2	protein	Q00987	UNIPROT	TP53	protein	P04637	UNIPROT	"down-regulates quantity by destabilization"	ubiquitination			9606									23150757	t		lperfetto	"Dual Roles of MDM2 in the Regulation of p53: Ubiquitination Dependent and Ubiquitination Independent Mechanisms of MDM2 Repression of p53 Activity"	0.968	SIGNOR-199371
SIGNOR-PC	"Prostate Cancer"	MYC	protein	P01106	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				10090		BTO:0000724							7882978	f		irozzo	"These observations indicate that continued late-stage expression of L-myc affected differentiation processes directly, rather than indirectly through deregulated growth control, whereas constitutive c-myc expression inhibited proliferative arrest, but did not appear to disturb differentiation."	0.7	SIGNOR-259110
SIGNOR-PC	"Prostate Cancer"	MYC	protein	P01106	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									9552384	f		gcesareni	"C-myc has emerged as one of the central regulators of mammalian cell proliferation."	0.7	SIGNOR-56572
SIGNOR-PC	"Prostate Cancer"	MYC	protein	P01106	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606		BTO:0001103							21408055	f		"andrea cerquone perpetuini"	"We have demonstrated that following muscle damage, phosphorylated STAT3 (p-STAT3) in SCs increases early (within one hour), inducing downstream target genes (i.e. GP130 and SOCS3), which further regulate the increase in STAT3 production and response (as induced via IL-6), leading to increased cMyc expression, which drives cell proliferation"	0.7	SIGNOR-255414
SIGNOR-PC	"Prostate Cancer"	NCOA2	protein	Q15596	UNIPROT	AR	protein	P10275	UNIPROT	"up-regulates activity"	binding			9606									24239470	t		miannu	"The NCOA2 gene encodes a transcriptional coactivator (SRC-2) that modulates gene expression by hormone receptors, including AR. NCOA2 is both amplified and rarely mutated in prostate cancers, with higher NCOA2 levels resulting in increased androgen signaling readout. Furthermore, as mentioned previously, SRC-3, a close homolog encoded by NCOA3, is a substrate of SPOP whose protein levels are increased by SPOP mutation, potentially linking these common point mutations to the androgen axis"	0.901	SIGNOR-251531
SIGNOR-PC	"Prostate Cancer"	NCOA2	protein	Q15596	UNIPROT	PPARG	protein	P37231	UNIPROT	up-regulates	binding			9606									18584035	t		gcesareni	"Collectively, our data provide the first evidence that erbeta-deficiency protects against diet-induced ir and glucose intolerance which involves an augmented ppargamma signaling in adipose tissue. Moreover, our data suggest that the coactivators src1 and tif2 are involved in this interaction."	0.768	SIGNOR-179175
SIGNOR-PC	"Prostate Cancer"	NCOA2	protein	Q15596	UNIPROT	AR	protein	P10275	UNIPROT	"up-regulates activity"	binding			9606									24239470	t		miannu	"The NCOA2 gene encodes a transcriptional coactivator (SRC-2) that modulates gene expression by hormone receptors, including AR. NCOA2 is both amplified and rarely mutated in prostate cancers, with higher NCOA2 levels resulting in increased androgen signaling readout. Furthermore, as mentioned previously, SRC-3, a close homolog encoded by NCOA3, is a substrate of SPOP whose protein levels are increased by SPOP mutation, potentially linking these common point mutations to the androgen axis"	0.901	SIGNOR-251530
SIGNOR-PC	"Prostate Cancer"	NKX3-1	protein	Q99801	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"down-regulates activity"				9606									16697957	t		miannu	"NKX3.1 negatively regulates AKT activity in an AR-dependent manner"	0.524	SIGNOR-251552
SIGNOR-PC	"Prostate Cancer"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	AR	protein	P10275	UNIPROT	"down-regulates activity"	phosphorylation	Ser792	CVRMRHLsQEFGWLQ	9534	BTO:0001538								11404460	t		lperfetto	"Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor. Here, we demonstrate that akt phosphorylates the androgen receptor (ar) at ser-210 and ser-790"	0.2	SIGNOR-244136
SIGNOR-PC	"Prostate Cancer"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	AR	protein	P10275	UNIPROT	down-regulates	phosphorylation	Ser215	SGRAREAsGAPTSSK	9606	BTO:0000938								17470458	t		lperfetto	"The work presented here is the first demonstration that phosphorylation at s215 and s792 by akt regulates ligand binding, and the subcellular distribution of the receptor"	0.2	SIGNOR-244140
SIGNOR-PC	"Prostate Cancer"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	MDM2	protein	Q00987	UNIPROT	"up-regulates activity"	phosphorylation	Ser166	SSRRRAIsETEENSD	9606									15169778	t		lperfetto	"Stabilization of mdm2 via decreased ubiquitination is mediated by protein kinase b/akt-dependent phosphorylation."	0.2	SIGNOR-244296
SIGNOR-PC	"Prostate Cancer"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	MDM2	protein	Q00987	UNIPROT	"up-regulates activity"	phosphorylation	Ser186	RQRKRHKsDSISLSF	9606									11504915	t		lperfetto	"Mitogen-induced activation of phosphatidylinositol 3-kinase (pi3-kinase) and its downstream target, the akt/pkb serine-threonine kinase, results in phosphorylation of mdm2 on serine 166 and serine 186. Phosphorylation on these sites is necessary for translocation of mdm2 from the cytoplasm into the nucleus.Both akt expression and serum treatment induced phosphorylation of mdm2 at ser186."	0.2	SIGNOR-244292
SIGNOR-PC	"Prostate Cancer"	NKX3-1	protein	Q99801	UNIPROT	HDAC1	protein	Q13547	UNIPROT	"down-regulates activity"	binding			9606									16697957	t		miannu	"NKX3.1 also binds HDAC1 and releases p53 from p53-MDM2-HDAC1 complex, promoting p53 acetylation and activity."	0.367	SIGNOR-251549
SIGNOR-PC	"Prostate Cancer"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	MDM2	protein	Q00987	UNIPROT	"up-regulates activity"	phosphorylation	Ser188	RKRHKSDsISLSFDE	9606									15169778	t		lperfetto	"Stabilization of mdm2 via decreased ubiquitination is mediated by protein kinase b/akt-dependent phosphorylationhere we show that pkb inhibits mdm2 self-ubiquitination via phosphorylation of mdm2 on ser(166) and ser(188)"	0.2	SIGNOR-244300
SIGNOR-PC	"Prostate Cancer"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				10090									16982699	f			"Protein kinase B (PKB/Akt) is an important modulator of insulin signaling, cell proliferation, and survival. Using small interfering RNA duplexes in nontransformed mammalian cells, we show that only Akt1 is essential for cell proliferation"	0.7	SIGNOR-254353
SIGNOR-PC	"Prostate Cancer"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									24743741	f			"Activation of PDGFRα stimulates proliferation of PDGFRα(+) cells through PI3K-Akt and MEK2-MAPK signaling pathways, and aberrant accumulation of PDGFRα(+) cells was conspicuous in muscles of patients with both genetic and non-genetic muscle diseases."	0.7	SIGNOR-257606
SIGNOR-PC	"Prostate Cancer"	NKX3-1	protein	Q99801	UNIPROT	TP53	protein	P04637	UNIPROT	"up-regulates quantity by stabilization"				9606									16697957	f		miannu	"NKX3.1 stabilizes p53.NKX3.1 can physically associate with HDAC1 and promotes p53 acetylation by recruiting HDAC1 from p53-MDM2-HDAC1 complex"	0.357	SIGNOR-251548
SIGNOR-PC	"Prostate Cancer"	PDPK1	protein	O15530	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation			9606									15743829	t		lperfetto	"3-phosphoinositide-dependent kinase 1 (PDK1) phosphorylates the activation loop of a number of protein serine/threonine kinases of the AGC kinase superfamily, including protein kinase B (PKB; also called Akt),"	0.746	SIGNOR-244469
SIGNOR-PC	"Prostate Cancer"	PDPK1	protein	O15530	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation	Thr308	KDGATMKtFCGTPEY	10090									12808134	t		lperfetto	"Akt1 and akt2 are phosphorylated and activated by the protein kinase pdk1 at thr-308 or thr-309, respectively, in the activation t-loop, and further activation occurs through phosphorylation at ser-473 or ser-474, respectively. In this paper, we demonstrate that this is indeed the case, and report the purification and initial characterization of a 3 phosphoinositide-dependent protein kinase, pdk1, which activates pkb by phosphorylating it at thr308. Akt is directly phosphorylated and activated by pdk1. Akt/pkb activation requires the phosphorylation of thr308 in the activation loop by the phosphoinositide-dependent kinase 1 (pdk1)."	0.746	SIGNOR-134477
SIGNOR-PC	"Prostate Cancer"	PDPK1	protein	O15530	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation	Thr308	KDGATMKtFCGTPEY	10116		BTO:0000142							10226025	t		lperfetto	"Protein kinase B (PKB) is activated by phosphorylation of Thr308 and of Ser473. Thr308 is phosphorylated by the 3-phosphoinositide-dependent protein kinase-1 (PDK1) but the identity of the kinase that phosphorylates Ser473 (provisionally termed PDK2) is unknown."	0.746	SIGNOR-244421
SIGNOR-PC	"Prostate Cancer"	PDPK1	protein	O15530	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation	Thr308	KDGATMKtFCGTPEY	9606									15718470	t		gcesareni	"Akt/PKB activation requires the phosphorylation of Thr308 in the activation loop by the phosphoinositide-dependent kinase 1 (PDK1) and Ser473 within the carboxyl-terminal hydrophobic motif by an unknown kinase."	0.746	SIGNOR-243203
SIGNOR-PC	"Prostate Cancer"	PDPK1	protein	O15530	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation	Thr308	KDGATMKtFCGTPEY	9606		BTO:0000887;BTO:0001103;BTO:0001760							9512493	t		lperfetto	"The activation of PKBbeta and PKBamma by PDK11 was accompanied by the phosphorylation of the residues equivalent to Thr308 in PKBalpha, namely Thr309 (PKBbeta) and Thr305 (PKBgamma)"	0.746	SIGNOR-244480
SIGNOR-PC	"Prostate Cancer"	PDPK1	protein	O15530	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	up-regulates	phosphorylation			9606									21798082	t		lperfetto	"Positive feedback involves mtorc2, which phosphorylates akt at serine 473, a phosphorylation required for maximum activation of akt in addition to phosphorylation at threonine 308 by pdk1."	0.746	SIGNOR-244396
SIGNOR-PC	"Prostate Cancer"	PIK3CA	protein	P42336	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"				9606		BTO:0000150							19573809	f		lperfetto	"However, here we show through phosphoprotein profiling and functional genomic studies that many PIK3CA mutant cancer cell lines and human breast tumors exhibit only minimal AKT activation and a diminished reliance on AKT for anchorage-independent growth"	0.821	SIGNOR-236436
SIGNOR-PC	"Prostate Cancer"	PIK3CA	protein	P42336	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation			9606									12167717	t		lperfetto	"PKB induction requires phosphorylation of two critical residues, threonine 308 in the activation loop and serine 473 near the carboxyl terminus. Membrane localization of PKB was found to be a primary determinant of serine 473 phosphorylation. PI3K activity was equally important for promoting phosphorylation of serine 473,"	0.821	SIGNOR-244429
SIGNOR-PC	"Prostate Cancer"	PIK3CA	protein	P42336	UNIPROT	Survival	phenotype	SIGNOR-PH13	SIGNOR	up-regulates				9534	BTO:0004055								14665640	f		lperfetto	"Signal transduction pathways triggered by Tie2 have been extensively examined. Tyr-1101of Tie2 directly associates in a phosphotyrosine (pTyr)-dependent manner with the p85 regulatory subunit of phosphatidylinositol (PI) 3-kinase, which in turn activate PI 3-kinase, leading to cell motility and survival"	0.7	SIGNOR-242649
SIGNOR-PC	"Prostate Cancer"	PPARG	protein	P37231	UNIPROT	HDAC1	protein	Q13547	UNIPROT	down-regulates	relocalization			9606									16431920	t		fspada	"These data suggest that c/ebp beta activates a single unified pathway of adipogenesis involving its stimulation of ppargamma expression, which then activates c/ebp alpha expression by dislodging hdac1 from the promoter for degradation in the proteasome"	0.619	SIGNOR-143961
SIGNOR-PC	"Prostate Cancer"	PPARG	protein	P37231	UNIPROT	PTEN	protein	P60484	UNIPROT	"down-regulates activity"				9606									23128507	t	"PAX8-PPARγ fusion protein"	miannu	"The PAX8-PPARγ rearrangement leads to strong induction of the PPARγ protein and the consequent abrogation of the normal PPARγ function. PPARγ overexpression abolishes the PTEN-inhibitory effect on immunoactive AKT, which in turn induces the PI3K signaling pathway."	0.458	SIGNOR-251997
SIGNOR-PC	"Prostate Cancer"	PTEN	protein	P60484	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"down-regulates activity"				9606	BTO:0001271								20596030	f		lperfetto	"Exposure of eol-1r cells to imatinib failed to dephosphorylate akt, erk and stat5, although pdgfralpha was effectively inactivated. The forced expression of pten negatively regulated these signal pathways and sensitized eol-1r cells to imatinib."	0.633	SIGNOR-166478
SIGNOR-PC	"Prostate Cancer"	PTEN	protein	P60484	UNIPROT	PIK3CA	protein	P42336	UNIPROT	"down-regulates activity"				9606									18794881	f		lperfetto	"The pten tumour suppressor is a lipid and protein phosphatase that inhibits phosphoinositide 3-kinase (pi3k)-dependent by dephosphorylating phosphatidylinositol 3,4,5-trisphosphate (ptdinsp(3))."	0.738	SIGNOR-209856
SIGNOR-PC	"Prostate Cancer"	SPOP	protein	O43791	UNIPROT	NCOA3	protein	Q9Y6Q9	UNIPROT	"down-regulates quantity by destabilization"	binding			9606									24239470	t		miannu	"Mutations in SPOP represent the most common point mutations in primary prostate cancer,with recurrent mutations in SPOP in 6% to 15% of multiple independent cohorts.  Wild-type SPOP will bind and promote the degradation of SRC-3,whereas prostate cancer–derived SPOP mutants lose this ability,leading to increased androgen signaling in certain model systems."	0.478	SIGNOR-251529
SIGNOR-PC	"Prostate Cancer"	UBE2C	protein	O00762	UNIPROT	Mitotic_checkpoint	phenotype	SIGNOR-PH28	SIGNOR	down-regulates				9606									19632176	f		miannu	"The evolution of prostate cancer from an androgen-dependent state (ADPCa) to one that is androgen-independent (AIPCa) marks its lethal progression. The androgen receptor (AR) is essential in both, though its function in AIPCa is poorly understood. We have defined the direct AR-dependent target genes in both AIPCa and ADPCa by generating AR-dependent gene expression profiles and AR cistromes. In contrast to ADPCa, AR selectively up-regulates M-phase cell cycle genes in AIPCa including UBE2C, a gene that inactivates the M-phase checkpoint."	0.7	SIGNOR-251544
SIGNOR-PC	"Prostate Cancer"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	EZH2	protein	Q15910	UNIPROT	"down-regulates activity"	phosphorylation	Ser21	CWRKRVKsEYMRLRQ	9606									16224021	t		lperfetto	"Enhancer of zeste homolog 2 (ezh2) is a methyltransferase that plays an important role in many biological processes through its ability to trimethylate lysine 27 in histone h3. Here, we show that akt phosphorylates ezh2 at serine 21 and suppresses its methyltransferase activity by impeding ezh2 binding to histone h3"	0.2	SIGNOR-244259
SIGNOR-PC	"Prostate Cancer"	AR	protein	P10275	UNIPROT	Survival	phenotype	SIGNOR-PH13	SIGNOR	up-regulates				9606									15861399	f		miannu	"AR homodimers recruit a panoply of factors including coactivators and mediator proteins whose enzymatic activities promote chromatin remodeling and transcriptional regulation of target genes leading to cell differentiation, survival, and proliferation"	0.7	SIGNOR-251539
SIGNOR-PC	"Prostate Cancer"	EZH2	protein	Q15910	UNIPROT	AR	protein	P10275	UNIPROT	"up-regulates activity"	binding			9606									23239736	t		miannu	"This study demonstrates that phosphorylation of EZH2 at Ser21, mediated directly or indirectly by the PI3K-Akt pathway, can switch its function from a Polycomb repressor to a transcriptional coactivator of AR (and potentially other factors)."	0.54	SIGNOR-251542
SIGNOR-PC	"Prostate Cancer"	MDM2	protein	Q00987	UNIPROT	TP53	protein	P04637	UNIPROT	"down-regulates quantity by destabilization"	ubiquitination			9606									10935507	t		lperfetto	"Many posttranslational modifications of p53, such as phosphorylation, dephosphorylation, acetylation and ribosylation, have been shown to occur following cellular stress. Some of these modifications may activate the p53 protein, interfere with MDM2 binding and/or dictate cellular localization of p53."	0.968	SIGNOR-80528
SIGNOR-PC	"Prostate Cancer"	MDM2	protein	Q00987	UNIPROT	TP53	protein	P04637	UNIPROT	"down-regulates quantity by destabilization"	ubiquitination			9606									22337874	t		lperfetto	"The E3 ubiquitin ligase, MDM2, uses a dual-site mechanism to ubiquitinate and degrade the tumor suppressor protein p53, involving interactions with the N-terminal hydrophobic pocket and the acidic domain of MDM2."	0.968	SIGNOR-196116
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	CyclinD1/CDK6	complex	SIGNOR-C143	SIGNOR	CTNNB1	protein	P35222	UNIPROT	"down-regulates activity"	phosphorylation	Ser45	GATTTAPsLSGKGNP	-1									17208333	t		llicata	"We showed that CCND1-CDK6 phosphorylates beta-catenin on serine 45 (S45). This phosphorylation creates a priming site for glycogen synthase kinase 3beta (GSK3beta) and is both necessary and sufficient to initiate the beta-catenin phosphorylation-degradation cascade."	0.639	SIGNOR-250647
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	CDK4	protein	P11802	UNIPROT	CyclinD/CDK4	complex	SIGNOR-C18	SIGNOR	"form complex"	binding			9606									7736585	t		gcesareni	"D-type cyclins (cyclin d1, d2, or d3) and their associated cyclin-dependent kinases (cdk4, cdk6) connect signals from cytokines to the cell cycle machinery, and they propel cells through the g1 restriction point and into the s phase when activated by cyclin d1, cdk4 is able to phosphorylate prb,"	0.964	SIGNOR-32301
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	CTNNB1	protein	P35222	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									18697834	f		"Simone Vumbaca"	"we showed that β-catenin, a key component of the canonical Wnt-signalling cascade, is present in quiescent satellite cells in the inactive form, but subsequently becomes activated following satellite-cell activation. This observation suggests that the proliferation initiated by the Wnt-signalling cascade does not have to rely on transcription of β-catenin, but rather on activation of this protein, which is already present within the quiescent satellite cells."	0.7	SIGNOR-255654
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	CDKN2A	protein	P42771	UNIPROT	CyclinD1/CDK6	complex	SIGNOR-C143	SIGNOR	down-regulates	binding			9606									8891723	t		luana	"The first group, including p16ink4a, p15ink4b,p18ink4cand p19ink4d, is specific for the g1 cdks,cdk4and cdk6, inhibiting the kinase activity of cyclin d/cdk4-cdk6 complexes on prb."	0.813	SIGNOR-259810
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	EGFR	protein	P00533	UNIPROT	STAT3	protein	P40763	UNIPROT	"up-regulates activity"	phosphorylation			9606									14967450	t		lperfetto	"The transcription factors stat1, stat3, and stat5 are directly phosphorylated by erbb-1, subsequent to which they dimerize through phosphotyrosine-sh2 domain interactions and translocate to the nucleus to activate gene trascription critical for proliferation."	0.881	SIGNOR-121965
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	EGFR	protein	P00533	UNIPROT	STAT3	protein	P40763	UNIPROT	"up-regulates activity"	phosphorylation			9606	BTO:0000150								22693070	t		lperfetto	"The transcription factors stat1, stat3, and stat5 are directly phosphorylated by erbb-1, subsequent to which they dimerize through phosphotyrosine-sh2 domain interactions and translocate to the nucleus to activate gene trascription critical for proliferation."	0.881	SIGNOR-235692
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	STAT3	protein	P40763	UNIPROT	VEGFA	protein	P15692	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			9606									12545153	t		luana	"Stat3 directly regulated the promoter of the VEGF gene. Blockade of activated Stat3 by ectopic expression of dominant-negative Stat3 significantly inhibited VEGF expression, and the growth and metastasis of human pancreatic cancer cells. "	0.79	SIGNOR-259456
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	VEGFA	protein	P15692	UNIPROT	Angiogenesis	phenotype	SIGNOR-PH46	SIGNOR	up-regulates													17326328	f		lperfetto	"More than a dozen different proteins have been identified as angiogenic activators, including vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), angiogenin, transforming growth factor (TGF)-α, TGF-β, tumor necrosis factor (TNF)-α, platelet-derived endothelial growth factor, granulocyte colony-stimulating factor, placental growth factor, interleukin-8, hepatocyte growth factor, and epidermal growth factor"	0.7	SIGNOR-252275
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	EGFR	protein	P00533	UNIPROT	PI3K	complex	SIGNOR-C156	SIGNOR	up-regulates	binding			9606									14967450	t		lperfetto	"The egf-r coimmunoprecipitated with p85 alpha"	0.784	SIGNOR-252672
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	Survival	phenotype	SIGNOR-PH13	SIGNOR	up-regulates				9606									16288293	f		miannu	"Akt promotes both cell growth and cell survival by inactivating its downstream substrates including GSK3, BAD, FOXO and TSC2."	0.7	SIGNOR-251550
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	PIP3	smallmolecule	CHEBI:16618	ChEBI	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	relocalization			9606		BTO:0001130							23633519	t		lperfetto	"Akt is a serine-threonine protein kinase that plays important roles in cell growth, proliferation and apoptosis. It is activated after binding to phosphatidylinositol phosphates pips) with phosphate groups at positions 3,4 and 3,4,5 on the inositol ring."	0.8	SIGNOR-236490
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	NfKb-p65/p50	complex	SIGNOR-C13	SIGNOR	Apoptosis	phenotype	SIGNOR-PH2	SIGNOR	down-regulates				9606									22021368	f		apalma	"Once genetic mutation of AML1 occurs in hematopoietic cells, aberrant activation of NF-κB signaling exerts antiapoptotic and proliferation-promoting effects via activation of BCL-XL or JUNB."	0.7	SIGNOR-255693
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	NFKBIA	protein	P25963	UNIPROT	NfKb-p65/p50	complex	SIGNOR-C13	SIGNOR	"down-regulates activity"	binding			9606									1340770	t		lperfetto	"Nf-kappa b is an inducible transcription factor comprised of a 50-kd (p50) and a 65-kd (p65) subunit. Induction of nf-kappa b activity, which is a critical event in many signal transduction pathways, involves release from a cytoplasmic inhibitory protein, i kappa b, followed by translocation of the active transcription factor complex into the nucleus. we demonstrate by in vitro and in vivo methods that the recently cloned i kappa b/mad-3 interacts with both the p50 and p65 subunits of nf-kappa b"	0.814	SIGNOR-217394
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	NFKBIA	protein	P25963	UNIPROT	NfKb-p65/p50	complex	SIGNOR-C13	SIGNOR	"down-regulates activity"	binding			9606									9914500	t		lperfetto	"In nonstimulated cells, nf-kappab is present in the cytosol where it is complexed to its inhibitor ikappab  however, we found that only one of the activities, namely the ikk1/2 complex, exists as a pre-assembled kinase-substrate complex in which the ikks are directly or indirectly associated with several nf-kappab-related and ikappab-related proteins: rela, relb, crel, p100, p105, ikappa balpha, ikappa bbeta and ikappa bepsilon."	0.814	SIGNOR-64092
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	NfKb-p65/p50	complex	SIGNOR-C13	SIGNOR	Inflammation	phenotype	SIGNOR-PH12	SIGNOR	up-regulates													25309941	f			"Following GSK3β activation, NF-κB is translocated from the cytoplasm to the nucleus and binds transcriptional sites with CBP leading to an increase in the transcription of pro-inflammatory cytokines (IL-1β, TNF-α, and IL-6)."	0.7	SIGNOR-255489
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	NfKb-p65/p50	complex	SIGNOR-C13	SIGNOR	Inflammation	phenotype	SIGNOR-PH12	SIGNOR	up-regulates				9606									20457564	f		gcesareni	"The nuclear factor NF-kappaB pathway has long been considered a prototypical proinflammatory signaling pathway, largely based on the role of NF-kappaB in the expression of proinflammatory genes including cytokines, chemokines, and adhesion molecules."	0.7	SIGNOR-245039
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	PI3K	complex	SIGNOR-C156	SIGNOR	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"				9606		BTO:0000150							19573809	f		lperfetto	"However, here we show through phosphoprotein profiling and functional genomic studies that many PIK3CA mutant cancer cell lines and human breast tumors exhibit only minimal AKT activation and a diminished reliance on AKT for anchorage-independent growth"	0.796	SIGNOR-252703
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	PI3K	complex	SIGNOR-C156	SIGNOR	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"				9606									12167717	f		lperfetto	"PKB induction requires phosphorylation of two critical residues, threonine 308 in the activation loop and serine 473 near the carboxyl terminus. Membrane localization of PKB was found to be a primary determinant of serine 473 phosphorylation. PI3K activity was equally important for promoting phosphorylation of serine 473,"	0.796	SIGNOR-252715
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	TERT	protein	O14746	UNIPROT	Immortality	phenotype	SIGNOR-PH47	SIGNOR	up-regulates													11327115	f		lperfetto	"Telomerase is tightly repressed in the vast majority of normal human somatic cells but becomes activated during cellular immortalization and in cancers"	0.7	SIGNOR-252292
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	CDKN2B	protein	P42772	UNIPROT	CDK4	protein	P11802	UNIPROT	down-regulates	binding			9606		BTO:0000763							9042862	t		gcesareni	"We present evidence that the different subcellular location of p15 and p27 ensures the prior access of p15 to cdk4. In the cell, p15 is localized mostly in the cytoplasm, whereas p27 is nuclear. p15 prevails over p27 or a p27 construct consisting of the cdk inhibitory domain tagged with a nuclear localization signal. However, when p15 and p27 are forced to reside in the same subcellular location, either the cytoplasm or the nucleus, p15 no longer prevents p27 from binding to cdk4. These properties allow p15 and p27 to coordinately inhibit cdk4 and cdk2."	0.88	SIGNOR-46758
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	FHIT	protein	P49789	UNIPROT	MDM2	protein	Q00987	UNIPROT	down-regulates				9606	BTO:0000551								15313915	f		miannu	"We found that this synergistic inhibition of tumor cell growth corresponded with the fhit-mediated inactivation of mdm2, which thereby blocked the association of mdm2 with p53, thus stabilizing the p53 protein."	0.427	SIGNOR-127610
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	SMAD3/SMAD4	complex	SIGNOR-C9	SIGNOR	CDKN2B	protein	P42772	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			9606									11013220	f		irozzo	"Our data demonstrate the physical interactions and functional cooperativity of Sp1 with a complex of Smad2, Smad3 and Smad4 in the induction of the p15Ink4B gene. These findings explain the tumor suppressor roles of Smad2 and Smad4 in growth arrest signaling by TGF-β."	0.609	SIGNOR-256286
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	SMAD2/SMAD4	complex	SIGNOR-C8	SIGNOR	CDKN2B	protein	P42772	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			9606									11013220	f		irozzo	"Our data demonstrate the physical interactions and functional cooperativity of Sp1 with a complex of Smad2, Smad3 and Smad4 in the induction of the p15Ink4B gene. These findings explain the tumor suppressor roles of Smad2 and Smad4 in growth arrest signaling by TGF-β."	0.609	SIGNOR-256287
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	CDKN2A	protein	P42771	UNIPROT	CyclinD/CDK4	complex	SIGNOR-C18	SIGNOR	"down-regulates activity"	binding			9606									8891723	t		lperfetto	"The first group, including p16ink4a, p15ink4b,p18ink4cand p19ink4d, is specific for the g1 cdks,cdk4and cdk6, inhibiting the kinase activity of cyclin d/cdk4-cdk6 complexes on prb."	0.83	SIGNOR-217514
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	CDKN2A	protein	P42771	UNIPROT	CyclinD/CDK4	complex	SIGNOR-C18	SIGNOR	"down-regulates activity"	binding			9606									11154267	t		lperfetto	"Overexpression of p16INK4a in cells with functional pRb results in inhibition of both Cdk4- and Cdk6-associated kinase activity and pRb phosphorylation, with subsequent cell cycle arrest (46, 50). In addition, inhibition of D cyclin-Cdk4 complex formation by p16INK4a prevents sequestration of p21Cip1 and p27Kip1 by these complexes in early G1, leading to suppression of cyclin E-Cdk2 activity"	0.83	SIGNOR-245459
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	KRAS	protein	P01116	UNIPROT	PI3K	complex	SIGNOR-C156	SIGNOR	up-regulates	binding			9606									21779497	t		gcesareni	"Grb2 binds and activates sos, which then activates ras, and this activates p110 independently of p85./it was also described that ras interacts with pi3k in a direct manner./lysine residue 227 is essential for the interaction of ras with pi3k phosphatidylinositol 3-kinase (pi3k) is one of the main effector pathways of ras, regulating cell growth, cell cycle entry, cell survival, cytoskeleton reorganization, and metabolism."	0.742	SIGNOR-252698
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									19819937	f			"In addition to the JAK2–STAT5 pathway, the Ras GTPase–extracellular signal-regulated kinase (Ras–ERK) pathway has also been implicated in signaling of IL-5 and is important for IL-5-dependent cell survival, proliferation and differentiation of eosinophils."	0.7	SIGNOR-254354
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	up-regulates	phosphorylation			9606									11971971	t		lperfetto	"Mapk1 is phosphorylated by map2k1/mek1 and map2k2/mek2 on thr-185 and tyr-187 in response to external stimuli like insulin or ngf. Both phosphorylations are required for activity."	0.758	SIGNOR-244776
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606		BTO:0001103							20219869	f		apalma	"ERK1/2 activation is a component of the pathway through which many mitogenic growth factors can stimulate cell proliferation"	0.7	SIGNOR-256216
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	KRAS	protein	P01116	UNIPROT	BRAF	protein	P15056	UNIPROT	"up-regulates activity"	binding			9606									21779497	t		miannu	"The raf family of proteins (raf-1, a-raf, and b-raf) is serine/threonine kinases that bind to the effector region of ras-gtp, thus inducing translocation of the protein to the plasma membrane. Once there, raf proteins are activated and phosphorylated by different protein kinases."	0.878	SIGNOR-156906
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	TGFBR1	protein	P36897	UNIPROT	SMAD2	protein	Q15796	UNIPROT	"up-regulates activity"	phosphorylation	Ser465	SPSVRCSsMS	9534	BTO:0001538								9346908	t		lperfetto	"Recently, it was demonstrated that Smad2 interacts transiently with and is a direct substrate of the transforming growth factor-_ (TGF-_) type I receptor, T_RI. Phosphorylation sites on smad2 were localized to a carboxyl-terminal fragment containing three serine residues at positions 464, 465, and 467. In this report, we show that T_RI specifically phosphorylates Smad2 on serines 465 and 467.These results indicate that receptor-dependent phosphorylation of Smad2 on serines 465 and 467 is required in mammalian cells to permit association with Smad4 and to propagate TGF-_ signals."	0.828	SIGNOR-236107
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	SMAD4	protein	Q13485	UNIPROT	SMAD2/SMAD4	complex	SIGNOR-C8	SIGNOR	"form complex"	binding			9606									11274206	t		gcesareni	"the receptor-regulated Smad, such as Smad2, forms a heterocomplex with the co-mediator Smad, Smad4"	0.719	SIGNOR-235178
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	TGFBR2	protein	P37173	UNIPROT	TGFBR1	protein	P36897	UNIPROT	"up-regulates activity"	phosphorylation	Thr204	VQRTIARtIVLQESI	452646									7774578	t		lperfetto	"The TGF-beta type II receptor (T beta R-II) is a transmembrane serine/threonine kinase that, upon ligand binding, recruits and phosphorylates a second transmembrane kinase, T beta R-I, as a requirement for signal transduction. In contrast to the relatively innocuous nature of single site mutations in the ttsgsgsg sequence, mutation of thr200 or 204 to valine causes marked losses in ligand-induced phosphorylation and signaling."	0.72	SIGNOR-32748
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	SMAD4	protein	Q13485	UNIPROT	SMAD3/SMAD4	complex	SIGNOR-C9	SIGNOR	"form complex"	binding			9606									9843571	t		lperfetto	"TGF-beta treatment initiates a kinase cascade that results in the phosphorylation of Smad3, followed by its heteromerization with Smad4 and subsequent translocation into the nucleus."	0.71	SIGNOR-229560
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	SMAD3	protein	P84022	UNIPROT	SMAD3/SMAD4	complex	SIGNOR-C9	SIGNOR	"form complex"	binding			9606									9843571	t		lperfetto	"TGF-beta treatment initiates a kinase cascade that results in the phosphorylation of Smad3, followed by its heteromerization with Smad4 and subsequent translocation into the nucleus."	0.71	SIGNOR-229557
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	SMAD2	protein	Q15796	UNIPROT	SMAD4	protein	Q13485	UNIPROT	"up-regulates activity"	binding			9606					phosphorylation:Ser465;Ser467	SPSVRCSsMS;SVRCSSMs			11274206	t		gcesareni	"the receptor-regulated Smad, such as Smad2, forms a heterocomplex with the co-mediator Smad, Smad4"	0.719	SIGNOR-235183
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	SMAD3/SMAD4	complex	SIGNOR-C9	SIGNOR	AP1	complex	SIGNOR-C154	SIGNOR	"up-regulates activity"	binding			9606									9732876	t		lperfetto	"Smad3 and smad4 also act together with c-jun and c-fos to activate transcription in response to tgf-beta, through a tgf-beta-inducible association of c-jun with smad3 and an interaction of smad3 and c-fos"	0.649	SIGNOR-253332
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	SMAD3	protein	P84022	UNIPROT	SMAD4	protein	Q13485	UNIPROT	"up-regulates activity"	binding			9606									9843571	t		gcesareni	"TGF-² treatment initiates a kinase cascade that results in the phosphorylation of Smad3, followed by its heteromerization with Smad4 and subsequent translocation into the nucleus."	0.71	SIGNOR-235168
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	SMAD2	protein	Q15796	UNIPROT	SMAD2/SMAD4	complex	SIGNOR-C8	SIGNOR	"form complex"	binding			9606					phosphorylation:Ser465;Ser467	SPSVRCSsMS;SVRCSSMs			11274206	t		gcesareni	"the receptor-regulated Smad, such as Smad2, forms a heterocomplex with the co-mediator Smad, Smad4"	0.719	SIGNOR-235188
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	SMAD3/SMAD4	complex	SIGNOR-C9	SIGNOR	AP1	complex	SIGNOR-C154	SIGNOR	"up-regulates activity"	binding			9606									22926518	t		miannu	"The activated TGFβ type I receptor kinase propagates the signal within the cell through phosphorylation of the receptor-regulated (R-)Smad proteins Smad2 and Smad3 at their extreme carboxyl-terminal serine residues.1, 2 The activated R-Smads then form heteromeric complexes with the common-partner (Co-)Smad, Smad4, and accumulate in the nucleus, where they can bind DNA and regulate gene expression. The Smads control gene expression in a cell type-specific manner by interacting with other proteins, such as AP-1, AP-2 and Ets transcription factors and specific co-activators and co-repressors."	0.649	SIGNOR-256181
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	SMAD2/SMAD4	complex	SIGNOR-C8	SIGNOR	AP1	complex	SIGNOR-C154	SIGNOR	"up-regulates activity"	binding			9606									22926518	t		miannu	"The activated TGFβ type I receptor kinase propagates the signal within the cell through phosphorylation of the receptor-regulated (R-)Smad proteins Smad2 and Smad3 at their extreme carboxyl-terminal serine residues.1, 2 The activated R-Smads then form heteromeric complexes with the common-partner (Co-)Smad, Smad4, and accumulate in the nucleus, where they can bind DNA and regulate gene expression. The Smads control gene expression in a cell type-specific manner by interacting with other proteins, such as AP-1, AP-2 and Ets transcription factors and specific co-activators and co-repressors."	0.531	SIGNOR-256180
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	AP1	complex	SIGNOR-C154	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									9878062	f		lperfetto	"AP‐1 proteins, including c‐Fos and c‐Jun, are prominent nuclear targets of growth factor induced signaling, making AP‐1 a candidate nuclear effector of growth factor induced proliferation."	0.7	SIGNOR-252356
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	TGFBR2	protein	P37173	UNIPROT	TGFBR1	protein	P36897	UNIPROT	"up-regulates activity"	phosphorylation	Thr176	PFISEGTtLKDLIYD	9606									8576253	t		lperfetto	"Recent studies have revealed that upon TGF-beta binding several serine and threonine residues in the GS domain of TGF-beta type I receptor (T beta R-I) are phosphorylated by TGF-beta type II receptor (T beta R-II) and that the phosphorylation of GS domain is essential for TGF-beta signalingThese observations indicate that serine 172 and threonine 176 of T beta R-I are dispensable for extracellular matrix protein production but essential to the growth inhibition by TGF-beta"	0.72	SIGNOR-246732
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	TGFBR1	protein	P36897	UNIPROT	SMAD2	protein	Q15796	UNIPROT	"up-regulates activity"	phosphorylation	Ser467	SVRCSSMs	9534									9346908	t		lperfetto	"Recently, it was demonstrated that Smad2 interacts transiently with and is a direct substrate of the transforming growth factor-beta (TGF-beta) type I receptor, TbetaRI. Phosphorylation sites on Smad2 were localized to a carboxyl-terminal fragment containing three serine residues at positions 464, 465, and 467.   These results indicate that receptor-dependent phosphorylation of Smad2 on serines 465 and 467 is required in mammalian cells to permit association with Smad4 and to propagate TGF-_ signals."	0.828	SIGNOR-235995
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	TGFBR1	protein	P36897	UNIPROT	SMAD3	protein	P84022	UNIPROT	"up-regulates activity"	phosphorylation	Ser425	SIRCSSVs	10090	BTO:0005493;BTO:0000165								19458083	t		lperfetto	"A major event leading to Smad3 activation is the TGF-beta-induced, TbetaRI-mediated phosphorylation at two C-terminal serine residues, Ser-423 and Ser-425, which triggers dissociation of Smad3 from its receptors to form a complex with Smad4 and accumulate in the nucleus"	0.816	SIGNOR-235380
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	TGFBR1	protein	P36897	UNIPROT	SMAD3	protein	P84022	UNIPROT	"up-regulates activity"	phosphorylation	Ser423	SPSIRCSsVS	10090	BTO:0005493;BTO:0000165								19458083	t		lperfetto	"A major event leading to smad3 activation is the tgf-beta-induced, tbetari-mediated phosphorylation at two c-terminal serine residues, ser-423 and ser-425, which triggers dissociation of smad3 from its receptors to form a complex with smad4 and accumulate in the nucleus"	0.816	SIGNOR-235385
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	TGFBR2	protein	P37173	UNIPROT	TGFBR1	protein	P36897	UNIPROT	"up-regulates activity"	phosphorylation	Ser172	SLDRPFIsEGTTLKD	9606									8576253	t		lperfetto	"Recent studies have revealed that upon TGF-beta binding several serine and threonine residues in the GS domain of TGF-beta type I receptor (T beta R-I) are phosphorylated by TGF-beta type II receptor (T beta R-II) and that the phosphorylation of GS domain is essential for TGF-beta signalingThese observations indicate that serine 172 and threonine 176 of T beta R-I are dispensable for extracellular matrix protein production but essential to the growth inhibition by TGF-beta"	0.72	SIGNOR-246728
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	TGFBR2	protein	P37173	UNIPROT	TGFBR1	protein	P36897	UNIPROT	"up-regulates activity"	phosphorylation	Thr200	LPLLVQRtIARTIVL	-1									8576253	t		"giulio giuliani"	"From our present data, it is not easy to deduce the mechanistic significance of serine 172 and threonine 176 of TŒ≤R-I in TGF-Œ≤ signaling. Although it was reported that TGF-Œ≤-induced phosphorylation of these residues was not detected in vivo(22), it is still possible that TŒ≤R-II may phosphorylate these residues as minor phosphorylation site(s)."	0.72	SIGNOR-255962
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	TGFBR2	protein	P37173	UNIPROT	TGFBR1	protein	P36897	UNIPROT	"up-regulates activity"	phosphorylation	Thr200	LPLLVQRtIARTIVL	452646									7774578	t		lperfetto	"The tgf-beta type ii receptor (t beta r-ii) is a transmembrane serine/threonine kinase that, upon ligand binding, recruits and phosphorylates a second transmembrane kinase, t beta r-i, as a requirement for signal transduction.  In contrast to the relatively innocuous nature of single site mutations in the ttsgsgsg sequence, mutation of thr200 or 204 to valine causes marked losses in ligand-induced phosphorylation and signaling."	0.72	SIGNOR-32744
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	TGFb	proteinfamily	SIGNOR-PF5	SIGNOR	TGFBR2	protein	P37173	UNIPROT	"up-regulates activity"	binding			9606	BTO:0000801								22703233	t		miannu	"TGFbeta signals are transmitted via a cell surface receptor complex consisting of the TGFbeta type I receptor (TbetaRI) and TGFbeta type II receptor (TbetaRII). To initiate signal transduction, TGFbeta binds to TbetaRII, which in turn recruits TbetaRI, leading to the formation of a tetrameric receptor complex."	0.2	SIGNOR-256179
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	TGFb	proteinfamily	SIGNOR-PF5	SIGNOR	TGFBR2	protein	P37173	UNIPROT	"up-regulates activity"	binding			9606									22326956	t		miannu	"TGF-beta signaling mediates a wide range of biological activities in development and disease. TGF-beta ligands signal through heterodimeric type I and type II receptors (TGF-beta receptor type I [TbetaRI, also known as ALK5 and TGFBR1] and TbetaRII) that are members of the serine/threonine kinase family."	0.2	SIGNOR-256178
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	BRAF	protein	P15056	UNIPROT	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	"up-regulates activity"	phosphorylation			-1									8413257	t		lperfetto	"Raf-1 phosphorylation of MEK activated it, as judged by its ability to stimulate the phosphorylation of myelin basic protein by glutathione S-transferase-ERK1."	0.787	SIGNOR-244831
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	BRAF	protein	P15056	UNIPROT	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	up-regulates	phosphorylation			9606									8668348	t		lperfetto	"We show that, consequently, b-raf interacts with mek-1 and mek-2 with a better affinity than does c-raf-1, thus strengthening the notion that b-raf is a stronger mek activator than c-raf-l."	0.787	SIGNOR-244843
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	BRAF	protein	P15056	UNIPROT	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	"up-regulates activity"	phosphorylation			9606									21900390	t		miannu	"BRAFV600E has been shown to initiate thyroid follicular cell transformation. The BRAFV600E mutation disrupts the hydrophobic interaction, enabling the BRAF kinase to fold into a catalytically active formation, resulting in an almost 500-fold increase in kinase activity. Mutant BRAF can dimerize and activate MEK without Ras activation."	0.787	SIGNOR-251988
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	TERT	protein	O14746	UNIPROT	up-regulates	phosphorylation	Ser227	GARRRGGsASRSLPL	9606									10224060	t		lperfetto	"Akt kinase enhances human telomerase activity through phosphorylation of htert subunit as one of its substrate proteins."	0.2	SIGNOR-244361
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	TERT	protein	O14746	UNIPROT	up-regulates	phosphorylation	Ser824	AVRIRGKsYVQCQGI	9606									10224060	t		lperfetto	"Akt kinase enhances human telomerase activity through phosphorylation of htert subunit as one of its substrate proteins."	0.2	SIGNOR-244357
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	MDM2	protein	Q00987	UNIPROT	"up-regulates activity"	phosphorylation	Ser166	SSRRRAIsETEENSD	9606									15169778	t		lperfetto	"Stabilization of mdm2 via decreased ubiquitination is mediated by protein kinase b/akt-dependent phosphorylation."	0.2	SIGNOR-244296
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	MDM2	protein	Q00987	UNIPROT	"up-regulates activity"	phosphorylation	Ser186	RQRKRHKsDSISLSF	9606									11504915	t		lperfetto	"Mitogen-induced activation of phosphatidylinositol 3-kinase (pi3-kinase) and its downstream target, the akt/pkb serine-threonine kinase, results in phosphorylation of mdm2 on serine 166 and serine 186. Phosphorylation on these sites is necessary for translocation of mdm2 from the cytoplasm into the nucleus.Both akt expression and serum treatment induced phosphorylation of mdm2 at ser186."	0.2	SIGNOR-244292
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	MDM2	protein	Q00987	UNIPROT	"up-regulates activity"	phosphorylation	Ser188	RKRHKSDsISLSFDE	9606									15169778	t		lperfetto	"Stabilization of mdm2 via decreased ubiquitination is mediated by protein kinase b/akt-dependent phosphorylationhere we show that pkb inhibits mdm2 self-ubiquitination via phosphorylation of mdm2 on ser(166) and ser(188)"	0.2	SIGNOR-244300
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	RB1	protein	P06400	UNIPROT	G1/S_transition	phenotype	SIGNOR-PH50	SIGNOR	down-regulates				9606									21524151	f		lperfetto	"In its hypophosphorylated state, pRb binds transcription factors of the E2F family which are required for cell cycle progression. As the level of CyclinD/Cdk4/6 complexes increases, pRb becomes phosphorylated and progression through G1 occurs. At a critical level of phosphorylation, E2F is released from pRb. This activates the transcription of CyclinE which complexes with Cdk2 to fully release pRb repression by further phosphorylation, establishing a positive feedback loop. E2F further promotes the transcription of S-phase genes. Thus, CyclinD/Cdk4/6 and CyclinE/Cdk2 together regulate S-phase entry via phosphorylating pRb, which controls pRb binding to E2F"	0.7	SIGNOR-245483
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	MDM2	protein	Q00987	UNIPROT	TP53	protein	P04637	UNIPROT	"down-regulates quantity by destabilization"	ubiquitination			9606									22337874	t		lperfetto	"The E3 ubiquitin ligase, MDM2, uses a dual-site mechanism to ubiquitinate and degrade the tumor suppressor protein p53, involving interactions with the N-terminal hydrophobic pocket and the acidic domain of MDM2."	0.968	SIGNOR-196116
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	MDM2	protein	Q00987	UNIPROT	TP53	protein	P04637	UNIPROT	"down-regulates quantity by destabilization"	ubiquitination			9606									23150757	t		lperfetto	"Dual Roles of MDM2 in the Regulation of p53: Ubiquitination Dependent and Ubiquitination Independent Mechanisms of MDM2 Repression of p53 Activity"	0.968	SIGNOR-199371
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	MDM2	protein	Q00987	UNIPROT	TP53	protein	P04637	UNIPROT	"down-regulates quantity by destabilization"	ubiquitination			9606									10935507	t		lperfetto	"Many posttranslational modifications of p53, such as phosphorylation, dephosphorylation, acetylation and ribosylation, have been shown to occur following cellular stress. Some of these modifications may activate the p53 protein, interfere with MDM2 binding and/or dictate cellular localization of p53."	0.968	SIGNOR-80528
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	CyclinD/CDK4	complex	SIGNOR-C18	SIGNOR	RB1	protein	P06400	UNIPROT	"down-regulates activity"	phosphorylation	Thr356	DSFETQRtPRKSNLD	-1									9139732	t		llicata	"In summary, we have shown evidence that CDK4-cyclin D1 phosphorylates Thr5, Ser249, Thr252, Thr356, Thr373, Ser788, Ser795, Ser807, Ser811, and Thr826 of pRB."	0.864	SIGNOR-250760
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	CyclinD/CDK4	complex	SIGNOR-C18	SIGNOR	RB1	protein	P06400	UNIPROT	"down-regulates activity"	phosphorylation	Ser788	PIPHIPRsPYKFPSS	-1									9139732	t		llicata	"In summary, we have shown evidence that CDK4-cyclin D1 phosphorylates Thr5, Ser249, Thr252, Thr356, Thr373, Ser788, Ser795, Ser807, Ser811, and Thr826 of pRB."	0.864	SIGNOR-250759
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	CyclinD/CDK4	complex	SIGNOR-C18	SIGNOR	RB1	protein	P06400	UNIPROT	"down-regulates activity"	phosphorylation	Thr5	tPRKTAAT	-1									9139732	t		llicata	"In summary, we have shown evidence that CDK4-cyclin D1 phosphorylates Thr5, Ser249, Thr252, Thr356, Thr373, Ser788, Ser795, Ser807, Ser811, and Thr826 of pRB."	0.864	SIGNOR-250762
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	PI3K	complex	SIGNOR-C156	SIGNOR	PIP3	smallmolecule	CHEBI:16618	ChEBI	"up-regulates quantity"	"chemical modification"			9606									24647478	t		lperfetto	"Stimulation of tyrosine kinase receptors initiates a signaling cascade that activates pi3k. Activated pi3k uses pip2 to generate pip3, 24647478"	0.8	SIGNOR-252712
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	PI3K	complex	SIGNOR-C156	SIGNOR	PIP3	smallmolecule	CHEBI:16618	ChEBI	"up-regulates quantity"	"chemical modification"			9606									12040186	t		lperfetto	"The activated PI3K converts the plasma membrane lipid phosphatidylinositol-4,5-bisphosphate [PI(4,5)P2] to phosphatidylinositol-3,4,5-trisphosphate [PI(3,4,5)P3]."	0.8	SIGNOR-252713
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	"ErbB receptor family"	proteinfamily	SIGNOR-PF36	SIGNOR	PI3K	complex	SIGNOR-C156	SIGNOR	"up-regulates activity"	binding			9606									17306385	t		miannu	"Another phospholipid modifying signaling pathway activated by RTKs is the PI3K pathway. This heterodimeric enzyme comprises two subunits, the p85 regulatory subunit harboring two SH2 domains, and the p110 catalytic subunit. PI3K activation may be achieved by binding of its p85 regulatory subunit to an activated receptor. Alternatively, RTK signaling may activate the small G protein Ras, which in turn recruits PI3K to the plasma membrane and induces a stimulatory conformational change in the lipid kinase"	0.784	SIGNOR-256168
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	E2F1	protein	Q01094	UNIPROT	G1/S_transition	phenotype	SIGNOR-PH50	SIGNOR	up-regulates				9606									21524151	f		lperfetto	"In its hypophosphorylated state, pRb binds transcription factors of the E2F family which are required for cell cycle progression. As the level of CyclinD/Cdk4/6 complexes increases, pRb becomes phosphorylated and progression through G1 occurs. At a critical level of phosphorylation, E2F is released from pRb. This activates the transcription of CyclinE which complexes with Cdk2 to fully release pRb repression by further phosphorylation, establishing a positive feedback loop. E2F further promotes the transcription of S-phase genes. Thus, CyclinD/Cdk4/6 and CyclinE/Cdk2 together regulate S-phase entry via phosphorylating pRb, which controls pRb binding to E2F"	0.7	SIGNOR-245477
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	RB1	protein	P06400	UNIPROT	E2F1	protein	Q01094	UNIPROT	"down-regulates activity"	binding			9606									8255752	t		amattioni	"E2f binds rb. E2f activation domain is the target for rb-induced repression. Rb can silence the 57 residue e2f activation domain. Rb can mask e2f residues involved in the activation process, possibly by mimicking a component of the transcriptional machinery"	0.92	SIGNOR-37305
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	TP53	protein	P04637	UNIPROT	Apoptosis	phenotype	SIGNOR-PH2	SIGNOR	up-regulates				9606									24212651	f		miannu	"P53 is a nuclear transcription factor with a pro-apoptotic function"	0.7	SIGNOR-255678
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	CyclinD/CDK4	complex	SIGNOR-C18	SIGNOR	RB1	protein	P06400	UNIPROT	"down-regulates activity"	phosphorylation	Ser780	STRPPTLsPIPHIPR	9606	BTO:0000150								23336272	t		lperfetto	"Cyclin d1 is known to activate cdk4, which then phosphorylates the rb protein, leading to cell cycle progression."	0.864	SIGNOR-216988
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	CyclinD/CDK4	complex	SIGNOR-C18	SIGNOR	RB1	protein	P06400	UNIPROT	"down-regulates activity"	phosphorylation	Ser795	SPYKFPSsPLRIPGG	9606	BTO:0000150								23336272	t		lperfetto	"Cyclin d1 is known to activate cdk4, which then phosphorylates the rb protein, leading to cell cycle progression."	0.864	SIGNOR-216992
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	CyclinD/CDK4	complex	SIGNOR-C18	SIGNOR	RB1	protein	P06400	UNIPROT	"down-regulates activity"	phosphorylation	Thr826	LPTPTKMtPRSRILV	9606									9139732	t		lperfetto	"We demonstrate that phosphorylation by either cdk2-cyclin a, which phosphorylates t821, or cdk4-cyclin d1, which phosphorylates threonine 826, can disable prb for subsequent binding of an lxcxe protein."	0.864	SIGNOR-216957
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	TP53	protein	P04637	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	down-regulates				9606	BTO:0000452								7667317	f			"P53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts"	0.7	SIGNOR-255669
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	IKK-complex	complex	SIGNOR-C14	SIGNOR	NFKBIA	protein	P25963	UNIPROT	down-regulates	phosphorylation	Ser36	RHDSGLDsMKDEEYE	9606									9346241	t		lperfetto	"We described the purification of a 900 kda protein kinase complex, the ikb kinase (ikk), that phosphorylates ikbalfa and ikbbeta at the sites that mediate their ubiquitination and degradation"	0.889	SIGNOR-216389
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	IKK-complex	complex	SIGNOR-C14	SIGNOR	NFKBIA	protein	P25963	UNIPROT	down-regulates	phosphorylation	Ser32	LLDDRHDsGLDSMKD	9606									9346241	t		lperfetto	"We described the purification of a 900 kda protein kinase complex, the ikb kinase (ikk), that phosphorylates ikbalfa and ikbbeta at the sites that mediate their ubiquitination and degradation"	0.889	SIGNOR-216385
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	IKK-complex	complex	SIGNOR-C14	SIGNOR	NfKb-p65/p50	complex	SIGNOR-C13	SIGNOR	up-regulates	phosphorylation			9606	BTO:0000007								19609947	t		lperfetto	"Our data suggest that the stimulation of nfkb by akt is dependent on the phosphorylation of p65 at s534, mediated by ikk (ikb kinase) alfa and beta."	0.821	SIGNOR-216365
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	IKK-complex	complex	SIGNOR-C14	SIGNOR	up-regulates	phosphorylation			9606	BTO:0001454								19609947	t		lperfetto	"Although there are likely to be multiple levels of crosstalk between the pi3k-akt and nf-kb pathways, one mechanism has been attributed to direct phosphorylation of the amino acid residue t23 on ikb kinase alfa (ikkalfa) by akt, thereby leading to activation of this kinase upstream of nf-kb akt mediates ikkalpha phosphorylation at threonine 23 akt transiently associates in vivo with ikk and induces ikk activation. Akt mediates ikkalfa phosphorylation at threonine 23.Akt phosphorylates ikkalpha on t23, and this phosphorylation event is a prerequisite for the phosphorylation of p65 at s534 by ikkalpha and beta"	0.66	SIGNOR-244281
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	EGF	protein	P01133	UNIPROT	EGFR	protein	P00533	UNIPROT	"up-regulates activity"	binding			9606									12297050	t		lperfetto	"Epidermal growth factor (egf) regulates cell proliferation and differentiation by binding to the egf receptor (egfr) extracellular region, comprising domains i-iv, with the resultant dimerization of the receptor tyrosine kinase."	0.95	SIGNOR-186159
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	TGFA	protein	P01135	UNIPROT	EGFR	protein	P00533	UNIPROT	"up-regulates activity"	binding			9606	BTO:0000584								16585207	t	"Transforming growth factor alpha expression drives constitutive epidermal growth factor receptor pathway activation and sensitivity to gefitinib (Iressa) in human pancreatic cancer cell lines"	gcesareni	"Our data indicate that a subset of cell lines is dependent on TGF-_-mediated activation of the EGFR for cell proliferation and strongly suggest that pancreatic tumors expressing high levels of TGF-_ and phosphorylated (activated) EGFR are EGFR-dependent in vitro and in vivo."	0.9	SIGNOR-93199
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	mTORC1	complex	SIGNOR-C3	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606		BTO:0000007							20508131	f			"The mammalian target of rapamycin complex 1 (mTORC1) integrates mitogen and nutrient signals to control cell proliferation and cell size."	0.7	SIGNOR-256063
SIGNOR-PDAP	"Pancreatic ductal adenocarcinoma (PDA)"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	mTORC1	complex	SIGNOR-C3	SIGNOR	"up-regulates activity"	phosphorylation			9606		BTO:0000887;BTO:0001103;BTO:0001760							20138985	t		lperfetto	"Pras40 is an insulin-regulated inhibitor of the mtorc1 protein kinase. Insulin stimulates akt/pkb-mediated phosphorylation of pras40, which prevents its inhibition of mtorc1 in cells and in vitro. Phosphorylation of pras40 on thr246 by pkb/akt facilitates efficient phosphorylation of ser183 by mtorc1."	0.735	SIGNOR-217586
SIGNOR-RMS	Rhabdomyosarcoma	IGF1R	protein	P08069	UNIPROT	IGF1R	protein	P08069	UNIPROT	up-regulates	phosphorylation	Tyr973	RLGNGVLyASVNPEY	-1									7493944	t		lperfetto	"The insulin-like growth factor type I (IGF-I) receptor can become tyrosine phosphorylated and enzymatically activated either in response to ligand or because of the activity of the Src tyrosine kinase. We mapped the sites of IGF-I receptor autophosphorylation to peptides representing three different receptor domains: tyrosines 943 and 950 in the juxtamembrane region; tyrosines 1131, 1135, and 1136 within the kinase domain; and tyrosine 1316 in the carboxyl-terminal domain."	0.2	SIGNOR-246252
SIGNOR-RMS	Rhabdomyosarcoma	IGF1R	protein	P08069	UNIPROT	IGF1R	protein	P08069	UNIPROT	"up-regulates activity"	phosphorylation	Tyr1346	SFDERQPyAHMNGGR	-1									8940173	t		miannu	"The insulin-like growth factor type I (IGF-I) receptor can become tyrosine phosphorylated and enzymatically activated either in response to ligand or because of the activity of the Src tyrosine kinaseWe mapped the sites of IGF-I receptor autophosphorylation to peptides representing three different receptor domains: tyrosines 943 and 950 in the juxtamembrane region; tyrosines 1131, 1135, and 1136 within the kinase domain; and tyrosine 1316 in the carboxyl-terminal domain."	0.2	SIGNOR-246260
SIGNOR-RMS	Rhabdomyosarcoma	IGF1R	protein	P08069	UNIPROT	IGF1R	protein	P08069	UNIPROT	"up-regulates activity"	phosphorylation	Tyr1166	DIYETDYyRKGGKGL	9606									7493944	t		lperfetto	"Insulin and insulin-like growth factor (igf-i) receptors are heterotetrameric proteins consisting of two alpha-and two beta-subunits and members of the transmembrane tyrosine kinase receptors. Specific ligand binding to the receptor triggers a cascade of intracellular events, which begins with autophosphorylation of several tyrosine residues of the beta-subunit of the receptor."	0.2	SIGNOR-26590
SIGNOR-RMS	Rhabdomyosarcoma	IGF1R	protein	P08069	UNIPROT	IGF1R	protein	P08069	UNIPROT	"up-regulates activity"	phosphorylation	Tyr1166	DIYETDYyRKGGKGL	-1									8940173	t		miannu	"The insulin-like growth factor type I (IGF-I) receptor can become tyrosine phosphorylated and enzymatically activated either in response to ligand or because of the activity of the Src tyrosine kinaseWe mapped the sites of IGF-I receptor autophosphorylation to peptides representing three different receptor domains: tyrosines 943 and 950 in the juxtamembrane region; tyrosines 1131, 1135, and 1136 within the kinase domain; and tyrosine 1316 in the carboxyl-terminal domain."	0.2	SIGNOR-246244
SIGNOR-RMS	Rhabdomyosarcoma	IGF1R	protein	P08069	UNIPROT	IGF1R	protein	P08069	UNIPROT	"up-regulates activity"	phosphorylation	Tyr1161	FGMTRDIyETDYYRK	9606									7493944	t		lperfetto	"Insulin and insulin-like growth factor (igf-i) receptors are heterotetrameric proteins consisting of two alpha-and two beta-subunits and members of the transmembrane tyrosine kinase receptors. Specific ligand binding to the receptor triggers a cascade of intracellular events, which begins with autophosphorylation of several tyrosine residues of the beta-subunit of the receptor."	0.2	SIGNOR-26582
SIGNOR-RMS	Rhabdomyosarcoma	IGF1R	protein	P08069	UNIPROT	IGF1R	protein	P08069	UNIPROT	"up-regulates activity"	phosphorylation	Tyr1161	FGMTRDIyETDYYRK	-1									8940173	t		miannu	"The insulin-like growth factor type I (IGF-I) receptor can become tyrosine phosphorylated and enzymatically activated either in response to ligand or because of the activity of the Src tyrosine kinaseWe mapped the sites of IGF-I receptor autophosphorylation to peptides representing three different receptor domains: tyrosines 943 and 950 in the juxtamembrane region; tyrosines 1131, 1135, and 1136 within the kinase domain; and tyrosine 1316 in the carboxyl-terminal domain."	0.2	SIGNOR-246248
SIGNOR-RMS	Rhabdomyosarcoma	IGF1	protein	P05019	UNIPROT	IGF1R	protein	P08069	UNIPROT	up-regulates	binding			9606									19029956	t		lperfetto	"At the cellular level, the ligands IGF1, IGF2 and insulin bind to various members of the insulin receptor (IR) - IGF1 receptor (IGF1R) family."	0.956	SIGNOR-182484
SIGNOR-RMS	Rhabdomyosarcoma	IGF1	protein	P05019	UNIPROT	IGF1R	protein	P08069	UNIPROT	"up-regulates activity"	binding			9606									21798082	t		lperfetto	"Binding of IGF1 to its receptor leads to activation of its intrinsic tyrosine kinase and autophosphorylation, thus generating docking sites for insulin receptor substrate (IRS), which is also phosphorylated by the IGF1 receptor."	0.956	SIGNOR-175662
SIGNOR-RMS	Rhabdomyosarcoma	HGF	protein	P14210	UNIPROT	MET	protein	P08581	UNIPROT	up-regulates	binding			9606									8380735	t		gcesareni	"Hgf is the ligand for p190met, the receptor tyrosine kinase encoded by the met proto-oncogene."	0.929	SIGNOR-38429
SIGNOR-RMS	Rhabdomyosarcoma	GRB2	protein	P62993	UNIPROT	SOS1	protein	Q07889	UNIPROT	"up-regulates activity"	relocalization			9606	BTO:0001412								10570290	t	"GRB2 associated guanine nucleotide exchange factor Sos activates Ras through the exchange of GDP for GTP"	lperfetto	"Grb2 binds and activates sos, which then activates ras, and this activates p110 independently of p85."	0.914	SIGNOR-236792
SIGNOR-RMS	Rhabdomyosarcoma	GRB2	protein	P62993	UNIPROT	SOS1	protein	Q07889	UNIPROT	"up-regulates activity"	relocalization			9606									8479541	t	"GRB2 associated guanine nucleotide exchange factor Sos activates Ras through the exchange of GDP for GTP"	lperfetto	"Furthermore, our results indicate that the interaction domains of sos1 and grb2 have evolved so as to bind ligands not with maximal strength but with specificities and affinities that maintain cooperativity. Grb2 binds and activates sos, which then activates ras, and this activates p110 independently of p85."	0.914	SIGNOR-39163
SIGNOR-RMS	Rhabdomyosarcoma	GRB2	protein	P62993	UNIPROT	SOS1	protein	Q07889	UNIPROT	"up-regulates activity"	relocalization			10090	BTO:0000669								23452850	t	"GRB2 associated guanine nucleotide exchange factor Sos activates Ras through the exchange of GDP for GTP"	lperfetto	"Interaction domains of sos1/grb2 are finely tuned for cooperative control of embryonic stem cell fate."	0.914	SIGNOR-235773
SIGNOR-RMS	Rhabdomyosarcoma	GRB2	protein	P62993	UNIPROT	GAB1	protein	Q13480	UNIPROT	up-regulates	binding			9606									12766170	t	"Grb2-associated binding (Gab) scaffolding/adapter proteins are a family of three members including mammalian Gab1, Gab2, and Gab3 that are highly conserved."	lperfetto	"The gab1 docking protein forms a platform for the assembly of a multiprotein signaling complex downstream from receptor tyrosine kinases. In general, recruitment of gab1 occurs indirectly, via the adapter protein grb2"	0.874	SIGNOR-235917
SIGNOR-RMS	Rhabdomyosarcoma	GAB1	protein	Q13480	UNIPROT	PIK3CA	protein	P42336	UNIPROT	up-regulates	binding			9606									11043767	t		lperfetto	"We have shown that gab1 colocalizes pi3k with sh2 domain-containing inositol phosphatase (ship) and shp2, two enzymes that regulate pi3k-dependent signaling. The src homology 2 (sh2) domain of the phosphatidylinositol 3-kinase (pi3k) regulatory subunit binds gab1 in a phosphorylation-independent manner. Moreover, the regulatory subunit of pi3k can mediate the association of gab1 and receptor protein-tyrosine kinases including the insulin, egf, and ngf receptors, all of which phosphorylate gab1."	0.456	SIGNOR-83343
SIGNOR-RMS	Rhabdomyosarcoma	FOXO1	protein	Q12778	UNIPROT	STAT3	protein	P40763	UNIPROT	"down-regulates activity"	binding			9606	BTO:0000007								25510553	t		miannu	"FoxO1, which is up-regulated during early stages of diet-induced leptin resistance, directly interacts with STAT3 and prevents STAT3 from binding to specificity protein 1 (SP1)-pro-opiomelanocortin (POMC) promoter complex, and thereby inhibits STAT3-mediated regulation of POMC transcription."	0.603	SIGNOR-263496
SIGNOR-RMS	Rhabdomyosarcoma	FGFR4	protein	P22455	UNIPROT	STAT3	protein	P40763	UNIPROT	"up-regulates activity"	phosphorylation	Tyr705	DPGSAAPyLKTKFIC	9606									10918587	t			"Activation of Stat1 and Stat3 by FGFR derivatives. Lysates of 293T cells transfected as indicated were analysed by Western blotting using Phospho-Stat1 (Y701) antisera (top) or Stat1 antisera (bottom). (b) The same lysates in (a) were re-examined for phosphorylated Stat3 by Western blotting with Phospho-Stat3 (Y705) (top). all three FGFR family members examined here are able to lead to Stat activation. Expression of the 'TDII-like' derivatives of FGFR1, FGFR3, and FGFR4, as well as myrR1-WT, led to phosphorylation of both Stat1 and Stat3."	0.4	SIGNOR-251142
SIGNOR-RMS	Rhabdomyosarcoma	FGF1	protein	P05230	UNIPROT	FGFR4	protein	P22455	UNIPROT	up-regulates	binding			9606									1385111	t		gcesareni	"Our results establish an fgf binding profile for fgfr-4 with afgf having the highest affinity, followed by k-fgf/hst-1 and bfgf. In addition, fgf-6 was found to bind to fgfr-4 in ligand competition experiments. Ligands binding to fgfr-4 induced receptor autophosphorylation and phosphorylation of a set of cellular polypeptides."	0.828	SIGNOR-18454
SIGNOR-RMS	Rhabdomyosarcoma	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	Survival	phenotype	SIGNOR-PH13	SIGNOR	up-regulates				9606	BTO:0000830								15526160	f			"Numerous studies have implicated the critical importance of the Ras/Erk pathway in cell division and survival"	0.7	SIGNOR-254948
SIGNOR-RMS	Rhabdomyosarcoma	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606		BTO:0001103							20219869	f		apalma	"ERK1/2 activation is a component of the pathway through which many mitogenic growth factors can stimulate cell proliferation"	0.7	SIGNOR-256216
SIGNOR-RMS	Rhabdomyosarcoma	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	Survival	phenotype	SIGNOR-PH13	SIGNOR	up-regulates				9606	BTO:0000876	BTO:0001103							11602185	f		apalma	"The GM-CSF promoted cell survival and proliferation correlated with MEK-1 dependent ERK1/2, Elk-1 and CREB phosphorylation and Egr-1, c-Fos expression as well as with increased STAT-5, AP-1, c-Myb and NF-kappaB DNA-binding."	0.7	SIGNOR-255579
SIGNOR-RMS	Rhabdomyosarcoma	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606	BTO:0000876	BTO:0001103							11602185	f		apalma	"The GM-CSF promoted cell survival and proliferation correlated with MEK-1 dependent ERK1/2, Elk-1 and CREB phosphorylation and Egr-1, c-Fos expression as well as with increased STAT-5, AP-1, c-Myb and NF-kappaB DNA-binding."	0.7	SIGNOR-255580
SIGNOR-RMS	Rhabdomyosarcoma	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									24743741	f			"Activation of PDGFRα stimulates proliferation of PDGFRα(+) cells through PI3K-Akt and MEK2-MAPK signaling pathways, and aberrant accumulation of PDGFRα(+) cells was conspicuous in muscles of patients with both genetic and non-genetic muscle diseases."	0.7	SIGNOR-254374
SIGNOR-RMS	Rhabdomyosarcoma	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									19819937	f			"In addition to the JAK2–STAT5 pathway, the Ras GTPase–extracellular signal-regulated kinase (Ras–ERK) pathway has also been implicated in signaling of IL-5 and is important for IL-5-dependent cell survival, proliferation and differentiation of eosinophils."	0.7	SIGNOR-254354
SIGNOR-RMS	Rhabdomyosarcoma	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				10090									20219869	f		areggio	"Furthermore, stimulation of myoblasts with CCL2, CCL3, or CCL4 was sufficient to induce phosphorylation and activation of ERK1/2. This outcome may be functionally important because ERK1/2 activation is a component of the pathway through which many mitogenic growth factors can stimulate cell proliferation."	0.7	SIGNOR-255120
SIGNOR-RMS	Rhabdomyosarcoma	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	MYC	protein	P01106	UNIPROT	"up-regulates quantity by stabilization"	phosphorylation	Ser62	LLPTPPLsPSRRSGL	10116	BTO:0004725								11018017	t			"Phosphorylation of Ser 62 is required for Ras-induced stabilization of Myc, likely mediated through the action of ERK."	0.2	SIGNOR-252079
SIGNOR-RMS	Rhabdomyosarcoma	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	BRAF	protein	P15056	UNIPROT	down-regulates	phosphorylation	Thr401	STTGLSAtPPASLPG	9606									21135229	t		lperfetto	"We show that b-raf is a calcineurin substrate;among calcineurin target residues on b-raf is t401, a site of negative feedback phosphorylation by erk1/2. Blocking calcineurin activity in _ cells prevents dephosphorylation of b-raf t401 and decreases b-raf and erk1/2 activities."	0.2	SIGNOR-170339
SIGNOR-RMS	Rhabdomyosarcoma	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	CDKN1A	protein	P38936	UNIPROT	"down-regulates quantity by destabilization"	phosphorylation	Thr57	NFDFVTEtPLEGDFA	9606									19364816	t		lperfetto	"We have shown that erk2 interacts with and phosphorylates p21cip1, promoting p21cip1_ubiquitination. We identified two erk2 phosphorylation sites, thr57 and ser130, in p21cip1_and showed that phosphorylation of these residues increases p21cip1_cytoplasmic distribution and proteasome-dependent degradation."	0.2	SIGNOR-244513
SIGNOR-RMS	Rhabdomyosarcoma	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	BRAF	protein	P15056	UNIPROT	"down-regulates activity"	phosphorylation	Ser151	VARSNPKsPQKPIVR	9606	BTO:0000848								21478863	t			"We show that overactivation of the MAPK pathway, induced by the oncogenic Ras in melanoma, induces constitutive phosphorylation of BRAF on Ser151 by ERK, which inhibits NRAS-BRAF interaction"	0.2	SIGNOR-259919
SIGNOR-RMS	Rhabdomyosarcoma	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	GAB1	protein	Q13480	UNIPROT	"up-regulates activity"	phosphorylation	Ser597	VPMNPNLsSEDPNLF	9606									15379552	t		lperfetto	"Erk phosphorylation enhances hgf-dependent gab1/pi3k but inhibits egf-dependent gab1/pi3k association and activation implicates that mapk activation provides another specific regulatory mechanism which can result in divergent effects for distinct rtks.we identified four serine and two threonine residues that are phosphorylated by erk in vitro. Five of these phosphorylation sites (t312, s454, t476, s581, s597)"	0.2	SIGNOR-129192
SIGNOR-RMS	Rhabdomyosarcoma	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	GAB1	protein	Q13480	UNIPROT	"up-regulates activity"	phosphorylation	Thr476	EANYVPMtPGTFDFS	9606									15379552	t		lperfetto	"Erk phosphorylation enhances hgf-dependent gab1/pi3k but inhibits egf-dependent gab1/pi3k association and activation implicates that mapk activation provides another specific regulatory mechanism which can result in divergent effects for distinct rtks.we identified four serine and two threonine residues that are phosphorylated by erk in vitro. Five of these phosphorylation sites (t312, s454, t476, s581, s597)"	0.2	SIGNOR-129200
SIGNOR-RMS	Rhabdomyosarcoma	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	GAB1	protein	Q13480	UNIPROT	"up-regulates activity"	phosphorylation	Thr312	ISYDIPPtPGNTYQI	9606									15379552	t		lperfetto	"Erk phosphorylation enhances hgf-dependent gab1/pi3k but inhibits egf-dependent gab1/pi3k association and activation implicates that mapk activation provides another specific regulatory mechanism which can result in divergent effects for distinct rtks.we identified four serine and two threonine residues that are phosphorylated by erk in vitro. Five of these phosphorylation sites (t312, s454, t476, s581, s597)"	0.2	SIGNOR-129196
SIGNOR-RMS	Rhabdomyosarcoma	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	GAB1	protein	Q13480	UNIPROT	"up-regulates activity"	phosphorylation	Ser454	YVPMNPNsPPRQHSS	9606									15379552	t		lperfetto	"Erk phosphorylation enhances hgf-dependent gab1/pi3k but inhibits egf-dependent gab1/pi3k association and activation implicates that mapk activation provides another specific regulatory mechanism which can result in divergent effects for distinct rtks.we identified four serine and two threonine residues that are phosphorylated by erk in vitro. Five of these phosphorylation sites (t312, s454, t476, s581, s597)"	0.2	SIGNOR-129188
SIGNOR-RMS	Rhabdomyosarcoma	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	CDKN1A	protein	P38936	UNIPROT	"down-regulates quantity by destabilization"	phosphorylation	Ser130	SGEQAEGsPGGPGDS	9606									19364816	t		gcesareni	"Extracellular signal-regulated kinase 2-dependent phosphorylation induces cytoplasmic localization and degradation of p21cip1.|Phosphopeptide analysis of in vitro ERK2-phosphorylated p21(Cip1) revealed two phosphorylation sites, Thr57 and Ser130."	0.2	SIGNOR-244618
SIGNOR-RMS	Rhabdomyosarcoma	CyclinD/CDK4	complex	SIGNOR-C18	SIGNOR	MYOG	protein	P15173	UNIPROT	down-regulates	binding			9606									21902831	t		lperfetto	"In contrast to cdk2, cyclin d/cdk4 blocks myod activity through an as yet unclear mechanism that may involve direct binding. Cyclin d/cdk4 can also block the activity of myogenin and all mef2 isoforms."	0.339	SIGNOR-216972
SIGNOR-RMS	Rhabdomyosarcoma	CyclinD/CDK4	complex	SIGNOR-C18	SIGNOR	MYOD1	protein	P15172	UNIPROT	down-regulates	binding			9606									21902831	t		lperfetto	"In contrast to cdk2, cyclin d/cdk4 blocks myod activity through an as yet unclear mechanism that may involve direct binding. Cyclin d/cdk4 can also block the activity of myogenin and all mef2 isoforms."	0.433	SIGNOR-216969
SIGNOR-RMS	Rhabdomyosarcoma	CTNNB1	protein	P35222	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									23645839	f		apalma	"For example, prostaglandin E2 (PGE2), 1 of the major metabolites downstream of both COX-1 and COX-2, has been shown to activate β-catenin–dependent signaling in hematopoietic stem cells (HSCs) and promote HSC expansion"	0.7	SIGNOR-255695
SIGNOR-RMS	Rhabdomyosarcoma	CTNNB1	protein	P35222	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									18697834	f		"Simone Vumbaca"	"we showed that β-catenin, a key component of the canonical Wnt-signalling cascade, is present in quiescent satellite cells in the inactive form, but subsequently becomes activated following satellite-cell activation. This observation suggests that the proliferation initiated by the Wnt-signalling cascade does not have to rely on transcription of β-catenin, but rather on activation of this protein, which is already present within the quiescent satellite cells."	0.7	SIGNOR-255654
SIGNOR-RMS	Rhabdomyosarcoma	CTNNB1	protein	P35222	UNIPROT	MYOD1	protein	P15172	UNIPROT	"up-regulates activity"	binding												18316399	t		"Simone Vumbaca"	"Together, these results suggest that B-Cat increases MyoD binding to E box elements"	0.408	SIGNOR-255653
SIGNOR-RMS	Rhabdomyosarcoma	CTNNB1	protein	P35222	UNIPROT	MYOD1	protein	P15172	UNIPROT	"up-regulates activity"	binding			9606		BTO:0000887							18316399	t		gcesareni	"We showed that beta-catenin interacts directly with myod, a basic helix-loop-helix transcription factor essential for muscle differentiation and enhances its binding to e box elements and transcriptional activity."	0.408	SIGNOR-161113
SIGNOR-RMS	Rhabdomyosarcoma	CTNNB1	protein	P35222	UNIPROT	MYC	protein	P01106	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			9606									16510874	f		gcesareni	"Beta-cat promotes h3k4 trimethylation at the c-myc gene in vivo. H3k4 trimethylation in vivo requires prior ubiquitination of h2b, and we find that ubiquitin is necessary for transcription initiation on chromatin but not nonchromatin templates in vitro.Chromatin Immunoprecipitation experiments reveal that beta-cat recruits pygopus, bcl-9/legless, and mll/set1-type complexes to the c-myc enhancertogether with the negative wnt regulators, apc, and betatrcp."	0.75	SIGNOR-19153
SIGNOR-RMS	Rhabdomyosarcoma	CDKN2A	protein	P42771	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	down-regulates				9606	BTO:0000176								7972006	f			"Transfection of the p16INK4 cDNA expression vector into carcinoma cells inhibits their colony-forming efficiency and the p16INK4 expressing cells are selected against with continued passage in vitro. These results are consistent with the hypothesis that p16INK4 is a tumor-suppressor protein and that genetic and epigenetic abnormalities in genes controlling the G1 checkpoint can lead to both escape from senescence and cancer formation."	0.7	SIGNOR-259406
SIGNOR-RMS	Rhabdomyosarcoma	CDKN2A	protein	P42771	UNIPROT	CyclinD/CDK4	complex	SIGNOR-C18	SIGNOR	"down-regulates activity"	binding			9606									8891723	t		lperfetto	"The first group, including p16ink4a, p15ink4b,p18ink4cand p19ink4d, is specific for the g1 cdks,cdk4and cdk6, inhibiting the kinase activity of cyclin d/cdk4-cdk6 complexes on prb."	0.83	SIGNOR-217514
SIGNOR-RMS	Rhabdomyosarcoma	CDKN2A	protein	P42771	UNIPROT	CyclinD/CDK4	complex	SIGNOR-C18	SIGNOR	"down-regulates activity"	binding			9606									11154267	t		lperfetto	"Overexpression of p16INK4a in cells with functional pRb results in inhibition of both Cdk4- and Cdk6-associated kinase activity and pRb phosphorylation, with subsequent cell cycle arrest (46, 50). In addition, inhibition of D cyclin-Cdk4 complex formation by p16INK4a prevents sequestration of p21Cip1 and p27Kip1 by these complexes in early G1, leading to suppression of cyclin E-Cdk2 activity"	0.83	SIGNOR-245459
SIGNOR-RMS	Rhabdomyosarcoma	BRAF	protein	P15056	UNIPROT	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	up-regulates	phosphorylation			9606									8668348	t		lperfetto	"We show that, consequently, b-raf interacts with mek-1 and mek-2 with a better affinity than does c-raf-1, thus strengthening the notion that b-raf is a stronger mek activator than c-raf-l."	0.787	SIGNOR-244843
SIGNOR-RMS	Rhabdomyosarcoma	BRAF	protein	P15056	UNIPROT	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	"up-regulates activity"	phosphorylation			9606									21900390	t		miannu	"BRAFV600E has been shown to initiate thyroid follicular cell transformation. The BRAFV600E mutation disrupts the hydrophobic interaction, enabling the BRAF kinase to fold into a catalytically active formation, resulting in an almost 500-fold increase in kinase activity. Mutant BRAF can dimerize and activate MEK without Ras activation."	0.787	SIGNOR-251988
SIGNOR-RMS	Rhabdomyosarcoma	BRAF	protein	P15056	UNIPROT	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	"up-regulates activity"	phosphorylation			-1									8413257	t		lperfetto	"Raf-1 phosphorylation of MEK activated it, as judged by its ability to stimulate the phosphorylation of myelin basic protein by glutathione S-transferase-ERK1."	0.787	SIGNOR-244831
SIGNOR-RMS	Rhabdomyosarcoma	BRAF	protein	P15056	UNIPROT	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	"up-regulates activity"	phosphorylation			10090									8131746	t		lperfetto	"Activation of mek family kinases requires phosphorylation of two conserved ser/thr residueserine residues 218 and 222 of human mek1 are the primary sites for phosphorylation by c-raf."	0.787	SIGNOR-244827
SIGNOR-RMS	Rhabdomyosarcoma	BRAF	protein	P15056	UNIPROT	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	"up-regulates activity"				9606									21900390	f		miannu	"RAF, a cytoplasmic serine-threonine protein kinase, is a member of the RAS-RAF-MEK-ERK cell-signaling pathway [also known as the MAP kinase (MAPK) pathway], and it plays an essential role in mediating cellular differentiation, proliferation, senescence, and survival in response to extracellular cues. Raf phosphorylates and activates MAP-ERK kinase (MEK), which phosphorylates and activates extracellular signal-regulated kinase (ERK)."	0.661	SIGNOR-260082
SIGNOR-RMS	Rhabdomyosarcoma	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	CDKN1A	protein	P38936	UNIPROT	"down-regulates activity"	binding			9606	BTO:0000222								16982699	t		lperfetto	"More importantly, the consequences of phosphorylation of either Thr145 or Ser146 are distinct. When p21 is phosphorylated on Thr145, it localizes to the nucleus and results in the disruption of the association between proliferating cell nuclear antigen and p21. Furthermore, phosphorylation of Thr145 promotes stabilization of p21"	0.2	SIGNOR-244187
SIGNOR-RMS	Rhabdomyosarcoma	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	Survival	phenotype	SIGNOR-PH13	SIGNOR	up-regulates				9606									16288293	f		miannu	"Akt promotes both cell growth and cell survival by inactivating its downstream substrates including GSK3, BAD, FOXO and TSC2."	0.7	SIGNOR-251550
SIGNOR-RMS	Rhabdomyosarcoma	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	Survival	phenotype	SIGNOR-PH13	SIGNOR	up-regulates				9606	BTO:0000830								15526160	f		miannu	"c-Kit promotes survival via PI3-kinase-dependent activation of Akt and phosphorylation of Bad, a pro-apoptotic molecule, at S136 in vivo."	0.7	SIGNOR-254952
SIGNOR-RMS	Rhabdomyosarcoma	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									24743741	f			"Activation of PDGFRα stimulates proliferation of PDGFRα(+) cells through PI3K-Akt and MEK2-MAPK signaling pathways, and aberrant accumulation of PDGFRα(+) cells was conspicuous in muscles of patients with both genetic and non-genetic muscle diseases."	0.7	SIGNOR-257606
SIGNOR-RMS	Rhabdomyosarcoma	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				10090									16982699	f			"Protein kinase B (PKB/Akt) is an important modulator of insulin signaling, cell proliferation, and survival. Using small interfering RNA duplexes in nontransformed mammalian cells, we show that only Akt1 is essential for cell proliferation"	0.7	SIGNOR-254353
SIGNOR-RMS	Rhabdomyosarcoma	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	FOXO1	protein	Q12778	UNIPROT	down-regulates	relocalization			10090	BTO:0002572								18423396	t		lperfetto	"Akt1/PKBalpha was found to be the major regulator of phosphorylation and nuclear export of FoxO1, whose presence in the nucleus strongly attenuates adipocyte differentiation"	0.2	SIGNOR-252351
SIGNOR-RMS	Rhabdomyosarcoma	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	FOXO1	protein	Q12778	UNIPROT	"down-regulates activity"	phosphorylation	Thr24	LPRPRSCtWPLPRPE	-1	BTO:0000318								10377430	t		lperfetto	"Here we show that the activation of phosphatidylinositol 3 (PI3) kinase by extracellular growth factors induces phosphorylation, nuclear export, and transcriptional inactivation of FKHR1, a member of the FKHR subclass of the forkhead family of transcription factors. Protein kinase B (PKB)/Akt, a key mediator of PI3 kinase signal transduction, phosphorylated recombinant FKHR1 in vitro at threonine-24 and serine-253. Mutants FKHR1(T24A), FKHR1(S253A), and FKHR1(T24A/S253A) were resistant to both PKB/Akt-mediated phosphorylation and PI3 kinase-stimulated nuclear export."	0.2	SIGNOR-252347
SIGNOR-RMS	Rhabdomyosarcoma	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	FOXO1	protein	Q12778	UNIPROT	"down-regulates activity"	phosphorylation	Ser319	TFRPRTSsNASTISG	9606									11237865	t		lperfetto	"The transcription factor, forkhead in rhabdomyosarcoma (fkhr), is phosphorylated at three amino acid residues (thr-24, ser-256 and ser-319) by protein kinase b (pkb)alpha.Fkhr (forkhead in rhabdomyosarcoma), afx (all1 fused gene from chromosome x) and fkhrl1 (fkhr-like 1) are phosphorylated directly by pkb in cells, preventing them from stimulating gene transcription and leading to their exit from the nucleus"	0.2	SIGNOR-252349
SIGNOR-RMS	Rhabdomyosarcoma	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	FOXO1	protein	Q12778	UNIPROT	"down-regulates activity"	phosphorylation	Ser256	SPRRRAAsMDNNSKF	-1	BTO:0000318								10377430	t		lperfetto	"Here we show that the activation of phosphatidylinositol 3 (PI3) kinase by extracellular growth factors induces phosphorylation, nuclear export, and transcriptional inactivation of FKHR1, a member of the FKHR subclass of the forkhead family of transcription factors. Protein kinase B (PKB)/Akt, a key mediator of PI3 kinase signal transduction, phosphorylated recombinant FKHR1 in vitro at threonine-24 and serine-253. Mutants FKHR1(T24A), FKHR1(S253A), and FKHR1(T24A/S253A) were resistant to both PKB/Akt-mediated phosphorylation and PI3 kinase-stimulated nuclear export. These results indicate that phosphorylation by PKB/Akt negatively regulates FKHR1 by promoting export from the nucleus."	0.2	SIGNOR-252346
SIGNOR-RMS	Rhabdomyosarcoma	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	FOXO1	protein	Q12778	UNIPROT	"down-regulates activity"	phosphorylation			9606									21798082	t		lperfetto	"Akt inactivates protein degradation by phosphorylating and thus repressing the transcription factors of the foxo family, and stimulates protein synthesis via the mammalian target of rapamycin (mtor) and glycogen synthase kinase 3b (gsk3b)."	0.2	SIGNOR-252352
SIGNOR-RMS	Rhabdomyosarcoma	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	FOXO1	protein	Q12778	UNIPROT	"down-regulates activity"	phosphorylation			9606									21440011	t		lperfetto	"Phosphorylation of FoxOs by Akt inhibits transcriptional functions of FoxOs and contributes to cell survival, growth and proliferation.The PI3K/Akt signaling regulates cell proliferation and survival in part by phosphorylating FoxOs to promote their interaction with 14-3-3 protein that results in nuclear exclusion and eventual ubiquitin proteasome pathway (UPP)-dependent degradation of FoxOs"	0.2	SIGNOR-252348
SIGNOR-RMS	Rhabdomyosarcoma	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	FOXO1	protein	Q12778	UNIPROT	"down-regulates activity"	phosphorylation			10090	BTO:0002572								18423396	t		lperfetto	"Akt1/PKBalpha was found to be the major regulator of phosphorylation and nuclear export of FoxO1, whose presence in the nucleus strongly attenuates adipocyte differentiation"	0.2	SIGNOR-252350
SIGNOR-RMS	Rhabdomyosarcoma	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	CTNNB1	protein	P35222	UNIPROT	"up-regulates activity"				9606									16293724	f		lperfetto	"We show that pge2 stimulates colon cancer cell growth through its heterotrimeric guanine nucleotide-binding protein (g protein) coupled receptor, ep2, by a signaling route that involves the activation of phosphoinositide 3-kinase and the protein kinase akt by free g protein bg subunits and the direct association of the g protein as subunit with the regulator of g protein signaling (rgs) domain of axin. This leads to the inactivation and release of glycogen synthase kinase 3b from its complex with axin, thereby relieving the inhibitory phosphorylation of b-catenin and activating its signaling pathway."	0.2	SIGNOR-244225
SIGNOR-RMS	Rhabdomyosarcoma	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	BRAF	protein	P15056	UNIPROT	down-regulates	phosphorylation	Thr440	EDRNRMKtLGRRDSS	9606									10869359	t		lperfetto	"We show that phosphorylation of b-raf by akt occurs at multiple residues within its amino terminal regulatory domain, at both the conserved and unique phosphorylation sites. Akt phosphorylated b-raf on s364 and s428 to inactivate its kinase activity b-raf contains three akt consensus sites, table i. One site, ser364 is conserved with c-raf;however, two sites, ser428 and thr439, are unique to b-raf"	0.2	SIGNOR-244156
SIGNOR-RMS	Rhabdomyosarcoma	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	BRAF	protein	P15056	UNIPROT	down-regulates	phosphorylation	Ser428	GPQRERKsSSSSEDR	9606									10869359	t		lperfetto	"We show that phosphorylation of b-raf by akt occurs at multiple residues within its amino terminal regulatory domain, at both the conserved and unique phosphorylation sites. Akt phosphorylated b-raf on s364 and s428 to inactivate its kinase activity b-raf contains three akt consensus sites, table i. One site, ser364 is conserved with c-raf;however, two sites, ser428 and thr439, are unique to b-raf"	0.2	SIGNOR-244160
SIGNOR-RMS	Rhabdomyosarcoma	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	BRAF	protein	P15056	UNIPROT	down-regulates	phosphorylation	Ser364	FGQRDRSsSAPNVHI	9606									10869359	t		lperfetto	"We show that phosphorylation of b-raf by akt occurs at multiple residues within its amino terminal regulatory domain, at both the conserved and unique phosphorylation sites. Akt phosphorylated b-raf on s364 and s428 to inactivate its kinase activity b-raf contains three akt consensus sites, table i. One site, ser364 is conserved with c-raf;however, two sites, ser428 and thr439, are unique to b-raf"	0.2	SIGNOR-244152
SIGNOR-RMS	Rhabdomyosarcoma	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	CTNNB1	protein	P35222	UNIPROT	up-regulates	phosphorylation	Ser552	QDTQRRTsMGGTQQQ	9606									17287208	t		lperfetto	"Phosphorylation of beta-catenin by akt promotes beta-catenin transcriptional activity|we have demonstrated that akt phosphorylates beta-catenin at ser552 in vitro and in vivo."	0.2	SIGNOR-244222
SIGNOR-RMS	Rhabdomyosarcoma	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	CDKN1A	protein	P38936	UNIPROT	"up-regulates quantity by stabilization"	phosphorylation	Thr145	QGRKRRQtSMTDFYH	9606									16982699	t		gcesareni	"Whereas akt1 phosphorylates p21, inducing its release from cdk2 and cytoplasmic localization as previously described for akt."	0.2	SIGNOR-244184
SIGNOR-RMS	Rhabdomyosarcoma	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	CDKN1A	protein	P38936	UNIPROT	"up-regulates quantity by stabilization"	phosphorylation	Thr145	QGRKRRQtSMTDFYH	9606									16982699	t		gcesareni	"Whereas akt1 phosphorylates p21, inducing its release from cdk2 and cytoplasmic localization as previously described for akt, akt2 binds p21 in the region spanning the t145 site of p21, thus competing with phosphorylation by akt1 and inducing its accumulation in the nucleus. These distinct roles of akt/pkb isoforms in modulating proliferation and p21 have important implications for the development of drugs aimed at inhibiting cancer cell proliferation.[...] We next investigated if phosphorylation of p21-t145 interfered with akt2 binding. As shown in fig. ?Fig.8e8e (right lane), phosphorylation of p21 on t145 effectively prevented akt2 interaction."	0.2	SIGNOR-244180
SIGNOR-RMS	Rhabdomyosarcoma	SRC	protein	P12931	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation	Tyr326	EVLEDNDyGRAVDWW	9534	BTO:0004055								11445557	t		lperfetto	"Regulation of Akt/PKB Activation by Tyrosine PhosphorylationAs shown in Fig. 2 d, while mutation of Tyr340 has little effect on either tyrosine phosphorylation or kinase activity of Akt induced by Src527F, substitution of Tyr315 or Tyr326 with a phenylalanine, respectively, dramatically reduces both the tyrosine phosphorylation and kinase activity of Akt. The combination of these two mutations abolishes Src-induced tyrosine phosphorylation of Akt as well as its kinase activity."	0.679	SIGNOR-246377
SIGNOR-RMS	Rhabdomyosarcoma	SRC	protein	P12931	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation	Tyr315	TFCGTPEyLAPEVLE	9606	BTO:0000007								12600984	t		lperfetto	"We also showed that phosphorylation of Tyr-315 in Akt induced by Src or EGF is dependent on the integrity of this proline-rich motif. Furthermore, the Akt mutant lacking this proline motif fails to block the transcription activity of Forkhead in 293 cells and poorly stimulates the proliferation of Madin-Darby canine kidney cells. Taken together, our data suggest that the interaction between the SH3 domain of Src family kinases and the proline-rich motif in the C-terminal regulatory region of Akt is required for tyrosine phosphorylation of Akt and its subsequent activation."	0.679	SIGNOR-246373
SIGNOR-RMS	Rhabdomyosarcoma	SRC	protein	P12931	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation	Tyr315	TFCGTPEyLAPEVLE	9534	BTO:0004055								11445557	t		lperfetto	"Regulation of Akt/PKB Activation by Tyrosine PhosphorylationAs shown in Fig. 2 d, while mutation of Tyr340 has little effect on either tyrosine phosphorylation or kinase activity of Akt induced by Src527F, substitution of Tyr315 or Tyr326 with a phenylalanine, respectively, dramatically reduces both the tyrosine phosphorylation and kinase activity of Akt. The combination of these two mutations abolishes Src-induced tyrosine phosphorylation of Akt as well as its kinase activity."	0.679	SIGNOR-246368
SIGNOR-RMS	Rhabdomyosarcoma	SOS1	protein	Q07889	UNIPROT	KRAS	protein	P01116	UNIPROT	up-regulates	"guanine nucleotide exchange factor"			9606									25624485	t	"Ras proteins bind GDP/GTP and possess intrinsic GTPase activity."	gcesareni	"Because the KRAS-GDP to KRAS-GTP transition catalyzed by the GEF, son of sevenless 1 (SOS1), represents the rate-limiting step for nucleotide exchange, disrupting the activating SOS1/KRAS protein interaction has also been the focus of drug development efforts"	0.829	SIGNOR-201703
SIGNOR-RMS	Rhabdomyosarcoma	SOS1	protein	Q07889	UNIPROT	KRAS	protein	P01116	UNIPROT	up-regulates	"guanine nucleotide exchange factor"			9606									25624485	t	"Ras proteins bind GDP/GTP and possess intrinsic GTPase activity."	gcesareni	"Because the KRAS-GDP to KRAS-GTP transition catalyzed by the GEF, son of sevenless 1 (SOS1), represents the rate-limiting step for nucleotide exchange, disrupting the activating SOS1/KRAS protein interaction has also been the focus of drug development efforts"	0.829	SIGNOR-175256
SIGNOR-RMS	Rhabdomyosarcoma	SOS1	protein	Q07889	UNIPROT	KRAS	protein	P01116	UNIPROT	up-regulates	"guanine nucleotide exchange factor"			9606									25624485	t	"Ras proteins bind GDP/GTP and possess intrinsic GTPase activity."	gcesareni	"Because the KRAS-GDP to KRAS-GTP transition catalyzed by the GEF, son of sevenless 1 (SOS1), represents the rate-limiting step for nucleotide exchange, disrupting the activating SOS1/KRAS protein interaction has also been the focus of drug development efforts"	0.829	SIGNOR-141647
SIGNOR-RMS	Rhabdomyosarcoma	SOS1	protein	Q07889	UNIPROT	KRAS	protein	P01116	UNIPROT	up-regulates	"guanine nucleotide exchange factor"			9606									25624485	t	"Ras proteins bind GDP/GTP and possess intrinsic GTPase activity."	gcesareni	"Because the KRAS-GDP to KRAS-GTP transition catalyzed by the GEF, son of sevenless 1 (SOS1), represents the rate-limiting step for nucleotide exchange, disrupting the activating SOS1/KRAS protein interaction has also been the focus of drug development efforts"	0.829	SIGNOR-122075
SIGNOR-RMS	Rhabdomyosarcoma	PIK3CA	protein	P42336	UNIPROT	Survival	phenotype	SIGNOR-PH13	SIGNOR	up-regulates				9534	BTO:0004055								14665640	f		lperfetto	"Signal transduction pathways triggered by Tie2 have been extensively examined. Tyr-1101of Tie2 directly associates in a phosphotyrosine (pTyr)-dependent manner with the p85 regulatory subunit of phosphatidylinositol (PI) 3-kinase, which in turn activate PI 3-kinase, leading to cell motility and survival"	0.7	SIGNOR-242649
SIGNOR-RMS	Rhabdomyosarcoma	PIK3CA	protein	P42336	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation			9606									12167717	t		lperfetto	"PKB induction requires phosphorylation of two critical residues, threonine 308 in the activation loop and serine 473 near the carboxyl terminus. Membrane localization of PKB was found to be a primary determinant of serine 473 phosphorylation. PI3K activity was equally important for promoting phosphorylation of serine 473,"	0.821	SIGNOR-244429
SIGNOR-RMS	Rhabdomyosarcoma	PIK3CA	protein	P42336	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"				9606		BTO:0000150							19573809	f		lperfetto	"However, here we show through phosphoprotein profiling and functional genomic studies that many PIK3CA mutant cancer cell lines and human breast tumors exhibit only minimal AKT activation and a diminished reliance on AKT for anchorage-independent growth"	0.821	SIGNOR-236436
SIGNOR-RMS	Rhabdomyosarcoma	PDPK1	protein	O15530	UNIPROT	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	up-regulates	phosphorylation			9606									15175348	t		lperfetto	"The identified pdk1 phosphorylation sites in mek1 and mek2 are ser222 and ser226, respectively, and are known to be essential for full activation."	0.272	SIGNOR-244938
SIGNOR-RMS	Rhabdomyosarcoma	PDPK1	protein	O15530	UNIPROT	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	"up-regulates activity"	phosphorylation			9606	BTO:0000007								15175348	t		lperfetto	"In vitro kinase assay revealed that the direct targets of pdk1 in the mapk pathway were the upstream mapk kinases mek1 and mek2. The identified pdk1 phosphorylation sites in mek1 and mek2 are ser222 and ser226, respectively, and are known to be essential for full activation"	0.272	SIGNOR-244934
SIGNOR-RMS	Rhabdomyosarcoma	PDPK1	protein	O15530	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	up-regulates	phosphorylation			9606									21798082	t		lperfetto	"Positive feedback involves mtorc2, which phosphorylates akt at serine 473, a phosphorylation required for maximum activation of akt in addition to phosphorylation at threonine 308 by pdk1."	0.746	SIGNOR-244396
SIGNOR-RMS	Rhabdomyosarcoma	PDPK1	protein	O15530	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation	Thr308	KDGATMKtFCGTPEY	9606		BTO:0000887;BTO:0001103;BTO:0001760							9512493	t		lperfetto	"The activation of PKBbeta and PKBamma by PDK11 was accompanied by the phosphorylation of the residues equivalent to Thr308 in PKBalpha, namely Thr309 (PKBbeta) and Thr305 (PKBgamma)"	0.746	SIGNOR-244480
SIGNOR-RMS	Rhabdomyosarcoma	PDPK1	protein	O15530	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation	Thr308	KDGATMKtFCGTPEY	9606									15718470	t		gcesareni	"Akt/PKB activation requires the phosphorylation of Thr308 in the activation loop by the phosphoinositide-dependent kinase 1 (PDK1) and Ser473 within the carboxyl-terminal hydrophobic motif by an unknown kinase."	0.746	SIGNOR-243203
SIGNOR-RMS	Rhabdomyosarcoma	PDPK1	protein	O15530	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation	Thr308	KDGATMKtFCGTPEY	10116		BTO:0000142							10226025	t		lperfetto	"Protein kinase B (PKB) is activated by phosphorylation of Thr308 and of Ser473. Thr308 is phosphorylated by the 3-phosphoinositide-dependent protein kinase-1 (PDK1) but the identity of the kinase that phosphorylates Ser473 (provisionally termed PDK2) is unknown."	0.746	SIGNOR-244421
SIGNOR-RMS	Rhabdomyosarcoma	PDPK1	protein	O15530	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation	Thr308	KDGATMKtFCGTPEY	10090									12808134	t		lperfetto	"Akt1 and akt2 are phosphorylated and activated by the protein kinase pdk1 at thr-308 or thr-309, respectively, in the activation t-loop, and further activation occurs through phosphorylation at ser-473 or ser-474, respectively. In this paper, we demonstrate that this is indeed the case, and report the purification and initial characterization of a 3 phosphoinositide-dependent protein kinase, pdk1, which activates pkb by phosphorylating it at thr308. Akt is directly phosphorylated and activated by pdk1. Akt/pkb activation requires the phosphorylation of thr308 in the activation loop by the phosphoinositide-dependent kinase 1 (pdk1)."	0.746	SIGNOR-134477
SIGNOR-RMS	Rhabdomyosarcoma	PDPK1	protein	O15530	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation			9606									15743829	t		lperfetto	"3-phosphoinositide-dependent kinase 1 (PDK1) phosphorylates the activation loop of a number of protein serine/threonine kinases of the AGC kinase superfamily, including protein kinase B (PKB; also called Akt),"	0.746	SIGNOR-244469
SIGNOR-RMS	Rhabdomyosarcoma	PDGFRA	protein	P16234	UNIPROT	SRC	protein	P12931	UNIPROT	"up-regulates activity"	phosphorylation	Tyr419	RLIEDNEyTARQGAK	9606									15489898	t		gcesareni	"The increased Src activity is mainly due to the phosphorylation of Tyr-419, rather than the dephosphorylation of Tyr-530 of Src protein. PDGFR, not FAK or EGFR, appears to be the upstream protein tyrosine kinase responsible for the detachment-induced Src activation in the lung tumor cells."	0.495	SIGNOR-247984
SIGNOR-RMS	Rhabdomyosarcoma	PDGFRA	protein	P16234	UNIPROT	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	up-regulates				9606									24743741	f			"To further investigate the signaling pathway through which PDGFRαpromotes the proliferation of PDGFRα+ cells, we used inhibitors of PI3K-Akt and Ras-MAPK pathways, which are known to be downstream signaling pathways of PDGFRα. Thus, both PI3K-Akt and MEK2-MAPK pathways are necessary for PDGFRα-driven proliferation."	0.323	SIGNOR-254377
SIGNOR-RMS	Rhabdomyosarcoma	PDGFB	protein	P01127	UNIPROT	PDGFRA	protein	P16234	UNIPROT	"up-regulates activity"	binding			9606									11331882	t		miannu	"Pdgf-b activates both pdgfr-alpha and pdgfr-beta"	0.721	SIGNOR-107397
SIGNOR-RMS	Rhabdomyosarcoma	PDGFA	protein	P04085	UNIPROT	PDGFRA	protein	P16234	UNIPROT	up-regulates	binding			9606		BTO:0000887;BTO:0000763							11803579	t		gcesareni	"Platelet-derived growth factors (pdgf) constitute a family of four gene products (pdgf-a-d) acting by means of two receptor tyrosine kinases, pdgfr alpha and beta. Three of the ligands (pdgf-a, -b, and -c) bind to pdgfr alpha with high affinity."	0.776	SIGNOR-114268
SIGNOR-RMS	Rhabdomyosarcoma	PAX7	protein	P23759	UNIPROT	Skeletal_muscle_differentiation	phenotype	SIGNOR-PH1	SIGNOR	down-regulates				9606		BTO:0001103;BTO:0002314							22493066	f		lperfetto	"Constitutive Notch Activation Upregulates Pax7 and Promotes the Self-Renewal of Skeletal Muscle Satellite Cells"	0.7	SIGNOR-219371
SIGNOR-RMS	Rhabdomyosarcoma	PAX7	protein	P23759	UNIPROT	MYOD1	protein	P15172	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			9606									18854138	f		lperfetto	"Our cell-based assays and in vitro studies reveal a tight codependent partnership between foxo3 and pax3/7 to coordinately recruit rna polymerase ii and form a preinitiation complex (pic) to activate myod transcription in myoblasts."	0.598	SIGNOR-181624
SIGNOR-RMS	Rhabdomyosarcoma	PAX7	protein	P23759	UNIPROT	MYOD1	protein	P15172	UNIPROT	"down-regulates quantity by destabilization"				10090									17548510	f		"Simone Vumbaca"	"Previously, we showed that Pax7 overexpression in adult primary myoblasts down-regulates MyoD and prevents myogenin induction, inhibiting myogenesis. We show that Pax7 prevents muscle differentiation independently of its transcriptional activity, affecting MyoD function. [...] Pax7 expression affects MyoD protein stability"	0.598	SIGNOR-255637
SIGNOR-RMS	Rhabdomyosarcoma	PAX3	protein	P23760	UNIPROT	TBX2	protein	Q13207	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			9606	BTO:0002267								25211658	t		lperfetto	"We have recently found that a T-box gene family member, TBX2, is highly overexpressed in both ERMS and ARMS cells (Zhu et al, 2014). The regulation of TBX2 is uncharacterised in RMS cells, but is likely to link TBX2 expression to the known deregulation of signalling pathways in RMS. In melanoma cells, TBX2 is regulated by PAX3"	0.347	SIGNOR-249596
SIGNOR-RMS	Rhabdomyosarcoma	PAX3	protein	P23760	UNIPROT	MYOD1	protein	P15172	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			9606	BTO:0000222								18854138	f		gcesareni	"Our cell-based assays and in vitro studies reveal a tight codependent partnership between foxo3 and pax3/7 to coordinately recruit rna polymerase ii and form a preinitiation complex (pic) to activate myod transcription in myoblasts."	0.482	SIGNOR-181621
SIGNOR-RMS	Rhabdomyosarcoma	PAX3	protein	P23760	UNIPROT	FGFR4	protein	P22455	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			9606									25211658	t			"FGFR4 is a transcriptional target of PAX3 and the PAX3-FOXO1 fusion protein found in ARMS."	0.366	SIGNOR-251572
SIGNOR-RMS	Rhabdomyosarcoma	MYOG	protein	P15173	UNIPROT	PAX7	protein	P23759	UNIPROT	"down-regulates quantity by destabilization"				10090	BTO:0004058								17548510	f		"Simone Vumbaca"	"Indeed, we observed a reduction in Pax7 protein levels upon ectopic myogenin expression in MM14 myoblasts, even under proliferation conditions"	0.493	SIGNOR-255638
SIGNOR-RMS	Rhabdomyosarcoma	MYOG	protein	P15173	UNIPROT	CDKN1A	protein	P38936	UNIPROT	"down-regulates quantity by repression"	"transcriptional regulation"			9606									25211658	t			"P21 is regulated by MyoD and myogenin in normal muscle cells and the inactivation of these factors in RMS cells contributes to the silencing of p21 in RMS cells"	0.333	SIGNOR-251575
SIGNOR-RMS	Rhabdomyosarcoma	MYOD1	protein	P15172	UNIPROT	CDKN1A	protein	P38936	UNIPROT	up-regulates				10090									7791789	f		lperfetto	"The upregulation of p21 occurred at the levels of mrna and protein,"	0.402	SIGNOR-235831
SIGNOR-RMS	Rhabdomyosarcoma	MYOD1	protein	P15172	UNIPROT	Skeletal_muscle_differentiation	phenotype	SIGNOR-PH1	SIGNOR	up-regulates				9606									8288123	f		lperfetto	"The myogenic regulators myod, myogenin, myf5, and mrf4 share -80% amino acid identity within a basic helix-loop-helix (bHLH) motif that mediates dimerization and dna binding. [...] myogenic bHLH proteins form heterodimers with ubiquitous bHLH proteins, known as e proteins, and activate the transcription of muscle-specific genes by binding to the e-box consensus sequence (canntg) in muscle gene promoters and enhancers."	0.7	SIGNOR-37458
SIGNOR-RMS	Rhabdomyosarcoma	MYOD1	protein	P15172	UNIPROT	MYOG	protein	P15173	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"					BTO:0001103							15870273	t		"Simone Vumbaca"	"We suggest that the interaction between MyoD and Pbx is necessary to initially target MyoD to the myogenin promoter"	0.466	SIGNOR-255639
SIGNOR-RMS	Rhabdomyosarcoma	MYOD1	protein	P15172	UNIPROT	MYOG	protein	P15173	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"					BTO:0001103							12694204	t		"Simone Vumbaca"	"We conclude that MyoD is the major MRF that binds to the E-box from the myogenin promoter during differentiation."	0.466	SIGNOR-255640
SIGNOR-RMS	Rhabdomyosarcoma	MYOD1	protein	P15172	UNIPROT	MYOG	protein	P15173	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			9606		BTO:0000887							15870273	f		lperfetto	"We observed that the homeodomain factor pbx1, which cooperates with myod to stimulate myogenin expression, is constitutively bound to the myogenin promoter in a swi/snf-independent manner, suggesting a two-step mechanism in which myod initially interacts indirectly with the myogenin promoter and attracts chromatin-remodeling enzymes, which then facilitate direct binding by myod and other regulatory proteins."	0.466	SIGNOR-135984
SIGNOR-RMS	Rhabdomyosarcoma	MYOD1	protein	P15172	UNIPROT	MYOG	protein	P15173	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			9606									18676376	f		gcesareni	" provide a novel transcriptional paradigm for the first steps of myogenesis, where a calcineurin/NFATc3 pathway regulates myogenin induction in cooperation with MyoD during myogenesis."	0.466	SIGNOR-235009
SIGNOR-RMS	Rhabdomyosarcoma	MYOD1	protein	P15172	UNIPROT	CDKN1A	protein	P38936	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			10090	BTO:0000165								10373569	t		gcesareni	"Here we report that, at the onset of differentiation, activation by MyoD of the Rb, p21, and cyclin D3 genes occurs in the absence of new protein synthesis and with the requirement of the p300 transcriptional coactivator."	0.402	SIGNOR-238529
SIGNOR-RMS	Rhabdomyosarcoma	MYOD1	protein	P15172	UNIPROT	CDKN1A	protein	P38936	UNIPROT	up-regulates	"transcriptional regulation"			9606									25211658	t			"P21 is regulated by MyoD and myogenin in normal muscle cells and the inactivation of these factors in RMS cells contributes to the silencing of p21 in RMS cells"	0.402	SIGNOR-251574
SIGNOR-RMS	Rhabdomyosarcoma	MYC	protein	P01106	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606		BTO:0001103							21408055	f		"andrea cerquone perpetuini"	"We have demonstrated that following muscle damage, phosphorylated STAT3 (p-STAT3) in SCs increases early (within one hour), inducing downstream target genes (i.e. GP130 and SOCS3), which further regulate the increase in STAT3 production and response (as induced via IL-6), leading to increased cMyc expression, which drives cell proliferation"	0.7	SIGNOR-255414
SIGNOR-RMS	Rhabdomyosarcoma	MYC	protein	P01106	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									9552384	f		gcesareni	"C-myc has emerged as one of the central regulators of mammalian cell proliferation."	0.7	SIGNOR-56572
SIGNOR-RMS	Rhabdomyosarcoma	MYC	protein	P01106	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				10090		BTO:0000724							7882978	f		irozzo	"These observations indicate that continued late-stage expression of L-myc affected differentiation processes directly, rather than indirectly through deregulated growth control, whereas constitutive c-myc expression inhibited proliferative arrest, but did not appear to disturb differentiation."	0.7	SIGNOR-259110
SIGNOR-RMS	Rhabdomyosarcoma	MYC	protein	P01106	UNIPROT	CDKN2A	protein	P42771	UNIPROT	"down-regulates quantity by repression"	"transcriptional regulation"			9606									12835716	t		gcesareni	"C-myc also directly represses transcription of cdk kinase inhibitors including p27kip1, p21cip1, p15ink4b and p16ink4a"	0.771	SIGNOR-102743
SIGNOR-RMS	Rhabdomyosarcoma	MYC	protein	P01106	UNIPROT	CDKN1A	protein	P38936	UNIPROT	"down-regulates quantity by repression"	"transcriptional regulation"			9606									12835716	t		gcesareni	"C-myc also directly represses transcription of cdk kinase inhibitors including p27kip1, p21cip1, p15ink4b and p16ink4a"	0.784	SIGNOR-102740
SIGNOR-RMS	Rhabdomyosarcoma	MET	protein	P08581	UNIPROT	GRB2	protein	P62993	UNIPROT	"up-regulates activity"	binding			9606									22128289	t		irozzo	"For activation of the mitogen-activated protein kinase (MAPK) cascades, c-MET activation stimulates the activity of the rat sarcoma viral oncogene homolog (RAS) guanine nucleotide exchanger son of sevenless (SOS) via binding with SHC and GRB2 leading to the activation of RAS."	0.698	SIGNOR-256261
SIGNOR-RMS	Rhabdomyosarcoma	MET	protein	P08581	UNIPROT	GAB1	protein	Q13480	UNIPROT	"up-regulates activity"	phosphorylation	Tyr659	VADERVDyVVVDQQK	9606	BTO:0000018								10734310	t		miannu	"Gab-1 is phosphorylated on the same residues by HGF and EGF receptors. Among 16 peptides only nine were phosphorylated by the EGF and HGF receptors, namely peptides containing the tyrosine residues 285, 307, 373, 407, 448, 473, 590, 628 and 660. we show that in the response to HGF or EGF, Gab1 is phosphorylated in vivo on the same residues. However, a sustained activation of signaling pathways downstream to Gab1 (as a result of its sustained phosphorylation) is achieved only in response to HGF."	0.677	SIGNOR-250290
SIGNOR-RMS	Rhabdomyosarcoma	MET	protein	P08581	UNIPROT	GAB1	protein	Q13480	UNIPROT	"up-regulates activity"	phosphorylation	Tyr627	KGDKQVEyLDLDLDS	9606	BTO:0000018								10734310	t		miannu	"Gab-1 is phosphorylated on the same residues by HGF and EGF receptors. Among 16 peptides only nine were phosphorylated by the EGF and HGF receptors, namely peptides containing the tyrosine residues 285, 307, 373, 407, 448, 473, 590, 628 and 660. we show that in the response to HGF or EGF, Gab1 is phosphorylated in vivo on the same residues. However, a sustained activation of signaling pathways downstream to Gab1 (as a result of its sustained phosphorylation) is achieved only in response to HGF."	0.677	SIGNOR-250289
SIGNOR-RMS	Rhabdomyosarcoma	MET	protein	P08581	UNIPROT	GAB1	protein	Q13480	UNIPROT	"up-regulates activity"	phosphorylation	Tyr589	SHDSEENyVPMNPNL	9606	BTO:0000018								10734310	t		miannu	"Gab-1 is phosphorylated on the same residues by HGF and EGF receptors. Among 16 peptides only nine were phosphorylated by the EGF and HGF receptors, namely peptides containing the tyrosine residues 285, 307, 373, 407, 448, 473, 590, 628 and 660. we show that in the response to HGF or EGF, Gab1 is phosphorylated in vivo on the same residues. However, a sustained activation of signaling pathways downstream to Gab1 (as a result of its sustained phosphorylation) is achieved only in response to HGF."	0.677	SIGNOR-250288
SIGNOR-RMS	Rhabdomyosarcoma	MET	protein	P08581	UNIPROT	GAB1	protein	Q13480	UNIPROT	"up-regulates activity"	phosphorylation	Tyr285	TEADGELyVFNTPSG	9606	BTO:0000018								10734310	t		miannu	"Gab-1 is phosphorylated on the same residues by HGF and EGF receptors. Among 16 peptides only nine were phosphorylated by the EGF and HGF receptors, namely peptides containing the tyrosine residues 285, 307, 373, 407, 448, 473, 590, 628 and 660. we show that in the response to HGF or EGF, Gab1 is phosphorylated in vivo on the same residues. However, a sustained activation of signaling pathways downstream to Gab1 (as a result of its sustained phosphorylation) is achieved only in response to HGF."	0.677	SIGNOR-250552
SIGNOR-RMS	Rhabdomyosarcoma	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	up-regulates	phosphorylation			9606									11971971	t		lperfetto	"Mapk1 is phosphorylated by map2k1/mek1 and map2k2/mek2 on thr-185 and tyr-187 in response to external stimuli like insulin or ngf. Both phosphorylations are required for activity."	0.758	SIGNOR-244776
SIGNOR-RMS	Rhabdomyosarcoma	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	"up-regulates activity"	phosphorylation			10090									11730323	t			"Raf proteins have been shown to phosphorylate and activate MAPKKs (MAP kinase kinases) called MEKs (MAPK or ERK kinases) which in turn phosphorylate and activate MAPKs (MAP kinases) called ERKs"	0.758	SIGNOR-258989
SIGNOR-RMS	Rhabdomyosarcoma	KRAS	protein	P01116	UNIPROT	PIK3CA	protein	P42336	UNIPROT	up-regulates	binding			9606									21779497	t		gcesareni	"Grb2 binds and activates sos, which then activates ras, and this activates p110 independently of p85./it was also described that ras interacts with pi3k in a direct manner./lysine residue 227 is essential for the interaction of ras with pi3k phosphatidylinositol 3-kinase (pi3k) is one of the main effector pathways of ras, regulating cell growth, cell cycle entry, cell survival, cytoskeleton reorganization, and metabolism."	0.911	SIGNOR-175204
SIGNOR-RMS	Rhabdomyosarcoma	KRAS	protein	P01116	UNIPROT	BRAF	protein	P15056	UNIPROT	"up-regulates activity"	binding			9606									21779497	t		miannu	"The raf family of proteins (raf-1, a-raf, and b-raf) is serine/threonine kinases that bind to the effector region of ras-gtp, thus inducing translocation of the protein to the plasma membrane. Once there, raf proteins are activated and phosphorylated by different protein kinases."	0.878	SIGNOR-156906
SIGNOR-RMS	Rhabdomyosarcoma	IGF2	protein	P01344	UNIPROT	IGF1R	protein	P08069	UNIPROT	"up-regulates activity"	binding			9606									22810696	t		lperfetto	"These results strongly suggest that the IGF2–IGF1R–IRS2 axis signals to PI3K in CRC and imply that therapeutic targeting of the pathway could act to block PI3K activity in this subset of patients."	0.825	SIGNOR-251495
SIGNOR-RMS	Rhabdomyosarcoma	IGF1R	protein	P08069	UNIPROT	IGF1R	protein	P08069	UNIPROT	"up-regulates activity"	phosphorylation	Tyr980	YASVNPEyFSAADVY	-1									7493944	t		lperfetto	"The insulin-like growth factor type I (IGF-I) receptor can become tyrosine phosphorylated and enzymatically activated either in response to ligand or because of the activity of the Src tyrosine kinase. We mapped the sites of IGF-I receptor autophosphorylation to peptides representing three different receptor domains: tyrosines 943 and 950 in the juxtamembrane region; tyrosines 1131, 1135, and 1136 within the kinase domain; and tyrosine 1316 in the carboxyl-terminal domain."	0.2	SIGNOR-246256
SIGNOR-RMS	Rhabdomyosarcoma	IGF1R	protein	P08069	UNIPROT	PDPK1	protein	O15530	UNIPROT	up-regulates	phosphorylation	Tyr376	DEDCYGNyDNLLSQF	9606									20044479	t		lperfetto	"We have described that upon ligand binding, igf-1r directly interacts with and phosphorylates pdk1 at tyr373/376"	0.34	SIGNOR-236544
SIGNOR-RMS	Rhabdomyosarcoma	IGF1R	protein	P08069	UNIPROT	PDPK1	protein	O15530	UNIPROT	up-regulates	phosphorylation	Tyr376	DEDCYGNyDNLLSQF	9606									20643654	t		lperfetto	"Previous studies indicate that optimal activation of PDK1 requires phosphorylation of Tyr373/376, and growth factor receptor activation leads to PDK1 recruitment to the plasma membrane, followed by sequential phosphorylation of Tyr9 and then Tyr373/376"	0.34	SIGNOR-166714
SIGNOR-RMS	Rhabdomyosarcoma	IGF1R	protein	P08069	UNIPROT	PDPK1	protein	O15530	UNIPROT	up-regulates	phosphorylation	Tyr373	SEDDEDCyGNYDNLL	9606									20643654	t		lperfetto	"Previous studies indicate that optimal activation of PDK1 requires phosphorylation of Tyr373/376 (11, 12, 14, 17), and growth factor receptor activation leads to PDK1 recruitment to the plasma membrane, followed by sequential phosphorylation of Tyr9 and then Tyr373/376"	0.34	SIGNOR-166710
SIGNOR-RMS	Rhabdomyosarcoma	IGF1R	protein	P08069	UNIPROT	PDPK1	protein	O15530	UNIPROT	up-regulates	phosphorylation	Tyr373	SEDDEDCyGNYDNLL	-1									20044479	t		lperfetto	"IGF-1R Directly Interacts with and Phosphorylates PDK1 in Vitro"	0.34	SIGNOR-236548
SIGNOR-RMS	Rhabdomyosarcoma	IGF1R	protein	P08069	UNIPROT	IGF1R	protein	P08069	UNIPROT	up-regulates	phosphorylation	Tyr1165	RDIYETDyYRKGGKG	9606									7493944	t		lperfetto	"Insulin and insulin-like growth factor (IGF-I) receptors are heterotetrameric proteins consisting of two alpha-and two beta-subunits and members of the transmembrane tyrosine kinase receptors. Specific ligand binding to the receptor triggers a cascade of intracellular events, which begins with autophosphorylation of several tyrosine residues of the beta-subunit of the receptor."	0.2	SIGNOR-26586
SIGNOR-RMS	Rhabdomyosarcoma	RB1	protein	P06400	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	down-regulates				9606									21524151	f		miannu	"Consistent with this, the magnitude of the response (i.e. the fraction of cells undergoing arrest) appears to diminish the closer the cells are to the time of S-phase entry. The existence of a time gap between full pRb phosphorylation and S-phase entry is also consistent with the notion that E2F, once released from pRb, transcriptionally activates factors needed for S-phase entry, a process which likely requires a significant amount of time."	0.7	SIGNOR-262533
SIGNOR-RMS	Rhabdomyosarcoma	CDKN1A	protein	P38936	UNIPROT	RB1	protein	P06400	UNIPROT	"up-regulates activity"				9606									10439039	f		gcesareni	"P21 may inhibit cell cycle progression by preventing the phosphorylation of prb."	0.719	SIGNOR-69925
SIGNOR-RMS	Rhabdomyosarcoma	TBX2	protein	Q13207	UNIPROT	Skeletal_muscle_differentiation	phenotype	SIGNOR-PH1	SIGNOR	down-regulates				9606									24470334	f			"TBX2 blocks myogenesis and promotes proliferation in rhabdomyosarcoma cells"	0.7	SIGNOR-251563
SIGNOR-RMS	Rhabdomyosarcoma	TBX2	protein	Q13207	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									24470334	f			"TBX2 blocks myogenesis and promotes proliferation in rhabdomyosarcoma cells"	0.7	SIGNOR-251562
SIGNOR-RMS	Rhabdomyosarcoma	TBX2	protein	Q13207	UNIPROT	MYOG	protein	P15173	UNIPROT	"down-regulates activity"	binding			9606									24470334	t			"We have found that TBX2 is highly up regulated in both ERMS and ARMS subtypes of RMS and demonstrate that TBX2 is a repressor of myogenesis by binding to MyoD and myogenin and inhibiting their activity."	0.25	SIGNOR-251561
SIGNOR-RMS	Rhabdomyosarcoma	TBX2	protein	Q13207	UNIPROT	MYOD1	protein	P15172	UNIPROT	"down-regulates activity"	binding			9606									24470334	t			"We have found that TBX2 is highly up regulated in both ERMS and ARMS subtypes of RMS and demonstrate that TBX2 is a repressor of myogenesis by binding to MyoD and myogenin and inhibiting their activity."	0.311	SIGNOR-251560
SIGNOR-RMS	Rhabdomyosarcoma	TBX2	protein	Q13207	UNIPROT	CDKN1A	protein	P38936	UNIPROT	"down-regulates quantity by repression"	"transcriptional regulation"			9606	BTO:0002267								25211658	t		lperfetto	"TBX2 and TBX3 function as transcriptional repressors and both have been shown to inhibit myogenesis (Carlson et al, 2002; Zhu et al, 2014). Abnormal expression of TBX2 has been reported in several cancers including breast, pancreas, and melanoma, where it has been shown to drive proliferation (reviewed in Abrahams et al (2010)). As has been previously shown in other cell types, TBX2 was found to induce a downregulation of p14/19ARF and function as a direct repressor of p21 in RMS"	0.347	SIGNOR-249593
SIGNOR-RMS	Rhabdomyosarcoma	STAT3	protein	P40763	UNIPROT	HGF	protein	P14210	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			10090									11278729	t		lperfetto	"Coexpression of activated c-Src and Stat3 synergistically induced strong HGF promoter activity in SP1 cells"	0.629	SIGNOR-251742
SIGNOR-RMS	Rhabdomyosarcoma	STAT3	protein	P40763	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606	BTO:0003298	BTO:0001103							30029643	f			"In summary, our results indicate IL-15 can stimulate the proliferation of FAPs through Jak-STAT pathway."	0.7	SIGNOR-256256
SIGNOR-RMS	Rhabdomyosarcoma	STAT3	protein	P40763	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606	BTO:0002314								25194572	f		lperfetto	"STAT3 signaling controls satellite cell expansion and skeletal muscle repair"	0.7	SIGNOR-245048
SIGNOR-RMS	Rhabdomyosarcoma	STAT3	protein	P40763	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606	BTO:0002314								18177723	f		miannu	"Altogether, these data demonstrate that IL-6 loss results in deficient STAT3 signaling in activated satellite cells, leading to their reduced proliferation and myogenic progression, and highlight the major role played by the IL-6/STAT3 axis in controlling these processes during compensatory hypertrophy."	0.7	SIGNOR-255632
SIGNOR-RMS	Rhabdomyosarcoma	STAT3	protein	P40763	UNIPROT	MYOD1	protein	P15172	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			10090									25194572	f		miannu	"Here we show that IL-6-activated Stat3 signaling regulates satellite cell behavior, promoting myogenic lineage progression through myogenic differentiation 1 (Myod1) regulation.  IL-6 stimulation promoted an increase in the mRNA levels of both Stat3 and Myod1. Stat3 mediated this effect, as IL-6‚Äìdependent Myod1 upregulation was impaired after infection with the shStat3 lentivirus."	0.519	SIGNOR-255416
SIGNOR-RMS	Rhabdomyosarcoma	STAT3	protein	P40763	UNIPROT	MYC	protein	P01106	UNIPROT	"up-regulates quantity by expression"				9606		BTO:0001103							21408055	f		"andrea cerquone perpetuini"	"Additionally, cMyc, a STAT3 downstream gene, was significantly up-regulated in SCs at T24 versus PRE [...]An increase in the number of cMyc+ SCs indicated that human SCs were induced to proliferate under the control of STAT3 signaling."	0.758	SIGNOR-255413
SIGNOR-RMS	Rhabdomyosarcoma	SRC	protein	P12931	UNIPROT	IGF1R	protein	P08069	UNIPROT	up-regulates	phosphorylation	Tyr1161	FGMTRDIyETDYYRK	9606									8940173	t		lperfetto	"Src phosphorylates the insulin-like growth factor type i receptor on the autophosphorylation sites. Requirement for transformation by srcsrc kinase can substitute for the receptor kinase in phosphorylating and activating the igf-i receptor"	0.584	SIGNOR-45122
SIGNOR-RMS	Rhabdomyosarcoma	SRC	protein	P12931	UNIPROT	GAB1	protein	Q13480	UNIPROT	up-regulates	phosphorylation	Tyr242	FFQQQMIyDSPPSRA	9606									19881549	t		lperfetto	"Using both mutagenesis and mass spectrometry approaches, y242, y259, y317, y373 and y627 of gab1 were identified to be phosphorylated by c-src a gab1 mutant with substitutions of the src phosphorylation sites failed to promote hgf-induced dna synthesis"	0.709	SIGNOR-236314
SIGNOR-RMS	Rhabdomyosarcoma	SRC	protein	P12931	UNIPROT	STAT3	protein	P40763	UNIPROT	"up-regulates activity"	phosphorylation	Tyr705	DPGSAAPyLKTKFIC	9606	BTO:0000007								14551213	t		lperfetto	"In the present study, we have delineated the mechanism by which Galpha16 stimulates STAT3 in human embryonic kidney 293 cells. A constitutively active Galpha16 mutant, Galpha16QL, stimulated STAT3-dependent luciferase activity as well as the phosphorylation of STAT3 at both Tyr705 and Ser727.The involvement of tyrosine kinases such as c-Src and Janus kinase 2 and 3 (JAK2 and JAK3) in Galpha16QL-induced activation of STAT3 was illustrated by the combined use of selective inhibitors and dominant negative mutants."	0.793	SIGNOR-247341
SIGNOR-RMS	Rhabdomyosarcoma	SRC	protein	P12931	UNIPROT	STAT3	protein	P40763	UNIPROT	"up-regulates activity"	phosphorylation			10090	BTO:0000944								9566874	t		lperfetto	"Previous studies have demonstrated that one STAT family member, Stat3, possesses constitutively elevated tyrosine phosphorylation and DNA-binding activity in fibroblasts stably transformed by the Src oncoprotein.We conclude that Stat3 activation by the Src oncoprotein leads to specific gene regulation and that Stat3 is one of the critical signaling pathways involved in Src oncogenesis."	0.793	SIGNOR-235445
SIGNOR-RMS	Rhabdomyosarcoma	SRC	protein	P12931	UNIPROT	PDPK1	protein	O15530	UNIPROT	up-regulates	phosphorylation	Tyr376	DEDCYGNyDNLLSQF	9606									20643654	t		miannu	"Src-dependent pdk1 tyr373/376 tyrosine phosphorylation. / optimal activation of pdk1 requires phosphorylation of tyr373/376"	0.586	SIGNOR-166722
SIGNOR-RMS	Rhabdomyosarcoma	SRC	protein	P12931	UNIPROT	PDPK1	protein	O15530	UNIPROT	up-regulates	phosphorylation	Tyr373	SEDDEDCyGNYDNLL	9606									20643654	t		miannu	"Src-dependent pdk1 tyr373/376 tyrosine phosphorylation. / optimal activation of pdk1 requires phosphorylation of tyr373/376"	0.586	SIGNOR-166718
SIGNOR-RMS	Rhabdomyosarcoma	SRC	protein	P12931	UNIPROT	PDPK1	protein	O15530	UNIPROT	"up-regulates activity"	phosphorylation	Tyr9	ARTTSQLyDAVPIQS	9606									11481331	t		lperfetto	"Using site-directed mutants, we show that, although phosphorylation on tyr-373/376 is important for pdk1 activity, phosphorylation on tyr-9 has no effect on the activity of the kinase. Both of these residues can be phosphorylated by v-src tyrosine kinase in vitro, and co-expression of v-src leads to tyrosine phosphorylation and activation of pdk1."	0.586	SIGNOR-109533
SIGNOR-RMS	Rhabdomyosarcoma	SRC	protein	P12931	UNIPROT	KRAS	protein	P01116	UNIPROT	up-regulates	phosphorylation			9606									9096340	t		gcesareni	"Expression of v-src, a transforming nonreceptor tyrosine kinase, results in ras activation, and ras function in nih 3t3 cells suppresses transformation by v-src, indicating that in these cells ras-dependent signaling pathways are required for v-src to exert its biological effects."	0.663	SIGNOR-47152
SIGNOR-RMS	Rhabdomyosarcoma	SRC	protein	P12931	UNIPROT	IGF1R	protein	P08069	UNIPROT	up-regulates	phosphorylation	Tyr1166	DIYETDYyRKGGKGL	9606									8940173	t		lperfetto	"Src phosphorylates the insulin-like growth factor type i receptor on the autophosphorylation sites. Requirement for transformation by srcsrc kinase can substitute for the receptor kinase in phosphorylating and activating the igf-i receptor"	0.584	SIGNOR-45130
SIGNOR-RMS	Rhabdomyosarcoma	SRC	protein	P12931	UNIPROT	IGF1R	protein	P08069	UNIPROT	up-regulates	phosphorylation	Tyr1165	RDIYETDyYRKGGKG	9606									8940173	t		lperfetto	"Src phosphorylates the insulin-like growth factor type i receptor on the autophosphorylation sites. Requirement for transformation by srcsrc kinase can substitute for the receptor kinase in phosphorylating and activating the igf-i receptor"	0.584	SIGNOR-45126
SIGNOR-RMS	Rhabdomyosarcoma	SRC	protein	P12931	UNIPROT	IGF1R	protein	P08069	UNIPROT	up-regulates	phosphorylation	Tyr1165	RDIYETDyYRKGGKG	-1									7493944	t		lperfetto	"The insulin-like growth factor type I (IGF-I) receptor can become tyrosine phosphorylated and enzymatically activated either in response to ligand or because of the activity of the Src tyrosine kinaseWe mapped the sites of IGF-I receptor autophosphorylation to peptides representing three different receptor domains: tyrosines 943 and 950 in the juxtamembrane region; tyrosines 1131, 1135, and 1136 within the kinase domain; and tyrosine 1316 in the carboxyl-terminal domain."	0.584	SIGNOR-246264
SIGNOR-RMS	Rhabdomyosarcoma	SRC	protein	P12931	UNIPROT	IGF1R	protein	P08069	UNIPROT	"up-regulates activity"	phosphorylation	Tyr980	YASVNPEyFSAADVY	-1									8940173	t		lperfetto	"The insulin-like growth factor type I (IGF-I) receptor can become tyrosine phosphorylated and enzymatically activated either in response to ligand or because of the activity of the Src tyrosine kinaseWe mapped the sites of IGF-I receptor autophosphorylation to peptides representing three different receptor domains: tyrosines 943 and 950 in the juxtamembrane region; tyrosines 1131, 1135, and 1136 within the kinase domain; and tyrosine 1316 in the carboxyl-terminal domain."	0.584	SIGNOR-247197
SIGNOR-RMS	Rhabdomyosarcoma	SRC	protein	P12931	UNIPROT	IGF1R	protein	P08069	UNIPROT	"up-regulates activity"	phosphorylation	Tyr973	RLGNGVLyASVNPEY	-1									8940173	t		lperfetto	"The insulin-like growth factor type I (IGF-I) receptor can become tyrosine phosphorylated and enzymatically activated either in response to ligand or because of the activity of the Src tyrosine kinaseWe mapped the sites of IGF-I receptor autophosphorylation to peptides representing three different receptor domains: tyrosines 943 and 950 in the juxtamembrane region; tyrosines 1131, 1135, and 1136 within the kinase domain; and tyrosine 1316 in the carboxyl-terminal domain."	0.584	SIGNOR-247193
SIGNOR-RMS	Rhabdomyosarcoma	SRC	protein	P12931	UNIPROT	IGF1R	protein	P08069	UNIPROT	"up-regulates activity"	phosphorylation	Tyr1346	SFDERQPyAHMNGGR	-1									7493944	t		lperfetto	"The insulin-like growth factor type I (IGF-I) receptor can become tyrosine phosphorylated and enzymatically activated either in response to ligand or because of the activity of the Src tyrosine kinaseWe mapped the sites of IGF-I receptor autophosphorylation to peptides representing three different receptor domains: tyrosines 943 and 950 in the juxtamembrane region; tyrosines 1131, 1135, and 1136 within the kinase domain; and tyrosine 1316 in the carboxyl-terminal domain."	0.584	SIGNOR-246276
SIGNOR-RMS	Rhabdomyosarcoma	SRC	protein	P12931	UNIPROT	IGF1R	protein	P08069	UNIPROT	"up-regulates activity"	phosphorylation	Tyr1166	DIYETDYyRKGGKGL	-1									7493944	t		lperfetto	"The insulin-like growth factor type I (IGF-I) receptor can become tyrosine phosphorylated and enzymatically activated either in response to ligand or because of the activity of the Src tyrosine kinaseWe mapped the sites of IGF-I receptor autophosphorylation to peptides representing three different receptor domains: tyrosines 943 and 950 in the juxtamembrane region; tyrosines 1131, 1135, and 1136 within the kinase domain; and tyrosine 1316 in the carboxyl-terminal domain."	0.584	SIGNOR-246268
SIGNOR-RMS	Rhabdomyosarcoma	SRC	protein	P12931	UNIPROT	IGF1R	protein	P08069	UNIPROT	"up-regulates activity"	phosphorylation	Tyr1161	FGMTRDIyETDYYRK	-1									7493944	t		lperfetto	"The insulin-like growth factor type I (IGF-I) receptor can become tyrosine phosphorylated and enzymatically activated either in response to ligand or because of the activity of the Src tyrosine kinaseWe mapped the sites of IGF-I receptor autophosphorylation to peptides representing three different receptor domains: tyrosines 943 and 950 in the juxtamembrane region; tyrosines 1131, 1135, and 1136 within the kinase domain; and tyrosine 1316 in the carboxyl-terminal domain."	0.584	SIGNOR-246272
SIGNOR-RMS	Rhabdomyosarcoma	SRC	protein	P12931	UNIPROT	GAB1	protein	Q13480	UNIPROT	"up-regulates activity"	phosphorylation	Tyr627	KGDKQVEyLDLDLDS	9606	BTO:0000007								19881549	t		lperfetto	"Using both mutagenesis and mass spectrometry approaches, y242, y259, y317, y373 and y627 of gab1 were identified to be phosphorylated by c-src a gab1 mutant with substitutions of the src phosphorylation sites failed to promote hgf-induced dna synthesis"	0.709	SIGNOR-236302
SIGNOR-RMS	Rhabdomyosarcoma	SRC	protein	P12931	UNIPROT	GAB1	protein	Q13480	UNIPROT	"up-regulates activity"	phosphorylation	Tyr373	ASDTDSSyCIPTAGM	9606									19881549	t		lperfetto	"Using both mutagenesis and mass spectrometry approaches, y242, y259, y317, y373 and y627 of gab1 were identified to be phosphorylated by c-src a gab1 mutant with substitutions of the src phosphorylation sites failed to promote hgf-induced dna synthesis"	0.709	SIGNOR-236318
SIGNOR-RMS	Rhabdomyosarcoma	SRC	protein	P12931	UNIPROT	GAB1	protein	Q13480	UNIPROT	"up-regulates activity"	phosphorylation	Tyr317	PPTPGNTyQIPRTFP	9606	BTO:0000007								19881549	t		lperfetto	"Using both mutagenesis and mass spectrometry approaches, y242, y259, y317, y373 and y627 of gab1 were identified to be phosphorylated by c-src a gab1 mutant with substitutions of the src phosphorylation sites failed to promote hgf-induced dna synthesis"	0.709	SIGNOR-236306
SIGNOR-RMS	Rhabdomyosarcoma	SRC	protein	P12931	UNIPROT	GAB1	protein	Q13480	UNIPROT	"up-regulates activity"	phosphorylation	Tyr259	ASVDSSLyNLPRSYS	9606	BTO:0000007								19881549	t		lperfetto	"Using both mutagenesis and mass spectrometry approaches, y242, y259, y317, y373 and y627 of gab1 were identified to be phosphorylated by c-src a gab1 mutant with substitutions of the src phosphorylation sites failed to promote hgf-induced dna synthesis"	0.709	SIGNOR-236310
SIGNOR-TC	"Thyroid cancer"	SLC5A5	protein	Q92911	UNIPROT	iodide	smallmolecule	CHEBI:16382	ChEBI	"up-regulates activity"	"chemical activation"			9606									14623893	t		miannu	"Iodide is an essential element in thyroid physiology as a critical component of thyroxine and triiodothyronine molecules and a key regulator of thyroid gland function. The first step in iodide metabolism is represented by thyroid trapping, which is achieved by an active, energy-dependent transport process across the basolateral plasma membrane of the thyrocytes. The protein responsible for this process, the sodium/iodide symporter (NIS),1 is an intrinsic plasma membrane protein that mediates active transport of I- in the thyroid, lactating mammary gland, stomach, and salivary glands"	0.8	SIGNOR-251996
SIGNOR-TC	"Thyroid cancer"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	BRAF	protein	P15056	UNIPROT	down-regulates	phosphorylation	Ser364	FGQRDRSsSAPNVHI	9606									10869359	t		lperfetto	"We show that phosphorylation of b-raf by akt occurs at multiple residues within its amino terminal regulatory domain, at both the conserved and unique phosphorylation sites. Akt phosphorylated b-raf on s364 and s428 to inactivate its kinase activity b-raf contains three akt consensus sites, table i. One site, ser364 is conserved with c-raf;however, two sites, ser428 and thr439, are unique to b-raf"	0.2	SIGNOR-244152
SIGNOR-TC	"Thyroid cancer"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	BRAF	protein	P15056	UNIPROT	down-regulates	phosphorylation	Thr440	EDRNRMKtLGRRDSS	9606									10869359	t		lperfetto	"We show that phosphorylation of b-raf by akt occurs at multiple residues within its amino terminal regulatory domain, at both the conserved and unique phosphorylation sites. Akt phosphorylated b-raf on s364 and s428 to inactivate its kinase activity b-raf contains three akt consensus sites, table i. One site, ser364 is conserved with c-raf;however, two sites, ser428 and thr439, are unique to b-raf"	0.2	SIGNOR-244156
SIGNOR-TC	"Thyroid cancer"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	BRAF	protein	P15056	UNIPROT	down-regulates	phosphorylation	Ser428	GPQRERKsSSSSEDR	9606									10869359	t		lperfetto	"We show that phosphorylation of b-raf by akt occurs at multiple residues within its amino terminal regulatory domain, at both the conserved and unique phosphorylation sites. Akt phosphorylated b-raf on s364 and s428 to inactivate its kinase activity b-raf contains three akt consensus sites, table i. One site, ser364 is conserved with c-raf;however, two sites, ser428 and thr439, are unique to b-raf"	0.2	SIGNOR-244160
SIGNOR-TC	"Thyroid cancer"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	CTNNB1	protein	P35222	UNIPROT	"up-regulates activity"				9606									16293724	f		lperfetto	"We show that pge2 stimulates colon cancer cell growth through its heterotrimeric guanine nucleotide-binding protein (g protein) coupled receptor, ep2, by a signaling route that involves the activation of phosphoinositide 3-kinase and the protein kinase akt by free g protein bg subunits and the direct association of the g protein as subunit with the regulator of g protein signaling (rgs) domain of axin. This leads to the inactivation and release of glycogen synthase kinase 3b from its complex with axin, thereby relieving the inhibitory phosphorylation of b-catenin and activating its signaling pathway."	0.2	SIGNOR-244225
SIGNOR-TC	"Thyroid cancer"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	CTNNB1	protein	P35222	UNIPROT	up-regulates	phosphorylation	Ser552	QDTQRRTsMGGTQQQ	9606									17287208	t		lperfetto	"Phosphorylation of beta-catenin by akt promotes beta-catenin transcriptional activity|we have demonstrated that akt phosphorylates beta-catenin at ser552 in vitro and in vivo."	0.2	SIGNOR-244222
SIGNOR-TC	"Thyroid cancer"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	FOXO3	protein	O43524	UNIPROT	"down-regulates quantity by destabilization"	phosphorylation	Thr32	QSRPRSCtWPLQRPE										19951971	t		lperfetto	"AKT phosphorylates FOXO3a at three conserved sites (Thr32, Ser253 and Ser315), therefore creating binding sites for the 14-3-3 chaperone proteins and leading to the active export of FOXO3a to the cytoplasm where it is targeted for proteasomal degradation."	0.2	SIGNOR-249645
SIGNOR-TC	"Thyroid cancer"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	FOXO3	protein	O43524	UNIPROT	"down-regulates quantity by destabilization"	phosphorylation	Ser253	APRRRAVsMDNSNKY										19951971	t		lperfetto	"AKT phosphorylates FOXO3a at three conserved sites (Thr32, Ser253 and Ser315), therefore creating binding sites for the 14-3-3 chaperone proteins and leading to the active export of FOXO3a to the cytoplasm where it is targeted for proteasomal degradation."	0.2	SIGNOR-249646
SIGNOR-TC	"Thyroid cancer"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	FOXO3	protein	O43524	UNIPROT	"down-regulates quantity by destabilization"	phosphorylation	Ser315	DFRSRTNsNASTVSG										19951971	t		lperfetto	"AKT phosphorylates FOXO3a at three conserved sites (Thr32, Ser253 and Ser315), therefore creating binding sites for the 14-3-3 chaperone proteins and leading to the active export of FOXO3a to the cytoplasm where it is targeted for proteasomal degradation."	0.2	SIGNOR-249647
SIGNOR-TC	"Thyroid cancer"	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	Survival	phenotype	SIGNOR-PH13	SIGNOR	up-regulates				9606									16288293	f		miannu	"Akt promotes both cell growth and cell survival by inactivating its downstream substrates including GSK3, BAD, FOXO and TSC2."	0.7	SIGNOR-251550
SIGNOR-TC	"Thyroid cancer"	BRAF	protein	P15056	UNIPROT	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	"up-regulates activity"	phosphorylation			10090									8131746	t		lperfetto	"Activation of mek family kinases requires phosphorylation of two conserved ser/thr residueserine residues 218 and 222 of human mek1 are the primary sites for phosphorylation by c-raf."	0.787	SIGNOR-244827
SIGNOR-TC	"Thyroid cancer"	BRAF	protein	P15056	UNIPROT	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	up-regulates	phosphorylation			9606									8668348	t		lperfetto	"We show that, consequently, b-raf interacts with mek-1 and mek-2 with a better affinity than does c-raf-1, thus strengthening the notion that b-raf is a stronger mek activator than c-raf-l."	0.787	SIGNOR-244843
SIGNOR-TC	"Thyroid cancer"	BRAF	protein	P15056	UNIPROT	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	"up-regulates activity"	phosphorylation			-1									8413257	t		lperfetto	"Raf-1 phosphorylation of MEK activated it, as judged by its ability to stimulate the phosphorylation of myelin basic protein by glutathione S-transferase-ERK1."	0.787	SIGNOR-244831
SIGNOR-TC	"Thyroid cancer"	BRAF	protein	P15056	UNIPROT	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	"up-regulates activity"	phosphorylation			9606									21900390	t		miannu	"BRAFV600E has been shown to initiate thyroid follicular cell transformation. The BRAFV600E mutation disrupts the hydrophobic interaction, enabling the BRAF kinase to fold into a catalytically active formation, resulting in an almost 500-fold increase in kinase activity. Mutant BRAF can dimerize and activate MEK without Ras activation."	0.787	SIGNOR-251988
SIGNOR-TC	"Thyroid cancer"	BRAF	protein	P15056	UNIPROT	SLC5A5	protein	Q92911	UNIPROT	"down-regulates quantity by repression"	"transcriptional regulation"			9606									19861538	t		miannu	"The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer.  BRAF induces TGFβ secretion leading to NIS repression in a MEK-ERK–independent manner but cooperating with the MEK-ERK pathway to induce strong tumor invasion, two major traits acquired during PTC progression."	0.2	SIGNOR-251989
SIGNOR-TC	"Thyroid cancer"	BRAF	protein	P15056	UNIPROT	TGFB1	protein	P01137	UNIPROT	"up-regulates quantity"	relocalization			9606									19861538	f		miannu	"The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer.  BRAF induces TGFβ secretion leading to NIS repression in a MEK-ERK–independent manner but cooperating with the MEK-ERK pathway to induce strong tumor invasion, two major traits acquired during PTC progression."	0.249	SIGNOR-251987
SIGNOR-TC	"Thyroid cancer"	CCDC6-RET	"fusion protein"	SIGNOR-FP9	SIGNOR	SHC1	protein	P29353	UNIPROT	"up-regulates activity"	binding			9606									16946010	t		miannu	"RET/PTC is tumorigenic in thyroid follicular cells; it transforms thyroid cells in culture and gives rise to thyroid carcinomas in transgenic mice. effects of RET/PTC activation require signaling along the MAPK pathway and, more specifically, the presence of the functional BRAF kinase. all breakpoints in the RET gene occur within intron 11, leaving intact the TK domain of the receptor and enabling the RET/PTC oncoprotein to bind SHC via Y1062 and activate the RAS-RAF-MAPK cascade"	0.2	SIGNOR-251986
SIGNOR-TC	"Thyroid cancer"	CTNNB1	protein	P35222	UNIPROT	MYC	protein	P01106	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			9606									16510874	f		gcesareni	"Beta-cat promotes h3k4 trimethylation at the c-myc gene in vivo. H3k4 trimethylation in vivo requires prior ubiquitination of h2b, and we find that ubiquitin is necessary for transcription initiation on chromatin but not nonchromatin templates in vitro.Chromatin Immunoprecipitation experiments reveal that beta-cat recruits pygopus, bcl-9/legless, and mll/set1-type complexes to the c-myc enhancertogether with the negative wnt regulators, apc, and betatrcp."	0.75	SIGNOR-19153
SIGNOR-TC	"Thyroid cancer"	CTNNB1	protein	P35222	UNIPROT	PPARG	protein	P37231	UNIPROT	down-regulates				9606	BTO:0000222								10937998	f		fspada	"Wnt-10b, is a molecular switch that governs adipogenesis. Wnt signaling maintains preadipocytes in an undifferentiated state through inhibition of the adipogenic transcription factors ccaat/enhancer binding protein alpha (c/ebpalpha) and peroxisome proliferator- activated receptor gamma (ppargamma)."	0.537	SIGNOR-80592
SIGNOR-TC	"Thyroid cancer"	ELE1-RET	"fusion protein"	SIGNOR-FP10	SIGNOR	SHC1	protein	P29353	UNIPROT	"up-regulates activity"	binding			9606									16946010	t		miannu	"RET/PTC is tumorigenic in thyroid follicular cells; it transforms thyroid cells in culture and gives rise to thyroid carcinomas in transgenic mice. effects of RET/PTC activation require signaling along the MAPK pathway and, more specifically, the presence of the functional BRAF kinase. all breakpoints in the RET gene occur within intron 11, leaving intact the TK domain of the receptor and enabling the RET/PTC oncoprotein to bind SHC via Y1062 and activate the RAS-RAF-MAPK cascade"	0.2	SIGNOR-251985
SIGNOR-TC	"Thyroid cancer"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	BRAF	protein	P15056	UNIPROT	down-regulates	phosphorylation	Thr401	STTGLSAtPPASLPG	9606									21135229	t		lperfetto	"We show that b-raf is a calcineurin substrate;among calcineurin target residues on b-raf is t401, a site of negative feedback phosphorylation by erk1/2. Blocking calcineurin activity in _ cells prevents dephosphorylation of b-raf t401 and decreases b-raf and erk1/2 activities."	0.2	SIGNOR-170339
SIGNOR-TC	"Thyroid cancer"	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	PPARG	protein	P37231	UNIPROT	"up-regulates quantity by expression"	phosphorylation			10090	BTO:0000011								12270934	t		lperfetto	"Our results suggest that activation of the MEK/ERK signaling pathway during the initial 12 h of adipogenesis enhances the activity of factors that regulate both C/EBPalpha and PPARgamma expression."	0.2	SIGNOR-235334
SIGNOR-TC	"Thyroid cancer"	FOXO3	protein	O43524	UNIPROT	Apoptosis	phenotype	SIGNOR-PH2	SIGNOR	up-regulates				9606	BTO:0000007								14976264	f		lperfetto	"Sirt1 inhibited foxo3's ability to induce cell death."	0.7	SIGNOR-217887
SIGNOR-TC	"Thyroid cancer"	GRB2	protein	P62993	UNIPROT	SOS1	protein	Q07889	UNIPROT	"up-regulates activity"	relocalization			10090	BTO:0000669								23452850	t	"GRB2 associated guanine nucleotide exchange factor Sos activates Ras through the exchange of GDP for GTP"	lperfetto	"Interaction domains of sos1/grb2 are finely tuned for cooperative control of embryonic stem cell fate."	0.914	SIGNOR-235773
SIGNOR-TC	"Thyroid cancer"	GRB2	protein	P62993	UNIPROT	SOS1	protein	Q07889	UNIPROT	"up-regulates activity"	relocalization			9606									8479541	t	"GRB2 associated guanine nucleotide exchange factor Sos activates Ras through the exchange of GDP for GTP"	lperfetto	"Furthermore, our results indicate that the interaction domains of sos1 and grb2 have evolved so as to bind ligands not with maximal strength but with specificities and affinities that maintain cooperativity. Grb2 binds and activates sos, which then activates ras, and this activates p110 independently of p85."	0.914	SIGNOR-39163
SIGNOR-TC	"Thyroid cancer"	"Ionizing radiation"	stimulus	SIGNOR-ST16	SIGNOR	CCDC6-RET	"fusion protein"	SIGNOR-FP9	SIGNOR	up-regulates				9606									23128507	f		miannu	"In PTC, genomic rearrangements juxtapose the RET tyrosine kinase domain to unrelated genes, thereby creating dominantly transforming oncogenes, denominated RET/PTC. The RET/PTC rearrangements are the 2nd most common genetic alteration described in PTC and observed in ∼13–43% of cases, mostly in pediatric cancers or in individuals exposed to ionizing radiation from nuclear accidents"	0.7	SIGNOR-251999
SIGNOR-TC	"Thyroid cancer"	"Ionizing radiation"	stimulus	SIGNOR-ST16	SIGNOR	ELE1-RET	"fusion protein"	SIGNOR-FP10	SIGNOR	up-regulates				9606									23128507	f		miannu	"In PTC, genomic rearrangements juxtapose the RET tyrosine kinase domain to unrelated genes, thereby creating dominantly transforming oncogenes, denominated RET/PTC. The RET/PTC rearrangements are the 2nd most common genetic alteration described in PTC and observed in ∼13–43% of cases, mostly in pediatric cancers or in individuals exposed to ionizing radiation from nuclear accidents"	0.7	SIGNOR-251984
SIGNOR-TC	"Thyroid cancer"	KRAS	protein	P01116	UNIPROT	BRAF	protein	P15056	UNIPROT	"up-regulates activity"	binding			9606									21779497	t		miannu	"The raf family of proteins (raf-1, a-raf, and b-raf) is serine/threonine kinases that bind to the effector region of ras-gtp, thus inducing translocation of the protein to the plasma membrane. Once there, raf proteins are activated and phosphorylated by different protein kinases."	0.878	SIGNOR-156906
SIGNOR-TC	"Thyroid cancer"	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	ERK1/2	proteinfamily	SIGNOR-PF1	SIGNOR	up-regulates	phosphorylation			9606									11971971	t		lperfetto	"Mapk1 is phosphorylated by map2k1/mek1 and map2k2/mek2 on thr-185 and tyr-187 in response to external stimuli like insulin or ngf. Both phosphorylations are required for activity."	0.758	SIGNOR-244776
SIGNOR-TC	"Thyroid cancer"	MYC	protein	P01106	UNIPROT	Proliferation	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									9552384	f		gcesareni	"C-myc has emerged as one of the central regulators of mammalian cell proliferation."	0.7	SIGNOR-56572
SIGNOR-TC	"Thyroid cancer"	PDPK1	protein	O15530	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation	Thr308	KDGATMKtFCGTPEY	9606		BTO:0000887;BTO:0001103;BTO:0001760							9512493	t		lperfetto	"The activation of PKBbeta and PKBamma by PDK11 was accompanied by the phosphorylation of the residues equivalent to Thr308 in PKBalpha, namely Thr309 (PKBbeta) and Thr305 (PKBgamma)"	0.746	SIGNOR-244480
SIGNOR-TC	"Thyroid cancer"	PDPK1	protein	O15530	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation	Thr308	KDGATMKtFCGTPEY	10116		BTO:0000142							10226025	t		lperfetto	"Protein kinase B (PKB) is activated by phosphorylation of Thr308 and of Ser473. Thr308 is phosphorylated by the 3-phosphoinositide-dependent protein kinase-1 (PDK1) but the identity of the kinase that phosphorylates Ser473 (provisionally termed PDK2) is unknown."	0.746	SIGNOR-244421
SIGNOR-TC	"Thyroid cancer"	PDPK1	protein	O15530	UNIPROT	AKT	proteinfamily	SIGNOR-PF24	SIGNOR	"up-regulates activity"	phosphorylation			9606									15743829	t		lperfetto	"3-phosphoinositide-dependent kinase 1 (PDK1) phosphorylates the activation loop of a number of protein serine/threonine kinases of the AGC kinase superfamily, including protein kinase B (PKB; also called Akt),"	0.746	SIGNOR-244469
SIGNOR-TC	"Thyroid cancer"	PDPK1	protein	O15530	UNIPROT	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	"up-regulates activity"	phosphorylation			9606	BTO:0000007								15175348	t		lperfetto	"In vitro kinase assay revealed that the direct targets of pdk1 in the mapk pathway were the upstream mapk kinases mek1 and mek2. The identified pdk1 phosphorylation sites in mek1 and mek2 are ser222 and ser226, respectively, and are known to be essential for full activation"	0.272	SIGNOR-244934
SIGNOR-TC	"Thyroid cancer"	PDPK1	protein	O15530	UNIPROT	MEK1/2	proteinfamily	SIGNOR-PF25	SIGNOR	up-regulates	phosphorylation			9606									15175348	t		lperfetto	"The identified pdk1 phosphorylation sites in mek1 and mek2 are ser222 and ser226, respectively, and are known to be essential for full activation."	0.272	SIGNOR-244938
SIGNOR-TC	"Thyroid cancer"	PPARG	protein	P37231	UNIPROT	CTNNB1	protein	P35222	UNIPROT	"down-regulates quantity by repression"	"transcriptional regulation"			9606									20303941	f		gcesareni	"The results from mammalian one-hybrid experiments showed that functional ppar gamma was necessary for ligand-dependent inhibition of beta-catenin transactivation."	0.537	SIGNOR-164516
SIGNOR-TC	"Thyroid cancer"	PPARG	protein	P37231	UNIPROT	PTEN	protein	P60484	UNIPROT	"down-regulates activity"				9606									23128507	t	"PAX8-PPARγ fusion protein"	miannu	"The PAX8-PPARγ rearrangement leads to strong induction of the PPARγ protein and the consequent abrogation of the normal PPARγ function. PPARγ overexpression abolishes the PTEN-inhibitory effect on immunoactive AKT, which in turn induces the PI3K signaling pathway."	0.458	SIGNOR-251997
SIGNOR-TC	"Thyroid cancer"	PTEN	protein	P60484	UNIPROT	PIP3	smallmolecule	CHEBI:16618	ChEBI	"down-regulates quantity"	"chemical modification"			9606									11875759	t		lperfetto	"PTEN dephosphorylates PI3P, lowering its cellular levels and resulting in the down-regulation of AKT."	0.8	SIGNOR-228145
SIGNOR-TC	"Thyroid cancer"	PIP3	smallmolecule	CHEBI:16618	ChEBI	PDPK1	protein	O15530	UNIPROT	"up-regulates activity"	relocalization			9606									21798082	t		lperfetto	"Pip3 acts in turn as a docking site for two kinases, phosphoinositide-dependent kinase 1 (PDK1) and AKT, and the subsequent phosphorylation of AKT at serine 308 by PDK1, leading to AKT activation."	0.8	SIGNOR-175253
SIGNOR-TC	"Thyroid cancer"	PIP3	smallmolecule	CHEBI:16618	ChEBI	PDPK1	protein	O15530	UNIPROT	"up-regulates activity"	relocalization			9534									9637919	t		lperfetto	"In response to PDGF, binding of ptdlns (3,4,5)p3 and/or ptdlns(3,4)p2 to the PH domain of PDK-1 causes its translocation to the plasma membrane where it co-localises with PKB, significantly contributing to the scale of PKB activation."	0.8	SIGNOR-58313
SIGNOR-TC	"Thyroid cancer"	PIP3	smallmolecule	CHEBI:16618	ChEBI	PDPK1	protein	O15530	UNIPROT	"up-regulates activity"	"chemical activation"			-1									9094314	t		gcesareni	"We tested the kinase in the presence of several inositol phospholipids and found that only low micromolar concentrations of the D enantiomers of either phosphatidylinositol 3,4,5-triphosphate (PtdIns(3,4,5)P3) or PtdIns(3,4)P2 were effective in potently activating the kinase, which has been named PtdIns(3,4,5)P3-dependent protein kinase-1 (PDK1)"	0.8	SIGNOR-243274
SIGNOR-TC	"Thyroid cancer"	RET	protein	P07949	UNIPROT	PDPK1	protein	O15530	UNIPROT	"up-regulates activity"	phosphorylation	Tyr9	ARTTSQLyDAVPIQS	10029									12738763	t		lperfetto	"Ret/ptc (rearranged in transformation/papillary thyroid carcinomas) tyrosine kinase phosphorylates and activates phosphoinositide-dependent kinase 1 (pdk1)  ret/ptc phosphorylates a specific tyrosine (y9) residue located in the n-terminal region of pdk1."	0.2	SIGNOR-235863
SIGNOR-TC	"Thyroid cancer"	RET	protein	P07949	UNIPROT	SHC1	protein	P29353	UNIPROT	up-regulates	binding			9606									8183561	t		gcesareni	"We have shown that the sh2 domain of the adaptor protein shc coimmunoprecipitates with all the ret."	0.659	SIGNOR-36902
SIGNOR-TC	"Thyroid cancer"	SHC1	protein	P29353	UNIPROT	GRB2	protein	P62993	UNIPROT	up-regulates	binding			10090	BTO:0005065								17673906	t		lperfetto	"TGF-beta-induced ShcA phosphorylation induces ShcA association with Grb2 and Sos, thereby initiating the well-characterised pathway linking receptor tyrosine kinases with Erk MAP kinases."	0.965	SIGNOR-236366
SIGNOR-TC	"Thyroid cancer"	SHC1	protein	P29353	UNIPROT	GRB2	protein	P62993	UNIPROT	up-regulates	binding			9606	BTO:0000776								10207047	t		lperfetto	"The results indicate that ship, shc, and grb2 form a ternary complex in stimulated b cells, with grb2 stabilizing the interaction between shc and ship. The interactions between shc, grb2, and ship are therefore analogous to the interactions between shc, grb2, and sos. Shc and grb2 may help to localize ship to the cell membrane, regulating ship's inhibitory function following bcr stimulation."	0.965	SIGNOR-235881
SIGNOR-TC	"Thyroid cancer"	SHC1	protein	P29353	UNIPROT	GRB2	protein	P62993	UNIPROT	up-regulates	binding			9606	BTO:0000782;BTO:0001271;BTO:0000785								24737791	t		lperfetto	"The signaling mechanism utilizes an adaptor protein, shc, which binds to a phosphotyrosine residue on the il-2/15r?, Resulting in activation of grb2 and onto akt via the shc-grb2-gab2-pi3k-akt signaling pathway to increase cell proliferation and/or survival"	0.965	SIGNOR-236236
SIGNOR-TC	"Thyroid cancer"	SHC1	protein	P29353	UNIPROT	SOS1	protein	Q07889	UNIPROT	up-regulates	binding			10090	BTO:0005065								17673906	t		lperfetto	"TGF-beta-induced ShcA phosphorylation induces ShcA association with Grb2 and Sos, thereby initiating the well-characterised pathway linking receptor tyrosine kinases with Erk MAP kinases."	0.774	SIGNOR-236363
SIGNOR-TC	"Thyroid cancer"	TSHB	protein	P01222	UNIPROT	SLC5A5	protein	Q92911	UNIPROT	"up-regulates quantity by stabilization"				9606									14623893	f		miannu	"Uptake is stimulated by TSH, the master hormone for thyroid gland regulation. TSH stimulation results, at least in part, from the cAMP-mediated increase in NIS biosynthesis. TSH not only stimulates NIS transcription and biosynthesis but is also required for modulating the NIS phosphorylation pattern, maintaining its half-life, and retaining NIS at the thyrocyte plasma membrane"	0.382	SIGNOR-251994
SIGNOR-TC	"Thyroid cancer"	TSHB	protein	P01222	UNIPROT	SLC5A5	protein	Q92911	UNIPROT	"up-regulates quantity by expression"	"transcriptional regulation"			9606									14623893	t		miannu	"Iâ€“ uptake is stimulated by TSH, the master hormone for thyroid gland regulation. TSH stimulation results, at least in part, from the cAMP-mediated increase in NIS biosynthesis. TSH not only stimulates NIS transcription and biosynthesis but is also required for modulating the NIS phosphorylation pattern, maintaining its half-life, and retaining NIS at the thyrocyte plasma membrane"	0.382	SIGNOR-251995
SIGNOR-TC	"Thyroid cancer"	TGFB1	protein	P01137	UNIPROT	TGFBR1	protein	P36897	UNIPROT	"up-regulates activity"	binding			9606									22703233	t		lperfetto	"TGFbeta signals are transmitted via a cell surface receptor complex consisting of the TGFbeta type I receptor (TbetaRI) and TGFbeta type II receptor (TbetaRII). To initiate signal transduction, TGFbeta binds to TbetaRII, which in turn recruits TbetaRI, leading to the formation of a tetrameric receptor complex."	0.846	SIGNOR-249548
SIGNOR-TC	"Thyroid cancer"	TGFBR1	protein	P36897	UNIPROT	SHC1	protein	P29353	UNIPROT	up-regulates	phosphorylation			10090	BTO:0005065								17673906	t		lperfetto	"We now report that upon TGF-_ stimulation, T_RI phosphorylates ShcA on serine and, to a lesser degree, on tyrosine to activate Erk MAP kinases."	0.552	SIGNOR-227503
SIGNOR-TC	"Thyroid cancer"	TGFB1	protein	P01137	UNIPROT	SLC5A5	protein	Q92911	UNIPROT	"down-regulates quantity by repression"	"transcriptional regulation"			9606									14623893	f		miannu	"The sodium/iodide symporter mediates the active transport of iodide in thyroid follicular cells.  A number of agents regulate NIS expression; among these, TGF-β is a potent inhibitor of both iodide uptake  and NIS gene expression"	0.2	SIGNOR-259912
SIGNOR-TC	"Thyroid cancer"	iodide	smallmolecule	CHEBI:16382	ChEBI	3,5-diiodo-L-tyrosine	smallmolecule	CHEBI:15768	ChEBI	"up-regulates quantity"	"precursor of"			9606									23349248	t		miannu	"After transport through the apical membrane, I‚àí is covalently bound to the tyrosyl residues of Tg by thyroid peroxidase (TPO)."	0.8	SIGNOR-259913
SIGNOR-TC	"Thyroid cancer"	TPO	protein	P07202	UNIPROT	TG	protein	P01266	UNIPROT	"up-regulates activity"	"catalytic activity"			9606									23349248	t		miannu	"After transport through the apical membrane, I− is covalently bound to the tyrosyl residues of Tg by thyroid peroxidase (TPO)."	0.507	SIGNOR-259914
SIGNOR-TC	"Thyroid cancer"	TG	protein	P01266	UNIPROT	Thyroid_hormonogenesis	phenotype	SIGNOR-PH110	SIGNOR	up-regulates				9606		BTO:0004710							30886364	f		miannu	"In humans, the thyroid hormones T3 and T4 are synthesized in the thyroid gland in a process that crucially involves the iodoglycoprotein thyroglobulin. The overall structure of thyroglobulin is conserved in all vertebrates. Upon thyroglobulin delivery from thyrocytes to the follicular lumen of the thyroid gland via the secretory pathway, multiple tyrosine residues can become iodinated to form mono-iodotyrosine (MIT) and/or di-iodotyrosine (DIT); however, selective tyrosine residues lead to preferential formation of T4 and T3 at distinct sites."	0.7	SIGNOR-259915
SIGNOR-TC	"Thyroid cancer"	SOS1	protein	Q07889	UNIPROT	KRAS	protein	P01116	UNIPROT	up-regulates	"guanine nucleotide exchange factor"			9606									25624485	t	"Ras proteins bind GDP/GTP and possess intrinsic GTPase activity."	gcesareni	"Because the KRAS-GDP to KRAS-GTP transition catalyzed by the GEF, son of sevenless 1 (SOS1), represents the rate-limiting step for nucleotide exchange, disrupting the activating SOS1/KRAS protein interaction has also been the focus of drug development efforts"	0.829	SIGNOR-122075
SIGNOR-TC	"Thyroid cancer"	SOS1	protein	Q07889	UNIPROT	KRAS	protein	P01116	UNIPROT	up-regulates	"guanine nucleotide exchange factor"			9606									25624485	t	"Ras proteins bind GDP/GTP and possess intrinsic GTPase activity."	gcesareni	"Because the KRAS-GDP to KRAS-GTP transition catalyzed by the GEF, son of sevenless 1 (SOS1), represents the rate-limiting step for nucleotide exchange, disrupting the activating SOS1/KRAS protein interaction has also been the focus of drug development efforts"	0.829	SIGNOR-141647
SIGNOR-TC	"Thyroid cancer"	SOS1	protein	Q07889	UNIPROT	KRAS	protein	P01116	UNIPROT	up-regulates	"guanine nucleotide exchange factor"			9606									25624485	t	"Ras proteins bind GDP/GTP and possess intrinsic GTPase activity."	gcesareni	"Because the KRAS-GDP to KRAS-GTP transition catalyzed by the GEF, son of sevenless 1 (SOS1), represents the rate-limiting step for nucleotide exchange, disrupting the activating SOS1/KRAS protein interaction has also been the focus of drug development efforts"	0.829	SIGNOR-175256
SIGNOR-TC	"Thyroid cancer"	iodide	smallmolecule	CHEBI:16382	ChEBI	TPO	protein	P07202	UNIPROT	"up-regulates activity"	"chemical activation"			9606		BTO:0004708							23349248	t		miannu	"After transport through the apical membrane, Iodide is covalently bound to the tyrosyl residues of Tg by thyroid peroxidase (TPO)."	0.8	SIGNOR-268139
